Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
GRCh38/hg38 2p25.3-22.3(chr2:12770-33711509)x3	LOC126806103|LOC126806104|LOC126806105|LOC126806106|LOC126806107|LOC126806108|LOC126806109|LOC126806110|LOC126806111|LOC126806112|LOC126806113|LOC126806114|LOC126806115|LOC126806116|LOC126806117|LOC126806118|LOC126806119|LOC126806120|LOC126806121|LOC126806122|LOC126806123|LOC126806124|LOC126806125|LOC126806126|LOC126806127|LOC126806128|LOC126806129|LOC126806130|LOC126806131|LOC126806132|LOC126806133|LOC126806134|LOC126806135|LOC126806136|LOC126806137|LOC126806138|LOC126806139|LOC126806140|LOC126806141|LOC126806142|LOC126806143|LOC126806144|LOC126806145|LOC126806146|LOC126806147|LOC126806148|LOC126806149|LOC126806150|LOC126806151|LOC126806152|LOC126806153|LOC126806154|LOC126806155|LOC126806156|LOC126806157|LOC126806158|LOC126806159|LOC126806160|LOC126806161|LOC126806162|LOC126806163|LOC126806164|LOC126806165|LOC126806166|LOC126806167|LOC126806168|LOC126806169|LOC126806170|LOC126806171|LOC126806172|LOC126806173|LOC126806174|LOC126806175|LOC126806176|LOC126806177|LOC126806178|LOC126806179|LOC126806180|LOC126806181|LOC126806182|LOC126806183|LOC126806184|LOC128772246|LOC128772247|LOC128772248|LOC128772249|LOC128772250|LOC128772251|LOC128772252|LOC128772253|LOC128897170|LOC128897171|LOC129388814|LOC129388815|LOC129388816|LOC129388817|LOC129388818|LOC129388819|LOC129388820|LOC129388821|LOC129388822|LOC129388823|LOC129388824|LOC129388825|LOC129388826|LOC129388827|LOC129388828|LOC129388829|LOC129388830|LOC129388831|LOC129388832|LOC129388833|LOC129388834|LOC129388835|LOC129388836|LOC129388837|LOC129388838|LOC129388839|LOC129388840|LOC129456127|LOC129932973|LOC129932974|LOC129932975|LOC129932976|LOC129932977|LOC129932978|LOC129932979|LOC129932980|LOC129932981|LOC129932982|LOC129932983|LOC129932984|LOC129932985|LOC129932986|LOC129932987|LOC129932988|LOC129932989|LOC129932990|LOC129932991|LOC129932992|LOC129932993|LOC129932994|LOC129932995|LOC129932996|LOC129932997|LOC129932998|LOC129932999|LOC129933000|LOC129933001|LOC129933002|LOC129933003|LOC129933004|LOC129933005|LOC129933006|LOC129933007|LOC129933008|LOC129933009|LOC129933010|LOC129933011|LOC129933012|LOC129933013|LOC129933014|LOC129933015|LOC129933016|LOC129933017|LOC129933018|LOC129933019|LOC129933020|LOC129933021|LOC129933022|LOC129933023|LOC129933024|LOC129933025|LOC129933026|LOC129933027|LOC129933028|LOC129933029|LOC129933030|LOC129933031|LOC129933032|LOC129933033|LOC129933034|LOC129933035|LOC129933036|LOC129933037|LOC129933038|LOC129933039|LOC129933040|LOC129933041|LOC129933042|LOC129933043|LOC129933044|LOC129933045|LOC129933046|LOC129933047|LOC129933048|LOC129933049|LOC129933050|LOC129933051|LOC129933052|LOC129933053|LOC129933054|LOC129933055|LOC129933056|LOC129933057|LOC129933058|LOC129933059|LOC129933060|LOC129933061|LOC129933062|LOC129933063|LOC129933064|LOC129933065|LOC129933066|LOC129933067|LOC129933068|LOC129933069|LOC129933070|LOC129933071|LOC129933072|LOC129933073|LOC129933074|LOC129933075|LOC129933076|LOC129933077|LOC129933078|LOC129933079|LOC129933080|LOC129933081|LOC129933082|LOC129933083|LOC129933084|LOC129933085|LOC129933086|LOC129933087|LOC129933088|LOC129933089|LOC129933090|LOC129933091|LOC129933092|LOC129933093|LOC129933094|LOC129933095|LOC129933096|LOC129933097|LOC129933098|LOC129933099|LOC129933100|LOC129933101|LOC129933102|LOC129933103|LOC129933104|LOC129933105|LOC129933106|LOC129933107|LOC129933108|LOC129933109|LOC129933110|LOC129933111|LOC129933112|LOC129933113|LOC129933114|LOC129933115|LOC129933116|LOC129933117|LOC129933118|LOC129933119|LOC129933120|LOC129933121|LOC129933122|LOC129933123|LOC129933124|LOC129933125|LOC129933126|LOC129933127|LOC129933128|LOC129933129|LOC129933130|LOC129933131|LOC129933132|LOC129933133|LOC129933134|LOC129933135|LOC129933136|LOC129933137|LOC129933138|LOC129933139|LOC129933140|LOC129933141|LOC129933142|LOC129933143|LOC129933144|LOC129933145|LOC129933146|LOC129933147|LOC129933148|LOC129933149|LOC129933150|LOC129933151|LOC129933152|LOC129933153|LOC129933154|LOC129933155|LOC129933156|LOC129933157|LOC129933158|LOC129933159|LOC129933160|LOC129933161|LOC129933162|LOC129933163|LOC129933164|LOC129933165|LOC129933166|LOC129933167|LOC129933168|LOC129933169|LOC129933170|LOC129933171|LOC129933172|LOC129933173|LOC129933174|LOC129933175|LOC129933176|LOC129933177|LOC129933178|LOC129933179|LOC129933180|LOC129933181|LOC129933182|LOC129933183|LOC129933184|LOC129933185|LOC129933186|LOC129933187|LOC129933188|LOC129933189|LOC129933190|LOC129933191|LOC129933192|LOC129933193|LOC129933194|LOC129933195|LOC129933196|LOC129933197|LOC129933198|LOC129933199|LOC129933200|LOC129933201|LOC129933202|LOC129933203|LOC129933204|LOC129933205|LOC129933206|LOC129933207|LOC129933208|LOC129933209|LOC129933210|LOC129933211|LOC129933212|LOC129933213|LOC129933214|LOC129933215|LOC129933216|LOC129933217|LOC129933218|LOC129933219|LOC129933220|LOC129933221|LOC129933222|LOC129933223|LOC129933224|LOC129933225|LOC129933226|LOC129933227|LOC129933228|LOC129933229|LOC129933230|LOC129933231|LOC129933232|LOC129933233|LOC129933234|LOC129933235|LOC129933236|LOC129933237|LOC129933238|LOC129933239|LOC129933240|LOC129933241|LOC129933242|LOC129933243|LOC129933244|LOC129933245|LOC129933246|LOC129933247|LOC129933248|LOC129933249|LOC129933250|LOC129933251|LOC129933252|LOC129933253|LOC129933254|LOC129933255|LOC129933256|LOC129933257|LOC129933258|LOC129933259|LOC129933260|LOC129933261|LOC129933262|LOC129933263|LOC129933264|LOC129933265|LOC129933266|LOC129933267|LOC129933268|LOC129933269|LOC129933270|LOC129933271|LOC129933272|LOC129933273|LOC129933274|LOC129933275|LOC129933276|LOC129933277|LOC129933278|LOC129933279|LOC129933280|LOC129933281|LOC129933282|LOC129933283|LOC129933284|LOC129933285|LOC129933286|LOC129933287|LOC129933288|LOC129933289|LOC129933290|LOC129933291|LOC129933292|LOC129933293|LOC129933294|LOC129933295|LOC129933296|LOC129933297|LOC129933298|LOC129933299|LOC129933300|LOC129933301|LOC129933302|LOC129933303|LOC129933304|LOC129933305|LOC129933306|LOC129933307|LOC129933308|LOC129933309|LOC129933310|LOC129933311|LOC129933312|LOC129933313|LOC129933314|LOC129933315|LOC129933316|LOC129933317|LOC129933318|LOC129933319|LOC129933320|LOC129933321|LOC129933322|LOC129933323|LOC129933324|LOC129933325|LOC129933326|LOC129933327|LOC129933328|LOC129933329|LOC129933330|LOC129933331|LOC129933332|LOC129933333|LOC129933334|LOC129933335|LOC129933336|LOC129933337|LOC129933338|LOC129933339|LOC129933340|LOC129933341|LOC129933342|LOC129933343|LOC129933344|LOC129933345|LOC129933346|LOC129933347|LOC129933348|LOC129933349|LOC129933350|LOC129933351|LOC129933352|LOC129933353|LOC129933354|LOC129933355|LOC129933356|ABHD1|ACP1|ADAM17|ADCY3|ADGRF3|ADI1|AGBL5|AGBL5-AS1|ALK|ALKAL2|ALLC|APOB|APOB-ICR|APOB3'MAR|ASAP2|ASXL2|ATAD2B|ATP6V1C2|ATRAID|BABAM2|BABAM2-AS1|BIRC6|BIRC6-AS2|C2orf48|CAD|CAPN13|CAPN14|CCDC121|CENPA|CENPO|CGREF1|CIB4|CIMIP2C|CIMIP5|CLIP4|CMPK2|COLEC11|CPSF3|CYRIA|CYS1|DCDC2C|DDX1|DNAJC27|DNAJC27-AS1|DNAJC5G|DNMT3A|DPY30|DPYSL5|DRC1|DTNB|DTNB-AS1|E2F6|EFR3B|EHD3|EIF2B4|EIPR1|EMILIN1|FAM110C|FAM228A|FAM228B|FAM98A|FKBP1B|FLJ33534|FNDC4|FOSL2|FOSL2-AS1|GACAT3|GALNT14|GAREM2|GCKR|GDF7|GEN1|GPN1|GRASLND|GREB1|GRHL1|GTF3C2|GTF3C2-AS1|GTF3C2-AS2|HADHA|HADHB|HPCAL1|HS1BP3|HS1BP3-IT1|IAH1|ID2|ID2-AS1|IFT172|ITGB1BP1|ITSN2|KCNF1|KCNK3|KCNS3|KHK|KIDINS220|KIF3C|KLF11|KLF11-DT|KLHL29|KRTCAP3|LAPTM4A|LAPTM4A-DT|LBH|LCLAT1|LDAH|LINC00276|LINC00298|LINC00299|LINC00486|LINC00487|LINC00570|LINC00954|LINC01115|LINC01246|LINC01247|LINC01248|LINC01249|LINC01250|LINC01304|LINC01317|LINC01376|LINC01381|LINC01460|LINC01804|LINC01808|LINC01810|LINC01814|LINC01822|LINC01830|LINC01865|LINC01871|LINC01874|LINC01875|LINC01884|LINC01936|LINC01939|LINC01946|LINC01954|LINC02850|LINC02923|LOC100271832|LOC100505716|LOC100505736|LOC100505774|LOC100506274|LOC100506405|LOC100506474|LOC100507562|LOC100996637|LOC101928196|LOC101929452|LOC101929551|LOC101929752|LOC102723530|LOC102723730|LOC105373346|LOC105373352|LOC105373390|LOC105373394|LOC105373414|LOC105373418|LOC105373438|LOC105373461|LOC105374378|LOC105374389|LOC106560211|LOC106728414|LOC107985792|LOC107985856|LOC108167315|LOC108281152|LOC110120665|LOC110121045|LOC110121085|LOC110121127|LOC110121131|LOC110121308|LOC111556161|LOC111811968|LOC111828513|LOC112806042|LOC112806072|LOC112840907|LOC112840916|LOC112840917|LOC112840921|LOC112840922|LOC112840923|LOC112840924|LOC112840925|LOC112840926|LOC112841600|LOC112841604|LOC112841605|LOC114004370|LOC114004371|LOC115804257|LOC115804258|LOC115804259|LOC115804260|LOC115804261|LOC115945147|LOC120961741|LOC120961742|LOC120961743|LOC121725077|LOC121725078|LOC121725079|LOC121725080|LOC121725081|LOC121725082|LOC121725083|LOC121725084|LOC121725085|LOC121725086|LOC121725087|LOC122710286|LOC122710287|LOC122710288|LOC122710289|LOC122756371|LOC122756372|LOC122756373|LOC122756374|LOC122756375|LOC122756376|LOC122756377|LOC122756378|LOC122756379|LOC122756380|LOC122756381|LOC122756382|LOC122756383|LOC122756384|LOC122756385|LOC122756386|LOC122756387|LOC122756388|LOC122756389|LOC122756390|LOC122756391|LOC122756392|LOC122756393|LOC122756667|LOC122756668|LOC122756669|LOC122756670|LOC122756671|LOC122756672|LOC122756673|LOC122756674|LOC122756675|LOC122756676|LOC122756677|LOC122756678|LOC122756679|LOC122756680|LOC122756681|LOC122756682|LOC122756683|LOC122756684|LOC122756685|LOC122756686|LOC122756687|LOC122756688|LOC122756689|LOC126806091|LOC126806092|LOC126806093|LOC126806094|LOC126806095|LOC126806096|LOC126806097|LOC126806098|LOC126806099|LOC126806100|LOC126806101|LOC126806102|LOC129933357|LOC129933358|LOC129933359|LOC129933360|LOC129933361|LOC129933362|LOC129933363|LOC129933364|LOC129933365|LOC129933366|LOC129933367|LOC129933368|LOC129933369|LOC129933370|LOC129933371|LOC129933372|LOC129933373|LOC129933374|LOC129933375|LOC129933376|LOC129933377|LOC129933378|LOC129933379|LOC129933380|LOC129933381|LOC129933382|LOC129933383|LOC129933384|LOC129933385|LOC129933386|LOC129933387|LOC129933388|LOC129933389|LOC129933390|LOC129933391|LOC129933392|LOC129933393|LOC129933394|LOC129933395|LOC129933396|LOC129933397|LOC129933398|LOC129933399|LOC129933400|LOC129933401|LOC129933402|LOC129933403|LOC129933404|LOC129933405|LOC129933406|LOC129933407|LOC129933408|LOC129933409|LOC129933410|LOC129933411|LOC129933412|LOC129933413|LOC129933414|LOC129933415|LOC129933416|LOC129933417|LOC129933418|LOC129933419|LOC129933420|LOC129933421|LOC129933422|LOC129933423|LOC129933424|LOC129933425|LOC129933426|LOC129933427|LOC129933428|LOC129933429|LOC129933430|LOC129933431|LOC129933432|LOC129933433|LOC129933434|LOC129933435|LOC129933436|LOC129933437|LOC129933438|LOC129933439|LOC129933440|LOC129933441|LOC129933442|LOC129933443|LOC129933444|LOC129933445|LOC129933446|LOC129933447|LOC129933448|LOC129933449|LOC129933450|LOC129933451|LOC129933452|LOC129933453|LOC129933454|LOC129933455|LOC129933456|LOC129933457|LOC129933458|LOC129933459|LOC129933460|LOC129933461|LOC129933462|LOC129933463|LOC129933464|LOC129933465|LOC129933466|LOC129933467|LOC129933468|LOC129933469|LOC129933470|LOC129933471|LOC129933472|LOC129933473|LOC129933474|LOC129933475|LOC129933476|LOC129933477|LOC132088754|LOC132088755|LOC132088756|LOC132088757|LOC132088838|LOC132088839|LOC132088840|LOC132088841|LOC132088842|LOC132088843|LOC132088844|LOC132088846|LOC132088849|LOC400940|LOC653602|LPIN1|LRATD1|LTBP1|MAPRE3|MAPRE3-AS1|MATN3|MBOAT2|MEMO1|MFSD2B|MIR1301|MIR3125|MIR3681|MIR3681HG|MIR4261|MIR4262|MIR4263|MIR4429|MIR4430|MIR4757|MIR4765|MIR548S|MIR558|MIR7158|MIR7515|MIR7515HG|MPV17|MRPL33|MSGN1|MYCN|MYCNOS|MYCNUT|MYT1L|MYT1L-AS1|NBAS|NCOA1|NLRC4|NOL10|NRBP1|NRIR|NT5C1B|NT5C1B-RDH14|NTSR2|ODC1|ODC1-DT|OSR1|OST4|OTOF|PCARE|PDIA6|PFN4|PLB1|POMC|PPM1G|PPP1CB|PREB|PRR30|PTRHD1|PUM2|PXDN|RAB10|RAD51AP2|RASGRP3|RASGRP3-AS1|RBKS|RDH14|RHOB|RNASEH1|RNASEH1-DT|RNF144A|ROCK2|RPS7|RRM2|RSAD2|SDC1|SELENOI|SF3B6|SH3YL1|SILC1|SLC30A3|SLC30A6|SLC30A6-DT|SLC35F6|SLC4A1AP|SLC5A6|SLC66A3|SMC6|SNORA10B|SNORA80B|SNORD53|SNORD53B|SNORD92|SNTG2|SNTG2-AS1|SNX17|SOX11|SPAST|SPATA31H1|SPDYA|SRD5A2|SUPT7L|TAF1B|TCF23|TDRD15|TMEM18|TMEM18-DT|TMEM214|TOGARAM2|TP53I3|TPO|TRA-AGC8-1|TRAPPC12|TRAPPC12-AS1|TRIB2|TRIM54|TRMT61B|TRY-GTA2-1|TTC27|TTC32|UBXN2A|UCN|VSNL1|WDCP|WDR35|WDR35-DT|WDR43|XDH|YIPF4|YPEL5|YWHAQ|ZNF512|ZNF513		See cases	VCV000153441	2	12770 - 33936576	2	12770 - 33711509	153441	163192			copy number gain		Pathogenic	Jun 18, 2013	no assertion criteria provided							
GRCh38/hg38 2p25.3-16.1(chr2:66097-55570637)x3	LOC129933311|LOC129933312|LOC129933313|LOC129933314|LOC129933315|LOC129933316|LOC129933317|LOC129933318|LOC129933319|LOC129933320|LOC129933321|LOC129933322|LOC129933323|LOC129933324|LOC129933325|LOC129933326|LOC129933327|LOC129933328|LOC129933329|LOC129933330|LOC129933331|LOC129933332|LOC129933333|LOC129933334|LOC129933335|LOC129933336|LOC129933337|LOC129933338|LOC129933339|LOC129933340|LOC129933341|LOC129933342|LOC129933343|LOC129933344|LOC129933345|LOC129933346|LOC129933347|LOC129933348|LOC129933349|LOC129933350|LOC129933351|LOC129933352|LOC129933353|LOC129933354|LOC129933355|LOC129933356|LOC129933357|LOC129933358|LOC129933359|LOC129933360|LOC129933361|LOC129933362|LOC129933363|LOC129933364|LOC129933365|LOC129933366|LOC129933367|LOC129933368|LOC129933369|LOC129933370|LOC129933371|LOC129933372|LOC129933373|LOC129933374|LOC129933375|LOC129933376|LOC129933377|LOC129933378|LOC129933379|LOC129933380|LOC129933381|LOC129933382|LOC129933383|LOC129933384|LOC129933385|LOC129933386|LOC129933387|LOC129933388|LOC129933389|LOC129933390|LOC129933391|LOC129933392|LOC129933393|LOC129933394|LOC129933395|LOC129933396|LOC129933397|LOC129933398|LOC129933399|LOC129933400|LOC129933401|LOC129933402|LOC129933403|LOC129933404|LOC129933405|LOC129933406|LOC129933407|LOC129933408|LOC129933409|LOC129933410|LOC129933411|LOC129933412|LOC129933413|LOC129933414|LOC129933415|LOC129933416|LOC129933417|LOC129933418|LOC129933419|LOC129933420|LOC129933421|LOC129933422|LOC129933423|LOC129933424|LOC129933425|LOC129933426|LOC129933427|LOC129933428|LOC129933429|LOC129933430|LOC129933431|LOC129933432|LOC129933433|LOC129933434|LOC129933435|LOC129933436|LOC129933437|LOC129933438|LOC129933439|LOC129933440|LOC129933441|LOC129933442|LOC129933443|LOC129933444|LOC129933445|LOC129933446|LOC129933447|LOC129933448|LOC129933449|LOC129933450|LOC129933451|LOC129933452|LOC129933453|LOC129933454|LOC129933455|LOC129933456|LOC129933457|LOC129933458|LOC129933459|LOC129933460|LOC129933461|LOC129933462|LOC129933463|LOC129933464|LOC129933465|LOC129933466|LOC129933467|LOC129933468|LOC129933469|LOC129933470|LOC129933471|LOC129933472|LOC129933473|LOC129933474|LOC129933475|LOC129933476|LOC129933477|LOC129933478|LOC129933479|LOC129933480|LOC129933481|LOC129933482|LOC129933483|LOC129933484|LOC129933485|LOC129933486|LOC129933487|LOC129933488|LOC129933489|LOC129933490|LOC129933491|LOC129933492|LOC129933493|LOC129933494|LOC129933495|LOC129933496|LOC129933497|LOC129933498|LOC129933499|LOC129933500|LOC129933501|LOC129933502|LOC129933503|LOC129933504|LOC129933505|LOC129933506|LOC129933507|LOC129933508|LOC129933509|LOC129933510|LOC129933511|LOC129933512|LOC129933513|LOC129933514|LOC129933515|LOC129933516|LOC129933518|LOC129933519|LOC129933520|LOC129933521|LOC129933522|LOC129933523|LOC129933524|LOC129933525|LOC129933526|LOC129933527|LOC129933528|LOC129933529|LOC129933530|LOC129933531|LOC129933532|LOC129933533|LOC129933534|LOC129933535|LOC129933536|LOC129933537|LOC129933538|LOC129933539|LOC129933540|LOC129933541|LOC129933542|LOC129933543|LOC129933544|LOC129933545|LOC129933546|LOC129933547|LOC129933548|LOC129933549|LOC129933550|LOC129933551|LOC129933552|LOC129933553|LOC129933554|LOC129933555|LOC129933556|LOC129933557|LOC129933558|LOC129933559|LOC129933560|LOC129933561|LOC129933562|LOC129933563|LOC129933564|LOC129933565|LOC129933566|LOC129933567|LOC129933568|LOC129933569|LOC129933570|LOC129933571|LOC129933572|LOC129933573|LOC129933574|LOC129933575|LOC129933576|LOC129933577|LOC129933578|LOC129933579|LOC129933580|LOC129933581|LOC129933582|LOC129933583|LOC129933584|LOC129933585|LOC129933586|LOC129933587|LOC129933588|LOC129933589|LOC129933590|LOC129933591|LOC129933592|LOC129933593|LOC129933594|LOC129933595|LOC129933596|LOC129933597|LOC129933598|LOC129933599|LOC129933600|LOC129933601|LOC129933602|LOC129933603|LOC129933604|LOC129933605|LOC129933606|LOC129933607|LOC129933608|LOC129933609|LOC129933610|LOC129933611|LOC129933612|LOC129933613|LOC129933614|LOC129933615|LOC129933616|LOC129933617|LOC129933618|LOC129933619|LOC129933620|LOC129933621|LOC129933622|LOC129933623|LOC129933624|LOC129933625|LOC129933626|LOC129933627|LOC129933628|LOC129933629|LOC129933630|LOC129933631|LOC129933632|LOC129933633|LOC129933634|LOC129933635|LOC129933636|LOC129933637|LOC129933638|LOC129933639|LOC129933640|LOC129933641|LOC129933642|LOC129933643|LOC129933644|LOC129933645|LOC129933646|LOC129933647|LOC129933648|LOC129933649|LOC129933650|LOC129933651|LOC129933652|LOC129933653|LOC129933654|LOC129933655|LOC129933656|LOC129933657|LOC129933658|LOC129933659|LOC129933660|LOC129933661|LOC129933662|LOC129933663|LOC129933664|LOC129933665|LOC129933666|LOC129933667|LOC129933668|LOC129933669|LOC129933670|LOC129933671|LOC129933672|LOC129933673|LOC129933674|LOC129933675|LOC129933676|LOC129933677|LOC129933678|LOC129933679|LOC129933680|LOC129933681|LOC129933682|LOC129933683|LOC129933684|LOC129933685|LOC129933686|LOC129933687|LOC129933688|LOC129933689|LOC129933690|LOC129933691|LOC129933692|LOC129933693|LOC129933694|LOC129933695|LOC129933696|LOC129933697|LOC129933698|LOC129933699|LOC129933700|LOC129933701|LOC129933702|LOC129933703|LOC129933704|LOC129933705|LOC129933706|LOC129933707|LOC129933708|LOC129933709|LOC129933710|LOC129933711|LOC129933712|LOC129933713|LOC129933714|LOC129933715|LOC129933716|LOC129933717|LOC129933718|LOC129933719|LOC129933720|LOC129933721|LOC129933722|LOC129933723|LOC129933724|LOC129933725|LOC129933726|LOC129933727|LOC129933728|LOC129933729|LOC129933730|LOC129933731|LOC129933732|LOC129933733|LOC129933734|LOC129933735|LOC129933736|LOC129933737|LOC129933738|LOC129933739|LOC129933740|LOC129933741|LOC129933742|LOC129933743|LOC129933744|LOC129933745|LOC129933746|LOC129933747|LOC129933748|LOC129933749|LOC129933750|LOC129933751|LOC129933752|LOC129933753|LOC129933754|LOC129933755|LOC129933756|LOC129933757|LOC129933758|LOC129933759|LOC129933760|LOC129933761|LOC129933762|LOC129933763|LOC129933764|LOC129933765|LOC129933766|LOC129933767|LOC132088754|LOC132088755|LOC132088756|LOC132088757|LOC132088838|LOC132088839|LOC132088840|LOC132088841|LOC132088842|LOC132088843|LOC132088844|LOC132088845|LOC132088846|LOC132088847|LOC132088849|LOC375196|LOC400940|LOC653602|LPIN1|LRATD1|LRPPRC|LTBP1|MAP4K3|MAP4K3-DT|MAPRE3|MAPRE3-AS1|MATN3|MBOAT2|MCFD2|MEMO1|MFSD2B|MIR1301|MIR3125|MIR3681|MIR3681HG|MIR3682|MIR4261|MIR4262|MIR4263|MIR4429|MIR4430|MIR4431|MIR4757|MIR4765|MIR548AD|MIR548BA|MIR548S|MIR558|MIR559|MIR7158|MIR7515|MIR7515HG|MIR8485|MORN2|MPV17|MRPL33|MSGN1|MSH2|LOC126806117|LOC126806118|LOC126806119|LOC126806120|LOC126806121|LOC126806122|LOC126806123|LOC126806124|LOC126806125|LOC126806126|LOC126806127|LOC126806128|LOC126806129|LOC126806130|LOC126806131|LOC126806132|LOC126806133|LOC126806134|LOC126806135|LOC126806136|LOC126806137|LOC126806138|LOC126806139|LOC126806140|LOC126806141|LOC126806142|LOC126806143|LOC126806144|LOC126806145|LOC126806146|LOC126806147|LOC126806148|LOC126806149|LOC126806150|LOC126806151|LOC126806152|LOC126806153|LOC126806154|LOC126806155|LOC126806156|LOC126806157|LOC126806158|LOC126806159|LOC126806160|LOC126806161|LOC126806162|LOC126806163|LOC126806164|LOC126806165|LOC126806166|LOC126806167|LOC126806168|LOC126806169|LOC126806170|LOC126806171|LOC126806172|LOC126806173|LOC126806174|LOC126806175|LOC126806176|LOC126806177|LOC126806178|LOC126806179|LOC126806180|LOC126806181|LOC126806182|LOC126806183|LOC126806184|LOC126806185|LOC126806186|LOC126806187|LOC126806188|LOC126806189|LOC126806190|LOC126806191|LOC126806192|LOC126806193|LOC126806194|LOC126806195|LOC126806196|LOC126806197|LOC126806198|LOC126806199|LOC126806200|LOC126806201|LOC126806202|LOC126806203|LOC126806204|LOC126806205|LOC126806206|LOC126806207|LOC126806208|LOC126806209|LOC126806210|LOC126806211|LOC126806212|LOC126806213|LOC126806214|LOC126806215|LOC126806216|LOC126806217|LOC126806218|LOC126806219|LOC126806220|LOC126806221|LOC128772246|LOC128772247|LOC128772248|LOC128772249|LOC128772250|LOC128772251|LOC128772252|LOC128772253|LOC128772254|LOC128897170|LOC128897171|LOC129388814|LOC129388815|LOC129388816|LOC129388817|LOC129388818|LOC129388819|LOC129388820|LOC129388821|LOC129388822|LOC129388823|LOC129388824|LOC129388825|LOC129388826|LOC129388827|LOC129388828|LOC129388829|LOC129388830|LOC129388831|LOC129388832|LOC129388833|LOC129388834|LOC129388835|LOC129388836|LOC129388837|LOC129388838|LOC129388839|LOC129388840|LOC129388841|LOC129388842|LOC129388843|LOC129388844|LOC129388845|LOC129388846|LOC129388847|LOC129388848|LOC129388849|LOC129388850|LOC129388851|LOC129388852|LOC129388853|LOC129388854|LOC129388855|LOC129388856|LOC129388857|LOC129388858|LOC129388859|LOC129388860|LOC129388861|LOC129456127|LOC129932973|LOC129932974|LOC129932975|LOC129932976|LOC129932977|LOC129932978|LOC129932979|LOC129932980|LOC129932981|LOC129932982|LOC129932983|LOC129932984|LOC129932985|LOC129932986|LOC129932987|LOC129932988|LOC129932989|LOC129932990|LOC129932991|LOC129932992|LOC129932993|LOC129932994|LOC129932995|LOC129932996|LOC129932997|LOC129932998|LOC129932999|LOC129933000|LOC129933001|LOC129933002|LOC129933003|LOC129933004|LOC129933005|LOC129933006|LOC129933007|LOC129933008|LOC129933009|LOC129933010|LOC129933011|LOC129933012|LOC129933013|LOC129933014|LOC129933015|LOC129933016|LOC129933017|LOC129933018|LOC129933019|LOC129933020|LOC129933021|LOC129933022|LOC129933023|LOC129933024|LOC129933025|LOC129933026|LOC129933027|LOC129933028|LOC129933029|LOC129933030|LOC129933031|LOC129933032|LOC129933033|LOC129933034|LOC129933035|LOC129933036|LOC129933037|LOC129933038|LOC129933039|LOC129933040|LOC129933041|LOC129933042|LOC129933043|LOC129933044|LOC129933045|LOC129933046|LOC129933047|LOC129933048|LOC129933049|LOC129933050|LOC129933051|LOC129933052|LOC129933053|LOC129933054|LOC129933055|LOC129933056|LOC129933057|LOC129933058|LOC129933059|LOC129933060|LOC129933061|LOC129933062|LOC129933063|LOC129933064|LOC129933065|LOC129933066|LOC129933067|LOC129933068|LOC129933069|LOC129933070|LOC129933071|LOC129933072|LOC129933073|LOC129933074|LOC129933075|LOC129933076|LOC129933077|LOC129933078|LOC129933079|LOC129933080|LOC129933081|LOC129933082|LOC129933083|LOC129933084|LOC129933085|LOC129933086|LOC129933087|LOC129933088|LOC129933089|LOC129933090|LOC129933091|LOC129933092|LOC129933093|LOC129933094|LOC129933095|LOC129933096|LOC129933097|LOC129933098|LOC129933099|LOC129933100|LOC129933101|LOC129933102|LOC129933103|LOC129933104|LOC129933105|LOC129933106|LOC129933107|LOC129933108|LOC129933109|LOC129933110|LOC129933111|LOC129933112|LOC129933113|LOC129933114|LOC129933115|LOC129933116|LOC129933117|LOC129933118|LOC129933119|LOC129933120|LOC129933121|LOC129933122|LOC129933123|LOC129933124|LOC129933125|LOC129933126|LOC129933127|LOC129933128|LOC129933129|LOC129933130|LOC129933131|LOC129933132|LOC129933133|LOC129933134|LOC129933135|LOC129933136|LOC129933137|LOC129933138|LOC129933139|LOC129933140|LOC129933141|LOC129933142|LOC129933143|LOC129933144|LOC129933145|LOC129933146|LOC129933147|LOC129933148|LOC129933149|LOC129933150|LOC129933151|LOC129933152|LOC129933153|LOC129933154|LOC129933155|LOC129933156|LOC129933157|LOC129933158|LOC129933159|LOC129933160|LOC129933161|LOC129933162|LOC129933163|LOC129933164|LOC129933165|LOC129933166|LOC129933167|LOC129933168|LOC129933169|LOC129933170|LOC129933171|LOC129933172|LOC129933173|LOC129933174|LOC129933175|LOC129933176|LOC129933177|LOC129933178|LOC129933179|LOC129933180|LOC129933181|LOC129933182|LOC129933183|LOC129933184|LOC129933185|LOC129933186|LOC129933187|LOC129933188|LOC129933189|LOC129933190|LOC129933191|LOC129933192|LOC129933193|LOC129933194|LOC129933195|LOC129933196|LOC129933197|LOC129933198|LOC129933199|LOC129933200|LOC129933201|LOC129933202|LOC129933203|LOC129933204|LOC129933205|LOC129933206|LOC129933207|LOC129933208|LOC129933209|LOC129933210|LOC129933211|LOC129933212|LOC129933213|LOC129933214|LOC129933215|LOC129933216|LOC129933217|LOC129933218|LOC129933219|LOC129933220|LOC129933221|LOC129933222|LOC129933223|LOC129933224|LOC129933225|LOC129933226|LOC129933227|LOC129933228|LOC129933229|LOC129933230|LOC129933231|LOC129933232|LOC129933233|LOC129933234|LOC129933235|LOC129933236|LOC129933237|LOC129933238|LOC129933239|LOC129933240|LOC129933241|LOC129933242|LOC129933243|LOC129933244|LOC129933245|LOC129933246|LOC129933247|LOC129933248|LOC129933249|LOC129933250|LOC129933251|LOC129933252|LOC129933253|LOC129933254|LOC129933255|LOC129933256|LOC129933257|LOC129933258|LOC129933259|LOC129933260|LOC129933261|LOC129933262|LOC129933263|LOC129933264|LOC129933265|LOC129933266|LOC129933267|LOC129933268|LOC129933269|LOC129933270|LOC129933271|LOC129933272|LOC129933273|LOC129933274|LOC129933275|LOC129933276|LOC129933277|LOC129933278|LOC129933279|LOC129933280|LOC129933281|LOC129933282|LOC129933283|LOC129933284|LOC129933285|LOC129933286|LOC129933287|LOC129933288|LOC129933289|LOC129933290|LOC129933291|LOC129933292|LOC129933293|LOC129933294|LOC129933295|LOC129933296|LOC129933297|LOC129933298|LOC129933299|LOC129933300|LOC129933301|LOC129933302|LOC129933303|LOC129933304|LOC129933305|LOC129933306|LOC129933307|LOC129933308|LOC129933309|LOC129933310|ABCG5|ABCG8|ABHD1|ACP1|ACYP2|ADAM17|ADCY3|ADGRF3|ADI1|AGBL5|AGBL5-AS1|ALK|ALKAL2|ALLC|APOB|APOB-ICR|APOB3'MAR|ARHGEF33|ASAP2|ASB3|ASXL2|ATAD2B|ATL2|ATP6V1C2|ATP6V1E2|ATRAID|BABAM2|BABAM2-AS1|BCYRN1|BIRC6|BIRC6-AS2|C1GALT1C1L|C2orf48|CAD|CALM2|CAMKMT|CAPN13|CAPN14|CCDC121|CCDC88A|CDC42EP3|CDKL4|CEBPZ|CEBPZOS|CENPA|CENPO|CFAP36|CGREF1|CHAC2|CIB4|CIMIP2C|CIMIP5|CIMIP6|CLHC1|CLIP4|CMPK2|COLEC11|COX7A2L|CPSF3|CRIM1|CRIM1-DT|CRIPT|CYP1B1|CYP1B1-AS1|CYRIA|CYS1|DCDC2C|DDX1|DHX57|DNAJC27|DNAJC27-AS1|DNAJC5G|DNMT3A|DPY30|DPYSL5|DRC1|DTNB|DTNB-AS1|DYNC2LI1|E2F6|EFR3B|EHD3|EIF2AK2|EIF2B4|EIPR1|EMILIN1|EML4|EML4-AS1|EML6|EML6-AS1|EPAS1|EPCAM|EPCAM-DT|ERLEC1|FAM228A|FAM228B|FAM98A|FBXO11|FEZ2|FKBP1B|FLJ33534|FNDC4|FOSL2|FOSL2-AS1|FOXN2|FSHR|GACAT3|GALM|GALNT14|GAREM2|GCKR|GDF7|GEMIN6|GEN1|GPATCH11|GPN1|GPR75|GPR75-ASB3|GRASLND|GREB1|GRHL1|GTF2A1L|GTF3C2|GTF3C2-AS1|GTF3C2-AS2|HAAO|HADHA|HADHB|HEATR5B|HNRNPLL|HPCAL1|HS1BP3|HS1BP3-IT1|IAH1|ID2|ID2-AS1|IFT172|ITGB1BP1|ITSN2|KCNF1|KCNG3|KCNK12|KCNK3|KCNS3|KHK|KIDINS220|KIF3C|KLF11|KLF11-DT|KLHL29|KRTCAP3|LAPTM4A|LAPTM4A-DT|LBH|LCLAT1|LDAH|LHCGR|LINC00276|LINC00298|LINC00299|LINC00486|LINC00487|LINC00570|LINC00954|LINC01115|LINC01118|LINC01119|LINC01121|LINC01126|LINC01246|LINC01247|LINC01248|LINC01249|LINC01250|LINC01304|LINC01317|LINC01318|LINC01320|LINC01376|LINC01381|LINC01460|LINC01794|LINC01804|LINC01808|LINC01810|LINC01814|LINC01819|LINC01820|LINC01822|LINC01830|LINC01833|LINC01865|LINC01867|LINC01871|LINC01874|LINC01875|LINC01883|LINC01884|LINC01913|LINC01914|LINC01936|LINC01939|LINC01946|LINC01954|LINC02580|LINC02583|LINC02613|LINC02850|LINC02898|LINC02923|LINC03063|LOC100271832|LOC100505716|LOC100505736|LOC100505774|LOC100506235|LOC100506274|LOC100506405|LOC100506474|LOC100507562|LOC100996637|LOC101928196|LOC101929452|LOC101929551|LOC101929752|LOC102723530|LOC102723730|LOC105369165|LOC105373346|LOC105373352|LOC105373390|LOC105373394|LOC105373414|LOC105373418|LOC105373438|LOC105373461|LOC105374378|LOC105374389|LOC106560211|LOC106728414|LOC107457596|LOC107985792|LOC107985856|LOC108167315|LOC108281152|LOC110120598|LOC110120665|LOC110120696|LOC110121045|LOC110121071|LOC110121085|LOC110121122|LOC110121127|LOC110121131|LOC110121222|LOC110121235|LOC110121308|LOC110599580|LOC111465020|LOC111556161|LOC111776219|LOC111776220|LOC111811968|LOC111828513|LOC112806042|LOC112806072|LOC112840907|LOC112840916|LOC112840917|LOC112840921|LOC112840922|LOC112840923|LOC112840924|LOC112840925|LOC112840926|LOC112840927|LOC112840929|LOC112840930|LOC112840931|LOC112840932|LOC112840935|LOC112840936|LOC112840937|LOC112840938|LOC112840939|LOC112840940|LOC112840941|LOC112840942|LOC112840943|LOC112841579|LOC112841580|LOC112841600|LOC112841604|LOC112841605|LOC114004370|LOC114004371|LOC114004372|LOC114827832|LOC114827839|LOC115804257|LOC115804258|LOC115804259|LOC115804260|LOC115804261|LOC115945147|LOC115945149|LOC115945150|LOC115945151|LOC115945152|LOC115945153|LOC115945154|LOC115945155|LOC115945156|LOC115945157|LOC115945158|LOC120961741|LOC120961742|LOC120961743|LOC120961744|LOC120961745|LOC120961746|LOC120961747|LOC120961748|LOC120961749|LOC120961750|LOC120961751|LOC120961752|LOC120961753|LOC120961754|LOC120961755|LOC120961756|LOC120961757|LOC120961758|LOC121725077|LOC121725078|LOC121725079|LOC121725080|LOC121725081|LOC121725082|LOC121725083|LOC121725084|LOC121725085|LOC121725086|LOC121725087|LOC121725088|LOC121725089|LOC121725090|LOC122710286|LOC122710287|LOC122710288|LOC122710289|LOC122756371|LOC122756372|LOC122756373|LOC122756374|LOC122756375|LOC122756376|LOC122756377|LOC122756378|LOC122756379|LOC122756380|LOC122756381|LOC122756382|LOC122756383|LOC122756384|LOC122756385|LOC122756386|LOC122756387|LOC122756388|LOC122756389|LOC122756390|LOC122756391|LOC122756392|LOC122756393|LOC122756667|LOC122756668|LOC122756669|LOC122756670|LOC122756671|LOC122756672|LOC122756673|LOC122756674|LOC122756675|LOC122756676|LOC122756677|LOC122756678|LOC122756679|LOC122756680|LOC122756681|LOC122756682|LOC122756683|LOC122756684|LOC122756685|LOC122756686|LOC122756687|LOC122756688|LOC122756689|LOC122756690|LOC122756691|LOC122757916|LOC122757917|LOC122757918|LOC122757919|LOC122757920|LOC122757921|LOC122757922|LOC122757923|LOC122757924|LOC122757925|LOC122757926|LOC122757927|LOC122757928|LOC122757929|LOC122757930|LOC122757931|LOC122757932|LOC122757933|LOC122757934|LOC122757935|LOC122757936|LOC122757937|LOC122757938|LOC122757939|LOC122757940|LOC122757941|LOC122757942|LOC122757943|LOC122757944|LOC122757945|LOC126264115|LOC126806091|LOC126806092|LOC126806093|LOC126806094|LOC126806095|LOC126806096|LOC126806097|LOC126806098|LOC126806099|LOC126806100|LOC126806101|LOC126806102|LOC126806103|LOC126806104|LOC126806105|LOC126806106|LOC126806107|LOC126806108|LOC126806109|LOC126806110|LOC126806111|LOC126806112|LOC126806113|LOC126806114|LOC126806115|LOC126806116|MSH2-OT1|MSH6|MTA3|MTIF2|MYCN|MYCNOS|MYCNUT|MYT1L|MYT1L-AS1|NBAS|NCOA1|NDUFAF7|NLRC4|NOL10|NRBP1|NRIR|NRXN1|NRXN1-DT|NT5C1B|NT5C1B-RDH14|NTSR2|ODC1|ODC1-DT|OSR1|OST4|OTOF|OXER1|PCARE|PDIA6|PFN4|PIGF|PIRAT1|PKDCC|PLB1|PLEKHH2|POMC|PPM1B|PPM1B-DT|PPM1G|PPP1CB|PPP1R21|PPP4R3B|PREB|PREPL|PRKCE|PRKCE-AS1|PRKD3|PRKD3-DT|PRR30|PSME4|PTRHD1|PUM2|PXDN|QPCT|RAB10|RAD51AP2|RASGRP3|RASGRP3-AS1|RBKS|RDH14|RHOB|RHOQ|RHOQ-AS1|RMDN2|RMDN2-AS1|RNASEH1|RNASEH1-DT|RNF144A|ROCK2|RPS27A|RPS7|RRM2|RSAD2|RTN4|SDC1|SELENOI|SF3B6|SH3YL1|SILC1|SIX2|SIX3|SIX3-AS1|SLC30A3|SLC30A6|SLC30A6-DT|SLC35F6|SLC3A1|SLC4A1AP|SLC5A6|SLC66A3|SLC8A1|SLC8A1-AS1|SMC6|SNORA10B|SNORA80B|SNORD53|SNORD53B|SNORD92|SNTG2|SNTG2-AS1|SNX17|SOCS5|SOS1|SOS1-IT1|SOX11|SPAST|SPATA31H1|SPDYA|SPTBN1|SPTBN1-AS1|SPTBN1-AS2|SRBD1|SRD5A2|SRSF7|STON1|STON1-GTF2A1L|STPG4|STRN|SULT6B1|SUPT7L|TAF1B|TCF23|TDRD15|THADA|THUMPD2|TMEM178A|TMEM18|TMEM18-DT|TMEM214|TMEM247|TOGARAM2|TP53I3|TPO|TRA-AGC8-1|TRAPPC12|TRAPPC12-AS1|TRI-TAT2-1|TRIB2|TRIM54|TRMT61B|TRY-GTA2-1|TSPYL6|TTC27|TTC32|TTC7A|UBXN2A|UCN|VIT|VSNL1|WDCP|WDR35|WDR35-DT|WDR43|XDH|YIPF4|YPEL5|YWHAQ|ZFP36L2|ZNF512|ZNF513		See cases	VCV000059133	2	66097 - 55797773	2	66097 - 55570637	59133	73728			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
GRCh38/hg38 2p25.3-21(chr2:236816-45983232)x3	LINC01115|LINC01121|LINC01126|LINC01246|LINC01247|LINC01248|LINC01249|LINC01250|LINC01304|LINC01317|LINC01318|LINC01320|LINC01376|LINC01381|LINC01460|LINC01794|LINC01804|LINC01808|LINC01810|LINC01814|LINC01819|LINC01822|LINC01830|LINC01833|LINC01865|LINC01871|LINC01874|LINC01875|LINC01883|LINC01884|LINC01913|LINC01914|LINC01936|LINC01939|LINC01946|LINC01954|LINC02580|LINC02613|LINC02850|LINC02898|LINC02923|LINC03063|LOC100271832|LOC100505716|LOC100505736|LOC100505774|LOC100506274|LOC100506405|LOC100506474|LOC100507562|LOC100996637|LOC101928196|LOC101929452|LOC101929551|LOC101929752|LOC102723530|LOC102723730|LOC105373346|LOC105373352|LOC105373390|LOC105373394|LOC105373414|LOC105373418|LOC105373438|LOC105373461|LOC105374378|LOC105374389|LOC106560211|LOC106728414|LOC107457596|LOC107985792|LOC107985856|LOC108167315|LOC108281152|LOC110120598|LOC110120665|LOC110120696|LOC110121045|LOC110121085|LOC110121122|LOC110121127|LOC110121131|LOC110121222|LOC110121308|LOC110599580|LOC111465020|LOC111556161|LOC111811968|LOC111828513|LOC112806042|LOC112806072|LOC112840907|LOC112840916|LOC112840917|LOC112840921|LOC112840922|LOC112840923|LOC112840924|LOC112840925|LOC112840926|LOC112840927|LOC112840929|LOC112840930|LOC112840931|LOC112840932|LOC112840935|LOC112840936|LOC112840937|LOC112841600|LOC112841604|LOC112841605|LOC114004370|LOC114004371|LOC114827839|LOC115804257|LOC115804258|LOC115804259|LOC115804260|LOC115804261|LOC115945147|LOC115945149|LOC115945150|LOC115945151|LOC115945152|LOC115945153|LOC115945154|LOC115945155|LOC115945156|LOC115945157|LOC120961741|LOC120961742|LOC120961743|LOC120961744|LOC120961745|LOC120961746|LOC120961747|LOC120961748|LOC120961749|LOC120961750|LOC120961751|LOC121725077|LOC121725078|LOC121725079|LOC121725080|LOC121725081|LOC121725082|LOC121725083|LOC121725084|LOC121725085|LOC121725086|LOC121725087|LOC121725088|LOC121725089|LOC121725090|LOC122710286|LOC122710287|LOC122710288|LOC122710289|LOC122756371|LOC122756372|LOC122756373|LOC122756374|LOC122756375|LOC122756376|LOC122756377|LOC122756378|LOC122756379|LOC122756380|LOC122756381|LOC122756382|LOC122756383|LOC122756384|LOC122756385|LOC122756386|LOC122756387|LOC122756388|LOC122756389|LOC122756390|LOC122756391|LOC122756392|LOC122756393|LOC122756667|LOC122756668|LOC122756669|LOC122756670|LOC122756671|LOC122756672|LOC122756673|LOC122756674|LOC122756675|LOC122756676|LOC122756677|LOC122756678|LOC122756679|LOC122756680|LOC122756681|LOC122756682|LOC122756683|LOC122756684|LOC122756685|LOC122756686|LOC122756687|LOC122756688|LOC122756689|LOC122756690|LOC122756691|LOC122757916|LOC122757917|LOC122757918|LOC122757919|LOC122757920|LOC122757921|LOC122757922|LOC122757923|LOC122757924|LOC122757925|LOC122757926|LOC122757927|LOC122757928|LOC122757929|LOC122757930|LOC122757931|LOC122757932|LOC122757933|LOC122757934|LOC126264115|LOC126806093|LOC126806094|LOC126806095|LOC126806096|LOC126806097|LOC126806098|LOC126806099|LOC126806100|LOC126806101|LOC126806102|LOC126806103|LOC126806104|LOC126806105|LOC126806106|LOC126806107|LOC126806108|LOC126806109|LOC126806110|LOC126806111|LOC126806112|LOC126806113|LOC126806114|LOC126806115|LOC126806116|LOC126806117|LOC126806118|LOC126806119|LOC126806120|LOC126806121|LOC126806122|LOC126806123|LOC126806124|LOC126806125|LOC126806126|LOC126806127|LOC126806128|LOC126806129|LOC126806130|LOC126806131|LOC126806132|LOC126806133|LOC126806134|LOC126806135|LOC126806136|LOC126806137|LOC126806138|LOC126806139|LOC126806140|LOC126806141|LOC126806142|LOC126806143|LOC126806144|LOC126806145|LOC126806146|LOC126806147|LOC126806148|LOC126806149|LOC126806150|LOC126806151|LOC126806152|LOC126806153|LOC126806154|LOC126806155|LOC126806156|LOC126806157|LOC126806158|LOC126806159|LOC126806160|LOC126806161|LOC126806162|LOC126806163|LOC126806164|LOC126806165|LOC126806166|LOC126806167|LOC126806168|LOC126806169|LOC126806170|LOC126806171|LOC126806172|LOC126806173|LOC126806174|LOC126806175|LOC126806176|LOC126806177|LOC126806178|LOC126806179|LOC126806180|LOC126806181|LOC126806182|LOC126806183|LOC126806184|LOC126806185|LOC126806186|LOC126806187|LOC126806188|LOC126806189|LOC126806190|LOC126806191|LOC126806192|LOC126806193|LOC126806194|LOC126806195|LOC126806196|LOC126806197|LOC126806198|LOC126806199|LOC126806200|LOC126806201|LOC126806202|LOC126806203|LOC126806204|LOC126806205|LOC126806206|LOC128772246|LOC128772247|LOC128772248|LOC128772249|LOC128772250|LOC128772251|LOC128772252|LOC128772253|LOC128772254|LOC128897170|LOC128897171|LOC129388814|LOC129388815|LOC129388816|LOC129388817|LOC129388818|LOC129388819|LOC129388820|LOC129388821|LOC129388822|LOC129388823|LOC129388824|LOC129388825|LOC129388826|LOC129388827|LOC129388828|LOC129388829|LOC129388830|LOC129388831|LOC129388832|LOC129388833|LOC129388834|LOC129388835|LOC129388836|LOC129388837|LOC129388838|LOC129388839|LOC129388840|LOC129388841|LOC129388842|LOC129388843|LOC129388844|LOC129388845|LOC129388846|LOC129388847|LOC129388848|LOC129388849|LOC129388850|LOC129388851|LOC129388852|LOC129388853|LOC129388854|LOC129388855|LOC129388856|LOC129388857|LOC129388858|LOC129388859|LOC129456127|LOC129932973|LOC129932974|LOC129932975|LOC129932976|LOC129932977|LOC129932978|LOC129932979|LOC129932980|LOC129932981|LOC129932982|LOC129932983|LOC129932984|LOC129932985|LOC129932986|LOC129932987|LOC129932988|LOC129932989|LOC129932990|LOC129932991|LOC129932992|LOC129932993|LOC129932994|LOC129932995|LOC129932996|LOC129932997|LOC129932998|LOC129932999|LOC129933000|LOC129933001|LOC129933002|LOC129933003|LOC129933004|LOC129933005|LOC129933006|LOC129933007|LOC129933008|LOC129933009|LOC129933010|LOC129933011|LOC129933012|LOC129933013|LOC129933014|LOC129933015|LOC129933016|LOC129933017|LOC129933018|LOC129933019|LOC129933020|LOC129933021|LOC129933022|LOC129933023|LOC129933024|LOC129933025|LOC129933026|LOC129933027|LOC129933028|LOC129933029|LOC129933030|LOC129933031|LOC129933032|LOC129933033|LOC129933034|LOC129933035|LOC129933036|LOC129933037|LOC129933038|LOC129933039|LOC129933040|LOC129933041|LOC129933042|LOC129933043|LOC129933044|LOC129933045|LOC129933046|LOC129933047|LOC129933048|LOC129933049|LOC129933050|LOC129933051|LOC129933052|LOC129933053|LOC129933054|LOC129933055|LOC129933056|LOC129933057|LOC129933058|LOC129933059|LOC129933060|LOC129933061|LOC129933062|LOC129933063|LOC129933064|LOC129933065|LOC129933066|LOC129933067|LOC129933068|LOC129933069|LOC129933070|LOC129933071|LOC129933072|LOC129933073|LOC129933074|LOC129933075|LOC129933076|LOC129933077|LOC129933078|LOC129933079|LOC129933080|LOC129933081|LOC129933082|LOC129933083|LOC129933084|LOC129933085|LOC129933086|LOC129933087|LOC129933088|LOC129933089|LOC129933090|LOC129933091|LOC129933092|LOC129933093|LOC129933094|ABCG5|ABCG8|ABHD1|ACP1|ADAM17|ADCY3|ADGRF3|ADI1|AGBL5|AGBL5-AS1|ALK|ALKAL2|ALLC|APOB|APOB-ICR|APOB3'MAR|ARHGEF33|ASAP2|ASXL2|ATAD2B|ATL2|ATP6V1C2|ATRAID|BABAM2|BABAM2-AS1|BIRC6|BIRC6-AS2|C1GALT1C1L|C2orf48|CAD|CAMKMT|CAPN13|CAPN14|CCDC121|CDC42EP3|CDKL4|CEBPZ|CEBPZOS|CENPA|CENPO|CGREF1|CIB4|CIMIP2C|CIMIP5|CLIP4|CMPK2|COLEC11|COX7A2L|CPSF3|CRIM1|CRIM1-DT|CYP1B1|CYP1B1-AS1|CYRIA|CYS1|DCDC2C|DDX1|DHX57|DNAJC27|DNAJC27-AS1|DNAJC5G|DNMT3A|DPY30|DPYSL5|DRC1|DTNB|DTNB-AS1|DYNC2LI1|E2F6|EFR3B|EHD3|EIF2AK2|EIF2B4|EIPR1|EMILIN1|EML4|EML4-AS1|FAM228A|FAM228B|FAM98A|FEZ2|FKBP1B|FLJ33534|FNDC4|FOSL2|FOSL2-AS1|GACAT3|GALM|GALNT14|GAREM2|GCKR|GDF7|GEMIN6|GEN1|GPATCH11|GPN1|GRASLND|GREB1|GRHL1|GTF3C2|GTF3C2-AS1|GTF3C2-AS2|HAAO|HADHA|HADHB|HEATR5B|HNRNPLL|HPCAL1|HS1BP3|HS1BP3-IT1|IAH1|ID2|ID2-AS1|IFT172|ITGB1BP1|ITSN2|KCNF1|KCNG3|KCNK3|KCNS3|KHK|KIDINS220|KIF3C|KLF11|KLF11-DT|KLHL29|KRTCAP3|LAPTM4A|LAPTM4A-DT|LBH|LCLAT1|LDAH|LINC00276|LINC00298|LINC00299|LINC00486|LINC00487|LINC00570|LINC00954|LOC129933608|LOC129933609|LOC129933610|LOC129933611|LOC129933612|LOC129933613|LOC129933614|LOC129933615|LOC129933616|LOC129933617|LOC129933618|LOC129933619|LOC129933620|LOC129933621|LOC129933622|LOC129933623|LOC129933624|LOC129933625|LOC129933626|LOC129933627|LOC129933628|LOC129933629|LOC129933630|LOC129933631|LOC129933632|LOC129933633|LOC129933634|LOC129933635|LOC129933636|LOC129933637|LOC129933638|LOC129933639|LOC129933640|LOC129933641|LOC129933642|LOC129933643|LOC129933644|LOC129933645|LOC129933646|LOC129933647|LOC129933648|LOC129933649|LOC129933650|LOC129933651|LOC132088754|LOC132088755|LOC132088756|LOC132088757|LOC132088838|LOC132088839|LOC132088840|LOC132088841|LOC132088842|LOC132088843|LOC132088844|LOC132088845|LOC132088846|LOC132088849|LOC375196|LOC400940|LOC653602|LPIN1|LRATD1|LRPPRC|LTBP1|MAP4K3|MAP4K3-DT|MAPRE3|MAPRE3-AS1|MATN3|MBOAT2|MEMO1|MFSD2B|MIR1301|MIR3125|MIR3681|MIR3681HG|MIR4261|MIR4262|MIR4263|MIR4429|MIR4430|MIR4757|MIR4765|MIR548AD|MIR548S|MIR558|MIR7158|MIR7515|MIR7515HG|MORN2|MPV17|MRPL33|MSGN1|MTA3|MYCN|MYCNOS|MYCNUT|MYT1L|MYT1L-AS1|NBAS|NCOA1|NDUFAF7|NLRC4|NOL10|NRBP1|NRIR|NT5C1B|NT5C1B-RDH14|NTSR2|ODC1|ODC1-DT|OSR1|OST4|OTOF|OXER1|PCARE|PDIA6|PFN4|PIRAT1|PKDCC|PLB1|PLEKHH2|POMC|PPM1B|PPM1B-DT|PPM1G|PPP1CB|PREB|PREPL|PRKCE|PRKCE-AS1|PRKD3|PRKD3-DT|PRR30|PTRHD1|PUM2|PXDN|QPCT|RAB10|RAD51AP2|RASGRP3|RASGRP3-AS1|RBKS|RDH14|RHOB|RMDN2|RMDN2-AS1|RNASEH1|RNASEH1-DT|RNF144A|ROCK2|RPS7|RRM2|RSAD2|SDC1|SELENOI|SF3B6|SH3YL1|SILC1|SIX2|SIX3|SIX3-AS1|SLC30A3|SLC30A6|SLC30A6-DT|SLC35F6|SLC3A1|SLC4A1AP|SLC5A6|SLC66A3|SLC8A1|SLC8A1-AS1|SMC6|SNORA10B|SNORA80B|SNORD53|SNORD53B|SNORD92|SNTG2|SNTG2-AS1|SNX17|SPDYA|SOS1|SOS1-IT1|SOX11|SPAST|SPATA31H1|SRBD1|SRD5A2|SRSF7|STRN|SULT6B1|SUPT7L|TAF1B|TCF23|TDRD15|THADA|THUMPD2|TMEM178A|TMEM18|TMEM18-DT|TMEM214|TOGARAM2|TP53I3|TPO|TRA-AGC8-1|TRAPPC12|TRAPPC12-AS1|TRI-TAT2-1|TRIB2|TRIM54|TRMT61B|TRY-GTA2-1|TTC27|TTC32|UBXN2A|UCN|VIT|VSNL1|WDCP|WDR35|WDR35-DT|WDR43|XDH|YIPF4|YPEL5|YWHAQ|ZFP36L2|ZNF512|ZNF513|LOC129933095|LOC129933096|LOC129933097|LOC129933098|LOC129933099|LOC129933100|LOC129933101|LOC129933102|LOC129933103|LOC129933104|LOC129933105|LOC129933106|LOC129933107|LOC129933108|LOC129933109|LOC129933110|LOC129933111|LOC129933112|LOC129933113|LOC129933114|LOC129933115|LOC129933116|LOC129933117|LOC129933118|LOC129933119|LOC129933120|LOC129933121|LOC129933122|LOC129933123|LOC129933124|LOC129933125|LOC129933126|LOC129933127|LOC129933128|LOC129933129|LOC129933130|LOC129933131|LOC129933132|LOC129933133|LOC129933134|LOC129933135|LOC129933136|LOC129933137|LOC129933138|LOC129933139|LOC129933140|LOC129933141|LOC129933142|LOC129933143|LOC129933144|LOC129933145|LOC129933146|LOC129933147|LOC129933148|LOC129933149|LOC129933150|LOC129933151|LOC129933152|LOC129933153|LOC129933154|LOC129933155|LOC129933156|LOC129933157|LOC129933158|LOC129933159|LOC129933160|LOC129933161|LOC129933162|LOC129933163|LOC129933164|LOC129933165|LOC129933166|LOC129933167|LOC129933168|LOC129933169|LOC129933170|LOC129933171|LOC129933172|LOC129933173|LOC129933174|LOC129933175|LOC129933176|LOC129933177|LOC129933178|LOC129933179|LOC129933180|LOC129933181|LOC129933182|LOC129933183|LOC129933184|LOC129933185|LOC129933186|LOC129933187|LOC129933188|LOC129933189|LOC129933190|LOC129933191|LOC129933192|LOC129933193|LOC129933194|LOC129933195|LOC129933196|LOC129933197|LOC129933198|LOC129933199|LOC129933200|LOC129933201|LOC129933202|LOC129933203|LOC129933204|LOC129933205|LOC129933206|LOC129933207|LOC129933208|LOC129933209|LOC129933210|LOC129933211|LOC129933212|LOC129933213|LOC129933214|LOC129933215|LOC129933216|LOC129933217|LOC129933218|LOC129933219|LOC129933220|LOC129933221|LOC129933222|LOC129933223|LOC129933224|LOC129933225|LOC129933226|LOC129933227|LOC129933228|LOC129933229|LOC129933230|LOC129933231|LOC129933232|LOC129933233|LOC129933234|LOC129933235|LOC129933236|LOC129933237|LOC129933238|LOC129933239|LOC129933240|LOC129933241|LOC129933242|LOC129933243|LOC129933244|LOC129933245|LOC129933246|LOC129933247|LOC129933248|LOC129933249|LOC129933250|LOC129933251|LOC129933252|LOC129933253|LOC129933254|LOC129933255|LOC129933256|LOC129933257|LOC129933258|LOC129933259|LOC129933260|LOC129933261|LOC129933262|LOC129933263|LOC129933264|LOC129933265|LOC129933266|LOC129933267|LOC129933268|LOC129933269|LOC129933270|LOC129933271|LOC129933272|LOC129933273|LOC129933274|LOC129933275|LOC129933276|LOC129933277|LOC129933278|LOC129933279|LOC129933280|LOC129933281|LOC129933282|LOC129933283|LOC129933284|LOC129933285|LOC129933286|LOC129933287|LOC129933288|LOC129933289|LOC129933290|LOC129933291|LOC129933292|LOC129933293|LOC129933294|LOC129933295|LOC129933296|LOC129933297|LOC129933298|LOC129933299|LOC129933300|LOC129933301|LOC129933302|LOC129933303|LOC129933304|LOC129933305|LOC129933306|LOC129933307|LOC129933308|LOC129933309|LOC129933310|LOC129933311|LOC129933312|LOC129933313|LOC129933314|LOC129933315|LOC129933316|LOC129933317|LOC129933318|LOC129933319|LOC129933320|LOC129933321|LOC129933322|LOC129933323|LOC129933324|LOC129933325|LOC129933326|LOC129933327|LOC129933328|LOC129933329|LOC129933330|LOC129933331|LOC129933332|LOC129933333|LOC129933334|LOC129933335|LOC129933336|LOC129933337|LOC129933338|LOC129933339|LOC129933340|LOC129933341|LOC129933342|LOC129933343|LOC129933344|LOC129933345|LOC129933346|LOC129933347|LOC129933348|LOC129933349|LOC129933350|LOC129933351|LOC129933352|LOC129933353|LOC129933354|LOC129933355|LOC129933356|LOC129933357|LOC129933358|LOC129933359|LOC129933360|LOC129933361|LOC129933362|LOC129933363|LOC129933364|LOC129933365|LOC129933366|LOC129933367|LOC129933368|LOC129933369|LOC129933370|LOC129933371|LOC129933372|LOC129933373|LOC129933374|LOC129933375|LOC129933376|LOC129933377|LOC129933378|LOC129933379|LOC129933380|LOC129933381|LOC129933382|LOC129933383|LOC129933384|LOC129933385|LOC129933386|LOC129933387|LOC129933388|LOC129933389|LOC129933390|LOC129933391|LOC129933392|LOC129933393|LOC129933394|LOC129933395|LOC129933396|LOC129933397|LOC129933398|LOC129933399|LOC129933400|LOC129933401|LOC129933402|LOC129933403|LOC129933404|LOC129933405|LOC129933406|LOC129933407|LOC129933408|LOC129933409|LOC129933410|LOC129933411|LOC129933412|LOC129933413|LOC129933414|LOC129933415|LOC129933416|LOC129933417|LOC129933418|LOC129933419|LOC129933420|LOC129933421|LOC129933422|LOC129933423|LOC129933424|LOC129933425|LOC129933426|LOC129933427|LOC129933428|LOC129933429|LOC129933430|LOC129933431|LOC129933432|LOC129933433|LOC129933434|LOC129933435|LOC129933436|LOC129933437|LOC129933438|LOC129933439|LOC129933440|LOC129933441|LOC129933442|LOC129933443|LOC129933444|LOC129933445|LOC129933446|LOC129933447|LOC129933448|LOC129933449|LOC129933450|LOC129933451|LOC129933452|LOC129933453|LOC129933454|LOC129933455|LOC129933456|LOC129933457|LOC129933458|LOC129933459|LOC129933460|LOC129933461|LOC129933462|LOC129933463|LOC129933464|LOC129933465|LOC129933466|LOC129933467|LOC129933468|LOC129933469|LOC129933470|LOC129933471|LOC129933472|LOC129933473|LOC129933474|LOC129933475|LOC129933476|LOC129933477|LOC129933478|LOC129933479|LOC129933480|LOC129933481|LOC129933482|LOC129933483|LOC129933484|LOC129933485|LOC129933486|LOC129933487|LOC129933488|LOC129933489|LOC129933490|LOC129933491|LOC129933492|LOC129933493|LOC129933494|LOC129933495|LOC129933496|LOC129933497|LOC129933498|LOC129933499|LOC129933500|LOC129933501|LOC129933502|LOC129933503|LOC129933504|LOC129933505|LOC129933506|LOC129933507|LOC129933508|LOC129933509|LOC129933510|LOC129933511|LOC129933512|LOC129933513|LOC129933514|LOC129933515|LOC129933516|LOC129933518|LOC129933519|LOC129933520|LOC129933521|LOC129933522|LOC129933523|LOC129933524|LOC129933525|LOC129933526|LOC129933527|LOC129933528|LOC129933529|LOC129933530|LOC129933531|LOC129933532|LOC129933533|LOC129933534|LOC129933535|LOC129933536|LOC129933537|LOC129933538|LOC129933539|LOC129933540|LOC129933541|LOC129933542|LOC129933543|LOC129933544|LOC129933545|LOC129933546|LOC129933547|LOC129933548|LOC129933549|LOC129933550|LOC129933551|LOC129933552|LOC129933553|LOC129933554|LOC129933555|LOC129933556|LOC129933557|LOC129933558|LOC129933559|LOC129933560|LOC129933561|LOC129933562|LOC129933563|LOC129933564|LOC129933565|LOC129933566|LOC129933567|LOC129933568|LOC129933569|LOC129933570|LOC129933571|LOC129933572|LOC129933573|LOC129933574|LOC129933575|LOC129933576|LOC129933577|LOC129933578|LOC129933579|LOC129933580|LOC129933581|LOC129933582|LOC129933583|LOC129933584|LOC129933585|LOC129933586|LOC129933587|LOC129933588|LOC129933589|LOC129933590|LOC129933591|LOC129933592|LOC129933593|LOC129933594|LOC129933595|LOC129933596|LOC129933597|LOC129933598|LOC129933599|LOC129933600|LOC129933601|LOC129933602|LOC129933603|LOC129933604|LOC129933605|LOC129933606|LOC129933607		See cases	VCV000155615	2	236816 - 46210371	2	236816 - 45983232	155615	165369			copy number gain		Pathogenic	Nov 19, 2013	no assertion criteria provided							
GRCh38/hg38 2p25.1-11.2(chr2:7495123-87705899)x3	LINC01851|LINC01867|LINC01871|LINC01873|LINC01883|LINC01884|LINC01888|LINC01890|LINC01913|LINC01914|LINC01936|LINC01943|LINC01946|LINC01954|LINC01964|LINC02245|LINC02576|LINC02579|LINC02580|LINC02583|LINC02613|LINC02831|LINC02850|LINC02898|LINC02923|LINC02934|LINC03050|LINC03063|LOC100129434|LOC100271832|LOC100505716|LOC100505736|LOC100505774|LOC100506235|LOC100506405|LOC100506474|LOC100507006|LOC100507562|LOC101927661|LOC101927723|LOC101927948|LOC101927967|LOC101928196|LOC101929551|LOC101929752|LOC102723530|LOC102724542|LOC102724579|LOC105369165|LOC105373414|LOC105373418|LOC105373438|LOC105373461|LOC105374378|LOC105374389|LOC105374768|LOC105374769|LOC105374780|LOC105374809|LOC105374820|LOC106560211|LOC106699567|LOC106728414|LOC106783498|LOC106783504|LOC107457596|LOC107984043|LOC107985792|LOC107985856|LOC108021854|LOC108021855|LOC108167315|LOC108281131|LOC108281152|LOC110120598|LOC110120611|LOC110120665|LOC110120667|LOC110120668|LOC110120669|LOC110120696|LOC110120746|LOC110120767|LOC110120782|LOC110120811|LOC110120817|LOC110120967|LOC110120978|LOC110120979|LOC110120980|LOC110120997|LOC110121003|LOC110121008|LOC110121015|LOC110121018|LOC110121024|LOC110121039|LOC110121045|LOC110121071|LOC110121121|LOC110121122|LOC110121131|LOC110121136|LOC110121178|LOC110121222|LOC110121235|LOC110121243|LOC110121268|LOC110121308|LOC110599580|LOC111258501|LOC111258509|LOC111258516|LOC111258517|LOC111258518|LOC111258520|LOC111465020|LOC111556161|LOC111776219|LOC111776220|LOC111828513|LOC112806042|LOC112806072|LOC112840907|LOC112840916|LOC112840917|LOC112840921|LOC112840922|LOC112840923|LOC112840924|LOC112840925|LOC112840926|LOC112840927|LOC112840929|LOC112840930|LOC112840931|LOC112840932|LOC112840935|LOC112840936|LOC112840937|LOC112840938|LOC112840939|LOC112840940|LOC112840941|LOC112840942|LOC112840943|LOC112841579|LOC112841580|LOC112841582|LOC112841589|LOC112841592|LOC112841595|LOC112841596|LOC112841597|LOC112841598|LOC112841599|LOC112841600|LOC112841601|LOC112841602|LOC112841603|LOC112841604|LOC112841605|LOC114004370|LOC114004372|LOC114004373|LOC114827832|LOC114827836|LOC114827839|LOC115804257|LOC115804258|LOC115804259|LOC115804260|LOC115804261|LOC115945147|LOC115945149|LOC115945150|LOC115945151|LOC115945152|LOC115945153|LOC115945154|LOC115945155|LOC115945156|LOC115945157|LOC115945158|LOC115945159|LOC115945160|LOC115945161|LOC115945162|LOC115945164|LOC115945183|LOC120961742|LOC120961743|LOC120961744|LOC120961745|LOC120961746|LOC120961747|LOC120961748|LOC120961749|LOC120961750|LOC120961751|LOC120961752|LOC120961753|LOC120961754|LOC120961755|LOC120961756|LOC120961757|LOC120961758|LOC120961759|LOC120961760|LOC120961761|LOC120961762|LOC120961763|LOC120961764|LOC120961765|LOC120961766|LOC120961767|LOC120961768|LOC121725079|LOC121725080|LOC121725081|LOC121725082|LOC121725083|LOC121725084|LOC121725085|LOC121725086|LOC121725087|LOC121725088|LOC121725089|LOC121725090|LOC121725091|LOC121725092|LOC121725093|LOC121725094|LOC121725095|LOC121725096|LOC121725097|LOC122710289|LOC122756371|LOC122756372|LOC122756373|LOC122756374|LOC122756375|LOC122756376|LOC122756377|LOC122756378|LOC122756379|LOC122756380|LOC122756381|LOC122756382|LOC122756383|LOC122756384|LOC122756385|LOC122756386|LOC122756387|LOC122756388|LOC122756389|LOC122756390|LOC122756391|LOC122756392|LOC122756393|LOC122756667|LOC122756668|LOC122756669|LOC122756670|LOC122756671|LOC122756672|LOC122756673|LOC122756674|LOC122756675|LOC122756676|LOC122756677|LOC122756678|LOC122756679|LOC122756680|LOC122756681|LOC122756682|LOC122756683|LOC122756684|LOC122756685|LOC122756686|LOC122756687|LOC122756688|LOC122756689|LOC122756690|LOC122756691|LOC122757916|LOC122757917|LOC122757918|LOC122757919|LOC122757920|LOC122757921|LOC122757922|LOC122757923|LOC122757924|LOC122757925|LOC122757926|LOC122757927|LOC122757928|LOC122757929|LOC122757930|LOC122757931|LOC122757932|LOC122757933|LOC122757934|LOC122757935|LOC122757936|LOC122757937|LOC122757938|LOC122757939|LOC122757940|LOC122757941|LOC122757942|LOC122757943|LOC122757944|LOC122757945|LOC122757946|LOC122757947|LOC122757948|LOC122757949|LOC122757950|LOC122757951|LOC122757952|LOC122757953|LOC122757954|LOC122757955|LOC122757956|LOC122757957|LOC122757958|LOC122757959|LOC122757960|LOC122757961|LOC122757962|LOC122757963|LOC122757964|LOC122757965|LOC122757966|LOC122787130|LOC122787131|LOC122787132|LOC122787133|LOC122787134|LOC122787135|LOC122787136|LOC122787137|LOC122787138|LOC122787139|LOC122787140|LOC122787141|LOC122787142|LOC122787143|LOC122787144|LOC122787145|LOC122787146|LOC122787147|LOC122787148|LOC126264115|LOC126806123|LOC126806124|LOC126806125|LOC126806126|LOC126806127|LOC126806128|LOC126806129|LOC126806130|LOC126806131|LOC126806132|LOC126806133|LOC126806134|LOC126806135|LOC126806136|LOC126806137|LOC126806138|LOC126806139|LOC126806140|LOC126806141|LOC126806142|LOC126806143|LOC126806144|LOC126806145|LOC126806146|LOC126806147|LOC126806148|LOC126806149|LOC126806150|LOC126806151|LOC126806152|LOC126806153|LOC126806154|LOC126806155|LOC126806156|LOC126806157|LOC126806158|LOC126806159|LOC126806160|LOC126806161|LOC126806162|LOC126806163|LOC126806164|LOC126806165|LOC126806166|LOC126806167|LOC126806168|LOC126806169|LOC126806170|LOC126806171|LOC126806172|LOC126806173|LOC126806174|LOC126806175|LOC126806176|LOC126806177|LOC126806178|LOC126806179|LOC126806180|LOC126806181|LOC126806182|LOC126806183|LOC126806184|LOC126806185|LOC126806186|LOC126806187|LOC126806188|LOC126806189|LOC126806190|LOC126806191|LOC126806192|LOC126806193|LOC126806194|LOC126806195|LOC126806196|LOC126806197|LOC126806198|LOC126806199|LOC126806200|LOC126806201|LOC126806202|LOC126806203|LOC126806204|LOC126806205|LOC126806206|LOC126806207|LOC126806208|LOC126806209|LOC126806210|LOC126806211|LOC126806212|LOC126806213|LOC126806214|LOC126806215|LOC126806216|LOC126806217|LOC126806218|LOC126806219|LOC126806220|LOC126806221|LOC126806222|LOC126806223|LOC126806224|LOC126806225|LOC126806226|LOC126806227|LOC126806228|LOC126806229|LOC126806230|LOC126806231|LOC126806232|LOC126806233|LOC126806234|LOC126806235|LOC126806236|LOC126806237|LOC126806238|LOC126806239|LOC126806240|LOC126806241|LOC126806242|LOC126806243|LOC126806244|LOC126806245|LOC126806246|LOC126806247|LOC126806248|LOC126806249|LOC126806250|LOC126806251|LOC126806252|LOC126806253|LOC126806254|LOC126806255|LOC126806256|LOC126806257|LOC126806258|LOC126806259|LOC126806260|LOC126806261|LOC126806262|LOC126806263|LOC126806264|LOC126806265|LOC126806266|LOC128772246|LOC128772247|LOC128772248|LOC128772249|LOC128772250|LOC128772251|LOC128772252|LOC128772253|LOC128772254|LOC128897170|LOC128897171|LOC129388817|LOC129388818|LOC129388819|LOC129388820|LOC129388821|LOC129388822|LOC129388823|LOC129388824|LOC129388825|LOC129388826|LOC129388827|LOC129388828|LOC129388829|LOC129388830|LOC129388831|LOC129388832|LOC129388833|LOC129388834|LOC129388835|LOC129388836|LOC129388837|ST3GAL5-AS1|STAMBP|STON1|STON1-GTF2A1L|STPG4|STRN|SUCLG1|SULT6B1|SUPT7L|TACR1|TACR1-AS1|TAF1B|TCF23|TCF7L1|TCF7L1-IT1|TDRD15|TET3|TEX261|TGFA|TGFA-IT1|TGOLN2|THADA|THUMPD2|TIA1|TLX2|TMEM150A|TMEM17|TMEM178A|TMEM214|TMEM247|TMSB10|TOGARAM2|TP53I3|TPRKB|TRA-AGC8-1|TRABD2A|TRG-CCC2-1|TRI-TAT2-1|TRIB2|TRIM54|TRMT61B|TRY-GTA2-1|TSPYL6|TTC27|TTC31|TTC32|TTC7A|UBXN2A|UCN|UGP2|USP34|USP34-DT|USP39|VAMP5|VAMP8|VAX2|VIT|VPS54|VRK2|VSNL1|WBP1|WDCP|WDPCP|WDR35|WDR35-DT|WDR43|WDR54|XDH|XPO1|YIPF4|YPEL5|YWHAQ|ZFP36L2|ZNF512|ZNF513|ZNF638|LOC129388838|LOC129388839|LOC129388840|LOC129388841|LOC129388842|LOC129388843|LOC129388844|LOC129388845|LOC129388846|LOC129388847|LOC129388848|LOC129388849|LOC129388850|LOC129388851|LOC129388852|LOC129388853|LOC129388854|LOC129388855|LOC129388856|LOC129388857|LOC129388858|LOC129388859|LOC129388860|LOC129388861|LOC129388862|LOC129388863|LOC129388864|LOC129388865|LOC129388866|LOC129388867|LOC129388868|LOC129388869|LOC129388870|LOC129388871|LOC129388872|LOC129388873|LOC129388874|LOC129388875|LOC129388876|LOC129388877|LOC129388878|LOC129388879|LOC129388880|LOC129388881|LOC129388882|LOC129388883|LOC129388884|LOC129388885|LOC129388886|LOC129388887|LOC129456127|LOC129933025|LOC129933026|LOC129933027|LOC129933028|LOC129933029|LOC129933030|LOC129933031|LOC129933032|LOC129933033|LOC129933034|LOC129933035|LOC129933036|LOC129933037|LOC129933038|LOC129933039|LOC129933040|LOC129933041|LOC129933042|LOC129933043|LOC129933044|LOC129933045|LOC129933046|LOC129933047|LOC129933048|LOC129933049|LOC129933050|LOC129933051|LOC129933052|LOC129933053|LOC129933054|LOC129933055|LOC129933056|LOC129933057|LOC129933058|LOC129933059|LOC129933060|LOC129933061|LOC129933062|LOC129933063|LOC129933064|LOC129933065|LOC129933066|LOC129933067|LOC129933068|LOC129933069|LOC129933070|LOC129933071|LOC129933072|LOC129933073|LOC129933074|LOC129933075|LOC129933076|LOC129933077|LOC129933078|LOC129933079|LOC129933080|LOC129933081|LOC129933082|LOC129933083|LOC129933084|LOC129933085|LOC129933086|LOC129933087|LOC129933088|LOC129933089|LOC129933090|LOC129933091|LOC129933092|LOC129933093|LOC129933094|LOC129933095|LOC129933096|LOC129933097|LOC129933098|LOC129933099|LOC129933100|LOC129933101|LOC129933102|LOC129933103|LOC129933104|LOC129933105|LOC129933106|LOC129933107|LOC129933108|LOC129933109|LOC129933110|LOC129933111|LOC129933112|LOC129933113|LOC129933114|LOC129933115|LOC129933116|LOC129933117|LOC129933118|LOC129933119|LOC129933120|LOC129933121|LOC129933122|LOC129933123|LOC129933124|LOC129933125|LOC129933126|LOC129933127|LOC129933128|LOC129933129|LOC129933130|LOC129933131|LOC129933132|LOC129933133|LOC129933134|LOC129933135|LOC129933136|LOC129933137|LOC129933138|LOC129933139|LOC129933140|LOC129933141|LOC129933142|LOC129933143|LOC129933144|LOC129933145|LOC129933146|LOC129933147|LOC129933148|LOC129933149|LOC129933150|LOC129933151|LOC129933152|LOC129933153|LOC129933154|LOC129933155|LOC129933156|LOC129933157|LOC129933158|LOC129933159|LOC129933160|LOC129933161|LOC129933162|LOC129933163|LOC129933164|LOC129933165|LOC129933166|LOC129933167|LOC129933168|LOC129933169|LOC129933170|LOC129933171|LOC129933172|LOC129933173|LOC129933174|LOC129933175|LOC129933176|LOC129933177|LOC129933178|LOC129933179|LOC129933180|LOC129933181|LOC129933182|LOC129933183|LOC129933184|LOC129933185|LOC129933186|LOC129933187|LOC129933188|LOC129933189|LOC129933190|LOC129933191|LOC129933192|LOC129933193|LOC129933194|LOC129933195|LOC129933196|LOC129933197|LOC129933198|LOC129933199|LOC129933200|LOC129933201|LOC129933202|LOC129933203|LOC129933204|LOC129933205|LOC129933206|LOC129933207|LOC129933208|LOC129933209|LOC129933210|LOC129933211|LOC129933212|LOC129933213|LOC129933214|LOC129933215|LOC129933216|LOC129933217|LOC129933218|LOC129933219|LOC129933220|LOC129933221|LOC129933222|LOC129933223|LOC129933224|LOC129933225|LOC129933226|LOC129933227|LOC129933228|LOC129933229|LOC129933230|LOC129933231|LOC129933232|LOC129933233|LOC129933234|LOC129933235|LOC129933236|LOC129933237|LOC129933238|LOC129933239|LOC129933240|LOC129933241|LOC129933242|LOC129933243|LOC129933244|LOC129933245|LOC129933246|LOC129933247|LOC129933248|LOC129933249|LOC129933250|LOC129933251|LOC129933252|LOC129933253|LOC129933254|LOC129933255|LOC129933256|LOC129933257|LOC129933258|LOC129933259|LOC129933260|LOC129933261|LOC129933262|LOC129933263|LOC129933264|LOC129933265|LOC129933266|LOC129933267|LOC129933268|LOC129933269|LOC129933270|LOC129933271|LOC129933272|LOC129933273|LOC129933274|LOC129933275|LOC129933276|LOC129933277|LOC129933278|LOC129933279|LOC129933280|LOC129933281|LOC129933282|LOC129933283|LOC129933284|LOC129933285|LOC129933286|LOC129933287|LOC129933288|LOC129933289|LOC129933290|LOC129933291|LOC129933292|LOC129933293|LOC129933294|LOC129933295|LOC129933296|LOC129933297|LOC129933298|LOC129933299|LOC129933300|LOC129933301|LOC129933302|LOC129933303|LOC129933304|LOC129933305|LOC129933306|LOC129933307|LOC129933308|LOC129933309|LOC129933310|LOC129933311|LOC129933312|LOC129933313|LOC129933314|LOC129933315|LOC129933316|LOC129933317|LOC129933318|LOC129933319|LOC129933320|LOC129933321|LOC129933322|LOC129933323|LOC129933324|LOC129933325|LOC129933326|LOC129933327|LOC129933328|LOC129933329|LOC129933330|LOC129933331|LOC129933332|LOC129933333|LOC129933334|LOC129933335|LOC129933336|LOC129933337|LOC129933338|LOC129933339|LOC129933340|LOC129933341|LOC129933342|LOC129933343|LOC129933344|LOC129933345|LOC129933346|LOC129933347|LOC129933348|LOC129933349|LOC129933350|LOC129933351|LOC129933352|LOC129933353|LOC129933354|LOC129933355|LOC129933356|LOC129933357|LOC129933358|LOC129933359|LOC129933360|LOC129933361|LOC129933362|LOC129933363|LOC129933364|LOC129933365|LOC129933366|LOC129933367|LOC129933368|LOC129933369|LOC129933370|LOC129933371|LOC129933372|LOC129933373|LOC129933374|LOC129933375|LOC129933376|LOC129933377|LOC129933378|LOC129933379|LOC129933380|LOC129933381|LOC129933382|LOC129933383|LOC129933384|LOC129933385|LOC129933386|LOC129933387|LOC129933388|LOC129933389|LOC129933390|LOC129933391|LOC129933392|LOC129933393|LOC129933394|LOC129933395|LOC129933396|LOC129933397|LOC129933398|LOC129933399|LOC129933400|LOC129933401|LOC129933402|LOC129933403|LOC129933404|LOC129933405|LOC129933406|LOC129933407|LOC129933408|LOC129933409|LOC129933410|LOC129933411|LOC129933412|LOC129933413|LOC129933414|LOC129933415|LOC129933416|LOC129933417|LOC129933418|LOC129933419|LOC129933420|LOC129933421|LOC129933422|LOC129933423|LOC129933424|LOC129933425|LOC129933426|LOC129933427|LOC129933428|LOC129933429|LOC129933430|LOC129933431|LOC129933432|LOC129933433|LOC129933434|LOC129933435|LOC129933436|LOC129933437|LOC129933438|LOC129933439|LOC129933440|LOC129933441|LOC129933442|LOC129933443|LOC129933444|LOC129933445|LOC129933446|LOC129933447|LOC129933448|LOC129933449|LOC129933450|LOC129933451|LOC129933452|LOC129933453|LOC129933454|LOC129933455|LOC129933456|LOC129933457|LOC129933458|LOC129933459|LOC129933460|LOC129933461|LOC129933462|LOC129933463|LOC129933464|LOC129933465|LOC129933466|LOC129933467|LOC129933468|LOC129933469|LOC129933470|LOC129933471|LOC129933472|LOC129933473|LOC129933474|LOC129933475|LOC129933476|LOC129933477|LOC129933478|LOC129933479|LOC129933480|LOC129933481|LOC129933482|LOC129933483|LOC129933484|LOC129933485|LOC129933486|LOC129933487|LOC129933488|LOC129933489|LOC129933490|LOC129933491|LOC129933492|LOC129933493|LOC129933494|LOC129933495|LOC129933496|LOC129933497|LOC129933498|LOC129933499|LOC129933500|LOC129933501|LOC129933502|LOC129933503|LOC129933504|LOC129933505|LOC129933506|LOC129933507|LOC129933508|LOC129933509|LOC129933510|LOC129933511|LOC129933512|LOC129933513|LOC129933514|LOC129933515|LOC129933516|LOC129933518|LOC129933519|LOC129933520|LOC129933521|LOC129933522|LOC129933523|LOC129933524|LOC129933525|LOC129933526|LOC129933527|LOC129933528|LOC129933529|LOC129933530|LOC129933531|LOC129933532|LOC129933533|LOC129933534|LOC129933535|LOC129933536|LOC129933537|LOC129933538|LOC129933539|LOC129933540|LOC129933541|LOC129933542|LOC129933543|LOC129933544|LOC129933545|LOC129933546|LOC129933547|LOC129933548|LOC129933549|LOC129933550|LOC129933551|LOC129933552|LOC129933553|LOC129933554|LOC129933555|LOC129933556|LOC129933557|LOC129933558|LOC129933559|LOC129933560|LOC129933561|LOC129933562|LOC129933563|LOC129933564|LOC129933565|LOC129933566|LOC129933567|LOC129933568|LOC129933569|LOC129933570|LOC129933571|LOC129933572|LOC129933573|LOC129933574|LOC129933575|LOC129933576|LOC129933577|LOC129933578|LOC129933579|LOC129933580|LOC129933581|LOC129933582|LOC129933583|LOC129933584|LOC129933585|LOC129933586|LOC129933587|LOC129933588|LOC129933589|LOC129933590|LOC129933591|LOC129933592|LOC129933593|LOC129933594|LOC129933595|LOC129933596|LOC129933597|LOC129933598|LOC129933599|LOC129933600|LOC129933601|LOC129933602|LOC129933603|LOC129933604|LOC129933605|LOC129933606|LOC129933607|LOC129933608|LOC129933609|LOC129933610|LOC129933611|LOC129933612|LOC129933613|LOC129933614|LOC129933615|LOC129933616|LOC129933617|LOC129933618|LOC129933619|LOC129933620|LOC129933621|LOC129933622|LOC129933623|LOC129933624|LOC129933625|LOC129933626|LOC129933627|LOC129933628|LOC129933629|LOC129933630|LOC129933631|LOC129933632|LOC129933633|LOC129933634|LOC129933635|LOC129933636|LOC129933637|LOC129933638|LOC129933639|LOC129933640|LOC129933641|LOC129933642|LOC129933643|LOC129933644|LOC129933645|LOC129933646|LOC129933647|LOC129933648|LOC129933649|LOC129933650|LOC129933651|LOC129933652|LOC129933653|LOC129933654|LOC129933655|LOC129933656|LOC129933657|LOC129933658|LOC129933659|LOC129933660|LOC129933661|LOC129933662|LOC129933663|LOC129933664|LOC129933665|LOC129933666|LOC129933667|LOC129933668|LOC129933669|LOC129933670|LOC129933671|LOC129933672|LOC129933673|LOC129933674|LOC129933675|LOC129933676|LOC129933677|LOC129933678|LOC129933679|LOC129933680|LOC129933681|LOC129933682|LOC129933683|LOC129933684|LOC129933685|LOC129933686|LOC129933687|LOC129933688|LOC129933689|LOC129933690|LOC129933691|LOC129933692|LOC129933693|LOC129933694|LOC129933695|LOC129933696|LOC129933697|LOC129933698|LOC129933699|LOC129933700|LOC129933701|LOC129933702|LOC129933703|LOC129933704|LOC129933705|LOC129933706|LOC129933707|LOC129933708|LOC129933709|LOC129933710|LOC129933711|LOC129933712|LOC129933713|LOC129933714|LOC129933715|LOC129933716|LOC129933717|LOC129933718|LOC129933719|LOC129933720|LOC129933721|LOC129933722|LOC129933723|LOC129933724|LOC129933725|LOC129933726|LOC129933727|LOC129933728|LOC129933729|LOC129933730|LOC129933731|LOC129933732|LOC129933733|LOC129933734|LOC129933735|LOC129933736|LOC129933737|LOC129933738|LOC129933739|LOC129933740|LOC129933741|LOC129933742|LOC129933743|LOC129933744|LOC129933745|LOC129933746|LOC129933747|LOC129933748|LOC129933749|LOC129933750|LOC129933751|LOC129933752|LOC129933753|LOC129933754|LOC129933755|LOC129933756|LOC129933757|LOC129933758|LOC129933759|LOC129933760|LOC129933761|LOC129933762|LOC129933763|LOC129933764|LOC129933765|LOC129933766|LOC129933767|LOC129933768|LOC129933769|LOC129933770|LOC129933771|LOC129933772|LOC129933773|LOC129933774|LOC129933775|LOC129933776|LOC129933777|LOC129933778|LOC129933779|LOC129933780|LOC129933781|LOC129933782|LOC129933783|LOC129933784|LOC129933785|LOC129933786|LOC129933787|LOC129933788|LOC129933789|LOC129933790|LOC129933791|LOC129933792|LOC129933793|LOC129933794|LOC129933795|LOC129933796|LOC129933797|LOC129933798|LOC129933799|LOC129933800|LOC129933801|LOC129933802|LOC129933803|LOC129933804|LOC129933805|LOC129933806|LOC129933807|LOC129933808|LOC129933809|LOC129933810|LOC129933811|LOC129933812|LOC129933813|LOC129933814|LOC129933815|LOC129933816|LOC129933817|LOC129933818|LOC129933819|LOC129933820|LOC129933821|LOC129933822|LOC129933823|LOC129933824|LOC129933825|LOC129933826|LOC129933827|LOC129933828|LOC129933829|LOC129933830|LOC129933831|LOC129933832|LOC129933833|LOC129933834|LOC129933835|LOC129933836|LOC129933837|LOC129933838|LOC129933839|LOC129933840|LOC129933841|LOC129933842|LOC129933843|LOC129933844|LOC129933845|LOC129933846|LOC129933847|LOC129933848|LOC129933849|LOC129933850|LOC129933851|LOC129933852|LOC129933853|LOC129933854|LOC129933855|LOC129933856|LOC129933857|LOC129933858|LOC129933859|LOC129933860|LOC129933861|LOC129933862|LOC129933863|LOC129933864|LOC129933865|LOC129933866|LOC129933867|LOC129933868|LOC129933869|LOC129933870|LOC129933871|LOC129933872|LOC129933873|LOC129933874|LOC129933875|LOC129933876|LOC129933877|LOC129933878|LOC129933879|LOC129933880|LOC129933881|LOC129933882|LOC129933883|LOC129933884|LOC129933885|LOC129933886|LOC129933887|LOC129933888|LOC129933889|LOC129933890|LOC129933891|LOC129933892|LOC129933893|LOC129933894|LOC129933895|LOC129933896|LOC129933897|LOC129933898|LOC129933899|LOC129933900|LOC129933901|LOC129933902|LOC129933903|LOC129933904|LOC129933905|LOC129933906|LOC129933907|LOC129933908|LOC129933909|LOC129933910|LOC129933911|LOC129933912|LOC129933913|LOC129933914|LOC129933915|LOC129933916|LOC129933917|LOC129933918|LOC129933919|LOC129933920|LOC129933921|LOC129933922|LOC129933923|LOC129933924|LOC129933925|LOC129933926|LOC129933927|LOC129933928|LOC129933929|LOC129933930|LOC129933931|LOC129933932|LOC129933933|LOC129933934|LOC129933935|LOC129933936|LOC129933937|LOC129933938|LOC129933939|LOC129933940|LOC129933941|LOC129933942|LOC129933943|LOC129933944|LOC129933945|LOC129933946|LOC129933947|LOC129933948|LOC129933949|LOC129933950|LOC129933951|LOC129933952|LOC129933953|LOC129933954|LOC129933955|LOC129933956|LOC129933957|LOC129933958|LOC129933959|LOC129933960|LOC129933961|LOC129933962|LOC129933963|LOC129933964|LOC129933965|LOC129933966|LOC129933967|LOC129933968|LOC129933969|LOC129933970|LOC129933971|LOC129933972|LOC129933973|LOC129933974|LOC129933975|LOC129933976|LOC129933977|LOC129933978|LOC129933979|LOC129933980|LOC129933981|LOC129933982|LOC129933983|LOC129933984|LOC129933985|LOC129933986|LOC129933987|LOC129933988|LOC129933989|LOC129933990|LOC129933991|LOC129933992|LOC129933993|LOC129933994|LOC129933995|LOC129933996|LOC129933997|LOC129933998|LOC129933999|LOC129934000|LOC129934001|LOC129934002|LOC129934003|LOC129934004|LOC129934005|AAK1|ABCG5|ABCG8|ABHD1|ACTG2|ACTR2|ACYP2|ADAM17|ADCY3|ADD2|ADGRF3|AFTPH|AFTPH-DT|AGBL5|AGBL5-AS1|ALK|ALMS1|ALMS1-IT1|ANKRD53|ANTXR1|ANXA4|APLF|APOB|APOB-ICR|APOB3'MAR|ARHGAP25|ARHGEF33|ASAP2|ASB3|ASPRV1|ASXL2|ATAD2B|ATL2|ATOH8|ATP6V1B1|ATP6V1B1-AS1|ATP6V1C2|ATP6V1E2|ATRAID|AUP1|B3GNT2|BABAM2|BABAM2-AS1|BCL11A|BCYRN1|BIRC6|BIRC6-AS2|BMP10|BOLA3|BOLA3-DT|C1D|C1GALT1C1L|C2orf42|C2orf48|C2orf68|C2orf74|C2orf74-AS1|C2orf74-DT|C2orf78|C2orf81|CAD|CALM2|CAMKMT|CAPG|CAPN13|CAPN14|CCDC121|CCDC142|CCDC85A|CCDC88A|CCT4|CCT7|CD207|CD8A|CD8B|CDC42EP3|CDKL4|CEBPZ|CEBPZOS|CENPA|CENPO|CEP68|CFAP36|CGREF1|CHAC2|CHMP3|CHMP3-AS1|CIB4|CIMIP2C|CIMIP5|CIMIP6|CLEC4F|CLHC1|CLIP4|CNRIP1|COMMD1|COX7A2L|CPSF3|CRIM1|CRIM1-DT|CRIPT|CTNNA2|CTNNA2-AS1|CYP1B1|CYP1B1-AS1|CYP26B1|CYRIA|CYS1|CYTOR|DCTN1|DCTN1-AS1|DDX1|DGUOK|DGUOK-AS1|DHX57|DNAAF10|DNAH6|DNAJC27|DNAJC27-AS1|DNAJC5G|DNMT3A|DOK1|DPY30|DPYSL5|DQX1|DRC1|DTNB|DTNB-AS1|DUSP11|DYNC2LI1|DYSF|E2F6|EFEMP1|EFR3B|EGR4|EHBP1|EHBP1-AS1|EHD3|EIF2AK2|EIF2B4|ELMOD3|EMILIN1|EML4|EML4-AS1|EML6|EML6-AS1|EMX1|EPAS1|EPCAM|EPCAM-DT|ERLEC1|ETAA1|EVA1A|EVA1A-AS|EXOC6B|FAM136A|FAM161A|FAM228A|FAM228B|FAM98A|FANCL|FBXO11|FBXO41|FBXO48|FEZ2|FIGLA|FKBP1B|FLJ33534|FNDC4|FOSL2|FOSL2-AS1|FOXN2|FSHR|GACAT3|GALM|GALNT14|GAREM2|GCFC2|GCKR|GDF7|GEMIN6|GEN1|GFPT1|GGCX|GKN1|GKN2|GMCL1|GNLY|GPATCH11|GPN1|GPR75|GPR75-ASB3|GREB1|GRHL1|GTF2A1L|GTF3C2|GTF3C2-AS1|GTF3C2-AS2|HAAO|HADHA|HADHB|HCNR606|HCNR617|HEATR5B|HHC2:065915|HHC2:065944|HHC2:066104|HHC2:066522|HHC2:066588|HHC2:066628|HHC2:066644|HHC2:066650|HHC2:066659|HHC2:066683|HHC2:067347|HK2|HK2-DT|HNRNPLL|HPCAL1|HS1BP3|HS1BP3-IT1|HTRA2|IAH1|ID2|ID2-AS1|IFT172|IMMT|INO80B|INO80B-WBP1|ITGB1BP1|ITSN2|KCMF1|KCNF1|KCNG3|KCNK12|KCNK3|KCNS3|KDM3A|KHK|KIDINS220|KIF3C|KLF11|KLF11-DT|KLHL29|KRTCAP3|LAPTM4A|LAPTM4A-DT|LBH|LBX2|LBX2-AS1|LCLAT1|LDAH|LGALSL|LHCGR|LINC00276|LINC00298|LINC00299|LINC00309|LINC00486|LINC00570|LINC00954|LINC01118|LINC01119|LINC01121|LINC01122|LINC01126|LINC01143|LINC01291|LINC01317|LINC01318|LINC01320|LINC01376|LINC01381|LINC01460|LINC01628|LINC01793|LINC01794|LINC01795|LINC01797|LINC01798|LINC01799|LINC01800|LINC01804|LINC01805|LINC01808|LINC01809|LINC01812|LINC01813|LINC01814|LINC01815|LINC01816|LINC01819|LINC01820|LINC01822|LINC01828|LINC01829|LINC01830|LINC01833|LOC129934006|LOC129934007|LOC129934008|LOC129934009|LOC129934010|LOC129934011|LOC129934012|LOC129934013|LOC129934014|LOC129934015|LOC129934016|LOC129934017|LOC129934018|LOC129934019|LOC129934020|LOC129934021|LOC129934022|LOC129934023|LOC129934024|LOC129934025|LOC129934026|LOC129934027|LOC129934028|LOC129934029|LOC129934030|LOC129934031|LOC129934032|LOC129934033|LOC129934034|LOC129934035|LOC129934036|LOC129934037|LOC129934038|LOC129934039|LOC129934040|LOC129934041|LOC129934042|LOC129934043|LOC129934044|LOC129934045|LOC129934046|LOC129934047|LOC129934048|LOC129934049|LOC129934050|LOC129934051|LOC129934052|LOC129934053|LOC129934054|LOC129934055|LOC129934056|LOC129934057|LOC129934058|LOC129934059|LOC129934060|LOC129934061|LOC129934062|LOC129934063|LOC129934064|LOC129934065|LOC129934066|LOC129934067|LOC129934068|LOC129934069|LOC129934070|LOC129934071|LOC129934072|LOC129934073|LOC129934074|LOC129934075|LOC129934076|LOC129934077|LOC129934078|LOC129934079|LOC129934080|LOC129934081|LOC129934082|LOC129934083|LOC129934084|LOC129934085|LOC129934086|LOC129934087|LOC129934088|LOC129934089|LOC129934090|LOC129934091|LOC129934092|LOC129934093|LOC129934094|LOC129934095|LOC129934096|LOC129934097|LOC129934098|LOC129934099|LOC129934100|LOC129934101|LOC129934102|LOC129934103|LOC129934104|LOC129934105|LOC129934106|LOC129934107|LOC129934108|LOC129934109|LOC129934110|LOC129934111|LOC129934112|LOC129934113|LOC129934114|LOC129934115|LOC129934116|LOC129934117|LOC129934118|LOC129934119|LOC129934120|LOC129934121|LOC129934122|LOC129934123|LOC129934124|LOC129934125|LOC129934126|LOC129934127|LOC129934128|LOC129934129|LOC129934130|LOC129934131|LOC129934132|LOC129934133|LOC129934134|LOC129934135|LOC129934136|LOC129934137|LOC129934138|LOC129934139|LOC129934140|LOC129934141|LOC129934142|LOC129934143|LOC129934144|LOC129934145|LOC129934146|LOC129934147|LOC129934148|LOC129934149|LOC129934150|LOC129934151|LOC129934152|LOC129934153|LOC129934154|LOC129934155|LOC129934156|LOC129934157|LOC129934158|LOC129934159|LOC129934160|LOC129934161|LOC129934162|LOC129934163|LOC129934164|LOC129934165|LOC129934166|LOC129934167|LOC129934168|LOC129934169|LOC129934170|LOC129934171|LOC129934172|LOC129934173|LOC129934174|LOC129934175|LOC129934176|LOC129934177|LOC129934178|LOC129934179|LOC129934180|LOC129934181|LOC129934182|LOC129934183|LOC129934184|LOC129934185|LOC129934186|LOC129934187|LOC129934188|LOC129934189|LOC129934190|LOC129934191|LOC129934192|LOC129934193|LOC129934194|LOC129934195|LOC129934196|LOC129934197|LOC129934198|LOC129934199|LOC129934200|LOC129934201|LOC129934202|LOC129934203|LOC129934204|LOC129934205|LOC129934206|LOC129934207|LOC129934208|LOC129934209|LOC129934210|LOC129934211|LOC129934212|LOC129934213|LOC129934214|LOC129934215|LOC129934216|LOC129934217|LOC129934218|LOC129934219|LOC129934220|LOC129934221|LOC129934222|LOC129934223|LOC129934224|LOC129934225|LOC129934226|LOC129934227|LOC129934228|LOC129934229|LOC129934230|LOC129934231|LOC129934232|LOC129934233|LOC129934234|LOC129934235|LOC129934236|LOC129934237|LOC129934238|LOC129934239|LOC129934240|LOC129934241|LOC129934242|LOC129934243|LOC129934244|LOC129934245|LOC129934246|LOC129934247|LOC129934248|LOC129934249|LOC129934250|LOC129934251|LOC129934252|LOC129934253|LOC129934254|LOC129934255|LOC129934256|LOC129934257|LOC129934258|LOC129934259|LOC129934260|LOC129934261|LOC129934262|LOC129934263|LOC129934264|LOC129934265|LOC129934266|LOC129934267|LOC132088754|LOC132088755|LOC132088756|LOC132088757|LOC132088838|LOC132088840|LOC132088845|LOC132088847|LOC132088848|LOC132088850|LOC132088851|LOC132088852|LOC132088853|LOC132088854|LOC132088855|LOC132088856|LOC132090678|LOC132090679|LOC284950|LOC375196|LOC653602|LOXL3|LPIN1|LRATD1|LRPPRC|LRRTM1|LRRTM4|LRRTM4-AS1|LTBP1|M1AP|MAP4K3|MAP4K3-DT|MAPRE3|MAPRE3-AS1|MAT2A|MATN3|MBOAT2|MCEE|MCFD2|MDH1|MEIS1|MEIS1-AS2|MEIS1-AS3|MEMO1|MFSD2B|MIR1285-2|MIR1301|MIR216A|MIR216B|MIR217|MIR217HG|MIR3125|MIR3126|MIR3681|MIR3681HG|MIR3682|MIR4261|MIR4262|MIR4263|MIR4264|MIR4429|MIR4430|MIR4431|MIR4432|MIR4432HG|MIR4433A|MIR4433B|MIR4434|MIR4435-1|MIR4757|MIR4765|MIR4771-1|MIR4778|MIR4779|MIR5000|MIR5192|MIR548AD|MIR548BA|MIR548S|MIR558|MIR559|MIR6071|MIR8080|MIR8485|MOB1A|MOGS|MORN2|MPHOSPH10|MPV17|MRPL19|MRPL33|MRPL35|MRPL53|MSGN1|MSH2|MSH2-OT1|MSH6|MTA3|MTHFD2|MTIF2|MXD1|MYCN|MYCNOS|MYCNUT|NAGK|NAT8|NAT8B|NBAS|NCAL1|NCOA1|NDUFAF7|NFU1|NLRC4|NOL10|NOTO|NRBP1|NRXN1|NRXN1-DT|NT5C1B|NT5C1B-RDH14|NTSR2|ODC1|ODC1-DT|OSR1|OST4|OTOF|OTX1|OXER1|PAIP2B|PAPOLG|PARTICL|PCARE|PCBP1|PCBP1-AS1|PCGF1|PCYOX1|PDIA6|PELI1|PEX13|PFN4|PIGF|PIRAT1|PKDCC|PLB1|PLEK|PLEKHH2|PLGLB1|PNO1|PNPT1|POLE4|POLR1A|POMC|PPM1B|PPM1B-DT|PPM1G|PPP1CB|PPP1R21|PPP3R1|PPP4R3B|PPP4R3B-DT|PRADC1|PREB|PREPL|PRKCE|PRKCE-AS1|PRKD3|PRKD3-DT|PROKR1|PRR30|PSME4|PTCD3|PTRHD1|PUM2|PUS10|QPCT|RAB10|RAB11FIP5|RAB1A|RAD51AP2|RASGRP3|RASGRP3-AS1|RBKS|RDH14|REEP1|REG1A|REG1B|REG3A|REG3G|REL|REL-DT|RETSAT|RGPD1|RHOB|RHOQ|RHOQ-AS1|RMDN2|RMDN2-AS1|RMND5A|RNF103|RNF103-CHMP3|RNF181|ROCK2|RPS27A|RRM2|RTKN|RTN4|SANBR|SDC1|SELENOI|SEMA4F|SERTAD2|SERTAD2-AS1|SF3B6|SFTPB|SFXN5|SH2D6|SIX2|SIX3|SIX3-AS1|SLC1A4|SLC30A3|SLC30A6|SLC30A6-DT|SLC35F6|SLC3A1|SLC4A1AP|SLC4A5|SLC5A6|SLC66A3|SLC8A1|SLC8A1-AS1|SMANTIS|SMC6|SMYD5|SNAR-H|SNORA10B|SNORA36C|SNORA70B|SNORA80B|SNORD53|SNORD53B|SNORD92|SNORD94|SNRNP27|SNRPG|SNX17|SOCS5|SOS1|SOS1-IT1|SPAST|SPATA31H1|SPDYA|SPR|SPRED2|SPTBN1|SPTBN1-AS1|SPTBN1-AS2|SRBD1|SRD5A2|SRSF7|ST3GAL5		See cases	VCV000152995	2	7635254 - 88005418	2	7495123 - 87705899	152995	162746			copy number gain		Benign	Feb 4, 2013	no assertion criteria provided							
GRCh38/hg38 2p23.2(chr2:28557445-29437643)x3	ALK|CLIP4|LOC100505774|LOC108281152|LOC112840923|LOC121725086|LOC122756682|LOC122756683|LOC129388837|LOC129933397|LOC129933398|LOC129933399|LOC129933400|LOC129933401|LOC129933402|LOC129933403|LOC129933404|LOC129933405|LOC129933406|LOC129933407|LOC129933408|LOC129933409|LOC129933410|LOC129933411|LOC129933412|LOC129933413|LOC129933414|LOC129933415|LOC129933416|PCARE|PLB1|PPP1CB|SNORD53|SNORD53B|SNORD92|SPDYA|TOGARAM2|TRMT61B|WDR43		See cases	VCV000155287	2	28780312 - 29660509	2	28557445 - 29437643	155287	165041			copy number gain		Uncertain significance	Apr 16, 2013	no assertion criteria provided							
GRCh38/hg38 2p23.2(chr2:28561270-29446956)x3	ALK|CLIP4|LOC100505774|LOC108281152|LOC112840923|LOC121725086|LOC122756682|LOC122756683|LOC129388837|LOC129933397|LOC129933398|LOC129933399|LOC129933400|LOC129933401|LOC129933402|LOC129933403|LOC129933404|LOC129933405|LOC129933406|LOC129933407|LOC129933408|LOC129933409|LOC129933410|LOC129933411|LOC129933412|LOC129933413|LOC129933414|LOC129933415|LOC129933416|PCARE|PLB1|PPP1CB|SNORD53|SNORD53B|SNORD92|SPDYA|TOGARAM2|TRMT61B|WDR43		See cases	VCV000154217	2	28784137 - 29669822	2	28561270 - 29446956	154217	163968			copy number gain		Uncertain significance	Mar 18, 2014	no assertion criteria provided							
GRCh38/hg38 2p23.2(chr2:28574111-29442195)x3	ALK|CLIP4|LOC100505774|LOC108281152|LOC112840923|LOC121725086|LOC122756682|LOC122756683|LOC129388837|LOC129933399|LOC129933400|LOC129933401|LOC129933402|LOC129933403|LOC129933404|LOC129933405|LOC129933406|LOC129933407|LOC129933408|LOC129933409|LOC129933410|LOC129933411|LOC129933412|LOC129933413|LOC129933414|LOC129933415|LOC129933416|PCARE|PLB1|PPP1CB|SNORD53|SNORD53B|SNORD92|SPDYA|TOGARAM2|TRMT61B|WDR43		See cases	VCV000149082	2	28796978 - 29665061	2	28574111 - 29442195	149082	158833			copy number gain		Uncertain significance	Jan 31, 2012	no assertion criteria provided							
NM_004304.5(ALK):c.*415G>A	ALK		Neuroblastoma Susceptibility	VCV000335676	2	29415675	2	29192809	335676	289357	rs886055925	NC_000002.12:29192808:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_004304.5(ALK):c.*407A>C	ALK		Neuroblastoma, susceptibility to, 3	VCV000899148	2	29415683	2	29192817	899148	884675	rs1668903341	NC_000002.12:29192816:T:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.*403T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV000895024	2	29415687	2	29192821	895024	884676	rs1668903533	NC_000002.12:29192820:A:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.*298C>T	ALK		not provided|Neuroblastoma, susceptibility to, 3	VCV000335677	2	29415792	2	29192926	335677	289362	rs1728828	NC_000002.12:29192925:G:A	single nucleotide variant	3 prime UTR variant	Benign	Jan 12, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.*246G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000895025	2	29415844	2	29192978	895025	884677	rs1668908633	NC_000002.12:29192977:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.*189T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV000335678	2	29415901	2	29193035	335678	286731	rs886055926	NC_000002.12:29193034:A:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.*185C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000335679	2	29415905	2	29193039	335679	288958	rs547955328	NC_000002.12:29193038:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.*111C>T	ALK		Neuroblastoma, susceptibility to, 3|not provided	VCV000335680	2	29415979	2	29193113	335680	285946	rs74669215	NC_000002.12:29193112:G:A	single nucleotide variant	3 prime UTR variant	Benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.*62_*65dup	ALK		Neuroblastoma Susceptibility	VCV000335681	2	29416024 - 29416025	2	29193158 - 29193159	335681	286735	rs886055927	NC_000002.12:29193158:CATT:CATTCATT	Duplication	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_004304.5(ALK):c.*61_*64dup	ALK		not provided|Neuroblastoma Susceptibility	VCV000335682	2	29416025 - 29416026	2	29193159 - 29193160	335682	288960	rs397706189	NC_000002.12:29193159:ATTG:ATTGATTG	Duplication	3 prime UTR variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.*63A>G	ALK		Neuroblastoma, susceptibility to, 3|not provided	VCV000335683	2	29416027	2	29193161	335683	288976	rs182561050	NC_000002.12:29193160:T:C	single nucleotide variant	3 prime UTR variant	Benign/Likely benign	Dec 24, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.*53G>C	ALK		not provided|Neuroblastoma, susceptibility to, 3	VCV000335684	2	29416037	2	29193171	335684	285952	rs80088378	NC_000002.12:29193170:C:G	single nucleotide variant	3 prime UTR variant	Benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.*45G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000335685	2	29416045	2	29193179	335685	286738	rs186421480	NC_000002.12:29193178:C:T	single nucleotide variant	3 prime UTR variant	Benign	Jan 12, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.4860_*12del (p.Ter1621LeuextTer?)	ALK		not provided|Neuroblastoma, susceptibility to, 3	VCV000947158	2	29416078 - 29416093	2	29193212 - 29193227	947158	922693	rs1456617295	NC_000002.12:29193211:GTGCGACCGAGCTCAGG:G	Deletion	frameshift variant	Uncertain significance	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NC_000002.11:g.(?_29416084)_(29754988_?)dup	ALK|LOC105374389|LOC122756683|LOC122756684		Neuroblastoma, susceptibility to, 3	VCV000538313	2	29416084 - 29754988	2	29193218 - 29532122	538313	516186			Duplication		Uncertain significance	Sep 4, 2017	criteria provided, single submitter							
Single allele	ALK|LOC122756683		Neuroblastoma, susceptibility to, 3	VCV000470729			2	29193218 - 29383865	470729	448538			Duplication		Uncertain significance	Apr 10, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.4861_*4del (p.Ter1621GlyextTer?)	ALK		Neuroblastoma, susceptibility to, 3	VCV002706000	2	29416086 - 29416092	2	29193220 - 29193226	2706000	2877325		NC_000002.12:29193219:GAGCTCAG:G	Deletion	frameshift variant|stop lost	Uncertain significance	Dec 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4862G>A (p.Ter1621=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001668158	2	29416091	2	29193225	1668158	1570023	rs1327032874	NC_000002.12:29193224:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4861T>C (p.Ter1621Arg)	ALK		Neuroblastoma, susceptibility to, 3	VCV001383984	2	29416092	2	29193226	1383984	1447580	rs2148136874	NC_000002.12:29193225:A:G	single nucleotide variant	stop lost	Uncertain significance	Oct 1, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4860C>G (p.Pro1620=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002156658	2	29416093	2	29193227	2156658	1882934		NC_000002.12:29193226:G:C	single nucleotide variant	synonymous variant	Likely benign	Feb 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4860C>T (p.Pro1620=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001595801	2	29416093	2	29193227	1595801	1569377	rs2148136879	NC_000002.12:29193226:G:A	single nucleotide variant	synonymous variant	Likely benign	May 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4859C>T (p.Pro1620Leu)	ALK	P552L, P1620L	Neuroblastoma, susceptibility to, 3	VCV000954390	2	29416094	2	29193228	954390	942839	rs1383494876	NC_000002.12:29193227:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4858C>T (p.Pro1620Ser)	ALK	P1620S, P552S	Hereditary cancer-predisposing syndrome	VCV003223916	2	29416095	2	29193229	3223916	3380938		NC_000002.12:29193228:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4857G>A (p.Gly1619=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001549031	2	29416096	2	29193230	1549031	1573146	rs2148136888	NC_000002.12:29193229:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4856G>A (p.Gly1619Glu)	ALK	G1619E, G551E	Hereditary cancer-predisposing syndrome	VCV003286014	2	29416097	2	29193231	3286014	3444754		NC_000002.12:29193230:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4856G>T (p.Gly1619Val)	ALK	G551V, G1619V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001743598	2	29416097	2	29193231	1743598	1801945		NC_000002.12:29193230:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4855G>A (p.Gly1619Arg)	ALK	G1619R, G551R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002133402	2	29416098	2	29193232	2133402	2190091		NC_000002.12:29193231:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4828_4854dup (p.Lys1610_Pro1618dup)	ALK		Neuroblastoma, susceptibility to, 3	VCV001038369	2	29416098 - 29416099	2	29193232 - 29193233	1038369	1024417	rs1668918005	NC_000002.12:29193232:AGGCTGGTTCATGCTATTCTTGCTTTT:AGGCTGGTTCATGCTATTCTTGCTTTTAGGCTGGTTCATGCTATTCTTGCTTTT	Duplication	inframe_insertion	Uncertain significance	Apr 6, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4854T>G (p.Pro1618=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003729423	2	29416099	2	29193233	3729423	3858752		NC_000002.12:29193232:A:C	single nucleotide variant	synonymous variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.4852C>A (p.Pro1618Thr)	ALK	P1618T, P550T	Hereditary cancer-predisposing syndrome	VCV003285929	2	29416101	2	29193235	3285929	3444669		NC_000002.12:29193234:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4852C>T (p.Pro1618Ser)	ALK	P1618S, P550S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000857975	2	29416101	2	29193235	857975	826268	rs1668918068	NC_000002.12:29193234:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4851G>T (p.Gln1617His)	ALK	Q1617H, Q549H	Neuroblastoma, susceptibility to, 3	VCV002736119	2	29416102	2	29193236	2736119	2894813		NC_000002.12:29193235:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4850A>G (p.Gln1617Arg)	ALK	Q1617R, Q549R	Hereditary cancer-predisposing syndrome	VCV003223915	2	29416103	2	29193237	3223915	3380937		NC_000002.12:29193236:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4849C>T (p.Gln1617Ter)	ALK	Q549*, Q1617*	Neuroblastoma, susceptibility to, 3	VCV001403268	2	29416104	2	29193238	1403268	1470491	rs1345614251	NC_000002.12:29193237:G:A	single nucleotide variant	nonsense	Uncertain significance	Dec 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4848C>T (p.Asn1616=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001080478	2	29416105	2	29193239	1080478	1069495	rs2148136916	NC_000002.12:29193238:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4845G>A (p.Met1615Ile)	ALK	M1615I, M547I	Neuroblastoma, susceptibility to, 3	VCV000404334	2	29416108	2	29193242	404334	392865	rs747978928	NC_000002.12:29193241:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4844T>A (p.Met1615Lys)	ALK	M547K, M1615K	Neuroblastoma, susceptibility to, 3	VCV003683359	2	29416109	2	29193243	3683359	3812085		NC_000002.12:29193242:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4844T>G (p.Met1615Arg)	ALK	M1615R, M547R	Hereditary cancer-predisposing syndrome	VCV001743524	2	29416109	2	29193243	1743524	1801871		NC_000002.12:29193242:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4844T>C (p.Met1615Thr)	ALK	M1615T, M547T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001007264	2	29416109	2	29193243	1007264	988665	rs1668918393	NC_000002.12:29193242:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4842C>T (p.Ser1614=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538244	2	29416111	2	29193245	538244	518073	rs1280729630	NC_000002.12:29193244:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4841G>A (p.Ser1614Asn)	ALK	S1614N, S546N	Hereditary cancer-predisposing syndrome	VCV003525234	2	29416112	2	29193246	3525234	3685590		NC_000002.12:29193245:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4841G>C (p.Ser1614Thr)	ALK	S546T, S1614T	Hereditary cancer-predisposing syndrome	VCV002452134	2	29416112	2	29193246	2452134	2426774		NC_000002.12:29193245:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4840A>T (p.Ser1614Cys)	ALK	S1614C, S546C	Neuroblastoma, susceptibility to, 3	VCV002914298	2	29416113	2	29193247	2914298	3071110		NC_000002.12:29193246:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4839T>G (p.Asn1613Lys)	ALK	N545K, N1613K	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001525474	2	29416114	2	29193248	1525474	1359932	rs1487769564	NC_000002.12:29193247:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4839T>C (p.Asn1613=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001106151	2	29416114	2	29193248	1106151	1091218	rs1487769564	NC_000002.12:29193247:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 31, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4838A>C (p.Asn1613Thr)	ALK	N1613T, N545T	Hereditary cancer-predisposing syndrome	VCV003524716	2	29416115	2	29193249	3524716	3688955		NC_000002.12:29193248:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4836G>T (p.Lys1612Asn)	ALK	K1612N, K544N	Neuroblastoma, susceptibility to, 3	VCV002828348	2	29416117	2	29193251	2828348	2990286		NC_000002.12:29193250:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4833_4836del (p.Ser1611fs)	ALK	S1611fs, S543fs	Neuroblastoma, susceptibility to, 3	VCV000582038	2	29416117 - 29416120	2	29193251 - 29193254	582038	557994	rs1558603069	NC_000002.12:29193250:CTTGCTT:CTT	Deletion	frameshift variant	Uncertain significance	Mar 14, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4836G>C (p.Lys1612Asn)	ALK	K1612N, K544N	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000422630	2	29416117	2	29193251	422630	405715	rs78174819	NC_000002.12:29193250:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 11, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4836G>A (p.Lys1612=)	ALK		not specified|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000239846	2	29416117	2	29193251	239846	238704	rs78174819	NC_000002.12:29193250:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4834A>C (p.Lys1612Gln)	ALK	K1612Q, K544Q	Hereditary cancer-predisposing syndrome	VCV002452105	2	29416119	2	29193253	2452105	2426745		NC_000002.12:29193252:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4832G>A (p.Ser1611Asn)	ALK	S1611N, S543N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001743445	2	29416121	2	29193255	1743445	1805591		NC_000002.12:29193254:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4832G>T (p.Ser1611Ile)	ALK	S1611I, S543I	Neuroblastoma, susceptibility to, 3	VCV000944371	2	29416121	2	29193255	944371	922694	rs1668918898	NC_000002.12:29193254:C:A	single nucleotide variant	missense variant	Uncertain significance	May 4, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4830A>G (p.Lys1610=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002419589	2	29416123	2	29193257	2419589	1938410		NC_000002.12:29193256:T:C	single nucleotide variant	synonymous variant	Likely benign	May 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4830A>T (p.Lys1610Asn)	ALK	K1610N, K542N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000950135	2	29416123	2	29193257	950135	922695	rs766072801	NC_000002.12:29193256:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4826T>C (p.Leu1609Pro)	ALK	L1609P, L541P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001006905	2	29416127	2	29193261	1006905	988666	rs1668919067	NC_000002.12:29193260:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4825C>A (p.Leu1609Met)	ALK	L1609M, L541M	Neuroblastoma, susceptibility to, 3	VCV003241531	2	29416128	2	29193262	3241531	3400509		NC_000002.12:29193261:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4825C>G (p.Leu1609Val)	ALK	L541V, L1609V	Hereditary cancer-predisposing syndrome	VCV000825209	2	29416128	2	29193262	825209	806879	rs57917930	NC_000002.12:29193261:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.4824T>C (p.Ile1608=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470887	2	29416129	2	29193263	470887	450960	rs537603430	NC_000002.12:29193262:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4821C>G (p.Thr1607=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538292	2	29416132	2	29193266	538292	518158	rs761101687	NC_000002.12:29193265:G:C	single nucleotide variant	synonymous variant	Likely benign	Jan 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4815G>A (p.Glu1605=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000723676	2	29416138	2	29193272	723676	733443	rs764304191	NC_000002.12:29193271:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4813G>T (p.Glu1605Ter)	ALK	E537*, E1605*	Neuroblastoma, susceptibility to, 3	VCV003645920	2	29416140	2	29193274	3645920	3780495		NC_000002.12:29193273:C:A	single nucleotide variant	nonsense	Uncertain significance	Mar 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4813G>A (p.Glu1605Lys)	ALK	E1605K, E537K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538267	2	29416140	2	29193274	538267	518078	rs754214919	NC_000002.12:29193273:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4812C>G (p.Tyr1604Ter)	ALK	Y536*, Y1604*	Neuroblastoma, susceptibility to, 3	VCV002116912	2	29416141	2	29193275	2116912	2172219		NC_000002.12:29193274:G:C	single nucleotide variant	nonsense	Uncertain significance	Apr 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4812C>T (p.Tyr1604=)	ALK		not specified|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000412943	2	29416141	2	29193275	412943	392590	rs753750497	NC_000002.12:29193274:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4812C>A (p.Tyr1604Ter)	ALK	Y1604*, Y536*	Neuroblastoma, susceptibility to, 3	VCV000404319	2	29416141	2	29193275	404319	392676	rs753750497	NC_000002.12:29193274:G:T	single nucleotide variant	nonsense	Uncertain significance	Jul 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4811A>G (p.Tyr1604Cys)	ALK	Y1604C, Y536C	Neuroblastoma, susceptibility to, 3|not provided|ALK-related disorder|Hereditary cancer-predisposing syndrome	VCV000239845	2	29416142	2	29193276	239845	238705	rs372440265	NC_000002.12:29193275:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4810T>C (p.Tyr1604His)	ALK	Y1604H, Y536H	not provided	VCV002571762	2	29416143	2	29193277	2571762	2736709		NC_000002.12:29193276:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4809T>C (p.His1603=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000701610	2	29416144	2	29193278	701610	686176	rs758502850	NC_000002.12:29193277:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4808A>G (p.His1603Arg)	ALK	H1603R, H535R	Neuroblastoma, susceptibility to, 3	VCV003651642	2	29416145	2	29193279	3651642	3788353		NC_000002.12:29193278:T:C	single nucleotide variant	missense variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4808A>T (p.His1603Leu)	ALK	H1603L, H535L	Neuroblastoma, susceptibility to, 3	VCV000960664	2	29416145	2	29193279	960664	942840	rs1668920233	NC_000002.12:29193278:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.4807C>T (p.His1603Tyr)	ALK	H535Y, H1603Y	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001743234	2	29416146	2	29193280	1743234	1805380		NC_000002.12:29193279:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4806T>G (p.Gly1602=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002852524	2	29416147	2	29193281	2852524	3010168		NC_000002.12:29193280:A:C	single nucleotide variant	synonymous variant	Likely benign	Apr 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4805G>C (p.Gly1602Ala)	ALK	G1602A, G534A	Neuroblastoma, susceptibility to, 3	VCV002703877	2	29416148	2	29193282	2703877	2856303		NC_000002.12:29193281:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4804G>A (p.Gly1602Ser)	ALK	G1602S, G534S	Neuroblastoma, susceptibility to, 3	VCV001450788	2	29416149	2	29193283	1450788	1351309	rs747161831	NC_000002.12:29193282:C:T	single nucleotide variant	missense variant	Uncertain significance	May 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4801G>A (p.Ala1601Thr)	ALK	A1601T, A533T	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404328	2	29416152	2	29193286	404328	392871	rs376702277	NC_000002.12:29193285:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 22, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4800A>G (p.Gly1600=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002157726	2	29416153	2	29193287	2157726	1890032		NC_000002.12:29193286:T:C	single nucleotide variant	synonymous variant	Likely benign	Oct 18, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4798G>A (p.Gly1600Arg)	ALK	G532R, G1600R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001743142	2	29416155	2	29193289	1743142	1805289		NC_000002.12:29193288:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4797T>G (p.Pro1599=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001998162	2	29416156	2	29193290	1998162	2053943		NC_000002.12:29193289:A:C	single nucleotide variant	synonymous variant	Likely benign	May 24, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4797T>C (p.Pro1599=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001103960	2	29416156	2	29193290	1103960	1091219	rs1573077216	NC_000002.12:29193289:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4796C>T (p.Pro1599Leu)	ALK	P531L, P1599L	Neuroblastoma, susceptibility to, 3	VCV003684855	2	29416157	2	29193291	3684855	3808842		NC_000002.12:29193290:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4796C>A (p.Pro1599His)	ALK	P1599H, P531H	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000133477	2	29416157	2	29193291	133477	137216	rs1881423	NC_000002.12:29193290:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4795C>T (p.Pro1599Ser)	ALK	P1599S, P531S	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404336	2	29416158	2	29193292	404336	392510	rs373037272	NC_000002.12:29193291:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4793C>T (p.Ala1598Val)	ALK	A1598V, A530V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001553058	2	29416160	2	29193294	1553058	1552842	rs577660779	NC_000002.12:29193293:G:A	single nucleotide variant	missense variant	Likely benign	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4779_4789del (p.Leu1593fs)	ALK	L525fs, L1593fs	Neuroblastoma, susceptibility to, 3	VCV002064533	2	29416164 - 29416174	2	29193298 - 29193308	2064533	2128516		NC_000002.12:29193297:TAGCGGCTTCT:	Deletion	frameshift variant	Uncertain significance	Dec 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4789A>G (p.Thr1597Ala)	ALK	T529A, T1597A	Neuroblastoma, susceptibility to, 3	VCV002047712	2	29416164	2	29193298	2047712	2110782		NC_000002.12:29193297:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4786G>T (p.Ala1596Ser)	ALK	A528S, A1596S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002562270	2	29416167	2	29193301	2562270	2721123		NC_000002.12:29193300:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4786G>A (p.Ala1596Thr)	ALK	A1596T, A528T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000839754	2	29416167	2	29193301	839754	826269	rs748822593	NC_000002.12:29193300:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 8, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4785C>A (p.Ala1595=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001161640	2	29416168	2	29193302	1161640	1133629	rs76150405	NC_000002.12:29193301:G:T	single nucleotide variant	synonymous variant	Likely benign	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4785C>T (p.Ala1595=)	ALK		Neuroblastoma, susceptibility to, 3|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000239844	2	29416168	2	29193302	239844	238706	rs76150405	NC_000002.12:29193301:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4784C>A (p.Ala1595Asp)	ALK	A1595D, A527D	Neuroblastoma, susceptibility to, 3	VCV002839246	2	29416169	2	29193303	2839246	2996517		NC_000002.12:29193302:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4784C>T (p.Ala1595Val)	ALK	A1595V, A527V	Neuroblastoma, susceptibility to, 3	VCV001720003	2	29416169	2	29193303	1720003	1779042		NC_000002.12:29193302:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4783G>T (p.Ala1595Ser)	ALK	A527S, A1595S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001035773	2	29416170	2	29193304	1035773	1024418	rs1668921952	NC_000002.12:29193303:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4780G>A (p.Glu1594Lys)	ALK	E1594K, E526K	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001015251	2	29416173	2	29193307	1015251	1003956	rs767191161	NC_000002.12:29193306:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 28, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4779A>G (p.Leu1593=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001669862	2	29416174	2	29193308	1669862	1582540	rs2148137147	NC_000002.12:29193307:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4778T>C (p.Leu1593Ser)	ALK	L525S, L1593S	Hereditary cancer-predisposing syndrome	VCV002586711	2	29416175	2	29193309	2586711	2756894		NC_000002.12:29193308:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4776C>T (p.Pro1592=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001090879	2	29416177	2	29193311	1090879	1069496	rs2148137153	NC_000002.12:29193310:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 26, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4775C>T (p.Pro1592Leu)	ALK	P1592L, P524L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000847846	2	29416178	2	29193312	847846	826270	rs1668922506	NC_000002.12:29193311:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4774C>A (p.Pro1592Thr)	ALK	P524T, P1592T	Hereditary cancer-predisposing syndrome	VCV001742989	2	29416179	2	29193313	1742989	1809070		NC_000002.12:29193312:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4773G>T (p.Leu1591Phe)	ALK	L523F, L1591F	Neuroblastoma, susceptibility to, 3	VCV001929144	2	29416180	2	29193314	1929144	1988032		NC_000002.12:29193313:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4773G>A (p.Leu1591=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001080507	2	29416180	2	29193314	1080507	1069497	rs1668922602	NC_000002.12:29193313:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4771T>C (p.Leu1591=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000700871	2	29416182	2	29193316	700871	686177	rs1008766442	NC_000002.12:29193315:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4770C>G (p.Gly1590=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003726344	2	29416183	2	29193317	3726344	3854835		NC_000002.12:29193316:G:C	single nucleotide variant	synonymous variant	Likely benign	Nov 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4770C>A (p.Gly1590=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003642704	2	29416183	2	29193317	3642704	3765475		NC_000002.12:29193316:G:T	single nucleotide variant	synonymous variant	Likely benign	Jun 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4770C>T (p.Gly1590=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000836483	2	29416183	2	29193317	836483	826271	rs1364640889	NC_000002.12:29193316:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4769G>A (p.Gly1590Asp)	ALK	G1590D, G522D	Neuroblastoma, susceptibility to, 3	VCV001447829	2	29416184	2	29193318	1447829	1403715	rs1457558507	NC_000002.12:29193317:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4769G>T (p.Gly1590Val)	ALK	G522V, G1590V	Neuroblastoma, susceptibility to, 3	VCV000655090	2	29416184	2	29193318	655090	629793	rs1457558507	NC_000002.12:29193317:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.4768G>C (p.Gly1590Arg)	ALK	G1590R, G522R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000862353	2	29416185	2	29193319	862353	826272	rs190639819	NC_000002.12:29193318:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4768G>A (p.Gly1590Ser)	ALK	G1590S, G522S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538188	2	29416185	2	29193319	538188	518080	rs190639819	NC_000002.12:29193318:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4767G>T (p.Gln1589His)	ALK	Q1589H, Q521H	Neuroblastoma, susceptibility to, 3	VCV003618997	2	29416186	2	29193320	3618997	3759477		NC_000002.12:29193319:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4766A>T (p.Gln1589Leu)	ALK	Q1589L, Q521L	Hereditary cancer-predisposing syndrome	VCV003223914	2	29416187	2	29193321	3223914	3380936		NC_000002.12:29193320:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4765C>T (p.Gln1589Ter)	ALK	Q1589*, Q521*	Neuroblastoma, susceptibility to, 3	VCV002914680	2	29416188	2	29193322	2914680	3079419		NC_000002.12:29193321:G:A	single nucleotide variant	nonsense	Uncertain significance	Dec 14, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4764A>C (p.Gln1588His)	ALK	Q520H, Q1588H	Hereditary cancer-predisposing syndrome	VCV001742913	2	29416189	2	29193323	1742913	1808994		NC_000002.12:29193322:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4763A>C (p.Gln1588Pro)	ALK	Q1588P, Q520P	Neuroblastoma, susceptibility to, 3	VCV001408028	2	29416190	2	29193324	1408028	1421676	rs2148137204	NC_000002.12:29193323:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4761G>C (p.Gln1587His)	ALK	Q1587H, Q519H	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470886	2	29416192	2	29193326	470886	451006	rs1396711236	NC_000002.12:29193325:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4760A>T (p.Gln1587Leu)	ALK	Q1587L, Q519L	not provided|Neuroblastoma, susceptibility to, 3	VCV002881177	2	29416193	2	29193327	2881177	3039737		NC_000002.12:29193326:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4760A>C (p.Gln1587Pro)	ALK	Q519P, Q1587P	Neuroblastoma, susceptibility to, 3	VCV002073998	2	29416193	2	29193327	2073998	2120646		NC_000002.12:29193326:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4758C>A (p.Tyr1586Ter)	ALK	Y1586*, Y518*	Hereditary cancer-predisposing syndrome	VCV003524807	2	29416195	2	29193329	3524807	3689046		NC_000002.12:29193328:G:T	single nucleotide variant	nonsense	Uncertain significance	Oct 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4757A>G (p.Tyr1586Cys)	ALK	Y1586C, Y518C	Neuroblastoma, susceptibility to, 3	VCV002868736	2	29416196	2	29193330	2868736	3030925		NC_000002.12:29193329:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4756T>C (p.Tyr1586His)	ALK	Y518H, Y1586H	Neuroblastoma, susceptibility to, 3	VCV001998754	2	29416197	2	29193331	1998754	2050675		NC_000002.12:29193330:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4755C>G (p.Gly1585=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404343	2	29416198	2	29193332	404343	392872	rs1060500217	NC_000002.12:29193331:G:C	single nucleotide variant	synonymous variant	Likely benign	Aug 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4753G>T (p.Gly1585Cys)	ALK	G1585C, G517C	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001525065	2	29416200	2	29193334	1525065	1363404	rs1573077410	NC_000002.12:29193333:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4753G>A (p.Gly1585Ser)	ALK	G1585S, G517S	Neuroblastoma, susceptibility to, 3	VCV001389001	2	29416200	2	29193334	1389001	1476581	rs1573077410	NC_000002.12:29193333:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4752C>G (p.Tyr1584Ter)	ALK	Y1584*, Y516*	Neuroblastoma, susceptibility to, 3	VCV002701385	2	29416201	2	29193335	2701385	2862379		NC_000002.12:29193334:G:C	single nucleotide variant	nonsense	Uncertain significance	Dec 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4752C>T (p.Tyr1584=)	ALK		Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000412939	2	29416201	2	29193335	412939	392530	rs758556216	NC_000002.12:29193334:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4751A>C (p.Tyr1584Ser)	ALK	Y1584S, Y516S	Neuroblastoma, susceptibility to, 3	VCV002875954	2	29416202	2	29193336	2875954	3038432		NC_000002.12:29193335:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4749T>C (p.Asn1583=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001122818	2	29416204	2	29193338	1122818	1112723	rs766508956	NC_000002.12:29193337:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4748A>T (p.Asn1583Ile)	ALK	N1583I, N515I	Neuroblastoma, susceptibility to, 3	VCV002147104	2	29416205	2	29193339	2147104	1870752		NC_000002.12:29193338:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4748A>G (p.Asn1583Ser)	ALK	N1583S, N515S	Neuroblastoma, susceptibility to, 3|not provided	VCV000538260	2	29416205	2	29193339	538260	518083	rs751677905	NC_000002.12:29193338:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4747A>G (p.Asn1583Asp)	ALK	N1583D, N515D	Neuroblastoma, susceptibility to, 3	VCV001433292	2	29416206	2	29193340	1433292	1493866	rs781448587	NC_000002.12:29193339:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4746C>T (p.Val1582=)	ALK		not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001089721	2	29416207	2	29193341	1089721	1069498	rs1237752481	NC_000002.12:29193340:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4745T>C (p.Val1582Ala)	ALK	V1582A, V514A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001482247	2	29416208	2	29193342	1482247	1445483	rs2148137261	NC_000002.12:29193341:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4744G>A (p.Val1582Ile)	ALK	V1582I, V514I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538221	2	29416209	2	29193343	538221	518064	rs1553386863	NC_000002.12:29193342:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4743T>A (p.Asn1581Lys)	ALK	N513K, N1581K	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001742787	2	29416210	2	29193344	1742787	1808870		NC_000002.12:29193343:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4743T>C (p.Asn1581=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001130781	2	29416210	2	29193344	1130781	1112724	rs747946035	NC_000002.12:29193343:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4742A>C (p.Asn1581Thr)	ALK	N1581T, N513T	Neuroblastoma, susceptibility to, 3	VCV001515776	2	29416211	2	29193345	1515776	1407055	rs1668924453	NC_000002.12:29193344:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4741A>T (p.Asn1581Tyr)	ALK	N1581Y, N513Y	Neuroblastoma, susceptibility to, 3	VCV003006705	2	29416212	2	29193346	3006705	3165654		NC_000002.12:29193345:T:A	single nucleotide variant	missense variant	Uncertain significance	May 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4740G>C (p.Gly1580=)	ALK		Hereditary cancer-predisposing syndrome	VCV002586699	2	29416213	2	29193347	2586699	2756882		NC_000002.12:29193346:C:G	single nucleotide variant	synonymous variant	Likely benign	Aug 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4740G>A (p.Gly1580=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001624680	2	29416213	2	29193347	1624680	1629299	rs2148137275	NC_000002.12:29193346:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 2, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4739G>T (p.Gly1580Val)	ALK	G1580V, G512V	Neuroblastoma, susceptibility to, 3	VCV002821854	2	29416214	2	29193348	2821854	2985506		NC_000002.12:29193347:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4738G>C (p.Gly1580Arg)	ALK	G1580R, G512R	Neuroblastoma, susceptibility to, 3	VCV003658249	2	29416215	2	29193349	3658249	3800476		NC_000002.12:29193348:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4738G>A (p.Gly1580Arg)	ALK	G1580R, G512R	not provided|Neuroblastoma, susceptibility to, 3	VCV000470884	2	29416215	2	29193349	470884	450963	rs370947313	NC_000002.12:29193348:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4737T>A (p.Cys1579Ter)	ALK	C1579*, C511*	Neuroblastoma, susceptibility to, 3	VCV001522114	2	29416216	2	29193350	1522114	1344129	rs553333897	NC_000002.12:29193349:A:T	single nucleotide variant	nonsense	Uncertain significance	Oct 1, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4737T>C (p.Cys1579=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538297	2	29416216	2	29193350	538297	518022	rs553333897	NC_000002.12:29193349:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4735T>G (p.Cys1579Gly)	ALK	C1579G, C511G	Neuroblastoma, susceptibility to, 3	VCV003728997	2	29416218	2	29193352	3728997	3861932		NC_000002.12:29193351:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.4734T>A (p.Pro1578=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001742740	2	29416219	2	29193353	1742740	1808823		NC_000002.12:29193352:A:T	single nucleotide variant	synonymous variant	Likely benign	Jan 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4734T>C (p.Pro1578=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001106802	2	29416219	2	29193353	1106802	1091221	rs749162642	NC_000002.12:29193352:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 31, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4734T>G (p.Pro1578=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001104563	2	29416219	2	29193353	1104563	1091220	rs749162642	NC_000002.12:29193352:A:C	single nucleotide variant	synonymous variant	Likely benign	Dec 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4733C>T (p.Pro1578Leu)	ALK	P1578L, P510L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001057192	2	29416220	2	29193354	1057192	1041359	rs1251627719	NC_000002.12:29193353:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4732C>G (p.Pro1578Ala)	ALK	P1578A, P510A	Hereditary cancer-predisposing syndrome	VCV003284904	2	29416221	2	29193355	3284904	3444083		NC_000002.12:29193354:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4730T>C (p.Phe1577Ser)	ALK	F509S, F1577S	Neuroblastoma, susceptibility to, 3	VCV002105736	2	29416223	2	29193357	2105736	2166197		NC_000002.12:29193356:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4729T>A (p.Phe1577Ile)	ALK	F509I, F1577I	Neuroblastoma, susceptibility to, 3	VCV003656075	2	29416224	2	29193358	3656075	3782942		NC_000002.12:29193357:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4729T>C (p.Phe1577Leu)	ALK	F1577L, F509L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001001771	2	29416224	2	29193358	1001771	988667	rs200829376	NC_000002.12:29193357:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4729T>G (p.Phe1577Val)	ALK	F1577V, F509V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000566447	2	29416224	2	29193358	566447	558344	rs200829376	NC_000002.12:29193357:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4728C>T (p.His1576=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001083455	2	29416225	2	29193359	1083455	1069499	rs1420285868	NC_000002.12:29193358:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4727A>G (p.His1576Arg)	ALK	H1576R, H508R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001368985	2	29416226	2	29193360	1368985	1417875	rs2148137340	NC_000002.12:29193359:T:C	single nucleotide variant	missense variant	Uncertain significance	May 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4726C>G (p.His1576Asp)	ALK	H508D, H1576D	Neuroblastoma, susceptibility to, 3	VCV002850036	2	29416227	2	29193361	2850036	3005991		NC_000002.12:29193360:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4725T>G (p.Arg1575=)	ALK		Hereditary cancer-predisposing syndrome	VCV001742688	2	29416228	2	29193362	1742688	1808771		NC_000002.12:29193361:A:C	single nucleotide variant	synonymous variant	Likely benign	Aug 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4724G>A (p.Arg1575His)	ALK	R1575H, R507H	Neuroblastoma, susceptibility to, 3	VCV000579141	2	29416229	2	29193363	579141	558346	rs745349865	NC_000002.12:29193362:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4724G>C (p.Arg1575Pro)	ALK	R1575P, R507P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000570981	2	29416229	2	29193363	570981	557996	rs745349865	NC_000002.12:29193362:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4723C>G (p.Arg1575Gly)	ALK	R1575G, R507G	Neuroblastoma, susceptibility to, 3	VCV003683517	2	29416230	2	29193364	3683517	3812243		NC_000002.12:29193363:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4723C>T (p.Arg1575Cys)	ALK	R1575C, R507C	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|ALK-related disorder	VCV001377825	2	29416230	2	29193364	1377825	1469630	rs148351049	NC_000002.12:29193363:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4722A>C (p.Leu1574=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003715000	2	29416231	2	29193365	3715000	3838519		NC_000002.12:29193364:T:G	single nucleotide variant	synonymous variant	Likely benign	Jan 27, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.4720C>T (p.Leu1574=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003669299	2	29416233	2	29193367	3669299	3796576		NC_000002.12:29193366:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4720C>G (p.Leu1574Val)	ALK	L506V, L1574V	Hereditary cancer-predisposing syndrome	VCV003523433	2	29416233	2	29193367	3523433	3685106		NC_000002.12:29193366:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4720C>A (p.Leu1574Ile)	ALK	L506I, L1574I	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002196240	2	29416233	2	29193367	2196240	1923714		NC_000002.12:29193366:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4719G>A (p.Arg1573=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003662095	2	29416234	2	29193368	3662095	3797960		NC_000002.12:29193367:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4717A>G (p.Arg1573Gly)	ALK	R1573G, R505G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000857842	2	29416236	2	29193370	857842	826273	rs1460362626	NC_000002.12:29193369:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4716C>G (p.Phe1572Leu)	ALK	F1572L, F504L	Hereditary cancer-predisposing syndrome	VCV002447099	2	29416237	2	29193371	2447099	2422222		NC_000002.12:29193370:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4715T>G (p.Phe1572Cys)	ALK	F504C, F1572C	Neuroblastoma, susceptibility to, 3	VCV003648597	2	29416238	2	29193372	3648597	3784454		NC_000002.12:29193371:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4713G>C (p.Leu1571=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002709330	2	29416240	2	29193374	2709330	2878076		NC_000002.12:29193373:C:G	single nucleotide variant	synonymous variant	Likely benign	Jan 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4713G>T (p.Leu1571=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002095848	2	29416240	2	29193374	2095848	2149765		NC_000002.12:29193373:C:A	single nucleotide variant	synonymous variant	Likely benign	Jan 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4713G>A (p.Leu1571=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001649470	2	29416240	2	29193374	1649470	1567325	rs2148137397	NC_000002.12:29193373:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4712T>G (p.Leu1571Arg)	ALK	L1571R, L503R	Hereditary cancer-predisposing syndrome	VCV003223913	2	29416241	2	29193375	3223913	3380935		NC_000002.12:29193374:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4710T>G (p.Pro1570=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002814039	2	29416243	2	29193377	2814039	2966153		NC_000002.12:29193376:A:C	single nucleotide variant	synonymous variant	Likely benign	Jun 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4710T>A (p.Pro1570=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002562274	2	29416243	2	29193377	2562274	2721127		NC_000002.12:29193376:A:T	single nucleotide variant	synonymous variant	Likely benign	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4709C>T (p.Pro1570Leu)	ALK	P1570L, P502L	Neuroblastoma, susceptibility to, 3	VCV000938794	2	29416244	2	29193378	938794	931335	rs1668925964	NC_000002.12:29193377:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4708C>T (p.Pro1570Ser)	ALK	P502S, P1570S	Neuroblastoma, susceptibility to, 3	VCV002812763	2	29416245	2	29193379	2812763	2975995		NC_000002.12:29193378:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4708C>G (p.Pro1570Ala)	ALK	P502A, P1570A	Neuroblastoma, susceptibility to, 3	VCV001361166	2	29416245	2	29193379	1361166	1383538	rs2148137416	NC_000002.12:29193378:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 31, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4707A>C (p.Val1569=)	ALK		Hereditary cancer-predisposing syndrome	VCV003286375	2	29416246	2	29193380	3286375	3455198		NC_000002.12:29193379:T:G	single nucleotide variant	synonymous variant	Likely benign	Jun 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4706T>C (p.Val1569Ala)	ALK	V1569A, V501A	Neuroblastoma, susceptibility to, 3	VCV001039893	2	29416247	2	29193381	1039893	1024419	rs1668926110	NC_000002.12:29193380:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4705G>A (p.Val1569Ile)	ALK	V1569I, V501I	Neuroblastoma, susceptibility to, 3	VCV002164536	2	29416248	2	29193382	2164536	1898442		NC_000002.12:29193381:C:T	single nucleotide variant	missense variant	Uncertain significance	May 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4704G>A (p.Glu1568=)	ALK		Hereditary cancer-predisposing syndrome	VCV001742567	2	29416249	2	29193383	1742567	1798768		NC_000002.12:29193382:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4703A>C (p.Glu1568Ala)	ALK	E1568A, E500A	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404320	2	29416250	2	29193384	404320	392534	rs763613910	NC_000002.12:29193383:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4701G>A (p.Lys1567=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001742557	2	29416252	2	29193386	1742557	1798758		NC_000002.12:29193385:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4701G>C (p.Lys1567Asn)	ALK	K1567N, K499N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000839534	2	29416252	2	29193386	839534	826274	rs1413940049	NC_000002.12:29193385:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4699A>G (p.Lys1567Glu)	ALK	K499E, K1567E	Neuroblastoma, susceptibility to, 3	VCV002964982	2	29416254	2	29193388	2964982	3117549		NC_000002.12:29193387:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4698G>C (p.Met1566Ile)	ALK	M1566I, M498I	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003223912	2	29416255	2	29193389	3223912	3380934		NC_000002.12:29193388:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4698G>A (p.Met1566Ile)	ALK	M498I, M1566I	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000650606	2	29416255	2	29193389	650606	629794	rs1291120133	NC_000002.12:29193388:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4697T>C (p.Met1566Thr)	ALK	M1566T, M498T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001035005	2	29416256	2	29193390	1035005	1024420	rs1356952469	NC_000002.12:29193389:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4696A>G (p.Met1566Val)	ALK	M1566V, M498V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000573928	2	29416257	2	29193391	573928	560573	rs1558603299	NC_000002.12:29193390:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4695T>C (p.Asn1565=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000757891	2	29416258	2	29193392	757891	763168	rs766990201	NC_000002.12:29193391:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4694A>G (p.Asn1565Ser)	ALK	N1565S, N497S	Neuroblastoma, susceptibility to, 3	VCV000839747	2	29416259	2	29193393	839747	826275	rs1208409389	NC_000002.12:29193392:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4692C>T (p.Ala1564=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001077582	2	29416261	2	29193395	1077582	1069500	rs751632696	NC_000002.12:29193394:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4690G>A (p.Ala1564Thr)	ALK	A496T, A1564T	Neuroblastoma, susceptibility to, 3	VCV000857388	2	29416263	2	29193397	857388	826276	rs1019065457	NC_000002.12:29193396:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4689T>C (p.Thr1563=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001084409	2	29416264	2	29193398	1084409	1069501	rs571671456	NC_000002.12:29193397:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4688C>A (p.Thr1563Asn)	ALK	T1563N, T495N	Hereditary cancer-predisposing syndrome	VCV003285730	2	29416265	2	29193399	3285730	3440961		NC_000002.12:29193398:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4687A>G (p.Thr1563Ala)	ALK	T495A, T1563A	Neuroblastoma, susceptibility to, 3	VCV000861044	2	29416266	2	29193400	861044	826277	rs1668927499	NC_000002.12:29193399:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4685T>C (p.Leu1562Pro)	ALK	L1562P, L494P	Neuroblastoma, susceptibility to, 3	VCV002078350	2	29416268	2	29193402	2078350	2138865		NC_000002.12:29193401:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4685T>G (p.Leu1562Arg)	ALK	L1562R, L494R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000647536	2	29416268	2	29193402	647536	629795	rs974930400	NC_000002.12:29193401:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4684C>T (p.Leu1562=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001742409	2	29416269	2	29193403	1742409	1798610		NC_000002.12:29193402:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4683G>T (p.Ser1561=)	ALK		Hereditary cancer-predisposing syndrome	VCV001742404	2	29416270	2	29193404	1742404	1798605		NC_000002.12:29193403:C:A	single nucleotide variant	synonymous variant	Likely benign	Aug 21, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4683G>A (p.Ser1561=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538278	2	29416270	2	29193404	538278	518163	rs150487874	NC_000002.12:29193403:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4682C>T (p.Ser1561Leu)	ALK	S1561L, S493L	ALK-related disorder|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538223	2	29416271	2	29193405	538223	518088	rs1209157216	NC_000002.12:29193404:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4680T>C (p.Ser1560=)	ALK		Hereditary cancer-predisposing syndrome	VCV001742395	2	29416273	2	29193407	1742395	1798596		NC_000002.12:29193406:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 28, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4679C>G (p.Ser1560Cys)	ALK	S492C, S1560C	Neuroblastoma, susceptibility to, 3	VCV003663216	2	29416274	2	29193408	3663216	3801613		NC_000002.12:29193407:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4678T>C (p.Ser1560Pro)	ALK	S1560P, S492P	Neuroblastoma, susceptibility to, 3	VCV002769040	2	29416275	2	29193409	2769040	2923315		NC_000002.12:29193408:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4678T>G (p.Ser1560Ala)	ALK	S492A, S1560A	Neuroblastoma, susceptibility to, 3	VCV002756903	2	29416275	2	29193409	2756903	2920674		NC_000002.12:29193408:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4677C>T (p.Pro1559=)	ALK		Hereditary cancer-predisposing syndrome	VCV001742362	2	29416276	2	29193410	1742362	1798563		NC_000002.12:29193409:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 25, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4677C>G (p.Pro1559=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001742358	2	29416276	2	29193410	1742358	1798559		NC_000002.12:29193409:G:C	single nucleotide variant	synonymous variant	Likely benign	Jul 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4677del (p.Ser1560fs)	ALK	S1560fs, S492fs	Neuroblastoma, susceptibility to, 3	VCV001061041	2	29416276	2	29193410	1061041	1041360	rs2148137540	NC_000002.12:29193409:GGG:GG	Deletion	frameshift variant	Uncertain significance	Sep 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4675C>T (p.Pro1559Ser)	ALK	P1559S, P491S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002418613	2	29416278	2	29193412	2418613	1944511		NC_000002.12:29193411:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4674G>A (p.Glu1558=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002904527	2	29416279	2	29193413	2904527	3058821		NC_000002.12:29193412:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4674G>C (p.Glu1558Asp)	ALK	E1558D, E490D	Hereditary cancer-predisposing syndrome	VCV001742347	2	29416279	2	29193413	1742347	1798548		NC_000002.12:29193412:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4673_4674delinsTC (p.Glu1558Val)	ALK	E490V, E1558V	Neuroblastoma, susceptibility to, 3	VCV001413932	2	29416279 - 29416280	2	29193413 - 29193414	1413932	1361835	rs2148137555	NC_000002.12:29193412:CT:GA	Indel	missense variant	Uncertain significance	Nov 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4673A>T (p.Glu1558Val)	ALK	E1558V, E490V	Hereditary cancer-predisposing syndrome	VCV001742341	2	29416280	2	29193414	1742341	1798542		NC_000002.12:29193413:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4673A>G (p.Glu1558Gly)	ALK	E490G, E1558G	Neuroblastoma, susceptibility to, 3	VCV000933497	2	29416280	2	29193414	933497	931336	rs1668928402	NC_000002.12:29193413:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4672G>C (p.Glu1558Gln)	ALK	E1558Q, E490Q	Hereditary cancer-predisposing syndrome	VCV003223911	2	29416281	2	29193415	3223911	3380933		NC_000002.12:29193414:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4672G>A (p.Glu1558Lys)	ALK	E490K, E1558K	Neuroblastoma, susceptibility to, 3	VCV001971589	2	29416281	2	29193415	1971589	2032876		NC_000002.12:29193414:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4671A>G (p.Leu1557=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000485082	2	29416282	2	29193416	485082	472698	rs1488644335	NC_000002.12:29193415:T:C	single nucleotide variant	synonymous variant	Likely benign	Aug 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4670T>C (p.Leu1557Pro)	ALK	L1557P, L489P	Neuroblastoma, susceptibility to, 3	VCV001971590	2	29416283	2	29193417	1971590	2032877		NC_000002.12:29193416:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4666C>G (p.Leu1556Val)	ALK	L1556V, L488V	Neuroblastoma, susceptibility to, 3	VCV001971591	2	29416287	2	29193421	1971591	2032878		NC_000002.12:29193420:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4666C>T (p.Leu1556Phe)	ALK	L1556F, L488F	Neuroblastoma, susceptibility to, 3	VCV001046892	2	29416287	2	29193421	1046892	1024421	rs1214400523	NC_000002.12:29193420:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4665G>A (p.Leu1555=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001567713	2	29416288	2	29193422	1567713	1591873	rs542234332	NC_000002.12:29193421:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 14, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4664T>C (p.Leu1555Pro)	ALK	L1555P, L487P	Neuroblastoma, susceptibility to, 3	VCV002895295	2	29416289	2	29193423	2895295	3049384		NC_000002.12:29193422:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4663C>G (p.Leu1555Val)	ALK	L1555V, L487V	Hereditary cancer-predisposing syndrome	VCV003223910	2	29416290	2	29193424	3223910	3380932		NC_000002.12:29193423:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4662A>T (p.Ser1554=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470882	2	29416291	2	29193425	470882	451015	rs1417400257	NC_000002.12:29193424:T:A	single nucleotide variant	synonymous variant	Likely benign	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4661C>T (p.Ser1554Leu)	ALK	S1554L, S486L	Neuroblastoma, susceptibility to, 3	VCV003659218	2	29416292	2	29193426	3659218	3790158		NC_000002.12:29193425:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4659C>A (p.Ala1553=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000703751	2	29416294	2	29193428	703751	691123	rs778797863	NC_000002.12:29193427:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4658C>G (p.Ala1553Gly)	ALK	A1553G, A485G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538207	2	29416295	2	29193429	538207	518068	rs1553386898	NC_000002.12:29193428:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4657G>A (p.Ala1553Thr)	ALK	A1553T, A485T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001415459	2	29416296	2	29193430	1415459	1374966	rs745390287	NC_000002.12:29193429:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4657G>C (p.Ala1553Pro)	ALK	A1553P, A485P	Neuroblastoma, susceptibility to, 3	VCV001410049	2	29416296	2	29193430	1410049	1435304	rs745390287	NC_000002.12:29193429:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4657G>T (p.Ala1553Ser)	ALK	A1553S, A485S	Neuroblastoma, susceptibility to, 3	VCV001042522	2	29416296	2	29193430	1042522	1024422	rs745390287	NC_000002.12:29193429:C:A	single nucleotide variant	missense variant	Uncertain significance	May 21, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4656G>C (p.Gly1552=)	ALK		Hereditary cancer-predisposing syndrome	VCV001742209	2	29416297	2	29193431	1742209	1801851		NC_000002.12:29193430:C:G	single nucleotide variant	synonymous variant	Likely benign	Feb 22, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4656G>T (p.Gly1552=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001468706	2	29416297	2	29193431	1468706	1359065	rs952457982	NC_000002.12:29193430:C:A	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4656G>A (p.Gly1552=)	ALK		Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000470881	2	29416297	2	29193431	470881	450966	rs952457982	NC_000002.12:29193430:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4655G>A (p.Gly1552Glu)	ALK	G484E, G1552E	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001742203	2	29416298	2	29193432	1742203	1801845		NC_000002.12:29193431:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4655G>C (p.Gly1552Ala)	ALK	G1552A, G484A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001008474	2	29416298	2	29193432	1008474	988669	rs1668929634	NC_000002.12:29193431:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4655G>T (p.Gly1552Val)	ALK	G1552V, G484V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000999110	2	29416298	2	29193432	999110	988668	rs1668929634	NC_000002.12:29193431:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4654G>A (p.Gly1552Arg)	ALK	G1552R, G484R	Neuroblastoma, susceptibility to, 3	VCV002025805	2	29416299	2	29193433	2025805	2081153		NC_000002.12:29193432:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4654G>C (p.Gly1552Arg)	ALK	G1552R, G484R	Neuroblastoma, susceptibility to, 3	VCV001368389	2	29416299	2	29193433	1368389	1339982	rs771570579	NC_000002.12:29193432:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4654G>T (p.Gly1552Trp)	ALK	G484W, G1552W	Neuroblastoma, susceptibility to, 3	VCV000941563	2	29416299	2	29193433	941563	931337	rs771570579	NC_000002.12:29193432:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4653G>A (p.Pro1551=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001670610	2	29416300	2	29193434	1670610	1604917	rs1376929970	NC_000002.12:29193433:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4653G>T (p.Pro1551=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000697817	2	29416300	2	29193434	697817	686178	rs1376929970	NC_000002.12:29193433:C:A	single nucleotide variant	synonymous variant	Likely benign	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4652C>T (p.Pro1551Leu)	ALK	P1551L, P483L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001006689	2	29416301	2	29193435	1006689	988670	rs200425614	NC_000002.12:29193434:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4650T>G (p.Leu1550=)	ALK		Hereditary cancer-predisposing syndrome	VCV002452098	2	29416303	2	29193437	2452098	2426738		NC_000002.12:29193436:A:C	single nucleotide variant	synonymous variant	Likely benign	Nov 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4649T>C (p.Leu1550Pro)	ALK	L1550P, L482P	Neuroblastoma, susceptibility to, 3	VCV001000122	2	29416304	2	29193438	1000122	988671	rs1668930030	NC_000002.12:29193437:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4648C>G (p.Leu1550Val)	ALK	L1550V, L482V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000335686	2	29416305	2	29193439	335686	285953	rs886055928	NC_000002.12:29193438:G:C	single nucleotide variant	missense variant	Uncertain significance	May 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4646G>T (p.Arg1549Ile)	ALK	R1549I, R481I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000404353	2	29416307	2	29193441	404353	392677	rs199646095	NC_000002.12:29193440:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4645A>G (p.Arg1549Gly)	ALK	R1549G, R481G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001742146	2	29416308	2	29193442	1742146	1801788		NC_000002.12:29193441:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4645A>C (p.Arg1549=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001154291	2	29416308	2	29193442	1154291	1133630	rs773780435	NC_000002.12:29193441:T:G	single nucleotide variant	synonymous variant	Likely benign	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4644G>C (p.Gly1548=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001668241	2	29416309	2	29193443	1668241	1570106	rs2148137650	NC_000002.12:29193442:C:G	single nucleotide variant	synonymous variant	Likely benign	Aug 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4644G>A (p.Gly1548=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001143259	2	29416309	2	29193443	1143259	1133631	rs2148137650	NC_000002.12:29193442:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 1, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4643G>A (p.Gly1548Glu)	ALK	G1548E, G480E	Neuroblastoma, susceptibility to, 3	VCV001435854	2	29416310	2	29193444	1435854	1500850	rs78868998	NC_000002.12:29193443:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4642G>A (p.Gly1548Arg)	ALK	G1548R, G480R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538259	2	29416311	2	29193445	538259	518090	rs1215807713	NC_000002.12:29193444:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4638A>G (p.Ala1546=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001742070	2	29416315	2	29193449	1742070	1801713		NC_000002.12:29193448:T:C	single nucleotide variant	synonymous variant	Likely benign	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4636G>C (p.Ala1546Pro)	ALK	A1546P, A478P	Neuroblastoma, susceptibility to, 3	VCV001358110	2	29416317	2	29193451	1358110	1460409	rs1668930591	NC_000002.12:29193450:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4636G>A (p.Ala1546Thr)	ALK	A1546T, A478T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000856366	2	29416317	2	29193451	856366	826278	rs1668930591	NC_000002.12:29193450:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4634T>G (p.Val1545Gly)	ALK	V1545G, V477G	Hereditary cancer-predisposing syndrome	VCV002586697	2	29416319	2	29193453	2586697	2756880		NC_000002.12:29193452:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4634T>C (p.Val1545Ala)	ALK	V1545A, V477A	Neuroblastoma, susceptibility to, 3	VCV000470880	2	29416319	2	29193453	470880	450969	rs1553386918	NC_000002.12:29193452:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4633G>T (p.Val1545Phe)	ALK	V477F, V1545F	Neuroblastoma, susceptibility to, 3	VCV001519673	2	29416320	2	29193454	1519673	1516962	rs1296992304	NC_000002.12:29193453:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4633G>A (p.Val1545Ile)	ALK	V477I, V1545I	Neuroblastoma, susceptibility to, 3	VCV000970509	2	29416320	2	29193454	970509	953056	rs1296992304	NC_000002.12:29193453:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4632C>T (p.Asn1544=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001152311	2	29416321	2	29193455	1152311	1133632	rs763403897	NC_000002.12:29193454:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4632C>A (p.Asn1544Lys)	ALK	N476K, N1544K	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000665965	2	29416321	2	29193455	665965	629796	rs763403897	NC_000002.12:29193454:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 26, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4630A>C (p.Asn1544His)	ALK	N1544H, N476H	Neuroblastoma, susceptibility to, 3	VCV001018378	2	29416323	2	29193457	1018378	1003957	rs1668930964	NC_000002.12:29193456:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4629T>G (p.Pro1543=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003724170	2	29416324	2	29193458	3724170	3857382		NC_000002.12:29193457:A:C	single nucleotide variant	synonymous variant	Likely benign	Oct 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4627C>A (p.Pro1543Thr)	ALK	P1543T, P475T	Neuroblastoma, susceptibility to, 3	VCV000643302	2	29416326	2	29193460	643302	629797	rs771622065	NC_000002.12:29193459:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4626A>G (p.Pro1542=)	ALK		Hereditary cancer-predisposing syndrome	VCV001741980	2	29416327	2	29193461	1741980	1801623		NC_000002.12:29193460:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4626A>C (p.Pro1542=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001086875	2	29416327	2	29193461	1086875	1069502	rs1668931146	NC_000002.12:29193460:T:G	single nucleotide variant	synonymous variant	Likely benign	Mar 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4625C>G (p.Pro1542Arg)	ALK	P1542R, P474R	Neuroblastoma, susceptibility to, 3	VCV001511592	2	29416328	2	29193462	1511592	1459073	rs878854659	NC_000002.12:29193461:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4625del (p.Pro1542fs)	ALK	P474fs, P1542fs	Neuroblastoma, susceptibility to, 3	VCV001044184	2	29416328	2	29193462	1044184	1024423	rs1174832921	NC_000002.12:29193461:GGG:GG	Deletion	frameshift variant	Uncertain significance	Sep 8, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4625C>T (p.Pro1542Leu)	ALK	P1542L, P474L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000239841	2	29416328	2	29193462	239841	238707	rs878854659	NC_000002.12:29193461:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4623C>G (p.Val1541=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001149121	2	29416330	2	29193464	1149121	1133633	rs774860532	NC_000002.12:29193463:G:C	single nucleotide variant	synonymous variant	Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4623C>T (p.Val1541=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000412903	2	29416330	2	29193464	412903	392680	rs774860532	NC_000002.12:29193463:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4622T>A (p.Val1541Asp)	ALK	V1541D, V473D	Neuroblastoma, susceptibility to, 3	VCV002877920	2	29416331	2	29193465	2877920	3039092		NC_000002.12:29193464:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4622T>C (p.Val1541Ala)	ALK	V473A, V1541A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000825052	2	29416331	2	29193465	825052	806880	rs552439944	NC_000002.12:29193464:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4620T>C (p.Thr1540=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002055060	2	29416333	2	29193467	2055060	2109060		NC_000002.12:29193466:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4619C>G (p.Thr1540Ser)	ALK	T1540S, T472S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001433627	2	29416334	2	29193468	1433627	1419300	rs1215255332	NC_000002.12:29193467:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4617T>C (p.Cys1539=)	ALK		Hereditary cancer-predisposing syndrome	VCV001741922	2	29416336	2	29193470	1741922	1801565		NC_000002.12:29193469:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 9, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4615T>C (p.Cys1539Arg)	ALK	C1539R, C471R	Neuroblastoma, susceptibility to, 3	VCV003022125	2	29416338	2	29193472	3022125	3179727		NC_000002.12:29193471:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4614C>T (p.Ser1538=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001671477	2	29416339	2	29193473	1671477	1583715	rs2148137743	NC_000002.12:29193472:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4613G>T (p.Ser1538Ile)	ALK	S1538I, S470I	Neuroblastoma, susceptibility to, 3	VCV000538261	2	29416340	2	29193474	538261	518070	rs1553386937	NC_000002.12:29193473:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4611A>T (p.Gly1537=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001361946	2	29416342	2	29193476	1361946	1376572	rs2148137752	NC_000002.12:29193475:T:A	single nucleotide variant	synonymous variant	Likely benign	Aug 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4610G>C (p.Gly1537Ala)	ALK	G1537A, G469A	Neuroblastoma, susceptibility to, 3	VCV001052698	2	29416343	2	29193477	1052698	1041361	rs1046265972	NC_000002.12:29193476:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.4610G>A (p.Gly1537Glu)	ALK	G469E, G1537E	Neuroblastoma, susceptibility to, 3	VCV000834575	2	29416343	2	29193477	834575	826279	rs1046265972	NC_000002.12:29193476:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4609G>A (p.Gly1537Arg)	ALK	G1537R, G469R	Hereditary cancer-predisposing syndrome	VCV003223909	2	29416344	2	29193478	3223909	3380931		NC_000002.12:29193477:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4609G>C (p.Gly1537Arg)	ALK	G469R, G1537R	Neuroblastoma, susceptibility to, 3	VCV001502835	2	29416344	2	29193478	1502835	1404428	rs958335893	NC_000002.12:29193477:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4608G>T (p.Glu1536Asp)	ALK	E1536D, E468D	Neuroblastoma, susceptibility to, 3	VCV001040760	2	29416345	2	29193479	1040760	1024424	rs147241767	NC_000002.12:29193478:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4608G>A (p.Glu1536=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000239840	2	29416345	2	29193479	239840	238708	rs147241767	NC_000002.12:29193478:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Oct 23, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4607A>G (p.Glu1536Gly)	ALK	E1536G, E468G	Neuroblastoma, susceptibility to, 3	VCV003013291	2	29416346	2	29193480	3013291	3177428		NC_000002.12:29193479:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4605_4606insAAGGAGCCACACGAGAGGGGTAACCTGGGGCTG (p.Leu1535_Glu1536insLysGluProHisGluArgGlyAsnLeuGlyLeu)	ALK		Neuroblastoma, susceptibility to, 3	VCV001355786	2	29416347 - 29416348	2	29193481 - 29193482	1355786	1509537	rs2148137777	NC_000002.12:29193481:CAGCCCCAGGTTACCCCT:CAGCCCCAGGTTACCCCTCTCGTGTGGCTCCTTCAGCCCCAGGTTACCCCT	Insertion	inframe_insertion	Uncertain significance	Jul 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4606G>C (p.Glu1536Gln)	ALK	E1536Q, E468Q	Neuroblastoma, susceptibility to, 3	VCV000863668	2	29416347	2	29193481	863668	826280	rs752701859	NC_000002.12:29193480:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4606G>A (p.Glu1536Lys)	ALK	E1536K, E468K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538216	2	29416347	2	29193481	538216	518081	rs752701859	NC_000002.12:29193480:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4605G>A (p.Leu1535=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001645250	2	29416348	2	29193482	1645250	1599148	rs1459765837	NC_000002.12:29193481:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4605G>T (p.Leu1535=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001102407	2	29416348	2	29193482	1102407	1091222	rs1459765837	NC_000002.12:29193481:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4604T>A (p.Leu1535Gln)	ALK	L1535Q, L467Q	Neuroblastoma, susceptibility to, 3	VCV003663741	2	29416349	2	29193483	3663741	3798332		NC_000002.12:29193482:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4602G>A (p.Gly1534=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001151846	2	29416351	2	29193485	1151846	1133634	rs1187162555	NC_000002.12:29193484:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4601G>C (p.Gly1534Ala)	ALK	G1534A, G466A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001043855	2	29416352	2	29193486	1043855	1024425	rs139185626	NC_000002.12:29193485:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4601G>A (p.Gly1534Glu)	ALK	G1534E, G466E	Neuroblastoma, susceptibility to, 3	VCV000470879	2	29416352	2	29193486	470879	450970	rs139185626	NC_000002.12:29193485:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4600G>C (p.Gly1534Arg)	ALK	G1534R, G466R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001491106	2	29416353	2	29193487	1491106	1508341	rs1453682751	NC_000002.12:29193486:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4600G>A (p.Gly1534Arg)	ALK	G1534R, G466R	Neuroblastoma, susceptibility to, 3	VCV001465922	2	29416353	2	29193487	1465922	1448747	rs1453682751	NC_000002.12:29193486:C:T	single nucleotide variant	missense variant	Uncertain significance	May 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4598T>C (p.Leu1533Pro)	ALK	L1533P, L465P	Neuroblastoma, susceptibility to, 3	VCV002899862	2	29416355	2	29193489	2899862	3067949		NC_000002.12:29193488:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4598T>G (p.Leu1533Arg)	ALK	L465R, L1533R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001405728	2	29416355	2	29193489	1405728	1480668	rs764298799	NC_000002.12:29193488:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4597C>G (p.Leu1533Val)	ALK	L1533V, L465V	Hereditary cancer-predisposing syndrome	VCV003285415	2	29416356	2	29193490	3285415	3440647		NC_000002.12:29193489:G:C	single nucleotide variant	missense variant	Uncertain significance	May 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4597C>T (p.Leu1533=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002916539	2	29416356	2	29193490	2916539	3079969		NC_000002.12:29193489:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4596C>A (p.Asn1532Lys)	ALK	N464K, N1532K	Neuroblastoma, susceptibility to, 3	VCV003645432	2	29416357	2	29193491	3645432	3783847		NC_000002.12:29193490:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4596C>G (p.Asn1532Lys)	ALK	N1532K, N464K	Hereditary cancer-predisposing syndrome	VCV001741731	2	29416357	2	29193491	1741731	1805174		NC_000002.12:29193490:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4596C>T (p.Asn1532=)	ALK		Hereditary cancer-predisposing syndrome|not specified|not provided|Neuroblastoma, susceptibility to, 3	VCV000335687	2	29416357	2	29193491	335687	289366	rs1881422	NC_000002.12:29193490:G:A	single nucleotide variant	synonymous variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4594A>T (p.Asn1532Tyr)	ALK	N1532Y, N464Y	Neuroblastoma, susceptibility to, 3	VCV001007946	2	29416359	2	29193493	1007946	988672	rs563126725	NC_000002.12:29193492:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4594A>G (p.Asn1532Asp)	ALK	N1532D, N464D	Neuroblastoma, susceptibility to, 3	VCV000847641	2	29416359	2	29193493	847641	826281	rs563126725	NC_000002.12:29193492:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.4592G>T (p.Gly1531Val)	ALK	G1531V, G463V	Neuroblastoma, susceptibility to, 3	VCV001053171	2	29416361	2	29193495	1053171	1041362	rs1668933433	NC_000002.12:29193494:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4592G>A (p.Gly1531Asp)	ALK	G463D, G1531D	Neuroblastoma, susceptibility to, 3	VCV001037252	2	29416361	2	29193495	1037252	1024426	rs1668933433	NC_000002.12:29193494:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4590G>A (p.Arg1530=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001528867	2	29416363	2	29193497	1528867	1634636	rs1668933679	NC_000002.12:29193496:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4590G>T (p.Arg1530Ser)	ALK	R1530S, R462S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000951840	2	29416363	2	29193497	951840	922696	rs1668933679	NC_000002.12:29193496:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4589G>C (p.Arg1530Thr)	ALK	R1530T, R462T	Neuroblastoma, susceptibility to, 3	VCV002857581	2	29416364	2	29193498	2857581	3021478		NC_000002.12:29193497:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4589G>T (p.Arg1530Met)	ALK	R1530M, R462M	Neuroblastoma, susceptibility to, 3	VCV001018204	2	29416364	2	29193498	1018204	1003958	rs141242925	NC_000002.12:29193497:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4589G>A (p.Arg1530Lys)	ALK	R1530K, R462K	Neuroblastoma, susceptibility to, 3	VCV000859884	2	29416364	2	29193498	859884	826282	rs141242925	NC_000002.12:29193497:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4588A>G (p.Arg1530Gly)	ALK	R1530G, R462G	Hereditary cancer-predisposing syndrome	VCV002452106	2	29416365	2	29193499	2452106	2426746		NC_000002.12:29193498:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4586_4587delinsTG (p.Asp1529Val)	ALK	D461V, D1529V	Neuroblastoma, susceptibility to, 3	VCV001038015	2	29416366 - 29416367	2	29193500 - 29193501	1038015	1024427	rs1668934153	NC_000002.12:29193499:GT:CA	Indel	missense variant	Uncertain significance	Jan 30, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4587C>G (p.Asp1529Glu)	ALK	D1529E, D461E	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not specified	VCV000133476	2	29416366	2	29193500	133476	137215	rs1881421	NC_000002.12:29193499:G:C	single nucleotide variant	missense variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4586A>T (p.Asp1529Val)	ALK	D1529V, D461V	Hereditary cancer-predisposing syndrome	VCV002477258	2	29416367	2	29193501	2477258	2453607		NC_000002.12:29193500:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4585G>C (p.Asp1529His)	ALK	D1529H, D461H	Neuroblastoma, susceptibility to, 3	VCV002676382	2	29416368	2	29193502	2676382	2832679		NC_000002.12:29193501:C:G	single nucleotide variant	missense variant	Uncertain significance	May 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4585G>A (p.Asp1529Asn)	ALK	D1529N, D461N	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404359	2	29416368	2	29193502	404359	392535	rs779663817	NC_000002.12:29193501:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4584C>G (p.His1528Gln)	ALK	H460Q, H1528Q	Neuroblastoma, susceptibility to, 3	VCV001443868	2	29416369	2	29193503	1443868	1487867	rs746470148	NC_000002.12:29193502:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4584C>A (p.His1528Gln)	ALK	H460Q, H1528Q	Ovarian cancer|Neuroblastoma, susceptibility to, 3	VCV001430972	2	29416369	2	29193503	1430972	1467649	rs746470148	NC_000002.12:29193502:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 5, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4584C>T (p.His1528=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001142323	2	29416369	2	29193503	1142323	1133635	rs746470148	NC_000002.12:29193502:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4583A>G (p.His1528Arg)	ALK	H1528R, H460R	Neuroblastoma, susceptibility to, 3	VCV002752642	2	29416370	2	29193504	2752642	2913383		NC_000002.12:29193503:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4583A>T (p.His1528Leu)	ALK	H1528L, H460L	Hereditary cancer-predisposing syndrome	VCV001741655	2	29416370	2	29193504	1741655	1805098		NC_000002.12:29193503:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4581A>G (p.Pro1527=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003656892	2	29416372	2	29193506	3656892	3789748		NC_000002.12:29193505:T:C	single nucleotide variant	synonymous variant	Likely benign	Jun 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4581A>C (p.Pro1527=)	ALK		Hereditary cancer-predisposing syndrome	VCV002447088	2	29416372	2	29193506	2447088	2422211		NC_000002.12:29193505:T:G	single nucleotide variant	synonymous variant	Likely benign	Dec 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4580C>T (p.Pro1527Leu)	ALK	P1527L, P459L	Hereditary cancer-predisposing syndrome	VCV001741643	2	29416373	2	29193507	1741643	1805086		NC_000002.12:29193506:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4579C>T (p.Pro1527Ser)	ALK	P459S, P1527S	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV001040502	2	29416374	2	29193508	1040502	1024428	rs1668934497	NC_000002.12:29193507:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4578G>C (p.Glu1526Asp)	ALK	E1526D, E458D	Neuroblastoma, susceptibility to, 3	VCV002133550	2	29416375	2	29193509	2133550	2190239		NC_000002.12:29193508:C:G	single nucleotide variant	missense variant	Uncertain significance	May 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4578G>A (p.Glu1526=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001115210	2	29416375	2	29193509	1115210	1091223	rs754743349	NC_000002.12:29193508:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4560_4577dup (p.Lys1525_Glu1526insAspProIleAlaLysLys)	ALK		Neuroblastoma, susceptibility to, 3	VCV001045769	2	29416375 - 29416376	2	29193509 - 29193510	1045769	1024429	rs780241185	NC_000002.12:29193509:TCCTTCTTTGCTATAGGAT:TCCTTCTTTGCTATAGGATCCTTCTTTGCTATAGGAT	Duplication	inframe_insertion	Uncertain significance	Sep 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4576G>A (p.Glu1526Lys)	ALK	E1526K, E458K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001023185	2	29416377	2	29193511	1023185	1003959	rs1558603565	NC_000002.12:29193510:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4575G>A (p.Lys1525=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001741589	2	29416378	2	29193512	1741589	1805032		NC_000002.12:29193511:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4570AAG[1] (p.Lys1525del)	ALK	K1525del, K457del	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000239839	2	29416378 - 29416380	2	29193512 - 29193514	239839	238709	rs755556501	NC_000002.12:29193511:CTTCTT:CTT	Microsatellite	inframe_deletion	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4574A>G (p.Lys1525Arg)	ALK	K1525R, K457R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003223908	2	29416379	2	29193513	3223908	3380930		NC_000002.12:29193512:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4573A>G (p.Lys1525Glu)	ALK	K1525E, K457E	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000133475	2	29416380	2	29193514	133475	137214	rs139437088	NC_000002.12:29193513:T:C	single nucleotide variant	missense variant	Benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4572G>A (p.Lys1524=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223907	2	29416381	2	29193515	3223907	3380929		NC_000002.12:29193514:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4571A>G (p.Lys1524Arg)	ALK	K1524R, K456R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001000602	2	29416382	2	29193516	1000602	988673	rs1668935395	NC_000002.12:29193515:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4568C>T (p.Ala1523Val)	ALK	A1523V, A455V	Neuroblastoma, susceptibility to, 3	VCV002839644	2	29416385	2	29193519	2839644	2993081		NC_000002.12:29193518:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4567G>C (p.Ala1523Pro)	ALK	A1523P, A455P	Neuroblastoma, susceptibility to, 3	VCV000470878	2	29416386	2	29193520	470878	450698	rs1553386968	NC_000002.12:29193519:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4566A>G (p.Ile1522Met)	ALK	I1522M, I454M	Neuroblastoma, susceptibility to, 3	VCV001056325	2	29416387	2	29193521	1056325	1041363	rs902642850	NC_000002.12:29193520:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.4565T>C (p.Ile1522Thr)	ALK	I1522T, I454T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001364429	2	29416388	2	29193522	1364429	1386368	rs771352312	NC_000002.12:29193521:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4565del (p.Ile1522fs)	ALK	I1522fs, I454fs	Neuroblastoma, susceptibility to, 3|not provided	VCV001045135	2	29416388	2	29193522	1045135	1024430	rs1668935806	NC_000002.12:29193521:A:	Deletion	frameshift variant	Uncertain significance	Mar 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4565T>G (p.Ile1522Arg)	ALK	I1522R, I454R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000647169	2	29416388	2	29193522	647169	629798	rs771352312	NC_000002.12:29193521:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4561C>A (p.Pro1521Thr)	ALK	P453T, P1521T	Neuroblastoma, susceptibility to, 3	VCV003011275	2	29416392	2	29193526	3011275	3180661		NC_000002.12:29193525:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4560T>A (p.Asn1520Lys)	ALK	N1520K, N452K	Neuroblastoma, susceptibility to, 3	VCV002708632	2	29416393	2	29193527	2708632	2870923		NC_000002.12:29193526:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4558A>C (p.Asn1520His)	ALK	N452H, N1520H	Neuroblastoma, susceptibility to, 3	VCV002106897	2	29416395	2	29193529	2106897	2159606		NC_000002.12:29193528:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4557T>G (p.Asn1519Lys)	ALK	N1519K, N451K	Hereditary cancer-predisposing syndrome	VCV001741466	2	29416396	2	29193530	1741466	1804910		NC_000002.12:29193529:A:C	single nucleotide variant	missense variant	Uncertain significance	May 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4557T>C (p.Asn1519=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001091855	2	29416396	2	29193530	1091855	1069503	rs1668936067	NC_000002.12:29193529:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4554_4555delinsTT (p.Lys1518_Asn1519delinsAsnTyr)	ALK		Neuroblastoma, susceptibility to, 3	VCV002766231	2	29416398 - 29416399	2	29193532 - 29193533	2766231	2932136		NC_000002.12:29193531:TC:AA	Indel	missense variant	Uncertain significance	Oct 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4554del (p.Asn1519fs)	ALK	N1519fs, N451fs	Neuroblastoma, susceptibility to, 3	VCV001517189	2	29416399	2	29193533	1517189	1515349	rs2148137938	NC_000002.12:29193532:C:	Deletion	frameshift variant	Uncertain significance	Jun 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4554G>T (p.Lys1518Asn)	ALK	K1518N, K450N	Neuroblastoma, susceptibility to, 3	VCV000846976	2	29416399	2	29193533	846976	826283	rs774746810	NC_000002.12:29193532:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4553A>G (p.Lys1518Arg)	ALK	K450R, K1518R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001929044	2	29416400	2	29193534	1929044	1987932		NC_000002.12:29193533:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4553del (p.Lys1518fs)	ALK	K1518fs, K450fs	Neuroblastoma, susceptibility to, 3	VCV001420590	2	29416400	2	29193534	1420590	1403198	rs2148137946	NC_000002.12:29193533:TTTTT:TTTT	Deletion	frameshift variant	Uncertain significance	Aug 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4548C>T (p.Thr1516=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001621524	2	29416405	2	29193539	1621524	1528670	rs2148137958	NC_000002.12:29193538:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4547C>T (p.Thr1516Ile)	ALK	T1516I, T448I	Neuroblastoma, susceptibility to, 3	VCV000940646	2	29416406	2	29193540	940646	931338	rs1668936237	NC_000002.12:29193539:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4546A>C (p.Thr1516Pro)	ALK	T448P, T1516P	Neuroblastoma, susceptibility to, 3	VCV002746222	2	29416407	2	29193541	2746222	2911732		NC_000002.12:29193540:T:G	single nucleotide variant	missense variant	Uncertain significance	May 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4543C>A (p.Pro1515Thr)	ALK	P1515T, P447T	Neuroblastoma, susceptibility to, 3	VCV002675809	2	29416410	2	29193544	2675809	2835928		NC_000002.12:29193543:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4542A>C (p.Lys1514Asn)	ALK	K1514N, K446N	Neuroblastoma, susceptibility to, 3	VCV001345946	2	29416411	2	29193545	1345946	1378235	rs2148137975	NC_000002.12:29193544:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4540A>G (p.Lys1514Glu)	ALK	K1514E, K446E	Neuroblastoma, susceptibility to, 3	VCV003241838	2	29416413	2	29193547	3241838	3400816		NC_000002.12:29193546:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4540A>C (p.Lys1514Gln)	ALK	K1514Q, K446Q	Hereditary cancer-predisposing syndrome	VCV002452100	2	29416413	2	29193547	2452100	2426740		NC_000002.12:29193546:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4539G>A (p.Glu1513=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001093202	2	29416414	2	29193548	1093202	1069504	rs148138515	NC_000002.12:29193547:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 10, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4538A>C (p.Glu1513Ala)	ALK	E1513A, E445A	Hereditary cancer-predisposing syndrome	VCV003525205	2	29416415	2	29193549	3525205	3685561		NC_000002.12:29193548:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4538A>G (p.Glu1513Gly)	ALK	E1513G, E445G	Neuroblastoma, susceptibility to, 3	VCV001942380	2	29416415	2	29193549	1942380	2005113		NC_000002.12:29193548:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4537G>C (p.Glu1513Gln)	ALK	E1513Q, E445Q	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000648409	2	29416416	2	29193550	648409	629799	rs374733353	NC_000002.12:29193549:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4537G>A (p.Glu1513Lys)	ALK	E1513K, E445K	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000538249	2	29416416	2	29193550	538249	518085	rs374733353	NC_000002.12:29193549:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4536A>G (p.Thr1512=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000239838	2	29416417	2	29193551	239838	238710	rs878854658	NC_000002.12:29193550:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4535C>T (p.Thr1512Ile)	ALK	T1512I, T444I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001951692	2	29416418	2	29193552	1951692	2010546		NC_000002.12:29193551:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4535C>G (p.Thr1512Arg)	ALK	T444R, T1512R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001449726	2	29416418	2	29193552	1449726	1412909	rs75681494	NC_000002.12:29193551:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4533T>C (p.Phe1511=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000743883	2	29416420	2	29193554	743883	747578	rs1573078266	NC_000002.12:29193553:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4531T>A (p.Phe1511Ile)	ALK	F1511I, F443I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001059412	2	29416422	2	29193556	1059412	1041364	rs1573078272	NC_000002.12:29193555:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4530G>A (p.Trp1510Ter)	ALK	W442*, W1510*	Neuroblastoma, susceptibility to, 3	VCV001489487	2	29416423	2	29193557	1489487	1495093	rs772430445	NC_000002.12:29193556:C:T	single nucleotide variant	nonsense	Uncertain significance	Nov 17, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4530G>C (p.Trp1510Cys)	ALK	W1510C, W442C	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000569779	2	29416423	2	29193557	569779	561274	rs772430445	NC_000002.12:29193556:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4529G>A (p.Trp1510Ter)	ALK	W1510*, W442*	Neuroblastoma, susceptibility to, 3	VCV001009502	2	29416424	2	29193558	1009502	988674	rs928177802	NC_000002.12:29193557:C:T	single nucleotide variant	nonsense	Uncertain significance	Jan 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4527C>G (p.Ser1509=)	ALK		Hereditary cancer-predisposing syndrome	VCV003525185	2	29416426	2	29193560	3525185	3685541		NC_000002.12:29193559:G:C	single nucleotide variant	synonymous variant	Likely benign	Nov 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4524C>T (p.Gly1508=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470877	2	29416429	2	29193563	470877	450978	rs760733288	NC_000002.12:29193562:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4522G>A (p.Gly1508Ser)	ALK	G1508S, G440S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470876	2	29416431	2	29193565	470876	450803	rs764315254	NC_000002.12:29193564:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4521C>T (p.Tyr1507=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470875	2	29416432	2	29193566	470875	451021	rs566993546	NC_000002.12:29193565:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4518G>A (p.Thr1506=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000239837	2	29416435	2	29193569	239837	238711	rs761628666	NC_000002.12:29193568:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4517C>T (p.Thr1506Met)	ALK	T1506M, T438M	Neuroblastoma, susceptibility to, 3	VCV002193741	2	29416436	2	29193570	2193741	1929417		NC_000002.12:29193569:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4516A>T (p.Thr1506Ser)	ALK	T1506S, T438S	Neuroblastoma, susceptibility to, 3	VCV000655530	2	29416437	2	29193571	655530	629800	rs1553386991	NC_000002.12:29193570:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4516A>G (p.Thr1506Ala)	ALK	T1506A, T438A	Neuroblastoma, susceptibility to, 3	VCV000538272	2	29416437	2	29193571	538272	518165	rs1553386991	NC_000002.12:29193570:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4515A>T (p.Pro1505=)	ALK		Hereditary cancer-predisposing syndrome	VCV001741155	2	29416438	2	29193572	1741155	1808532		NC_000002.12:29193571:T:A	single nucleotide variant	synonymous variant	Likely benign	Jan 17, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4512C>T (p.Asn1504=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001080864	2	29416441	2	29193575	1080864	1069505	rs527638667	NC_000002.12:29193574:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4512C>A (p.Asn1504Lys)	ALK	N1504K, N436K	Neuroblastoma, susceptibility to, 3	VCV000852565	2	29416441	2	29193575	852565	826284	rs527638667	NC_000002.12:29193574:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4506G>A (p.Leu1502=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000702941	2	29416447	2	29193581	702941	691124	rs758399865	NC_000002.12:29193580:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4503C>T (p.Ser1501=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001741061	2	29416450	2	29193584	1741061	1808438		NC_000002.12:29193583:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4502G>A (p.Ser1501Asn)	ALK	S1501N, S433N	Neuroblastoma, susceptibility to, 3	VCV003619227	2	29416451	2	29193585	3619227	3759707		NC_000002.12:29193584:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4500C>T (p.Thr1500=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001139177	2	29416453	2	29193587	1139177	1112725	rs2148138096	NC_000002.12:29193586:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 28, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4499C>T (p.Thr1500Ile)	ALK	T432I, T1500I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001044656	2	29416454	2	29193588	1044656	1024431	rs751170666	NC_000002.12:29193587:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4494G>A (p.Lys1498=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001740987	2	29416459	2	29193593	1740987	1808364		NC_000002.12:29193592:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4493A>G (p.Lys1498Arg)	ALK	K1498R, K430R	Neuroblastoma, susceptibility to, 3|Ovarian cancer	VCV002445362	2	29416460	2	29193594	2445362	2419088		NC_000002.12:29193593:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 27, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4493A>T (p.Lys1498Met)	ALK	K1498M, K430M	Neuroblastoma, susceptibility to, 3	VCV002131921	2	29416460	2	29193594	2131921	2187762		NC_000002.12:29193593:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4492A>G (p.Lys1498Glu)	ALK	K430E, K1498E	Hereditary cancer-predisposing syndrome	VCV001740977	2	29416461	2	29193595	1740977	1808354		NC_000002.12:29193594:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4491C>T (p.Asn1497=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223906	2	29416462	2	29193596	3223906	3380928		NC_000002.12:29193595:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4490A>G (p.Asn1497Ser)	ALK	N429S, N1497S	Neuroblastoma, susceptibility to, 3	VCV002133297	2	29416463	2	29193597	2133297	2189986		NC_000002.12:29193596:T:C	single nucleotide variant	missense variant	Uncertain significance	May 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4489A>C (p.Asn1497His)	ALK	N1497H, N429H	Neuroblastoma, susceptibility to, 3	VCV002737537	2	29416464	2	29193598	2737537	2899184		NC_000002.12:29193597:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4487G>A (p.Arg1496Lys)	ALK	R1496K, R428K	Neuroblastoma, susceptibility to, 3|not specified	VCV001062198	2	29416466	2	29193600	1062198	1041365	rs2148138148	NC_000002.12:29193599:C:T	single nucleotide variant	missense variant	Uncertain significance	May 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4486A>G (p.Arg1496Gly)	ALK	R428G, R1496G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001356066	2	29416467	2	29193601	1356066	1354362	rs1378185030	NC_000002.12:29193600:T:C	single nucleotide variant	missense variant	Uncertain significance	May 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4486A>C (p.Arg1496=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001134684	2	29416467	2	29193601	1134684	1112726	rs1378185030	NC_000002.12:29193600:T:G	single nucleotide variant	synonymous variant	Likely benign	Dec 20, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4485C>G (p.Ser1495=)	ALK		Hereditary cancer-predisposing syndrome	VCV002586671	2	29416468	2	29193602	2586671	2756854		NC_000002.12:29193601:G:C	single nucleotide variant	synonymous variant	Likely benign	Jun 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4484C>T (p.Ser1495Phe)	ALK	S1495F, S427F	Neuroblastoma, susceptibility to, 3	VCV003655470	2	29416469	2	29193603	3655470	3786186		NC_000002.12:29193602:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4483T>C (p.Ser1495Pro)	ALK	S1495P, S427P	Neuroblastoma, susceptibility to, 3	VCV001927731	2	29416470	2	29193604	1927731	1984033		NC_000002.12:29193603:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4483T>A (p.Ser1495Thr)	ALK	S1495T, S427T	Neuroblastoma, susceptibility to, 3	VCV001002872	2	29416470	2	29193604	1002872	988675	rs1441987948	NC_000002.12:29193603:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4481G>A (p.Gly1494Glu)	ALK	G1494E, G426E	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000470874	2	29416472	2	29193606	470874	450700	rs368484630	NC_000002.12:29193605:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4480G>A (p.Gly1494Arg)	ALK	G1494R, G426R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided|not specified	VCV000412937	2	29416473	2	29193607	412937	392875	rs199940609	NC_000002.12:29193606:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4479C>A (p.His1493Gln)	ALK	H1493Q, H425Q	Neuroblastoma, susceptibility to, 3	VCV002883919	2	29416474	2	29193608	2883919	3043221		NC_000002.12:29193607:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4479C>T (p.His1493=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001553703	2	29416474	2	29193608	1553703	1521883	rs2148138174	NC_000002.12:29193607:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4478A>G (p.His1493Arg)	ALK	H1493R, H425R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002178936	2	29416475	2	29193609	2178936	1909048		NC_000002.12:29193608:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4478A>T (p.His1493Leu)	ALK	H1493L, H425L	Neuroblastoma, susceptibility to, 3|not provided	VCV001064057	2	29416475	2	29193609	1064057	1041366	rs747759910	NC_000002.12:29193608:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4477C>T (p.His1493Tyr)	ALK	H425Y, H1493Y	Neuroblastoma, susceptibility to, 3	VCV002708634	2	29416476	2	29193610	2708634	2870925		NC_000002.12:29193609:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4476C>T (p.Val1492=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002421013	2	29416477	2	29193611	2421013	1938557		NC_000002.12:29193610:G:A	single nucleotide variant	synonymous variant	Likely benign	May 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4475T>C (p.Val1492Ala)	ALK	V1492A, V424A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001740851	2	29416478	2	29193612	1740851	1798351		NC_000002.12:29193611:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4474G>C (p.Val1492Leu)	ALK	V424L, V1492L	Neuroblastoma, susceptibility to, 3	VCV001415175	2	29416479	2	29193613	1415175	1474787	rs567438064	NC_000002.12:29193612:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 14, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4474G>A (p.Val1492Ile)	ALK	V424I, V1492I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000644626	2	29416479	2	29193613	644626	629801	rs567438064	NC_000002.12:29193612:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4473G>A (p.Lys1491=)	ALK		not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000412914	2	29416480	2	29193614	412914	392891	rs148987382	NC_000002.12:29193613:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4471_4472delinsCG (p.Lys1491Arg)	ALK	K1491R, K423R	Neuroblastoma, susceptibility to, 3	VCV000968430	2	29416481 - 29416482	2	29193615 - 29193616	968430	953057	rs1668940521	NC_000002.12:29193614:TT:CG	Indel	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.4472A>G (p.Lys1491Arg)	ALK	K1491R, K423R	Neuroblastoma, susceptibility to, 3|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000133474	2	29416481	2	29193615	133474	137213	rs1881420	NC_000002.12:29193614:T:C	single nucleotide variant	missense variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4471A>C (p.Lys1491Gln)	ALK	K423Q, K1491Q	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001740836	2	29416482	2	29193616	1740836	1798336		NC_000002.12:29193615:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 29, 2023	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4470C>G (p.His1490Gln)	ALK	H1490Q, H422Q	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001372332	2	29416483	2	29193617	1372332	1443577	rs1573078434	NC_000002.12:29193616:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4470C>T (p.His1490=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000761925	2	29416483	2	29193617	761925	763169	rs1573078434	NC_000002.12:29193616:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4469A>G (p.His1490Arg)	ALK	H422R, H1490R	Neuroblastoma, susceptibility to, 3	VCV002744322	2	29416484	2	29193618	2744322	2903799		NC_000002.12:29193617:T:C	single nucleotide variant	missense variant	Uncertain significance	May 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4468C>T (p.His1490Tyr)	ALK	H422Y, H1490Y	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001450773	2	29416485	2	29193619	1450773	1351294	rs2148138215	NC_000002.12:29193618:G:A	single nucleotide variant	missense variant	Uncertain significance	May 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4467G>A (p.Leu1489=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000758275	2	29416486	2	29193620	758275	763170	rs1452074719	NC_000002.12:29193619:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4466T>G (p.Leu1489Trp)	ALK	L1489W, L421W	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000580132	2	29416487	2	29193621	580132	557998	rs747098710	NC_000002.12:29193620:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4465T>C (p.Leu1489=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001575769	2	29416488	2	29193622	1575769	1551797	rs1573078445	NC_000002.12:29193621:A:G	single nucleotide variant	synonymous variant	Likely benign	Feb 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4464G>A (p.Glu1488=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003655419	2	29416489	2	29193623	3655419	3786135		NC_000002.12:29193622:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4462G>C (p.Glu1488Gln)	ALK	E420Q, E1488Q	Neuroblastoma, susceptibility to, 3	VCV001474602	2	29416491	2	29193625	1474602	1503689	rs776861631	NC_000002.12:29193624:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4461G>A (p.Ser1487=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001740780	2	29416492	2	29193626	1740780	1798280		NC_000002.12:29193625:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4458_4460del (p.Ser1487del)	ALK	S419del, S1487del	Neuroblastoma, susceptibility to, 3	VCV003685644	2	29416493 - 29416495	2	29193627 - 29193629	3685644	3819817		NC_000002.12:29193626:GAAG:G	Deletion		Uncertain significance	Jul 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4460C>T (p.Ser1487Leu)	ALK	S1487L, S419L	Neuroblastoma, susceptibility to, 3	VCV001061185	2	29416493	2	29193627	1061185	1041367	rs1182539285	NC_000002.12:29193626:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4459T>C (p.Ser1487Pro)	ALK	S1487P, S419P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000649236	2	29416494	2	29193628	649236	629802	rs762072069	NC_000002.12:29193627:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4458T>C (p.Pro1486=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001157228	2	29416495	2	29193629	1157228	1133636	rs1668941335	NC_000002.12:29193628:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 15, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4457C>T (p.Pro1486Leu)	ALK	P1486L, P418L	Hereditary cancer-predisposing syndrome	VCV001740738	2	29416496	2	29193630	1740738	1798238		NC_000002.12:29193629:G:A	single nucleotide variant	missense variant	Uncertain significance	May 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4455T>A (p.Pro1485=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV003223904	2	29416498	2	29193632	3223904	3380926		NC_000002.12:29193631:A:T	single nucleotide variant	synonymous variant	Likely benign	Apr 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4455T>G (p.Pro1485=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000696869	2	29416498	2	29193632	696869	683495	rs765346559	NC_000002.12:29193631:A:C	single nucleotide variant	synonymous variant	Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4454C>T (p.Pro1485Leu)	ALK	P1485L, P417L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000567581	2	29416499	2	29193633	567581	561275	rs556061961	NC_000002.12:29193632:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4453C>A (p.Pro1485Thr)	ALK	P417T, P1485T	Neuroblastoma, susceptibility to, 3	VCV003019573	2	29416500	2	29193634	3019573	3172081		NC_000002.12:29193633:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4451A>C (p.Asn1484Thr)	ALK	N1484T, N416T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001423088	2	29416502	2	29193636	1423088	1425367	rs752320442	NC_000002.12:29193635:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4451A>G (p.Asn1484Ser)	ALK	N1484S, N416S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000952348	2	29416502	2	29193636	952348	922697	rs752320442	NC_000002.12:29193635:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4450A>G (p.Asn1484Asp)	ALK	N1484D, N416D	Neuroblastoma, susceptibility to, 3	VCV002692717	2	29416503	2	29193637	2692717	2863544		NC_000002.12:29193636:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4447T>C (p.Ser1483Pro)	ALK	S1483P, S415P	Ovarian cancer	VCV002445317	2	29416506	2	29193640	2445317	2419043		NC_000002.12:29193639:A:G	single nucleotide variant	missense variant	Benign	Jan 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4446G>C (p.Gln1482His)	ALK	Q1482H, Q414H	Neuroblastoma, susceptibility to, 3	VCV003013745	2	29416507	2	29193641	3013745	3174037		NC_000002.12:29193640:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4445A>G (p.Gln1482Arg)	ALK	Q1482R, Q414R	Neuroblastoma, susceptibility to, 3	VCV001381117	2	29416508	2	29193642	1381117	1499959	rs751473124	NC_000002.12:29193641:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4445A>C (p.Gln1482Pro)	ALK	Q1482P, Q414P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470873	2	29416508	2	29193642	470873	450806	rs751473124	NC_000002.12:29193641:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4442C>T (p.Ser1481Phe)	ALK	S1481F, S413F	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000960596	2	29416511	2	29193645	960596	942841	rs1356575388	NC_000002.12:29193644:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4442C>G (p.Ser1481Cys)	ALK	S413C, S1481C	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000666206	2	29416511	2	29193645	666206	629803	rs1356575388	NC_000002.12:29193644:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4441T>G (p.Ser1481Ala)	ALK	S413A, S1481A	Neuroblastoma, susceptibility to, 3	VCV001995447	2	29416512	2	29193646	1995447	2059820		NC_000002.12:29193645:A:C	single nucleotide variant	missense variant	Uncertain significance	May 17, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4441T>C (p.Ser1481Pro)	ALK	S413P, S1481P	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001385708	2	29416512	2	29193646	1385708	1460856	rs2148138322	NC_000002.12:29193645:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4438T>G (p.Phe1480Val)	ALK	F412V, F1480V	Hereditary cancer-predisposing syndrome	VCV003523393	2	29416515	2	29193649	3523393	3685066		NC_000002.12:29193648:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4438T>C (p.Phe1480Leu)	ALK	F1480L, F412L	Neuroblastoma, susceptibility to, 3	VCV001424474	2	29416515	2	29193649	1424474	1438350	rs1410822315	NC_000002.12:29193648:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4437A>C (p.Ala1479=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001740589	2	29416516	2	29193650	1740589	1798090		NC_000002.12:29193649:T:G	single nucleotide variant	synonymous variant	Likely benign	Sep 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4436C>T (p.Ala1479Val)	ALK	A1479V, A411V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000570054	2	29416517	2	29193651	570054	558000	rs1558603789	NC_000002.12:29193650:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4434G>A (p.Met1478Ile)	ALK	M1478I, M410I	Neuroblastoma, susceptibility to, 3	VCV002702167	2	29416519	2	29193653	2702167	2855884		NC_000002.12:29193652:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4433T>C (p.Met1478Thr)	ALK	M1478T, M410T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000335688	2	29416520	2	29193654	335688	285967	rs141010693	NC_000002.12:29193653:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4430A>G (p.Asn1477Ser)	ALK	N1477S, N409S	Neuroblastoma, susceptibility to, 3	VCV000856478	2	29416523	2	29193657	856478	826285	rs1668942326	NC_000002.12:29193656:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4428G>A (p.Val1476=)	ALK		Hereditary cancer-predisposing syndrome	VCV002566566	2	29416525	2	29193659	2566566	2734409		NC_000002.12:29193658:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4427T>C (p.Val1476Ala)	ALK	V408A, V1476A	Neuroblastoma, susceptibility to, 3	VCV000657804	2	29416526	2	29193660	657804	629804	rs1329539708	NC_000002.12:29193659:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4426G>A (p.Val1476Met)	ALK	V1476M, V408M	Neuroblastoma, susceptibility to, 3	VCV000847172	2	29416527	2	29193661	847172	826286	rs1353772576	NC_000002.12:29193660:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.4425C>G (p.His1475Gln)	ALK	H1475Q, H407Q	Hereditary cancer-predisposing syndrome	VCV003524178	2	29416528	2	29193662	3524178	3682346		NC_000002.12:29193661:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4425C>A (p.His1475Gln)	ALK	H1475Q, H407Q	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000569434	2	29416528	2	29193662	569434	558348	rs139039449	NC_000002.12:29193661:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4425C>T (p.His1475=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000412904	2	29416528	2	29193662	412904	392688	rs139039449	NC_000002.12:29193661:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4422A>G (p.Gly1474=)	ALK		Hereditary cancer-predisposing syndrome	VCV003522680	2	29416531	2	29193665	3522680	3678664		NC_000002.12:29193664:T:C	single nucleotide variant	synonymous variant	Likely benign	Jul 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4421G>C (p.Gly1474Ala)	ALK	G1474A, G406A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001387747	2	29416532	2	29193666	1387747	1374368	rs1293939080	NC_000002.12:29193665:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4421G>A (p.Gly1474Glu)	ALK	G1474E, G406E	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538239	2	29416532	2	29193666	538239	518027	rs1293939080	NC_000002.12:29193665:C:T	single nucleotide variant	missense variant	Uncertain significance	May 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4420G>A (p.Gly1474Arg)	ALK	G1474R, G406R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002624789	2	29416533	2	29193667	2624789	2790284		NC_000002.12:29193666:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4420G>C (p.Gly1474Arg)	ALK	G406R, G1474R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001509481	2	29416533	2	29193667	1509481	1365102	rs2148138381	NC_000002.12:29193666:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4419G>T (p.Gly1473=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002151805	2	29416534	2	29193668	2151805	1881972		NC_000002.12:29193667:C:A	single nucleotide variant	synonymous variant	Likely benign	Mar 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4419G>A (p.Gly1473=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001651713	2	29416534	2	29193668	1651713	1547162	rs752227509	NC_000002.12:29193667:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 23, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4419G>C (p.Gly1473=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538300	2	29416534	2	29193668	538300	518092	rs752227509	NC_000002.12:29193667:C:G	single nucleotide variant	synonymous variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4418G>A (p.Gly1473Glu)	ALK	G1473E, G405E	Neuroblastoma, susceptibility to, 3	VCV000538273	2	29416535	2	29193669	538273	518038	rs1174344092	NC_000002.12:29193668:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 25, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4416A>G (p.Glu1472=)	ALK		Hereditary cancer-predisposing syndrome	VCV001740438	2	29416537	2	29193671	1740438	1791468		NC_000002.12:29193670:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 13, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4416A>T (p.Glu1472Asp)	ALK	E1472D, E404D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000133473	2	29416537	2	29193671	133473	137212	rs538459690	NC_000002.12:29193670:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4413G>A (p.Val1471=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001118076	2	29416540	2	29193674	1118076	1091224	rs1179096583	NC_000002.12:29193673:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4411G>T (p.Val1471Leu)	ALK	V403L, V1471L	Neuroblastoma, susceptibility to, 3	VCV003708273	2	29416542	2	29193676	3708273	3836550		NC_000002.12:29193675:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.4411G>A (p.Val1471Met)	ALK	V1471M, V403M	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000864205	2	29416542	2	29193676	864205	826287	rs201759867	NC_000002.12:29193675:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4410C>T (p.Ala1470=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001150102	2	29416543	2	29193677	1150102	1133637	rs990658464	NC_000002.12:29193676:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4407G>A (p.Pro1469=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000239836	2	29416546	2	29193680	239836	238712	rs372471601	NC_000002.12:29193679:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4406C>G (p.Pro1469Arg)	ALK	P401R, P1469R	Neuroblastoma, susceptibility to, 3	VCV001376816	2	29416547	2	29193681	1376816	1479680	rs758625575	NC_000002.12:29193680:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4406C>T (p.Pro1469Leu)	ALK	P401L, P1469L	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000664849	2	29416547	2	29193681	664849	629805	rs758625575	NC_000002.12:29193680:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4405C>T (p.Pro1469Ser)	ALK	P1469S, P401S	Neuroblastoma, susceptibility to, 3	VCV001014087	2	29416548	2	29193682	1014087	1003960	rs780571098	NC_000002.12:29193681:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4404G>A (p.Gly1468=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001145827	2	29416549	2	29193683	1145827	1133638	rs1256422825	NC_000002.12:29193682:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4402G>C (p.Gly1468Arg)	ALK	G1468R, G400R	Hereditary cancer-predisposing syndrome	VCV003223903	2	29416551	2	29193685	3223903	3380925		NC_000002.12:29193684:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4402G>A (p.Gly1468Arg)	ALK	G1468R, G400R	Neuroblastoma, susceptibility to, 3	VCV001721839	2	29416551	2	29193685	1721839	1779557		NC_000002.12:29193684:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4401A>G (p.Arg1467=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001090960	2	29416552	2	29193686	1090960	1069506	rs2148138435	NC_000002.12:29193685:T:C	single nucleotide variant	synonymous variant	Likely benign	Aug 20, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4400G>A (p.Arg1467Lys)	ALK	R1467K, R399K	Hereditary cancer-predisposing syndrome	VCV001740335	2	29416553	2	29193687	1740335	1791368		NC_000002.12:29193686:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4399A>G (p.Arg1467Gly)	ALK	R399G, R1467G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001740264	2	29416554	2	29193688	1740264	1791297		NC_000002.12:29193687:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4398T>C (p.Pro1466=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001149104	2	29416555	2	29193689	1149104	1133639	rs747467124	NC_000002.12:29193688:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4397C>T (p.Pro1466Leu)	ALK	P398L, P1466L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001518103	2	29416556	2	29193690	1518103	1512374	rs1368483124	NC_000002.12:29193689:G:A	single nucleotide variant	missense variant	Uncertain significance	May 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4396C>T (p.Pro1466Ser)	ALK	P1466S, P398S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000848784	2	29416557	2	29193691	848784	826288	rs1668945318	NC_000002.12:29193690:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4395C>T (p.Val1465=)	ALK		Hereditary cancer-predisposing syndrome	VCV003286240	2	29416558	2	29193692	3286240	3455063		NC_000002.12:29193691:G:A	single nucleotide variant	synonymous variant	Likely benign	May 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4393G>C (p.Val1465Leu)	ALK	V397L, V1465L	not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000644006	2	29416560	2	29193694	644006	629806	rs769128867	NC_000002.12:29193693:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4390_4391insCA (p.Arg1464fs)	ALK	R396fs, R1464fs	Neuroblastoma, susceptibility to, 3	VCV003664923	2	29416562 - 29416563	2	29193696 - 29193697	3664923	3802045		NC_000002.12:29193696::TG	Insertion	frameshift variant	Uncertain significance	Oct 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4391G>A (p.Arg1464Gln)	ALK	R1464Q, R396Q	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000404333	2	29416562	2	29193696	404333	392539	rs1060500213	NC_000002.12:29193695:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4390C>T (p.Arg1464Ter)	ALK	R1464*, R396*	not provided|Neuroblastoma, susceptibility to, 3	VCV001712103	2	29416563	2	29193697	1712103	1710525		NC_000002.12:29193696:G:A	single nucleotide variant	nonsense	Uncertain significance	Sep 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4390C>G (p.Arg1464Gly)	ALK	R1464G, R396G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470872	2	29416563	2	29193697	470872	450809	rs374135358	NC_000002.12:29193696:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4387G>A (p.Val1463Ile)	ALK	V1463I, V395I	Neuroblastoma, susceptibility to, 3	VCV001718964	2	29416566	2	29193700	1718964	1776468		NC_000002.12:29193699:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4387G>T (p.Val1463Phe)	ALK	V1463F, V395F	Neuroblastoma, susceptibility to, 3	VCV001495059	2	29416566	2	29193700	1495059	1368845	rs2148138487	NC_000002.12:29193699:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4383C>T (p.Ile1461=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001556564	2	29416570	2	29193704	1556564	1592708	rs368580204	NC_000002.12:29193703:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 21, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4382T>C (p.Ile1461Thr)	ALK	I393T, I1461T	Hereditary cancer-predisposing syndrome	VCV003524535	2	29416571	2	29193705	3524535	3679200		NC_000002.12:29193704:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4382T>G (p.Ile1461Ser)	ALK	I1461S, I393S	Hereditary cancer-predisposing syndrome	VCV003524386	2	29416571	2	29193705	3524386	3679051		NC_000002.12:29193704:A:C	single nucleotide variant	missense variant	Likely benign	Aug 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4381A>C (p.Ile1461Leu)	ALK	I1461L, I393L	Neuroblastoma, susceptibility to, 3	VCV003621867	2	29416572	2	29193706	3621867	3750962		NC_000002.12:29193705:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4376_4381delinsTAGAGG (p.Ala1459_Ile1461delinsValGluVal)	ALK		Neuroblastoma, susceptibility to, 3	VCV003586396	2	29416572 - 29416577	2	29193706 - 29193711	3586396	3717104		NC_000002.12:29193705:TCTCTG:CCTCTA	Indel	missense variant	Uncertain significance	May 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4381A>T (p.Ile1461Phe)	ALK	I393F, I1461F	Neuroblastoma, susceptibility to, 3	VCV002913624	2	29416572	2	29193706	2913624	3076295		NC_000002.12:29193705:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4380_4381delinsAG (p.Ile1461Val)	ALK	I393V, I1461V	Neuroblastoma, susceptibility to, 3	VCV001047157	2	29416572 - 29416573	2	29193706 - 29193707	1047157	1024432	rs1668946149	NC_000002.12:29193705:TC:CT	Indel	missense variant	Uncertain significance	May 21, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4381A>G (p.Ile1461Val)	ALK	I1461V, I393V	Neuroblastoma, susceptibility to, 3|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000133472	2	29416572	2	29193706	133472	137211	rs1670283	NC_000002.12:29193705:T:C	single nucleotide variant	missense variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4380G>C (p.Glu1460Asp)	ALK	E1460D, E392D	Neuroblastoma, susceptibility to, 3	VCV000577237	2	29416573	2	29193707	577237	558002	rs1558603894	NC_000002.12:29193706:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4379A>G (p.Glu1460Gly)	ALK	E1460G, E392G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000646803	2	29416574	2	29193708	646803	629807	rs773248596	NC_000002.12:29193707:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4378G>A (p.Glu1460Lys)	ALK	E1460K, E392K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001051514	2	29416575	2	29193709	1051514	1041369	rs2148138533	NC_000002.12:29193708:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4377A>G (p.Ala1459=)	ALK		Hereditary cancer-predisposing syndrome	VCV001740122	2	29416576	2	29193710	1740122	1791155		NC_000002.12:29193709:T:C	single nucleotide variant	synonymous variant	Likely benign	Mar 9, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4376C>T (p.Ala1459Val)	ALK	A391V, A1459V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002158782	2	29416577	2	29193711	2158782	1883764		NC_000002.12:29193710:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4375G>T (p.Ala1459Ser)	ALK	A1459S, A391S	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000335689	2	29416578	2	29193712	335689	285968	rs372612147	NC_000002.12:29193711:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4373C>A (p.Ala1458Asp)	ALK	A1458D, A390D	Neuroblastoma, susceptibility to, 3	VCV001509148	2	29416580	2	29193714	1509148	1452265	rs774448761	NC_000002.12:29193713:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4373C>T (p.Ala1458Val)	ALK	A390V, A1458V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001382901	2	29416580	2	29193714	1382901	1513375	rs774448761	NC_000002.12:29193713:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4372G>A (p.Ala1458Thr)	ALK	A1458T, A390T	Hereditary cancer-predisposing syndrome	VCV002586721	2	29416581	2	29193715	2586721	2756904		NC_000002.12:29193714:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4369A>C (p.Thr1457Pro)	ALK	T389P, T1457P	Neuroblastoma, susceptibility to, 3	VCV002903404	2	29416584	2	29193718	2903404	3064808		NC_000002.12:29193717:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4367C>T (p.Pro1456Leu)	ALK	P388L, P1456L	Neuroblastoma, susceptibility to, 3|not provided	VCV000843700	2	29416586	2	29193720	843700	826289	rs944804641	NC_000002.12:29193719:G:A	single nucleotide variant	missense variant	Uncertain significance	May 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4365A>T (p.Lys1455Asn)	ALK	K1455N, K387N	Neuroblastoma, susceptibility to, 3	VCV002077996	2	29416588	2	29193722	2077996	2138512		NC_000002.12:29193721:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4362G>A (p.Lys1454=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000703207	2	29416591	2	29193725	703207	691125	rs1040411489	NC_000002.12:29193724:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4361A>G (p.Lys1454Arg)	ALK	K1454R, K386R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003223902	2	29416592	2	29193726	3223902	3380924		NC_000002.12:29193725:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4359A>G (p.Ala1453=)	ALK		Hereditary cancer-predisposing syndrome	VCV001739977	2	29416594	2	29193728	1739977	1794423		NC_000002.12:29193727:T:C	single nucleotide variant	synonymous variant	Likely benign	Jul 7, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4359A>C (p.Ala1453=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538288	2	29416594	2	29193728	538288	518101	rs1553387086	NC_000002.12:29193727:T:G	single nucleotide variant	synonymous variant	Likely benign	Jan 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4358C>G (p.Ala1453Gly)	ALK	A385G, A1453G	Neuroblastoma, susceptibility to, 3	VCV002134731	2	29416595	2	29193729	2134731	2192288		NC_000002.12:29193728:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4357G>T (p.Ala1453Ser)	ALK	A1453S, A385S	Neuroblastoma, susceptibility to, 3	VCV001385974	2	29416596	2	29193730	1385974	1461120	rs752317227	NC_000002.12:29193729:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4357G>A (p.Ala1453Thr)	ALK	A1453T, A385T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001019773	2	29416596	2	29193730	1019773	1003961	rs752317227	NC_000002.12:29193729:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4355C>A (p.Ala1452Asp)	ALK	A1452D, A384D	Neuroblastoma, susceptibility to, 3	VCV002979860	2	29416598	2	29193732	2979860	3134624		NC_000002.12:29193731:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4354G>A (p.Ala1452Thr)	ALK	A1452T, A384T	Neuroblastoma, susceptibility to, 3	VCV002844414	2	29416599	2	29193733	2844414	3008055		NC_000002.12:29193732:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4350C>G (p.Gly1450=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002907105	2	29416603	2	29193737	2907105	3065910		NC_000002.12:29193736:G:C	single nucleotide variant	synonymous variant	Likely benign	Dec 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4350C>T (p.Gly1450=)	ALK		not provided	VCV002650789	2	29416603	2	29193737	2650789	2815648		NC_000002.12:29193736:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4349G>C (p.Gly1450Ala)	ALK	G1450A, G382A	Hereditary cancer-predisposing syndrome	VCV003223901	2	29416604	2	29193738	3223901	3380923		NC_000002.12:29193737:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4348G>A (p.Gly1450Ser)	ALK	G382S, G1450S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000957254	2	29416605	2	29193739	957254	942842	rs1346420173	NC_000002.12:29193738:C:T	single nucleotide variant	missense variant	Uncertain significance	May 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4347T>C (p.Ser1449=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001109018	2	29416606	2	29193740	1109018	1091225	rs1558603940	NC_000002.12:29193739:A:G	single nucleotide variant	synonymous variant	Likely benign	Jun 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4344C>T (p.Ser1448=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000335690	2	29416609	2	29193743	335690	288984	rs886055929	NC_000002.12:29193742:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Apr 29, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4331_4343del (p.Leu1444fs)	ALK	L1444fs, L376fs	Neuroblastoma, susceptibility to, 3	VCV002900304	2	29416610 - 29416622	2	29193744 - 29193756	2900304	3060647		NC_000002.12:29193743:GAGGTGGTAGGCAGAGGTGGT:GAGGTGGT	Deletion	frameshift variant	Uncertain significance	Dec 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4343C>T (p.Ser1448Phe)	ALK	S1448F, S380F	Neuroblastoma, susceptibility to, 3|Ovarian cancer	VCV000470871	2	29416610	2	29193744	470871	450708	rs1553387094	NC_000002.12:29193743:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2023	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4342T>C (p.Ser1448Pro)	ALK	S1448P, S380P	Neuroblastoma, susceptibility to, 3	VCV002826083	2	29416611	2	29193745	2826083	2979476		NC_000002.12:29193744:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4341dup (p.Ser1448fs)	ALK	S1448fs, S380fs	Neuroblastoma, susceptibility to, 3	VCV001056135	2	29416611 - 29416612	2	29193745 - 29193746	1056135	1041370	rs2148138649	NC_000002.12:29193745:GG:GGG	Duplication	frameshift variant	Uncertain significance	Jul 12, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4341C>G (p.Thr1447=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003672486	2	29416612	2	29193746	3672486	3805543		NC_000002.12:29193745:G:C	single nucleotide variant	synonymous variant	Likely benign	Sep 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4341C>T (p.Thr1447=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001092109	2	29416612	2	29193746	1092109	1069507	rs1256417576	NC_000002.12:29193745:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4340C>A (p.Thr1447Asn)	ALK	T379N, T1447N	Neuroblastoma, susceptibility to, 3	VCV003660454	2	29416613	2	29193747	3660454	3797595		NC_000002.12:29193746:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4340C>T (p.Thr1447Ile)	ALK	T379I, T1447I	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000955779	2	29416613	2	29193747	955779	942843	rs554599505	NC_000002.12:29193746:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 14, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4339A>G (p.Thr1447Ala)	ALK	T1447A, T379A	Neuroblastoma, susceptibility to, 3	VCV002970643	2	29416614	2	29193748	2970643	3135720		NC_000002.12:29193747:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4338C>A (p.Thr1446=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002857828	2	29416615	2	29193749	2857828	3017875		NC_000002.12:29193748:G:T	single nucleotide variant	synonymous variant	Likely benign	Apr 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4338C>T (p.Thr1446=)	ALK		Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3|not specified	VCV000259273	2	29416615	2	29193749	259273	250715	rs56132472	NC_000002.12:29193748:G:A	single nucleotide variant	synonymous variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4337C>A (p.Thr1446Asn)	ALK	T378N, T1446N	Neuroblastoma, susceptibility to, 3	VCV002707228	2	29416616	2	29193750	2707228	2866919		NC_000002.12:29193749:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4337C>T (p.Thr1446Ile)	ALK	T378I, T1446I	Neuroblastoma, susceptibility to, 3	VCV000839742	2	29416616	2	29193750	839742	826290	rs1668948533	NC_000002.12:29193749:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4335T>A (p.Pro1445=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000744192	2	29416618	2	29193752	744192	747579	rs1573078845	NC_000002.12:29193751:A:T	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.4333C>G (p.Pro1445Ala)	ALK	P1445A, P377A	Hereditary cancer-predisposing syndrome	VCV003285548	2	29416620	2	29193754	3285548	3440780		NC_000002.12:29193753:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4332G>A (p.Leu1444=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001992710	2	29416621	2	29193755	1992710	2059231		NC_000002.12:29193754:C:T	single nucleotide variant	synonymous variant	Likely benign	May 10, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4331T>C (p.Leu1444Pro)	ALK	L376P, L1444P	Neuroblastoma, susceptibility to, 3	VCV001997455	2	29416622	2	29193756	1997455	2060537		NC_000002.12:29193755:A:G	single nucleotide variant	missense variant	Uncertain significance	May 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4323ACC[1] (p.Pro1443del)	ALK	P1443del, P375del	Neuroblastoma, susceptibility to, 3	VCV001398089	2	29416625 - 29416627	2	29193759 - 29193761	1398089	1431018	rs2148138704	NC_000002.12:29193758:GGTGGTGG:GGTGG	Microsatellite	inframe_deletion	Uncertain significance	Mar 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4327C>T (p.Pro1443Ser)	ALK	P375S, P1443S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001955676	2	29416626	2	29193760	1955676	2008501		NC_000002.12:29193759:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4325C>G (p.Pro1442Arg)	ALK	P1442R, P374R	Hereditary cancer-predisposing syndrome	VCV003223900	2	29416628	2	29193762	3223900	3380922		NC_000002.12:29193761:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4324C>T (p.Pro1442Ser)	ALK	P374S, P1442S	Hereditary cancer-predisposing syndrome	VCV001739722	2	29416629	2	29193763	1739722	1794168		NC_000002.12:29193762:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4323A>T (p.Pro1441=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002759810	2	29416630	2	29193764	2759810	2924863		NC_000002.12:29193763:T:A	single nucleotide variant	synonymous variant	Likely benign	Sep 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4322C>T (p.Pro1441Leu)	ALK	P1441L, P373L	Neuroblastoma, susceptibility to, 3	VCV001061537	2	29416631	2	29193765	1061537	1041371	rs1668949114	NC_000002.12:29193764:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4321C>T (p.Pro1441Ser)	ALK	P1441S, P373S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003223899	2	29416632	2	29193766	3223899	3380921		NC_000002.12:29193765:G:A	single nucleotide variant	missense variant	Uncertain significance	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4319C>T (p.Ala1440Val)	ALK	A1440V, A372V	Neuroblastoma, susceptibility to, 3	VCV001356078	2	29416634	2	29193768	1356078	1354374	rs2148138722	NC_000002.12:29193767:G:A	single nucleotide variant	missense variant	Uncertain significance	May 25, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4318G>T (p.Ala1440Ser)	ALK	A1440S, A372S	Neuroblastoma, susceptibility to, 3	VCV001360791	2	29416635	2	29193769	1360791	1360357	rs1307483937	NC_000002.12:29193768:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4318G>A (p.Ala1440Thr)	ALK	A372T, A1440T	Neuroblastoma, susceptibility to, 3	VCV000952972	2	29416635	2	29193769	952972	922698	rs1307483937	NC_000002.12:29193768:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4318G>C (p.Ala1440Pro)	ALK	A1440P, A372P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000933467	2	29416635	2	29193769	933467	931339	rs1307483937	NC_000002.12:29193768:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4317T>G (p.Ala1439=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002586717	2	29416636	2	29193770	2586717	2756900		NC_000002.12:29193769:A:C	single nucleotide variant	synonymous variant	Likely benign	Sep 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4312C>A (p.Pro1438Thr)	ALK	P370T, P1438T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000857661	2	29416641	2	29193775	857661	826291	rs1558604000	NC_000002.12:29193774:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4312C>T (p.Pro1438Ser)	ALK	P1438S, P370S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000573604	2	29416641	2	29193775	573604	558350	rs1558604000	NC_000002.12:29193774:G:A	single nucleotide variant	missense variant	Uncertain significance	May 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4311C>G (p.Ser1437Arg)	ALK	S1437R, S369R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003525572	2	29416642	2	29193776	3525572	3685928		NC_000002.12:29193775:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4311C>A (p.Ser1437Arg)	ALK	S1437R, S369R	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000863770	2	29416642	2	29193776	863770	826292	rs1173440684	NC_000002.12:29193775:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4309A>T (p.Ser1437Cys)	ALK	S1437C, S369C	Neuroblastoma, susceptibility to, 3	VCV002006848	2	29416644	2	29193778	2006848	2066083		NC_000002.12:29193777:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4307G>A (p.Arg1436His)	ALK	R1436H, R368H	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000659084	2	29416646	2	29193780	659084	629808	rs544926207	NC_000002.12:29193779:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 18, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4306C>T (p.Arg1436Cys)	ALK	R368C, R1436C	Neuroblastoma, susceptibility to, 3	VCV001041110	2	29416647	2	29193781	1041110	1024433	rs201129468	NC_000002.12:29193780:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4306C>A (p.Arg1436Ser)	ALK	R1436S, R368S	Neuroblastoma, susceptibility to, 3	VCV001023647	2	29416647	2	29193781	1023647	1003962	rs201129468	NC_000002.12:29193780:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4297GAG[2] (p.Glu1435del)	ALK	E1435del, E367del	Neuroblastoma, susceptibility to, 3|not specified|Neuroblastoma Susceptibility|Hereditary cancer-predisposing syndrome	VCV000133471	2	29416648 - 29416650	2	29193782 - 29193784	133471	137210	rs138827116	NC_000002.12:29193781:CTCCTCCTCC:CTCCTCC	Microsatellite	inframe_deletion	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4303G>C (p.Glu1435Gln)	ALK	E1435Q, E367Q	Neuroblastoma, susceptibility to, 3	VCV000538236	2	29416650	2	29193784	538236	518170	rs769694344	NC_000002.12:29193783:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4303G>A (p.Glu1435Lys)	ALK	E1435K, E367K	Neuroblastoma, susceptibility to, 3	VCV000404351	2	29416650	2	29193784	404351	392899	rs769694344	NC_000002.12:29193783:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.4302G>T (p.Glu1434Asp)	ALK	E1434D, E366D	Hereditary cancer-predisposing syndrome	VCV003223898	2	29416651	2	29193785	3223898	3380920		NC_000002.12:29193784:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4301A>G (p.Glu1434Gly)	ALK	E1434G, E366G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002083802	2	29416652	2	29193786	2083802	2136461		NC_000002.12:29193785:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4300G>A (p.Glu1434Lys)	ALK	E366K, E1434K	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002447095	2	29416653	2	29193787	2447095	2422218		NC_000002.12:29193786:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4298_4299del (p.Glu1433fs)	ALK	E1433fs, E365fs	Rhabdomyosarcoma	VCV000978809	2	29416654 - 29416655	2	29193788 - 29193789	978809	966884	rs1668950344	NC_000002.12:29193787:CTC:C	Deletion	frameshift variant	Likely pathogenic	Sep 1, 2020	no assertion criteria provided							
NM_004304.5(ALK):c.4298A>G (p.Glu1433Gly)	ALK	E1433G, E365G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001378283	2	29416655	2	29193789	1378283	1492713	rs1668950412	NC_000002.12:29193788:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 7, 2022	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4297del (p.Glu1433fs)	ALK	E1433fs, E365fs	Neuroblastoma, susceptibility to, 3	VCV001346971	2	29416656	2	29193790	1346971	1453084	rs770888701	NC_000002.12:29193789:CCC:CC	Deletion	frameshift variant	Uncertain significance	Apr 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4297G>C (p.Glu1433Gln)	ALK	E365Q, E1433Q	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000964353	2	29416656	2	29193790	964353	942844	rs1668950485	NC_000002.12:29193789:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4296G>C (p.Arg1432=)	ALK		Hereditary cancer-predisposing syndrome	VCV002452125	2	29416657	2	29193791	2452125	2426765		NC_000002.12:29193790:C:G	single nucleotide variant	synonymous variant	Likely benign	Feb 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4295G>C (p.Arg1432Pro)	ALK	R1432P, R364P	Neuroblastoma, susceptibility to, 3	VCV001052915	2	29416658	2	29193792	1052915	1041372	rs1374838786	NC_000002.12:29193791:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4295G>A (p.Arg1432Gln)	ALK	R364Q, R1432Q	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000937696	2	29416658	2	29193792	937696	931340	rs1374838786	NC_000002.12:29193791:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4294C>T (p.Arg1432Trp)	ALK	R1432W, R364W	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001061935	2	29416659	2	29193793	1061935	1041373	rs1668950917	NC_000002.12:29193792:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4294C>G (p.Arg1432Gly)	ALK	R1432G, R364G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001008561	2	29416659	2	29193793	1008561	988676	rs1668950917	NC_000002.12:29193792:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4293A>C (p.Lys1431Asn)	ALK	K1431N, K363N	Neuroblastoma, susceptibility to, 3	VCV002738125	2	29416660	2	29193794	2738125	2895476		NC_000002.12:29193793:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4293A>G (p.Lys1431=)	ALK		Hereditary cancer-predisposing syndrome	VCV000824761	2	29416660	2	29193794	824761	806881	rs1573078992	NC_000002.12:29193793:T:C	single nucleotide variant	synonymous variant	Likely benign	Nov 9, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4292A>C (p.Lys1431Thr)	ALK	K1431T, K363T	Neuroblastoma, susceptibility to, 3	VCV002979300	2	29416661	2	29193795	2979300	3137892		NC_000002.12:29193794:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4290A>C (p.Ala1430=)	ALK		Hereditary cancer-predisposing syndrome	VCV002586709	2	29416663	2	29193797	2586709	2756892		NC_000002.12:29193796:T:G	single nucleotide variant	synonymous variant	Likely benign	Sep 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4288G>T (p.Ala1430Ser)	ALK	A1430S, A362S	Neuroblastoma, susceptibility to, 3|not provided	VCV002576892	2	29416665	2	29193799	2576892	2741789		NC_000002.12:29193798:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4287G>A (p.Gln1429=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000643947	2	29416666	2	29193800	643947	629809	rs1573079004	NC_000002.12:29193799:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Aug 12, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.4286A>C (p.Gln1429Pro)	ALK	Q1429P, Q361P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001054066	2	29416667	2	29193801	1054066	1041374	rs55906201	NC_000002.12:29193800:T:G	single nucleotide variant	missense variant	Uncertain significance	May 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4286A>G (p.Gln1429Arg)	ALK	Q1429R, Q361R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000947672	2	29416667	2	29193801	947672	922699	rs55906201	NC_000002.12:29193800:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4285C>A (p.Gln1429Lys)	ALK	Q361K, Q1429K	Neuroblastoma, susceptibility to, 3	VCV002961404	2	29416668	2	29193802	2961404	3120022		NC_000002.12:29193801:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4281T>C (p.Ser1427=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001141903	2	29416672	2	29193806	1141903	1133640	rs893790294	NC_000002.12:29193805:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4279T>G (p.Ser1427Ala)	ALK	S1427A, S359A	Neuroblastoma, susceptibility to, 3	VCV002115421	2	29416674	2	29193808	2115421	2161657		NC_000002.12:29193807:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4279T>C (p.Ser1427Pro)	ALK	S1427P, S359P	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001739316	2	29416674	2	29193808	1739316	1797686		NC_000002.12:29193807:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4278C>A (p.Val1426=)	ALK		Hereditary cancer-predisposing syndrome	VCV003285357	2	29416675	2	29193809	3285357	3440589		NC_000002.12:29193808:G:T	single nucleotide variant	synonymous variant	Likely benign	Mar 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4278C>G (p.Val1426=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002821920	2	29416675	2	29193809	2821920	2985572		NC_000002.12:29193808:G:C	single nucleotide variant	synonymous variant	Uncertain significance	Dec 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4278C>T (p.Val1426=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001671863	2	29416675	2	29193809	1671863	1636791	rs1235124703	NC_000002.12:29193808:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4277T>C (p.Val1426Ala)	ALK	V358A, V1426A	Hereditary cancer-predisposing syndrome	VCV003524368	2	29416676	2	29193810	3524368	3679033		NC_000002.12:29193809:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4277T>A (p.Val1426Asp)	ALK	V1426D, V358D	Neuroblastoma, susceptibility to, 3	VCV001509585	2	29416676	2	29193810	1509585	1365205	rs2148138831	NC_000002.12:29193809:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4276G>T (p.Val1426Phe)	ALK	V358F, V1426F	Neuroblastoma, susceptibility to, 3	VCV001357873	2	29416677	2	29193811	1357873	1367768	rs1558604058	NC_000002.12:29193810:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4276G>A (p.Val1426Ile)	ALK	V1426I, V358I	Neuroblastoma, susceptibility to, 3	VCV000568640	2	29416677	2	29193811	568640	558352	rs1558604058	NC_000002.12:29193810:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4275G>A (p.Leu1425=)	ALK		Hereditary cancer-predisposing syndrome|ALK-related disorder|Neuroblastoma, susceptibility to, 3|not provided	VCV000239835	2	29416678	2	29193812	239835	238713	rs749418931	NC_000002.12:29193811:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4274T>C (p.Leu1425Pro)	ALK	L1425P, L357P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003286251	2	29416679	2	29193813	3286251	3455074		NC_000002.12:29193812:A:G	single nucleotide variant	missense variant	Uncertain significance	May 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4272C>A (p.Leu1424=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002855335	2	29416681	2	29193815	2855335	3013843		NC_000002.12:29193814:G:T	single nucleotide variant	synonymous variant	Likely benign	Apr 12, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4272C>T (p.Leu1424=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001739267	2	29416681	2	29193815	1739267	1797637		NC_000002.12:29193814:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Aug 6, 2022	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4270C>G (p.Leu1424Val)	ALK	L1424V, L356V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000638944	2	29416683	2	29193817	638944	629810	rs1573079038	NC_000002.12:29193816:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4268C>T (p.Pro1423Leu)	ALK	P355L, P1423L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002624787	2	29416685	2	29193819	2624787	2790282		NC_000002.12:29193818:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4265C>T (p.Pro1422Leu)	ALK	P354L, P1422L	Hereditary cancer-predisposing syndrome	VCV001739199	2	29416688	2	29193822	1739199	1797569		NC_000002.12:29193821:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4264C>G (p.Pro1422Ala)	ALK	P1422A, P354A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000582206	2	29416689	2	29193823	582206	558017	rs1558604075	NC_000002.12:29193822:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4263T>C (p.Val1421=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003524655	2	29416690	2	29193824	3524655	3679319		NC_000002.12:29193823:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4262T>C (p.Val1421Ala)	ALK	V1421A, V353A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001720724	2	29416691	2	29193825	1720724	1776906		NC_000002.12:29193824:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4262T>G (p.Val1421Gly)	ALK	V1421G, V353G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000538195	2	29416691	2	29193825	538195	518176	rs1472924406	NC_000002.12:29193824:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4261del (p.Val1421fs)	ALK	V1421fs, V353fs	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002814443	2	29416692	2	29193826	2814443	2976396		NC_000002.12:29193825:CCCCC:CCCC	Deletion	frameshift variant	Uncertain significance	Dec 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4261G>T (p.Val1421Phe)	ALK	V1421F, V353F	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001366184	2	29416692	2	29193826	1366184	1411526	rs774358799	NC_000002.12:29193825:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4261G>A (p.Val1421Ile)	ALK	V1421I, V353I	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000646286	2	29416692	2	29193826	646286	629811	rs774358799	NC_000002.12:29193825:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4260G>A (p.Gly1420=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002031240	2	29416693	2	29193827	2031240	2078882		NC_000002.12:29193826:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4260G>T (p.Gly1420=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001669594	2	29416693	2	29193827	1669594	1665848	rs2148138882	NC_000002.12:29193826:C:A	single nucleotide variant	synonymous variant	Likely benign	Jan 7, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4259G>C (p.Gly1420Ala)	ALK	G1420A, G352A	Hereditary cancer-predisposing syndrome	VCV002566599	2	29416694	2	29193828	2566599	2734442		NC_000002.12:29193827:C:G	single nucleotide variant	missense variant	Uncertain significance	May 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4259G>A (p.Gly1420Glu)	ALK	G1420E, G352E	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000582253	2	29416694	2	29193828	582253	558021	rs200470125	NC_000002.12:29193827:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4258G>A (p.Gly1420Arg)	ALK	G1420R, G352R	Neuroblastoma, susceptibility to, 3	VCV002998816	2	29416695	2	29193829	2998816	3156585		NC_000002.12:29193828:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4257G>C (p.Glu1419Asp)	ALK	E1419D, E351D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001386564	2	29416696	2	29193830	1386564	1357691	rs888028409	NC_000002.12:29193829:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4257G>A (p.Glu1419=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001161929	2	29416696	2	29193830	1161929	1133641	rs888028409	NC_000002.12:29193829:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4256A>T (p.Glu1419Val)	ALK	E1419V, E351V	Hereditary cancer-predisposing syndrome	VCV001739122	2	29416697	2	29193831	1739122	1788119		NC_000002.12:29193830:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4255G>C (p.Glu1419Gln)	ALK	E1419Q, E351Q	Neuroblastoma, susceptibility to, 3	VCV001059076	2	29416698	2	29193832	1059076	1041375	rs56181542	NC_000002.12:29193831:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4255G>A (p.Glu1419Lys)	ALK	E1419K, E351K	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000133479	2	29416698	2	29193832	133479	137218	rs56181542	NC_000002.12:29193831:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4254T>C (p.Pro1418=)	ALK		Hereditary cancer-predisposing syndrome	VCV003285115	2	29416699	2	29193833	3285115	3444294		NC_000002.12:29193832:A:G	single nucleotide variant	synonymous variant	Likely benign	May 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4253C>G (p.Pro1418Arg)	ALK	P1418R, P350R	Neuroblastoma, susceptibility to, 3	VCV000945952	2	29416700	2	29193834	945952	922700	rs1668952882	NC_000002.12:29193833:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4251C>A (p.Asp1417Glu)	ALK	D349E, D1417E	Hereditary cancer-predisposing syndrome	VCV002452140	2	29416702	2	29193836	2452140	2426780		NC_000002.12:29193835:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4249G>A (p.Asp1417Asn)	ALK	D349N, D1417N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002981806	2	29416704	2	29193838	2981806	3152461		NC_000002.12:29193837:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4249G>T (p.Asp1417Tyr)	ALK	D349Y, D1417Y	Hereditary cancer-predisposing syndrome	VCV001739053	2	29416704	2	29193838	1739053	1788050		NC_000002.12:29193837:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4249G>C (p.Asp1417His)	ALK	D1417H, D349H	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001053635	2	29416704	2	29193838	1053635	1041376	rs1251673674	NC_000002.12:29193837:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4248G>C (p.Lys1416Asn)	ALK	K1416N, K348N	Neuroblastoma, susceptibility to, 3	VCV001044437	2	29416705	2	29193839	1044437	1024434	rs55782189	NC_000002.12:29193838:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4248G>A (p.Lys1416=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000695693	2	29416705	2	29193839	695693	683496	rs55782189	NC_000002.12:29193838:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4248G>T (p.Lys1416Asn)	ALK	K1416N, K348N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000573190	2	29416705	2	29193839	573190	561279	rs55782189	NC_000002.12:29193838:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 5, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4247A>T (p.Lys1416Met)	ALK	K348M, K1416M	Neuroblastoma, susceptibility to, 3	VCV001374719	2	29416706	2	29193840	1374719	1453688	rs1558604110	NC_000002.12:29193839:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4247A>C (p.Lys1416Thr)	ALK	K1416T, K348T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001014664	2	29416706	2	29193840	1014664	1003963	rs1558604110	NC_000002.12:29193839:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4247A>G (p.Lys1416Arg)	ALK	K1416R, K348R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000582971	2	29416706	2	29193840	582971	561283	rs1558604110	NC_000002.12:29193839:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4241G>A (p.Arg1414Lys)	ALK	R1414K, R346K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000934485	2	29416712	2	29193846	934485	931341	rs77762612	NC_000002.12:29193845:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4241G>T (p.Arg1414Met)	ALK	R1414M, R346M	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000640753	2	29416712	2	29193846	640753	629812	rs77762612	NC_000002.12:29193845:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4240A>C (p.Arg1414=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001738997	2	29416713	2	29193847	1738997	1787995		NC_000002.12:29193846:T:G	single nucleotide variant	synonymous variant	Likely benign	Feb 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4238dup (p.Arg1414fs)	ALK	R1414fs, R346fs	Neuroblastoma, susceptibility to, 3	VCV000470869	2	29416714 - 29416715	2	29193848 - 29193849	470869	450810	rs1553387176	NC_000002.12:29193848:A:AA	Duplication	frameshift variant	Uncertain significance	Jun 11, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4238T>G (p.Val1413Gly)	ALK	V1413G, V345G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000470870	2	29416715	2	29193849	470870	451023	rs779318085	NC_000002.12:29193848:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4237G>A (p.Val1413Met)	ALK	V345M, V1413M	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000969329	2	29416716	2	29193850	969329	953058	rs560530815	NC_000002.12:29193849:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 22, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4236T>C (p.Pro1412=)	ALK		Hereditary cancer-predisposing syndrome	VCV003285675	2	29416717	2	29193851	3285675	3440906		NC_000002.12:29193850:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4235C>G (p.Pro1412Arg)	ALK	P1412R, P344R	Neuroblastoma, susceptibility to, 3	VCV002765208	2	29416718	2	29193852	2765208	2925955		NC_000002.12:29193851:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4233G>C (p.Val1411=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002698202	2	29416720	2	29193854	2698202	2858343		NC_000002.12:29193853:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4232T>G (p.Val1411Gly)	ALK	V343G, V1411G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000952166	2	29416721	2	29193855	952166	922701	rs878854657	NC_000002.12:29193854:A:C	single nucleotide variant	missense variant	Uncertain significance	May 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4232T>C (p.Val1411Ala)	ALK	V1411A, V343A	Neuroblastoma, susceptibility to, 3	VCV000239834	2	29416721	2	29193855	239834	238714	rs878854657	NC_000002.12:29193854:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4231G>A (p.Val1411Met)	ALK	V343M, V1411M	Hereditary cancer-predisposing syndrome	VCV003286117	2	29416722	2	29193856	3286117	3444857		NC_000002.12:29193855:C:T	single nucleotide variant	missense variant	Uncertain significance	May 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4231G>C (p.Val1411Leu)	ALK	V1411L, V343L	Neuroblastoma, susceptibility to, 3	VCV001443315	2	29416722	2	29193856	1443315	1384261	rs748638070	NC_000002.12:29193855:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4226_4231del (p.Glu1409_Lys1410del)	ALK		Neuroblastoma, susceptibility to, 3	VCV001010224	2	29416722 - 29416727	2	29193856 - 29193861	1010224	988677	rs1460984349	NC_000002.12:29193855:CTTTCTCTT:CTT	Deletion	inframe_deletion	Uncertain significance	Sep 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4230A>G (p.Lys1410=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000749425	2	29416723	2	29193857	749425	747580	rs982208354	NC_000002.12:29193856:T:C	single nucleotide variant	synonymous variant	Likely benign	Aug 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4229A>G (p.Lys1410Arg)	ALK	K1410R, K342R	Hereditary cancer-predisposing syndrome	VCV001738874	2	29416724	2	29193858	1738874	1787873		NC_000002.12:29193857:T:C	single nucleotide variant	missense variant	Uncertain significance	May 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4228A>G (p.Lys1410Glu)	ALK	K1410E, K342E	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000859785	2	29416725	2	29193859	859785	826293	rs755276699	NC_000002.12:29193858:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4227G>C (p.Glu1409Asp)	ALK	E341D, E1409D	Neuroblastoma, susceptibility to, 3	VCV003636066	2	29416726	2	29193860	3636066	3767646		NC_000002.12:29193859:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4227G>A (p.Glu1409=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001738866	2	29416726	2	29193860	1738866	1787865		NC_000002.12:29193859:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4216GAAGAG[1] (p.Glu1408_Glu1409del)	ALK		Neuroblastoma, susceptibility to, 3	VCV001348304	2	29416726 - 29416731	2	29193860 - 29193865	1348304	1459534	rs1558604159	NC_000002.12:29193859:CTCTTCCTCTTCC:CTCTTCC	Microsatellite	inframe_deletion	Uncertain significance	Oct 30, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4227G>T (p.Glu1409Asp)	ALK	E1409D, E341D	Neuroblastoma, susceptibility to, 3	VCV000470868	2	29416726	2	29193860	470868	450812	rs139086136	NC_000002.12:29193859:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4226A>T (p.Glu1409Val)	ALK	E1409V, E341V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000862881	2	29416727	2	29193861	862881	826294	rs1286165795	NC_000002.12:29193860:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4226A>G (p.Glu1409Gly)	ALK	E1409G, E341G	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538250	2	29416727	2	29193861	538250	518179	rs1286165795	NC_000002.12:29193860:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4225G>A (p.Glu1409Lys)	ALK	E341K, E1409K	Hereditary cancer-predisposing syndrome	VCV001738858	2	29416728	2	29193862	1738858	1787857		NC_000002.12:29193861:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4224A>C (p.Glu1408Asp)	ALK	E1408D, E340D	Neuroblastoma, susceptibility to, 3	VCV001715428	2	29416729	2	29193863	1715428	1775573		NC_000002.12:29193862:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4224A>G (p.Glu1408=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001649343	2	29416729	2	29193863	1649343	1567198	rs2148139002	NC_000002.12:29193862:T:C	single nucleotide variant	synonymous variant	Likely benign	Jun 11, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4223A>G (p.Glu1408Gly)	ALK	E1408G, E340G	Neuroblastoma, susceptibility to, 3	VCV001445436	2	29416730	2	29193864	1445436	1490308	rs2148139005	NC_000002.12:29193863:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4222G>C (p.Glu1408Gln)	ALK	E1408Q, E340Q	Hereditary cancer-predisposing syndrome	VCV003223897	2	29416731	2	29193865	3223897	3380919		NC_000002.12:29193864:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4222G>A (p.Glu1408Lys)	ALK	E340K, E1408K	Neuroblastoma, susceptibility to, 3|not provided	VCV001445965	2	29416731	2	29193865	1445965	1390796	rs145600484	NC_000002.12:29193864:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4221G>C (p.Glu1407Asp)	ALK	E1407D, E339D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000835126	2	29416732	2	29193866	835126	826295	rs552187705	NC_000002.12:29193865:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4221G>A (p.Glu1407=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000702961	2	29416732	2	29193866	702961	691126	rs552187705	NC_000002.12:29193865:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4220A>T (p.Glu1407Val)	ALK	E1407V, E339V	Hereditary cancer-predisposing syndrome	VCV003525341	2	29416733	2	29193867	3525341	3685697		NC_000002.12:29193866:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4219G>A (p.Glu1407Lys)	ALK	E1407K, E339K	Neuroblastoma, susceptibility to, 3	VCV000935628	2	29416734	2	29193868	935628	931342	rs1334825922	NC_000002.12:29193867:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4218A>G (p.Glu1406=)	ALK		Hereditary cancer-predisposing syndrome	VCV001738789	2	29416735	2	29193869	1738789	1787788		NC_000002.12:29193868:T:C	single nucleotide variant	synonymous variant	Likely benign	May 11, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4217A>G (p.Glu1406Gly)	ALK	E338G, E1406G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002452095	2	29416736	2	29193870	2452095	2426735		NC_000002.12:29193869:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4216G>A (p.Glu1406Lys)	ALK	E1406K, E338K	Neuroblastoma, susceptibility to, 3	VCV000944049	2	29416737	2	29193871	944049	922702	rs1668955167	NC_000002.12:29193870:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4215G>A (p.Val1405=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001412501	2	29416738	2	29193872	1412501	1344482	rs2148139024	NC_000002.12:29193871:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4214T>A (p.Val1405Glu)	ALK	V1405E, V337E	Hereditary cancer-predisposing syndrome	VCV003223896	2	29416739	2	29193873	3223896	3380918		NC_000002.12:29193872:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4214T>C (p.Val1405Ala)	ALK	V1405A, V337A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000659713	2	29416739	2	29193873	659713	629813	rs777760767	NC_000002.12:29193872:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4212T>C (p.Leu1404=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223895	2	29416741	2	29193875	3223895	3380917		NC_000002.12:29193874:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4211T>C (p.Leu1404Pro)	ALK	L1404P, L336P	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000645717	2	29416742	2	29193876	645717	629814	rs377129811	NC_000002.12:29193875:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4210C>T (p.Leu1404Phe)	ALK	L1404F, L336F	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000574752	2	29416743	2	29193877	574752	558023	rs757615099	NC_000002.12:29193876:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4210C>G (p.Leu1404Val)	ALK	L1404V, L336V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Ovarian cancer|not provided	VCV000470867	2	29416743	2	29193877	470867	450815	rs757615099	NC_000002.12:29193876:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 6, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4208C>T (p.Pro1403Leu)	ALK	P1403L, P335L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000937757	2	29416745	2	29193879	937757	931343	rs1212504281	NC_000002.12:29193878:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4206T>A (p.Gly1402=)	ALK		Hereditary cancer-predisposing syndrome	VCV001738690	2	29416747	2	29193881	1738690	1791023		NC_000002.12:29193880:A:T	single nucleotide variant	synonymous variant	Likely benign	Oct 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4204G>T (p.Gly1402Cys)	ALK	G334C, G1402C	Hereditary cancer-predisposing syndrome	VCV003522744	2	29416749	2	29193883	3522744	3678728		NC_000002.12:29193882:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4204G>A (p.Gly1402Ser)	ALK	G1402S, G334S	Hereditary cancer-predisposing syndrome	VCV003285833	2	29416749	2	29193883	3285833	3444573		NC_000002.12:29193882:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4203T>C (p.Tyr1401=)	ALK		not provided|not specified|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000239833	2	29416750	2	29193884	239833	238715	rs55772745	NC_000002.12:29193883:A:G	single nucleotide variant	synonymous variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4201T>G (p.Tyr1401Asp)	ALK	Y333D, Y1401D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000949011	2	29416752	2	29193886	949011	922703	rs549395816	NC_000002.12:29193885:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4200A>T (p.Glu1400Asp)	ALK	E1400D, E332D	Neuroblastoma, susceptibility to, 3	VCV001525214	2	29416753	2	29193887	1525214	1363553	rs143647372	NC_000002.12:29193886:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4200A>C (p.Glu1400Asp)	ALK	E1400D, E332D	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|ALK-related disorder	VCV000404316	2	29416753	2	29193887	404316	392540	rs143647372	NC_000002.12:29193886:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4199A>G (p.Glu1400Gly)	ALK	E332G, E1400G	Neuroblastoma, susceptibility to, 3	VCV003696328	2	29416754	2	29193888	3696328	3829229		NC_000002.12:29193887:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4199A>C (p.Glu1400Ala)	ALK	E1400A, E332A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001051905	2	29416754	2	29193888	1051905	1041377	rs978004615	NC_000002.12:29193887:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4198G>C (p.Glu1400Gln)	ALK	E1400Q, E332Q	Neuroblastoma, susceptibility to, 3	VCV000654048	2	29416755	2	29193889	654048	629815	rs1573079264	NC_000002.12:29193888:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.4197A>C (p.Ile1399=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003284693	2	29416756	2	29193890	3284693	3433844		NC_000002.12:29193889:T:G	single nucleotide variant	synonymous variant	Likely benign	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4197A>G (p.Ile1399Met)	ALK	I1399M, I331M	Neuroblastoma, susceptibility to, 3	VCV002071896	2	29416756	2	29193890	2071896	2123273		NC_000002.12:29193889:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4196T>C (p.Ile1399Thr)	ALK	I1399T, I331T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000858250	2	29416757	2	29193891	858250	826296	rs746970974	NC_000002.12:29193890:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4194G>T (p.Pro1398=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001560485	2	29416759	2	29193893	1560485	1575976	rs201653228	NC_000002.12:29193892:C:A	single nucleotide variant	synonymous variant	Likely benign	Mar 18, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4194G>C (p.Pro1398=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000755815	2	29416759	2	29193893	755815	763171	rs201653228	NC_000002.12:29193892:C:G	single nucleotide variant	synonymous variant	Likely benign	Oct 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4194G>A (p.Pro1398=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000697517	2	29416759	2	29193893	697517	686179	rs201653228	NC_000002.12:29193892:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 3, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.4193C>G (p.Pro1398Arg)	ALK	P330R, P1398R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001738587	2	29416760	2	29193894	1738587	1790920		NC_000002.12:29193893:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4193C>T (p.Pro1398Leu)	ALK	P1398L, P330L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000470866	2	29416760	2	29193894	470866	450709	rs531490912	NC_000002.12:29193893:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 24, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4192C>A (p.Pro1398Thr)	ALK	P330T, P1398T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002476822	2	29416761	2	29193895	2476822	2457285		NC_000002.12:29193894:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4191G>A (p.Leu1397=)	ALK		Hereditary cancer-predisposing syndrome	VCV001738575	2	29416762	2	29193896	1738575	1790908		NC_000002.12:29193895:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 5, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4190T>C (p.Leu1397Ser)	ALK	L1397S, L329S	Neuroblastoma, susceptibility to, 3	VCV000239832	2	29416763	2	29193897	239832	238716	rs878854656	NC_000002.12:29193896:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4186G>T (p.Ala1396Ser)	ALK	A328S, A1396S	Neuroblastoma, susceptibility to, 3	VCV003011321	2	29416767	2	29193901	3011321	3180707		NC_000002.12:29193900:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4186G>A (p.Ala1396Thr)	ALK	A1396T, A328T	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000133478	2	29416767	2	29193901	133478	137217	rs201768549	NC_000002.12:29193900:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 10, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4185C>A (p.Thr1395=)	ALK		Hereditary cancer-predisposing syndrome	VCV002586677	2	29416768	2	29193902	2586677	2756860		NC_000002.12:29193901:G:T	single nucleotide variant	synonymous variant	Likely benign	Jun 30, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4185C>G (p.Thr1395=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000753136	2	29416768	2	29193902	753136	763172	rs571470900	NC_000002.12:29193901:G:C	single nucleotide variant	synonymous variant	Likely benign	Jul 21, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4185C>T (p.Thr1395=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470865	2	29416768	2	29193902	470865	450989	rs571470900	NC_000002.12:29193901:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4184C>T (p.Thr1395Ile)	ALK	T1395I, T327I	Neuroblastoma, susceptibility to, 3	VCV000404348	2	29416769	2	29193903	404348	392550	rs1060500220	NC_000002.12:29193902:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4181A>G (p.Asn1394Ser)	ALK	N326S, N1394S	Hereditary cancer-predisposing syndrome	VCV003285321	2	29416772	2	29193906	3285321	3440553		NC_000002.12:29193905:T:C	single nucleotide variant	missense variant	Uncertain significance	May 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4181A>T (p.Asn1394Ile)	ALK	N326I, N1394I	Neuroblastoma, susceptibility to, 3	VCV001037172	2	29416772	2	29193906	1037172	1024435	rs1668957374	NC_000002.12:29193905:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4180A>C (p.Asn1394His)	ALK	N326H, N1394H	Neuroblastoma, susceptibility to, 3	VCV002148634	2	29416773	2	29193907	2148634	1880962		NC_000002.12:29193906:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4179C>T (p.Ile1393=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223894	2	29416774	2	29193908	3223894	3380916		NC_000002.12:29193907:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4175T>C (p.Val1392Ala)	ALK	V1392A, V324A	Hereditary cancer-predisposing syndrome	VCV001738448	2	29416778	2	29193912	1738448	1790781		NC_000002.12:29193911:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4174G>A (p.Val1392Ile)	ALK	V324I, V1392I	Neuroblastoma, susceptibility to, 3	VCV001357292	2	29416779	2	29193913	1357292	1345268	rs1668957592	NC_000002.12:29193912:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4172A>C (p.Asp1391Ala)	ALK	D1391A, D323A	Neuroblastoma, susceptibility to, 3	VCV001378286	2	29416781	2	29193915	1378286	1492716	rs2148139166	NC_000002.12:29193914:T:G	single nucleotide variant	missense variant	Uncertain significance	May 26, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4171del (p.Asp1391fs)	ALK	D1391fs, D323fs	Neuroblastoma, susceptibility to, 3	VCV003606244	2	29416782	2	29193916	3606244	3743699		NC_000002.12:29193915:CC:C	Deletion	frameshift variant	Uncertain significance	Aug 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4171G>C (p.Asp1391His)	ALK	D323H, D1391H	Hereditary cancer-predisposing syndrome	VCV002477339	2	29416782	2	29193916	2477339	2453688		NC_000002.12:29193915:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4171G>A (p.Asp1391Asn)	ALK	D1391N, D323N	Neuroblastoma, susceptibility to, 3	VCV001020125	2	29416782	2	29193916	1020125	1003964	rs1231708230	NC_000002.12:29193915:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4170G>C (p.Pro1390=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001153907	2	29416783	2	29193917	1153907	1133642	rs753080753	NC_000002.12:29193916:C:G	single nucleotide variant	synonymous variant	Likely benign	Jun 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4170G>A (p.Pro1390=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000779037	2	29416783	2	29193917	779037	697541	rs753080753	NC_000002.12:29193916:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4169C>T (p.Pro1390Leu)	ALK	P1390L, P322L	Neuroblastoma, susceptibility to, 3	VCV002415731	2	29416784	2	29193918	2415731	1940841		NC_000002.12:29193917:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4168C>G (p.Pro1390Ala)	ALK	P1390A, P322A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001043723	2	29416785	2	29193919	1043723	1024436	rs1668958001	NC_000002.12:29193918:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4167C>T (p.Asp1389=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001738380	2	29416786	2	29193920	1738380	1790713		NC_000002.12:29193919:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4165G>T (p.Asp1389Tyr)	ALK	D1389Y, D321Y	Neuroblastoma, susceptibility to, 3	VCV001421764	2	29416788	2	29193922	1421764	1337379	rs2148139191	NC_000002.12:29193921:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4165G>C (p.Asp1389His)	ALK	D1389H, D321H	Neuroblastoma, susceptibility to, 3	VCV001365573	2	29416788	2	29193922	1365573	1402443	rs2148139191	NC_000002.12:29193921:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4165-1G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV003014092	2	29416789	2	29193923	3014092	3174384		NC_000002.12:29193922:C:T	single nucleotide variant	splice acceptor variant	Uncertain significance	Oct 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4165-2A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001494413	2	29416790	2	29193924	1494413	1350155	rs2148139200	NC_000002.12:29193923:T:C	single nucleotide variant	splice acceptor variant	Uncertain significance	May 28, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4165-6_4165-5delinsTA	ALK		Neuroblastoma, susceptibility to, 3	VCV003675583	2	29416793 - 29416794	2	29193927 - 29193928	3675583	3817081		NC_000002.12:29193926:CG:TA	Indel	intron variant	Uncertain significance	Nov 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4165-5G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV003651750	2	29416793	2	29193927	3651750	3788461		NC_000002.12:29193926:C:G	single nucleotide variant	intron variant	Likely benign	May 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4165-5G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001121652	2	29416793	2	29193927	1121652	1112727	rs1668958083	NC_000002.12:29193926:C:A	single nucleotide variant	intron variant	Likely benign	Jun 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4165-5G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000954070	2	29416793	2	29193927	954070	959636	rs1668958083	NC_000002.12:29193926:C:T	single nucleotide variant	intron variant	Uncertain significance	Dec 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4165-6C>T	ALK		not specified|Neuroblastoma, susceptibility to, 3|not provided	VCV000259272	2	29416794	2	29193928	259272	250716	rs17007646	NC_000002.12:29193927:G:A	single nucleotide variant	intron variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4165-11C>T	ALK		not provided|Neuroblastoma, susceptibility to, 3	VCV001613736	2	29416799	2	29193933	1613736	1536491	rs377759391	NC_000002.12:29193932:G:A	single nucleotide variant	intron variant	Likely benign	Nov 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4165-12C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001641392	2	29416800	2	29193934	1641392	1520326	rs757342767	NC_000002.12:29193933:G:A	single nucleotide variant	intron variant	Likely benign	Dec 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4165-16del	ALK		Neuroblastoma, susceptibility to, 3	VCV001582741	2	29416804	2	29193938	1582741	1567010	rs774264912	NC_000002.12:29193937:TT:T	Deletion	intron variant	Likely benign	Nov 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4165-17A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002158775	2	29416805	2	29193939	2158775	1883757		NC_000002.12:29193938:T:C	single nucleotide variant	intron variant	Likely benign	Apr 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4165-19del	ALK		Squamous cell lung carcinoma	VCV000873171	2	29416807	2	29193941	873171	861297	rs1668958808	NC_000002.12:29193940:TT:T	Deletion	intron variant	Uncertain significance	May 5, 2020	no assertion criteria provided							
NM_004304.5(ALK):c.4165-89_4165-88del	ALK		not provided	VCV001180153	2	29416876 - 29416877	2	29194010 - 29194011	1180153	1168915	rs113703903	NC_000002.12:29194009:ATAT:AT	Microsatellite	intron variant	Benign	Jun 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.4165-112C>A	ALK		not provided	VCV001297176	2	29416900	2	29194034	1297176	1286965	rs76728108	NC_000002.12:29194033:G:T	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4165-158A>G	ALK		not provided	VCV001175602	2	29416946	2	29194080	1175602	1164893	rs12619135	NC_000002.12:29194079:T:C	single nucleotide variant	intron variant	Benign	Jun 21, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4165-237C>G	ALK		not provided	VCV001297428	2	29417025	2	29194159	1297428	1287217	rs76119545	NC_000002.12:29194158:G:C	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.4164+223A>G	ALK		not provided	VCV001292654	2	29419413	2	29196547	1292654	1282460	rs1728826	NC_000002.12:29196546:T:C	single nucleotide variant	intron variant	Benign	Jun 24, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.4164+198A>G	ALK		not provided	VCV001297430	2	29419438	2	29196572	1297430	1287219	rs10202491	NC_000002.12:29196571:T:C	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.4164+171T>C	ALK		not provided	VCV001207136	2	29419465	2	29196599	1207136	1196904	rs10199947	NC_000002.12:29196598:A:G	single nucleotide variant	intron variant	Likely benign	Aug 21, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.4164+163T>C	ALK		not provided	VCV000676806	2	29419473	2	29196607	676806	659119	rs17007666	NC_000002.12:29196606:A:G	single nucleotide variant	intron variant	Benign	Jun 16, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.4164+45C>A	ALK		not provided	VCV000676841	2	29419591	2	29196725	676841	659127	rs1670284	NC_000002.12:29196724:G:T	single nucleotide variant	intron variant	Benign	Jun 15, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4164+18T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001640782	2	29419618	2	29196752	1640782	1550453	rs2148141656	NC_000002.12:29196751:A:C	single nucleotide variant	intron variant	Likely benign	Mar 22, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4164+17C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001996105	2	29419619	2	29196753	1996105	2056615		NC_000002.12:29196752:G:C	single nucleotide variant	intron variant	Likely benign	May 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4164+15C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002135296	2	29419621	2	29196755	2135296	2190704		NC_000002.12:29196754:G:A	single nucleotide variant	intron variant	Likely benign	Aug 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4164+12T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002759290	2	29419624	2	29196758	2759290	2917872		NC_000002.12:29196757:A:G	single nucleotide variant	intron variant	Likely benign	May 5, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4164+11T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003670319	2	29419625	2	29196759	3670319	3803544		NC_000002.12:29196758:A:C	single nucleotide variant	intron variant	Likely benign	Feb 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4164+10T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001621114	2	29419626	2	29196760	1621114	1615361	rs1669032265	NC_000002.12:29196759:A:G	single nucleotide variant	intron variant	Likely benign	Aug 2, 2021	criteria provided, single submitter							
NC_000002.12:g.(?_29196760)_(29717707_?)del	ALK|LOC105374389|LOC122756683|LOC122756684		Neuroblastoma, susceptibility to, 3	VCV000642044	2	29419626 - 29940573	2	29196760 - 29717707	642044	650750			Deletion		Uncertain significance	Oct 9, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.4164+9T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001997799	2	29419627	2	29196761	1997799	2057019		NC_000002.12:29196760:A:C	single nucleotide variant	intron variant	Likely benign	May 22, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4164+9T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001078641	2	29419627	2	29196761	1078641	1069508	rs1347445556	NC_000002.12:29196760:A:G	single nucleotide variant	intron variant	Likely benign	Oct 3, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4164+8A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001138493	2	29419628	2	29196762	1138493	1112728	rs2148141670	NC_000002.12:29196761:T:C	single nucleotide variant	intron variant	Likely benign	Feb 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4164+7C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001667438	2	29419629	2	29196763	1667438	1591376	rs1669032379	NC_000002.12:29196762:G:A	single nucleotide variant	intron variant	Likely benign	Oct 4, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4164+6A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003722168	2	29419630	2	29196764	3722168	3860272		NC_000002.12:29196763:T:C	single nucleotide variant	intron variant	Uncertain significance	Oct 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4164+5A>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002843239	2	29419631	2	29196765	2843239	2994110		NC_000002.12:29196764:T:G	single nucleotide variant	intron variant	Uncertain significance	Aug 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4164+4A>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002053064	2	29419632	2	29196766	2053064	2108361		NC_000002.12:29196765:T:A	single nucleotide variant	intron variant	Uncertain significance	Jul 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4164+3A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003586397	2	29419633	2	29196767	3586397	3717105		NC_000002.12:29196766:T:C	single nucleotide variant	intron variant	Uncertain significance	Jan 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4164G>C (p.Gln1388His)	ALK	Q1388H, Q320H	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000857155	2	29419636	2	29196770	857155	826297	rs200902932	NC_000002.12:29196769:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4164G>A (p.Gln1388=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000567316	2	29419636	2	29196770	567316	561289	rs200902932	NC_000002.12:29196769:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Oct 2, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4162C>G (p.Gln1388Glu)	ALK	Q1388E, Q320E	Hereditary cancer-predisposing syndrome	VCV003223893	2	29419638	2	29196772	3223893	3380915		NC_000002.12:29196771:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4161C>T (p.Thr1387=)	ALK		Hereditary cancer-predisposing syndrome	VCV001738347	2	29419639	2	29196773	1738347	1790680		NC_000002.12:29196772:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 25, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4161C>A (p.Thr1387=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001738345	2	29419639	2	29196773	1738345	1790678		NC_000002.12:29196772:G:T	single nucleotide variant	synonymous variant	Likely benign	Jan 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4160C>T (p.Thr1387Ile)	ALK	T319I, T1387I	Neuroblastoma, susceptibility to, 3	VCV002075414	2	29419640	2	29196774	2075414	2130763		NC_000002.12:29196773:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4160C>G (p.Thr1387Ser)	ALK	T1387S, T319S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001738342	2	29419640	2	29196774	1738342	1790675		NC_000002.12:29196773:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4158C>T (p.Cys1386=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002896521	2	29419642	2	29196776	2896521	3052762		NC_000002.12:29196775:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4157G>C (p.Cys1386Ser)	ALK	C1386S, C318S	Neuroblastoma, susceptibility to, 3	VCV002085222	2	29419643	2	29196777	2085222	2140563		NC_000002.12:29196776:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4153T>C (p.Tyr1385His)	ALK	Y317H, Y1385H	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003524087	2	29419647	2	29196781	3524087	3682255		NC_000002.12:29196780:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4152A>G (p.Glu1384=)	ALK		Hereditary cancer-predisposing syndrome	VCV003525368	2	29419648	2	29196782	3525368	3685724		NC_000002.12:29196781:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4151A>C (p.Glu1384Ala)	ALK	E1384A, E316A	Neuroblastoma, susceptibility to, 3	VCV003722593	2	29419649	2	29196783	3722593	3857106		NC_000002.12:29196782:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4151A>G (p.Glu1384Gly)	ALK	E1384G, E316G	Neuroblastoma, susceptibility to, 3	VCV001472844	2	29419649	2	29196783	1472844	1501089	rs1669032859	NC_000002.12:29196782:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 31, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4151A>T (p.Glu1384Val)	ALK	E1384V, E316V	Neuroblastoma, susceptibility to, 3	VCV001011299	2	29419649	2	29196783	1011299	988678	rs1669032859	NC_000002.12:29196782:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4149T>C (p.Ile1383=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002828297	2	29419651	2	29196785	2828297	2990235		NC_000002.12:29196784:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4148T>C (p.Ile1383Thr)	ALK	I1383T, I315T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000575890	2	29419652	2	29196786	575890	558354	rs1558606063	NC_000002.12:29196785:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4146G>C (p.Arg1382Ser)	ALK	R1382S, R314S	Neuroblastoma, susceptibility to, 3	VCV002853088	2	29419654	2	29196788	2853088	3006906		NC_000002.12:29196787:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4146G>A (p.Arg1382=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not specified	VCV000515291	2	29419654	2	29196788	515291	499906	rs1553387973	NC_000002.12:29196787:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4145G>A (p.Arg1382Lys)	ALK	R1382K, R314K	Hereditary cancer-predisposing syndrome	VCV002586703	2	29419655	2	29196789	2586703	2756886		NC_000002.12:29196788:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4143G>A (p.Glu1381=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002164014	2	29419657	2	29196791	2164014	1901845		NC_000002.12:29196790:C:T	single nucleotide variant	synonymous variant	Likely benign	May 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4142A>T (p.Glu1381Val)	ALK	E1381V, E313V	Hereditary cancer-predisposing syndrome	VCV003223892	2	29419658	2	29196792	3223892	3380914		NC_000002.12:29196791:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4141del (p.Glu1381fs)	ALK	E313fs, E1381fs	Hereditary cancer-predisposing syndrome	VCV003285759	2	29419659	2	29196793	3285759	3444499		NC_000002.12:29196792:CC:C	Deletion	frameshift variant	Uncertain significance	Apr 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4140G>C (p.Leu1380Phe)	ALK	L312F, L1380F	Neuroblastoma, susceptibility to, 3	VCV001922917	2	29419660	2	29196794	1922917	1979663		NC_000002.12:29196793:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4138T>G (p.Leu1380Val)	ALK	L1380V, L312V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000404342	2	29419662	2	29196796	404342	392594	rs1060500216	NC_000002.12:29196795:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4135A>G (p.Ile1379Val)	ALK	I1379V, I311V	Hereditary cancer-predisposing syndrome	VCV003524455	2	29419665	2	29196799	3524455	3679120		NC_000002.12:29196798:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4134C>T (p.Ile1378=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000705653	2	29419666	2	29196800	705653	691127	rs754359252	NC_000002.12:29196799:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4133T>G (p.Ile1378Ser)	ALK	I1378S, I310S	Hereditary cancer-predisposing syndrome	VCV002586695	2	29419667	2	29196801	2586695	2756878		NC_000002.12:29196800:A:C	single nucleotide variant	missense variant	Likely benign	Aug 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4132A>G (p.Ile1378Val)	ALK	I1378V, I310V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000846209	2	29419668	2	29196802	846209	826298	rs1669033638	NC_000002.12:29196801:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4129G>A (p.Ala1377Thr)	ALK	A1377T, A309T	Neuroblastoma, susceptibility to, 3	VCV001374769	2	29419671	2	29196805	1374769	1453737	rs2148141798	NC_000002.12:29196804:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4127T>A (p.Phe1376Tyr)	ALK	F1376Y, F308Y	Neuroblastoma, susceptibility to, 3	VCV001011171	2	29419673	2	29196807	1011171	988679	rs17694720	NC_000002.12:29196806:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4125C>T (p.Asn1375=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002991188	2	29419675	2	29196809	2991188	3151442		NC_000002.12:29196808:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 2, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4122C>A (p.Pro1374=)	ALK		Hereditary cancer-predisposing syndrome	VCV001738029	2	29419678	2	29196812	1738029	1797265		NC_000002.12:29196811:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4122C>T (p.Pro1374=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538279	2	29419678	2	29196812	538279	518087	rs758759672	NC_000002.12:29196811:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4121C>A (p.Pro1374His)	ALK	P1374H, P306H	Neuroblastoma, susceptibility to, 3	VCV001011027	2	29419679	2	29196813	1011027	988680	rs780310741	NC_000002.12:29196812:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4119G>T (p.Arg1373Ser)	ALK	R305S, R1373S	Neuroblastoma, susceptibility to, 3	VCV002998646	2	29419681	2	29196815	2998646	3156415		NC_000002.12:29196814:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4118G>T (p.Arg1373Met)	ALK	R305M, R1373M	Neuroblastoma, susceptibility to, 3	VCV001461418	2	29419682	2	29196816	1461418	1498249	rs1558606110	NC_000002.12:29196815:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4118G>A (p.Arg1373Lys)	ALK	R1373K, R305K	Neuroblastoma, susceptibility to, 3	VCV000572692	2	29419682	2	29196816	572692	558025	rs1558606110	NC_000002.12:29196815:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.4117A>G (p.Arg1373Gly)	ALK	R1373G, R305G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538252	2	29419683	2	29196817	538252	518181	rs1553387992	NC_000002.12:29196816:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4116C>T (p.Asp1372=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001560537	2	29419684	2	29196818	1560537	1576028	rs751325148	NC_000002.12:29196817:G:A	single nucleotide variant	synonymous variant	Likely benign	May 19, 2021	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4114G>C (p.Asp1372His)	ALK	D304H, D1372H	Hereditary cancer-predisposing syndrome	VCV001737949	2	29419686	2	29196820	1737949	1797185		NC_000002.12:29196819:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4114G>A (p.Asp1372Asn)	ALK	D1372N, D304N	Neuroblastoma, susceptibility to, 3	VCV001372927	2	29419686	2	29196820	1372927	1440305	rs535864522	NC_000002.12:29196819:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4114G>T (p.Asp1372Tyr)	ALK	D1372Y, D304Y	Neuroblastoma, susceptibility to, 3	VCV000538258	2	29419686	2	29196820	538258	518184	rs535864522	NC_000002.12:29196819:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4113A>C (p.Glu1371Asp)	ALK	E1371D, E303D	Neuroblastoma, susceptibility to, 3	VCV001437375	2	29419687	2	29196821	1437375	1513991	rs1287738986	NC_000002.12:29196820:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4112A>G (p.Glu1371Gly)	ALK	E1371G, E303G	Neuroblastoma, susceptibility to, 3	VCV001059980	2	29419688	2	29196822	1059980	1041378	rs781021461	NC_000002.12:29196821:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4111G>A (p.Glu1371Lys)	ALK	E303K, E1371K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001737933	2	29419689	2	29196823	1737933	1797170		NC_000002.12:29196822:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4109C>T (p.Pro1370Leu)	ALK	P1370L, P302L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001018947	2	29419691	2	29196825	1018947	1003965	rs748027591	NC_000002.12:29196824:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4109C>G (p.Pro1370Arg)	ALK	P1370R, P302R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001003664	2	29419691	2	29196825	1003664	988681	rs748027591	NC_000002.12:29196824:G:C	single nucleotide variant	missense variant	Uncertain significance	May 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4108C>T (p.Pro1370Ser)	ALK	P1370S, P302S	Neuroblastoma, susceptibility to, 3	VCV002881648	2	29419692	2	29196826	2881648	3037004		NC_000002.12:29196825:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4106A>C (p.Gln1369Pro)	ALK	Q301P, Q1369P	Hereditary cancer-predisposing syndrome	VCV003285287	2	29419694	2	29196828	3285287	3444465		NC_000002.12:29196827:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4104_4106del (p.His1368del)	ALK	H1368del, H300del	Hereditary cancer-predisposing syndrome	VCV003223891	2	29419694 - 29419696	2	29196828 - 29196830	3223891	3380913		NC_000002.12:29196827:TGATG:TG	Deletion	inframe_deletion	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4106A>G (p.Gln1369Arg)	ALK	Q1369R, Q301R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001360839	2	29419694	2	29196828	1360839	1360405	rs2148141895	NC_000002.12:29196827:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4100_4106del (p.Gln1367fs)	ALK	Q299fs, Q1367fs	Neuroblastoma, susceptibility to, 3	VCV000859530	2	29419694 - 29419700	2	29196828 - 29196834	859530	826299	rs1370805516	NC_000002.12:29196827:TGATGTT:	Deletion	frameshift variant	Uncertain significance	Nov 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4104T>C (p.His1368=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001127280	2	29419696	2	29196830	1127280	1112729	rs2148141904	NC_000002.12:29196829:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4102C>T (p.His1368Tyr)	ALK	H1368Y, H300Y	Neuroblastoma, susceptibility to, 3	VCV002762716	2	29419698	2	29196832	2762716	2931210		NC_000002.12:29196831:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4101A>G (p.Gln1367=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001160481	2	29419699	2	29196833	1160481	1133643	rs2148141916	NC_000002.12:29196832:T:C	single nucleotide variant	synonymous variant	Likely benign	Apr 24, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4099C>A (p.Gln1367Lys)	ALK	Q1367K, Q299K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000943907	2	29419701	2	29196835	943907	931344	rs1669035172	NC_000002.12:29196834:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4098G>T (p.Trp1366Cys)	ALK	W1366C, W298C	Neuroblastoma, susceptibility to, 3	VCV002801199	2	29419702	2	29196836	2801199	2959727		NC_000002.12:29196835:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4097G>A (p.Trp1366Ter)	ALK	W1366*, W298*	Neuroblastoma, susceptibility to, 3	VCV003645927	2	29419703	2	29196837	3645927	3780502		NC_000002.12:29196836:C:T	single nucleotide variant	nonsense	Uncertain significance	Mar 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4096T>C (p.Trp1366Arg)	ALK	W1366R, W298R	Hereditary cancer-predisposing syndrome	VCV003223890	2	29419704	2	29196838	3223890	3380912		NC_000002.12:29196837:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4096T>A (p.Trp1366Arg)	ALK	W298R, W1366R	Hereditary cancer-predisposing syndrome	VCV002566609	2	29419704	2	29196838	2566609	2734452		NC_000002.12:29196837:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4092G>C (p.Gln1364His)	ALK	Q296H, Q1364H	Neuroblastoma, susceptibility to, 3	VCV002739327	2	29419708	2	29196842	2739327	2899680		NC_000002.12:29196841:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4092G>A (p.Gln1364=)	ALK		Hereditary cancer-predisposing syndrome	VCV001737760	2	29419708	2	29196842	1737760	1787623		NC_000002.12:29196841:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4091A>C (p.Gln1364Pro)	ALK	Q296P, Q1364P	Hereditary cancer-predisposing syndrome	VCV001737747	2	29419709	2	29196843	1737747	1787610		NC_000002.12:29196842:T:G	single nucleotide variant	missense variant	Uncertain significance	May 27, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4089T>C (p.Thr1363=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001662329	2	29419711	2	29196845	1662329	1642553	rs2148141958	NC_000002.12:29196844:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 17, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4088C>T (p.Thr1363Ile)	ALK	T295I, T1363I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002803970	2	29419712	2	29196846	2803970	2973632		NC_000002.12:29196845:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4087A>T (p.Thr1363Ser)	ALK	T1363S, T295S	Neuroblastoma, susceptibility to, 3	VCV003727053	2	29419713	2	29196847	3727053	3851674		NC_000002.12:29196846:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4087A>C (p.Thr1363Pro)	ALK	T1363P, T295P	Hereditary cancer-predisposing syndrome	VCV001737671	2	29419713	2	29196847	1737671	1787535		NC_000002.12:29196846:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4086G>A (p.Met1362Ile)	ALK	M294I, M1362I	Hereditary cancer-predisposing syndrome	VCV003285823	2	29419714	2	29196848	3285823	3444563		NC_000002.12:29196847:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4083A>G (p.Ile1361Met)	ALK	I293M, I1361M	Neuroblastoma, susceptibility to, 3	VCV002828968	2	29419717	2	29196851	2828968	2983634		NC_000002.12:29196850:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4082T>C (p.Ile1361Thr)	ALK	I1361T, I293T	Neuroblastoma, susceptibility to, 3	VCV001052870	2	29419718	2	29196852	1052870	1041379	rs2148141969	NC_000002.12:29196851:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.4080G>A (p.Arg1360=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223889	2	29419720	2	29196854	3223889	3380911		NC_000002.12:29196853:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4079G>T (p.Arg1360Leu)	ALK	R1360L, R292L	Neuroblastoma, susceptibility to, 3	VCV001370859	2	29419721	2	29196855	1370859	1430926	rs1215186876	NC_000002.12:29196854:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4079G>A (p.Arg1360Gln)	ALK	R1360Q, R292Q	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000485084	2	29419721	2	29196855	485084	472764	rs1215186876	NC_000002.12:29196854:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4078C>A (p.Arg1360=)	ALK		Hereditary cancer-predisposing syndrome	VCV003523013	2	29419722	2	29196856	3523013	3688572		NC_000002.12:29196855:G:T	single nucleotide variant	synonymous variant	Uncertain significance	Dec 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4078C>G (p.Arg1360Gly)	ALK	R1360G, R292G	Hereditary cancer-predisposing syndrome	VCV003223887	2	29419722	2	29196856	3223887	3380909		NC_000002.12:29196855:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4078C>T (p.Arg1360Trp)	ALK	R292W, R1360W	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000862850	2	29419722	2	29196856	862850	826300	rs777303002	NC_000002.12:29196855:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4077C>G (p.Tyr1359Ter)	ALK	Y291*, Y1359*	Neuroblastoma, susceptibility to, 3	VCV002843372	2	29419723	2	29196857	2843372	3004027		NC_000002.12:29196856:G:C	single nucleotide variant	nonsense	Uncertain significance	Mar 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4077C>T (p.Tyr1359=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002018566	2	29419723	2	29196857	2018566	2072649		NC_000002.12:29196856:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4076A>G (p.Tyr1359Cys)	ALK	Y1359C, Y291C	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001023179	2	29419724	2	29196858	1023179	1003966	rs748787875	NC_000002.12:29196857:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4074-3T>C	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000938125	2	29419729	2	29196863	938125	939886	rs770544095	NC_000002.12:29196862:A:G	single nucleotide variant	intron variant	Uncertain significance	Dec 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4074-5T>C	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002757407	2	29419731	2	29196865	2757407	2917279		NC_000002.12:29196864:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 7, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4074-13CTT[2]	ALK		not provided|Neuroblastoma, susceptibility to, 3	VCV001061256	2	29419731 - 29419733	2	29196865 - 29196867	1061256	1041380	rs2148141994	NC_000002.12:29196864:AAGAAGAAG:AAGAAG	Microsatellite	intron variant	Conflicting classifications of pathogenicity	Feb 17, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4074-7C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001995387	2	29419733	2	29196867	1995387	2049887		NC_000002.12:29196866:G:A	single nucleotide variant	intron variant	Likely benign	May 17, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4074-8T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002988529	2	29419734	2	29196868	2988529	3143726		NC_000002.12:29196867:A:G	single nucleotide variant	intron variant	Likely benign	Nov 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4074-11T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001644814	2	29419737	2	29196871	1644814	1522861	rs201675388	NC_000002.12:29196870:A:C	single nucleotide variant	intron variant	Likely benign	Dec 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4074-13C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002758243	2	29419739	2	29196873	2758243	2910342		NC_000002.12:29196872:G:T	single nucleotide variant	intron variant	Likely benign	Sep 5, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4074-14G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001644659	2	29419740	2	29196874	1644659	1522706	rs373693980	NC_000002.12:29196873:C:T	single nucleotide variant	intron variant	Likely benign	Jan 30, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.4074-15T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002709103	2	29419741	2	29196875	2709103	2867513		NC_000002.12:29196874:A:G	single nucleotide variant	intron variant	Likely benign	Oct 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4074-17T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001555802	2	29419743	2	29196877	1555802	1626676	rs1390482554	NC_000002.12:29196876:A:G	single nucleotide variant	intron variant	Likely benign	Oct 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4074-279G>T	ALK		not provided	VCV001218873	2	29420005	2	29197139	1218873	1208852	rs145976429	NC_000002.12:29197138:C:A	single nucleotide variant	intron variant	Likely benign	Feb 3, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4073+260C>T	ALK		not provided	VCV001194070	2	29420148	2	29197282	1194070	1183176	rs139848273	NC_000002.12:29197281:G:A	single nucleotide variant	intron variant	Likely benign	Feb 13, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4073+112del	ALK		not provided	VCV001297177	2	29420296	2	29197430	1297177	1286966	rs66469942	NC_000002.12:29197429:GGG:GG	Deletion	intron variant	Benign	Jun 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.4073+93G>A	ALK		not provided	VCV000676883	2	29420315	2	29197449	676883	658977	rs3738870	NC_000002.12:29197448:C:T	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4073+20A>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002067836	2	29420388	2	29197522	2067836	2129225		NC_000002.12:29197521:T:A	single nucleotide variant	intron variant	Likely benign	Feb 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4073+20A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001572821	2	29420388	2	29197522	1572821	1658440	rs1176333736	NC_000002.12:29197521:T:C	single nucleotide variant	intron variant	Likely benign	Nov 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4073+17A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001591595	2	29420391	2	29197525	1591595	1577711	rs762255617	NC_000002.12:29197524:T:C	single nucleotide variant	intron variant	Likely benign	Feb 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4073+16G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001577226	2	29420392	2	29197526	1577226	1553262	rs1669052730	NC_000002.12:29197525:C:A	single nucleotide variant	intron variant	Likely benign	Sep 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4073+15G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002085956	2	29420393	2	29197527	2085956	2133545		NC_000002.12:29197526:C:T	single nucleotide variant	intron variant	Likely benign	May 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4073+13T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002875739	2	29420395	2	29197529	2875739	3041254		NC_000002.12:29197528:A:G	single nucleotide variant	intron variant	Likely benign	Dec 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4073+12T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001551948	2	29420396	2	29197530	1551948	1520559	rs770438785	NC_000002.12:29197529:A:G	single nucleotide variant	intron variant	Likely benign	Feb 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4073+10T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001593706	2	29420398	2	29197532	1593706	1655125	rs773788274	NC_000002.12:29197531:A:G	single nucleotide variant	intron variant	Likely benign	Dec 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4073+9C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001145070	2	29420399	2	29197533	1145070	1133644	rs1047366816	NC_000002.12:29197532:G:C	single nucleotide variant	intron variant	Likely benign	Aug 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4073+8T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002174866	2	29420400	2	29197534	2174866	1901006		NC_000002.12:29197533:A:G	single nucleotide variant	intron variant	Likely benign	Oct 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4073+7C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001117151	2	29420401	2	29197535	1117151	1091226	rs896724137	NC_000002.12:29197534:G:A	single nucleotide variant	intron variant	Likely benign	Oct 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4058_4073+6del	ALK		Hereditary cancer-predisposing syndrome	VCV001737426	2	29420402 - 29420423	2	29197536 - 29197557	1737426	1790625		NC_000002.12:29197535:TCATACACAGGCCCAGGGCAGTTC:TC	Deletion	splice donor variant	Uncertain significance	Oct 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4073+6A>C	ALK		Neuroblastoma, susceptibility to, 3	VCV000839863	2	29420402	2	29197536	839863	851420	rs1404039400	NC_000002.12:29197535:T:G	single nucleotide variant	intron variant	Uncertain significance	Aug 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4073+5G>A	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001428764	2	29420403	2	29197537	1428764	1457728	rs1325951899	NC_000002.12:29197536:C:T	single nucleotide variant	intron variant	Uncertain significance	Jun 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4073+3A>C	ALK		Hereditary cancer-predisposing syndrome	VCV003285964	2	29420405	2	29197539	3285964	3444704		NC_000002.12:29197538:T:G	single nucleotide variant	intron variant	Uncertain significance	May 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4073+1G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002167268	2	29420407	2	29197541	2167268	1906389		NC_000002.12:29197540:C:T	single nucleotide variant	splice donor variant	Uncertain significance	Jun 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4073T>C (p.Val1358Ala)	ALK	V290A, V1358A	Neuroblastoma, susceptibility to, 3	VCV002919913	2	29420408	2	29197542	2919913	3080717		NC_000002.12:29197541:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4072G>A (p.Val1358Ile)	ALK	V1358I, V290I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470863	2	29420409	2	29197543	470863	450817	rs774271469	NC_000002.12:29197542:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4070C>T (p.Pro1357Leu)	ALK	P1357L, P289L	Neuroblastoma, susceptibility to, 3	VCV003661293	2	29420411	2	29197545	3661293	3790952		NC_000002.12:29197544:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4070C>A (p.Pro1357His)	ALK	P289H, P1357H	Neuroblastoma, susceptibility to, 3	VCV002173574	2	29420411	2	29197545	2173574	1897244		NC_000002.12:29197544:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4069C>G (p.Pro1357Ala)	ALK	P1357A, P289A	Neuroblastoma, susceptibility to, 3	VCV000639789	2	29420412	2	29197546	639789	629816	rs1573084515	NC_000002.12:29197545:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4068G>A (p.Gly1356=)	ALK		Hereditary cancer-predisposing syndrome	VCV003286095	2	29420413	2	29197547	3286095	3444835		NC_000002.12:29197546:C:T	single nucleotide variant	synonymous variant	Likely benign	May 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4068G>C (p.Gly1356=)	ALK		Hereditary cancer-predisposing syndrome	VCV003285208	2	29420413	2	29197547	3285208	3444386		NC_000002.12:29197546:C:G	single nucleotide variant	synonymous variant	Likely benign	Apr 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4067G>A (p.Gly1356Glu)	ALK	G1356E, G288E	Hereditary cancer-predisposing syndrome	VCV003223886	2	29420414	2	29197548	3223886	3380908		NC_000002.12:29197547:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4066G>A (p.Gly1356Arg)	ALK	G1356R, G288R	Hereditary cancer-predisposing syndrome	VCV002452139	2	29420415	2	29197549	2452139	2426779		NC_000002.12:29197548:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4065T>C (p.Pro1355=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001737502	2	29420416	2	29197550	1737502	1787366		NC_000002.12:29197549:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4064C>G (p.Pro1355Arg)	ALK	P1355R, P287R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001737494	2	29420417	2	29197551	1737494	1787358		NC_000002.12:29197550:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4064C>T (p.Pro1355Leu)	ALK	P1355L, P287L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000824559	2	29420417	2	29197551	824559	806882	rs1573084525	NC_000002.12:29197550:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4061G>T (p.Cys1354Phe)	ALK	C1354F, C286F	Neuroblastoma, susceptibility to, 3	VCV000834766	2	29420420	2	29197554	834766	826301	rs963770969	NC_000002.12:29197553:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4060T>G (p.Cys1354Gly)	ALK	C1354G, C286G	Hereditary cancer-predisposing syndrome	VCV002452094	2	29420421	2	29197555	2452094	2426734		NC_000002.12:29197554:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4060T>C (p.Cys1354Arg)	ALK	C286R, C1354R	Neuroblastoma, susceptibility to, 3	VCV000846308	2	29420421	2	29197555	846308	826302	rs1669054082	NC_000002.12:29197554:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4059C>T (p.Asn1353=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002707988	2	29420422	2	29197556	2707988	2878020		NC_000002.12:29197555:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4059C>G (p.Asn1353Lys)	ALK	N1353K, N285K	Neuroblastoma, susceptibility to, 3	VCV002058158	2	29420422	2	29197556	2058158	2113445		NC_000002.12:29197555:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4059C>A (p.Asn1353Lys)	ALK	N285K, N1353K	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000824546	2	29420422	2	29197556	824546	806883	rs1352529334	NC_000002.12:29197555:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4058A>G (p.Asn1353Ser)	ALK	N1353S, N285S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV001055093	2	29420423	2	29197557	1055093	1041381	rs2148143237	NC_000002.12:29197556:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4056G>T (p.Lys1352Asn)	ALK	K1352N, K284N	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002624785	2	29420425	2	29197559	2624785	2790280		NC_000002.12:29197558:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4056G>A (p.Lys1352=)	ALK		Hereditary cancer-predisposing syndrome	VCV002566592	2	29420425	2	29197559	2566592	2734435		NC_000002.12:29197558:C:T	single nucleotide variant	synonymous variant	Uncertain significance	May 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4056G>C (p.Lys1352Asn)	ALK	K284N, K1352N	Hereditary cancer-predisposing syndrome	VCV001737412	2	29420425	2	29197559	1737412	1790611		NC_000002.12:29197558:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4052C>A (p.Pro1351His)	ALK	P283H, P1351H	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000965394	2	29420429	2	29197563	965394	953059	rs1669054292	NC_000002.12:29197562:G:T	single nucleotide variant	missense variant	Uncertain significance	May 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4051C>G (p.Pro1351Ala)	ALK	P1351A, P283A	Neuroblastoma, susceptibility to, 3	VCV000947003	2	29420430	2	29197564	947003	922704	rs1669054438	NC_000002.12:29197563:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4049C>T (p.Pro1350Leu)	ALK	P1350L, P282L	Neuroblastoma, susceptibility to, 3	VCV003676803	2	29420432	2	29197566	3676803	3806836		NC_000002.12:29197565:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4048C>T (p.Pro1350Ser)	ALK	P1350S, P282S	Hereditary cancer-predisposing syndrome	VCV003223885	2	29420433	2	29197567	3223885	3380907		NC_000002.12:29197566:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4045G>A (p.Asp1349Asn)	ALK	D1349N, D281N	Neuroblastoma, susceptibility to, 3	VCV000957377	2	29420436	2	29197570	957377	942845	rs368744524	NC_000002.12:29197569:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4045G>C (p.Asp1349His)	ALK	D1349H, D281H	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000850828	2	29420436	2	29197570	850828	826303	rs368744524	NC_000002.12:29197569:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4044G>A (p.Met1348Ile)	ALK	M1348I, M280I	Hereditary cancer-predisposing syndrome	VCV001737309	2	29420437	2	29197571	1737309	1790508		NC_000002.12:29197570:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 2, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4041del (p.Met1348fs)	ALK	M1348fs, M280fs	Neuroblastoma, susceptibility to, 3	VCV002714078	2	29420440	2	29197574	2714078	2868616		NC_000002.12:29197573:CC:C	Deletion	frameshift variant	Uncertain significance	Jan 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4040G>A (p.Arg1347Gln)	ALK	R1347Q, R279Q	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470861	2	29420441	2	29197575	470861	451025	rs573049471	NC_000002.12:29197574:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4039C>T (p.Arg1347Trp)	ALK	R1347W, R279W	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001045895	2	29420442	2	29197576	1045895	1024437	rs865887581	NC_000002.12:29197575:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4038C>T (p.Gly1346=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000840014	2	29420443	2	29197577	840014	826304	rs1669055383	NC_000002.12:29197576:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Dec 20, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4036G>A (p.Gly1346Ser)	ALK	G1346S, G278S	Hereditary cancer-predisposing syndrome	VCV001737239	2	29420445	2	29197579	1737239	1790438		NC_000002.12:29197578:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4033G>A (p.Gly1345Arg)	ALK	G277R, G1345R	Neuroblastoma, susceptibility to, 3	VCV001363092	2	29420448	2	29197582	1363092	1396412	rs2148143330	NC_000002.12:29197581:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4031G>C (p.Ser1344Thr)	ALK	S1344T, S276T	Hereditary cancer-predisposing syndrome	VCV001737211	2	29420450	2	29197584	1737211	1790410		NC_000002.12:29197583:C:G	single nucleotide variant	missense variant	Uncertain significance	May 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4030A>G (p.Ser1344Gly)	ALK	S1344G, S276G	Hereditary cancer-predisposing syndrome	VCV003223884	2	29420451	2	29197585	3223884	3380906		NC_000002.12:29197584:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4029C>G (p.Thr1343=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001602752	2	29420452	2	29197586	1602752	1611091	rs2148143357	NC_000002.12:29197585:G:C	single nucleotide variant	synonymous variant	Likely benign	Sep 4, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.4028C>G (p.Thr1343Ser)	ALK	T1343S, T275S	Hereditary cancer-predisposing syndrome	VCV001737157	2	29420453	2	29197587	1737157	1790356		NC_000002.12:29197586:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4028C>T (p.Thr1343Ile)	ALK	T1343I, T275I	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000566608	2	29420453	2	29197587	566608	558027	rs753763148	NC_000002.12:29197586:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 13, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.4026C>T (p.Val1342=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001105365	2	29420455	2	29197589	1105365	1091227	rs2148143373	NC_000002.12:29197588:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 14, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.4025T>A (p.Val1342Asp)	ALK	V1342D, V274D	Neuroblastoma, susceptibility to, 3	VCV002840075	2	29420456	2	29197590	2840075	3003297		NC_000002.12:29197589:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4024G>A (p.Val1342Ile)	ALK	V1342I, V274I	Hereditary cancer-predisposing syndrome	VCV003525602	2	29420457	2	29197591	3525602	3682455		NC_000002.12:29197590:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4023T>C (p.Phe1341=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002700221	2	29420458	2	29197592	2700221	2859073		NC_000002.12:29197591:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4022_4023del (p.Phe1341fs)	ALK	F1341fs, F273fs	Hereditary cancer-predisposing syndrome	VCV001737122	2	29420458 - 29420459	2	29197592 - 29197593	1737122	1790321		NC_000002.12:29197591:AAA:A	Deletion	frameshift variant	Uncertain significance	Jan 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4020G>A (p.Glu1340=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001130321	2	29420461	2	29197595	1130321	1112730	rs2148143395	NC_000002.12:29197594:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 6, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4019A>G (p.Glu1340Gly)	ALK	E1340G, E272G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000485086	2	29420462	2	29197596	485086	472731	rs1469977891	NC_000002.12:29197595:T:C	single nucleotide variant	missense variant	Uncertain significance	May 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4017G>A (p.Leu1339=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000793690	2	29420464	2	29197598	793690	781299	rs1573084654	NC_000002.12:29197597:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.4015C>T (p.Leu1339=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001737055	2	29420466	2	29197600	1737055	1790254		NC_000002.12:29197599:G:A	single nucleotide variant	synonymous variant	Likely benign	May 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4015C>G (p.Leu1339Val)	ALK	L271V, L1339V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV001465854	2	29420466	2	29197600	1465854	1354086	rs1416439647	NC_000002.12:29197599:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4012G>A (p.Val1338Ile)	ALK	V1338I, V270I	Neuroblastoma, susceptibility to, 3	VCV001715889	2	29420469	2	29197603	1715889	1773834		NC_000002.12:29197602:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4012G>T (p.Val1338Phe)	ALK	V270F, V1338F	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000644691	2	29420469	2	29197603	644691	629817	rs1573084680	NC_000002.12:29197602:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4011A>G (p.Glu1337=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001094697	2	29420470	2	29197604	1094697	1069509	rs2148143423	NC_000002.12:29197603:T:C	single nucleotide variant	synonymous variant	Likely benign	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4007A>G (p.Gln1336Arg)	ALK	Q1336R, Q268R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001510067	2	29420474	2	29197608	1510067	1445986	rs1669056352	NC_000002.12:29197607:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4006C>T (p.Gln1336Ter)	ALK	Q1336*, Q268*	Neuroblastoma, susceptibility to, 3	VCV003586398	2	29420475	2	29197609	3586398	3717106		NC_000002.12:29197608:G:A	single nucleotide variant	nonsense	Uncertain significance	May 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.4005C>T (p.Asn1335=)	ALK		Hereditary cancer-predisposing syndrome	VCV001736965	2	29420476	2	29197610	1736965	1794007		NC_000002.12:29197609:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 26, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.4002C>T (p.Ser1334=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223883	2	29420479	2	29197613	3223883	3380905		NC_000002.12:29197612:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 10, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4002C>G (p.Ser1334Arg)	ALK	S1334R, S266R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001406414	2	29420479	2	29197613	1406414	1408435	rs1669056558	NC_000002.12:29197612:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4001G>C (p.Ser1334Thr)	ALK	S266T, S1334T	Neuroblastoma, susceptibility to, 3	VCV002118284	2	29420480	2	29197614	2118284	2176066		NC_000002.12:29197613:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.4001G>A (p.Ser1334Asn)	ALK	S266N, S1334N	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000954238	2	29420480	2	29197614	954238	942846	rs1209406542	NC_000002.12:29197613:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.4000A>T (p.Ser1334Cys)	ALK	S266C, S1334C	Neuroblastoma, susceptibility to, 3	VCV000658658	2	29420481	2	29197615	658658	629818	rs1307066116	NC_000002.12:29197614:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.4000A>G (p.Ser1334Gly)	ALK	S1334G, S266G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000570019	2	29420481	2	29197615	570019	560575	rs1307066116	NC_000002.12:29197614:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3998A>C (p.Lys1333Thr)	ALK	K265T, K1333T	Hereditary cancer-predisposing syndrome	VCV002566602	2	29420483	2	29197617	2566602	2734445		NC_000002.12:29197616:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3995_3996insTCATTTCTCTAAAATGAAATGACTGGTGTCTCCATTTGCCCATATG (p.Ser1332_Lys1333insHisPheSerLysMetLysTer)	ALK		not provided	VCV003603105	2	29420485 - 29420486	2	29197619 - 29197620	3603105	3735819		NC_000002.12:29197619:C:CATATGGGCAAATGGAGACACCAGTCATTTCATTTTAGAGAAATGAC	Insertion	nonsense|inframe_insertion	Uncertain significance	Aug 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3995G>T (p.Ser1332Ile)	ALK	S264I, S1332I	Hereditary cancer-predisposing syndrome	VCV001736793	2	29420486	2	29197620	1736793	1793835		NC_000002.12:29197619:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3992C>A (p.Pro1331His)	ALK	P1331H, P263H	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001398383	2	29420489	2	29197623	1398383	1431312	rs370364694	NC_000002.12:29197622:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3992C>T (p.Pro1331Leu)	ALK	P263L, P1331L	Neuroblastoma, susceptibility to, 3	VCV000937565	2	29420489	2	29197623	937565	931345	rs370364694	NC_000002.12:29197622:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3990C>A (p.Tyr1330Ter)	ALK	Y262*, Y1330*	Neuroblastoma, susceptibility to, 3	VCV001485824	2	29420491	2	29197625	1485824	1468305	rs2148143481	NC_000002.12:29197624:G:T	single nucleotide variant	nonsense	Uncertain significance	Nov 17, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3988T>C (p.Tyr1330His)	ALK	Y1330H, Y262H	Neuroblastoma, susceptibility to, 3	VCV000957636	2	29420493	2	29197627	957636	942847	rs1669057104	NC_000002.12:29197626:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3987A>G (p.Pro1329=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002043448	2	29420494	2	29197628	2043448	2092309		NC_000002.12:29197627:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 15, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3986C>T (p.Pro1329Leu)	ALK	P1329L, P261L	Neuroblastoma, susceptibility to, 3	VCV001405491	2	29420495	2	29197629	1405491	1480431	rs2148143494	NC_000002.12:29197628:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3985C>T (p.Pro1329Ser)	ALK	P1329S, P261S	Neuroblastoma, susceptibility to, 3	VCV002710242	2	29420496	2	29197630	2710242	2871266		NC_000002.12:29197629:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3984G>A (p.Met1328Ile)	ALK	M1328I, M260I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000239831	2	29420497	2	29197631	239831	238717	rs540427775	NC_000002.12:29197630:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3983T>C (p.Met1328Thr)	ALK	M260T, M1328T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001422622	2	29420498	2	29197632	1422622	1412516	rs2148143507	NC_000002.12:29197631:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3981T>G (p.Tyr1327Ter)	ALK	Y1327*, Y259*	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001014679	2	29420500	2	29197634	1014679	1003967	rs1669057406	NC_000002.12:29197633:A:C	single nucleotide variant	nonsense	Uncertain significance	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3978A>G (p.Gly1326=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470860	2	29420503	2	29197637	470860	450995	rs200256900	NC_000002.12:29197636:T:C	single nucleotide variant	synonymous variant	Uncertain significance	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3975T>C (p.Leu1325=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002745062	2	29420506	2	29197640	2745062	2897225		NC_000002.12:29197639:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3974T>C (p.Leu1325Pro)	ALK	L1325P, L257P	Hereditary cancer-predisposing syndrome	VCV003223882	2	29420507	2	29197641	3223882	3380904		NC_000002.12:29197640:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3972T>A (p.Ser1324=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001674142	2	29420509	2	29197643	1674142	1617955	rs2148143547	NC_000002.12:29197642:A:T	single nucleotide variant	synonymous variant	Likely benign	Jul 12, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3971C>G (p.Ser1324Cys)	ALK	S1324C, S256C	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000573985	2	29420510	2	29197644	573985	561295	rs758127441	NC_000002.12:29197643:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3969T>C (p.Phe1323=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001105745	2	29420512	2	29197646	1105745	1091228	rs1372668818	NC_000002.12:29197645:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3969T>G (p.Phe1323Leu)	ALK	F1323L, F255L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470859	2	29420512	2	29197646	470859	450819	rs1372668818	NC_000002.12:29197645:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3968T>C (p.Phe1323Ser)	ALK	F1323S, F255S	Hereditary cancer-predisposing syndrome	VCV001736574	2	29420513	2	29197647	1736574	1797107		NC_000002.12:29197646:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3966C>G (p.Ile1322Met)	ALK	I1322M, I254M	Neuroblastoma, susceptibility to, 3	VCV001415584	2	29420515	2	29197649	1415584	1375091	rs2148143567	NC_000002.12:29197648:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3966C>A (p.Ile1322=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001090706	2	29420515	2	29197649	1090706	1069510	rs2148143567	NC_000002.12:29197648:G:T	single nucleotide variant	synonymous variant	Likely benign	Feb 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3965T>A (p.Ile1322Asn)	ALK	I1322N, I254N	Neuroblastoma, susceptibility to, 3	VCV002840312	2	29420516	2	29197650	2840312	3000136		NC_000002.12:29197649:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3963A>C (p.Glu1321Asp)	ALK	E1321D, E253D	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002452110	2	29420518	2	29197652	2452110	2426750		NC_000002.12:29197651:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3959G>A (p.Trp1320Ter)	ALK	W1320*, W252*	Neuroblastoma, susceptibility to, 3	VCV001344812	2	29420522	2	29197656	1344812	1336584	rs2148143597	NC_000002.12:29197655:C:T	single nucleotide variant	nonsense	Uncertain significance	Jul 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3958T>C (p.Trp1320Arg)	ALK	W1320R, W252R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000470858	2	29420523	2	29197657	470858	451028	rs779796155	NC_000002.12:29197656:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3957A>C (p.Leu1319=)	ALK		Hereditary cancer-predisposing syndrome	VCV002586680	2	29420524	2	29197658	2586680	2756863		NC_000002.12:29197657:T:G	single nucleotide variant	synonymous variant	Likely benign	Jul 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3957A>G (p.Leu1319=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001736474	2	29420524	2	29197658	1736474	1797007		NC_000002.12:29197657:T:C	single nucleotide variant	synonymous variant	Likely benign	Jun 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3956T>C (p.Leu1319Pro)	ALK	L251P, L1319P	Hereditary cancer-predisposing syndrome	VCV003524867	2	29420525	2	29197659	3524867	3689106		NC_000002.12:29197658:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3954G>C (p.Leu1318=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223881	2	29420527	2	29197661	3223881	3380903		NC_000002.12:29197660:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3953T>C (p.Leu1318Pro)	ALK	L1318P, L250P	Neuroblastoma, susceptibility to, 3	VCV002101145	2	29420528	2	29197662	2101145	2151165		NC_000002.12:29197661:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3951G>A (p.Val1317=)	ALK		Hereditary cancer-predisposing syndrome	VCV001692786	2	29420530	2	29197664	1692786	1685226	rs2148143628	NC_000002.12:29197663:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3949G>A (p.Val1317Met)	ALK	V249M, V1317M	Neuroblastoma, susceptibility to, 3	VCV000861644	2	29420532	2	29197666	861644	826305	rs770242459	NC_000002.12:29197665:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3948A>G (p.Gly1316=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001157088	2	29420533	2	29197667	1157088	1133645	rs2148143639	NC_000002.12:29197666:T:C	single nucleotide variant	synonymous variant	Likely benign	Oct 20, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3947G>A (p.Gly1316Glu)	ALK	G1316E, G248E	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000574488	2	29420534	2	29197668	574488	558029	rs1285677926	NC_000002.12:29197667:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3946G>T (p.Gly1316Ter)	ALK	G248*, G1316*	Neuroblastoma, susceptibility to, 3	VCV002770919	2	29420535	2	29197669	2770919	2923893		NC_000002.12:29197668:C:A	single nucleotide variant	nonsense	Uncertain significance	Oct 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3945dup (p.Gly1316fs)	ALK	G248fs, G1316fs	Hereditary cancer-predisposing syndrome	VCV002586696	2	29420535 - 29420536	2	29197669 - 29197670	2586696	2756879		NC_000002.12:29197669:AAA:AAAA	Duplication	frameshift variant	Uncertain significance	Aug 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3945T>C (p.Phe1315=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001132854	2	29420536	2	29197670	1132854	1112731	rs1669058336	NC_000002.12:29197669:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3944T>C (p.Phe1315Ser)	ALK	F1315S, F247S	Neuroblastoma, susceptibility to, 3	VCV002675845	2	29420537	2	29197671	2675845	2835962		NC_000002.12:29197670:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3942C>G (p.Ser1314=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001658228	2	29420539	2	29197673	1658228	1594229	rs2148143670	NC_000002.12:29197672:G:C	single nucleotide variant	synonymous variant	Likely benign	May 13, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3941C>G (p.Ser1314Cys)	ALK	S246C, S1314C	Hereditary cancer-predisposing syndrome	VCV001736358	2	29420540	2	29197674	1736358	1796891		NC_000002.12:29197673:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3939G>T (p.Trp1313Cys)	ALK	W1313C, W245C	Neuroblastoma, susceptibility to, 3	VCV000404345	2	29420542	2	29197676	404345	392901	rs1060500218	NC_000002.12:29197675:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2016	criteria provided, single submitter							
NM_004304.5(ALK):c.3939-1G>A	ALK		Hereditary cancer-predisposing syndrome	VCV003523729	2	29420543	2	29197677	3523729	3685401		NC_000002.12:29197676:C:T	single nucleotide variant	splice acceptor variant	Uncertain significance	Dec 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3939-3C>T	ALK		Hereditary cancer-predisposing syndrome	VCV002562263	2	29420545	2	29197679	2562263	2721116		NC_000002.12:29197678:G:A	single nucleotide variant	intron variant	Uncertain significance	Apr 5, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3939-4C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002799230	2	29420546	2	29197680	2799230	2959054		NC_000002.12:29197679:G:A	single nucleotide variant	intron variant	Likely benign	Feb 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3939-5C>T	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000706470	2	29420547	2	29197681	706470	695143	rs1573084845	NC_000002.12:29197680:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Apr 22, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3939-7T>A	ALK		Neuroblastoma, susceptibility to, 3	VCV003661382	2	29420549	2	29197683	3661382	3801061		NC_000002.12:29197682:A:T	single nucleotide variant	intron variant	Uncertain significance	Aug 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3939-7T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002902983	2	29420549	2	29197683	2902983	3068478		NC_000002.12:29197682:A:G	single nucleotide variant	intron variant	Likely benign	Nov 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3939-8A>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001106129	2	29420550	2	29197684	1106129	1091229	rs3738869	NC_000002.12:29197683:T:G	single nucleotide variant	intron variant	Likely benign	Apr 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3939-8A>G	ALK		Neuroblastoma, susceptibility to, 3|not specified	VCV000239830	2	29420550	2	29197684	239830	238718	rs3738869	NC_000002.12:29197683:T:C	single nucleotide variant	intron variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3939-9C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000538310	2	29420551	2	29197685	538310	518095	rs749848775	NC_000002.12:29197684:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 24, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3939-10C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001474455	2	29420552	2	29197686	1474455	1410986	rs2148143702	NC_000002.12:29197685:G:C	single nucleotide variant	intron variant	Likely benign	Feb 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3939-11C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001668438	2	29420553	2	29197687	1668438	1633812	rs771308439	NC_000002.12:29197686:G:C	single nucleotide variant	intron variant	Likely benign	Sep 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3939-15C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002106470	2	29420557	2	29197691	2106470	2159179		NC_000002.12:29197690:G:A	single nucleotide variant	intron variant	Likely benign	Oct 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3939-18C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001650481	2	29420560	2	29197694	1650481	1602193	rs1213805336	NC_000002.12:29197693:G:A	single nucleotide variant	intron variant	Likely benign	Aug 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3939-19T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV003644866	2	29420561	2	29197695	3644866	3786702		NC_000002.12:29197694:A:G	single nucleotide variant	intron variant	Likely benign	Mar 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3939-197G>C	ALK		not provided	VCV001187166	2	29420739	2	29197873	1187166	1176163	rs62130563	NC_000002.12:29197872:C:G	single nucleotide variant	intron variant	Likely benign	Jun 21, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3938+295_3938+296insAA	ALK		not provided	VCV001240473	2	29429741 - 29429742	2	29206875 - 29206876	1240473	1231297	rs10623528	NC_000002.12:29206875::TT	Insertion	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3938+273A>G	ALK		not provided	VCV001195353	2	29429764	2	29206898	1195353	1183177	rs79349452	NC_000002.12:29206897:T:C	single nucleotide variant	intron variant	Likely benign	Mar 16, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3938+149C>T	ALK		not provided	VCV001235187	2	29429888	2	29207022	1235187	1223016	rs4666178	NC_000002.12:29207021:G:A	single nucleotide variant	intron variant	Benign	Jun 24, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3938+57C>T	ALK		not provided	VCV001192988	2	29429980	2	29207114	1192988	1183178	rs111505977	NC_000002.12:29207113:G:A	single nucleotide variant	intron variant	Likely benign	Jul 6, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3938+20C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003684728	2	29430017	2	29207151	3684728	3815881		NC_000002.12:29207150:G:A	single nucleotide variant	intron variant	Likely benign	Aug 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3938+19T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002032870	2	29430018	2	29207152	2032870	2079231		NC_000002.12:29207151:A:G	single nucleotide variant	intron variant	Likely benign	Sep 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3938+17C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002048721	2	29430020	2	29207154	2048721	2114365		NC_000002.12:29207153:G:A	single nucleotide variant	intron variant	Likely benign	Nov 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3938+12A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001554525	2	29430025	2	29207159	1554525	1651961	rs757915888	NC_000002.12:29207158:T:C	single nucleotide variant	intron variant	Likely benign	Apr 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3938+7_3938+8dup	ALK		Neuroblastoma, susceptibility to, 3	VCV001536567	2	29430028 - 29430029	2	29207162 - 29207163	1536567	1618656	rs752257152	NC_000002.12:29207162:TG:TGTG	Duplication	intron variant	Likely benign	Feb 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3938+8A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000412913	2	29430029	2	29207163	412913	392903	rs1060503877	NC_000002.12:29207162:T:C	single nucleotide variant	intron variant	Likely benign	May 13, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3938+7C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000538307	2	29430030	2	29207164	538307	518106	rs1553390731	NC_000002.12:29207163:G:A	single nucleotide variant	intron variant	Likely benign	Jul 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3938+6T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV003679659	2	29430031	2	29207165	3679659	3814683		NC_000002.12:29207164:A:G	single nucleotide variant	intron variant	Uncertain significance	Dec 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3938+6T>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001947269	2	29430031	2	29207165	1947269	1996232		NC_000002.12:29207164:A:T	single nucleotide variant	intron variant	Uncertain significance	May 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3938+5dup	ALK		Neuroblastoma, susceptibility to, 3|not provided	VCV000639134	2	29430031 - 29430032	2	29207165 - 29207166	639134	650951	rs1573098880	NC_000002.12:29207165:C:CC	Duplication	intron variant	Uncertain significance	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3938+5G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002749984	2	29430032	2	29207166	2749984	2918942		NC_000002.12:29207165:C:T	single nucleotide variant	intron variant	Uncertain significance	May 30, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3938+4A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001428308	2	29430033	2	29207167	1428308	1379600	rs754655331	NC_000002.12:29207166:T:C	single nucleotide variant	intron variant	Uncertain significance	Apr 11, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3938+3A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001005268	2	29430034	2	29207168	1005268	988682	rs1669333067	NC_000002.12:29207167:T:C	single nucleotide variant	intron variant	Uncertain significance	Feb 4, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3938+2T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001993219	2	29430035	2	29207169	1993219	2052872		NC_000002.12:29207168:A:G	single nucleotide variant	splice donor variant	Uncertain significance	Jul 30, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3938+1G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003640507	2	29430036	2	29207170	3640507	3772092		NC_000002.12:29207169:C:A	single nucleotide variant	splice donor variant	Uncertain significance	Feb 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3938+1G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV000848783	2	29430036	2	29207170	848783	850853	rs1553390736	NC_000002.12:29207169:C:G	single nucleotide variant	splice donor variant	Uncertain significance	Aug 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3938+1G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000470856	2	29430036	2	29207170	470856	450714	rs1553390736	NC_000002.12:29207169:C:T	single nucleotide variant	splice donor variant	Uncertain significance	May 22, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.3938G>A (p.Trp1313Ter)	ALK	W1313*, W245*	Neuroblastoma, susceptibility to, 3|not provided	VCV000654329	2	29430037	2	29207171	654329	629819	rs1573098889	NC_000002.12:29207170:C:T	single nucleotide variant	nonsense	Uncertain significance	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3937T>C (p.Trp1313Arg)	ALK	W1313R, W245R	Neuroblastoma, susceptibility to, 3	VCV001002785	2	29430038	2	29207172	1002785	988683	rs1669333264	NC_000002.12:29207171:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3936A>T (p.Thr1312=)	ALK		Hereditary cancer-predisposing syndrome	VCV002452112	2	29430039	2	29207173	2452112	2426752		NC_000002.12:29207172:T:A	single nucleotide variant	synonymous variant	Likely benign	Jan 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3935C>T (p.Thr1312Ile)	ALK	T1312I, T244I	Hereditary cancer-predisposing syndrome	VCV001736294	2	29430040	2	29207174	1736294	1796827		NC_000002.12:29207173:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3933C>T (p.Asp1311=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001132725	2	29430042	2	29207176	1132725	1112732	rs1669333390	NC_000002.12:29207175:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3929C>T (p.Thr1310Ile)	ALK	T1310I, T242I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000404377	2	29430046	2	29207180	404377	392695	rs1060500226	NC_000002.12:29207179:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3928A>G (p.Thr1310Ala)	ALK	T1310A, T242A	Neuroblastoma, susceptibility to, 3	VCV000470855	2	29430047	2	29207181	470855	450824	rs1553390742	NC_000002.12:29207180:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.3926A>T (p.Lys1309Ile)	ALK	K1309I, K241I	Neuroblastoma, susceptibility to, 3	VCV003241661	2	29430049	2	29207183	3241661	3400639		NC_000002.12:29207182:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3926A>C (p.Lys1309Thr)	ALK	K1309T, K241T	Hereditary cancer-predisposing syndrome	VCV001736229	2	29430049	2	29207183	1736229	1796763		NC_000002.12:29207182:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3925A>G (p.Lys1309Glu)	ALK	K241E, K1309E	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002195172	2	29430050	2	29207184	2195172	1929539		NC_000002.12:29207183:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3924T>C (p.Ser1308=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001083661	2	29430051	2	29207185	1083661	1069511	rs2148151967	NC_000002.12:29207184:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3923C>T (p.Ser1308Phe)	ALK	S1308F, S240F	Neuroblastoma, susceptibility to, 3	VCV001949013	2	29430052	2	29207186	1949013	2006581		NC_000002.12:29207185:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3920C>G (p.Thr1307Ser)	ALK	T239S, T1307S	Neuroblastoma, susceptibility to, 3	VCV003641035	2	29430055	2	29207189	3641035	3768753		NC_000002.12:29207188:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3919A>G (p.Thr1307Ala)	ALK	T239A, T1307A	Neuroblastoma, susceptibility to, 3	VCV001522368	2	29430056	2	29207190	1522368	1369312	rs1669333746	NC_000002.12:29207189:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3918C>T (p.Phe1306=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001112554	2	29430057	2	29207191	1112554	1091230	rs2148151984	NC_000002.12:29207190:G:A	single nucleotide variant	synonymous variant	Likely benign	May 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3916T>C (p.Phe1306Leu)	ALK	F1306L, F238L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002055091	2	29430059	2	29207193	2055091	2109091		NC_000002.12:29207192:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3914T>C (p.Ile1305Thr)	ALK	I237T, I1305T	Neuroblastoma, susceptibility to, 3	VCV002703881	2	29430061	2	29207195	2703881	2856307		NC_000002.12:29207194:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3913A>C (p.Ile1305Leu)	ALK	I237L, I1305L	Neuroblastoma, susceptibility to, 3	VCV003706295	2	29430062	2	29207196	3706295	3839748		NC_000002.12:29207195:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3911G>A (p.Gly1304Glu)	ALK	G236E, G1304E	Neuroblastoma, susceptibility to, 3	VCV002917461	2	29430064	2	29207198	2917461	3074703		NC_000002.12:29207197:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3907G>A (p.Glu1303Lys)	ALK	E235K, E1303K	Hereditary cancer-predisposing syndrome	VCV003285003	2	29430068	2	29207202	3285003	3444182		NC_000002.12:29207201:C:T	single nucleotide variant	missense variant	Uncertain significance	May 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3906G>A (p.Met1302Ile)	ALK	M1302I, M234I	Neuroblastoma, susceptibility to, 3	VCV003644847	2	29430069	2	29207203	3644847	3786683		NC_000002.12:29207202:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3905T>C (p.Met1302Thr)	ALK	M1302T, M234T	Neuroblastoma, susceptibility to, 3	VCV003675767	2	29430070	2	29207204	3675767	3817265		NC_000002.12:29207203:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3905T>G (p.Met1302Arg)	ALK	M1302R, M234R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000566432	2	29430070	2	29207204	566432	560577	rs749608713	NC_000002.12:29207203:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3903C>T (p.Phe1301=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001671962	2	29430072	2	29207206	1671962	1647271	rs2148152025	NC_000002.12:29207205:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 1, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3902T>G (p.Phe1301Cys)	ALK	F1301C, F233C	Hereditary cancer-predisposing syndrome	VCV002566597	2	29430073	2	29207207	2566597	2734440		NC_000002.12:29207206:A:C	single nucleotide variant	missense variant	Uncertain significance	May 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3902del (p.Phe1301fs)	ALK	F1301fs, F233fs	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001009087	2	29430073	2	29207207	1009087	988684	rs1669334076	NC_000002.12:29207206:AA:A	Deletion	frameshift variant	Uncertain significance	May 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3901T>C (p.Phe1301Leu)	ALK	F233L, F1301L	Neuroblastoma, susceptibility to, 3	VCV001398159	2	29430074	2	29207208	1398159	1431088	rs2148152031	NC_000002.12:29207207:A:G	single nucleotide variant	missense variant	Uncertain significance	May 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3900C>T (p.Ala1300=)	ALK		Hereditary cancer-predisposing syndrome	VCV001736021	2	29430075	2	29207209	1736021	1787180		NC_000002.12:29207208:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 23, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3897G>A (p.Glu1299=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003649516	2	29430078	2	29207212	3649516	3777478		NC_000002.12:29207211:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3897G>C (p.Glu1299Asp)	ALK	E1299D, E231D	Neuroblastoma, susceptibility to, 3	VCV001716148	2	29430078	2	29207212	1716148	1771445		NC_000002.12:29207211:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3896A>G (p.Glu1299Gly)	ALK	E231G, E1299G	Neuroblastoma, susceptibility to, 3	VCV003713986	2	29430079	2	29207213	3713986	3844831		NC_000002.12:29207212:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.3894A>T (p.Pro1298=)	ALK		Hereditary cancer-predisposing syndrome	VCV001735918	2	29430081	2	29207215	1735918	1787079		NC_000002.12:29207214:T:A	single nucleotide variant	synonymous variant	Likely benign	Jun 26, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3892C>T (p.Pro1298Ser)	ALK	P1298S, P230S	Hereditary cancer-predisposing syndrome	VCV003223880	2	29430083	2	29207217	3223880	3380902		NC_000002.12:29207216:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3891C>G (p.Pro1297=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002033978	2	29430084	2	29207218	2033978	2097038		NC_000002.12:29207217:G:C	single nucleotide variant	synonymous variant	Likely benign	Mar 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3890C>T (p.Pro1297Leu)	ALK	P229L, P1297L	Neuroblastoma, susceptibility to, 3	VCV000850139	2	29430085	2	29207219	850139	826306	rs1669334369	NC_000002.12:29207218:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3888G>A (p.Met1296Ile)	ALK	M1296I, M228I	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000485087	2	29430087	2	29207221	485087	472679	rs1553390763	NC_000002.12:29207220:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3887T>C (p.Met1296Thr)	ALK	M228T, M1296T	Neuroblastoma, susceptibility to, 3	VCV002916576	2	29430088	2	29207222	2916576	3080006		NC_000002.12:29207221:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3886A>G (p.Met1296Val)	ALK	M228V, M1296V	Neuroblastoma, susceptibility to, 3	VCV003723585	2	29430089	2	29207223	3723585	3850796		NC_000002.12:29207222:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3884G>A (p.Trp1295Ter)	ALK	W1295*, W227*	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000639161	2	29430091	2	29207225	639161	629820	rs1417330585	NC_000002.12:29207224:C:T	single nucleotide variant	nonsense	Uncertain significance	Feb 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3882G>C (p.Lys1294Asn)	ALK	K1294N, K226N	Hereditary cancer-predisposing syndrome	VCV002586668	2	29430093	2	29207227	2586668	2756851		NC_000002.12:29207226:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3881A>C (p.Lys1294Thr)	ALK	K1294T, K226T	Neuroblastoma, susceptibility to, 3	VCV002969352	2	29430094	2	29207228	2969352	3131894		NC_000002.12:29207227:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 31, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3877G>A (p.Val1293Ile)	ALK	V1293I, V225I	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000864298	2	29430098	2	29207232	864298	826307	rs1024193740	NC_000002.12:29207231:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3876A>T (p.Pro1292=)	ALK		Hereditary cancer-predisposing syndrome	VCV001735751	2	29430099	2	29207233	1735751	1786912		NC_000002.12:29207232:T:A	single nucleotide variant	synonymous variant	Likely benign	Oct 30, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3875C>T (p.Pro1292Leu)	ALK	P224L, P1292L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001496138	2	29430100	2	29207234	1496138	1363053	rs2148152117	NC_000002.12:29207233:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3874C>G (p.Pro1292Ala)	ALK	P224A, P1292A	Neuroblastoma, susceptibility to, 3	VCV003666374	2	29430101	2	29207235	3666374	3792178		NC_000002.12:29207234:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3873G>T (p.Leu1291=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001122993	2	29430102	2	29207236	1122993	1112733	rs772093140	NC_000002.12:29207235:C:A	single nucleotide variant	synonymous variant	Likely benign	Feb 14, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3872T>C (p.Leu1291Pro)	ALK	L1291P, L223P	Hereditary cancer-predisposing syndrome	VCV003525358	2	29430103	2	29207237	3525358	3685714		NC_000002.12:29207236:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3870G>A (p.Met1290Ile)	ALK	M1290I, M222I	Neuroblastoma, susceptibility to, 3	VCV001361037	2	29430105	2	29207239	1361037	1383409	rs2148152138	NC_000002.12:29207238:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3869T>C (p.Met1290Thr)	ALK	M222T, M1290T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001735661	2	29430106	2	29207240	1735661	1790155		NC_000002.12:29207239:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3868A>G (p.Met1290Val)	ALK	M1290V, M222V	Neuroblastoma, susceptibility to, 3	VCV002824289	2	29430107	2	29207241	2824289	2978963		NC_000002.12:29207240:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3866C>T (p.Ala1289Val)	ALK	A1289V, A221V	Neuroblastoma, susceptibility to, 3	VCV000470854	2	29430109	2	29207243	470854	451035	rs1173246434	NC_000002.12:29207242:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3863G>A (p.Cys1288Tyr)	ALK	C1288Y, C220Y	Neuroblastoma, susceptibility to, 3	VCV002806668	2	29430112	2	29207246	2806668	2967757		NC_000002.12:29207245:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3862T>G (p.Cys1288Gly)	ALK	C220G, C1288G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002447090	2	29430113	2	29207247	2447090	2422213		NC_000002.12:29207246:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3861C>T (p.Gly1287=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001735613	2	29430114	2	29207248	1735613	1790107		NC_000002.12:29207247:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3860G>A (p.Gly1287Asp)	ALK	G219D, G1287D	Neuroblastoma, susceptibility to, 3	VCV001525449	2	29430115	2	29207249	1525449	1359907	rs2148152174	NC_000002.12:29207248:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 11, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3859G>A (p.Gly1287Ser)	ALK	G1287S, G219S	Neuroblastoma, susceptibility to, 3	VCV001004009	2	29430116	2	29207250	1004009	988685	rs1669335550	NC_000002.12:29207249:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3856G>A (p.Gly1286Arg)	ALK	G1286R, G218R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001735559	2	29430119	2	29207253	1735559	1790053		NC_000002.12:29207252:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3855G>T (p.Lys1285Asn)	ALK	K1285N, K217N	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001723060	2	29430120	2	29207254	1723060	1780562		NC_000002.12:29207253:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3855G>A (p.Lys1285=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470851	2	29430120	2	29207254	470851	450999	rs776547376	NC_000002.12:29207253:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3854A>T (p.Lys1285Met)	ALK	K217M, K1285M	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002097642	2	29430121	2	29207255	2097642	2150262		NC_000002.12:29207254:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3850A>C (p.Arg1284=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001661275	2	29430125	2	29207259	1661275	1554527	rs2148152215	NC_000002.12:29207258:T:G	single nucleotide variant	synonymous variant	Likely benign	Dec 13, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3849T>C (p.Tyr1283=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000824294	2	29430126	2	29207260	824294	806884	rs960416635	NC_000002.12:29207259:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3845A>G (p.Tyr1282Cys)	ALK	Y1282C, Y214C	Hereditary cancer-predisposing syndrome	VCV003223879	2	29430130	2	29207264	3223879	3380901		NC_000002.12:29207263:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3844T>A (p.Tyr1282Asn)	ALK	Y1282N, Y214N	Hereditary cancer-predisposing syndrome	VCV003223878	2	29430131	2	29207265	3223878	3380900		NC_000002.12:29207264:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3844T>C (p.Tyr1282His)	ALK	Y1282H, Y214H	Hereditary cancer-predisposing syndrome	VCV001735459	2	29430131	2	29207265	1735459	1789954		NC_000002.12:29207264:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3842G>A (p.Ser1281Asn)	ALK	S1281N, S213N	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000663680	2	29430133	2	29207267	663680	629821	rs761459938	NC_000002.12:29207266:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 30, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3840G>A (p.Ala1280=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV001105586	2	29430135	2	29207269	1105586	1091231	rs765226629	NC_000002.12:29207268:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 26, 2024	criteria provided, multiple submitters, no conflicts							
NC_000002.12:g.29207270_29207273del	ALK		Neuroblastoma, susceptibility to, 3	VCV001014027	2	29430135 - 29430138	2	29207269 - 29207272	1014027	1003968	rs1669336181	NC_000002.12:29207268:CGCCC:C	Deletion		Uncertain significance	Nov 29, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3840G>C (p.Ala1280=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000704183	2	29430135	2	29207269	704183	691128	rs765226629	NC_000002.12:29207268:C:G	single nucleotide variant	synonymous variant	Likely benign	Sep 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3839C>A (p.Ala1280Glu)	ALK	A1280E, A212E	Neuroblastoma, susceptibility to, 3	VCV002802603	2	29430136	2	29207270	2802603	2963288		NC_000002.12:29207269:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3839C>T (p.Ala1280Val)	ALK	A1280V, A212V	Neuroblastoma Susceptibility|Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000335691	2	29430136	2	29207270	335691	286740	rs74716434	NC_000002.12:29207269:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 13, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3837-3C>T	ALK		Hereditary cancer-predisposing syndrome	VCV003223877	2	29430141	2	29207275	3223877	3380899		NC_000002.12:29207274:G:A	single nucleotide variant	intron variant	Uncertain significance	Dec 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3837-8dup	ALK		Neuroblastoma, susceptibility to, 3	VCV001168399	2	29430142 - 29430143	2	29207276 - 29207277	1168399	1154132	rs2148152286	NC_000002.12:29207276:GGGG:GGGGG	Duplication	intron variant	Benign	May 13, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3837-6C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001140332	2	29430144	2	29207278	1140332	1112734	rs2148152290	NC_000002.12:29207277:G:A	single nucleotide variant	intron variant	Likely benign	Oct 31, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3837-9_3837-7dup	ALK		not specified|Neuroblastoma, susceptibility to, 3|Familial isolated pituitary adenoma|not provided|Hereditary cancer-predisposing syndrome	VCV000239829	2	29430144 - 29430145	2	29207278 - 29207279	239829	238719	rs373764155	NC_000002.12:29207278:GGA:GGAGGA	Duplication	intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3837-8C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001120420	2	29430146	2	29207280	1120420	1112735	rs2148152298	NC_000002.12:29207279:G:A	single nucleotide variant	intron variant	Likely benign	Apr 23, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3837-11C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002916593	2	29430149	2	29207283	2916593	3080023		NC_000002.12:29207282:G:C	single nucleotide variant	intron variant	Likely benign	Nov 17, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3837-13T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV003677292	2	29430151	2	29207285	3677292	3817493		NC_000002.12:29207284:A:G	single nucleotide variant	intron variant	Likely benign	Dec 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3837-14del	ALK		Neuroblastoma, susceptibility to, 3	VCV002877190	2	29430152	2	29207286	2877190	3033295		NC_000002.12:29207285:G:	Deletion	intron variant	Likely benign	Jan 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3837-16C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002919138	2	29430154	2	29207288	2919138	3075062		NC_000002.12:29207287:G:A	single nucleotide variant	intron variant	Likely benign	Nov 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3837-17C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002156959	2	29430155	2	29207289	2156959	1883235		NC_000002.12:29207288:G:A	single nucleotide variant	intron variant	Likely benign	Aug 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3837-19T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001983615	2	29430157	2	29207291	1983615	2042770		NC_000002.12:29207290:A:G	single nucleotide variant	intron variant	Likely benign	May 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3837-20T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001670202	2	29430158	2	29207292	1670202	1635567	rs2148152332	NC_000002.12:29207291:A:C	single nucleotide variant	intron variant	Likely benign	May 7, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3837-293A>G	ALK		not provided	VCV001270878	2	29430431	2	29207565	1270878	1260731	rs80098307	NC_000002.12:29207564:T:C	single nucleotide variant	intron variant	Benign	Mar 24, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3837-327T>C	ALK		not provided	VCV001251206	2	29430465	2	29207599	1251206	1241552	rs6754837	NC_000002.12:29207598:A:G	single nucleotide variant	intron variant	Benign	Feb 28, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3836+248C>T	ALK		not provided	VCV001246132	2	29432404	2	29209538	1246132	1237375	rs113989944	NC_000002.12:29209537:G:A	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3836+223dup	ALK		not provided	VCV001178612	2	29432408 - 29432409	2	29209542 - 29209543	1178612	1167954	rs76343130	NC_000002.12:29209542:AAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAA	Duplication	intron variant	Likely benign	Aug 7, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3836+234_3836+243del	ALK		not provided	VCV001292852	2	29432409 - 29432418	2	29209543 - 29209552	1292852	1282658	rs76343130	NC_000002.12:29209542:AAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAA	Deletion	intron variant	Benign	Aug 7, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3836+242_3836+243del	ALK		not provided	VCV001262102	2	29432409 - 29432410	2	29209543 - 29209544	1262102	1250716	rs76343130	NC_000002.12:29209542:AAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAA	Deletion	intron variant	Benign	Aug 16, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3836+243del	ALK		not provided	VCV001238291	2	29432409	2	29209543	1238291	1228706	rs76343130	NC_000002.12:29209542:AAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAA	Deletion	intron variant	Benign	Aug 9, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3836+235_3836+243del	ALK		not provided	VCV001207900	2	29432409 - 29432417	2	29209543 - 29209551	1207900	1196905	rs76343130	NC_000002.12:29209542:AAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAA	Deletion	intron variant	Likely benign	Aug 7, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3836+175G>A	ALK		not provided	VCV001200498	2	29432477	2	29209611	1200498	1189887	rs75750780	NC_000002.12:29209610:C:T	single nucleotide variant	intron variant	Likely benign	Jul 20, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3836+27G>T	ALK		not provided	VCV001292655	2	29432625	2	29209759	1292655	1282461	rs3738868	NC_000002.12:29209758:C:A	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3836+16C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001543451	2	29432636	2	29209770	1543451	1632908	rs2148154954	NC_000002.12:29209769:G:T	single nucleotide variant	intron variant	Likely benign	May 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3836+10G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002843525	2	29432642	2	29209776	2843525	3004180		NC_000002.12:29209775:C:T	single nucleotide variant	intron variant	Likely benign	Mar 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3836+10G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001105980	2	29432642	2	29209776	1105980	1091232	rs2148154982	NC_000002.12:29209775:C:G	single nucleotide variant	intron variant	Likely benign	Nov 13, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3836+8A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002109111	2	29432644	2	29209778	2109111	2166976		NC_000002.12:29209777:T:C	single nucleotide variant	intron variant	Likely benign	Mar 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3836+6T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000841128	2	29432646	2	29209780	841128	851172	rs1669413751	NC_000002.12:29209779:A:C	single nucleotide variant	intron variant	Uncertain significance	Nov 25, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3836+5G>A	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001045366	2	29432647	2	29209781	1045366	1024438	rs1669413814	NC_000002.12:29209780:C:T	single nucleotide variant	intron variant	Uncertain significance	Sep 13, 2021	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3836+2T>C	ALK		Hereditary cancer-predisposing syndrome	VCV002566553	2	29432650	2	29209784	2566553	2734396		NC_000002.12:29209783:A:G	single nucleotide variant	splice donor variant	Uncertain significance	Apr 13, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3836+1G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV003711841	2	29432651	2	29209785	3711841	3837523		NC_000002.12:29209784:C:T	single nucleotide variant	splice donor variant	Uncertain significance	Feb 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3836+1G>T	ALK		Hereditary cancer-predisposing syndrome	VCV003285606	2	29432651	2	29209785	3285606	3440838		NC_000002.12:29209784:C:A	single nucleotide variant	splice donor variant	Uncertain significance	Apr 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3836G>A (p.Arg1279Lys)	ALK	R1279K, R211K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000950417	2	29432652	2	29209786	950417	922705	rs1300517321	NC_000002.12:29209785:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3835A>C (p.Arg1279=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000663435	2	29432653	2	29209787	663435	629822	rs1573102711	NC_000002.12:29209786:T:G	single nucleotide variant	synonymous variant	Uncertain significance	Nov 10, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3832dup (p.Tyr1278fs)	ALK	Y210fs, Y1278fs	Neuroblastoma, susceptibility to, 3	VCV003722499	2	29432655 - 29432656	2	29209789 - 29209790	3722499	3857012		NC_000002.12:29209789:A:AA	Duplication	frameshift variant	Uncertain significance	Oct 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3833A>G (p.Tyr1278Cys)	ALK	Y210C, Y1278C	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002601823	2	29432655	2	29209789	2601823	2778121		NC_000002.12:29209788:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3833A>C (p.Tyr1278Ser)	ALK	Y1278S, Y210S	Neuroblastoma, susceptibility to, 3	VCV000217858	2	29432655	2	29209789	217858	214506	rs863225285	NC_000002.12:29209788:T:G	single nucleotide variant	missense variant	Pathogenic	Nov 6, 2015	no assertion criteria provided							
NM_004304.5(ALK):c.3830T>C (p.Ile1277Thr)	ALK	I1277T, I209T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002562268	2	29432658	2	29209792	2562268	2721121		NC_000002.12:29209791:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3829A>G (p.Ile1277Val)	ALK	I209V, I1277V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000824268	2	29432659	2	29209793	824268	806885	rs1573102719	NC_000002.12:29209792:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3828C>T (p.Asp1276=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470850	2	29432660	2	29209794	470850	450846	rs1553391471	NC_000002.12:29209793:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3826G>C (p.Asp1276His)	ALK	D1276H, D208H	Hereditary cancer-predisposing syndrome	VCV001735306	2	29432662	2	29209796	1735306	1789801		NC_000002.12:29209795:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3825A>C (p.Arg1275=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003662642	2	29432663	2	29209797	3662642	3791012		NC_000002.12:29209796:T:G	single nucleotide variant	synonymous variant	Likely benign	Aug 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3824G>A (p.Arg1275Gln)	ALK	R1275Q, R207Q	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000018083	2	29432664	2	29209798	18083	33122	rs113994087	NC_000002.12:29209797:C:T	single nucleotide variant	missense variant	Pathogenic	Jun 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3823C>T (p.Arg1275Ter)	ALK	R1275*, R207*	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000572189	2	29432665	2	29209799	572189	561297	rs543620241	NC_000002.12:29209798:G:A	single nucleotide variant	nonsense	Uncertain significance	Sep 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3822C>T (p.Ala1274=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000750123	2	29432666	2	29209800	750123	747581	rs1573102740	NC_000002.12:29209799:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3820G>A (p.Ala1274Thr)	ALK	A1274T, A206T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470849	2	29432668	2	29209802	470849	450720	rs45502292	NC_000002.12:29209801:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3819G>A (p.Met1273Ile)	ALK	M1273I, M205I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001516400	2	29432669	2	29209803	1516400	1499054	rs2148155078	NC_000002.12:29209802:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3817del (p.Met1273fs)	ALK	M1273fs, M205fs	Neuroblastoma, susceptibility to, 3	VCV001035582	2	29432671	2	29209805	1035582	1024439	rs1669414764	NC_000002.12:29209804:T:	Deletion	frameshift variant	Uncertain significance	Jan 18, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3816G>T (p.Gly1272=)	ALK		Hereditary cancer-predisposing syndrome	VCV001735203	2	29432672	2	29209806	1735203	1793542		NC_000002.12:29209805:C:A	single nucleotide variant	synonymous variant	Likely benign	Aug 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3816G>A (p.Gly1272=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000702214	2	29432672	2	29209806	702214	691129	rs748365353	NC_000002.12:29209805:C:T	single nucleotide variant	synonymous variant	Likely benign	May 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3814G>A (p.Gly1272Arg)	ALK	G1272R, G204R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000572216	2	29432674	2	29209808	572216	558356	rs770027238	NC_000002.12:29209807:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3813C>A (p.Phe1271Leu)	ALK	F1271L, F203L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003019524	2	29432675	2	29209809	3019524	3172032		NC_000002.12:29209808:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3813C>T (p.Phe1271=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000824251	2	29432675	2	29209809	824251	806886	rs1297505919	NC_000002.12:29209808:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3812T>A (p.Phe1271Tyr)	ALK	F1271Y, F203Y	ALK-related disorder|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470848	2	29432676	2	29209810	470848	450721	rs1348950153	NC_000002.12:29209809:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3811T>C (p.Phe1271Leu)	ALK	F1271L, F203L	Hereditary cancer-predisposing syndrome	VCV001735165	2	29432677	2	29209811	1735165	1793504		NC_000002.12:29209810:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3810C>T (p.Asp1270=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470847	2	29432678	2	29209812	470847	451001	rs773207399	NC_000002.12:29209811:G:A	single nucleotide variant	synonymous variant	Likely benign	May 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3807A>G (p.Gly1269=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001735109	2	29432681	2	29209815	1735109	1793448		NC_000002.12:29209814:T:C	single nucleotide variant	synonymous variant	Likely benign	Nov 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3806G>A (p.Gly1269Glu)	ALK	G1269E, G201E	Hereditary cancer-predisposing syndrome	VCV002586674	2	29432682	2	29209816	2586674	2756857		NC_000002.12:29209815:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3806del (p.Gly1269fs)	ALK	G1269fs, G201fs	Neuroblastoma, susceptibility to, 3	VCV001515191	2	29432682	2	29209816	1515191	1482380	rs2148155141	NC_000002.12:29209815:CC:C	Deletion	frameshift variant	Uncertain significance	May 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3806G>C (p.Gly1269Ala)	ALK	G1269A, G201A	Hereditary cancer-predisposing syndrome	VCV000376132	2	29432682	2	29209816	376132	363011	rs1057519781	NC_000002.12:29209815:C:G	single nucleotide variant	missense variant	Uncertain significance	May 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3805G>A (p.Gly1269Arg)	ALK	G201R, G1269R	Hereditary cancer-predisposing syndrome	VCV003524223	2	29432683	2	29209817	3524223	3682391		NC_000002.12:29209816:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3802A>T (p.Ile1268Phe)	ALK	I1268F, I200F	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001489753	2	29432686	2	29209820	1489753	1507746	rs1669415629	NC_000002.12:29209819:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3801G>C (p.Lys1267Asn)	ALK	K1267N, K199N	Neuroblastoma, susceptibility to, 3	VCV000575655	2	29432687	2	29209821	575655	560579	rs1558614450	NC_000002.12:29209820:C:G	single nucleotide variant	missense variant	Uncertain significance	May 30, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3799A>G (p.Lys1267Glu)	ALK	K1267E, K199E	Hereditary cancer-predisposing syndrome	VCV003223876	2	29432689	2	29209823	3223876	3380898		NC_000002.12:29209822:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3798C>T (p.Ala1266=)	ALK		Hereditary cancer-predisposing syndrome	VCV001734999	2	29432690	2	29209824	1734999	1793338		NC_000002.12:29209823:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 16, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3798C>A (p.Ala1266=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000470846	2	29432690	2	29209824	470846	451005	rs1553391502	NC_000002.12:29209823:G:T	single nucleotide variant	synonymous variant	Likely benign	Jun 21, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3795G>A (p.Val1265=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001734977	2	29432693	2	29209827	1734977	1793316		NC_000002.12:29209826:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3794T>C (p.Val1265Ala)	ALK	V1265A, V197A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001501607	2	29432694	2	29209828	1501607	1398475	rs1669415878	NC_000002.12:29209827:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3793G>C (p.Val1265Leu)	ALK	V1265L, V197L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002676078	2	29432695	2	29209829	2676078	2834499		NC_000002.12:29209828:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3792A>C (p.Arg1264Ser)	ALK	R1264S, R196S	Neuroblastoma, susceptibility to, 3	VCV001490783	2	29432696	2	29209830	1490783	1511890	rs2148155204	NC_000002.12:29209829:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3791G>T (p.Arg1264Ile)	ALK	R196I, R1264I	Neuroblastoma, susceptibility to, 3	VCV002954658	2	29432697	2	29209831	2954658	3115012		NC_000002.12:29209830:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3791G>A (p.Arg1264Lys)	ALK	R196K, R1264K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001734957	2	29432697	2	29209831	1734957	1793296		NC_000002.12:29209830:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3789A>G (p.Gly1263=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000757274	2	29432699	2	29209833	757274	763173	rs148124123	NC_000002.12:29209832:T:C	single nucleotide variant	synonymous variant	Likely benign	May 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3788G>T (p.Gly1263Val)	ALK	G1263V, G195V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470845	2	29432700	2	29209834	470845	450847	rs1174034094	NC_000002.12:29209833:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3787G>A (p.Gly1263Arg)	ALK	G195R, G1263R	Neuroblastoma, susceptibility to, 3	VCV002747259	2	29432701	2	29209835	2747259	2908019		NC_000002.12:29209834:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3786T>G (p.Pro1262=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002799208	2	29432702	2	29209836	2799208	2962485		NC_000002.12:29209835:A:C	single nucleotide variant	synonymous variant	Likely benign	Apr 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3786del (p.Gly1263fs)	ALK	G1263fs, G195fs	Hereditary cancer-predisposing syndrome	VCV001734891	2	29432702	2	29209836	1734891	1796682		NC_000002.12:29209835:A:	Deletion	frameshift variant	Uncertain significance	Jan 2, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3785C>T (p.Pro1262Leu)	ALK	P1262L, P194L	Hereditary cancer-predisposing syndrome	VCV003524903	2	29432703	2	29209837	3524903	3689142		NC_000002.12:29209836:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3785C>G (p.Pro1262Arg)	ALK	P1262R, P194R	Neuroblastoma, susceptibility to, 3	VCV002712974	2	29432703	2	29209837	2712974	2879121		NC_000002.12:29209836:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3784C>T (p.Pro1262Ser)	ALK	P1262S, P194S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001413574	2	29432704	2	29209838	1413574	1361477	rs774360880	NC_000002.12:29209837:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3784C>A (p.Pro1262Thr)	ALK	P1262T, P194T	Neuroblastoma, susceptibility to, 3	VCV001395203	2	29432704	2	29209838	1395203	1412217	rs774360880	NC_000002.12:29209837:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3783C>T (p.Gly1261=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003670298	2	29432705	2	29209839	3670298	3803523		NC_000002.12:29209838:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3782G>A (p.Gly1261Asp)	ALK	G1261D, G193D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001479918	2	29432706	2	29209840	1479918	1364588	rs1669416575	NC_000002.12:29209839:C:T	single nucleotide variant	missense variant	Uncertain significance	May 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3781G>A (p.Gly1261Ser)	ALK	G193S, G1261S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000655393	2	29432707	2	29209841	655393	629823	rs759144859	NC_000002.12:29209840:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3779C>T (p.Pro1260Leu)	ALK	P1260L, P192L	Neuroblastoma, susceptibility to, 3	VCV001916821	2	29432709	2	29209843	1916821	1974447		NC_000002.12:29209842:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3778C>T (p.Pro1260Ser)	ALK	P1260S, P192S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002566610	2	29432710	2	29209844	2566610	2734453		NC_000002.12:29209843:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3778C>G (p.Pro1260Ala)	ALK	P1260A, P192A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538230	2	29432710	2	29209844	538230	518107	rs766988856	NC_000002.12:29209843:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3777T>C (p.Cys1259=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000824195	2	29432711	2	29209845	824195	806887	rs1573102854	NC_000002.12:29209844:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3776G>C (p.Cys1259Ser)	ALK	C1259S, C191S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001062816	2	29432712	2	29209846	1062816	1041382	rs1669417026	NC_000002.12:29209845:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3776G>A (p.Cys1259Tyr)	ALK	C1259Y, C191Y	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000858036	2	29432712	2	29209846	858036	826308	rs1669417026	NC_000002.12:29209845:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3775T>C (p.Cys1259Arg)	ALK	C1259R, C191R	Neuroblastoma, susceptibility to, 3	VCV003721663	2	29432713	2	29209847	3721663	3850163		NC_000002.12:29209846:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3772A>C (p.Thr1258Pro)	ALK	T1258P, T190P	Hereditary cancer-predisposing syndrome	VCV002586667	2	29432716	2	29209850	2586667	2756850		NC_000002.12:29209849:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3772A>G (p.Thr1258Ala)	ALK	T1258A, T190A	Neuroblastoma, susceptibility to, 3	VCV001482837	2	29432716	2	29209850	1482837	1464820	rs2148155294	NC_000002.12:29209849:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3769_3770del (p.Leu1257fs)	ALK	L1257fs, L189fs	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470843	2	29432718 - 29432719	2	29209852 - 29209853	470843	451008	rs1553391515	NC_000002.12:29209851:AA:	Deletion	frameshift variant	Uncertain significance	Jan 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3769T>C (p.Leu1257=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470844	2	29432719	2	29209853	470844	450723	rs775036385	NC_000002.12:29209852:A:G	single nucleotide variant	synonymous variant	Likely benign	Feb 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3768C>G (p.Leu1256=)	ALK		Hereditary cancer-predisposing syndrome	VCV001734727	2	29432720	2	29209854	1734727	1796519		NC_000002.12:29209853:G:C	single nucleotide variant	synonymous variant	Likely benign	Aug 22, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3766C>T (p.Leu1256Phe)	ALK	L1256F, L188F	not provided	VCV002650790	2	29432722	2	29209856	2650790	2815649		NC_000002.12:29209855:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3757_3766del (p.Arg1253fs)	ALK	R1253fs, R185fs	Neuroblastoma, susceptibility to, 3	VCV000999186	2	29432722 - 29432731	2	29209856 - 29209865	999186	988686	rs1669417270	NC_000002.12:29209855:GGCAGTTTCTGGCAG:GGCAG	Deletion	frameshift variant	Uncertain significance	Feb 17, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3764G>C (p.Cys1255Ser)	ALK	C1255S, C187S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003525054	2	29432724	2	29209858	3525054	3689293		NC_000002.12:29209857:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3764G>A (p.Cys1255Tyr)	ALK	C187Y, C1255Y	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002130965	2	29432724	2	29209858	2130965	2186260		NC_000002.12:29209857:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3764G>T (p.Cys1255Phe)	ALK	C1255F, C187F	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000824178	2	29432724	2	29209858	824178	806888	rs1190225184	NC_000002.12:29209857:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3763T>C (p.Cys1255Arg)	ALK	C187R, C1255R	Neuroblastoma, susceptibility to, 3	VCV002759661	2	29432725	2	29209859	2759661	2924714		NC_000002.12:29209858:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3762C>T (p.Asn1254=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001155111	2	29432726	2	29209860	1155111	1133646	rs2148155344	NC_000002.12:29209859:G:A	single nucleotide variant	synonymous variant	Likely benign	May 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3761del (p.Asn1254fs)	ALK	N186fs, N1254fs	Hereditary cancer-predisposing syndrome	VCV003286077	2	29432727	2	29209861	3286077	3444817		NC_000002.12:29209860:TTT:TT	Deletion	frameshift variant	Uncertain significance	May 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3752C>T (p.Ala1251Val)	ALK	A1251V, A183V	Hereditary cancer-predisposing syndrome	VCV001734577	2	29432736	2	29209870	1734577	1796369		NC_000002.12:29209869:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3750T>C (p.Ile1250=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001734563	2	29432738	2	29209872	1734563	1796355		NC_000002.12:29209871:A:G	single nucleotide variant	synonymous variant	Likely benign	Feb 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3750T>A (p.Ile1250=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001734560	2	29432738	2	29209872	1734560	1796352		NC_000002.12:29209871:A:T	single nucleotide variant	synonymous variant	Likely benign	Mar 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3750T>G (p.Ile1250Met)	ALK	I1250M, I182M	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470842	2	29432738	2	29209872	470842	450855	rs760315884	NC_000002.12:29209871:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3749T>C (p.Ile1250Thr)	ALK	I1250T, I182T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000021867	2	29432739	2	29209873	21867	34719	rs113994092	NC_000002.12:29209872:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3748A>G (p.Ile1250Val)	ALK	I182V, I1250V	Neuroblastoma, susceptibility to, 3	VCV002920426	2	29432740	2	29209874	2920426	3077865		NC_000002.12:29209873:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3747C>T (p.Asp1249=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002991184	2	29432741	2	29209875	2991184	3151438		NC_000002.12:29209874:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 26, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3745G>T (p.Asp1249Tyr)	ALK	D1249Y, D181Y	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000485088	2	29432743	2	29209877	485088	472703	rs1553391522	NC_000002.12:29209876:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3744A>C (p.Arg1248=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002725004	2	29432744	2	29209878	2725004	2885496		NC_000002.12:29209877:T:G	single nucleotide variant	synonymous variant	Uncertain significance	Jun 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3744-2del	ALK		Neuroblastoma, susceptibility to, 3	VCV002905028	2	29432746	2	29209880	2905028	3069222		NC_000002.12:29209879:T:	Deletion	splice acceptor variant	Uncertain significance	Mar 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3744-2A>G	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV001345177	2	29432746	2	29209880	1345177	1443143	rs2148155402	NC_000002.12:29209879:T:C	single nucleotide variant	splice acceptor variant	Uncertain significance	May 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3744-4C>T	ALK		Hereditary cancer-predisposing syndrome	VCV001734496	2	29432748	2	29209882	1734496	1796288		NC_000002.12:29209881:G:A	single nucleotide variant	intron variant	Likely benign	Sep 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3744-5C>T	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001560357	2	29432749	2	29209883	1560357	1606891	rs750800690	NC_000002.12:29209882:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 8, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3744-6T>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000856297	2	29432750	2	29209884	856297	851174	rs1573102909	NC_000002.12:29209883:A:T	single nucleotide variant	intron variant	Likely benign	Dec 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3744-7T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001970265	2	29432751	2	29209885	1970265	2028978		NC_000002.12:29209884:A:G	single nucleotide variant	intron variant	Uncertain significance	Aug 14, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3744-12_3744-8dup	ALK		Neuroblastoma, susceptibility to, 3	VCV001928710	2	29432751 - 29432752	2	29209885 - 29209886	1928710	1991477		NC_000002.12:29209885:GAAAGGAAA:GAAAGGAAAGGAAA	Duplication	intron variant	Likely benign	May 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3744-12_3744-8del	ALK		Neuroblastoma, susceptibility to, 3	VCV001617695	2	29432752 - 29432756	2	29209886 - 29209890	1617695	1614548	rs779303121	NC_000002.12:29209885:GAAAGGAAA:GAAA	Deletion	intron variant	Likely benign	Jun 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3744-17A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002746644	2	29432761	2	29209895	2746644	2897519		NC_000002.12:29209894:T:C	single nucleotide variant	intron variant	Likely benign	Sep 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3744-18C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002080390	2	29432762	2	29209896	2080390	2135623		NC_000002.12:29209895:G:A	single nucleotide variant	intron variant	Likely benign	Jul 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3744-19G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001551288	2	29432763	2	29209897	1551288	1638324	rs1437758932	NC_000002.12:29209896:C:A	single nucleotide variant	intron variant	Likely benign	Aug 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3744-20T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV003663308	2	29432764	2	29209898	3663308	3801705		NC_000002.12:29209897:A:G	single nucleotide variant	intron variant	Likely benign	Aug 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3744-32A>G	ALK		not provided	VCV000676805	2	29432776	2	29209910	676805	659134	rs3738867	NC_000002.12:29209909:T:C	single nucleotide variant	intron variant	Benign	Jun 16, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3744-53del	ALK		Squamous cell lung carcinoma	VCV000873172	2	29432797	2	29209931	873172	861298	rs1669420011	NC_000002.12:29209930:A:	Deletion	intron variant	Uncertain significance	May 5, 2020	no assertion criteria provided							
NM_004304.5(ALK):c.3744-238G>A	ALK		not provided	VCV001228036	2	29432982	2	29210116	1228036	1218002	rs6748797	NC_000002.12:29210115:C:T	single nucleotide variant	intron variant	Benign	Jun 21, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3743+217C>A	ALK		not provided	VCV000676840	2	29436633	2	29213767	676840	658978	rs1625283	NC_000002.12:29213766:G:T	single nucleotide variant	intron variant	Benign	Jun 18, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3743+19G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001931675	2	29436831	2	29213965	1931675	1981938		NC_000002.12:29213964:C:T	single nucleotide variant	intron variant	Likely benign	Sep 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3743+16T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002913674	2	29436834	2	29213968	2913674	3076345		NC_000002.12:29213967:A:G	single nucleotide variant	intron variant	Likely benign	Oct 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3743+16T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002123061	2	29436834	2	29213968	2123061	2180955		NC_000002.12:29213967:A:C	single nucleotide variant	intron variant	Likely benign	Apr 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3743+13dup	ALK		Neuroblastoma, susceptibility to, 3	VCV003679289	2	29436836 - 29436837	2	29213970 - 29213971	3679289	3814313		NC_000002.12:29213970:C:CC	Duplication	intron variant	Likely benign	Jun 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3743+13G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001605436	2	29436837	2	29213971	1605436	1646490	rs2148159198	NC_000002.12:29213970:C:A	single nucleotide variant	intron variant	Likely benign	Sep 18, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3743+12T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002012388	2	29436838	2	29213972	2012388	2063894		NC_000002.12:29213971:A:C	single nucleotide variant	intron variant	Likely benign	Jul 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3743+11G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002859891	2	29436839	2	29213973	2859891	3018650		NC_000002.12:29213972:C:T	single nucleotide variant	intron variant	Likely benign	Apr 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3743+10_3743+11delinsGA	ALK		Neuroblastoma, susceptibility to, 3	VCV002706552	2	29436839 - 29436840	2	29213973 - 29213974	2706552	2874006		NC_000002.12:29213972:CT:TC	Indel	intron variant	Uncertain significance	Dec 30, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3743+9_3743+10del	ALK		Neuroblastoma, susceptibility to, 3	VCV001160693	2	29436840 - 29436841	2	29213974 - 29213975	1160693	1133647	rs1330066908	NC_000002.12:29213973:TTT:T	Deletion	intron variant	Likely benign	Dec 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3743+9A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001673434	2	29436841	2	29213975	1673434	1595621	rs1573108782	NC_000002.12:29213974:T:C	single nucleotide variant	intron variant	Likely benign	Mar 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3743+9A>C	ALK		Neuroblastoma, susceptibility to, 3	VCV000796114	2	29436841	2	29213975	796114	787115	rs1573108782	NC_000002.12:29213974:T:G	single nucleotide variant	intron variant	Likely benign	Nov 24, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3743+3_3743+6dup	ALK		Neuroblastoma, susceptibility to, 3	VCV000864321	2	29436843 - 29436844	2	29213977 - 29213978	864321	850855	rs1669531978	NC_000002.12:29213977:ACTCAC:ACTCACTCAC	Duplication	splice donor variant	Likely benign	Apr 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3743+7C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000538285	2	29436843	2	29213977	538285	518100	rs1436256175	NC_000002.12:29213976:G:A	single nucleotide variant	intron variant	Likely benign	Aug 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3743+5G>C	ALK		Hereditary cancer-predisposing syndrome	VCV003223875	2	29436845	2	29213979	3223875	3380897		NC_000002.12:29213978:C:G	single nucleotide variant	intron variant	Uncertain significance	Jan 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3743+3G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001006584	2	29436847	2	29213981	1006584	988687	rs1669532102	NC_000002.12:29213980:C:A	single nucleotide variant	intron variant	Uncertain significance	Jul 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3743+3G>A	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000965854	2	29436847	2	29213981	965854	960473	rs1669532102	NC_000002.12:29213980:C:T	single nucleotide variant	intron variant	Uncertain significance	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3743+1G>A	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001734489	2	29436849	2	29213983	1734489	1796281		NC_000002.12:29213982:C:T	single nucleotide variant	splice donor variant	Uncertain significance	Dec 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3743+1G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001484143	2	29436849	2	29213983	1484143	1455073	rs1333697872	NC_000002.12:29213982:C:G	single nucleotide variant	splice donor variant	Uncertain significance	Nov 13, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3743G>C (p.Arg1248Pro)	ALK	R180P, R1248P	Hereditary cancer-predisposing syndrome	VCV001734493	2	29436850	2	29213984	1734493	1796285		NC_000002.12:29213983:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3743G>A (p.Arg1248Gln)	ALK	R1248Q, R180Q	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000404358	2	29436850	2	29213984	404358	392696	rs368059424	NC_000002.12:29213983:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3742C>A (p.Arg1248=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223874	2	29436851	2	29213985	3223874	3380896		NC_000002.12:29213984:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 12, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3742C>T (p.Arg1248Ter)	ALK	R1248*, R180*	not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000404369	2	29436851	2	29213985	404369	392601	rs145028315	NC_000002.12:29213984:G:A	single nucleotide variant	nonsense	Conflicting classifications of pathogenicity	Jan 8, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3741C>T (p.His1247=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001669570	2	29436852	2	29213986	1669570	1665824	rs371659159	NC_000002.12:29213985:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3740A>T (p.His1247Leu)	ALK	H1247L, H179L	Neuroblastoma, susceptibility to, 3	VCV002753386	2	29436853	2	29213987	2753386	2909384		NC_000002.12:29213986:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3740A>C (p.His1247Pro)	ALK	H1247P, H179P	Hereditary cancer-predisposing syndrome	VCV002566574	2	29436853	2	29213987	2566574	2734417		NC_000002.12:29213986:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3739del (p.His1247fs)	ALK	H1247fs, H179fs	Neuroblastoma, susceptibility to, 3	VCV002029147	2	29436854	2	29213988	2029147	2081940		NC_000002.12:29213987:GG:G	Deletion	frameshift variant	Uncertain significance	Sep 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3738C>T (p.Ile1246=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002823719	2	29436855	2	29213989	2823719	2982232		NC_000002.12:29213988:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 24, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3737T>G (p.Ile1246Ser)	ALK	I1246S, I178S	Hereditary cancer-predisposing syndrome	VCV003524056	2	29436856	2	29213990	3524056	3682224		NC_000002.12:29213989:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3737T>C (p.Ile1246Thr)	ALK	I178T, I1246T	Hereditary cancer-predisposing syndrome	VCV003285794	2	29436856	2	29213990	3285794	3444534		NC_000002.12:29213989:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3736A>C (p.Ile1246Leu)	ALK	I1246L, I178L	Hereditary cancer-predisposing syndrome	VCV003286531	2	29436857	2	29213991	3286531	3455354		NC_000002.12:29213990:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3735C>A (p.Phe1245Leu)	ALK	F1245L, F177L	Neuroblastoma, susceptibility to, 3	VCV000217857	2	29436858	2	29213992	217857	214507	rs863225284	NC_000002.12:29213991:G:T	single nucleotide variant	missense variant	Pathogenic	Oct 7, 2015	no assertion criteria provided							
NM_004304.5(ALK):c.3734T>G (p.Phe1245Cys)	ALK	F1245C, F177C	Neuroblastoma, susceptibility to, 3	VCV000217856	2	29436859	2	29213993	217856	214508	rs863225283	NC_000002.12:29213992:A:C	single nucleotide variant	missense variant	Pathogenic	Oct 7, 2015	no assertion criteria provided							
NM_004304.5(ALK):c.3733T>A (p.Phe1245Ile)	ALK	F1245I, F177I	Neuroblastoma, susceptibility to, 3	VCV000217855	2	29436860	2	29213994	217855	214509	rs281864720	NC_000002.12:29213993:A:T	single nucleotide variant	missense variant	Pathogenic	Nov 6, 2015	no assertion criteria provided							
NM_004304.5(ALK):c.3733T>G (p.Phe1245Val)	ALK	F1245V, F177V	Neuroblastoma, susceptibility to, 3	VCV000065671	2	29436860	2	29213994	65671	76579	rs281864720	NC_000002.12:29213993:A:C	single nucleotide variant	missense variant	not provided		no classification provided							
NM_004304.5(ALK):c.3731A>G (p.His1244Arg)	ALK	H1244R, H176R	Neuroblastoma, susceptibility to, 3	VCV000470841	2	29436862	2	29213996	470841	451013	rs1553392309	NC_000002.12:29213995:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3730C>T (p.His1244Tyr)	ALK	H1244Y, H176Y	Hereditary cancer-predisposing syndrome	VCV000824138	2	29436863	2	29213997	824138	806889	rs1573108857	NC_000002.12:29213996:G:A	single nucleotide variant	missense variant	Uncertain significance	May 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3729C>T (p.Asn1243=)	ALK		Hereditary cancer-predisposing syndrome	VCV003524473	2	29436864	2	29213998	3524473	3679138		NC_000002.12:29213997:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3721G>A (p.Glu1241Lys)	ALK	E173K, E1241K	Neuroblastoma, susceptibility to, 3	VCV002763866	2	29436872	2	29214006	2763866	2922035		NC_000002.12:29214005:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3721G>C (p.Glu1241Gln)	ALK	E173Q, E1241Q	Neuroblastoma, susceptibility to, 3	VCV002049651	2	29436872	2	29214006	2049651	2107538		NC_000002.12:29214005:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 25, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3720G>C (p.Leu1240Phe)	ALK	L1240F, L172F	Hereditary cancer-predisposing syndrome	VCV002586678	2	29436873	2	29214007	2586678	2756861		NC_000002.12:29214006:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3720G>A (p.Leu1240=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002031241	2	29436873	2	29214007	2031241	2078883		NC_000002.12:29214006:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3718T>G (p.Leu1240Val)	ALK	L1240V, L172V	Neuroblastoma, susceptibility to, 3	VCV000217854	2	29436875	2	29214009	217854	214510	rs863225282	NC_000002.12:29214008:A:C	single nucleotide variant	missense variant	Likely pathogenic	Nov 3, 2015	no assertion criteria provided							
NM_004304.5(ALK):c.3712_3715del (p.Gln1238fs)	ALK	Q1238fs, Q170fs	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001016794	2	29436878 - 29436881	2	29214012 - 29214015	1016794	1003969	rs750775950	NC_000002.12:29214011:ACTGAC:AC	Deletion	frameshift variant	Uncertain significance	Nov 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3714G>A (p.Gln1238=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001131953	2	29436879	2	29214013	1131953	1112736	rs1423030946	NC_000002.12:29214012:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3709_3712dup (p.Gln1238fs)	ALK	Q1238fs, Q170fs	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001355520	2	29436880 - 29436881	2	29214014 - 29214015	1355520	1509271	rs2148159371	NC_000002.12:29214014:GACAG:GACAGACAG	Duplication	frameshift variant	Uncertain significance	Mar 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3707G>A (p.Gly1236Asp)	ALK	G1236D, G168D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003016533	2	29436886	2	29214020	3016533	3182015		NC_000002.12:29214019:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3706G>A (p.Gly1236Ser)	ALK	G1236S, G168S	Hereditary cancer-predisposing syndrome	VCV003223872	2	29436887	2	29214021	3223872	3380894		NC_000002.12:29214020:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3705T>G (p.Cys1235Trp)	ALK	C1235W, C167W	Hereditary cancer-predisposing syndrome	VCV003223871	2	29436888	2	29214022	3223871	3380893		NC_000002.12:29214021:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3705T>C (p.Cys1235=)	ALK		Hereditary cancer-predisposing syndrome	VCV001734140	2	29436888	2	29214022	1734140	1786559		NC_000002.12:29214021:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 7, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3704G>A (p.Cys1235Tyr)	ALK	C1235Y, C167Y	not provided|Neuroblastoma, susceptibility to, 3	VCV001382985	2	29436889	2	29214023	1382985	1509581	rs2148159392	NC_000002.12:29214022:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3701C>A (p.Ala1234Asp)	ALK	A166D, A1234D	Hereditary cancer-predisposing syndrome	VCV003524098	2	29436892	2	29214026	3524098	3682266		NC_000002.12:29214025:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3701C>T (p.Ala1234Val)	ALK	A166V, A1234V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000665689	2	29436892	2	29214026	665689	629824	rs1573108894	NC_000002.12:29214025:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3699T>G (p.Ile1233Met)	ALK	I165M, I1233M	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000824088	2	29436894	2	29214028	824088	806890	rs1573108910	NC_000002.12:29214027:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2020	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3698T>C (p.Ile1233Thr)	ALK	I165T, I1233T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001492522	2	29436895	2	29214029	1492522	1516660	rs1669533889	NC_000002.12:29214028:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3695A>G (p.Asp1232Gly)	ALK	D1232G, D164G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001355135	2	29436898	2	29214032	1355135	1512763	rs2148159418	NC_000002.12:29214031:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3694del (p.Asp1232fs)	ALK	D1232fs, D164fs	Hereditary cancer-predisposing syndrome	VCV003522501	2	29436899	2	29214033	3522501	3681989		NC_000002.12:29214032:CCC:CC	Deletion	frameshift variant	Uncertain significance	Jun 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3694G>A (p.Asp1232Asn)	ALK	D164N, D1232N	Neuroblastoma, susceptibility to, 3	VCV002828311	2	29436899	2	29214033	2828311	2990249		NC_000002.12:29214032:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3693G>C (p.Arg1231=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003722823	2	29436900	2	29214034	3722823	3853916		NC_000002.12:29214033:C:G	single nucleotide variant	synonymous variant	Likely benign	Oct 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3692G>A (p.Arg1231Gln)	ALK	R1231Q, R163Q	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404363	2	29436901	2	29214035	404363	392700	rs200110351	NC_000002.12:29214034:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3691C>T (p.Arg1231Trp)	ALK	R1231W, R163W	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000470840	2	29436902	2	29214036	470840	451016	rs771475772	NC_000002.12:29214035:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 6, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3688G>A (p.Ala1230Thr)	ALK	A1230T, A162T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001004608	2	29436905	2	29214039	1004608	988688	rs375448626	NC_000002.12:29214038:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3685G>T (p.Val1229Leu)	ALK	V1229L, V161L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000647528	2	29436908	2	29214042	647528	629825	rs776228721	NC_000002.12:29214041:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3685G>A (p.Val1229Met)	ALK	V1229M, V161M	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000217853	2	29436908	2	29214042	217853	214511	rs776228721	NC_000002.12:29214041:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3684C>A (p.His1228Gln)	ALK	H1228Q, H160Q	Neuroblastoma, susceptibility to, 3	VCV002829808	2	29436909	2	29214043	2829808	2990470		NC_000002.12:29214042:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3684C>T (p.His1228=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538295	2	29436909	2	29214043	538295	518102	rs763332339	NC_000002.12:29214042:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3684C>G (p.His1228Gln)	ALK	H1228Q, H160Q	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000538206	2	29436909	2	29214043	538206	518109	rs763332339	NC_000002.12:29214042:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3682C>T (p.His1228Tyr)	ALK	H1228Y, H160Y	Neuroblastoma, susceptibility to, 3	VCV002728470	2	29436911	2	29214045	2728470	2886367		NC_000002.12:29214044:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3681G>C (p.Leu1227=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001733894	2	29436912	2	29214046	1733894	1789644		NC_000002.12:29214045:C:G	single nucleotide variant	synonymous variant	Likely benign	Mar 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3680T>C (p.Leu1227Pro)	ALK	L1227P, L159P	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000840336	2	29436913	2	29214047	840336	826309	rs1669534712	NC_000002.12:29214046:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3678T>C (p.Leu1226=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001997639	2	29436915	2	29214049	1997639	2056859		NC_000002.12:29214048:A:G	single nucleotide variant	synonymous variant	Likely benign	May 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3676C>T (p.Leu1226Phe)	ALK	L1226F, L158F	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001733834	2	29436917	2	29214051	1733834	1789584		NC_000002.12:29214050:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3675C>T (p.Asp1225=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002105833	2	29436918	2	29214052	2105833	2166294		NC_000002.12:29214051:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3673G>A (p.Asp1225Asn)	ALK	D1225N, D157N	Hereditary cancer-predisposing syndrome	VCV000375886	2	29436920	2	29214054	375886	362765	rs1057519696	NC_000002.12:29214053:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3672G>A (p.Leu1224=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000824056	2	29436921	2	29214055	824056	806891	rs142523023	NC_000002.12:29214054:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3670C>G (p.Leu1224Val)	ALK	L1224V, L156V	Hereditary cancer-predisposing syndrome	VCV003223870	2	29436923	2	29214057	3223870	3380892		NC_000002.12:29214056:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3670C>T (p.Leu1224=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002062027	2	29436923	2	29214057	2062027	2121175		NC_000002.12:29214056:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3669G>C (p.Met1223Ile)	ALK	M1223I, M155I	Neuroblastoma, susceptibility to, 3	VCV003651317	2	29436924	2	29214058	3651317	3777995		NC_000002.12:29214057:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3668T>C (p.Met1223Thr)	ALK	M1223T, M155T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002741734	2	29436925	2	29214059	2741734	2896485		NC_000002.12:29214058:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3667A>G (p.Met1223Val)	ALK	M155V, M1223V	Hereditary cancer-predisposing syndrome	VCV001733732	2	29436926	2	29214060	1733732	1789482		NC_000002.12:29214059:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3667A>C (p.Met1223Leu)	ALK	M155L, M1223L	Neuroblastoma, susceptibility to, 3	VCV000948489	2	29436926	2	29214060	948489	922706	rs1573108993	NC_000002.12:29214059:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 23, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3667A>T (p.Met1223Leu)	ALK	M1223L, M155L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000648001	2	29436926	2	29214060	648001	629826	rs1573108993	NC_000002.12:29214059:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3666C>T (p.Ala1222=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000741703	2	29436927	2	29214061	741703	747582	rs1053645006	NC_000002.12:29214060:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3665C>A (p.Ala1222Asp)	ALK	A1222D, A154D	Neuroblastoma, susceptibility to, 3	VCV001450769	2	29436928	2	29214062	1450769	1351290	rs2148159538	NC_000002.12:29214061:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3664G>A (p.Ala1222Thr)	ALK	A1222T, A154T	Neuroblastoma, susceptibility to, 3	VCV003680433	2	29436929	2	29214063	3680433	3807873		NC_000002.12:29214062:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3664G>C (p.Ala1222Pro)	ALK	A1222P, A154P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404310	2	29436929	2	29214063	404310	392702	rs1060500207	NC_000002.12:29214062:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3663G>A (p.Leu1221=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000836741	2	29436930	2	29214064	836741	826310	rs751889072	NC_000002.12:29214063:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3663G>C (p.Leu1221=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000824041	2	29436930	2	29214064	824041	806892	rs751889072	NC_000002.12:29214063:C:G	single nucleotide variant	synonymous variant	Likely benign	Aug 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3661C>T (p.Leu1221=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223869	2	29436932	2	29214066	3223869	3380891		NC_000002.12:29214065:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3660C>G (p.Ser1220=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000485080	2	29436933	2	29214067	485080	472769	rs202010057	NC_000002.12:29214066:G:C	single nucleotide variant	synonymous variant	Likely benign	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3659C>A (p.Ser1220Tyr)	ALK	S1220Y, S152Y	not provided	VCV003371607	2	29436934	2	29214068	3371607	3530797		NC_000002.12:29214067:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3659C>T (p.Ser1220Phe)	ALK	S1220F, S152F	Hereditary cancer-predisposing syndrome	VCV003286512	2	29436934	2	29214068	3286512	3455335		NC_000002.12:29214067:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3657C>T (p.Ser1219=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000699831	2	29436936	2	29214070	699831	686180	rs149254561	NC_000002.12:29214069:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3656C>T (p.Ser1219Phe)	ALK	S1219F, S151F	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000943541	2	29436937	2	29214071	943541	931346	rs752728718	NC_000002.12:29214070:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 2, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3654C>T (p.Pro1218=)	ALK		not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001733619	2	29436939	2	29214073	1733619	1793240		NC_000002.12:29214072:G:A	single nucleotide variant	synonymous variant	Likely benign	May 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3654C>G (p.Pro1218=)	ALK		Hereditary cancer-predisposing syndrome	VCV001733618	2	29436939	2	29214073	1733618	1793239		NC_000002.12:29214072:G:C	single nucleotide variant	synonymous variant	Likely benign	May 30, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3653C>T (p.Pro1218Leu)	ALK	P150L, P1218L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001411169	2	29436940	2	29214074	1411169	1343559	rs1159709305	NC_000002.12:29214073:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3653C>G (p.Pro1218Arg)	ALK	P1218R, P150R	Neuroblastoma, susceptibility to, 3	VCV001006263	2	29436940	2	29214074	1006263	988689	rs1159709305	NC_000002.12:29214073:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3651G>A (p.Gln1217=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000824031	2	29436942	2	29214076	824031	806893	rs1009496053	NC_000002.12:29214075:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3650A>G (p.Gln1217Arg)	ALK	Q1217R, Q149R	Neuroblastoma, susceptibility to, 3	VCV002818217	2	29436943	2	29214077	2818217	2984432		NC_000002.12:29214076:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3649C>G (p.Gln1217Glu)	ALK	Q149E, Q1217E	not provided|Neuroblastoma, susceptibility to, 3	VCV000968907	2	29436944	2	29214078	968907	953060	rs1669536093	NC_000002.12:29214077:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3648C>T (p.Ser1216=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002108667	2	29436945	2	29214079	2108667	2170425		NC_000002.12:29214078:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 17, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3646A>G (p.Ser1216Gly)	ALK	S1216G, S148G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000947154	2	29436947	2	29214081	947154	922707	rs543229475	NC_000002.12:29214080:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3646-3C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001399421	2	29436950	2	29214084	1399421	1365781	rs1060500208	NC_000002.12:29214083:G:C	single nucleotide variant	intron variant	Uncertain significance	Apr 2, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3646-3C>T	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000404311	2	29436950	2	29214084	404311	392912	rs1060500208	NC_000002.12:29214083:G:A	single nucleotide variant	intron variant	Uncertain significance	Oct 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3646-4A>C	ALK		Hereditary cancer-predisposing syndrome	VCV003223868	2	29436951	2	29214085	3223868	3380890		NC_000002.12:29214084:T:G	single nucleotide variant	intron variant	Likely benign	Jan 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3646-4A>G	ALK		Hereditary cancer-predisposing syndrome	VCV001733554	2	29436951	2	29214085	1733554	1793175		NC_000002.12:29214084:T:C	single nucleotide variant	intron variant	Uncertain significance	Nov 24, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3646-5C>T	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470839	2	29436952	2	29214086	470839	450858	rs1444967093	NC_000002.12:29214085:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 16, 2023	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3646-6C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002718577	2	29436953	2	29214087	2718577	2876973		NC_000002.12:29214086:G:A	single nucleotide variant	intron variant	Likely benign	Jan 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3646-9T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV003682602	2	29436956	2	29214090	3682602	3818928		NC_000002.12:29214089:A:G	single nucleotide variant	intron variant	Likely benign	Nov 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3646-11T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002022702	2	29436958	2	29214092	2022702	2076766		NC_000002.12:29214091:A:G	single nucleotide variant	intron variant	Uncertain significance	Aug 10, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3646-14_3646-13del	ALK		Neuroblastoma, susceptibility to, 3	VCV002772206	2	29436960 - 29436961	2	29214094 - 29214095	2772206	2924316		NC_000002.12:29214093:AGA:A	Deletion	intron variant	Likely benign	Nov 2, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3646-13T>C	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001644881	2	29436960	2	29214094	1644881	1522928	rs2148159628	NC_000002.12:29214093:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 31, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3646-14C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001630324	2	29436961	2	29214095	1630324	1649529	rs898045539	NC_000002.12:29214094:G:A	single nucleotide variant	intron variant	Likely benign	Oct 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3646-17C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002845852	2	29436964	2	29214098	2845852	3008212		NC_000002.12:29214097:G:T	single nucleotide variant	intron variant	Likely benign	Apr 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3646-17C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002164093	2	29436964	2	29214098	2164093	1901924		NC_000002.12:29214097:G:A	single nucleotide variant	intron variant	Likely benign	Mar 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3646-18G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001658026	2	29436965	2	29214099	1658026	1594027	rs754062671	NC_000002.12:29214098:C:T	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.3646-19C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001672862	2	29436966	2	29214100	1672862	1531309	rs368380756	NC_000002.12:29214099:G:A	single nucleotide variant	intron variant	Likely benign	Dec 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3646-19C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001594953	2	29436966	2	29214100	1594953	1590593	rs368380756	NC_000002.12:29214099:G:C	single nucleotide variant	intron variant	Likely benign	Dec 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3646-20C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002076343	2	29436967	2	29214101	2076343	2138146		NC_000002.12:29214100:G:A	single nucleotide variant	intron variant	Likely benign	Feb 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3646-20C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001621637	2	29436967	2	29214101	1621637	1528783	rs778921889	NC_000002.12:29214100:G:T	single nucleotide variant	intron variant	Likely benign	May 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3646-126C>T	ALK		not provided	VCV001218857	2	29437073	2	29214207	1218857	1208836	rs114194052	NC_000002.12:29214206:G:A	single nucleotide variant	intron variant	Likely benign	Jun 3, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3646-148A>G	ALK		not provided	VCV000676870	2	29437095	2	29214229	676870	658979	rs115332650	NC_000002.12:29214228:T:C	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3646-235A>G	ALK		not provided	VCV000676839	2	29437182	2	29214316	676839	659162	rs1630306	NC_000002.12:29214315:T:C	single nucleotide variant	intron variant	Benign	Jun 16, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3645+199C>T	ALK		not provided	VCV001289254	2	29443373	2	29220507	1289254	1279085	rs4665446	NC_000002.12:29220506:G:A	single nucleotide variant	intron variant	Benign	Jun 21, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3645+188G>A	ALK		not provided	VCV001293432	2	29443384	2	29220518	1293432	1283237	rs77835003	NC_000002.12:29220517:C:T	single nucleotide variant	intron variant	Benign	Jul 20, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3645+16T>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001550928	2	29443556	2	29220690	1550928	1637965	rs141531355	NC_000002.12:29220689:A:T	single nucleotide variant	intron variant	Benign	Jan 27, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.3645+15G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002874313	2	29443557	2	29220691	2874313	3038092		NC_000002.12:29220690:C:G	single nucleotide variant	intron variant	Likely benign	Nov 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3645+15G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002056217	2	29443557	2	29220691	2056217	2112800		NC_000002.12:29220690:C:T	single nucleotide variant	intron variant	Likely benign	Dec 23, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3645+14A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001575110	2	29443558	2	29220692	1575110	1638395	rs764315663	NC_000002.12:29220691:T:C	single nucleotide variant	intron variant	Likely benign	Dec 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3645+13C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002093010	2	29443559	2	29220693	2093010	2145752		NC_000002.12:29220692:G:A	single nucleotide variant	intron variant	Likely benign	Feb 17, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3645+12C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002149291	2	29443560	2	29220694	2149291	1877740		NC_000002.12:29220693:G:T	single nucleotide variant	intron variant	Likely benign	Nov 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3645+12C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002075339	2	29443560	2	29220694	2075339	2134454		NC_000002.12:29220693:G:C	single nucleotide variant	intron variant	Likely benign	Sep 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3645+9G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001614570	2	29443563	2	29220697	1614570	1663844	rs2148166225	NC_000002.12:29220696:C:G	single nucleotide variant	intron variant	Likely benign	Apr 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3645+6_3645+9del	ALK		Neuroblastoma, susceptibility to, 3	VCV000566791	2	29443563 - 29443566	2	29220697 - 29220700	566791	558358	rs780363656	NC_000002.12:29220696:CTCACTCAC:CTCAC	Microsatellite	splice donor variant	Uncertain significance	Dec 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3645+7G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000412910	2	29443565	2	29220699	412910	392604	rs1060503876	NC_000002.12:29220698:C:T	single nucleotide variant	intron variant	Likely benign	Apr 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3645+2T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000538227	2	29443570	2	29220704	538227	518187	rs1553393848	NC_000002.12:29220703:A:C	single nucleotide variant	splice donor variant	Uncertain significance	Oct 30, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.3645G>A (p.Pro1215=)	ALK		Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000485074	2	29443572	2	29220706	485074	472683	rs775768862	NC_000002.12:29220705:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Dec 18, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3644C>A (p.Pro1215Gln)	ALK	P147Q, P1215Q	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000645965	2	29443573	2	29220707	645965	629827	rs779222532	NC_000002.12:29220706:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3644C>T (p.Pro1215Leu)	ALK	P1215L, P147L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000538241	2	29443573	2	29220707	538241	518105	rs779222532	NC_000002.12:29220706:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3643C>T (p.Pro1215Ser)	ALK	P1215S, P147S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001719143	2	29443574	2	29220708	1719143	1774447		NC_000002.12:29220707:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3642C>G (p.Arg1214=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001137824	2	29443575	2	29220709	1137824	1112737	rs1394591243	NC_000002.12:29220708:G:C	single nucleotide variant	synonymous variant	Likely benign	Dec 6, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3642C>T (p.Arg1214=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001097299	2	29443575	2	29220709	1097299	1069512	rs1394591243	NC_000002.12:29220708:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3641G>A (p.Arg1214His)	ALK	R1214H, R146H	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000485079	2	29443576	2	29220710	485079	472684	rs750194005	NC_000002.12:29220709:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3640C>A (p.Arg1214Ser)	ALK	R1214S, R146S	Neuroblastoma, susceptibility to, 3	VCV003659219	2	29443577	2	29220711	3659219	3790159		NC_000002.12:29220710:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3640C>T (p.Arg1214Cys)	ALK	R1214C, R146C	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000485083	2	29443577	2	29220711	485083	472705	rs758172315	NC_000002.12:29220710:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3639T>A (p.Pro1213=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001733467	2	29443578	2	29220712	1733467	1793088		NC_000002.12:29220711:A:T	single nucleotide variant	synonymous variant	Likely benign	Dec 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3638C>T (p.Pro1213Leu)	ALK	P1213L, P145L	Hereditary cancer-predisposing syndrome	VCV002586720	2	29443579	2	29220713	2586720	2756903		NC_000002.12:29220712:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3637C>A (p.Pro1213Thr)	ALK	P1213T, P145T	Neuroblastoma, susceptibility to, 3	VCV002813146	2	29443580	2	29220714	2813146	2972948		NC_000002.12:29220713:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3637C>G (p.Pro1213Ala)	ALK	P1213A, P145A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002676106	2	29443580	2	29220714	2676106	2834527		NC_000002.12:29220713:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3635G>C (p.Arg1212Pro)	ALK	R1212P, R144P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470838	2	29443582	2	29220716	470838	450860	rs143790259	NC_000002.12:29220715:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3635G>A (p.Arg1212His)	ALK	R1212H, R144H	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000069581	2	29443582	2	29220716	69581	80472	rs143790259	NC_000002.12:29220715:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3634C>A (p.Arg1212Ser)	ALK	R1212S, R144S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002447087	2	29443583	2	29220717	2447087	2422210		NC_000002.12:29220716:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3634C>T (p.Arg1212Cys)	ALK	R144C, R1212C	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000853821	2	29443583	2	29220717	853821	826311	rs1462510005	NC_000002.12:29220716:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3633C>T (p.Thr1211=)	ALK		Hereditary cancer-predisposing syndrome	VCV001733427	2	29443584	2	29220718	1733427	1793049		NC_000002.12:29220717:G:A	single nucleotide variant	synonymous variant	Likely benign	May 22, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3633C>A (p.Thr1211=)	ALK		not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000335692	2	29443584	2	29220718	335692	288986	rs144437923	NC_000002.12:29220717:G:T	single nucleotide variant	synonymous variant	Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3632C>T (p.Thr1211Ile)	ALK	T1211I, T143I	Neuroblastoma, susceptibility to, 3	VCV002866538	2	29443585	2	29220719	2866538	3020146		NC_000002.12:29220718:G:A	single nucleotide variant	missense variant	Uncertain significance	May 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3631A>C (p.Thr1211Pro)	ALK	T1211P, T143P	Neuroblastoma, susceptibility to, 3	VCV001720766	2	29443586	2	29220720	1720766	1776948		NC_000002.12:29220719:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3630G>A (p.Glu1210=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000239828	2	29443587	2	29220721	239828	238720	rs780746584	NC_000002.12:29220720:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3629A>T (p.Glu1210Val)	ALK	E1210V, E142V	Neuroblastoma, susceptibility to, 3	VCV002818049	2	29443588	2	29220722	2818049	2987690		NC_000002.12:29220721:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3628G>A (p.Glu1210Lys)	ALK	E1210K, E142K	Hereditary cancer-predisposing syndrome	VCV000824007	2	29443589	2	29220723	824007	806894	rs1573120111	NC_000002.12:29220722:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3626G>C (p.Arg1209Pro)	ALK	R1209P, R141P	Neuroblastoma, susceptibility to, 3	VCV001460580	2	29443591	2	29220725	1460580	1504629	rs747643140	NC_000002.12:29220724:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3626G>A (p.Arg1209Gln)	ALK	R141Q, R1209Q	not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000958217	2	29443591	2	29220725	958217	942848	rs747643140	NC_000002.12:29220724:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3625C>T (p.Arg1209Ter)	ALK	R1209*, R141*	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000651692	2	29443592	2	29220726	651692	629828	rs769449619	NC_000002.12:29220725:G:A	single nucleotide variant	nonsense	Uncertain significance	May 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3624C>T (p.Leu1208=)	ALK		Hereditary cancer-predisposing syndrome	VCV001733354	2	29443593	2	29220727	1733354	1792976		NC_000002.12:29220726:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 15, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3622C>T (p.Leu1208Phe)	ALK	L1208F, L140F	Neuroblastoma, susceptibility to, 3	VCV002676130	2	29443595	2	29220729	2676130	2834551		NC_000002.12:29220728:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3621C>T (p.Phe1207=)	ALK		Hereditary cancer-predisposing syndrome	VCV001733328	2	29443596	2	29220730	1733328	1792950		NC_000002.12:29220729:G:A	single nucleotide variant	synonymous variant	Likely benign	May 8, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3620T>C (p.Phe1207Ser)	ALK	F1207S, F139S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001733322	2	29443597	2	29220731	1733322	1792944		NC_000002.12:29220730:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3618C>T (p.Ser1206=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001573914	2	29443599	2	29220733	1573914	1539118	rs2148166379	NC_000002.12:29220732:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 26, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3616T>G (p.Ser1206Ala)	ALK	S138A, S1206A	Neuroblastoma, susceptibility to, 3	VCV002068352	2	29443601	2	29220735	2068352	2125876		NC_000002.12:29220734:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3614A>G (p.Lys1205Arg)	ALK	K1205R, K137R	Neuroblastoma, susceptibility to, 3	VCV002011294	2	29443603	2	29220737	2011294	2074368		NC_000002.12:29220736:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3613A>G (p.Lys1205Glu)	ALK	K137E, K1205E	Hereditary cancer-predisposing syndrome	VCV002452092	2	29443604	2	29220738	2452092	2426732		NC_000002.12:29220737:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3612C>G (p.Leu1204=)	ALK		Hereditary cancer-predisposing syndrome	VCV001733243	2	29443605	2	29220739	1733243	1792865		NC_000002.12:29220738:G:C	single nucleotide variant	synonymous variant	Likely benign	Feb 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3610C>T (p.Leu1204Phe)	ALK	L1204F, L136F	Neuroblastoma, susceptibility to, 3	VCV001906146	2	29443607	2	29220741	1906146	1965083		NC_000002.12:29220740:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3610C>G (p.Leu1204Val)	ALK	L1204V, L136V	Hereditary cancer-predisposing syndrome	VCV000485085	2	29443607	2	29220741	485085	472773	rs1553393864	NC_000002.12:29220740:G:C	single nucleotide variant	missense variant	Uncertain significance	May 25, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.3609C>A (p.Asp1203Glu)	ALK	D135E, D1203E	Neuroblastoma, susceptibility to, 3	VCV001460906	2	29443608	2	29220742	1460906	1419715	rs2148166410	NC_000002.12:29220741:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3608A>G (p.Asp1203Gly)	ALK	D135G, D1203G	Neuroblastoma, susceptibility to, 3	VCV002065391	2	29443609	2	29220743	2065391	2121950		NC_000002.12:29220742:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3608A>C (p.Asp1203Ala)	ALK	D1203A, D135A	Neuroblastoma, susceptibility to, 3	VCV001713795	2	29443609	2	29220743	1713795	1773066		NC_000002.12:29220742:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3607G>A (p.Asp1203Asn)	ALK	D1203N, D135N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001513564	2	29443610	2	29220744	1513564	1468753	rs759845895	NC_000002.12:29220743:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3607G>C (p.Asp1203His)	ALK	D135H, D1203H	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001481268	2	29443610	2	29220744	1481268	1451706	rs759845895	NC_000002.12:29220743:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3606A>C (p.Gly1202=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003643672	2	29443611	2	29220745	3643672	3783368		NC_000002.12:29220744:T:G	single nucleotide variant	synonymous variant	Likely benign	May 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3606A>T (p.Gly1202=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003630381	2	29443611	2	29220745	3630381	3769721		NC_000002.12:29220744:T:A	single nucleotide variant	synonymous variant	Likely benign	Dec 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3605dup (p.Asp1203fs)	ALK	D135fs, D1203fs	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000653463	2	29443611 - 29443612	2	29220745 - 29220746	653463	629829	rs1573120189	NC_000002.12:29220745:CCCCCC:CCCCCCC	Duplication	frameshift variant	Uncertain significance	Sep 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3605G>C (p.Gly1202Ala)	ALK	G1202A, G134A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003524985	2	29443612	2	29220746	3524985	3689224		NC_000002.12:29220745:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3605G>A (p.Gly1202Glu)	ALK	G1202E, G134E	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002062033	2	29443612	2	29220746	2062033	2121181		NC_000002.12:29220745:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3604G>C (p.Gly1202Arg)	ALK	G134R, G1202R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002566583	2	29443613	2	29220747	2566583	2734426		NC_000002.12:29220746:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3604G>A (p.Gly1202Arg)	ALK	G1202R, G134R	Neuroblastoma, susceptibility to, 3	VCV000376134	2	29443613	2	29220747	376134	363013	rs1057519783	NC_000002.12:29220746:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3603G>C (p.Gly1201=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001733133	2	29443614	2	29220748	1733133	1796207		NC_000002.12:29220747:C:G	single nucleotide variant	synonymous variant	Likely benign	Apr 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3603G>A (p.Gly1201=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001733131	2	29443614	2	29220748	1733131	1796205		NC_000002.12:29220747:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3601_3602insA (p.Gly1201fs)	ALK	G133fs, G1201fs	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003522916	2	29443615 - 29443616	2	29220749 - 29220750	3522916	3678900		NC_000002.12:29220749::T	Insertion	frameshift variant	Uncertain significance	Jul 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3602G>C (p.Gly1201Ala)	ALK	G1201A, G133A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002120307	2	29443615	2	29220749	2120307	2173027		NC_000002.12:29220748:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3602G>A (p.Gly1201Glu)	ALK	G1201E, G133E	Neuroblastoma, susceptibility to, 3	VCV001517245	2	29443615	2	29220749	1517245	1515405	rs1187025942	NC_000002.12:29220748:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3601G>A (p.Gly1201Arg)	ALK	G1201R, G133R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002586704	2	29443616	2	29220750	2586704	2756887		NC_000002.12:29220749:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3601G>T (p.Gly1201Trp)	ALK	G1201W, G133W	Neuroblastoma, susceptibility to, 3	VCV001984497	2	29443616	2	29220750	1984497	2035950		NC_000002.12:29220749:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3601G>C (p.Gly1201Arg)	ALK	G133R, G1201R	Neuroblastoma, susceptibility to, 3	VCV001400504	2	29443616	2	29220750	1400504	1440731	rs761333959	NC_000002.12:29220749:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3600G>T (p.Ala1200=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000702274	2	29443617	2	29220751	702274	691130	rs56247462	NC_000002.12:29220750:C:A	single nucleotide variant	synonymous variant	Likely benign	Oct 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3600G>C (p.Ala1200=)	ALK		not specified|Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000239827	2	29443617	2	29220751	239827	238721	rs56247462	NC_000002.12:29220750:C:G	single nucleotide variant	synonymous variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3600G>A (p.Ala1200=)	ALK		not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000239826	2	29443617	2	29220751	239826	238722	rs56247462	NC_000002.12:29220750:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3599C>G (p.Ala1200Gly)	ALK	A1200G, A132G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001423594	2	29443618	2	29220752	1423594	1418653	rs200585833	NC_000002.12:29220751:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3599C>T (p.Ala1200Val)	ALK	A1200V, A132V	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000239825	2	29443618	2	29220752	239825	238723	rs200585833	NC_000002.12:29220751:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 11, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3598G>A (p.Ala1200Thr)	ALK	A1200T, A132T	Hereditary cancer-predisposing syndrome	VCV003223867	2	29443619	2	29220753	3223867	3380889		NC_000002.12:29220752:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3597G>T (p.Met1199Ile)	ALK	M131I, M1199I	Neuroblastoma, susceptibility to, 3	VCV001390312	2	29443620	2	29220754	1390312	1396485	rs1669779479	NC_000002.12:29220753:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3597G>A (p.Met1199Ile)	ALK	M131I, M1199I	Neuroblastoma, susceptibility to, 3	VCV000954236	2	29443620	2	29220754	954236	942849	rs1669779479	NC_000002.12:29220753:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3596T>C (p.Met1199Thr)	ALK	M1199T, M131T	Hereditary cancer-predisposing syndrome	VCV003223866	2	29443621	2	29220755	3223866	3380888		NC_000002.12:29220754:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3595A>T (p.Met1199Leu)	ALK	M1199L, M131L	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000569205	2	29443622	2	29220756	569205	558360	rs1400239417	NC_000002.12:29220755:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3595A>C (p.Met1199Leu)	ALK	M1199L, M131L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470837	2	29443622	2	29220756	470837	451024	rs1400239417	NC_000002.12:29220755:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3594C>T (p.Leu1198=)	ALK		not specified|Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000239824	2	29443623	2	29220757	239824	238724	rs56071005	NC_000002.12:29220756:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3592C>A (p.Leu1198Ile)	ALK	L1198I, L130I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000946161	2	29443625	2	29220759	946161	922708	rs751306825	NC_000002.12:29220758:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3591G>A (p.Glu1197=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001159428	2	29443626	2	29220760	1159428	1133648	rs754966084	NC_000002.12:29220759:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3588G>A (p.Leu1196=)	ALK		Hereditary cancer-predisposing syndrome	VCV001732959	2	29443629	2	29220763	1732959	1796033		NC_000002.12:29220762:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 21, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3587T>C (p.Leu1196Pro)	ALK	L1196P, L128P	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000998890	2	29443630	2	29220764	998890	988690	rs1669780202	NC_000002.12:29220763:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3586C>T (p.Leu1196=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002829764	2	29443631	2	29220765	2829764	2990426		NC_000002.12:29220764:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3586C>A (p.Leu1196Met)	ALK	L1196M, L128M	Lung cancer	VCV000376135	2	29443631	2	29220765	376135	363014	rs1057519784	NC_000002.12:29220764:G:T	single nucleotide variant	missense variant	Likely pathogenic		no assertion criteria provided							
NM_004304.5(ALK):c.3585G>T (p.Leu1195=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002822734	2	29443632	2	29220766	2822734	2978693		NC_000002.12:29220765:C:A	single nucleotide variant	synonymous variant	Likely benign	Dec 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3585G>C (p.Leu1195=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002749192	2	29443632	2	29220766	2749192	2912533		NC_000002.12:29220765:C:G	single nucleotide variant	synonymous variant	Likely benign	Aug 2, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3585G>A (p.Leu1195=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001113306	2	29443632	2	29220766	1113306	1091233	rs2148166518	NC_000002.12:29220765:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3584T>G (p.Leu1195Arg)	ALK	L1195R, L127R	Hereditary cancer-predisposing syndrome	VCV001732929	2	29443633	2	29220767	1732929	1796003		NC_000002.12:29220766:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3582C>T (p.Ile1194=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000823955	2	29443635	2	29220769	823955	806895	rs1573120317	NC_000002.12:29220768:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3579C>G (p.Phe1193Leu)	ALK	F125L, F1193L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001732850	2	29443638	2	29220772	1732850	1795924		NC_000002.12:29220771:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3578T>C (p.Phe1193Ser)	ALK	F1193S, F125S	Neuroblastoma, susceptibility to, 3	VCV002772170	2	29443639	2	29220773	2772170	2924280		NC_000002.12:29220772:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3576G>A (p.Arg1192=)	ALK		Hereditary cancer-predisposing syndrome	VCV001732829	2	29443641	2	29220775	1732829	1795903		NC_000002.12:29220774:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 28, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3576G>T (p.Arg1192=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538291	2	29443641	2	29220775	538291	518108	rs1553393901	NC_000002.12:29220774:C:A	single nucleotide variant	synonymous variant	Likely benign	Sep 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3575G>T (p.Arg1192Leu)	ALK	R1192L, R124L	not provided	VCV003371603	2	29443642	2	29220776	3371603	3530793		NC_000002.12:29220775:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3575G>A (p.Arg1192Gln)	ALK	R124Q, R1192Q	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000823946	2	29443642	2	29220776	823946	806896	rs113994089	NC_000002.12:29220775:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3575G>C (p.Arg1192Pro)	ALK	R1192P, R124P	Neuroblastoma, susceptibility to, 3	VCV000018085	2	29443642	2	29220776	18085	33124	rs113994089	NC_000002.12:29220775:C:G	single nucleotide variant	missense variant	Pathogenic	Sep 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3574C>A (p.Arg1192=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000665546	2	29443643	2	29220777	665546	629830	rs534852056	NC_000002.12:29220776:G:T	single nucleotide variant	synonymous variant	Likely benign	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3574C>G (p.Arg1192Gly)	ALK	R1192G, R124G	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000538242	2	29443643	2	29220777	538242	518113	rs534852056	NC_000002.12:29220776:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3574C>T (p.Arg1192Trp)	ALK	R1192W, R124W	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538184	2	29443643	2	29220777	538184	518039	rs534852056	NC_000002.12:29220776:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3573C>T (p.Pro1191=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001732813	2	29443644	2	29220778	1732813	1795887		NC_000002.12:29220777:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3572C>A (p.Pro1191His)	ALK	P1191H, P123H	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000404321	2	29443645	2	29220779	404321	392551	rs1060500210	NC_000002.12:29220778:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3571C>A (p.Pro1191Thr)	ALK	P1191T, P123T	Neuroblastoma, susceptibility to, 3	VCV002162469	2	29443646	2	29220780	2162469	1894765		NC_000002.12:29220779:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3570G>T (p.Leu1190=)	ALK		Hereditary cancer-predisposing syndrome	VCV002586690	2	29443647	2	29220781	2586690	2756873		NC_000002.12:29220780:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3569T>C (p.Leu1190Pro)	ALK	L122P, L1190P	Neuroblastoma, susceptibility to, 3	VCV000849292	2	29443648	2	29220782	849292	826312	rs1669780974	NC_000002.12:29220781:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3568del (p.Leu1190fs)	ALK	L1190fs, L122fs	Neuroblastoma, susceptibility to, 3	VCV003717659	2	29443649	2	29220783	3717659	3852635		NC_000002.12:29220782:GGG:GG	Deletion	frameshift variant	Uncertain significance	Sep 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3567C>T (p.Ser1189=)	ALK		Hereditary cancer-predisposing syndrome	VCV001732752	2	29443650	2	29220784	1732752	1786439		NC_000002.12:29220783:G:A	single nucleotide variant	synonymous variant	Likely benign	May 7, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3567C>G (p.Ser1189=)	ALK		Hereditary cancer-predisposing syndrome	VCV001732751	2	29443650	2	29220784	1732751	1786438		NC_000002.12:29220783:G:C	single nucleotide variant	synonymous variant	Likely benign	Jan 3, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3566C>A (p.Ser1189Tyr)	ALK	S1189Y, S121Y	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470836	2	29443651	2	29220785	470836	450874	rs971799902	NC_000002.12:29220784:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3564A>G (p.Gln1188=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223865	2	29443653	2	29220787	3223865	3380887		NC_000002.12:29220786:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3563A>G (p.Gln1188Arg)	ALK	Q1188R, Q120R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001024506	2	29443654	2	29220788	1024506	1003970	rs1669781212	NC_000002.12:29220787:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3562C>T (p.Gln1188Ter)	ALK	Q1188*, Q120*	Hereditary cancer-predisposing syndrome	VCV001732720	2	29443655	2	29220789	1732720	1786407		NC_000002.12:29220788:G:A	single nucleotide variant	nonsense	Uncertain significance	Mar 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3557G>A (p.Ser1186Asn)	ALK	S1186N, S118N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000823924	2	29443660	2	29220794	823924	806897	rs755576991	NC_000002.12:29220793:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3556A>T (p.Ser1186Cys)	ALK	S1186C, S118C	Neuroblastoma, susceptibility to, 3	VCV003241594	2	29443661	2	29220795	3241594	3400572		NC_000002.12:29220794:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3555G>T (p.Val1185=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000823920	2	29443662	2	29220796	823920	806898	rs777309744	NC_000002.12:29220795:C:A	single nucleotide variant	synonymous variant	Likely benign	Oct 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3555G>A (p.Val1185=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000703545	2	29443662	2	29220796	703545	691131	rs777309744	NC_000002.12:29220795:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3553del (p.Gly1184_Val1185insTer)	ALK		Neuroblastoma, susceptibility to, 3	VCV002022776	2	29443664	2	29220798	2022776	2076840		NC_000002.12:29220797:CCCC:CCC	Deletion	nonsense	Uncertain significance	Aug 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3553G>T (p.Val1185Leu)	ALK	V1185L, V117L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000944986	2	29443664	2	29220798	944986	922709	rs749016081	NC_000002.12:29220797:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3552G>A (p.Gly1184=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002875543	2	29443665	2	29220799	2875543	3041058		NC_000002.12:29220798:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3552G>C (p.Gly1184=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000239823	2	29443665	2	29220799	239823	238725	rs878854655	NC_000002.12:29220798:C:G	single nucleotide variant	synonymous variant	Likely benign	Sep 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3549T>G (p.Ile1183Met)	ALK	I115M, I1183M	Neuroblastoma, susceptibility to, 3	VCV000649917	2	29443668	2	29220802	649917	629831	rs1573120422	NC_000002.12:29220801:A:C	single nucleotide variant	missense variant	Uncertain significance	May 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3548T>C (p.Ile1183Thr)	ALK	I1183T, I115T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000643179	2	29443669	2	29220803	643179	629832	rs1002995598	NC_000002.12:29220802:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3547A>G (p.Ile1183Val)	ALK	I115V, I1183V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001420262	2	29443670	2	29220804	1420262	1503042	rs770456378	NC_000002.12:29220803:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3545G>A (p.Cys1182Tyr)	ALK	C114Y, C1182Y	Neuroblastoma, susceptibility to, 3	VCV002816650	2	29443672	2	29220806	2816650	2984152		NC_000002.12:29220805:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3542G>A (p.Arg1181His)	ALK	R1181H, R113H	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470835	2	29443675	2	29220809	470835	450875	rs1034835558	NC_000002.12:29220808:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3541C>T (p.Arg1181Cys)	ALK	R1181C, R113C	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000538181	2	29443676	2	29220810	538181	518114	rs56315533	NC_000002.12:29220809:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3540T>G (p.Val1180=)	ALK		Hereditary cancer-predisposing syndrome	VCV001732478	2	29443677	2	29220811	1732478	1786165		NC_000002.12:29220810:A:C	single nucleotide variant	synonymous variant	Likely benign	Jun 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3540T>C (p.Val1180=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001131851	2	29443677	2	29220811	1131851	1112738	rs2148166648	NC_000002.12:29220810:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3538G>A (p.Val1180Ile)	ALK	V112I, V1180I	Neuroblastoma, susceptibility to, 3	VCV002056207	2	29443679	2	29220813	2056207	2112790		NC_000002.12:29220812:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3538G>C (p.Val1180Leu)	ALK	V112L, V1180L	Lung cancer	VCV001705031	2	29443679	2	29220813	1705031	1699563		NC_000002.12:29220812:C:G	single nucleotide variant	missense variant	Likely pathogenic		no assertion criteria provided							
NM_004304.5(ALK):c.3537dup (p.Val1180fs)	ALK	V1180fs, V112fs	Neuroblastoma, susceptibility to, 3	VCV001409456	2	29443679 - 29443680	2	29220813 - 29220814	1409456	1340526	rs2148166666	NC_000002.12:29220813:AA:AAA	Duplication	frameshift variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3537T>C (p.Ile1179=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001117184	2	29443680	2	29220814	1117184	1091234	rs2148166662	NC_000002.12:29220813:A:G	single nucleotide variant	synonymous variant	Likely benign	Feb 14, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3536T>C (p.Ile1179Thr)	ALK	I111T, I1179T	Neuroblastoma, susceptibility to, 3	VCV001524234	2	29443681	2	29220815	1524234	1382796	rs2148166668	NC_000002.12:29220814:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3534C>T (p.Asn1178=)	ALK		Hereditary cancer-predisposing syndrome	VCV001732389	2	29443683	2	29220817	1732389	1786076		NC_000002.12:29220816:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 4, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3530A>C (p.Gln1177Pro)	ALK	Q1177P, Q109P	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000404382	2	29443687	2	29220821	404382	392913	rs1060500229	NC_000002.12:29220820:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3529C>G (p.Gln1177Glu)	ALK	Q1177E, Q109E	Neuroblastoma, susceptibility to, 3	VCV002701401	2	29443688	2	29220822	2701401	2862395		NC_000002.12:29220821:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3528C>T (p.His1176=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001732322	2	29443689	2	29220823	1732322	1789353		NC_000002.12:29220822:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3526C>A (p.His1176Asn)	ALK	H1176N, H108N	Neuroblastoma, susceptibility to, 3	VCV000538193	2	29443691	2	29220825	538193	518189	rs1553393928	NC_000002.12:29220824:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 28, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.3524A>G (p.Asn1175Ser)	ALK	N1175S, N107S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000470834	2	29443693	2	29220827	470834	450882	rs774872969	NC_000002.12:29220826:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3522C>T (p.Phe1174=)	ALK		Hereditary cancer-predisposing syndrome	VCV002566589	2	29443695	2	29220829	2566589	2734432		NC_000002.12:29220828:G:A	single nucleotide variant	synonymous variant	Likely benign	May 5, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3522C>G (p.Phe1174Leu)	ALK	F1174L, F106L	Neuroblastoma, susceptibility to, 3	VCV000217852	2	29443695	2	29220829	217852	214512	rs863225281	NC_000002.12:29220828:G:C	single nucleotide variant	missense variant	Pathogenic	Nov 6, 2015	no assertion criteria provided							
NM_004304.5(ALK):c.3522C>A (p.Phe1174Leu)	ALK	F1174L, F106L	Neuroblastoma, susceptibility to, 3	VCV000217851	2	29443695	2	29220829	217851	214513	rs863225281	NC_000002.12:29220828:G:T	single nucleotide variant	missense variant	Pathogenic	Oct 7, 2015	no assertion criteria provided							
NM_004304.5(ALK):c.3521T>G (p.Phe1174Cys)	ALK	F1174C, F106C	ALK-related disorder	VCV000375887	2	29443696	2	29220830	375887	362766	rs1057519697	NC_000002.12:29220829:A:C	single nucleotide variant	missense variant	Likely pathogenic	May 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3520T>A (p.Phe1174Ile)	ALK	F1174I, F106I	Neuroblastoma, susceptibility to, 3	VCV000217850	2	29443697	2	29220831	217850	214515	rs281864719	NC_000002.12:29220830:A:T	single nucleotide variant	missense variant	Pathogenic	Nov 6, 2015	no assertion criteria provided							
NM_004304.5(ALK):c.3520T>C (p.Phe1174Leu)	ALK	F1174L, F106L	Neuroblastoma, susceptibility to, 3	VCV000217849	2	29443697	2	29220831	217849	214514	rs281864719	NC_000002.12:29220830:A:G	single nucleotide variant	missense variant	Pathogenic	Oct 7, 2015	no assertion criteria provided							
NM_004304.5(ALK):c.3520T>G (p.Phe1174Val)	ALK	F1174V, F106V	Neuroblastoma, susceptibility to, 3	VCV000065670	2	29443697	2	29220831	65670	76578	rs281864719	NC_000002.12:29220830:A:C	single nucleotide variant	missense variant	Pathogenic	Oct 7, 2015	no assertion criteria provided							
NM_004304.5(ALK):c.3516C>G (p.Ser1172Arg)	ALK	S1172R, S104R	Hereditary cancer-predisposing syndrome	VCV001732207	2	29443701	2	29220835	1732207	1789238		NC_000002.12:29220834:G:C	single nucleotide variant	missense variant	Uncertain significance	May 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3516-1G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002736791	2	29443702	2	29220836	2736791	2905362		NC_000002.12:29220835:C:T	single nucleotide variant	splice acceptor variant	Uncertain significance	Jul 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3516-2A>G	ALK		Hereditary cancer-predisposing syndrome	VCV003286323	2	29443703	2	29220837	3286323	3455146		NC_000002.12:29220836:T:C	single nucleotide variant	splice acceptor variant	Uncertain significance	Jun 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3516-2A>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002097811	2	29443703	2	29220837	2097811	2150431		NC_000002.12:29220836:T:G	single nucleotide variant	splice acceptor variant	Uncertain significance	Feb 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3516-3C>T	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000572578	2	29443704	2	29220838	572578	558362	rs769293928	NC_000002.12:29220837:G:A	single nucleotide variant	intron variant	Uncertain significance	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3516-4G>A	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001112544	2	29443705	2	29220839	1112544	1091235	rs1177192411	NC_000002.12:29220838:C:T	single nucleotide variant	intron variant	Likely benign	Nov 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3516-6C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001943706	2	29443707	2	29220841	1943706	1995247		NC_000002.12:29220840:G:A	single nucleotide variant	intron variant	Likely benign	Sep 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3516-9G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001605108	2	29443710	2	29220844	1605108	1537436	rs777242640	NC_000002.12:29220843:C:A	single nucleotide variant	intron variant	Likely benign	Dec 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3516-10T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002885594	2	29443711	2	29220845	2885594	3043599		NC_000002.12:29220844:A:G	single nucleotide variant	intron variant	Likely benign	Sep 30, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3516-15CT[2]	ALK		Neuroblastoma, susceptibility to, 3	VCV002772859	2	29443711 - 29443712	2	29220845 - 29220846	2772859	2930137		NC_000002.12:29220844:AGAGAG:AGAG	Microsatellite	intron variant	Likely benign	Nov 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3516-10T>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001513636	2	29443711	2	29220845	1513636	1468825	rs2148166765	NC_000002.12:29220844:A:T	single nucleotide variant	intron variant	Uncertain significance	Jun 16, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3516-28_3516-14del	ALK		Neuroblastoma, susceptibility to, 3	VCV001566652	2	29443715 - 29443729	2	29220849 - 29220863	1566652	1569176	rs2148166778	NC_000002.12:29220848:AGGGATGTAACCAAAA:A	Deletion	intron variant	Likely benign	Jun 18, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3516-15C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002816666	2	29443716	2	29220850	2816666	2984168		NC_000002.12:29220849:G:A	single nucleotide variant	intron variant	Likely benign	Nov 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3516-16C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV003003106	2	29443717	2	29220851	3003106	3164640		NC_000002.12:29220850:G:T	single nucleotide variant	intron variant	Likely benign	Mar 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3516-17C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002739730	2	29443718	2	29220852	2739730	2895781		NC_000002.12:29220851:G:A	single nucleotide variant	intron variant	Likely benign	Dec 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3516-25G>C	ALK		not provided	VCV001186341	2	29443726	2	29220860	1186341	1176164	rs146360301	NC_000002.12:29220859:C:G	single nucleotide variant	intron variant	Likely benign	Sep 16, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3516-48C>A	ALK		not provided	VCV001242087	2	29443749	2	29220883	1242087	1232862	rs80152976	NC_000002.12:29220882:G:T	single nucleotide variant	intron variant	Benign	Jul 20, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3515+97G>A	ALK		not provided	VCV000677843	2	29445113	2	29222247	677843	659146	rs72852030	NC_000002.12:29222246:C:T	single nucleotide variant	intron variant	Benign	Jun 16, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3515+53C>G	ALK		not provided	VCV000677750	2	29445157	2	29222291	677750	659147	rs76002034	NC_000002.12:29222290:G:C	single nucleotide variant	intron variant	Benign	Jun 18, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3515+19_3515+20del	ALK		Neuroblastoma, susceptibility to, 3	VCV002771500	2	29445190 - 29445191	2	29222324 - 29222325	2771500	2933516		NC_000002.12:29222323:GTGT:GT	Microsatellite	intron variant	Likely benign	Nov 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3515+18C>T	ALK		Neuroblastoma, susceptibility to, 3|not specified	VCV000516594	2	29445192	2	29222326	516594	499915	rs79325200	NC_000002.12:29222325:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3515+17A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003674118	2	29445193	2	29222327	3674118	3813029		NC_000002.12:29222326:T:C	single nucleotide variant	intron variant	Likely benign	Aug 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3515+12GA[2]	ALK		Neuroblastoma, susceptibility to, 3	VCV001583903	2	29445193 - 29445194	2	29222327 - 29222328	1583903	1528349	rs1669825028	NC_000002.12:29222326:TCTCTCT:TCTCT	Microsatellite	intron variant	Likely benign	Oct 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3515+16G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002032654	2	29445194	2	29222328	2032654	2082872		NC_000002.12:29222327:C:G	single nucleotide variant	intron variant	Likely benign	Sep 26, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3515+16G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001665163	2	29445194	2	29222328	1665163	1621032	rs2148168446	NC_000002.12:29222327:C:T	single nucleotide variant	intron variant	Likely benign	Jun 24, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3515+15A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001553161	2	29445195	2	29222329	1553161	1552945	rs111982937	NC_000002.12:29222328:T:C	single nucleotide variant	intron variant	Likely benign	May 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3515+14G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001951925	2	29445196	2	29222330	1951925	2010779		NC_000002.12:29222329:C:T	single nucleotide variant	intron variant	Likely benign	Apr 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3515+14G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001916858	2	29445196	2	29222330	1916858	1974484		NC_000002.12:29222329:C:G	single nucleotide variant	intron variant	Likely benign	Apr 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3515+13A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001998523	2	29445197	2	29222331	1998523	2050444		NC_000002.12:29222330:T:C	single nucleotide variant	intron variant	Likely benign	May 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3515+12G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002070064	2	29445198	2	29222332	2070064	2126287		NC_000002.12:29222331:C:T	single nucleotide variant	intron variant	Likely benign	May 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3515+7C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002700031	2	29445203	2	29222337	2700031	2858883		NC_000002.12:29222336:G:T	single nucleotide variant	intron variant	Likely benign	Dec 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3515+2T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002872678	2	29445208	2	29222342	2872678	3037757		NC_000002.12:29222341:A:G	single nucleotide variant	splice donor variant	Uncertain significance	Dec 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3514A>C (p.Ser1172Arg)	ALK	S104R, S1172R	Neuroblastoma, susceptibility to, 3	VCV002813107	2	29445211	2	29222345	2813107	2972909		NC_000002.12:29222344:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3514A>T (p.Ser1172Cys)	ALK	S1172C, S104C	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000965082	2	29445211	2	29222345	965082	953061	rs1669825339	NC_000002.12:29222344:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3513C>T (p.Ile1171=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223864	2	29445212	2	29222346	3223864	3380886		NC_000002.12:29222345:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 31, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3513C>G (p.Ile1171Met)	ALK	I1171M, I103M	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000640114	2	29445212	2	29222346	640114	629833	rs760322018	NC_000002.12:29222345:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3512T>C (p.Ile1171Thr)	ALK	I1171T, I103T	Neuroblastoma	VCV000545115	2	29445213	2	29222347	545115	535377	rs1057519698	NC_000002.12:29222346:A:G	single nucleotide variant	missense variant	Pathogenic	Jan 1, 2017	no assertion criteria provided							
NM_004304.5(ALK):c.3507_3509del (p.Ile1171del)	ALK	I103del, I1171del	Neuroblastoma, susceptibility to, 3	VCV002866039	2	29445216 - 29445218	2	29222350 - 29222352	2866039	3023512		NC_000002.12:29222349:ATCA:A	Deletion	inframe_deletion	Uncertain significance	May 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3509T>A (p.Ile1170Asn)	ALK	I1170N, I102N	Neuroblastoma, susceptibility to, 3	VCV000470831	2	29445216	2	29222350	470831	450729	rs1553394197	NC_000002.12:29222349:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.3507G>A (p.Leu1169=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001151419	2	29445218	2	29222352	1151419	1133649	rs2148168572	NC_000002.12:29222351:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3504C>G (p.Ala1168=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001732097	2	29445221	2	29222355	1732097	1789128		NC_000002.12:29222354:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3499G>A (p.Glu1167Lys)	ALK	E1167K, E99K	Neuroblastoma, susceptibility to, 3	VCV002791971	2	29445226	2	29222360	2791971	2960437		NC_000002.12:29222359:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3498G>A (p.Met1166Ile)	ALK	M1166I, M98I	Hereditary cancer-predisposing syndrome	VCV003223863	2	29445227	2	29222361	3223863	3380885		NC_000002.12:29222360:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3497T>C (p.Met1166Thr)	ALK	M1166T, M98T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001461292	2	29445228	2	29222362	1461292	1498123	rs1057520019	NC_000002.12:29222361:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3495C>T (p.Leu1165=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000707285	2	29445230	2	29222364	707285	691132	rs764123976	NC_000002.12:29222363:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3493C>T (p.Leu1165Phe)	ALK	L1165F, L97F	Hereditary cancer-predisposing syndrome	VCV002566611	2	29445232	2	29222366	2566611	2734454		NC_000002.12:29222365:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3492C>T (p.Phe1164=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001554906	2	29445233	2	29222367	1554906	1564650	rs2148168619	NC_000002.12:29222366:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 5, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3487G>A (p.Asp1163Asn)	ALK	D1163N, D95N	Hereditary cancer-predisposing syndrome	VCV001692784	2	29445238	2	29222372	1692784	1685224	rs753670250	NC_000002.12:29222371:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3487G>C (p.Asp1163His)	ALK	D95H, D1163H	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000823830	2	29445238	2	29222372	823830	806899	rs753670250	NC_000002.12:29222371:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3486G>A (p.Leu1162=)	ALK		Hereditary cancer-predisposing syndrome	VCV003525314	2	29445239	2	29222373	3525314	3685670		NC_000002.12:29222372:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3486G>C (p.Leu1162=)	ALK		Hereditary cancer-predisposing syndrome	VCV001731878	2	29445239	2	29222373	1731878	1792781		NC_000002.12:29222372:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 23, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3485T>A (p.Leu1162Gln)	ALK	L1162Q, L94Q	Hereditary cancer-predisposing syndrome	VCV002452093	2	29445240	2	29222374	2452093	2426733		NC_000002.12:29222373:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3484C>T (p.Leu1162=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001731866	2	29445241	2	29222375	1731866	1792769		NC_000002.12:29222374:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3481_3482delinsAC (p.Glu1161Thr)	ALK	E93T, E1161T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470830	2	29445243 - 29445244	2	29222377 - 29222378	470830	450731	rs1553394207	NC_000002.12:29222376:TC:GT	Indel	missense variant	Uncertain significance	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3481G>A (p.Glu1161Lys)	ALK	E1161K, E93K	ALK-related disorder|Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000569028	2	29445244	2	29222378	569028	558364	rs145194836	NC_000002.12:29222377:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3480C>T (p.Asp1160=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000772001	2	29445245	2	29222379	772001	697542	rs888578421	NC_000002.12:29222378:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3479A>G (p.Asp1160Gly)	ALK	D1160G, D92G	not provided	VCV001712645	2	29445246	2	29222380	1712645	1760311		NC_000002.12:29222379:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3476A>T (p.Gln1159Leu)	ALK	Q1159L, Q91L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000941004	2	29445249	2	29222383	941004	931347	rs1270501196	NC_000002.12:29222382:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3472G>A (p.Glu1158Lys)	ALK	E1158K, E90K	Neuroblastoma, susceptibility to, 3	VCV000961489	2	29445253	2	29222387	961489	942850	rs749951867	NC_000002.12:29222386:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3471T>C (p.Ser1157=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000756890	2	29445254	2	29222388	756890	763174	rs758185429	NC_000002.12:29222387:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3469T>C (p.Ser1157Pro)	ALK	S89P, S1157P	Neuroblastoma, susceptibility to, 3	VCV000964795	2	29445256	2	29222390	964795	953062	rs1669827171	NC_000002.12:29222389:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3466T>C (p.Cys1156Arg)	ALK	C1156R, C88R	Hereditary cancer-predisposing syndrome	VCV003223862	2	29445259	2	29222393	3223862	3380884		NC_000002.12:29222392:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3466T>G (p.Cys1156Gly)	ALK	C1156G, C88G	Neuroblastoma, susceptibility to, 3	VCV002848020	2	29445259	2	29222393	2848020	3005263		NC_000002.12:29222392:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3465G>A (p.Val1155=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001658647	2	29445260	2	29222394	1658647	1564023	rs2148168706	NC_000002.12:29222393:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3464T>C (p.Val1155Ala)	ALK	V87A, V1155A	Neuroblastoma, susceptibility to, 3	VCV001036856	2	29445261	2	29222395	1036856	1024440	rs1669827315	NC_000002.12:29222394:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3463G>A (p.Val1155Met)	ALK	V1155M, V87M	Neuroblastoma, susceptibility to, 3	VCV003630089	2	29445262	2	29222396	3630089	3769431		NC_000002.12:29222395:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.3461A>C (p.Glu1154Ala)	ALK	E1154A, E86A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000843593	2	29445264	2	29222398	843593	826313	rs1669827472	NC_000002.12:29222397:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3460G>A (p.Glu1154Lys)	ALK	E86K, E1154K	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000660309	2	29445265	2	29222399	660309	629835	rs1005846150	NC_000002.12:29222398:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3460G>C (p.Glu1154Gln)	ALK	E86Q, E1154Q	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000654548	2	29445265	2	29222399	654548	629834	rs1005846150	NC_000002.12:29222398:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3459T>A (p.Pro1153=)	ALK		not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000681534	2	29445266	2	29222400	681534	655442	rs1402836708	NC_000002.12:29222399:A:T	single nucleotide variant	synonymous variant	Likely benign	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3458C>G (p.Pro1153Arg)	ALK	P1153R, P85R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV001319120	2	29445267	2	29222401	1319120	1309373	rs917295547	NC_000002.12:29222400:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3456G>A (p.Leu1152=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003722364	2	29445269	2	29222403	3722364	3856877		NC_000002.12:29222402:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3455T>A (p.Leu1152Gln)	ALK	L84Q, L1152Q	Neuroblastoma, susceptibility to, 3	VCV003655266	2	29445270	2	29222404	3655266	3789409		NC_000002.12:29222403:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3453G>A (p.Thr1151=)	ALK		Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000480962	2	29445272	2	29222406	480962	472686	rs145061595	NC_000002.12:29222405:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3452C>A (p.Thr1151Lys)	ALK	T83K, T1151K	Neuroblastoma, susceptibility to, 3	VCV003706690	2	29445273	2	29222407	3706690	3836262		NC_000002.12:29222406:G:T	single nucleotide variant	missense variant	Uncertain significance	May 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3452C>T (p.Thr1151Met)	ALK	T1151M, T83M	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000018086	2	29445273	2	29222407	18086	33125	rs113994091	NC_000002.12:29222406:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 30, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3451A>C (p.Thr1151Pro)	ALK	T1151P, T83P	Neuroblastoma, susceptibility to, 3	VCV000843226	2	29445274	2	29222408	843226	826314	rs1669828114	NC_000002.12:29222407:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3451-1G>A	ALK		Hereditary cancer-predisposing syndrome	VCV003523473	2	29445275	2	29222409	3523473	3685146		NC_000002.12:29222408:C:T	single nucleotide variant	splice acceptor variant	Uncertain significance	Aug 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3451-3C>T	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001731568	2	29445277	2	29222411	1731568	1792472		NC_000002.12:29222410:G:A	single nucleotide variant	intron variant	Uncertain significance	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3451-3C>G	ALK		Hereditary cancer-predisposing syndrome	VCV001731567	2	29445277	2	29222411	1731567	1792471		NC_000002.12:29222410:G:C	single nucleotide variant	intron variant	Uncertain significance	Jan 4, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3451-5C>T	ALK		Hereditary cancer-predisposing syndrome	VCV001731569	2	29445279	2	29222413	1731569	1792473		NC_000002.12:29222412:G:A	single nucleotide variant	intron variant	Uncertain significance	Aug 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3451-6G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001985423	2	29445280	2	29222414	1985423	2043275		NC_000002.12:29222413:C:T	single nucleotide variant	intron variant	Likely benign	Apr 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3451-8C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001641076	2	29445282	2	29222416	1641076	1520011	rs1305183150	NC_000002.12:29222415:G:A	single nucleotide variant	intron variant	Likely benign	Nov 30, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3451-11T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001622087	2	29445285	2	29222419	1622087	1593290	rs376746597	NC_000002.12:29222418:A:G	single nucleotide variant	intron variant	Likely benign	Nov 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3451-13dup	ALK		Neuroblastoma, susceptibility to, 3	VCV001981766	2	29445286 - 29445287	2	29222420 - 29222421	1981766	2046132		NC_000002.12:29222420:GGGG:GGGGG	Duplication	intron variant	Benign	Jul 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3451-13C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002766562	2	29445287	2	29222421	2766562	2929025		NC_000002.12:29222420:G:A	single nucleotide variant	intron variant	Likely benign	Nov 29, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3451-14C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001585677	2	29445288	2	29222422	1585677	1540193	rs2148168812	NC_000002.12:29222421:G:C	single nucleotide variant	intron variant	Likely benign	Oct 4, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3451-16C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001576377	2	29445290	2	29222424	1576377	1586708	rs749807424	NC_000002.12:29222423:G:C	single nucleotide variant	intron variant	Likely benign	Jan 28, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.3451-17T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002716243	2	29445291	2	29222425	2716243	2879789		NC_000002.12:29222424:A:C	single nucleotide variant	intron variant	Likely benign	Dec 12, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3451-18del	ALK		Neuroblastoma, susceptibility to, 3	VCV002696070	2	29445292	2	29222426	2696070	2860925		NC_000002.12:29222425:GGG:GG	Deletion	intron variant	Likely benign	Nov 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3451-19C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV003653959	2	29445293	2	29222427	3653959	3785962		NC_000002.12:29222426:G:T	single nucleotide variant	intron variant	Likely benign	May 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3451-19C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002103173	2	29445293	2	29222427	2103173	2158477		NC_000002.12:29222426:G:A	single nucleotide variant	intron variant	Likely benign	Feb 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3451-20C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001587900	2	29445294	2	29222428	1587900	1605923	rs1225272641	NC_000002.12:29222427:G:A	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.3451-35TCC[3]	ALK		Squamous cell lung carcinoma	VCV000873173	2	29445298 - 29445300	2	29222432 - 29222434	873173	861299	rs775243091	NC_000002.12:29222431:GGAGGAGGAGGAGG:GGAGGAGGAGG	Microsatellite	intron variant	Uncertain significance	May 5, 2020	no assertion criteria provided							
NM_004304.5(ALK):c.3450+19_3450+20del	ALK		Neuroblastoma, susceptibility to, 3	VCV002780894	2	29445363 - 29445364	2	29222497 - 29222498	2780894	2940747		NC_000002.12:29222496:AA:	Deletion	intron variant	Likely benign	Dec 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3450+16C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001627627	2	29445367	2	29222501	1627627	1530845	rs1669831430	NC_000002.12:29222500:G:A	single nucleotide variant	intron variant	Likely benign	Apr 23, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3450+14C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002993049	2	29445369	2	29222503	2993049	3148188		NC_000002.12:29222502:G:C	single nucleotide variant	intron variant	Likely benign	Apr 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3445_3450+13dup	ALK		Neuroblastoma, susceptibility to, 3	VCV002148598	2	29445369 - 29445370	2	29222503 - 29222504	2148598	1880926		NC_000002.12:29222503:AGCCACTTCTTACCTTCACAGCCACTT:AGCCACTTCTTACCTTCACAGCCACTTCTTACCTTCACAGCCACTT	Duplication	splice donor variant	Uncertain significance	Sep 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3450+14C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002139401	2	29445369	2	29222503	2139401	1871688		NC_000002.12:29222502:G:A	single nucleotide variant	intron variant	Likely benign	Nov 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3450+12C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001589938	2	29445371	2	29222505	1589938	1576484	rs1669831571	NC_000002.12:29222504:G:A	single nucleotide variant	intron variant	Likely benign	Mar 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3450+11G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001549223	2	29445372	2	29222506	1549223	1626300	rs2148169065	NC_000002.12:29222505:C:A	single nucleotide variant	intron variant	Likely benign	Aug 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3450+10G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001122656	2	29445373	2	29222507	1122656	1112739	rs2148169071	NC_000002.12:29222506:C:T	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.3450+6_3450+8del	ALK		Neuroblastoma, susceptibility to, 3	VCV001518504	2	29445375 - 29445377	2	29222509 - 29222511	1518504	1508897	rs2148169076	NC_000002.12:29222508:CTTCTT:CTT	Microsatellite	intron variant	Uncertain significance	Sep 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3450+6_3450+7delinsTG	ALK		Neuroblastoma, susceptibility to, 3	VCV001365443	2	29445376 - 29445377	2	29222510 - 29222511	1365443	1402313	rs2148169081	NC_000002.12:29222509:TT:CA	Indel	intron variant	Uncertain significance	Jul 2, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3450+7A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000538282	2	29445376	2	29222510	538282	518115	rs1553394250	NC_000002.12:29222509:T:C	single nucleotide variant	intron variant	Likely benign	Jan 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3450+6A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003020158	2	29445377	2	29222511	3020158	3183025		NC_000002.12:29222510:T:C	single nucleotide variant	intron variant	Uncertain significance	Sep 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3450+5G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002870403	2	29445378	2	29222512	2870403	3031287		NC_000002.12:29222511:C:T	single nucleotide variant	intron variant	Uncertain significance	Mar 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3450+4A>G	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002566570	2	29445379	2	29222513	2566570	2734413		NC_000002.12:29222512:T:C	single nucleotide variant	intron variant	Uncertain significance	Dec 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3450+3A>G	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001731564	2	29445380	2	29222514	1731564	1792468		NC_000002.12:29222513:T:C	single nucleotide variant	intron variant	Uncertain significance	May 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3450+2T>C	ALK		Hereditary cancer-predisposing syndrome	VCV001731563	2	29445381	2	29222515	1731563	1792467		NC_000002.12:29222514:A:G	single nucleotide variant	splice donor variant	Uncertain significance	Sep 18, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3450_3450+1delinsTT	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538231	2	29445382 - 29445383	2	29222516 - 29222517	538231	518110	rs1553394254	NC_000002.12:29222515:CC:AA	Indel	splice donor variant	Uncertain significance	Dec 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3450G>A (p.Lys1150=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000847382	2	29445383	2	29222517	847382	826315	rs1558622960	NC_000002.12:29222516:C:T	single nucleotide variant	synonymous variant	Uncertain significance	May 16, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3449A>C (p.Lys1150Thr)	ALK	K82T, K1150T	Neuroblastoma, susceptibility to, 3	VCV001483945	2	29445384	2	29222518	1483945	1458727	rs2148169104	NC_000002.12:29222517:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3447G>A (p.Val1149=)	ALK		Hereditary cancer-predisposing syndrome	VCV002452124	2	29445386	2	29222520	2452124	2426764		NC_000002.12:29222519:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3446T>C (p.Val1149Ala)	ALK	V1149A, V81A	Neuroblastoma, susceptibility to, 3	VCV002752182	2	29445387	2	29222521	2752182	2915950		NC_000002.12:29222520:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3445G>A (p.Val1149Met)	ALK	V1149M, V81M	Neuroblastoma, susceptibility to, 3	VCV001961322	2	29445388	2	29222522	1961322	2020168		NC_000002.12:29222521:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3445G>C (p.Val1149Leu)	ALK	V1149L, V81L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001063801	2	29445388	2	29222522	1063801	1041383	rs1669832449	NC_000002.12:29222521:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3442G>A (p.Ala1148Thr)	ALK	A1148T, A80T	Hereditary cancer-predisposing syndrome	VCV000823777	2	29445391	2	29222525	823777	806900	rs1573123548	NC_000002.12:29222524:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3441G>T (p.Val1147=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001115841	2	29445392	2	29222526	1115841	1091236	rs1669832691	NC_000002.12:29222525:C:A	single nucleotide variant	synonymous variant	Likely benign	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3440T>A (p.Val1147Glu)	ALK	V79E, V1147E	Hereditary cancer-predisposing syndrome	VCV003285885	2	29445393	2	29222527	3285885	3444625		NC_000002.12:29222526:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3440T>C (p.Val1147Ala)	ALK	V1147A, V79A	Neuroblastoma, susceptibility to, 3	VCV001015313	2	29445393	2	29222527	1015313	1003971	rs1669832761	NC_000002.12:29222526:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3439G>C (p.Val1147Leu)	ALK	V1147L, V79L	not provided|Neuroblastoma, susceptibility to, 3	VCV000961168	2	29445394	2	29222528	961168	942851	rs1378239568	NC_000002.12:29222527:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3437A>T (p.Gln1146Leu)	ALK	Q1146L, Q78L	Neuroblastoma, susceptibility to, 3	VCV002009025	2	29445396	2	29222530	2009025	2063098		NC_000002.12:29222529:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3436C>A (p.Gln1146Lys)	ALK	Q1146K, Q78K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001372612	2	29445397	2	29222531	1372612	1443855	rs2148169149	NC_000002.12:29222530:G:T	single nucleotide variant	missense variant	Uncertain significance	May 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3435G>A (p.Leu1145=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002447086	2	29445398	2	29222532	2447086	2422209		NC_000002.12:29222531:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3435G>T (p.Leu1145=)	ALK		Hereditary cancer-predisposing syndrome	VCV001731412	2	29445398	2	29222532	1731412	1795785		NC_000002.12:29222531:C:A	single nucleotide variant	synonymous variant	Likely benign	Jan 14, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3433C>T (p.Leu1145=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002760361	2	29445400	2	29222534	2760361	2921541		NC_000002.12:29222533:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 13, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3432C>T (p.Pro1144=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470829	2	29445401	2	29222535	470829	450733	rs148284008	NC_000002.12:29222534:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3431C>G (p.Pro1144Arg)	ALK	P1144R, P76R	Neuroblastoma, susceptibility to, 3	VCV002840079	2	29445402	2	29222536	2840079	3003301		NC_000002.12:29222535:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3431C>T (p.Pro1144Leu)	ALK	P1144L, P76L	Hereditary cancer-predisposing syndrome	VCV001731382	2	29445402	2	29222536	1731382	1795755		NC_000002.12:29222535:G:A	single nucleotide variant	missense variant	Uncertain significance	May 3, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3430C>T (p.Pro1144Ser)	ALK	P76S, P1144S	Hereditary cancer-predisposing syndrome	VCV001731377	2	29445403	2	29222537	1731377	1795750		NC_000002.12:29222536:G:A	single nucleotide variant	missense variant	Uncertain significance	May 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3429C>T (p.Ser1143=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001578258	2	29445404	2	29222538	1578258	1587726	rs1203831222	NC_000002.12:29222537:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3428G>T (p.Ser1143Ile)	ALK	S75I, S1143I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000963459	2	29445405	2	29222539	963459	942852	rs1669833411	NC_000002.12:29222538:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3425C>T (p.Pro1142Leu)	ALK	P1142L, P74L	Hereditary cancer-predisposing syndrome	VCV002566580	2	29445408	2	29222542	2566580	2734423		NC_000002.12:29222541:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3424C>T (p.Pro1142Ser)	ALK	P74S, P1142S	Hereditary cancer-predisposing syndrome	VCV003285748	2	29445409	2	29222543	3285748	3444488		NC_000002.12:29222542:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3422A>G (p.Asp1141Gly)	ALK	D73G, D1141G	Hereditary cancer-predisposing syndrome	VCV003523702	2	29445411	2	29222545	3523702	3685374		NC_000002.12:29222544:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3421G>A (p.Asp1141Asn)	ALK	D1141N, D73N	not specified|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000470828	2	29445412	2	29222546	470828	450890	rs748493584	NC_000002.12:29222545:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3420C>A (p.Asn1140Lys)	ALK	N1140K, N72K	Neuroblastoma, susceptibility to, 3	VCV001446175	2	29445413	2	29222547	1446175	1391004	rs150785816	NC_000002.12:29222546:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3420C>G (p.Asn1140Lys)	ALK	N72K, N1140K	Neuroblastoma, susceptibility to, 3	VCV001045380	2	29445413	2	29222547	1045380	1024441	rs150785816	NC_000002.12:29222546:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3420C>T (p.Asn1140=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000470827	2	29445413	2	29222547	470827	451026	rs150785816	NC_000002.12:29222546:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3419A>G (p.Asn1140Ser)	ALK	N1140S, N72S	Neuroblastoma, susceptibility to, 3	VCV001488707	2	29445414	2	29222548	1488707	1420177	rs2148169203	NC_000002.12:29222547:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3417C>T (p.Pro1139=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000772985	2	29445416	2	29222550	772985	697543	rs1366017808	NC_000002.12:29222549:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3416C>T (p.Pro1139Leu)	ALK	P1139L, P71L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001350664	2	29445417	2	29222551	1350664	1492252	rs769855519	NC_000002.12:29222550:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3414G>A (p.Met1138Ile)	ALK	M70I, M1138I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002734400	2	29445419	2	29222553	2734400	2894437		NC_000002.12:29222552:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 4, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3413T>G (p.Met1138Arg)	ALK	M70R, M1138R	Neuroblastoma, susceptibility to, 3	VCV003715547	2	29445420	2	29222554	3715547	3845097		NC_000002.12:29222553:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3413T>C (p.Met1138Thr)	ALK	M1138T, M70T	Neuroblastoma, susceptibility to, 3	VCV001347846	2	29445420	2	29222554	1347846	1391762	rs2148169223	NC_000002.12:29222553:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 23, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3410G>A (p.Gly1137Glu)	ALK	G1137E, G69E	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV001397808	2	29445423	2	29222557	1397808	1353008	rs1669834120	NC_000002.12:29222556:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3409G>C (p.Gly1137Arg)	ALK	G1137R, G69R	Neuroblastoma, susceptibility to, 3	VCV001491756	2	29445424	2	29222558	1491756	1342793	rs762571775	NC_000002.12:29222557:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3409G>A (p.Gly1137Arg)	ALK	G1137R, G69R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000538248	2	29445424	2	29222558	538248	518122	rs762571775	NC_000002.12:29222557:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3408C>T (p.Ser1136=)	ALK		Hereditary cancer-predisposing syndrome|not provided|not specified|Neuroblastoma, susceptibility to, 3	VCV000335693	2	29445425	2	29222559	335693	286754	rs56146053	NC_000002.12:29222558:G:A	single nucleotide variant	synonymous variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3392_3406del (p.Tyr1131_Val1135del)	ALK		Neuroblastoma, susceptibility to, 3	VCV001489907	2	29445427 - 29445441	2	29222561 - 29222575	1489907	1514900	rs2148169260	NC_000002.12:29222560:ACACCTGGCCTTCATACACCT:ACACCT	Deletion	inframe_deletion	Uncertain significance	Oct 27, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3406T>G (p.Ser1136Ala)	ALK	S1136A, S68A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV001021741	2	29445427	2	29222561	1021741	1003972	rs1669834540	NC_000002.12:29222560:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3405G>A (p.Val1135=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001104597	2	29445428	2	29222562	1104597	1091237	rs773665287	NC_000002.12:29222561:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3404T>C (p.Val1135Ala)	ALK	V1135A, V67A	Neuroblastoma, susceptibility to, 3	VCV001053173	2	29445429	2	29222563	1053173	1041384	rs2148169266	NC_000002.12:29222562:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3403G>T (p.Val1135Leu)	ALK	V67L, V1135L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001359955	2	29445430	2	29222564	1359955	1473828	rs2148169270	NC_000002.12:29222563:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3402G>A (p.Gln1134=)	ALK		Hereditary cancer-predisposing syndrome	VCV002452122	2	29445431	2	29222565	2452122	2426762		NC_000002.12:29222564:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3401A>G (p.Gln1134Arg)	ALK	Q1134R, Q66R	Hereditary cancer-predisposing syndrome	VCV002562266	2	29445432	2	29222566	2562266	2721119		NC_000002.12:29222565:T:C	single nucleotide variant	missense variant	Uncertain significance	May 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3401A>T (p.Gln1134Leu)	ALK	Q1134L, Q66L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470826	2	29445432	2	29222566	470826	450893	rs1172239019	NC_000002.12:29222565:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3399C>A (p.Gly1133=)	ALK		Hereditary cancer-predisposing syndrome	VCV003524359	2	29445434	2	29222568	3524359	3679024		NC_000002.12:29222567:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3399C>T (p.Gly1133=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001359535	2	29445434	2	29222568	1359535	1370715	rs1294436101	NC_000002.12:29222567:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3398G>T (p.Gly1133Val)	ALK	G1133V, G65V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000573048	2	29445435	2	29222569	573048	561305	rs773881309	NC_000002.12:29222568:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3397G>C (p.Gly1133Arg)	ALK	G1133R, G65R	Hereditary cancer-predisposing syndrome	VCV003525214	2	29445436	2	29222570	3525214	3685570		NC_000002.12:29222569:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3394G>A (p.Glu1132Lys)	ALK	E1132K, E64K	Hereditary cancer-predisposing syndrome	VCV001692783	2	29445439	2	29222573	1692783	1685223	rs2148169318	NC_000002.12:29222572:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3393T>C (p.Tyr1131=)	ALK		Hereditary cancer-predisposing syndrome	VCV001730932	2	29445440	2	29222574	1730932	1785920		NC_000002.12:29222573:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 10, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3391T>G (p.Tyr1131Asp)	ALK	Y1131D, Y63D	Neuroblastoma, susceptibility to, 3	VCV002728325	2	29445442	2	29222576	2728325	2886222		NC_000002.12:29222575:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3390G>A (p.Val1130=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000823711	2	29445443	2	29222577	823711	806901	rs1573123747	NC_000002.12:29222576:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3388G>A (p.Val1130Met)	ALK	V1130M, V62M	Neuroblastoma, susceptibility to, 3	VCV001420642	2	29445445	2	29222579	1420642	1403249	rs1060500215	NC_000002.12:29222578:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3388G>T (p.Val1130Leu)	ALK	V1130L, V62L	Neuroblastoma, susceptibility to, 3	VCV000404339	2	29445445	2	29222579	404339	392915	rs1060500215	NC_000002.12:29222578:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2016	criteria provided, single submitter							
NM_004304.5(ALK):c.3387G>T (p.Glu1129Asp)	ALK	E1129D, E61D	Neuroblastoma, susceptibility to, 3	VCV002823601	2	29445446	2	29222580	2823601	2985966		NC_000002.12:29222579:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3387G>A (p.Glu1129=)	ALK		Hereditary cancer-predisposing syndrome	VCV002586687	2	29445446	2	29222580	2586687	2756870		NC_000002.12:29222579:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3385G>A (p.Glu1129Lys)	ALK	E1129K, E61K	Neuroblastoma, susceptibility to, 3	VCV001721855	2	29445448	2	29222582	1721855	1779573		NC_000002.12:29222581:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3383G>A (p.Gly1128Glu)	ALK	G60E, G1128E	not provided|Neuroblastoma, susceptibility to, 3	VCV002713569	2	29445450	2	29222584	2713569	2875866		NC_000002.12:29222583:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3383G>C (p.Gly1128Ala)	ALK	G1128A, G60A	Neuroblastoma, susceptibility to, 3	VCV000018084	2	29445450	2	29222584	18084	33123	rs113994088	NC_000002.12:29222583:C:G	single nucleotide variant	missense variant	Pathogenic; risk factor	Oct 7, 2015	no assertion criteria provided							
NM_004304.5(ALK):c.3380T>G (p.Phe1127Cys)	ALK	F1127C, F59C	Hereditary cancer-predisposing syndrome	VCV003286610	2	29445453	2	29222587	3286610	3455433		NC_000002.12:29222586:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3380T>C (p.Phe1127Ser)	ALK	F1127S, F59S	not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001703293	2	29445453	2	29222587	1703293	1695684		NC_000002.12:29222586:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3377C>A (p.Ala1126Asp)	ALK	A1126D, A58D	Neuroblastoma, susceptibility to, 3	VCV002010797	2	29445456	2	29222590	2010797	2063587		NC_000002.12:29222589:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3376G>C (p.Ala1126Pro)	ALK	A1126P, A58P	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001718087	2	29445457	2	29222591	1718087	1772063		NC_000002.12:29222590:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3376G>A (p.Ala1126Thr)	ALK	A1126T, A58T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000843692	2	29445457	2	29222591	843692	826316	rs757580052	NC_000002.12:29222590:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3374_3375delinsAA (p.Gly1125Glu)	ALK	G1125E, G57E	Hereditary cancer-predisposing syndrome	VCV003524768	2	29445458 - 29445459	2	29222592 - 29222593	3524768	3689007		NC_000002.12:29222591:GC:TT	Indel	missense variant	Uncertain significance	Sep 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3375C>T (p.Gly1125=)	ALK		not specified|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000392892	2	29445458	2	29222592	392892	366537	rs3795850	NC_000002.12:29222591:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3375C>A (p.Gly1125=)	ALK		not provided|Hereditary cancer-predisposing syndrome|not specified|Neuroblastoma, susceptibility to, 3	VCV000335694	2	29445458	2	29222592	335694	289376	rs3795850	NC_000002.12:29222591:G:T	single nucleotide variant	synonymous variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3374G>A (p.Gly1125Asp)	ALK	G1125D, G57D	Hereditary cancer-predisposing syndrome	VCV003524626	2	29445459	2	29222593	3524626	3679291		NC_000002.12:29222592:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3369C>T (p.Gly1123=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000767234	2	29445464	2	29222598	767234	697544	rs148547594	NC_000002.12:29222597:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3366G>C (p.Leu1122=)	ALK		Hereditary cancer-predisposing syndrome	VCV001730660	2	29445467	2	29222601	1730660	1785649		NC_000002.12:29222600:C:G	single nucleotide variant	synonymous variant	Likely benign	Apr 22, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3366G>A (p.Leu1122=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000485081	2	29445467	2	29222601	485081	472776	rs758871506	NC_000002.12:29222600:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3363T>A (p.Gly1121=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000412909	2	29445470	2	29222604	412909	392607	rs201767904	NC_000002.12:29222603:A:T	single nucleotide variant	synonymous variant	Likely benign	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3362G>T (p.Gly1121Val)	ALK	G53V, G1121V	Neuroblastoma, susceptibility to, 3	VCV002197783	2	29445471	2	29222605	2197783	1923944		NC_000002.12:29222604:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3362G>A (p.Gly1121Asp)	ALK	G1121D, G53D	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404380	2	29445471	2	29222605	404380	392709	rs55760835	NC_000002.12:29222604:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 26, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3361G>C (p.Gly1121Arg)	ALK	G53R, G1121R	Neuroblastoma, susceptibility to, 3	VCV003658516	2	29445472	2	29222606	3658516	3796937		NC_000002.12:29222605:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3361G>A (p.Gly1121Ser)	ALK	G53S, G1121S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000949736	2	29445472	2	29222606	949736	922710	rs781411935	NC_000002.12:29222605:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3360G>C (p.Arg1120=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003723504	2	29445473	2	29222607	3723504	3850715		NC_000002.12:29222606:C:G	single nucleotide variant	synonymous variant	Uncertain significance	Oct 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3360G>A (p.Arg1120=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000823662	2	29445473	2	29222607	823662	806902	rs747985440	NC_000002.12:29222606:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Dec 5, 2023	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3360-1G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001351397	2	29445474	2	29222608	1351397	1407746	rs1573123877	NC_000002.12:29222607:C:T	single nucleotide variant	splice acceptor variant	Uncertain significance	Jul 3, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3360-1G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000663088	2	29445474	2	29222608	663088	650924	rs1573123877	NC_000002.12:29222607:C:A	single nucleotide variant	splice acceptor variant	Uncertain significance	Jan 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3360-2A>G	ALK		Hereditary cancer-predisposing syndrome	VCV001730607	2	29445475	2	29222609	1730607	1788940		NC_000002.12:29222608:T:C	single nucleotide variant	splice acceptor variant	Uncertain significance	Feb 10, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3360-3C>T	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000575256	2	29445476	2	29222610	575256	560581	rs1464715041	NC_000002.12:29222609:G:A	single nucleotide variant	intron variant	Uncertain significance	Sep 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3360-4del	ALK		Neuroblastoma, susceptibility to, 3	VCV002703333	2	29445477	2	29222611	2703333	2859624		NC_000002.12:29222610:T:	Deletion	intron variant	Likely benign	Dec 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3360-5C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV003706594	2	29445478	2	29222612	3706594	3836166		NC_000002.12:29222611:G:T	single nucleotide variant	intron variant	Likely benign	Mar 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3360-8T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV003702497	2	29445481	2	29222615	3702497	3838548		NC_000002.12:29222614:A:G	single nucleotide variant	intron variant	Likely benign	Dec 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3360-11_3360-9del	ALK		Neuroblastoma, susceptibility to, 3	VCV002174162	2	29445482 - 29445484	2	29222616 - 29222618	2174162	1908110		NC_000002.12:29222615:AGGAG:AG	Deletion	intron variant	Likely benign	Jun 22, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3360-11C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002849527	2	29445484	2	29222618	2849527	3009316		NC_000002.12:29222617:G:C	single nucleotide variant	intron variant	Likely benign	Mar 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3360-11C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001574599	2	29445484	2	29222618	1574599	1659784	rs1191359394	NC_000002.12:29222617:G:A	single nucleotide variant	intron variant	Likely benign	Aug 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3360-12T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002918279	2	29445485	2	29222619	2918279	3080399		NC_000002.12:29222618:A:G	single nucleotide variant	intron variant	Likely benign	Feb 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3360-12del	ALK		Neuroblastoma, susceptibility to, 3	VCV001546015	2	29445485	2	29222619	1546015	1623082	rs2148169485	NC_000002.12:29222618:A:	Deletion	intron variant	Likely benign	Mar 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3360-13C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002833390	2	29445486	2	29222620	2833390	3001717		NC_000002.12:29222619:G:A	single nucleotide variant	intron variant	Likely benign	Apr 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3360-16C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001650231	2	29445489	2	29222623	1650231	1601943	rs2148169494	NC_000002.12:29222622:G:A	single nucleotide variant	intron variant	Likely benign	Dec 5, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3360-17T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001655130	2	29445490	2	29222624	1655130	1549703	rs1669837765	NC_000002.12:29222623:A:G	single nucleotide variant	intron variant	Likely benign	Aug 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3360-18G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001585854	2	29445491	2	29222625	1585854	1540370	rs769660063	NC_000002.12:29222624:C:T	single nucleotide variant	intron variant	Likely benign	Jan 29, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.3360-20T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001657255	2	29445493	2	29222627	1657255	1628419	rs2148169505	NC_000002.12:29222626:A:G	single nucleotide variant	intron variant	Likely benign	Apr 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3359+226C>G	ALK		not provided	VCV001224558	2	29445982	2	29223116	1224558	1217112	rs11689436	NC_000002.12:29223115:G:C	single nucleotide variant	intron variant	Benign	Jun 24, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3359+165G>T	ALK		not provided	VCV001208516	2	29446043	2	29223177	1208516	1196906	rs78365742	NC_000002.12:29223176:C:A	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3359+80T>C	ALK		not provided	VCV000677559	2	29446128	2	29223262	677559	658982	rs12989497	NC_000002.12:29223261:A:G	single nucleotide variant	intron variant	Benign	Jun 20, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3359+16_3359+27del	ALK		Neuroblastoma, susceptibility to, 3	VCV002818518	2	29446181 - 29446192	2	29223315 - 29223326	2818518	2984733		NC_000002.12:29223314:CTCCCAGGACGGC:C	Deletion	intron variant	Likely benign	Dec 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3359+24G>C	ALK		not provided	VCV000873174	2	29446184	2	29223318	873174	861300	rs2276550	NC_000002.12:29223317:C:G	single nucleotide variant	intron variant	Benign	Jun 21, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3359+18G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001575132	2	29446190	2	29223324	1575132	1638417	rs373046668	NC_000002.12:29223323:C:T	single nucleotide variant	intron variant	Likely benign	Feb 2, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.3359+17C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001632407	2	29446191	2	29223325	1632407	1630934	rs200832204	NC_000002.12:29223324:G:A	single nucleotide variant	intron variant	Benign	Jan 17, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.3359+17C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001507989	2	29446191	2	29223325	1507989	1442643	rs200832204	NC_000002.12:29223324:G:T	single nucleotide variant	intron variant	Likely benign	Aug 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3359+16C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002783326	2	29446192	2	29223326	2783326	2947925		NC_000002.12:29223325:G:A	single nucleotide variant	intron variant	Likely benign	Sep 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3359+16C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002141174	2	29446192	2	29223326	2141174	1872165		NC_000002.12:29223325:G:T	single nucleotide variant	intron variant	Likely benign	May 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3359+12G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003691428	2	29446196	2	29223330	3691428	3824051		NC_000002.12:29223329:C:A	single nucleotide variant	intron variant	Likely benign	May 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3359+12G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001612014	2	29446196	2	29223330	1612014	1535642	rs2148170566	NC_000002.12:29223329:C:T	single nucleotide variant	intron variant	Likely benign	Aug 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3359+9C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001099090	2	29446199	2	29223333	1099090	1091238	rs2148170575	NC_000002.12:29223332:G:A	single nucleotide variant	intron variant	Likely benign	Oct 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3359+7G>A	ALK		not specified|Neuroblastoma, susceptibility to, 3	VCV000389610	2	29446201	2	29223335	389610	366611	rs778841767	NC_000002.12:29223334:C:T	single nucleotide variant	intron variant	Likely benign	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3359+4_3359+6delinsGGT	ALK		Hereditary cancer-predisposing syndrome|not provided	VCV001730573	2	29446202 - 29446204	2	29223336 - 29223338	1730573	1788907		NC_000002.12:29223335:GCT:ACC	Indel	intron variant	Uncertain significance	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3359+6C>T	ALK		not provided|not specified|Neuroblastoma, susceptibility to, 3	VCV000259271	2	29446202	2	29223336	259271	250717	rs4622670	NC_000002.12:29223335:G:A	single nucleotide variant	intron variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3359+4A>G	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000823658	2	29446204	2	29223338	823658	815235	rs1573125072	NC_000002.12:29223337:T:C	single nucleotide variant	intron variant	Uncertain significance	Jun 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3359+3G>A	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001730572	2	29446205	2	29223339	1730572	1788906		NC_000002.12:29223338:C:T	single nucleotide variant	intron variant	Uncertain significance	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3359+1G>A	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000943911	2	29446207	2	29223341	943911	939887	rs1669858309	NC_000002.12:29223340:C:T	single nucleotide variant	splice donor variant	Uncertain significance	Sep 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3359+1G>T	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000839530	2	29446207	2	29223341	839530	850900	rs1669858309	NC_000002.12:29223340:C:A	single nucleotide variant	splice donor variant	Uncertain significance	Oct 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3359G>A (p.Arg1120Gln)	ALK	R1120Q, R52Q	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001010916	2	29446208	2	29223342	1010916	988691	rs374188635	NC_000002.12:29223341:C:T	single nucleotide variant	missense variant	Uncertain significance	May 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3358C>A (p.Arg1120=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001464006	2	29446209	2	29223343	1464006	1342362	rs774951734	NC_000002.12:29223342:G:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Apr 9, 2022	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3358C>T (p.Arg1120Trp)	ALK	R1120W, R52W	not specified|Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000485077	2	29446209	2	29223343	485077	472777	rs774951734	NC_000002.12:29223342:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3357T>C (p.Ile1119=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002793476	2	29446210	2	29223344	2793476	2950723		NC_000002.12:29223343:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3354C>G (p.Leu1118=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002105761	2	29446213	2	29223347	2105761	2166222		NC_000002.12:29223346:G:C	single nucleotide variant	synonymous variant	Likely benign	Mar 2, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3354C>T (p.Leu1118=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001083456	2	29446213	2	29223347	1083456	1069513	rs371592787	NC_000002.12:29223346:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3354C>A (p.Leu1118=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000239821	2	29446213	2	29223347	239821	238726	rs371592787	NC_000002.12:29223346:G:T	single nucleotide variant	synonymous variant	Likely benign	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3352C>T (p.Leu1118Phe)	ALK	L50F, L1118F	Neuroblastoma, susceptibility to, 3	VCV002958814	2	29446215	2	29223349	2958814	3126121		NC_000002.12:29223348:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3352C>G (p.Leu1118Val)	ALK	L50V, L1118V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001359579	2	29446215	2	29223349	1359579	1370759	rs1472845031	NC_000002.12:29223348:G:C	single nucleotide variant	missense variant	Uncertain significance	May 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3351C>T (p.Thr1117=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001730521	2	29446216	2	29223350	1730521	1788855		NC_000002.12:29223349:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3350C>T (p.Thr1117Ile)	ALK	T1117I, T49I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001060098	2	29446217	2	29223351	1060098	1041385	rs1669859051	NC_000002.12:29223350:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3350C>A (p.Thr1117Asn)	ALK	T49N, T1117N	Neuroblastoma, susceptibility to, 3	VCV000940453	2	29446217	2	29223351	940453	931348	rs1669859051	NC_000002.12:29223350:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3348C>T (p.Ile1116=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001730478	2	29446219	2	29223353	1730478	1788812		NC_000002.12:29223352:G:A	single nucleotide variant	synonymous variant	Likely benign	May 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3348C>A (p.Ile1116=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000697492	2	29446219	2	29223353	697492	686181	rs374587233	NC_000002.12:29223352:G:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3346A>C (p.Ile1116Leu)	ALK	I1116L, I48L	Hereditary cancer-predisposing syndrome	VCV000823639	2	29446221	2	29223355	823639	806903	rs1573125125	NC_000002.12:29223354:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3345C>T (p.Asn1115=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001730454	2	29446222	2	29223356	1730454	1788788		NC_000002.12:29223355:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3342A>G (p.Lys1114=)	ALK		Hereditary cancer-predisposing syndrome	VCV001730426	2	29446225	2	29223359	1730426	1788760		NC_000002.12:29223358:T:C	single nucleotide variant	synonymous variant	Likely benign	Jun 13, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3341A>G (p.Lys1114Arg)	ALK	K1114R, K46R	Neuroblastoma, susceptibility to, 3	VCV003241765	2	29446226	2	29223360	3241765	3400743		NC_000002.12:29223359:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3338G>A (p.Arg1113Gln)	ALK	R1113Q, R45Q	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000485075	2	29446229	2	29223363	485075	472732	rs199987354	NC_000002.12:29223362:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3337C>G (p.Arg1113Gly)	ALK	R1113G, R45G	Neuroblastoma, susceptibility to, 3	VCV000968081	2	29446230	2	29223364	968081	953063	rs773583710	NC_000002.12:29223363:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3337C>T (p.Arg1113Trp)	ALK	R1113W, R45W	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404357	2	29446230	2	29223364	404357	392711	rs773583710	NC_000002.12:29223363:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3336G>C (p.Pro1112=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003644544	2	29446231	2	29223365	3644544	3776343		NC_000002.12:29223364:C:G	single nucleotide variant	synonymous variant	Likely benign	Aug 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3336G>T (p.Pro1112=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001655143	2	29446231	2	29223365	1655143	1549716	rs146074150	NC_000002.12:29223364:C:A	single nucleotide variant	synonymous variant	Likely benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3336G>A (p.Pro1112=)	ALK		not specified|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000335695	2	29446231	2	29223365	335695	288988	rs146074150	NC_000002.12:29223364:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3335C>T (p.Pro1112Leu)	ALK	P44L, P1112L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000823621	2	29446232	2	29223366	823621	806904	rs1319794557	NC_000002.12:29223365:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3334C>A (p.Pro1112Thr)	ALK	P1112T, P44T	Neuroblastoma, susceptibility to, 3	VCV002746673	2	29446233	2	29223367	2746673	2897548		NC_000002.12:29223366:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3334C>G (p.Pro1112Ala)	ALK	P1112A, P44A	Neuroblastoma, susceptibility to, 3	VCV002091673	2	29446233	2	29223367	2091673	2156056		NC_000002.12:29223366:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3334C>T (p.Pro1112Ser)	ALK	P1112S, P44S	Neuroblastoma, susceptibility to, 3	VCV001460768	2	29446233	2	29223367	1460768	1419577	rs2148170705	NC_000002.12:29223366:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3333G>C (p.Val1111=)	ALK		Hereditary cancer-predisposing syndrome	VCV002452116	2	29446234	2	29223368	2452116	2426756		NC_000002.12:29223367:C:G	single nucleotide variant	synonymous variant	Likely benign	Jan 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3333G>A (p.Val1111=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000823619	2	29446234	2	29223368	823619	806905	rs1179566480	NC_000002.12:29223367:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3332T>C (p.Val1111Ala)	ALK	V1111A, V43A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001434723	2	29446235	2	29223369	1434723	1506928	rs558282902	NC_000002.12:29223368:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3331G>A (p.Val1111Met)	ALK	V43M, V1111M	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002566571	2	29446236	2	29223370	2566571	2734414		NC_000002.12:29223369:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3331G>T (p.Val1111Leu)	ALK	V1111L, V43L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000823616	2	29446236	2	29223370	823616	806906	rs752052590	NC_000002.12:29223369:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 8, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3330G>A (p.Glu1110=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002903048	2	29446237	2	29223371	2903048	3068542		NC_000002.12:29223370:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3330G>C (p.Glu1110Asp)	ALK	E1110D, E42D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000470825	2	29446237	2	29223371	470825	451044	rs140606509	NC_000002.12:29223370:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3329A>C (p.Glu1110Ala)	ALK	E1110A, E42A	Hereditary cancer-predisposing syndrome	VCV001730274	2	29446238	2	29223372	1730274	1788609		NC_000002.12:29223371:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3328G>A (p.Glu1110Lys)	ALK	E42K, E1110K	Neuroblastoma, susceptibility to, 3	VCV002099635	2	29446239	2	29223373	2099635	2147193		NC_000002.12:29223372:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3327G>A (p.Lys1109=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001730264	2	29446240	2	29223374	1730264	1788599		NC_000002.12:29223373:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3326A>T (p.Lys1109Met)	ALK	K41M, K1109M	Hereditary cancer-predisposing syndrome	VCV001730246	2	29446241	2	29223375	1730246	1788581		NC_000002.12:29223374:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3324G>A (p.Leu1108=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001948006	2	29446243	2	29223377	1948006	2002993		NC_000002.12:29223376:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3322C>A (p.Leu1108Met)	ALK	L40M, L1108M	Neuroblastoma, susceptibility to, 3	VCV002087495	2	29446245	2	29223379	2087495	2133787		NC_000002.12:29223378:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3322C>G (p.Leu1108Val)	ALK	L40V, L1108V	Neuroblastoma, susceptibility to, 3	VCV000954389	2	29446245	2	29223379	954389	942853	rs1669860335	NC_000002.12:29223378:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3321C>T (p.Asp1107=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002778587	2	29446246	2	29223380	2778587	2943625		NC_000002.12:29223379:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3321C>A (p.Asp1107Glu)	ALK	D1107E, D39E	Neuroblastoma, susceptibility to, 3	VCV000538186	2	29446246	2	29223380	538186	518120	rs1553394438	NC_000002.12:29223379:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3319G>C (p.Asp1107His)	ALK	D1107H, D39H	Hereditary cancer-predisposing syndrome	VCV001730167	2	29446248	2	29223382	1730167	1792373		NC_000002.12:29223381:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3318T>A (p.Ser1106Arg)	ALK	S1106R, S38R	Hereditary cancer-predisposing syndrome	VCV003523143	2	29446249	2	29223383	3523143	3688701		NC_000002.12:29223382:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3313_3316dup (p.Ser1106fs)	ALK	S38fs, S1106fs	Neuroblastoma, susceptibility to, 3	VCV003727050	2	29446250 - 29446251	2	29223384 - 29223385	3727050	3851671		NC_000002.12:29223384:TGAT:TGATTGAT	Duplication	frameshift variant	Uncertain significance	Dec 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3314_3316dup (p.Ile1105dup)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001481059	2	29446250 - 29446251	2	29223384 - 29223385	1481059	1451497	rs1373907084	NC_000002.12:29223384:TGATG:TGATGATG	Duplication	inframe_insertion	Uncertain significance	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3316A>C (p.Ser1106Arg)	ALK	S1106R, S38R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002996149	2	29446251	2	29223385	2996149	3162857		NC_000002.12:29223384:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3314T>A (p.Ile1105Asn)	ALK	I37N, I1105N	Hereditary cancer-predisposing syndrome	VCV001730123	2	29446253	2	29223387	1730123	1792329		NC_000002.12:29223386:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3313A>G (p.Ile1105Val)	ALK	I1105V, I37V	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000570258	2	29446254	2	29223388	570258	561311	rs1426033956	NC_000002.12:29223387:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3312del (p.Ile1105fs)	ALK	I1105fs, I37fs	Hereditary cancer-predisposing syndrome	VCV001730105	2	29446255	2	29223389	1730105	1792311		NC_000002.12:29223388:GG:G	Deletion	frameshift variant	Uncertain significance	Apr 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3307TCC[1] (p.Ser1104del)	ALK	S1104del, S36del	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000578856	2	29446255 - 29446257	2	29223389 - 29223391	578856	560583	rs1338813327	NC_000002.12:29223388:GGAGGAGG:GGAGG	Microsatellite	inframe_deletion	Uncertain significance	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3310T>C (p.Ser1104Pro)	ALK	S36P, S1104P	Neuroblastoma, susceptibility to, 3	VCV002169406	2	29446257	2	29223391	2169406	1903353		NC_000002.12:29223390:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3310T>A (p.Ser1104Thr)	ALK	S1104T, S36T	Neuroblastoma, susceptibility to, 3	VCV001004861	2	29446257	2	29223391	1004861	988692	rs759935726	NC_000002.12:29223390:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3309C>G (p.Ser1103=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003729596	2	29446258	2	29223392	3729596	3858925		NC_000002.12:29223391:G:C	single nucleotide variant	synonymous variant	Likely benign	Jan 26, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.3307T>G (p.Ser1103Ala)	ALK	S35A, S1103A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001903187	2	29446260	2	29223394	1903187	1961264		NC_000002.12:29223393:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3307T>C (p.Ser1103Pro)	ALK	S1103P, S35P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001017999	2	29446260	2	29223394	1017999	1003973	rs1669861057	NC_000002.12:29223393:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3306C>G (p.Thr1102=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000823529	2	29446261	2	29223395	823529	806907	rs767673065	NC_000002.12:29223394:G:C	single nucleotide variant	synonymous variant	Likely benign	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3305C>G (p.Thr1102Ser)	ALK	T1102S, T34S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002676264	2	29446262	2	29223396	2676264	2834685		NC_000002.12:29223395:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3305C>A (p.Thr1102Asn)	ALK	T34N, T1102N	Neuroblastoma, susceptibility to, 3	VCV002125216	2	29446262	2	29223396	2125216	2177817		NC_000002.12:29223395:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3303G>T (p.Lys1101Asn)	ALK	K33N, K1101N	Hereditary cancer-predisposing syndrome	VCV002566568	2	29446264	2	29223398	2566568	2734411		NC_000002.12:29223397:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3303G>A (p.Lys1101=)	ALK		Hereditary cancer-predisposing syndrome	VCV001730006	2	29446264	2	29223398	1730006	1792212		NC_000002.12:29223397:C:T	single nucleotide variant	synonymous variant	Likely benign	May 19, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3301A>G (p.Lys1101Glu)	ALK	K1101E, K33E	Hereditary cancer-predisposing syndrome	VCV003223861	2	29446266	2	29223400	3223861	3380883		NC_000002.12:29223399:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3300C>G (p.Gly1100=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001146166	2	29446267	2	29223401	1146166	1133650	rs752819935	NC_000002.12:29223400:G:C	single nucleotide variant	synonymous variant	Likely benign	Mar 11, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3300C>T (p.Gly1100=)	ALK		not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000485076	2	29446267	2	29223401	485076	472784	rs752819935	NC_000002.12:29223400:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3299G>A (p.Gly1100Asp)	ALK	G1100D, G32D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000939174	2	29446268	2	29223402	939174	931349	rs1669861474	NC_000002.12:29223401:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3298G>T (p.Gly1100Cys)	ALK	G1100C, G32C	Hereditary cancer-predisposing syndrome	VCV002566567	2	29446269	2	29223403	2566567	2734410		NC_000002.12:29223402:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3295G>A (p.Ala1099Thr)	ALK	A31T, A1099T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000963394	2	29446272	2	29223406	963394	942854	rs1669861611	NC_000002.12:29223405:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3294T>A (p.Phe1098Leu)	ALK	F1098L, F30L	Neuroblastoma, susceptibility to, 3	VCV001401060	2	29446273	2	29223407	1401060	1463912	rs566982691	NC_000002.12:29223406:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3287_3292del (p.Tyr1096_Cys1097del)	ALK		Neuroblastoma, susceptibility to, 3	VCV002185716	2	29446275 - 29446280	2	29223409 - 29223414	2185716	1910650		NC_000002.12:29223408:AGCAGTAG:AG	Deletion	inframe_deletion	Uncertain significance	May 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3291C>G (p.Cys1097Trp)	ALK	C1097W, C29W	Neuroblastoma, susceptibility to, 3	VCV002775462	2	29446276	2	29223410	2775462	2942654		NC_000002.12:29223409:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3291C>T (p.Cys1097=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000470824	2	29446276	2	29223410	470824	451048	rs370170353	NC_000002.12:29223409:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Dec 10, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3290G>A (p.Cys1097Tyr)	ALK	C1097Y, C29Y	Neuroblastoma, susceptibility to, 3	VCV003723295	2	29446277	2	29223411	3723295	3850506		NC_000002.12:29223410:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3289T>C (p.Cys1097Arg)	ALK	C1097R, C29R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538269	2	29446278	2	29223412	538269	518194	rs1553394453	NC_000002.12:29223411:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3288C>T (p.Tyr1096=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000798778	2	29446279	2	29223413	798778	781300	rs1361786352	NC_000002.12:29223412:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3286T>C (p.Tyr1096His)	ALK	Y28H, Y1096H	Hereditary cancer-predisposing syndrome	VCV002566607	2	29446281	2	29223415	2566607	2734450		NC_000002.12:29223414:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3282C>T (p.Pro1094=)	ALK		Hereditary cancer-predisposing syndrome	VCV003524698	2	29446285	2	29223419	3524698	3679362		NC_000002.12:29223418:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3282C>G (p.Pro1094=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001084417	2	29446285	2	29223419	1084417	1069514	rs187005015	NC_000002.12:29223418:G:C	single nucleotide variant	synonymous variant	Likely benign	Jun 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3281C>T (p.Pro1094Leu)	ALK	P1094L, P26L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002675995	2	29446286	2	29223420	2675995	2834416		NC_000002.12:29223419:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3280C>T (p.Pro1094Ser)	ALK	P1094S, P26S	Hereditary cancer-predisposing syndrome	VCV003223860	2	29446287	2	29223421	3223860	3380882		NC_000002.12:29223420:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3279C>T (p.Asn1093=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001133404	2	29446288	2	29223422	1133404	1112740	rs779601068	NC_000002.12:29223421:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3274T>G (p.Tyr1092Asp)	ALK	Y1092D, Y24D	Hereditary cancer-predisposing syndrome	VCV002447089	2	29446293	2	29223427	2447089	2422212		NC_000002.12:29223426:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3273C>T (p.Asp1091=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002838060	2	29446294	2	29223428	2838060	2992778		NC_000002.12:29223427:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3272A>G (p.Asp1091Gly)	ALK	D1091G, D23G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002147031	2	29446295	2	29223429	2147031	1870680		NC_000002.12:29223428:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3271G>A (p.Asp1091Asn)	ALK	D1091N, D23N	Familial isolated pituitary adenoma|not specified|Neuroblastoma, susceptibility to, 3	VCV000218628	2	29446296	2	29223430	218628	215257	rs864309584	NC_000002.12:29223429:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3270C>T (p.Thr1090=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001089805	2	29446297	2	29223431	1089805	1069515	rs746468058	NC_000002.12:29223430:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3269C>A (p.Thr1090Asn)	ALK	T1090N, T22N	Hereditary cancer-predisposing syndrome	VCV003286677	2	29446298	2	29223432	3286677	3451548		NC_000002.12:29223431:G:T	single nucleotide variant	missense variant	Uncertain significance	May 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3269C>T (p.Thr1090Ile)	ALK	T1090I, T22I	Hereditary cancer-predisposing syndrome	VCV001729589	2	29446298	2	29223432	1729589	1795265		NC_000002.12:29223431:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3267G>A (p.Met1089Ile)	ALK	M1089I, M21I	Neuroblastoma, susceptibility to, 3	VCV000645271	2	29446300	2	29223434	645271	629836	rs1573125389	NC_000002.12:29223433:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3266T>C (p.Met1089Thr)	ALK	M1089T, M21T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001434026	2	29446301	2	29223435	1434026	1497724	rs925658268	NC_000002.12:29223434:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3265A>G (p.Met1089Val)	ALK	M1089V, M21V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002090281	2	29446302	2	29223436	2090281	2152064		NC_000002.12:29223435:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3264C>A (p.Ile1088=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001615022	2	29446303	2	29223437	1615022	1578889	rs2148170939	NC_000002.12:29223436:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 3, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3262A>G (p.Ile1088Val)	ALK	I1088V, I20V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404379	2	29446305	2	29223439	404379	392714	rs1060500228	NC_000002.12:29223438:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3261C>T (p.Thr1087=)	ALK		Hereditary cancer-predisposing syndrome	VCV001729534	2	29446306	2	29223440	1729534	1795210		NC_000002.12:29223439:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 17, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3260C>G (p.Thr1087Ser)	ALK	T1087S, T19S	Neuroblastoma, susceptibility to, 3	VCV001000849	2	29446307	2	29223441	1000849	988693	rs113994090	NC_000002.12:29223440:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3260C>A (p.Thr1087Asn)	ALK	T1087N, T19N	Neuroblastoma, susceptibility to, 3	VCV000898165	2	29446307	2	29223441	898165	884678	rs113994090	NC_000002.12:29223440:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.3260C>T (p.Thr1087Ile)	ALK	T1087I, T19I	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Ovarian cancer	VCV000021395	2	29446307	2	29223441	21395	34247	rs113994090	NC_000002.12:29223440:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 12, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3259A>G (p.Thr1087Ala)	ALK	T19A, T1087A	Neuroblastoma, susceptibility to, 3	VCV003690623	2	29446308	2	29223442	3690623	3831299		NC_000002.12:29223441:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3258G>T (p.Ser1086=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002854948	2	29446309	2	29223443	2854948	3017128		NC_000002.12:29223442:C:A	single nucleotide variant	synonymous variant	Likely benign	Apr 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3258G>C (p.Ser1086=)	ALK		Hereditary cancer-predisposing syndrome	VCV002586719	2	29446309	2	29223443	2586719	2756902		NC_000002.12:29223442:C:G	single nucleotide variant	synonymous variant	Likely benign	Sep 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3258G>A (p.Ser1086=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000823330	2	29446309	2	29223443	823330	806908	rs373589068	NC_000002.12:29223442:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3257C>T (p.Ser1086Leu)	ALK	S1086L, S18L	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000239820	2	29446310	2	29223444	239820	238727	rs138589984	NC_000002.12:29223443:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3255C>A (p.Thr1085=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001588215	2	29446312	2	29223446	1588215	1574758	rs1372058960	NC_000002.12:29223445:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3255C>T (p.Thr1085=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001104998	2	29446312	2	29223446	1104998	1091239	rs1372058960	NC_000002.12:29223445:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3254C>T (p.Thr1085Ile)	ALK	T1085I, T17I	Hereditary cancer-predisposing syndrome	VCV002586691	2	29446313	2	29223447	2586691	2756874		NC_000002.12:29223446:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3254C>A (p.Thr1085Asn)	ALK	T17N, T1085N	Neuroblastoma, susceptibility to, 3	VCV000941551	2	29446313	2	29223447	941551	931350	rs1460007760	NC_000002.12:29223446:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3193_3251dup (p.Arg1084_Thr1085insSerCysLysProCysArgTrpSerCysArgAlaLeuSerThrSerTer)	ALK		Neuroblastoma, susceptibility to, 3	VCV001406770	2	29446315 - 29446316	2	29223449 - 29223450	1406770	1486828	rs2148170992		Duplication	nonsense|inframe_insertion|initiator_codon_variant	Uncertain significance	Feb 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3251G>A (p.Arg1084His)	ALK	R1084H, R16H	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404330	2	29446316	2	29223450	404330	392917	rs760151617	NC_000002.12:29223449:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3250C>T (p.Arg1084Cys)	ALK	R16C, R1084C	Neuroblastoma, susceptibility to, 3	VCV000648334	2	29446317	2	29223451	648334	629837	rs768123237	NC_000002.12:29223450:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3249C>T (p.Leu1083=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003691429	2	29446318	2	29223452	3691429	3824052		NC_000002.12:29223451:G:A	single nucleotide variant	synonymous variant	Likely benign	May 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3248T>C (p.Leu1083Pro)	ALK	L1083P, L15P	Neuroblastoma, susceptibility to, 3	VCV002696358	2	29446319	2	29223453	2696358	2861213		NC_000002.12:29223452:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3248T>G (p.Leu1083Arg)	ALK	L1083R, L15R	Hereditary cancer-predisposing syndrome	VCV001692782	2	29446319	2	29223453	1692782	1685222	rs1452386636	NC_000002.12:29223452:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3247C>A (p.Leu1083Ile)	ALK	L1083I, L15I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002452128	2	29446320	2	29223454	2452128	2426768		NC_000002.12:29223453:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3246G>C (p.Lys1082Asn)	ALK	K1082N, K14N	Hereditary cancer-predisposing syndrome	VCV003286574	2	29446321	2	29223455	3286574	3455397		NC_000002.12:29223454:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3246G>A (p.Lys1082=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002105699	2	29446321	2	29223455	2105699	2166160		NC_000002.12:29223454:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 2, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3243C>G (p.Ser1081Arg)	ALK	S1081R, S13R	Neuroblastoma, susceptibility to, 3	VCV001344811	2	29446324	2	29223458	1344811	1336583	rs1669864463	NC_000002.12:29223457:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3243C>A (p.Ser1081Arg)	ALK	S1081R, S13R	Neuroblastoma, susceptibility to, 3	VCV000947113	2	29446324	2	29223458	947113	922711	rs1669864463	NC_000002.12:29223457:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3242G>A (p.Ser1081Asn)	ALK	S1081N, S13N	Hereditary cancer-predisposing syndrome	VCV003223859	2	29446325	2	29223459	3223859	3380881		NC_000002.12:29223458:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3241A>G (p.Ser1081Gly)	ALK	S1081G, S13G	Hereditary cancer-predisposing syndrome	VCV003524351	2	29446326	2	29223460	3524351	3679016		NC_000002.12:29223459:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3240G>A (p.Leu1080=)	ALK		Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV001638385	2	29446327	2	29223461	1638385	1624071	rs760768939	NC_000002.12:29223460:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3236A>C (p.Lys1079Thr)	ALK	K1079T, K11T	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000538237	2	29446331	2	29223465	538237	518051	rs754163075	NC_000002.12:29223464:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 31, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3233A>G (p.Tyr1078Cys)	ALK	Y1078C, Y10C	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000404344	2	29446334	2	29223468	404344	392610	rs912992612	NC_000002.12:29223467:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3232T>C (p.Tyr1078His)	ALK	Y10H, Y1078H	Neuroblastoma, susceptibility to, 3	VCV003676686	2	29446335	2	29223469	3676686	3806719		NC_000002.12:29223468:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3231G>A (p.Glu1077=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001669771	2	29446336	2	29223470	1669771	1582449	rs2148171039	NC_000002.12:29223469:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3230A>G (p.Glu1077Gly)	ALK	E1077G, E9G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002601904	2	29446337	2	29223471	2601904	2778202		NC_000002.12:29223470:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3229G>C (p.Glu1077Gln)	ALK	E1077Q, E9Q	Neuroblastoma, susceptibility to, 3	VCV002743518	2	29446338	2	29223472	2743518	2906871		NC_000002.12:29223471:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3229G>T (p.Glu1077Ter)	ALK	E1077*, E9*	Neuroblastoma, susceptibility to, 3	VCV000572717	2	29446338	2	29223472	572717	558031	rs1553394491	NC_000002.12:29223471:C:A	single nucleotide variant	nonsense	Uncertain significance	Jan 10, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3229G>A (p.Glu1077Lys)	ALK	E1077K, E9K	Neuroblastoma, susceptibility to, 3	VCV000470822	2	29446338	2	29223472	470822	451029	rs1553394491	NC_000002.12:29223471:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3228T>A (p.Pro1076=)	ALK		Hereditary cancer-predisposing syndrome	VCV001729147	2	29446339	2	29223473	1729147	1785436		NC_000002.12:29223472:A:T	single nucleotide variant	synonymous variant	Likely benign	Sep 12, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3228T>C (p.Pro1076=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538290	2	29446339	2	29223473	538290	518121	rs199685862	NC_000002.12:29223472:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3225C>T (p.Ser1075=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003660775	2	29446342	2	29223476	3660775	3794490		NC_000002.12:29223475:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3225C>A (p.Ser1075Arg)	ALK	S1075R, S7R	Neuroblastoma, susceptibility to, 3	VCV001021162	2	29446342	2	29223476	1021162	1003974	rs1669865494	NC_000002.12:29223475:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3220C>T (p.Gln1074Ter)	ALK	Q6*, Q1074*	Neuroblastoma, susceptibility to, 3	VCV003718884	2	29446347	2	29223481	3718884	3859586		NC_000002.12:29223480:G:A	single nucleotide variant	nonsense	Uncertain significance	Feb 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3218T>C (p.Leu1073Pro)	ALK	L1073P, L5P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001729014	2	29446349	2	29223483	1729014	1785304		NC_000002.12:29223482:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3217C>G (p.Leu1073Val)	ALK	L1073V, L5V	Hereditary cancer-predisposing syndrome	VCV003285458	2	29446350	2	29223484	3285458	3440690		NC_000002.12:29223483:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3213G>A (p.Met1071Ile)	ALK	M1071I, M3I	Neuroblastoma, susceptibility to, 3	VCV001371117	2	29446354	2	29223488	1371117	1427323	rs1241116907	NC_000002.12:29223487:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3212T>C (p.Met1071Thr)	ALK	M1071T, M3T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000862282	2	29446355	2	29223489	862282	826317	rs1669865941	NC_000002.12:29223488:A:G	single nucleotide variant	missense variant	Uncertain significance	May 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3210G>C (p.Gln1070His)	ALK	Q2H, Q1070H	Neuroblastoma, susceptibility to, 3	VCV002198005	2	29446357	2	29223491	2198005	1924166		NC_000002.12:29223490:C:G	single nucleotide variant	missense variant	Uncertain significance	May 2, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3210G>A (p.Gln1070=)	ALK		Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000538303	2	29446357	2	29223491	538303	518196	rs138178848	NC_000002.12:29223490:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Dec 23, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3206T>G (p.Met1069Arg)	ALK	M1069R, M1R	Neuroblastoma, susceptibility to, 3	VCV003650173	2	29446361	2	29223495	3650173	3788169		NC_000002.12:29223494:A:C	single nucleotide variant	missense variant|initiator_codon_variant	Uncertain significance	Apr 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3205A>G (p.Met1069Val)	ALK	M1V, M1069V	Neuroblastoma, susceptibility to, 3	VCV002779226	2	29446362	2	29223496	2779226	2940377		NC_000002.12:29223495:T:C	single nucleotide variant	missense variant|initiator_codon_variant	Uncertain significance	Aug 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3204C>T (p.Ala1068=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002966695	2	29446363	2	29223497	2966695	3127949		NC_000002.12:29223496:G:A	single nucleotide variant	5 prime UTR variant|synonymous variant	Likely benign	Oct 29, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3203C>T (p.Ala1068Val)	ALK	A1068V	not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001692781	2	29446364	2	29223498	1692781	1685221	rs754439273	NC_000002.12:29223497:G:A	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	Jul 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3202G>A (p.Ala1068Thr)	ALK	A1068T	Hereditary cancer-predisposing syndrome	VCV003525281	2	29446365	2	29223499	3525281	3685637		NC_000002.12:29223498:C:T	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	Nov 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3198G>A (p.Leu1066=)	ALK		Hereditary cancer-predisposing syndrome|not provided	VCV002476956	2	29446369	2	29223503	2476956	2457419		NC_000002.12:29223502:C:T	single nucleotide variant	5 prime UTR variant|synonymous variant	Likely benign	Aug 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3197T>G (p.Leu1066Arg)	ALK	L1066R	Neuroblastoma, susceptibility to, 3	VCV001720093	2	29446370	2	29223504	1720093	1779132		NC_000002.12:29223503:A:C	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	Sep 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3196C>T (p.Leu1066=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001665831	2	29446371	2	29223505	1665831	1655560	rs2148171140	NC_000002.12:29223504:G:A	single nucleotide variant	5 prime UTR variant|synonymous variant	Likely benign	Jun 8, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3195G>A (p.Glu1065=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002171486	2	29446372	2	29223506	2171486	1900210		NC_000002.12:29223505:C:T	single nucleotide variant	5 prime UTR variant|synonymous variant	Likely benign	Nov 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3194A>C (p.Glu1065Ala)	ALK	E1065A	Hereditary cancer-predisposing syndrome	VCV002566556	2	29446373	2	29223507	2566556	2734399		NC_000002.12:29223506:T:G	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	Mar 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3192G>A (p.Gln1064=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000470820	2	29446375	2	29223509	470820	451051	rs868053991	NC_000002.12:29223508:C:T	single nucleotide variant	5 prime UTR variant|synonymous variant	Likely benign	Oct 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3189C>G (p.His1063Gln)	ALK	H1063Q	Neuroblastoma, susceptibility to, 3	VCV001369099	2	29446378	2	29223512	1369099	1417989	rs1669866903	NC_000002.12:29223511:G:C	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	Aug 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3187C>A (p.His1063Asn)	ALK	H1063N	Neuroblastoma, susceptibility to, 3	VCV002758373	2	29446380	2	29223514	2758373	2910472		NC_000002.12:29223513:G:T	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	Sep 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3187C>T (p.His1063Tyr)	ALK	H1063Y	Neuroblastoma, susceptibility to, 3	VCV000940487	2	29446380	2	29223514	940487	931351	rs1669867065	NC_000002.12:29223513:G:A	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	Oct 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3186G>A (p.Lys1062=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000703280	2	29446381	2	29223515	703280	691133	rs1374146241	NC_000002.12:29223514:C:T	single nucleotide variant	5 prime UTR variant|synonymous variant	Conflicting classifications of pathogenicity	Dec 9, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3184A>G (p.Lys1062Glu)	ALK	K1062E	Neuroblastoma, susceptibility to, 3	VCV001349115	2	29446383	2	29223517	1349115	1479126	rs2148171179	NC_000002.12:29223516:T:C	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	Apr 26, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3182G>A (p.Arg1061Gln)	ALK	R1061Q	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000133470	2	29446385	2	29223519	133470	137209	rs72852032	NC_000002.12:29223518:C:T	single nucleotide variant	5 prime UTR variant|missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3181C>A (p.Arg1061=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000937715	2	29446386	2	29223520	937715	931352	rs371521416	NC_000002.12:29223519:G:T	single nucleotide variant	5 prime UTR variant|synonymous variant	Uncertain significance	Nov 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3181C>T (p.Arg1061Trp)	ALK	R1061W	Neuroblastoma, susceptibility to, 3	VCV000538192	2	29446386	2	29223520	538192	518055	rs371521416	NC_000002.12:29223519:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Dec 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3180C>G (p.Arg1060=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002850419	2	29446387	2	29223521	2850419	3016027		NC_000002.12:29223520:G:C	single nucleotide variant	5 prime UTR variant|synonymous variant	Likely benign	Mar 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3180C>T (p.Arg1060=)	ALK		Hereditary cancer-predisposing syndrome	VCV001728543	2	29446387	2	29223521	1728543	1791943		NC_000002.12:29223520:G:A	single nucleotide variant	5 prime UTR variant|synonymous variant	Likely benign	Mar 16, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3179G>A (p.Arg1060His)	ALK	R1060H	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000847740	2	29446388	2	29223522	847740	826318	rs769322016	NC_000002.12:29223521:C:T	single nucleotide variant	5 prime UTR variant|missense variant	Conflicting classifications of pathogenicity	Dec 26, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3178C>T (p.Arg1060Cys)	ALK	R1060C	Neuroblastoma, susceptibility to, 3	VCV000565659	2	29446389	2	29223523	565659	558033	rs774836034	NC_000002.12:29223522:G:A	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	Mar 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3177C>T (p.Tyr1059=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003627890	2	29446390	2	29223524	3627890	3761876		NC_000002.12:29223523:G:A	single nucleotide variant	5 prime UTR variant|synonymous variant	Likely benign	Nov 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3176A>G (p.Tyr1059Cys)	ALK	Y1059C	Hereditary cancer-predisposing syndrome	VCV003522961	2	29446391	2	29223525	3522961	3688520		NC_000002.12:29223524:T:C	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	Sep 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3173T>C (p.Val1058Ala)	ALK	V1058A	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000858594	2	29446394	2	29223528	858594	826319	rs772708400	NC_000002.12:29223527:A:G	single nucleotide variant	5 prime UTR variant|missense variant	Uncertain significance	Feb 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3173-3C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001042145	2	29446397	2	29223531	1042145	1024442	rs898517103	NC_000002.12:29223530:G:C	single nucleotide variant	5 prime UTR variant|intron variant	Uncertain significance	Jul 15, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3173-4G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001132938	2	29446398	2	29223532	1132938	1112741	rs2148171234	NC_000002.12:29223531:C:T	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Oct 20, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3173-6C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001634987	2	29446400	2	29223534	1634987	1610713	rs1229164523	NC_000002.12:29223533:G:A	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Oct 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3173-6del	ALK		Neuroblastoma, susceptibility to, 3	VCV001062554	2	29446400	2	29223534	1062554	1041386	rs1669868152	NC_000002.12:29223533:GG:G	Deletion	5 prime UTR variant|intron variant	Likely benign	Apr 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3173-7C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002066291	2	29446401	2	29223535	2066291	2128976		NC_000002.12:29223534:G:C	single nucleotide variant	5 prime UTR variant|intron variant	Uncertain significance	Dec 30, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3173-7C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002058793	2	29446401	2	29223535	2058793	2106319		NC_000002.12:29223534:G:T	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Jun 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3173-7C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001093855	2	29446401	2	29223535	1093855	1069516	rs1669868225	NC_000002.12:29223534:G:A	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Apr 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3173-8A>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001158875	2	29446402	2	29223536	1158875	1133651	rs1573125720	NC_000002.12:29223535:T:G	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Feb 5, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3173-11C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001605740	2	29446405	2	29223539	1605740	1646792	rs79339096	NC_000002.12:29223538:G:C	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Sep 19, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3173-11C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001585676	2	29446405	2	29223539	1585676	1540192	rs79339096	NC_000002.12:29223538:G:T	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Oct 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3173-11C>T	ALK		Hereditary cancer-predisposing syndrome|not specified|Neuroblastoma Susceptibility|Neuroblastoma, susceptibility to, 3	VCV000335696	2	29446405	2	29223539	335696	288992	rs79339096	NC_000002.12:29223538:G:A	single nucleotide variant	5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Dec 26, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3173-13C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003626384	2	29446407	2	29223541	3626384	3758215		NC_000002.12:29223540:G:A	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Apr 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3173-13C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002762838	2	29446407	2	29223541	2762838	2931332		NC_000002.12:29223540:G:C	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Dec 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3173-14C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001663523	2	29446408	2	29223542	1663523	1619832	rs1370170133	NC_000002.12:29223541:G:C	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Apr 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3173-16G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003649024	2	29446410	2	29223544	3649024	3781033		NC_000002.12:29223543:C:A	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Apr 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3173-16G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002763336	2	29446410	2	29223544	2763336	2925375		NC_000002.12:29223543:C:T	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Dec 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3173-16G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002044980	2	29446410	2	29223544	2044980	2092553		NC_000002.12:29223543:C:G	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Feb 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3173-147T>A	ALK		not provided	VCV001222711	2	29446541	2	29223675	1222711	1211820	rs76146270	NC_000002.12:29223674:A:T	single nucleotide variant	5 prime UTR variant|intron variant	Benign	Jul 20, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3173-307A>G	ALK		not provided	VCV001270699	2	29446701	2	29223835	1270699	1261836	rs12619049	NC_000002.12:29223834:T:C	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3173-662del	ALK		not provided	VCV002650791	2	29447056	2	29224190	2650791	2815650		NC_000002.12:29224189:A:	Deletion	intron variant	Benign	Sep 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3173-791C>A	ALK		not provided	VCV002650792	2	29447185	2	29224319	2650792	2815651		NC_000002.12:29224318:G:T	single nucleotide variant	intron variant	Benign	Aug 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3172+722A>G	ALK		not provided	VCV002650793	2	29447605	2	29224739	2650793	2815652		NC_000002.12:29224738:T:C	single nucleotide variant	intron variant	Benign	Feb 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3172+678C>T	ALK		not provided	VCV002650794	2	29447649	2	29224783	2650794	2815653		NC_000002.12:29224782:G:A	single nucleotide variant	intron variant	Benign	Jul 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3172+549T>C	ALK		not provided	VCV002650795	2	29447778	2	29224912	2650795	2815654		NC_000002.12:29224911:A:G	single nucleotide variant	intron variant	Benign	Nov 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3172+347G>A	ALK		not provided	VCV001711496	2	29447980	2	29225114	1711496	1709912		NC_000002.12:29225113:C:T	single nucleotide variant	intron variant	Benign	Sep 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3172+300C>G	ALK		not provided	VCV001211273	2	29448027	2	29225161	1211273	1201271	rs73920736	NC_000002.12:29225160:G:C	single nucleotide variant	intron variant	Likely benign	May 25, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3172+20G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003612894	2	29448307	2	29225441	3612894	3745161		NC_000002.12:29225440:C:A	single nucleotide variant	intron variant	Likely benign	Nov 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3172+18dup	ALK		Neuroblastoma, susceptibility to, 3	VCV002984477	2	29448308 - 29448309	2	29225442 - 29225443	2984477	3146089		NC_000002.12:29225442:GGGG:GGGGG	Duplication	intron variant	Likely benign	Feb 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3172+18C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002154267	2	29448309	2	29225443	2154267	1889160		NC_000002.12:29225442:G:C	single nucleotide variant	intron variant	Likely benign	Apr 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3172+17C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002107040	2	29448310	2	29225444	2107040	2170094		NC_000002.12:29225443:G:C	single nucleotide variant	intron variant	Likely benign	Mar 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3172+15C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002031265	2	29448312	2	29225446	2031265	2078907		NC_000002.12:29225445:G:A	single nucleotide variant	intron variant	Likely benign	Jul 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3172+12G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001573174	2	29448315	2	29225449	1573174	1573540	rs1271239593	NC_000002.12:29225448:C:T	single nucleotide variant	intron variant	Likely benign	Sep 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3172+12G>C	ALK		not specified	VCV000511365	2	29448315	2	29225449	511365	500150	rs1271239593	NC_000002.12:29225448:C:G	single nucleotide variant	intron variant	Likely benign	Aug 7, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.3172+10_3172+11del	ALK		Neuroblastoma, susceptibility to, 3	VCV000470819	2	29448316 - 29448317	2	29225450 - 29225451	470819	451054	rs374518328	NC_000002.12:29225449:TGTG:TG	Microsatellite	intron variant	Likely benign	Jan 29, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.3172+10C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002165410	2	29448317	2	29225451	2165410	1905828		NC_000002.12:29225450:G:C	single nucleotide variant	intron variant	Likely benign	May 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3172+10C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000754133	2	29448317	2	29225451	754133	774696	rs1573128671	NC_000002.12:29225450:G:A	single nucleotide variant	intron variant	Likely benign	Oct 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3172+8C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001129789	2	29448319	2	29225453	1129789	1112742	rs77798934	NC_000002.12:29225452:G:A	single nucleotide variant	intron variant	Likely benign	Jul 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3172+7G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002031571	2	29448320	2	29225454	2031571	2089476		NC_000002.12:29225453:C:G	single nucleotide variant	intron variant	Likely benign	Sep 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3172+6T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001504290	2	29448321	2	29225455	1504290	1337165	rs2148176274	NC_000002.12:29225454:A:G	single nucleotide variant	intron variant	Uncertain significance	Nov 17, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3172+1G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000581515	2	29448326	2	29225460	581515	561317	rs1558625168	NC_000002.12:29225459:C:T	single nucleotide variant	splice donor variant	Uncertain significance	Sep 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3170T>G (p.Ile1057Ser)	ALK	I1057S	Hereditary cancer-predisposing syndrome	VCV002586665	2	29448329	2	29225463	2586665	2756848		NC_000002.12:29225462:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3170T>C (p.Ile1057Thr)	ALK	I1057T	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000851037	2	29448329	2	29225463	851037	826320	rs747594544	NC_000002.12:29225462:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3168G>A (p.Met1056Ile)	ALK	M1056I	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001017658	2	29448331	2	29225465	1017658	1003975	rs1663940304	NC_000002.12:29225464:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3167T>C (p.Met1056Thr)	ALK	M1056T	Neuroblastoma, susceptibility to, 3	VCV001436772	2	29448332	2	29225466	1436772	1341162	rs2148176295	NC_000002.12:29225465:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3166A>G (p.Met1056Val)	ALK	M1056V	Hereditary cancer-predisposing syndrome	VCV003525451	2	29448333	2	29225467	3525451	3685807		NC_000002.12:29225466:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3166A>C (p.Met1056Leu)	ALK	M1056L	Hereditary cancer-predisposing syndrome	VCV003223858	2	29448333	2	29225467	3223858	3380880		NC_000002.12:29225466:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3165C>T (p.Ile1055=)	ALK		Hereditary cancer-predisposing syndrome	VCV002586672	2	29448334	2	29225468	2586672	2756855		NC_000002.12:29225467:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3163A>T (p.Ile1055Phe)	ALK	I1055F	Neuroblastoma, susceptibility to, 3	VCV001047037	2	29448336	2	29225470	1047037	1024443	rs755804208	NC_000002.12:29225469:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3162C>T (p.Gly1054=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001728325	2	29448337	2	29225471	1728325	1791725		NC_000002.12:29225470:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3161G>A (p.Gly1054Asp)	ALK	G1054D	Neuroblastoma, susceptibility to, 3	VCV001424544	2	29448338	2	29225472	1424544	1438420	rs2148176315	NC_000002.12:29225471:C:T	single nucleotide variant	missense variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3161G>T (p.Gly1054Val)	ALK	G1054V	Neuroblastoma, susceptibility to, 3	VCV001059169	2	29448338	2	29225472	1059169	1041387	rs2148176315	NC_000002.12:29225471:C:A	single nucleotide variant	missense variant	Uncertain significance	May 3, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3160G>A (p.Gly1054Ser)	ALK	G1054S	Familial isolated pituitary adenoma|not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404335	2	29448339	2	29225473	404335	392715	rs375889530	NC_000002.12:29225472:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3159C>T (p.Ser1053=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000702234	2	29448340	2	29225474	702234	691134	rs369764867	NC_000002.12:29225473:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3158C>T (p.Ser1053Phe)	ALK	S1053F	Neuroblastoma, susceptibility to, 3	VCV000860124	2	29448341	2	29225475	860124	826321	rs1663940716	NC_000002.12:29225474:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3157T>C (p.Ser1053Pro)	ALK	S1053P	Neuroblastoma, susceptibility to, 3	VCV002819439	2	29448342	2	29225476	2819439	2987794		NC_000002.12:29225475:A:G	single nucleotide variant	missense variant	Uncertain significance	May 31, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3156C>T (p.Phe1052=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002020352	2	29448343	2	29225477	2020352	2079537		NC_000002.12:29225476:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 29, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3154T>C (p.Phe1052Leu)	ALK	F1052L	Hereditary cancer-predisposing syndrome	VCV001728226	2	29448345	2	29225479	1728226	1791626		NC_000002.12:29225478:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3154T>G (p.Phe1052Val)	ALK	F1052V	Neuroblastoma, susceptibility to, 3	VCV001000852	2	29448345	2	29225479	1000852	988694	rs1663940813	NC_000002.12:29225478:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3153T>C (p.Ala1051=)	ALK		Hereditary cancer-predisposing syndrome	VCV002566603	2	29448346	2	29225480	2566603	2734446		NC_000002.12:29225479:A:G	single nucleotide variant	synonymous variant	Likely benign	May 31, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3151G>T (p.Ala1051Ser)	ALK	A1051S	Neuroblastoma, susceptibility to, 3	VCV002979687	2	29448348	2	29225482	2979687	3134451		NC_000002.12:29225481:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3150G>C (p.Leu1050=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001964408	2	29448349	2	29225483	1964408	2021095		NC_000002.12:29225482:C:G	single nucleotide variant	synonymous variant	Likely benign	May 29, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3150G>A (p.Leu1050=)	ALK		Hereditary cancer-predisposing syndrome	VCV001728191	2	29448349	2	29225483	1728191	1791591		NC_000002.12:29225482:C:T	single nucleotide variant	synonymous variant	Likely benign	May 23, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3148C>T (p.Leu1050=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001147749	2	29448351	2	29225485	1147749	1133652	rs2148176357	NC_000002.12:29225484:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3147C>A (p.Val1049=)	ALK		Hereditary cancer-predisposing syndrome	VCV001728135	2	29448352	2	29225486	1728135	1791535		NC_000002.12:29225485:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3147C>T (p.Val1049=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001619659	2	29448352	2	29225486	1619659	1615205	rs2148176361	NC_000002.12:29225485:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 29, 2021	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3133_3147del (p.Val1045_Val1049del)	ALK		Neuroblastoma, susceptibility to, 3	VCV000647701	2	29448352 - 29448366	2	29225486 - 29225500	647701	629838	rs1573128739	NC_000002.12:29225485:GACCAGGGCGGCCACGA:GA	Deletion	inframe_deletion	Uncertain significance	Dec 17, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3145G>T (p.Val1049Phe)	ALK	V1049F	Hereditary cancer-predisposing syndrome	VCV003223857	2	29448354	2	29225488	3223857	3380879		NC_000002.12:29225487:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3145G>A (p.Val1049Ile)	ALK	V1049I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000944983	2	29448354	2	29225488	944983	922712	rs143452915	NC_000002.12:29225487:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3144G>C (p.Leu1048=)	ALK		Hereditary cancer-predisposing syndrome	VCV001728119	2	29448355	2	29225489	1728119	1794987		NC_000002.12:29225488:C:G	single nucleotide variant	synonymous variant	Likely benign	Sep 8, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3141C>T (p.Ala1047=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001728094	2	29448358	2	29225492	1728094	1794962		NC_000002.12:29225491:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3141C>A (p.Ala1047=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001728093	2	29448358	2	29225492	1728093	1794961		NC_000002.12:29225491:G:T	single nucleotide variant	synonymous variant	Likely benign	Jan 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3140C>T (p.Ala1047Val)	ALK	A1047V	Neuroblastoma, susceptibility to, 3	VCV003722503	2	29448359	2	29225493	3722503	3857016		NC_000002.12:29225492:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3140C>G (p.Ala1047Gly)	ALK	A1047G	Neuroblastoma, susceptibility to, 3	VCV001010622	2	29448359	2	29225493	1010622	988695	rs1217558142	NC_000002.12:29225492:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3139G>C (p.Ala1047Pro)	ALK	A1047P	Neuroblastoma, susceptibility to, 3	VCV002010014	2	29448360	2	29225494	2010014	2070536		NC_000002.12:29225493:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3139G>A (p.Ala1047Thr)	ALK	A1047T	Neuroblastoma, susceptibility to, 3|not specified|Hereditary cancer-predisposing syndrome	VCV000133468	2	29448360	2	29225494	133468	137207	rs370049091	NC_000002.12:29225493:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3138C>G (p.Ala1046=)	ALK		Hereditary cancer-predisposing syndrome	VCV002624784	2	29448361	2	29225495	2624784	2790279		NC_000002.12:29225494:G:C	single nucleotide variant	synonymous variant	Likely benign	Jun 30, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3138C>T (p.Ala1046=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000697670	2	29448361	2	29225495	697670	686182	rs747588801	NC_000002.12:29225494:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3137C>T (p.Ala1046Val)	ALK	A1046V	Neuroblastoma, susceptibility to, 3|not provided	VCV002662004	2	29448362	2	29225496	2662004	2829455		NC_000002.12:29225495:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3135G>A (p.Val1045=)	ALK		not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000956824	2	29448364	2	29225498	956824	942855	rs371735276	NC_000002.12:29225497:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 5, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3134T>C (p.Val1045Ala)	ALK	V1045A	Neuroblastoma, susceptibility to, 3	VCV000664679	2	29448365	2	29225499	664679	629839	rs1573128792	NC_000002.12:29225498:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3133G>C (p.Val1045Leu)	ALK	V1045L	Neuroblastoma, susceptibility to, 3	VCV000470817	2	29448366	2	29225500	470817	450740	rs200641396	NC_000002.12:29225499:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3133G>A (p.Val1045Met)	ALK	V1045M	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404329	2	29448366	2	29225500	404329	392720	rs200641396	NC_000002.12:29225499:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3132C>A (p.Leu1044=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003707198	2	29448367	2	29225501	3707198	3846684		NC_000002.12:29225500:G:T	single nucleotide variant	synonymous variant	Likely benign	Apr 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3132C>G (p.Leu1044=)	ALK		Hereditary cancer-predisposing syndrome	VCV003286454	2	29448367	2	29225501	3286454	3455277		NC_000002.12:29225500:G:C	single nucleotide variant	synonymous variant	Likely benign	Jun 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3132C>T (p.Leu1044=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470816	2	29448367	2	29225501	470816	451030	rs776786956	NC_000002.12:29225500:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3130C>T (p.Leu1044Phe)	ALK	L1044F	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000644322	2	29448369	2	29225503	644322	629840	rs1573128815	NC_000002.12:29225502:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3128C>T (p.Ala1043Val)	ALK	A1043V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000566619	2	29448371	2	29225505	566619	558366	rs757521797	NC_000002.12:29225504:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3127G>A (p.Ala1043Thr)	ALK	A1043T	Hereditary cancer-predisposing syndrome	VCV003522289	2	29448372	2	29225506	3522289	3681777		NC_000002.12:29225505:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3126T>C (p.Ser1042=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000701572	2	29448373	2	29225507	701572	686183	rs770090734	NC_000002.12:29225506:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3123C>T (p.Thr1041=)	ALK		Neuroblastoma, susceptibility to, 3|not specified|Hereditary cancer-predisposing syndrome	VCV000514374	2	29448376	2	29225510	514374	499660	rs773260725	NC_000002.12:29225509:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3122C>T (p.Thr1041Ile)	ALK	T1041I	Neuroblastoma, susceptibility to, 3	VCV000845967	2	29448377	2	29225511	845967	826322	rs1365149175	NC_000002.12:29225510:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3121A>G (p.Thr1041Ala)	ALK	T1041A	Neuroblastoma, susceptibility to, 3	VCV002676377	2	29448378	2	29225512	2676377	2834797		NC_000002.12:29225511:T:C	single nucleotide variant	missense variant	Uncertain significance	May 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3120G>A (p.Val1040=)	ALK		Neuroblastoma, susceptibility to, 3|not specified	VCV000496223	2	29448379	2	29225513	496223	486936	rs1553394893	NC_000002.12:29225512:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3119T>C (p.Val1040Ala)	ALK	V1040A	Hereditary cancer-predisposing syndrome	VCV003285910	2	29448380	2	29225514	3285910	3444650		NC_000002.12:29225513:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3119T>G (p.Val1040Gly)	ALK	V1040G	Neuroblastoma, susceptibility to, 3	VCV002140619	2	29448380	2	29225514	2140619	1878993		NC_000002.12:29225513:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3118G>T (p.Val1040Leu)	ALK	V1040L	Neuroblastoma, susceptibility to, 3	VCV000641443	2	29448381	2	29225515	641443	629841	rs763143588	NC_000002.12:29225514:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3118G>A (p.Val1040Met)	ALK	V1040M	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538199	2	29448381	2	29225515	538199	518200	rs763143588	NC_000002.12:29225514:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3116T>C (p.Val1039Ala)	ALK	V1039A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001053493	2	29448383	2	29225517	1053493	1041388	rs1663943658	NC_000002.12:29225516:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3115G>T (p.Val1039Leu)	ALK	V1039L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000849511	2	29448384	2	29225518	849511	826323	rs200080181	NC_000002.12:29225517:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3115G>A (p.Val1039Met)	ALK	V1039M	not provided|Neuroblastoma, susceptibility to, 3|Familial isolated pituitary adenoma|Hereditary cancer-predisposing syndrome	VCV000404367	2	29448384	2	29225518	404367	392722	rs200080181	NC_000002.12:29225517:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3115G>C (p.Val1039Leu)	ALK	V1039L	Neuroblastoma, susceptibility to, 3|not provided	VCV000404324	2	29448384	2	29225518	404324	392612	rs200080181	NC_000002.12:29225517:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3111_3114del (p.Ser1038fs)	ALK	S1038fs	Neuroblastoma, susceptibility to, 3	VCV000959821	2	29448385 - 29448388	2	29225519 - 29225522	959821	942856	rs750796687	NC_000002.12:29225518:AGAGAG:AG	Microsatellite	frameshift variant	Uncertain significance	Feb 3, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.3111C>A (p.Leu1037=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002720551	2	29448388	2	29225522	2720551	2890954		NC_000002.12:29225521:G:T	single nucleotide variant	synonymous variant	Likely benign	Sep 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3111C>G (p.Leu1037=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001727752	2	29448388	2	29225522	1727752	1794620		NC_000002.12:29225521:G:C	single nucleotide variant	synonymous variant	Likely benign	May 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3111C>T (p.Leu1037=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000796742	2	29448388	2	29225522	796742	781301	rs1304972455	NC_000002.12:29225521:G:A	single nucleotide variant	synonymous variant	Likely benign	May 14, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3110T>C (p.Leu1037Pro)	ALK	L1037P	Hereditary cancer-predisposing syndrome	VCV003523894	2	29448389	2	29225523	3523894	3682062		NC_000002.12:29225522:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3108C>T (p.Ile1036=)	ALK		Hereditary cancer-predisposing syndrome	VCV001727710	2	29448391	2	29225525	1727710	1794578		NC_000002.12:29225524:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 23, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3107T>A (p.Ile1036Asn)	ALK	I1036N	Neuroblastoma, susceptibility to, 3	VCV001414488	2	29448392	2	29225526	1414488	1369692	rs1663944377	NC_000002.12:29225525:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3106A>G (p.Ile1036Val)	ALK	I1036V	Neuroblastoma, susceptibility to, 3	VCV001005283	2	29448393	2	29225527	1005283	988696	rs1663944530	NC_000002.12:29225526:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3104T>G (p.Leu1035Arg)	ALK	L1035R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000655508	2	29448395	2	29225529	655508	629842	rs1366270319	NC_000002.12:29225528:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3102G>A (p.Ser1034=)	ALK		Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000412908	2	29448397	2	29225531	412908	392614	rs138771319	NC_000002.12:29225530:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3101C>A (p.Ser1034Ter)	ALK	S1034*	Neuroblastoma, susceptibility to, 3	VCV001434320	2	29448398	2	29225532	1434320	1494136	rs900240239	NC_000002.12:29225531:G:T	single nucleotide variant	nonsense	Uncertain significance	Feb 24, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3101C>G (p.Ser1034Trp)	ALK	S1034W	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000999071	2	29448398	2	29225532	999071	988697	rs900240239	NC_000002.12:29225531:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3101C>T (p.Ser1034Leu)	ALK	S1034L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000951333	2	29448398	2	29225532	951333	922713	rs900240239	NC_000002.12:29225531:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3099C>T (p.Leu1033=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001727542	2	29448400	2	29225534	1727542	1785022		NC_000002.12:29225533:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3098T>C (p.Leu1033Pro)	ALK	L1033P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001499076	2	29448401	2	29225535	1499076	1488821	rs572614173	NC_000002.12:29225534:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3098T>G (p.Leu1033Arg)	ALK	L1033R	Neuroblastoma, susceptibility to, 3	VCV001412978	2	29448401	2	29225535	1412978	1356575	rs572614173	NC_000002.12:29225534:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3098T>A (p.Leu1033His)	ALK	L1033H	Neuroblastoma, susceptibility to, 3|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000706161	2	29448401	2	29225535	706161	691135	rs572614173	NC_000002.12:29225534:A:T	single nucleotide variant	missense variant	Likely benign	Sep 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3097C>A (p.Leu1033Ile)	ALK	L1033I	Hereditary cancer-predisposing syndrome	VCV002566573	2	29448402	2	29225536	2566573	2734416		NC_000002.12:29225535:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3097C>T (p.Leu1033Phe)	ALK	L1033F	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000955714	2	29448402	2	29225536	955714	942857	rs139365887	NC_000002.12:29225535:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3096A>G (p.Pro1032=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003649285	2	29448403	2	29225537	3649285	3781294		NC_000002.12:29225536:T:C	single nucleotide variant	synonymous variant	Likely benign	Apr 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3096A>T (p.Pro1032=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000702673	2	29448403	2	29225537	702673	691136	rs1309558657	NC_000002.12:29225536:T:A	single nucleotide variant	synonymous variant	Likely benign	Dec 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3095C>A (p.Pro1032Gln)	ALK	P1032Q	Neuroblastoma, susceptibility to, 3	VCV001487852	2	29448404	2	29225538	1487852	1481885	rs752256731	NC_000002.12:29225537:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3095C>T (p.Pro1032Leu)	ALK	P1032L	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000566080	2	29448404	2	29225538	566080	560585	rs752256731	NC_000002.12:29225537:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3094C>T (p.Pro1032Ser)	ALK	P1032S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001431379	2	29448405	2	29225539	1431379	1490678	rs369347067	NC_000002.12:29225538:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3093G>A (p.Leu1031=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002017692	2	29448406	2	29225540	2017692	2065333		NC_000002.12:29225539:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3093G>T (p.Leu1031=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001107354	2	29448406	2	29225540	1107354	1091240	rs1293404546	NC_000002.12:29225539:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3093G>C (p.Leu1031=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000794954	2	29448406	2	29225540	794954	781302	rs1293404546	NC_000002.12:29225539:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 10, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3092T>G (p.Leu1031Arg)	ALK	L1031R	Hereditary cancer-predisposing syndrome	VCV001692779	2	29448407	2	29225541	1692779	1685219	rs2148176506	NC_000002.12:29225540:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3091C>T (p.Leu1031=)	ALK		Hereditary cancer-predisposing syndrome|not specified|Neuroblastoma, susceptibility to, 3	VCV000929022	2	29448408	2	29225542	929022	916862	rs755537480	NC_000002.12:29225541:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 10, 2020	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3090C>G (p.His1030Gln)	ALK	H1030Q	Neuroblastoma, susceptibility to, 3	VCV003670393	2	29448409	2	29225543	3670393	3799802		NC_000002.12:29225542:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3089_3090delinsTT (p.His1030Leu)	ALK	H1030L	Neuroblastoma, susceptibility to, 3	VCV002194599	2	29448409 - 29448410	2	29225543 - 29225544	2194599	1923381		NC_000002.12:29225542:GT:AA	Indel	missense variant	Uncertain significance	Sep 14, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3090C>T (p.His1030=)	ALK		Hereditary cancer-predisposing syndrome	VCV001727461	2	29448409	2	29225543	1727461	1784941		NC_000002.12:29225542:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 30, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3090C>A (p.His1030Gln)	ALK	H1030Q	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001059173	2	29448409	2	29225543	1059173	1041389	rs1663946773	NC_000002.12:29225542:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3087_3089del (p.His1030del)	ALK	H1030del	Hereditary cancer-predisposing syndrome	VCV003284412	2	29448410 - 29448412	2	29225544 - 29225546	3284412	3437453		NC_000002.12:29225543:TGT:	Deletion	inframe_deletion	Benign	Mar 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3081_3089del (p.Glu1028_His1030del)	ALK		Hereditary cancer-predisposing syndrome	VCV003284403	2	29448410 - 29448418	2	29225544 - 29225552	3284403	3437444		NC_000002.12:29225543:TGTGGCTCC:	Deletion	inframe_deletion	Benign	Mar 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3089A>C (p.His1030Pro)	ALK	H1030P	Hereditary cancer-predisposing syndrome|not provided	VCV001181511	2	29448410	2	29225544	1181511	1170956	rs200992945	NC_000002.12:29225543:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 19, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3088C>T (p.His1030Tyr)	ALK	H1030Y	Neuroblastoma, susceptibility to, 3	VCV001047211	2	29448411	2	29225545	1047211	1024444	rs1284585137	NC_000002.12:29225544:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3087A>C (p.Pro1029=)	ALK		Hereditary cancer-predisposing syndrome	VCV003521642	2	29448412	2	29225546	3521642	3684630		NC_000002.12:29225545:T:G	single nucleotide variant	synonymous variant	Likely benign	Aug 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3087A>T (p.Pro1029=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001095669	2	29448412	2	29225546	1095669	1069517	rs753474713	NC_000002.12:29225545:T:A	single nucleotide variant	synonymous variant	Likely benign	Sep 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3085C>T (p.Pro1029Ser)	ALK	P1029S	Neuroblastoma, susceptibility to, 3	VCV002730583	2	29448414	2	29225548	2730583	2883319		NC_000002.12:29225547:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3085C>G (p.Pro1029Ala)	ALK	P1029A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000335697	2	29448414	2	29225548	335697	289378	rs543328121	NC_000002.12:29225547:G:C	single nucleotide variant	missense variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3081_3084del (p.Glu1028fs)	ALK	E1028fs	Hereditary cancer-predisposing syndrome	VCV003284422	2	29448415 - 29448418	2	29225549 - 29225552	3284422	3437463		NC_000002.12:29225548:CTCC:	Deletion	frameshift variant	Benign	Mar 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3082del (p.Glu1028fs)	ALK	E1028fs	Neuroblastoma, susceptibility to, 3	VCV000850207	2	29448417	2	29225551	850207	826324	rs1663951981	NC_000002.12:29225550:CC:C	Deletion	frameshift variant	Uncertain significance	Jul 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3081G>C (p.Pro1027=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001115373	2	29448418	2	29225552	1115373	1091241	rs747320964	NC_000002.12:29225551:C:G	single nucleotide variant	synonymous variant	Likely benign	Mar 14, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3081G>A (p.Pro1027=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000470815	2	29448418	2	29225552	470815	451034	rs747320964	NC_000002.12:29225551:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3080C>A (p.Pro1027Gln)	ALK	P1027Q	Neuroblastoma, susceptibility to, 3	VCV001720064	2	29448419	2	29225553	1720064	1779103		NC_000002.12:29225552:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3080C>T (p.Pro1027Leu)	ALK	P1027L	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000133467	2	29448419	2	29225553	133467	137206	rs140733978	NC_000002.12:29225552:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3078C>T (p.Thr1026=)	ALK		Hereditary cancer-predisposing syndrome	VCV001727329	2	29448421	2	29225555	1727329	1784809		NC_000002.12:29225554:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 9, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3078C>A (p.Thr1026=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001104690	2	29448421	2	29225555	1104690	1091242	rs2148176571	NC_000002.12:29225554:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3077C>A (p.Thr1026Asn)	ALK	T1026N	Neuroblastoma, susceptibility to, 3	VCV002011710	2	29448422	2	29225556	2011710	2070939		NC_000002.12:29225555:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3076A>G (p.Thr1026Ala)	ALK	T1026A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000657588	2	29448423	2	29225557	657588	629843	rs781515382	NC_000002.12:29225556:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3076A>C (p.Thr1026Pro)	ALK	T1026P	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000648437	2	29448423	2	29225557	648437	629844	rs781515382	NC_000002.12:29225556:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3075C>T (p.Pro1025=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003016961	2	29448424	2	29225558	3016961	3178479		NC_000002.12:29225557:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3075C>A (p.Pro1025=)	ALK		Hereditary cancer-predisposing syndrome	VCV001727300	2	29448424	2	29225558	1727300	1784780		NC_000002.12:29225557:G:T	single nucleotide variant	synonymous variant	Likely benign	May 30, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3074C>T (p.Pro1025Leu)	ALK	P1025L	Hereditary cancer-predisposing syndrome	VCV002586701	2	29448425	2	29225559	2586701	2756884		NC_000002.12:29225558:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3074C>A (p.Pro1025His)	ALK	P1025H	Hereditary cancer-predisposing syndrome	VCV002566560	2	29448425	2	29225559	2566560	2734403		NC_000002.12:29225558:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 31, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3071C>T (p.Ser1024Leu)	ALK	S1024L	Hereditary cancer-predisposing syndrome	VCV001727261	2	29448428	2	29225562	1727261	1784741		NC_000002.12:29225561:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3068T>G (p.Val1023Gly)	ALK	V1023G	Neuroblastoma, susceptibility to, 3	VCV002706778	2	29448431	2	29225565	2706778	2870351		NC_000002.12:29225564:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3068-7C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002919927	2	29448438	2	29225572	2919927	3080731		NC_000002.12:29225571:G:T	single nucleotide variant	intron variant	Uncertain significance	Jan 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3068-7C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002736322	2	29448438	2	29225572	2736322	2895014		NC_000002.12:29225571:G:A	single nucleotide variant	intron variant	Likely benign	Jul 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3068-8T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002120254	2	29448439	2	29225573	2120254	2172974		NC_000002.12:29225572:A:G	single nucleotide variant	intron variant	Uncertain significance	Nov 22, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3068-9G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000771651	2	29448440	2	29225574	771651	777269	rs1409418856	NC_000002.12:29225573:C:T	single nucleotide variant	intron variant	Likely benign	Dec 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3068-11C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003653171	2	29448442	2	29225576	3653171	3778560		NC_000002.12:29225575:G:A	single nucleotide variant	intron variant	Likely benign	May 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3068-12C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001672391	2	29448443	2	29225577	1672391	1616646	rs1020176274	NC_000002.12:29225576:G:T	single nucleotide variant	intron variant	Likely benign	Dec 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3068-13A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001642057	2	29448444	2	29225578	1642057	1651100	rs1018923976	NC_000002.12:29225577:T:C	single nucleotide variant	intron variant	Likely benign	Mar 24, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3068-13A>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001593029	2	29448444	2	29225578	1593029	1620584	rs1018923976	NC_000002.12:29225577:T:A	single nucleotide variant	intron variant	Likely benign	Sep 13, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3068-19A>C	ALK		Neuroblastoma, susceptibility to, 3	VCV003668356	2	29448450	2	29225584	3668356	3802881		NC_000002.12:29225583:T:G	single nucleotide variant	intron variant	Likely benign	Aug 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3068-19A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002147377	2	29448450	2	29225584	2147377	1880567		NC_000002.12:29225583:T:C	single nucleotide variant	intron variant	Uncertain significance	Dec 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3068-43A>G	ALK		not provided	VCV002650796	2	29448474	2	29225608	2650796	2815655		NC_000002.12:29225607:T:C	single nucleotide variant	intron variant	Likely benign	Nov 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3068-225C>A	ALK		not provided	VCV001219865	2	29448656	2	29225790	1219865	1209842	rs184052100	NC_000002.12:29225789:G:T	single nucleotide variant	intron variant	Likely benign	Apr 3, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3068-228A>T	ALK		not provided	VCV001204792	2	29448659	2	29225793	1204792	1193144	rs114110162	NC_000002.12:29225792:T:A	single nucleotide variant	intron variant	Likely benign	Sep 16, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3068-241G>T	ALK		not provided	VCV001297432	2	29448672	2	29225806	1297432	1287221	rs72852040	NC_000002.12:29225805:C:A	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.3068-329G>A	ALK		not provided	VCV001277832	2	29448760	2	29225894	1277832	1269165	rs34935102	NC_000002.12:29225893:C:T	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3068-360_3068-357del	ALK		not provided	VCV002650797	2	29448788 - 29448791	2	29225922 - 29225925	2650797	2815656		NC_000002.12:29225921:GTAAGTAA:GTAA	Microsatellite	intron variant	Likely benign	Nov 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3068-504C>T	ALK		not provided	VCV002650798	2	29448935	2	29226069	2650798	2815657		NC_000002.12:29226068:G:A	single nucleotide variant	intron variant	Benign	Sep 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+514C>A	ALK		not provided	VCV003026427	2	29449274	2	29226408	3026427	3186739		NC_000002.12:29226407:G:T	single nucleotide variant	intron variant	Benign	Dec 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+262G>A	ALK		not provided	VCV001279411	2	29449526	2	29226660	1279411	1269444	rs1881419	NC_000002.12:29226659:C:T	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+91G>A	ALK		not provided	VCV002650799	2	29449697	2	29226831	2650799	2815658		NC_000002.12:29226830:C:T	single nucleotide variant	intron variant	Likely benign	Sep 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+89C>G	ALK		not provided	VCV002650800	2	29449699	2	29226833	2650800	2815659		NC_000002.12:29226832:G:C	single nucleotide variant	intron variant	Benign	Nov 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+26A>G	ALK		not provided	VCV002650801	2	29449762	2	29226896	2650801	2815660		NC_000002.12:29226895:T:C	single nucleotide variant	intron variant	Likely benign	Oct 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+19G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV003728459	2	29449769	2	29226903	3728459	3851790		NC_000002.12:29226902:C:G	single nucleotide variant	intron variant	Likely benign	Jan 2, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+19G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV003628710	2	29449769	2	29226903	3628710	3756041		NC_000002.12:29226902:C:T	single nucleotide variant	intron variant	Likely benign	Jul 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+17A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002145184	2	29449771	2	29226905	2145184	1870129		NC_000002.12:29226904:T:C	single nucleotide variant	intron variant	Likely benign	Jun 28, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+17del	ALK		Neuroblastoma, susceptibility to, 3	VCV001598745	2	29449771	2	29226905	1598745	1630742	rs781479217	NC_000002.12:29226904:T:	Deletion	intron variant	Benign	Jan 28, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+16C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002786284	2	29449772	2	29226906	2786284	2938790		NC_000002.12:29226905:G:A	single nucleotide variant	intron variant	Likely benign	Sep 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+16C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002169937	2	29449772	2	29226906	2169937	1899958		NC_000002.12:29226905:G:T	single nucleotide variant	intron variant	Likely benign	Oct 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+15C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001673823	2	29449773	2	29226907	1673823	1649123	rs2148178230	NC_000002.12:29226906:G:C	single nucleotide variant	intron variant	Likely benign	May 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+14G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003703516	2	29449774	2	29226908	3703516	3845597		NC_000002.12:29226907:C:A	single nucleotide variant	intron variant	Likely benign	Nov 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+13G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002920530	2	29449775	2	29226909	2920530	3077969		NC_000002.12:29226908:C:T	single nucleotide variant	intron variant	Likely benign	Mar 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+12G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002701420	2	29449776	2	29226910	2701420	2862414		NC_000002.12:29226909:C:G	single nucleotide variant	intron variant	Likely benign	Dec 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+10C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000566882	2	29449778	2	29226912	566882	558368	rs1553395203	NC_000002.12:29226911:G:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+10C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000538304	2	29449778	2	29226912	538304	518124	rs1553395203	NC_000002.12:29226911:G:C	single nucleotide variant	intron variant	Likely benign	Jul 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+9G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002080456	2	29449779	2	29226913	2080456	2135689		NC_000002.12:29226912:C:G	single nucleotide variant	intron variant	Likely benign	Mar 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+9G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001144011	2	29449779	2	29226913	1144011	1133653	rs1664016363	NC_000002.12:29226912:C:T	single nucleotide variant	intron variant	Likely benign	Jan 1, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+9G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001003201	2	29449779	2	29226913	1003201	988698	rs1664016363	NC_000002.12:29226912:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 23, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3067+6G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000658899	2	29449782	2	29226916	658899	651016	rs1573131521	NC_000002.12:29226915:C:A	single nucleotide variant	intron variant	Uncertain significance	Apr 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+3A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000645288	2	29449785	2	29226919	645288	650952	rs753385730	NC_000002.12:29226918:T:C	single nucleotide variant	intron variant	Uncertain significance	Feb 2, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.3067+1G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001426854	2	29449787	2	29226921	1426854	1366527	rs2148178263	NC_000002.12:29226920:C:A	single nucleotide variant	splice donor variant	Uncertain significance	Mar 22, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3067G>C (p.Val1023Leu)	ALK	V1023L	Neuroblastoma, susceptibility to, 3	VCV002024309	2	29449788	2	29226922	2024309	2077086		NC_000002.12:29226921:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3067G>A (p.Val1023Met)	ALK	V1023M	Neuroblastoma, susceptibility to, 3	VCV000239818	2	29449788	2	29226922	239818	238728	rs756986057	NC_000002.12:29226921:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.3066T>G (p.Ile1022Met)	ALK	I1022M	Hereditary cancer-predisposing syndrome	VCV002562273	2	29449789	2	29226923	2562273	2721126		NC_000002.12:29226922:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3065T>A (p.Ile1022Asn)	ALK	I1022N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002864174	2	29449790	2	29226924	2864174	3026539		NC_000002.12:29226923:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3065T>G (p.Ile1022Ser)	ALK	I1022S	Neuroblastoma, susceptibility to, 3	VCV001025790	2	29449790	2	29226924	1025790	1003976	rs778643763	NC_000002.12:29226923:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3065T>C (p.Ile1022Thr)	ALK	I1022T	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000857306	2	29449790	2	29226924	857306	826325	rs778643763	NC_000002.12:29226923:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3064A>G (p.Ile1022Val)	ALK	I1022V	Neuroblastoma, susceptibility to, 3	VCV002849460	2	29449791	2	29226925	2849460	3009249		NC_000002.12:29226924:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3063C>T (p.Cys1021=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001105986	2	29449792	2	29226926	1105986	1091243	rs1664017012	NC_000002.12:29226925:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3062G>C (p.Cys1021Ser)	ALK	C1021S	Neuroblastoma, susceptibility to, 3	VCV001716721	2	29449793	2	29226927	1716721	1778402		NC_000002.12:29226926:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3060C>T (p.Ser1020=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000412940	2	29449795	2	29226929	412940	392726	rs1060503883	NC_000002.12:29226928:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 4, 2016	criteria provided, single submitter							
NM_004304.5(ALK):c.3057C>A (p.Val1019=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided|not specified	VCV000335698	2	29449798	2	29226932	335698	285971	rs138406372	NC_000002.12:29226931:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3055G>T (p.Val1019Phe)	ALK	V1019F	Neuroblastoma, susceptibility to, 3	VCV001002387	2	29449800	2	29226934	1002387	988699	rs76742576	NC_000002.12:29226933:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3055G>A (p.Val1019Ile)	ALK	V1019I	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470814	2	29449800	2	29226934	470814	451055	rs76742576	NC_000002.12:29226933:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.3054C>G (p.Gly1018=)	ALK		Hereditary cancer-predisposing syndrome	VCV001799288	2	29449801	2	29226935	1799288	1854897		NC_000002.12:29226934:G:C	single nucleotide variant	synonymous variant	Likely benign	May 27, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.3054C>T (p.Gly1018=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000697190	2	29449801	2	29226935	697190	683497	rs777769103	NC_000002.12:29226934:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3052G>A (p.Gly1018Ser)	ALK	G1018S	Neuroblastoma, susceptibility to, 3	VCV000404327	2	29449803	2	29226937	404327	392732	rs1060500212	NC_000002.12:29226936:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3050A>G (p.Asp1017Gly)	ALK	D1017G	Neuroblastoma, susceptibility to, 3	VCV003658972	2	29449805	2	29226939	3658972	3793969		NC_000002.12:29226938:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3048_3050del (p.Glu1016del)	ALK	E1016del	Neuroblastoma, susceptibility to, 3	VCV003638932	2	29449805 - 29449807	2	29226939 - 29226941	3638932	3771798		NC_000002.12:29226938:TCCTC:TC	Deletion		Uncertain significance	Feb 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3048G>C (p.Glu1016Asp)	ALK	E1016D	Neuroblastoma, susceptibility to, 3	VCV003654594	2	29449807	2	29226941	3654594	3778689		NC_000002.12:29226940:C:G	single nucleotide variant	missense variant	Uncertain significance	May 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3043G>A (p.Ala1015Thr)	ALK	A1015T	Neuroblastoma, susceptibility to, 3	VCV002756852	2	29449812	2	29226946	2756852	2910253		NC_000002.12:29226945:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3043G>T (p.Ala1015Ser)	ALK	A1015S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000651283	2	29449812	2	29226946	651283	629845	rs1263029598	NC_000002.12:29226945:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3042G>A (p.Leu1014=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538276	2	29449813	2	29226947	538276	518059	rs1553395215	NC_000002.12:29226946:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3040C>T (p.Leu1014=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223856	2	29449815	2	29226949	3223856	3380878		NC_000002.12:29226948:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3039G>T (p.Val1013=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003660760	2	29449816	2	29226950	3660760	3794475		NC_000002.12:29226949:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3039G>A (p.Val1013=)	ALK		Hereditary cancer-predisposing syndrome	VCV003524199	2	29449816	2	29226950	3524199	3682367		NC_000002.12:29226949:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3037G>T (p.Val1013Leu)	ALK	V1013L	Neuroblastoma, susceptibility to, 3	VCV001986549	2	29449818	2	29226952	1986549	2036698		NC_000002.12:29226951:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3036_3037delinsAT (p.Val1013Leu)	ALK	V1013L	Neuroblastoma, susceptibility to, 3	VCV001379905	2	29449818 - 29449819	2	29226952 - 29226953	1379905	1483284	rs2148178369	NC_000002.12:29226951:CC:AT	Indel	missense variant	Uncertain significance	Jun 26, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3036G>A (p.Thr1012=)	ALK		Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3|not specified	VCV000259270	2	29449819	2	29226953	259270	250718	rs2293563	NC_000002.12:29226952:C:T	single nucleotide variant	synonymous variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3035C>T (p.Thr1012Met)	ALK	T1012M	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000133465	2	29449820	2	29226954	133465	137204	rs35073634	NC_000002.12:29226953:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3031G>C (p.Gly1011Arg)	ALK	G1011R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001799052	2	29449824	2	29226958	1799052	1856320		NC_000002.12:29226957:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3031G>A (p.Gly1011Arg)	ALK	G1011R	Neuroblastoma, susceptibility to, 3|not provided	VCV000133466	2	29449824	2	29226958	133466	137205	rs587778021	NC_000002.12:29226957:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3030C>T (p.His1010=)	ALK		not specified|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000239817	2	29449825	2	29226959	239817	238729	rs367642503	NC_000002.12:29226958:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3029A>G (p.His1010Arg)	ALK	H1010R	Neuroblastoma, susceptibility to, 3	VCV003730296	2	29449826	2	29226960	3730296	3862362		NC_000002.12:29226959:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3028C>T (p.His1010Tyr)	ALK	H1010Y	Hereditary cancer-predisposing syndrome	VCV003223855	2	29449827	2	29226961	3223855	3380877		NC_000002.12:29226960:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3027C>A (p.Asp1009Glu)	ALK	D1009E	Neuroblastoma, susceptibility to, 3	VCV002816067	2	29449828	2	29226962	2816067	2976737		NC_000002.12:29226961:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3027C>T (p.Asp1009=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002086648	2	29449828	2	29226962	2086648	2140689		NC_000002.12:29226961:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3026A>G (p.Asp1009Gly)	ALK	D1009G	Hereditary cancer-predisposing syndrome	VCV003284507	2	29449829	2	29226963	3284507	3433658		NC_000002.12:29226962:T:C	single nucleotide variant	missense variant	Uncertain significance	May 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3025G>C (p.Asp1009His)	ALK	D1009H	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000940005	2	29449830	2	29226964	940005	931353	rs376962390	NC_000002.12:29226963:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3020T>C (p.Phe1007Ser)	ALK	F1007S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000572738	2	29449835	2	29226969	572738	558370	rs1558626190	NC_000002.12:29226968:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3019T>G (p.Phe1007Val)	ALK	F1007V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000647054	2	29449836	2	29226970	647054	629846	rs1573131702	NC_000002.12:29226969:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3018C>A (p.Cys1006Ter)	ALK	C1006*	Neuroblastoma, susceptibility to, 3	VCV003638781	2	29449837	2	29226971	3638781	3771648		NC_000002.12:29226970:G:T	single nucleotide variant	nonsense	Uncertain significance	Feb 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3018C>T (p.Cys1006=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000762039	2	29449837	2	29226971	762039	763175	rs1573131707	NC_000002.12:29226970:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 7, 2019	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3017G>T (p.Cys1006Phe)	ALK	C1006F	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538200	2	29449838	2	29226972	538200	518127	rs1553395221	NC_000002.12:29226971:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3016T>C (p.Cys1006Arg)	ALK	C1006R	Hereditary cancer-predisposing syndrome	VCV003286045	2	29449839	2	29226973	3286045	3444785		NC_000002.12:29226972:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3014T>C (p.Ile1005Thr)	ALK	I1005T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001041118	2	29449841	2	29226975	1041118	1024445	rs1452461214	NC_000002.12:29226974:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3013A>G (p.Ile1005Val)	ALK	I1005V	Neuroblastoma, susceptibility to, 3	VCV000948016	2	29449842	2	29226976	948016	922714	rs1664019256	NC_000002.12:29226975:T:C	single nucleotide variant	missense variant	Uncertain significance	May 8, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.3012C>T (p.Val1004=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003655758	2	29449843	2	29226977	3655758	3786474		NC_000002.12:29226976:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3012C>G (p.Val1004=)	ALK		Hereditary cancer-predisposing syndrome	VCV001798820	2	29449843	2	29226977	1798820	1856089		NC_000002.12:29226976:G:C	single nucleotide variant	synonymous variant	Likely benign	Aug 24, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3011T>C (p.Val1004Ala)	ALK	V1004A	Neuroblastoma, susceptibility to, 3	VCV001411149	2	29449844	2	29226978	1411149	1343539	rs2148178460	NC_000002.12:29226977:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 13, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.3010G>A (p.Val1004Ile)	ALK	V1004I	Hereditary cancer-predisposing syndrome	VCV002566606	2	29449845	2	29226979	2566606	2734449		NC_000002.12:29226978:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3009G>C (p.Lys1003Asn)	ALK	K1003N	Hereditary cancer-predisposing syndrome	VCV003525431	2	29449846	2	29226980	3525431	3685787		NC_000002.12:29226979:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.3008A>T (p.Lys1003Met)	ALK	K1003M	Hereditary cancer-predisposing syndrome	VCV003223854	2	29449847	2	29226981	3223854	3380876		NC_000002.12:29226980:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.3008A>G (p.Lys1003Arg)	ALK	K1003R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002418764	2	29449847	2	29226981	2418764	1941322		NC_000002.12:29226980:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3007A>C (p.Lys1003Gln)	ALK	K1003Q	Neuroblastoma, susceptibility to, 3	VCV001983744	2	29449848	2	29226982	1983744	2042899		NC_000002.12:29226981:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3005A>C (p.His1002Pro)	ALK	H1002P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001023757	2	29449850	2	29226984	1023757	1003977	rs760587817	NC_000002.12:29226983:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3004C>T (p.His1002Tyr)	ALK	H1002Y	Neuroblastoma, susceptibility to, 3	VCV000581241	2	29449851	2	29226985	581241	561320	rs764036965	NC_000002.12:29226984:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3002G>A (p.Ser1001Asn)	ALK	S1001N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538233	2	29449853	2	29226987	538233	518134	rs997289275	NC_000002.12:29226986:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.3001A>G (p.Ser1001Gly)	ALK	S1001G	Neuroblastoma, susceptibility to, 3	VCV002966003	2	29449854	2	29226988	2966003	3121161		NC_000002.12:29226987:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.3000A>G (p.Glu1000=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002181068	2	29449855	2	29226989	2181068	1920169		NC_000002.12:29226988:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2999A>G (p.Glu1000Gly)	ALK	E1000G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000665247	2	29449856	2	29226990	665247	629847	rs776287213	NC_000002.12:29226989:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2998G>C (p.Glu1000Gln)	ALK	E1000Q	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001022703	2	29449857	2	29226991	1022703	1003978	rs1664020327	NC_000002.12:29226990:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2997T>G (p.Pro999=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001082583	2	29449858	2	29226992	1082583	1069518	rs2148178500	NC_000002.12:29226991:A:C	single nucleotide variant	synonymous variant	Likely benign	Feb 12, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2996C>T (p.Pro999Leu)	ALK	P999L	Neuroblastoma, susceptibility to, 3	VCV002725783	2	29449859	2	29226993	2725783	2892290		NC_000002.12:29226992:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2994C>T (p.Asp998=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001537162	2	29449861	2	29226995	1537162	1596755	rs1377614762	NC_000002.12:29226994:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2993A>T (p.Asp998Val)	ALK	D998V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001914561	2	29449862	2	29226996	1914561	1977369		NC_000002.12:29226995:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2993A>C (p.Asp998Ala)	ALK	D998A	Neuroblastoma, susceptibility to, 3	VCV001014055	2	29449862	2	29226996	1014055	1003979	rs1664020706	NC_000002.12:29226995:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2992G>A (p.Asp998Asn)	ALK	D998N	Neuroblastoma, susceptibility to, 3	VCV002899670	2	29449863	2	29226997	2899670	3067757		NC_000002.12:29226996:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2991G>A (p.Met997Ile)	ALK	M997I	Hereditary cancer-predisposing syndrome	VCV003286486	2	29449864	2	29226998	3286486	3455309		NC_000002.12:29226997:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2990T>C (p.Met997Thr)	ALK	M997T	Neuroblastoma, susceptibility to, 3	VCV002980282	2	29449865	2	29226999	2980282	3131592		NC_000002.12:29226998:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2990T>A (p.Met997Lys)	ALK	M997K	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002721444	2	29449865	2	29226999	2721444	2884534		NC_000002.12:29226998:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2989A>G (p.Met997Val)	ALK	M997V	Neuroblastoma, susceptibility to, 3	VCV001978533	2	29449866	2	29227000	1978533	2041609		NC_000002.12:29226999:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2988dup (p.Met997fs)	ALK	M997fs	Neuroblastoma, susceptibility to, 3	VCV000651879	2	29449866 - 29449867	2	29227000 - 29227001	651879	629848	rs1573131798	NC_000002.12:29227000:G:GG	Duplication	frameshift variant	Uncertain significance	Nov 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2988C>T (p.His996=)	ALK		Hereditary cancer-predisposing syndrome	VCV001798471	2	29449867	2	29227001	1798471	1856610		NC_000002.12:29227000:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 10, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2985T>C (p.Cys995=)	ALK		Hereditary cancer-predisposing syndrome	VCV001798439	2	29449870	2	29227004	1798439	1856579		NC_000002.12:29227003:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 7, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2984G>T (p.Cys995Phe)	ALK	C995F	Hereditary cancer-predisposing syndrome	VCV003286520	2	29449871	2	29227005	3286520	3455343		NC_000002.12:29227004:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2982dup (p.Cys995fs)	ALK	C995fs	Neuroblastoma, susceptibility to, 3	VCV002201609	2	29449872 - 29449873	2	29227006 - 29227007	2201609	1925145		NC_000002.12:29227006:TT:TTT	Duplication	frameshift variant	Uncertain significance	Jan 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2982A>T (p.Glu994Asp)	ALK	E994D	Hereditary cancer-predisposing syndrome	VCV002586716	2	29449873	2	29227007	2586716	2756899		NC_000002.12:29227006:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2980G>A (p.Glu994Lys)	ALK	E994K	Neuroblastoma, susceptibility to, 3	VCV000864661	2	29449875	2	29227009	864661	826326	rs150344432	NC_000002.12:29227008:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2979C>A (p.Asp993Glu)	ALK	D993E	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000862216	2	29449876	2	29227010	862216	826327	rs761999849	NC_000002.12:29227009:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2979C>T (p.Asp993=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470812	2	29449876	2	29227010	470812	450894	rs761999849	NC_000002.12:29227009:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Nov 28, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2978A>T (p.Asp993Val)	ALK	D993V	Neuroblastoma, susceptibility to, 3	VCV001383268	2	29449877	2	29227011	1383268	1509864	rs1451931405	NC_000002.12:29227010:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2978A>G (p.Asp993Gly)	ALK	D993G	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000847831	2	29449877	2	29227011	847831	826328	rs1451931405	NC_000002.12:29227010:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2977G>C (p.Asp993His)	ALK	D993H	Neuroblastoma, susceptibility to, 3	VCV002159337	2	29449878	2	29227012	2159337	1890346		NC_000002.12:29227011:C:G	single nucleotide variant	missense variant	Uncertain significance	May 14, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2977G>A (p.Asp993Asn)	ALK	D993N	Neuroblastoma, susceptibility to, 3	VCV002091579	2	29449878	2	29227012	2091579	2155962		NC_000002.12:29227011:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2976A>G (p.Val992=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001101884	2	29449879	2	29227013	1101884	1091244	rs2148178556	NC_000002.12:29227012:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 19, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2973G>A (p.Glu991=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000701601	2	29449882	2	29227016	701601	686184	rs1308382986	NC_000002.12:29227015:C:T	single nucleotide variant	synonymous variant	Likely benign	May 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2970_2971del (p.Cys990_Glu991delinsTer)	ALK		Neuroblastoma, susceptibility to, 3	VCV002707730	2	29449884 - 29449885	2	29227018 - 29227019	2707730	2877762		NC_000002.12:29227017:CACA:CA	Microsatellite	nonsense	Uncertain significance	Jan 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2967C>T (p.His989=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001531534	2	29449888	2	29227022	1531534	1666030	rs2148178589	NC_000002.12:29227021:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2965C>A (p.His989Asn)	ALK	H989N	Neuroblastoma, susceptibility to, 3	VCV003009503	2	29449890	2	29227024	3009503	3180194		NC_000002.12:29227023:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2965C>T (p.His989Tyr)	ALK	H989Y	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001010479	2	29449890	2	29227024	1010479	988700	rs1664021582	NC_000002.12:29227023:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2962A>C (p.Ser988Arg)	ALK	S988R	Neuroblastoma, susceptibility to, 3	VCV001504622	2	29449893	2	29227027	1504622	1417373	rs2148178601	NC_000002.12:29227026:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2961C>T (p.Cys987=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001136951	2	29449894	2	29227028	1136951	1112743	rs1400037080	NC_000002.12:29227027:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 20, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2960G>C (p.Cys987Ser)	ALK	C987S	Hereditary cancer-predisposing syndrome	VCV001798165	2	29449895	2	29227029	1798165	1853783		NC_000002.12:29227028:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2958C>T (p.Asn986=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001140755	2	29449897	2	29227031	1140755	1112744	rs2148178617	NC_000002.12:29227030:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2953C>T (p.Leu985=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002823745	2	29449902	2	29227036	2823745	2982258		NC_000002.12:29227035:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 24, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2952T>G (p.Tyr984Ter)	ALK	Y984*	Neuroblastoma, susceptibility to, 3	VCV000577462	2	29449903	2	29227037	577462	561321	rs1558626238	NC_000002.12:29227036:A:C	single nucleotide variant	nonsense	Uncertain significance	Oct 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2951A>C (p.Tyr984Ser)	ALK	Y984S	Hereditary cancer-predisposing syndrome	VCV001798058	2	29449904	2	29227038	1798058	1853676		NC_000002.12:29227037:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2950T>C (p.Tyr984His)	ALK	Y984H	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000645449	2	29449905	2	29227039	645449	629849	rs1573131855	NC_000002.12:29227038:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2949T>C (p.His983=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001106946	2	29449906	2	29227040	1106946	1091245	rs539585617	NC_000002.12:29227039:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2948A>G (p.His983Arg)	ALK	H983R	Neuroblastoma, susceptibility to, 3	VCV002836828	2	29449907	2	29227041	2836828	3002600		NC_000002.12:29227040:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2947C>T (p.His983Tyr)	ALK	H983Y	Neuroblastoma, susceptibility to, 3	VCV002956011	2	29449908	2	29227042	2956011	3118519		NC_000002.12:29227041:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2946G>T (p.Lys982Asn)	ALK	K982N	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000568663	2	29449909	2	29227043	568663	561323	rs1344108786	NC_000002.12:29227042:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2944A>G (p.Lys982Glu)	ALK	K982E	Neuroblastoma, susceptibility to, 3	VCV003729948	2	29449911	2	29227045	3729948	3862726		NC_000002.12:29227044:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2942T>C (p.Ile981Thr)	ALK	I981T	Neuroblastoma, susceptibility to, 3	VCV003631613	2	29449913	2	29227047	3631613	3773094		NC_000002.12:29227046:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2940T>C (p.Asn980=)	ALK		Hereditary cancer-predisposing syndrome	VCV001797917	2	29449915	2	29227049	1797917	1853536		NC_000002.12:29227048:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 22, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2935G>A (p.Val979Met)	ALK	V979M	Hereditary cancer-predisposing syndrome	VCV003223851	2	29449920	2	29227054	3223851	3380873		NC_000002.12:29227053:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2932G>A (p.Glu978Lys)	ALK	E978K	Hereditary cancer-predisposing syndrome	VCV003523876	2	29449923	2	29227057	3523876	3682044		NC_000002.12:29227056:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2929G>T (p.Gly977Trp)	ALK	G977W	Neuroblastoma, susceptibility to, 3	VCV002696369	2	29449926	2	29227060	2696369	2861224		NC_000002.12:29227059:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2929G>A (p.Gly977Arg)	ALK	G977R	Neuroblastoma, susceptibility to, 3|not provided	VCV000835560	2	29449926	2	29227060	835560	826329	rs568177600	NC_000002.12:29227059:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2928C>A (p.His976Gln)	ALK	H976Q	Neuroblastoma, susceptibility to, 3	VCV002119820	2	29449927	2	29227061	2119820	2180300		NC_000002.12:29227060:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2928C>T (p.His976=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000239816	2	29449927	2	29227061	239816	238730	rs75895956	NC_000002.12:29227060:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2927A>C (p.His976Pro)	ALK	H976P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003241803	2	29449928	2	29227062	3241803	3400781		NC_000002.12:29227061:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2926C>T (p.His976Tyr)	ALK	H976Y	Neuroblastoma, susceptibility to, 3	VCV000844656	2	29449929	2	29227063	844656	826330	rs1664022542	NC_000002.12:29227062:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2925C>G (p.Gly975=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003722301	2	29449930	2	29227064	3722301	3860405		NC_000002.12:29227063:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2924G>T (p.Gly975Val)	ALK	G975V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001519392	2	29449931	2	29227065	1519392	1433887	rs1472378906	NC_000002.12:29227064:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2924G>C (p.Gly975Ala)	ALK	G975A	Neuroblastoma, susceptibility to, 3	VCV000999811	2	29449931	2	29227065	999811	988701	rs1472378906	NC_000002.12:29227064:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2922A>C (p.Glu974Asp)	ALK	E974D	Hereditary cancer-predisposing syndrome	VCV002566595	2	29449933	2	29227067	2566595	2734438		NC_000002.12:29227066:T:G	single nucleotide variant	missense variant	Uncertain significance	May 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2919G>A (p.Met973Ile)	ALK	M973I	Neuroblastoma, susceptibility to, 3	VCV001474208	2	29449936	2	29227070	1474208	1410739	rs2148178726	NC_000002.12:29227069:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2917A>G (p.Met973Val)	ALK	M973V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000934465	2	29449938	2	29227072	934465	931354	rs1664022726	NC_000002.12:29227071:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2915T>C (p.Val972Ala)	ALK	V972A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001797622	2	29449940	2	29227074	1797622	1854540		NC_000002.12:29227073:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2915-4C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003650636	2	29449944	2	29227078	3650636	3785211		NC_000002.12:29227077:G:C	single nucleotide variant	intron variant	Uncertain significance	Apr 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2915-4C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001642403	2	29449944	2	29227078	1642403	1552501	rs2148178748	NC_000002.12:29227077:G:A	single nucleotide variant	intron variant	Likely benign	Dec 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2915-5A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003726048	2	29449945	2	29227079	3726048	3857956		NC_000002.12:29227078:T:C	single nucleotide variant	intron variant	Likely benign	Nov 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2915-6C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV003710152	2	29449946	2	29227080	3710152	3837130		NC_000002.12:29227079:G:T	single nucleotide variant	intron variant	Likely benign	Jan 19, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2915-9T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002188340	2	29449949	2	29227083	2188340	1918384		NC_000002.12:29227082:A:C	single nucleotide variant	intron variant	Likely benign	Dec 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2915-12_2915-9del	ALK		Neuroblastoma, susceptibility to, 3	VCV001950098	2	29449949 - 29449952	2	29227083 - 29227086	1950098	1999926		NC_000002.12:29227082:AAGGA:A	Deletion	intron variant	Uncertain significance	Feb 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2915-9T>C	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not specified	VCV000412924	2	29449949	2	29227083	412924	392734	rs373765395	NC_000002.12:29227082:A:G	single nucleotide variant	intron variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2915-11C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002003178	2	29449951	2	29227085	2003178	2055098		NC_000002.12:29227084:G:C	single nucleotide variant	intron variant	Likely benign	Jun 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2915-11C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001607799	2	29449951	2	29227085	1607799	1637753	rs1286574271	NC_000002.12:29227084:G:A	single nucleotide variant	intron variant	Likely benign	Oct 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2915-12C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001558805	2	29449952	2	29227086	1558805	1563470	rs2148178772	NC_000002.12:29227085:G:A	single nucleotide variant	intron variant	Likely benign	May 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2915-14C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002749638	2	29449954	2	29227088	2749638	2908235		NC_000002.12:29227087:G:C	single nucleotide variant	intron variant	Likely benign	Jan 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2915-14C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001968224	2	29449954	2	29227088	1968224	2032099		NC_000002.12:29227087:G:A	single nucleotide variant	intron variant	Likely benign	Aug 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2915-19C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002724304	2	29449959	2	29227093	2724304	2892104		NC_000002.12:29227092:G:T	single nucleotide variant	intron variant	Likely benign	Jun 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2915-19C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001554670	2	29449959	2	29227093	1554670	1652106	rs749399627	NC_000002.12:29227092:G:A	single nucleotide variant	intron variant	Likely benign	Dec 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2915-20C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002203370	2	29449960	2	29227094	2203370	1934659		NC_000002.12:29227093:G:C	single nucleotide variant	intron variant	Likely benign	Jul 30, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2915-242C>T	ALK		not provided	VCV001218745	2	29450182	2	29227316	1218745	1208725	rs10166470	NC_000002.12:29227315:G:A	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2914+140_2914+149del	ALK		not provided	VCV001261248	2	29450291 - 29450300	2	29227425 - 29227434	1261248	1252447	rs11278557	NC_000002.12:29227424:TGTGGTGACCTG:TG	Deletion	intron variant	Benign	Jun 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2914+67A>T	ALK		not provided	VCV001198950	2	29450373	2	29227507	1198950	1186433	rs77289834	NC_000002.12:29227506:T:A	single nucleotide variant	intron variant	Likely benign	Oct 3, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2914+57C>T	ALK		not provided	VCV001200701	2	29450383	2	29227517	1200701	1189888	rs114991822	NC_000002.12:29227516:G:A	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2914+19A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001667527	2	29450421	2	29227555	1667527	1656811	rs1489499396	NC_000002.12:29227554:T:C	single nucleotide variant	intron variant	Likely benign	Sep 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2914+17G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002092441	2	29450423	2	29227557	2092441	2148951		NC_000002.12:29227556:C:T	single nucleotide variant	intron variant	Likely benign	Feb 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2914+14_2914+15insTTTTAA	ALK		Neuroblastoma, susceptibility to, 3	VCV003603859	2	29450425 - 29450426	2	29227559 - 29227560	3603859	3746333		NC_000002.12:29227559::TTAAAA	Insertion	intron variant	Likely benign	Sep 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2914+15A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002202609	2	29450425	2	29227559	2202609	1928259		NC_000002.12:29227558:T:C	single nucleotide variant	intron variant	Likely benign	Aug 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2914+14C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002698196	2	29450426	2	29227560	2698196	2858337		NC_000002.12:29227559:G:A	single nucleotide variant	intron variant	Likely benign	Nov 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2914+12G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002814445	2	29450428	2	29227562	2814445	2976398		NC_000002.12:29227561:C:A	single nucleotide variant	intron variant	Likely benign	Nov 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2914+11T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002160978	2	29450429	2	29227563	2160978	1890689		NC_000002.12:29227562:A:G	single nucleotide variant	intron variant	Likely benign	Nov 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2914+9T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001144550	2	29450431	2	29227565	1144550	1133654	rs1573132544	NC_000002.12:29227564:A:G	single nucleotide variant	intron variant	Likely benign	Feb 19, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2914+5C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000935386	2	29450435	2	29227569	935386	939888	rs750459441	NC_000002.12:29227568:G:A	single nucleotide variant	intron variant	Uncertain significance	Jan 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2914+4G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000651989	2	29450436	2	29227570	651989	650983	rs1573132557	NC_000002.12:29227569:C:T	single nucleotide variant	intron variant	Uncertain significance	Nov 22, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2914G>T (p.Val972Leu)	ALK	V972L	not provided	VCV003343159	2	29450440	2	29227574	3343159	3502391		NC_000002.12:29227573:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2910A>G (p.Leu970=)	ALK		Hereditary cancer-predisposing syndrome	VCV001692777	2	29450444	2	29227578	1692777	1685217	rs2148179292	NC_000002.12:29227577:T:C	single nucleotide variant	synonymous variant	Likely benign	Mar 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2906C>T (p.Ala969Val)	ALK	A969V	Hereditary cancer-predisposing syndrome	VCV001797515	2	29450448	2	29227582	1797515	1854433		NC_000002.12:29227581:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2906C>G (p.Ala969Gly)	ALK	A969G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001035922	2	29450448	2	29227582	1035922	1024446	rs954019663	NC_000002.12:29227581:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2905G>A (p.Ala969Thr)	ALK	A969T	Hereditary cancer-predisposing syndrome	VCV003286293	2	29450449	2	29227583	3286293	3455116		NC_000002.12:29227582:C:T	single nucleotide variant	missense variant	Uncertain significance	May 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2904A>G (p.Pro968=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000978510	2	29450450	2	29227584	978510	691137	rs112828378	NC_000002.12:29227583:T:C	single nucleotide variant	synonymous variant	Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2903C>T (p.Pro968Leu)	ALK	P968L	Neuroblastoma, susceptibility to, 3	VCV002113393	2	29450451	2	29227585	2113393	2160928		NC_000002.12:29227584:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2901C>T (p.Thr967=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001797462	2	29450453	2	29227587	1797462	1854380		NC_000002.12:29227586:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2901C>A (p.Thr967=)	ALK		not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000335699	2	29450453	2	29227587	335699	286756	rs886055930	NC_000002.12:29227586:G:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Aug 4, 2023	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2900C>A (p.Thr967Asn)	ALK	T967N	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000538224	2	29450454	2	29227588	538224	518140	rs780284256	NC_000002.12:29227587:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2898C>T (p.Tyr966=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000772184	2	29450456	2	29227590	772184	697545	rs113303272	NC_000002.12:29227589:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2897del (p.Tyr966fs)	ALK	Y966fs	Neuroblastoma, susceptibility to, 3	VCV002845032	2	29450457	2	29227591	2845032	3014488		NC_000002.12:29227590:T:	Deletion	frameshift variant	Uncertain significance	Mar 12, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2895G>C (p.Leu965=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001797348	2	29450459	2	29227593	1797348	1855922		NC_000002.12:29227592:C:G	single nucleotide variant	synonymous variant	Likely benign	Apr 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2895G>A (p.Leu965=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001538745	2	29450459	2	29227593	1538745	1544230	rs528928041	NC_000002.12:29227592:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2893C>A (p.Leu965Met)	ALK	L965M	Neuroblastoma, susceptibility to, 3	VCV002161719	2	29450461	2	29227595	2161719	1887498		NC_000002.12:29227594:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2893C>T (p.Leu965=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001097843	2	29450461	2	29227595	1097843	1069519	rs1458969615	NC_000002.12:29227594:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2891T>C (p.Ile964Thr)	ALK	I964T	Neuroblastoma, susceptibility to, 3	VCV003621096	2	29450463	2	29227597	3621096	3756828		NC_000002.12:29227596:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2891T>A (p.Ile964Asn)	ALK	I964N	Neuroblastoma, susceptibility to, 3	VCV001393999	2	29450463	2	29227597	1393999	1422537	rs768623350	NC_000002.12:29227596:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2890A>G (p.Ile964Val)	ALK	I964V	Hereditary cancer-predisposing syndrome	VCV003286344	2	29450464	2	29227598	3286344	3455167		NC_000002.12:29227597:T:C	single nucleotide variant	missense variant	Uncertain significance	May 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2890A>T (p.Ile964Phe)	ALK	I964F	Neuroblastoma, susceptibility to, 3|not provided	VCV001442128	2	29450464	2	29227598	1442128	1474993	rs2148179307	NC_000002.12:29227597:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2889C>A (p.Gly963=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV003006695	2	29450465	2	29227599	3006695	3165644		NC_000002.12:29227598:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2888dup (p.Ile964fs)	ALK	I964fs	Neuroblastoma, susceptibility to, 3	VCV002707110	2	29450465 - 29450466	2	29227599 - 29227600	2707110	2870683		NC_000002.12:29227599:CCC:CCCC	Duplication	frameshift variant	Uncertain significance	Jan 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2888G>C (p.Gly963Ala)	ALK	G963A	Neuroblastoma, susceptibility to, 3	VCV002904378	2	29450466	2	29227600	2904378	3058672		NC_000002.12:29227599:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2887G>A (p.Gly963Ser)	ALK	G963S	Neuroblastoma, susceptibility to, 3	VCV002746890	2	29450467	2	29227601	2746890	2897765		NC_000002.12:29227600:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2886G>A (p.Leu962=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000659472	2	29450468	2	29227602	659472	629850	rs1573132628	NC_000002.12:29227601:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Jan 24, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2881_2885del (p.Pro961fs)	ALK	P961fs	Neuroblastoma, susceptibility to, 3	VCV001011315	2	29450469 - 29450473	2	29227603 - 29227607	1011315	988702	rs1317343191	NC_000002.12:29227602:AGTGGA:A	Deletion	frameshift variant	Uncertain significance	Oct 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2884C>A (p.Leu962Met)	ALK	L962M	not provided|Hereditary cancer-predisposing syndrome	VCV002562260	2	29450470	2	29227604	2562260	2721113		NC_000002.12:29227603:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2884C>T (p.Leu962=)	ALK		Hereditary cancer-predisposing syndrome	VCV001797211	2	29450470	2	29227604	1797211	1855785		NC_000002.12:29227603:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 19, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2879_2884delinsT (p.Ser960fs)	ALK	S960fs	Neuroblastoma, susceptibility to, 3	VCV000581077	2	29450470 - 29450475	2	29227604 - 29227609	581077	560587	rs1558626541	NC_000002.12:29227603:GTGGAC:A	Indel	frameshift variant	Uncertain significance	Dec 17, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2883A>G (p.Pro961=)	ALK		Hereditary cancer-predisposing syndrome	VCV002452089	2	29450471	2	29227605	2452089	2426729		NC_000002.12:29227604:T:C	single nucleotide variant	synonymous variant	Likely benign	Nov 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2882C>T (p.Pro961Leu)	ALK	P961L	Hereditary cancer-predisposing syndrome	VCV001797192	2	29450472	2	29227606	1797192	1855766		NC_000002.12:29227605:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2881C>G (p.Pro961Ala)	ALK	P961A	Neuroblastoma, susceptibility to, 3	VCV001006706	2	29450473	2	29227607	1006706	988703	rs1664044463	NC_000002.12:29227606:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2880T>C (p.Ser960=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001557296	2	29450474	2	29227608	1557296	1561955	rs2148179320	NC_000002.12:29227607:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 8, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2879G>T (p.Ser960Ile)	ALK	S960I	Neuroblastoma, susceptibility to, 3	VCV002165725	2	29450475	2	29227609	2165725	1902264		NC_000002.12:29227608:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2878A>G (p.Ser960Gly)	ALK	S960G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002728881	2	29450476	2	29227610	2728881	2882907		NC_000002.12:29227609:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2875A>C (p.Ile959Leu)	ALK	I959L	Neuroblastoma, susceptibility to, 3	VCV002822769	2	29450479	2	29227613	2822769	2978727		NC_000002.12:29227612:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2875A>G (p.Ile959Val)	ALK	I959V	Neuroblastoma, susceptibility to, 3	VCV001440593	2	29450479	2	29227613	1440593	1461878	rs748167212	NC_000002.12:29227612:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2874C>T (p.Phe958=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001797084	2	29450480	2	29227614	1797084	1855658		NC_000002.12:29227613:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Dec 12, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2872T>G (p.Phe958Val)	ALK	F958V	Neuroblastoma, susceptibility to, 3	VCV003688565	2	29450482	2	29227616	3688565	3820156		NC_000002.12:29227615:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2871C>T (p.Ser957=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003626126	2	29450483	2	29227617	3626126	3761420		NC_000002.12:29227616:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Jan 11, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2867T>C (p.Val956Ala)	ALK	V956A	Hereditary cancer-predisposing syndrome	VCV002566596	2	29450487	2	29227621	2566596	2734439		NC_000002.12:29227620:A:G	single nucleotide variant	missense variant	Uncertain significance	May 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2866G>T (p.Val956Phe)	ALK	V956F	Neuroblastoma, susceptibility to, 3	VCV002956105	2	29450488	2	29227622	2956105	3118613		NC_000002.12:29227621:C:A	single nucleotide variant	missense variant	Uncertain significance	May 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2866G>A (p.Val956Ile)	ALK	V956I	Neuroblastoma, susceptibility to, 3	VCV000843188	2	29450488	2	29227622	843188	826331	rs769837053	NC_000002.12:29227621:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2865G>A (p.Gly955=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002885766	2	29450489	2	29227623	2885766	3043771		NC_000002.12:29227622:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Aug 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2862T>C (p.Asp954=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001077618	2	29450492	2	29227626	1077618	1069520	rs2148179347	NC_000002.12:29227625:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2860G>A (p.Asp954Asn)	ALK	D954N	Neuroblastoma, susceptibility to, 3	VCV002756912	2	29450494	2	29227628	2756912	2920683		NC_000002.12:29227627:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2859A>G (p.Glu953=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003055044	2	29450495	2	29227629	3055044	3206201		NC_000002.12:29227628:T:C	single nucleotide variant	synonymous variant	Uncertain significance	May 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2857G>A (p.Glu953Lys)	ALK	E953K	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000838140	2	29450497	2	29227631	838140	826332	rs1664045661	NC_000002.12:29227630:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2856G>A (p.Gly952=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001650597	2	29450498	2	29227632	1650597	1663379	rs1323611569	NC_000002.12:29227631:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2855G>A (p.Gly952Glu)	ALK	G952E	Hereditary cancer-predisposing syndrome	VCV003525078	2	29450499	2	29227633	3525078	3689317		NC_000002.12:29227632:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2853T>C (p.Asp951=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000412918	2	29450501	2	29227635	412918	392737	rs201222888	NC_000002.12:29227634:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2851G>T (p.Asp951Tyr)	ALK	D951Y	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV003241812	2	29450503	2	29227637	3241812	3400790		NC_000002.12:29227636:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2851G>A (p.Asp951Asn)	ALK	D951N	Hereditary cancer-predisposing syndrome	VCV003223849	2	29450503	2	29227637	3223849	3380871		NC_000002.12:29227636:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2850G>C (p.Met950Ile)	ALK	M950I	Neuroblastoma, susceptibility to, 3	VCV003648399	2	29450504	2	29227638	3648399	3787678		NC_000002.12:29227637:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2849T>C (p.Met950Thr)	ALK	M950T	Neuroblastoma, susceptibility to, 3	VCV001713353	2	29450505	2	29227639	1713353	1777248		NC_000002.12:29227638:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2848A>G (p.Met950Val)	ALK	M950V	Neuroblastoma, susceptibility to, 3	VCV001995017	2	29450506	2	29227640	1995017	2049517		NC_000002.12:29227639:T:C	single nucleotide variant	missense variant	Uncertain significance	May 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2847A>G (p.Glu949=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002089416	2	29450507	2	29227641	2089416	2144746		NC_000002.12:29227640:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2847A>C (p.Glu949Asp)	ALK	E949D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001796776	2	29450507	2	29227641	1796776	1855351		NC_000002.12:29227640:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2845G>A (p.Glu949Lys)	ALK	E949K	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000659817	2	29450509	2	29227643	659817	629851	rs774004991	NC_000002.12:29227642:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 7, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2844C>A (p.Pro948=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003522837	2	29450510	2	29227644	3522837	3678821		NC_000002.12:29227643:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2844C>T (p.Pro948=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000701558	2	29450510	2	29227644	701558	686185	rs759086883	NC_000002.12:29227643:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2843C>A (p.Pro948His)	ALK	P948H	Hereditary cancer-predisposing syndrome	VCV002452107	2	29450511	2	29227645	2452107	2426747		NC_000002.12:29227644:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2842C>G (p.Pro948Ala)	ALK	P948A	Neuroblastoma, susceptibility to, 3	VCV001471925	2	29450512	2	29227646	1471925	1388952	rs764482518	NC_000002.12:29227645:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2842C>T (p.Pro948Ser)	ALK	P948S	Neuroblastoma, susceptibility to, 3|not provided	VCV000949982	2	29450512	2	29227646	949982	922715	rs764482518	NC_000002.12:29227645:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2841C>T (p.Asp947=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223848	2	29450513	2	29227647	3223848	3380870		NC_000002.12:29227646:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 5, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2841C>G (p.Asp947Glu)	ALK	D947E	not provided	VCV002502571	2	29450513	2	29227647	2502571	2667677		NC_000002.12:29227646:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2836_2838del (p.Asn946del)	ALK	N946del	Neuroblastoma, susceptibility to, 3	VCV000837022	2	29450516 - 29450518	2	29227650 - 29227652	837022	826333	rs1664046295	NC_000002.12:29227649:ATT:	Deletion	inframe_deletion	Uncertain significance	Jan 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2837A>G (p.Asn946Ser)	ALK	N946S	Neuroblastoma, susceptibility to, 3	VCV002875459	2	29450517	2	29227651	2875459	3032868		NC_000002.12:29227650:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2834_2837del (p.Asn945fs)	ALK	N945fs	Neuroblastoma, susceptibility to, 3	VCV000470809	2	29450517 - 29450520	2	29227651 - 29227654	470809	450741	rs1239836109	NC_000002.12:29227650:TTGTTTG:TTG	Deletion	frameshift variant	Uncertain significance	Oct 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2836A>G (p.Asn946Asp)	ALK	N946D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000643057	2	29450518	2	29227652	643057	629852	rs1573132720	NC_000002.12:29227651:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2833A>G (p.Asn945Asp)	ALK	N945D	Hereditary cancer-predisposing syndrome	VCV001796610	2	29450521	2	29227655	1796610	1855185		NC_000002.12:29227654:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2829C>T (p.Ala943=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001796537	2	29450525	2	29227659	1796537	1849440		NC_000002.12:29227658:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2827G>C (p.Ala943Pro)	ALK	A943P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001796516	2	29450527	2	29227661	1796516	1849419		NC_000002.12:29227660:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2826A>G (p.Ala942=)	ALK		Hereditary cancer-predisposing syndrome	VCV003286003	2	29450528	2	29227662	3286003	3444743		NC_000002.12:29227661:T:C	single nucleotide variant	synonymous variant	Likely benign	Apr 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2825C>T (p.Ala942Val)	ALK	A942V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001478934	2	29450529	2	29227663	1478934	1426305	rs2148179408	NC_000002.12:29227662:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2824G>A (p.Ala942Thr)	ALK	A942T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV001022860	2	29450530	2	29227664	1022860	1003981	rs1664046731	NC_000002.12:29227663:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2823T>A (p.Asn941Lys)	ALK	N941K	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001796478	2	29450531	2	29227665	1796478	1852913		NC_000002.12:29227664:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2823T>C (p.Asn941=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001126150	2	29450531	2	29227665	1126150	1112745	rs2148179417	NC_000002.12:29227664:A:G	single nucleotide variant	synonymous variant	Likely benign	May 31, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2822A>G (p.Asn941Ser)	ALK	N941S	not provided|Neuroblastoma, susceptibility to, 3|ALK-related disorder	VCV000404381	2	29450532	2	29227666	404381	392553	rs368654781	NC_000002.12:29227665:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2821A>G (p.Asn941Asp)	ALK	N941D	Hereditary cancer-predisposing syndrome	VCV001796452	2	29450533	2	29227667	1796452	1852887		NC_000002.12:29227666:T:C	single nucleotide variant	missense variant	Uncertain significance	May 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2821A>C (p.Asn941His)	ALK	N941H	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538203	2	29450533	2	29227667	538203	518142	rs1379843994	NC_000002.12:29227666:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2820C>T (p.Gly940=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002841470	2	29450534	2	29227668	2841470	2993623		NC_000002.12:29227667:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Feb 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2820C>A (p.Gly940=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000538287	2	29450534	2	29227668	538287	518144	rs765665803	NC_000002.12:29227667:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 16, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2818G>T (p.Gly940Cys)	ALK	G940C	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000567904	2	29450536	2	29227670	567904	560589	rs372008367	NC_000002.12:29227669:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2818G>A (p.Gly940Ser)	ALK	G940S	Neuroblastoma, susceptibility to, 3	VCV000538183	2	29450536	2	29227670	538183	518211	rs372008367	NC_000002.12:29227669:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2817C>T (p.Gly939=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470808	2	29450537	2	29227671	470808	451038	rs112022466	NC_000002.12:29227670:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2816-1G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002002163	2	29450539	2	29227673	2002163	2051508		NC_000002.12:29227672:C:T	single nucleotide variant	splice acceptor variant	Uncertain significance	Jun 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2816-2A>C	ALK		Neuroblastoma, susceptibility to, 3	VCV000854957	2	29450540	2	29227674	854957	850902	rs1664047349	NC_000002.12:29227673:T:G	single nucleotide variant	splice acceptor variant	Uncertain significance	Oct 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2816-3C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000837088	2	29450541	2	29227675	837088	851422	rs533733008	NC_000002.12:29227674:G:A	single nucleotide variant	intron variant	Uncertain significance	Dec 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2816-4T>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002737789	2	29450542	2	29227676	2737789	2899436		NC_000002.12:29227675:A:T	single nucleotide variant	intron variant	Uncertain significance	Sep 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2816-5C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001080198	2	29450543	2	29227677	1080198	1069521	rs532808222	NC_000002.12:29227676:G:A	single nucleotide variant	intron variant	Likely benign	Jul 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2816-6A>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002849461	2	29450544	2	29227678	2849461	3009250		NC_000002.12:29227677:T:A	single nucleotide variant	intron variant	Uncertain significance	Mar 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2816-7T>C	ALK		not provided|Neuroblastoma, susceptibility to, 3	VCV000239815	2	29450545	2	29227679	239815	238731	rs755251438	NC_000002.12:29227678:A:G	single nucleotide variant	intron variant	Likely benign	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2816-9G>A	ALK		Neuroblastoma, susceptibility to, 3|not specified	VCV000512590	2	29450547	2	29227681	512590	499916	rs200463420	NC_000002.12:29227680:C:T	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2816-10T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003660561	2	29450548	2	29227682	3660561	3794276		NC_000002.12:29227681:A:C	single nucleotide variant	intron variant	Uncertain significance	Apr 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2816-13G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002722964	2	29450551	2	29227685	2722964	2888191		NC_000002.12:29227684:C:T	single nucleotide variant	intron variant	Likely benign	Oct 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2816-18_2816-14del	ALK		Neuroblastoma, susceptibility to, 3	VCV001598072	2	29450552 - 29450556	2	29227686 - 29227690	1598072	1660678	rs1415263384	NC_000002.12:29227685:CAGAGCAGAG:CAGAG	Microsatellite	intron variant	Likely benign	Oct 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2816-15T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002807244	2	29450553	2	29227687	2807244	2964479		NC_000002.12:29227686:A:G	single nucleotide variant	intron variant	Uncertain significance	Dec 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2816-19G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001623657	2	29450557	2	29227691	1623657	1594424	rs2148179464	NC_000002.12:29227690:C:T	single nucleotide variant	intron variant	Likely benign	Aug 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2816-67C>T	ALK		not provided	VCV001210763	2	29450605	2	29227739	1210763	1200761	rs80250630	NC_000002.12:29227738:G:A	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2816-146C>T	ALK		not provided	VCV001231350	2	29450684	2	29227818	1231350	1221311	rs35787487	NC_000002.12:29227817:G:A	single nucleotide variant	intron variant	Benign	Jun 25, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2815+239G>C	ALK		not provided	VCV001267658	2	29451511	2	29228645	1267658	1257994	rs11687789	NC_000002.12:29228644:C:G	single nucleotide variant	intron variant	Benign	Jun 24, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2815+74_2815+75insGCCCC	ALK		not provided	VCV001281436	2	29451675 - 29451676	2	29228809 - 29228810	1281436	1270431	rs141563891	NC_000002.12:29228809:GGGC:GGGCGGGGC	Insertion	intron variant	Benign	Jun 21, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2815+17T>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001930455	2	29451733	2	29228867	1930455	1991927		NC_000002.12:29228866:A:T	single nucleotide variant	intron variant	Likely benign	Sep 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2815+16G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001596356	2	29451734	2	29228868	1596356	1633439	rs368572534	NC_000002.12:29228867:C:T	single nucleotide variant	intron variant	Likely benign	Jan 28, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2815+14G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002970321	2	29451736	2	29228870	2970321	3139332		NC_000002.12:29228869:C:G	single nucleotide variant	intron variant	Likely benign	Jul 31, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2815+14G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002064332	2	29451736	2	29228870	2064332	2128316		NC_000002.12:29228869:C:A	single nucleotide variant	intron variant	Likely benign	May 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2815+14G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001579650	2	29451736	2	29228870	1579650	1533608	rs1288484506	NC_000002.12:29228869:C:T	single nucleotide variant	intron variant	Likely benign	Jul 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2815+13C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002894475	2	29451737	2	29228871	2894475	3056116		NC_000002.12:29228870:G:A	single nucleotide variant	intron variant	Likely benign	Dec 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2815+13C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002140411	2	29451737	2	29228871	2140411	1878785		NC_000002.12:29228870:G:C	single nucleotide variant	intron variant	Likely benign	May 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2815+12T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002873665	2	29451738	2	29228872	2873665	3032380		NC_000002.12:29228871:A:C	single nucleotide variant	intron variant	Likely benign	Jul 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2815+9G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003654853	2	29451741	2	29228875	3654853	3778948		NC_000002.12:29228874:C:A	single nucleotide variant	intron variant	Likely benign	Dec 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2815G>A (p.Gly939Ser)	ALK	G939S	Neuroblastoma, susceptibility to, 3	VCV002034848	2	29451750	2	29228884	2034848	2090196		NC_000002.12:29228883:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2813T>C (p.Ile938Thr)	ALK	I938T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000646716	2	29451752	2	29228886	646716	629853	rs1280047183	NC_000002.12:29228885:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2804G>A (p.Gly935Glu)	ALK	G935E	Neuroblastoma, susceptibility to, 3	VCV003653071	2	29451761	2	29228895	3653071	3778460		NC_000002.12:29228894:C:T	single nucleotide variant	missense variant	Uncertain significance	May 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2803G>A (p.Gly935Arg)	ALK	G935R	Neuroblastoma, susceptibility to, 3	VCV000470807	2	29451762	2	29228896	470807	451043	rs766551269	NC_000002.12:29228895:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2802C>T (p.Gly934=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000702297	2	29451763	2	29228897	702297	691138	rs751581475	NC_000002.12:29228896:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2796AGG[1] (p.Gly936del)	ALK	G936del	Neuroblastoma, susceptibility to, 3	VCV002882392	2	29451764 - 29451766	2	29228898 - 29228900	2882392	3042994		NC_000002.12:29228897:CCTCCTCC:CCTCC	Microsatellite	inframe_deletion	Uncertain significance	Jan 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2798del (p.Gly933fs)	ALK	G933fs	Neuroblastoma, susceptibility to, 3	VCV000960099	2	29451767	2	29228901	960099	942858	rs1664095457	NC_000002.12:29228900:CC:C	Deletion	frameshift variant	Uncertain significance	Jul 17, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2778_2798del (p.Cys928_Gly934del)	ALK		Neuroblastoma, susceptibility to, 3	VCV000949821	2	29451767 - 29451787	2	29228901 - 29228921	949821	922716	rs1664095568	NC_000002.12:29228900:CCTCCACCTGAGGAGCACCCCCCTCCACC:CCTCCACC	Deletion	inframe_deletion	Uncertain significance	Aug 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2796A>C (p.Gly932=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002197058	2	29451769	2	29228903	2197058	1930117		NC_000002.12:29228902:T:G	single nucleotide variant	synonymous variant	Likely benign	Dec 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2795G>A (p.Gly932Glu)	ALK	G932E	Neuroblastoma, susceptibility to, 3	VCV003723297	2	29451770	2	29228904	3723297	3850508		NC_000002.12:29228903:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2795G>C (p.Gly932Ala)	ALK	G932A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001420316	2	29451770	2	29228904	1420316	1503095	rs755261455	NC_000002.12:29228903:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2793T>C (p.Gly931=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000795592	2	29451772	2	29228906	795592	781303	rs1573134379	NC_000002.12:29228905:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2784CTC[1] (p.Ser930del)	ALK	S930del	Neuroblastoma, susceptibility to, 3	VCV002127138	2	29451776 - 29451778	2	29228910 - 29228912	2127138	2178451		NC_000002.12:29228909:GAGGAG:GAG	Microsatellite	inframe_deletion	Uncertain significance	Sep 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2789C>T (p.Ser930Leu)	ALK	S930L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001435961	2	29451776	2	29228910	1435961	1497077	rs767777102	NC_000002.12:29228909:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2789C>G (p.Ser930Ter)	ALK	S930*	Neuroblastoma, susceptibility to, 3	VCV000852594	2	29451776	2	29228910	852594	826334	rs767777102	NC_000002.12:29228909:G:C	single nucleotide variant	nonsense	Uncertain significance	Apr 19, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2786C>G (p.Ser929Cys)	ALK	S929C	Neuroblastoma, susceptibility to, 3	VCV000965129	2	29451779	2	29228913	965129	953064	rs752568687	NC_000002.12:29228912:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2786C>T (p.Ser929Phe)	ALK	S929F	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000640156	2	29451779	2	29228913	640156	629854	rs752568687	NC_000002.12:29228912:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2785T>G (p.Ser929Ala)	ALK	S929A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002726353	2	29451780	2	29228914	2726353	2888987		NC_000002.12:29228913:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2784C>T (p.Cys928=)	ALK		Hereditary cancer-predisposing syndrome	VCV003286260	2	29451781	2	29228915	3286260	3455083		NC_000002.12:29228914:G:A	single nucleotide variant	synonymous variant	Likely benign	May 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2784C>G (p.Cys928Trp)	ALK	C928W	Neuroblastoma, susceptibility to, 3	VCV000470806	2	29451781	2	29228915	470806	450895	rs1553395572	NC_000002.12:29228914:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2781dup (p.Cys928fs)	ALK	C928fs	Hereditary cancer-predisposing syndrome	VCV003285636	2	29451783 - 29451784	2	29228917 - 29228918	3285636	3440868		NC_000002.12:29228917:CCCCCC:CCCCCCC	Duplication	frameshift variant	Benign	Mar 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2782T>G (p.Cys928Gly)	ALK	C928G	Hereditary cancer-predisposing syndrome	VCV001795956	2	29451783	2	29228917	1795956	1853315		NC_000002.12:29228916:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2782T>C (p.Cys928Arg)	ALK	C928R	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV001469019	2	29451783	2	29228917	1469019	1370129	rs1664096277	NC_000002.12:29228916:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2781del (p.Cys928fs)	ALK	C928fs	Neuroblastoma, susceptibility to, 3	VCV001347916	2	29451784	2	29228918	1347916	1391832	rs772809305	NC_000002.12:29228917:CCCCCC:CCCCC	Deletion	frameshift variant	Uncertain significance	Nov 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2781G>C (p.Gly927=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000799261	2	29451784	2	29228918	799261	781304	rs1264537420	NC_000002.12:29228917:C:G	single nucleotide variant	synonymous variant	Likely benign	Dec 29, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2781G>T (p.Gly927=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000703707	2	29451784	2	29228918	703707	691139	rs1264537420	NC_000002.12:29228917:C:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Oct 21, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2781G>A (p.Gly927=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000470805	2	29451784	2	29228918	470805	451046	rs1264537420	NC_000002.12:29228917:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2780G>C (p.Gly927Ala)	ALK	G927A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001489372	2	29451785	2	29228919	1489372	1494978	rs2148180455	NC_000002.12:29228918:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2780G>T (p.Gly927Val)	ALK	G927V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001395135	2	29451785	2	29228919	1395135	1412149	rs2148180455	NC_000002.12:29228918:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2779G>C (p.Gly927Arg)	ALK	G927R	Hereditary cancer-predisposing syndrome	VCV003524675	2	29451786	2	29228920	3524675	3679339		NC_000002.12:29228919:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2778G>A (p.Gly926=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001586214	2	29451787	2	29228921	1586214	1593859	rs1664096879	NC_000002.12:29228920:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 16, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2778G>T (p.Gly926=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000847881	2	29451787	2	29228921	847881	826335	rs1664096879	NC_000002.12:29228920:C:A	single nucleotide variant	synonymous variant	Likely benign	Feb 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2777G>T (p.Gly926Val)	ALK	G926V	Neuroblastoma, susceptibility to, 3	VCV003612545	2	29451788	2	29228922	3612545	3748536		NC_000002.12:29228921:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2777G>A (p.Gly926Glu)	ALK	G926E	Hereditary cancer-predisposing syndrome	VCV001795864	2	29451788	2	29228922	1795864	1853223		NC_000002.12:29228921:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2776G>T (p.Gly926Trp)	ALK	G926W	Neuroblastoma, susceptibility to, 3	VCV001356961	2	29451789	2	29228923	1356961	1348392	rs1664097034	NC_000002.12:29228922:C:A	single nucleotide variant	missense variant	Uncertain significance	May 28, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2776G>A (p.Gly926Arg)	ALK	G926R	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001021122	2	29451789	2	29228923	1021122	1003982	rs1664097034	NC_000002.12:29228922:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2775A>C (p.Gly925=)	ALK		Hereditary cancer-predisposing syndrome	VCV001795841	2	29451790	2	29228924	1795841	1853200		NC_000002.12:29228923:T:G	single nucleotide variant	synonymous variant	Likely benign	Jun 10, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2775A>G (p.Gly925=)	ALK		not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000895174	2	29451790	2	29228924	895174	884679	rs777406442	NC_000002.12:29228923:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2772T>G (p.Gly924=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000239814	2	29451793	2	29228927	239814	238732	rs749286400	NC_000002.12:29228926:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2771G>C (p.Gly924Ala)	ALK	G924A	Neuroblastoma, susceptibility to, 3	VCV003672161	2	29451794	2	29228928	3672161	3805218		NC_000002.12:29228927:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2771G>T (p.Gly924Val)	ALK	G924V	Neuroblastoma, susceptibility to, 3	VCV003608280	2	29451794	2	29228928	3608280	3740558		NC_000002.12:29228927:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2771G>A (p.Gly924Asp)	ALK	G924D	Neuroblastoma, susceptibility to, 3	VCV000657207	2	29451794	2	29228928	657207	629855	rs75861155	NC_000002.12:29228927:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2770G>C (p.Gly924Arg)	ALK	G924R	not provided|Neuroblastoma, susceptibility to, 3	VCV001357501	2	29451795	2	29228929	1357501	1345475	rs78086548	NC_000002.12:29228928:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2768_2769delinsAA (p.Gly923Glu)	ALK	G923E	Neuroblastoma, susceptibility to, 3	VCV002848005	2	29451796 - 29451797	2	29228930 - 29228931	2848005	3005248		NC_000002.12:29228929:CC:TT	Indel	missense variant	Uncertain significance	Mar 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2769G>T (p.Gly923=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002031164	2	29451796	2	29228930	2031164	2078806		NC_000002.12:29228929:C:A	single nucleotide variant	synonymous variant	Likely benign	Sep 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2769G>A (p.Gly923=)	ALK		Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV001147885	2	29451796	2	29228930	1147885	1133655	rs75434768	NC_000002.12:29228929:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Sep 2, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2768G>A (p.Gly923Glu)	ALK	G923E	Neuroblastoma, susceptibility to, 3	VCV003646534	2	29451797	2	29228931	3646534	3787087		NC_000002.12:29228930:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2767G>A (p.Gly923Arg)	ALK	G923R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000957255	2	29451798	2	29228932	957255	942859	rs1664097953	NC_000002.12:29228931:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2766A>G (p.Gly922=)	ALK		Hereditary cancer-predisposing syndrome	VCV003521635	2	29451799	2	29228933	3521635	3688507		NC_000002.12:29228932:T:C	single nucleotide variant	synonymous variant	Likely benign	Aug 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2760_2766del (p.Phe921fs)	ALK	F921fs	Hereditary cancer-predisposing syndrome	VCV003284433	2	29451799 - 29451805	2	29228933 - 29228939	3284433	3433584		NC_000002.12:29228932:TCCGAAA:	Deletion	frameshift variant	Benign	Mar 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2766A>T (p.Gly922=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223847	2	29451799	2	29228933	3223847	3380869		NC_000002.12:29228932:T:A	single nucleotide variant	synonymous variant	Likely benign	Feb 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2764G>A (p.Gly922Arg)	ALK	G922R	Neuroblastoma, susceptibility to, 3	VCV000857732	2	29451801	2	29228935	857732	826336	rs745317944	NC_000002.12:29228934:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2763C>G (p.Phe921Leu)	ALK	F921L	not provided|Hereditary cancer-predisposing syndrome	VCV001319121	2	29451802	2	29228936	1319121	1309374	rs201042802	NC_000002.12:29228935:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 19, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2763C>T (p.Phe921=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538277	2	29451802	2	29228936	538277	518123	rs201042802	NC_000002.12:29228935:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2762T>G (p.Phe921Cys)	ALK	F921C	Hereditary cancer-predisposing syndrome	VCV001050300	2	29451803	2	29228937	1050300	1037178	rs1170626086	NC_000002.12:29228936:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2759G>T (p.Gly920Val)	ALK	G920V	Hereditary cancer-predisposing syndrome	VCV003524397	2	29451806	2	29228940	3524397	3679062		NC_000002.12:29228939:C:A	single nucleotide variant	missense variant	Likely benign	Aug 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2759G>A (p.Gly920Asp)	ALK	G920D	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000470804	2	29451806	2	29228940	470804	451049	rs746643773	NC_000002.12:29228939:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2758G>T (p.Gly920Cys)	ALK	G920C	Neuroblastoma, susceptibility to, 3	VCV003673433	2	29451807	2	29228941	3673433	3806058		NC_000002.12:29228940:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2758G>A (p.Gly920Ser)	ALK	G920S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002566613	2	29451807	2	29228941	2566613	2734456		NC_000002.12:29228940:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2757G>A (p.Gly919=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002884697	2	29451808	2	29228942	2884697	3053708		NC_000002.12:29228941:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2756G>C (p.Gly919Ala)	ALK	G919A	Hereditary cancer-predisposing syndrome	VCV003223846	2	29451809	2	29228943	3223846	3380868		NC_000002.12:29228942:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2755G>T (p.Gly919Trp)	ALK	G919W	Neuroblastoma, susceptibility to, 3	VCV000999649	2	29451810	2	29228944	999649	988704	rs1664099541	NC_000002.12:29228943:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2755G>A (p.Gly919Arg)	ALK	G919R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000949739	2	29451810	2	29228944	949739	922717	rs1664099541	NC_000002.12:29228943:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2754A>G (p.Arg918=)	ALK		Hereditary cancer-predisposing syndrome	VCV003284442	2	29451811	2	29228945	3284442	3433593		NC_000002.12:29228944:T:C	single nucleotide variant	synonymous variant	Likely benign	May 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2754A>T (p.Arg918Ser)	ALK	R918S	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000660252	2	29451811	2	29228945	660252	629856	rs770236199	NC_000002.12:29228944:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2753G>C (p.Arg918Thr)	ALK	R918T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002417122	2	29451812	2	29228946	2417122	1941006		NC_000002.12:29228945:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2752A>G (p.Arg918Gly)	ALK	R918G	Hereditary cancer-predisposing syndrome	VCV003522460	2	29451813	2	29228947	3522460	3681948		NC_000002.12:29228946:T:C	single nucleotide variant	missense variant	Likely benign	Aug 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2750C>G (p.Thr917Arg)	ALK	T917R	Hereditary cancer-predisposing syndrome	VCV003524408	2	29451815	2	29228949	3524408	3679073		NC_000002.12:29228948:G:C	single nucleotide variant	missense variant	Likely benign	Aug 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2750C>A (p.Thr917Lys)	ALK	T917K	Hereditary cancer-predisposing syndrome	VCV003521718	2	29451815	2	29228949	3521718	3684706		NC_000002.12:29228948:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2750C>T (p.Thr917Ile)	ALK	T917I	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000239813	2	29451815	2	29228949	239813	238733	rs773447647	NC_000002.12:29228948:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2749A>G (p.Thr917Ala)	ALK	T917A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001417811	2	29451816	2	29228950	1417811	1374297	rs2148180542	NC_000002.12:29228949:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2748G>T (p.Glu916Asp)	ALK	E916D	Hereditary cancer-predisposing syndrome	VCV001795510	2	29451817	2	29228951	1795510	1854169		NC_000002.12:29228950:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2747A>G (p.Glu916Gly)	ALK	E916G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001795492	2	29451818	2	29228952	1795492	1854151		NC_000002.12:29228951:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2746G>A (p.Glu916Lys)	ALK	E916K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001487869	2	29451819	2	29228953	1487869	1481902	rs2148180551	NC_000002.12:29228952:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2744G>A (p.Trp915Ter)	ALK	W915*	Neuroblastoma, susceptibility to, 3	VCV002032044	2	29451821	2	29228955	2032044	2086104		NC_000002.12:29228954:C:T	single nucleotide variant	nonsense	Uncertain significance	Sep 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2744G>C (p.Trp915Ser)	ALK	W915S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001017169	2	29451821	2	29228955	1017169	1003983	rs1241864472	NC_000002.12:29228954:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2743T>G (p.Trp915Gly)	ALK	W915G	Hereditary cancer-predisposing syndrome	VCV003521690	2	29451822	2	29228956	3521690	3684678		NC_000002.12:29228955:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2742dup (p.Trp915fs)	ALK	W915fs	Neuroblastoma, susceptibility to, 3	VCV002824371	2	29451822 - 29451823	2	29228956 - 29228957	2824371	2979045		NC_000002.12:29228956:CCCCC:CCCCCC	Duplication	frameshift variant	Uncertain significance	Dec 26, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2742G>A (p.Gly914=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001795455	2	29451823	2	29228957	1795455	1854114		NC_000002.12:29228956:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2741G>C (p.Gly914Ala)	ALK	G914A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002723916	2	29451824	2	29228958	2723916	2881828		NC_000002.12:29228957:C:G	single nucleotide variant	missense variant	Uncertain significance	May 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2741G>A (p.Gly914Glu)	ALK	G914E	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002169678	2	29451824	2	29228958	2169678	1899701		NC_000002.12:29228957:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2741G>T (p.Gly914Val)	ALK	G914V	Neuroblastoma, susceptibility to, 3	VCV002109890	2	29451824	2	29228958	2109890	2163765		NC_000002.12:29228957:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2740G>C (p.Gly914Arg)	ALK	G914R	Neuroblastoma, susceptibility to, 3	VCV001036585	2	29451825	2	29228959	1036585	1024447	rs1220052371	NC_000002.12:29228958:C:G	single nucleotide variant	missense variant	Uncertain significance	May 10, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2740G>A (p.Gly914Arg)	ALK	G914R	Neuroblastoma, susceptibility to, 3	VCV000538240	2	29451825	2	29228959	538240	518060	rs1220052371	NC_000002.12:29228958:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2738G>C (p.Trp913Ser)	ALK	W913S	Hereditary cancer-predisposing syndrome	VCV003522925	2	29451827	2	29228961	3522925	3678909		NC_000002.12:29228960:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2738G>A (p.Trp913Ter)	ALK	W913*	Neuroblastoma, susceptibility to, 3	VCV001062679	2	29451827	2	29228961	1062679	1041390	rs1280277994	NC_000002.12:29228960:C:T	single nucleotide variant	nonsense	Uncertain significance	Sep 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2737T>G (p.Trp913Gly)	ALK	W913G	Hereditary cancer-predisposing syndrome	VCV003521707	2	29451828	2	29228962	3521707	3684695		NC_000002.12:29228961:A:C	single nucleotide variant	missense variant	Likely benign	Aug 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2736G>A (p.Lys912=)	ALK		Neuroblastoma, susceptibility to, 3|not provided	VCV000705985	2	29451829	2	29228963	705985	691140	rs1489025810	NC_000002.12:29228962:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Nov 3, 2023	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2732A>G (p.Lys911Arg)	ALK	K911R	Neuroblastoma, susceptibility to, 3	VCV000856471	2	29451833	2	29228967	856471	826337	rs1664101463	NC_000002.12:29228966:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2731A>C (p.Lys911Gln)	ALK	K911Q	Neuroblastoma, susceptibility to, 3	VCV001006051	2	29451834	2	29228968	1006051	988705	rs1664101526	NC_000002.12:29228967:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2728A>C (p.Met910Leu)	ALK	M910L	Hereditary cancer-predisposing syndrome	VCV003223845	2	29451837	2	29228971	3223845	3380867		NC_000002.12:29228970:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2727C>T (p.Ala909=)	ALK		not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001099383	2	29451838	2	29228972	1099383	1091246	rs1236590521	NC_000002.12:29228971:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Aug 29, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2726C>A (p.Ala909Asp)	ALK	A909D	Neuroblastoma, susceptibility to, 3	VCV000838224	2	29451839	2	29228973	838224	826338	rs1664101854	NC_000002.12:29228972:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2725G>A (p.Ala909Thr)	ALK	A909T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001348738	2	29451840	2	29228974	1348738	1456126	rs2148180596	NC_000002.12:29228973:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2724G>C (p.Gln908His)	ALK	Q908H	Neuroblastoma, susceptibility to, 3	VCV000863032	2	29451841	2	29228975	863032	826339	rs1441852921	NC_000002.12:29228974:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2722dup (p.Gln908fs)	ALK	Q908fs	Neuroblastoma, susceptibility to, 3	VCV002908081	2	29451842 - 29451843	2	29228976 - 29228977	2908081	3059779		NC_000002.12:29228976:GGGGG:GGGGGG	Duplication	frameshift variant	Uncertain significance	Jan 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2723A>G (p.Gln908Arg)	ALK	Q908R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000650173	2	29451842	2	29228976	650173	629857	rs1573134667	NC_000002.12:29228975:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2722C>T (p.Gln908Ter)	ALK	Q908*	Neuroblastoma, susceptibility to, 3	VCV003677290	2	29451843	2	29228977	3677290	3817491		NC_000002.12:29228976:G:A	single nucleotide variant	nonsense	Uncertain significance	Apr 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2722C>A (p.Gln908Lys)	ALK	Q908K	Hereditary cancer-predisposing syndrome	VCV003285737	2	29451843	2	29228977	3285737	3444477		NC_000002.12:29228976:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2721C>G (p.Pro907=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002703492	2	29451844	2	29228978	2703492	2859783		NC_000002.12:29228977:G:C	single nucleotide variant	synonymous variant	Likely benign	Dec 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2720C>T (p.Pro907Leu)	ALK	P907L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003223844	2	29451845	2	29228979	3223844	3380866		NC_000002.12:29228978:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2718C>T (p.Cys906=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001113773	2	29451847	2	29228981	1113773	1091247	rs763576249	NC_000002.12:29228980:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2716_2717insTT (p.Cys906fs)	ALK	C906fs	Neuroblastoma, susceptibility to, 3	VCV001386424	2	29451848 - 29451849	2	29228982 - 29228983	1386424	1357551	rs2148180615	NC_000002.12:29228982:A:AAA	Insertion	frameshift variant	Uncertain significance	Aug 6, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2714C>T (p.Ser905Phe)	ALK	S905F	Neuroblastoma, susceptibility to, 3	VCV003653421	2	29451851	2	29228985	3653421	3788854		NC_000002.12:29228984:G:A	single nucleotide variant	missense variant	Uncertain significance	May 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2712T>C (p.His904=)	ALK		Hereditary cancer-predisposing syndrome	VCV001795093	2	29451853	2	29228987	1795093	1849302		NC_000002.12:29228986:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2712T>A (p.His904Gln)	ALK	H904Q	not provided|Neuroblastoma, susceptibility to, 3	VCV000470803	2	29451853	2	29228987	470803	450743	rs766742720	NC_000002.12:29228986:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2711A>C (p.His904Pro)	ALK	H904P	Neuroblastoma, susceptibility to, 3	VCV002099238	2	29451854	2	29228988	2099238	2150559		NC_000002.12:29228987:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2702_2711del (p.Thr901fs)	ALK	T901fs	Neuroblastoma, susceptibility to, 3	VCV000936274	2	29451854 - 29451863	2	29228988 - 29228997	936274	931355	rs1664102433	NC_000002.12:29228987:TGTCCTCCGGTG:TG	Deletion	frameshift variant	Uncertain significance	Sep 23, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2710C>T (p.His904Tyr)	ALK	H904Y	not provided|Neuroblastoma, susceptibility to, 3	VCV001006268	2	29451855	2	29228989	1006268	988706	rs1474942302	NC_000002.12:29228988:G:A	single nucleotide variant	missense variant	Uncertain significance	May 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2706A>C (p.Gly902=)	ALK		Hereditary cancer-predisposing syndrome	VCV001794977	2	29451859	2	29228993	1794977	1849186		NC_000002.12:29228992:T:G	single nucleotide variant	synonymous variant	Likely benign	Oct 17, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2704G>A (p.Gly902Arg)	ALK	G902R	Neuroblastoma, susceptibility to, 3	VCV000662188	2	29451861	2	29228995	662188	629858	rs774488715	NC_000002.12:29228994:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2703C>G (p.Thr901=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001794953	2	29451862	2	29228996	1794953	1849162		NC_000002.12:29228995:G:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Apr 17, 2023	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2703C>T (p.Thr901=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470802	2	29451862	2	29228996	470802	450896	rs375296866	NC_000002.12:29228995:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2702C>T (p.Thr901Ile)	ALK	T901I	Neuroblastoma, susceptibility to, 3	VCV002859379	2	29451863	2	29228997	2859379	3021992		NC_000002.12:29228996:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2700C>A (p.Ala900=)	ALK		Hereditary cancer-predisposing syndrome	VCV003286055	2	29451865	2	29228999	3286055	3444795		NC_000002.12:29228998:G:T	single nucleotide variant	synonymous variant	Likely benign	Apr 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2699C>T (p.Ala900Val)	ALK	A900V	Neuroblastoma, susceptibility to, 3	VCV002887398	2	29451866	2	29229000	2887398	3044103		NC_000002.12:29228999:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2699C>G (p.Ala900Gly)	ALK	A900G	Hereditary cancer-predisposing syndrome	VCV002447100	2	29451866	2	29229000	2447100	2422223		NC_000002.12:29228999:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2698G>C (p.Ala900Pro)	ALK	A900P	Hereditary cancer-predisposing syndrome	VCV003223843	2	29451867	2	29229001	3223843	3380865		NC_000002.12:29229000:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2697T>G (p.Gly899=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002165085	2	29451868	2	29229002	2165085	1895225		NC_000002.12:29229001:A:C	single nucleotide variant	synonymous variant	Likely benign	Dec 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2695G>T (p.Gly899Cys)	ALK	G899C	Hereditary cancer-predisposing syndrome	VCV002624788	2	29451870	2	29229004	2624788	2790283		NC_000002.12:29229003:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2694G>C (p.Glu898Asp)	ALK	E898D	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002900238	2	29451871	2	29229005	2900238	3064236		NC_000002.12:29229004:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2692G>A (p.Glu898Lys)	ALK	E898K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001418057	2	29451873	2	29229007	1418057	1397111	rs1374366049	NC_000002.12:29229006:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2688G>C (p.Leu896Phe)	ALK	L896F	Neuroblastoma, susceptibility to, 3	VCV002093026	2	29451877	2	29229011	2093026	2145767		NC_000002.12:29229010:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2687T>C (p.Leu896Ser)	ALK	L896S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV003000361	2	29451878	2	29229012	3000361	3156832		NC_000002.12:29229011:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2682dup (p.Ser895fs)	ALK	S895fs	Neuroblastoma, susceptibility to, 3	VCV000861509	2	29451882 - 29451883	2	29229016 - 29229017	861509	826340	rs1664103646	NC_000002.12:29229016:TTTT:TTTTT	Duplication	frameshift variant	Uncertain significance	Jan 13, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2682A>G (p.Lys894=)	ALK		Hereditary cancer-predisposing syndrome	VCV002586712	2	29451883	2	29229017	2586712	2756895		NC_000002.12:29229016:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2681A>T (p.Lys894Ile)	ALK	K894I	Neuroblastoma, susceptibility to, 3	VCV003719798	2	29451884	2	29229018	3719798	3849617		NC_000002.12:29229017:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2677G>C (p.Gly893Arg)	ALK	G893R	Neuroblastoma, susceptibility to, 3	VCV001507919	2	29451888	2	29229022	1507919	1352378	rs764014697	NC_000002.12:29229021:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2677G>A (p.Gly893Arg)	ALK	G893R	Neuroblastoma, susceptibility to, 3|not provided	VCV000843943	2	29451888	2	29229022	843943	826341	rs764014697	NC_000002.12:29229021:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2676C>G (p.Ala892=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003635071	2	29451889	2	29229023	3635071	3773957		NC_000002.12:29229022:G:C	single nucleotide variant	synonymous variant	Uncertain significance	Oct 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2676C>T (p.Ala892=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000239811	2	29451889	2	29229023	239811	238734	rs138668699	NC_000002.12:29229022:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2674dup (p.Ala892fs)	ALK	A892fs	Neuroblastoma, susceptibility to, 3	VCV002845235	2	29451890 - 29451891	2	29229024 - 29229025	2845235	3014690		NC_000002.12:29229024:CCC:CCCC	Duplication	frameshift variant	Uncertain significance	Mar 12, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2675C>A (p.Ala892Asp)	ALK	A892D	Neuroblastoma, susceptibility to, 3	VCV001953105	2	29451890	2	29229024	1953105	2014539		NC_000002.12:29229023:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2674G>A (p.Ala892Thr)	ALK	A892T	not provided|Neuroblastoma, susceptibility to, 3	VCV001904053	2	29451891	2	29229025	1904053	1954792		NC_000002.12:29229024:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2671T>C (p.Trp891Arg)	ALK	W891R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002197690	2	29451894	2	29229028	2197690	1923852		NC_000002.12:29229027:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2670C>A (p.Leu890=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002916687	2	29451895	2	29229029	2916687	3080115		NC_000002.12:29229028:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2670C>T (p.Leu890=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001794546	2	29451895	2	29229029	1794546	1852292		NC_000002.12:29229028:G:A	single nucleotide variant	synonymous variant	Likely benign	May 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2670C>G (p.Leu890=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001100501	2	29451895	2	29229029	1100501	1091248	rs555222775	NC_000002.12:29229028:G:C	single nucleotide variant	synonymous variant	Likely benign	Aug 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2667G>A (p.Leu889=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003658060	2	29451898	2	29229032	3658060	3800287		NC_000002.12:29229031:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2667G>T (p.Leu889Phe)	ALK	L889F	Neuroblastoma, susceptibility to, 3	VCV001041569	2	29451898	2	29229032	1041569	1024448	rs1664104202	NC_000002.12:29229031:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2667G>C (p.Leu889Phe)	ALK	L889F	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000935609	2	29451898	2	29229032	935609	931356	rs1664104202	NC_000002.12:29229031:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2666T>C (p.Leu889Ser)	ALK	L889S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000946340	2	29451899	2	29229033	946340	922718	rs1203845715	NC_000002.12:29229032:A:G	single nucleotide variant	missense variant	Uncertain significance	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2664C>T (p.Ser888=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001161002	2	29451901	2	29229035	1161002	1133656	rs1322781138	NC_000002.12:29229034:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2661T>C (p.Thr887=)	ALK		Hereditary cancer-predisposing syndrome	VCV001794456	2	29451904	2	29229038	1794456	1852202		NC_000002.12:29229037:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 26, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2660C>T (p.Thr887Ile)	ALK	T887I	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002447085	2	29451905	2	29229039	2447085	2422208		NC_000002.12:29229038:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2658C>T (p.Asn886=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001568107	2	29451907	2	29229041	1568107	1657615	rs2148180703	NC_000002.12:29229040:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2657A>T (p.Asn886Ile)	ALK	N886I	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001014221	2	29451908	2	29229042	1014221	1003984	rs1452092742	NC_000002.12:29229041:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2656A>G (p.Asn886Asp)	ALK	N886D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001468173	2	29451909	2	29229043	1468173	1362418	rs2148180711	NC_000002.12:29229042:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2654A>G (p.Asp885Gly)	ALK	D885G	not provided|Neuroblastoma, susceptibility to, 3	VCV000470799	2	29451911	2	29229045	470799	450746	rs745406091	NC_000002.12:29229044:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2653G>T (p.Asp885Tyr)	ALK	D885Y	Neuroblastoma, susceptibility to, 3	VCV002862754	2	29451912	2	29229046	2862754	3022803		NC_000002.12:29229045:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2653G>A (p.Asp885Asn)	ALK	D885N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000651089	2	29451912	2	29229046	651089	629859	rs925802421	NC_000002.12:29229045:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2649G>C (p.Trp883Cys)	ALK	W883C	Neuroblastoma, susceptibility to, 3	VCV003241758	2	29451916	2	29229050	3241758	3400736		NC_000002.12:29229049:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2649G>A (p.Trp883Ter)	ALK	W883*	Neuroblastoma, susceptibility to, 3	VCV001965052	2	29451916	2	29229050	1965052	2027645		NC_000002.12:29229049:C:T	single nucleotide variant	nonsense	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2648G>A (p.Trp883Ter)	ALK	W883*	Neuroblastoma, susceptibility to, 3	VCV001055161	2	29451917	2	29229051	1055161	1041391	rs2148180715	NC_000002.12:29229050:C:T	single nucleotide variant	nonsense	Uncertain significance	Jul 16, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2647T>C (p.Trp883Arg)	ALK	W883R	Hereditary cancer-predisposing syndrome	VCV002452090	2	29451918	2	29229052	2452090	2426730		NC_000002.12:29229051:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2646C>A (p.Gly882=)	ALK		Hereditary cancer-predisposing syndrome	VCV001794250	2	29451919	2	29229053	1794250	1852921		NC_000002.12:29229052:G:T	single nucleotide variant	synonymous variant	Likely benign	Apr 28, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2645G>A (p.Gly882Asp)	ALK	G882D	Hereditary cancer-predisposing syndrome	VCV002624794	2	29451920	2	29229054	2624794	2790289		NC_000002.12:29229053:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2644G>A (p.Gly882Ser)	ALK	G882S	Neuroblastoma, susceptibility to, 3	VCV002703079	2	29451921	2	29229055	2703079	2862775		NC_000002.12:29229054:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2641G>T (p.Gly881Cys)	ALK	G881C	Neuroblastoma, susceptibility to, 3	VCV001995694	2	29451924	2	29229058	1995694	2060066		NC_000002.12:29229057:C:A	single nucleotide variant	missense variant	Uncertain significance	May 17, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2641G>C (p.Gly881Arg)	ALK	G881R	Neuroblastoma, susceptibility to, 3	VCV000934580	2	29451924	2	29229058	934580	931357	rs1256624924	NC_000002.12:29229057:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2639G>A (p.Gly880Glu)	ALK	G880E	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000538175	2	29451926	2	29229060	538175	518146	rs1179544655	NC_000002.12:29229059:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2637T>C (p.Gly879=)	ALK		Hereditary cancer-predisposing syndrome	VCV001794137	2	29451928	2	29229062	1794137	1842417		NC_000002.12:29229061:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 19, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2633G>C (p.Gly878Ala)	ALK	G878A	Neuroblastoma, susceptibility to, 3	VCV003639827	2	29451932	2	29229066	3639827	3765170		NC_000002.12:29229065:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2633G>A (p.Gly878Asp)	ALK	G878D	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000842359	2	29451932	2	29229066	842359	826342	rs1664106372	NC_000002.12:29229065:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2633-2A>C	ALK		Neuroblastoma, susceptibility to, 3	VCV003729270	2	29451934	2	29229068	3729270	3858600		NC_000002.12:29229067:T:G	single nucleotide variant	splice acceptor variant	Uncertain significance	Jan 20, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2633-2A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001064376	2	29451934	2	29229068	1064376	1041392	rs1471857749	NC_000002.12:29229067:T:C	single nucleotide variant	splice acceptor variant	Uncertain significance	Oct 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2633-3C>T	ALK		not provided|Familial isolated pituitary adenoma|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000620627	2	29451935	2	29229069	620627	612029	rs200341945	NC_000002.12:29229068:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 15, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2633-4G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001107696	2	29451936	2	29229070	1107696	1091249	rs199575811	NC_000002.12:29229069:C:G	single nucleotide variant	intron variant	Likely benign	Aug 8, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2633-4G>A	ALK		Neuroblastoma, susceptibility to, 3|not specified|Hereditary cancer-predisposing syndrome	VCV000412934	2	29451936	2	29229070	412934	392559	rs199575811	NC_000002.12:29229069:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2633-5C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001157785	2	29451937	2	29229071	1157785	1133657	rs773644242	NC_000002.12:29229070:G:A	single nucleotide variant	intron variant	Likely benign	Apr 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2633-5C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000755287	2	29451937	2	29229071	755287	774821	rs773644242	NC_000002.12:29229070:G:C	single nucleotide variant	intron variant	Likely benign	Nov 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2633-6C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000946520	2	29451938	2	29229072	946520	940706	rs577768628	NC_000002.12:29229071:G:T	single nucleotide variant	intron variant	Uncertain significance	Dec 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2633-6C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000239810	2	29451938	2	29229072	239810	238735	rs577768628	NC_000002.12:29229071:G:A	single nucleotide variant	intron variant	Likely benign	Jan 26, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2633-8_2633-7delinsAT	ALK		Neuroblastoma, susceptibility to, 3	VCV002084849	2	29451939 - 29451940	2	29229073 - 29229074	2084849	2144064		NC_000002.12:29229072:GA:AT	Indel	intron variant	Likely benign	May 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2633-11T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001541953	2	29451943	2	29229077	1541953	1545707	rs2148180747	NC_000002.12:29229076:A:G	single nucleotide variant	intron variant	Likely benign	Jan 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2633-12C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003630834	2	29451944	2	29229078	3630834	3766300		NC_000002.12:29229077:G:C	single nucleotide variant	intron variant	Likely benign	Jan 12, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2633-12C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002149447	2	29451944	2	29229078	2149447	1873965		NC_000002.12:29229077:G:A	single nucleotide variant	intron variant	Likely benign	Feb 17, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2633-14A>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002117378	2	29451946	2	29229080	2117378	2183019		NC_000002.12:29229079:T:A	single nucleotide variant	intron variant	Likely benign	May 2, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2633-14A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001924395	2	29451946	2	29229080	1924395	1983295		NC_000002.12:29229079:T:C	single nucleotide variant	intron variant	Likely benign	Apr 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2633-15T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001573052	2	29451947	2	29229081	1573052	1573418	rs1558627607	NC_000002.12:29229080:A:G	single nucleotide variant	intron variant	Likely benign	Oct 17, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2633-17C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002080517	2	29451949	2	29229083	2080517	2135750		NC_000002.12:29229082:G:T	single nucleotide variant	intron variant	Likely benign	Oct 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2633-17C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001572357	2	29451949	2	29229083	1572357	1538426	rs771497081	NC_000002.12:29229082:G:A	single nucleotide variant	intron variant	Likely benign	Jan 19, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2633-18C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001546406	2	29451950	2	29229084	1546406	1526256	rs2148180757	NC_000002.12:29229083:G:A	single nucleotide variant	intron variant	Likely benign	May 25, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2633-19T>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002740821	2	29451951	2	29229085	2740821	2902888		NC_000002.12:29229084:A:T	single nucleotide variant	intron variant	Uncertain significance	Aug 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2633-54G>A	ALK		not provided	VCV001292653	2	29451986	2	29229120	1292653	1282459	rs62130588	NC_000002.12:29229119:C:T	single nucleotide variant	intron variant	Benign	Jun 21, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2633-83G>A	ALK		not provided	VCV001199966	2	29452015	2	29229149	1199966	1189889	rs73920741	NC_000002.12:29229148:C:T	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2633-306G>C	ALK		not provided	VCV001297824	2	29452238	2	29229372	1297824	1287611	rs62130589	NC_000002.12:29229371:C:G	single nucleotide variant	intron variant	Benign	Feb 24, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2632+268_2632+269insTGGGTTTTACCAACT	ALK		not provided	VCV001297825	2	29454901 - 29454902	2	29232035 - 29232036	1297825	1287612	rs6146693	NC_000002.12:29232035:CA:CAAGTTGGTAAAACCCA	Insertion	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2632+179C>T	ALK		not provided	VCV001205235	2	29454991	2	29232125	1205235	1193145	rs115666889	NC_000002.12:29232124:G:A	single nucleotide variant	intron variant	Likely benign	Oct 3, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2632+154G>A	ALK		not provided	VCV001291577	2	29455016	2	29232150	1291577	1281391	rs12714270	NC_000002.12:29232149:C:T	single nucleotide variant	intron variant	Benign	Jun 24, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2632+18T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001597425	2	29455152	2	29232286	1597425	1664959	rs1664233676	NC_000002.12:29232285:A:G	single nucleotide variant	intron variant	Likely benign	Nov 9, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2632+17G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV003704835	2	29455153	2	29232287	3704835	3835701		NC_000002.12:29232286:C:G	single nucleotide variant	intron variant	Likely benign	Nov 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2632+17G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001620777	2	29455153	2	29232287	1620777	1549249	rs201350160	NC_000002.12:29232286:C:T	single nucleotide variant	intron variant	Likely benign	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2632+16C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001601710	2	29455154	2	29232288	1601710	1523655	rs200835934	NC_000002.12:29232287:G:A	single nucleotide variant	intron variant	Benign	Jan 29, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2632+14A>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002201643	2	29455156	2	29232290	2201643	1934245		NC_000002.12:29232289:T:A	single nucleotide variant	intron variant	Likely benign	Jul 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2632+13A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003642690	2	29455157	2	29232291	3642690	3765461		NC_000002.12:29232290:T:C	single nucleotide variant	intron variant	Likely benign	May 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2632+11dup	ALK		Hereditary cancer-predisposing syndrome|not specified|Neuroblastoma, susceptibility to, 3	VCV000508073	2	29455158 - 29455159	2	29232292 - 29232293	508073	499661	rs766699720	NC_000002.12:29232292:C:CC	Duplication	intron variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2632+11G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002781146	2	29455159	2	29232293	2781146	2937544		NC_000002.12:29232292:C:T	single nucleotide variant	intron variant	Likely benign	Dec 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2632+11G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001999128	2	29455159	2	29232293	1999128	2060921		NC_000002.12:29232292:C:A	single nucleotide variant	intron variant	Likely benign	Oct 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2632+10del	ALK		Neuroblastoma, susceptibility to, 3	VCV002703509	2	29455160	2	29232294	2703509	2859800		NC_000002.12:29232293:A:	Deletion	intron variant	Likely benign	Dec 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2632+8G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000412907	2	29455162	2	29232296	412907	392560	rs199653862	NC_000002.12:29232295:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2632+7C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002778042	2	29455163	2	29232297	2778042	2946536		NC_000002.12:29232296:G:C	single nucleotide variant	intron variant	Likely benign	Sep 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2632+7C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000771969	2	29455163	2	29232297	771969	777309	rs565599959	NC_000002.12:29232296:G:A	single nucleotide variant	intron variant	Likely benign	Dec 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2632+2T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002001259	2	29455168	2	29232302	2001259	2057899		NC_000002.12:29232301:A:G	single nucleotide variant	splice donor variant	Uncertain significance	Nov 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2631A>C (p.Ala877=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002822287	2	29455171	2	29232305	2822287	2982090		NC_000002.12:29232304:T:G	single nucleotide variant	synonymous variant	Uncertain significance	Dec 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2629G>T (p.Ala877Ser)	ALK	A877S	Neuroblastoma, susceptibility to, 3	VCV000566745	2	29455173	2	29232307	566745	561324	rs746442213	NC_000002.12:29232306:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2629G>A (p.Ala877Thr)	ALK	A877T	Neuroblastoma, susceptibility to, 3	VCV000404362	2	29455173	2	29232307	404362	392620	rs746442213	NC_000002.12:29232306:C:T	single nucleotide variant	missense variant	Uncertain significance	May 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2628C>T (p.Ala876=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000702024	2	29455174	2	29232308	702024	686186	rs1573139394	NC_000002.12:29232307:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2627C>G (p.Ala876Gly)	ALK	A876G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002161442	2	29455175	2	29232309	2161442	1887221		NC_000002.12:29232308:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2626G>C (p.Ala876Pro)	ALK	A876P	Neuroblastoma, susceptibility to, 3	VCV002842044	2	29455176	2	29232310	2842044	3000581		NC_000002.12:29232309:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2625A>T (p.Gly875=)	ALK		Hereditary cancer-predisposing syndrome	VCV002452136	2	29455177	2	29232311	2452136	2426776		NC_000002.12:29232310:T:A	single nucleotide variant	synonymous variant	Likely benign	Feb 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2624G>T (p.Gly875Val)	ALK	G875V	Hereditary cancer-predisposing syndrome	VCV002452137	2	29455178	2	29232312	2452137	2426777		NC_000002.12:29232311:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2624G>A (p.Gly875Glu)	ALK	G875E	Neuroblastoma, susceptibility to, 3	VCV000570138	2	29455178	2	29232312	570138	558035	rs374375387	NC_000002.12:29232311:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2623G>A (p.Gly875Arg)	ALK	G875R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000582569	2	29455179	2	29232313	582569	558372	rs148001139	NC_000002.12:29232312:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2622C>G (p.Ser874=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001793965	2	29455180	2	29232314	1793965	1842245		NC_000002.12:29232313:G:C	single nucleotide variant	synonymous variant	Likely benign	Jan 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2622C>T (p.Ser874=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000412917	2	29455180	2	29232314	412917	392622	rs528315610	NC_000002.12:29232313:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2620T>C (p.Ser874Pro)	ALK	S874P	Neuroblastoma, susceptibility to, 3	VCV002731651	2	29455182	2	29232316	2731651	2890406		NC_000002.12:29232315:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2618A>T (p.Asn873Ile)	ALK	N873I	Neuroblastoma, susceptibility to, 3	VCV001719398	2	29455184	2	29232318	1719398	1774702		NC_000002.12:29232317:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2616C>A (p.Gly872=)	ALK		Hereditary cancer-predisposing syndrome	VCV001793855	2	29455186	2	29232320	1793855	1845980		NC_000002.12:29232319:G:T	single nucleotide variant	synonymous variant	Likely benign	Sep 28, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2616C>T (p.Gly872=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001057888	2	29455186	2	29232320	1057888	1041393	rs2148183266	NC_000002.12:29232319:G:A	single nucleotide variant	synonymous variant	Uncertain significance	May 13, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2615G>T (p.Gly872Val)	ALK	G872V	Neuroblastoma, susceptibility to, 3	VCV003658383	2	29455187	2	29232321	3658383	3796804		NC_000002.12:29232320:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2615G>A (p.Gly872Asp)	ALK	G872D	Neuroblastoma, susceptibility to, 3	VCV002099863	2	29455187	2	29232321	2099863	2147421		NC_000002.12:29232320:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2614G>A (p.Gly872Ser)	ALK	G872S	Neuroblastoma, susceptibility to, 3	VCV000470798	2	29455188	2	29232322	470798	451058	rs1343280200	NC_000002.12:29232321:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2613C>G (p.Asn871Lys)	ALK	N871K	Hereditary cancer-predisposing syndrome	VCV003223841	2	29455189	2	29232323	3223841	3380863		NC_000002.12:29232322:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2613C>T (p.Asn871=)	ALK		Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000239809	2	29455189	2	29232323	239809	238736	rs150557024	NC_000002.12:29232322:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2611A>G (p.Asn871Asp)	ALK	N871D	Hereditary cancer-predisposing syndrome	VCV002586686	2	29455191	2	29232325	2586686	2756869		NC_000002.12:29232324:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2610A>G (p.Leu870=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001655712	2	29455192	2	29232326	1655712	1616062	rs2148183276	NC_000002.12:29232325:T:C	single nucleotide variant	synonymous variant	Likely benign	Aug 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2609T>C (p.Leu870Pro)	ALK	L870P	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001513784	2	29455193	2	29232327	1513784	1468973	rs1279549141	NC_000002.12:29232326:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2608C>T (p.Leu870=)	ALK		Hereditary cancer-predisposing syndrome	VCV001793753	2	29455194	2	29232328	1793753	1845878		NC_000002.12:29232327:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 30, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2606G>A (p.Gly869Glu)	ALK	G869E	Neuroblastoma, susceptibility to, 3	VCV002790770	2	29455196	2	29232330	2790770	2957081		NC_000002.12:29232329:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2604A>G (p.Leu868=)	ALK		Hereditary cancer-predisposing syndrome	VCV003285237	2	29455198	2	29232332	3285237	3444415		NC_000002.12:29232331:T:C	single nucleotide variant	synonymous variant	Likely benign	Jun 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2603T>A (p.Leu868Gln)	ALK	L868Q	not provided|Neuroblastoma, susceptibility to, 3	VCV000335700	2	29455199	2	29232333	335700	289379	rs55941323	NC_000002.12:29232332:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2602C>T (p.Leu868=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001972400	2	29455200	2	29232334	1972400	2025959		NC_000002.12:29232333:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2600T>C (p.Val867Ala)	ALK	V867A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000960993	2	29455202	2	29232336	960993	942860	rs1664236109	NC_000002.12:29232335:A:G	single nucleotide variant	missense variant	Uncertain significance	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2599G>A (p.Val867Ile)	ALK	V867I	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001011650	2	29455203	2	29232337	1011650	988707	rs1402889581	NC_000002.12:29232336:C:T	single nucleotide variant	missense variant	Uncertain significance	May 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2598G>C (p.Ser866=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001112206	2	29455204	2	29232338	1112206	1091250	rs56304041	NC_000002.12:29232337:C:G	single nucleotide variant	synonymous variant	Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2598G>A (p.Ser866=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000703053	2	29455204	2	29232338	703053	691141	rs56304041	NC_000002.12:29232337:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2592CTC[1] (p.Ser866del)	ALK	S866del	Neuroblastoma, susceptibility to, 3	VCV003720391	2	29455205 - 29455207	2	29232339 - 29232341	3720391	3859791		NC_000002.12:29232338:GAGGAG:GAG	Microsatellite		Uncertain significance	Jul 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2597C>T (p.Ser866Leu)	ALK	S866L	Neuroblastoma, susceptibility to, 3|not provided	VCV000570576	2	29455205	2	29232339	570576	561335	rs528844155	NC_000002.12:29232338:G:A	single nucleotide variant	missense variant	Uncertain significance	May 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2596T>G (p.Ser866Ala)	ALK	S866A	Hereditary cancer-predisposing syndrome	VCV003223840	2	29455206	2	29232340	3223840	3380862		NC_000002.12:29232339:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2596T>A (p.Ser866Thr)	ALK	S866T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002447098	2	29455206	2	29232340	2447098	2422221		NC_000002.12:29232339:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2596T>C (p.Ser866Pro)	ALK	S866P	Neuroblastoma, susceptibility to, 3	VCV000538177	2	29455206	2	29232340	538177	518217	rs1553396171	NC_000002.12:29232339:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2595C>T (p.Ser865=)	ALK		Hereditary cancer-predisposing syndrome	VCV003524937	2	29455207	2	29232341	3524937	3689176		NC_000002.12:29232340:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2594C>G (p.Ser865Cys)	ALK	S865C	Hereditary cancer-predisposing syndrome	VCV002566586	2	29455208	2	29232342	2566586	2734429		NC_000002.12:29232341:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2593T>C (p.Ser865Pro)	ALK	S865P	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002586670	2	29455209	2	29232343	2586670	2756853		NC_000002.12:29232342:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2592C>T (p.Asn864=)	ALK		Hereditary cancer-predisposing syndrome	VCV003285998	2	29455210	2	29232344	3285998	3444738		NC_000002.12:29232343:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2591A>G (p.Asn864Ser)	ALK	N864S	Hereditary cancer-predisposing syndrome	VCV003524873	2	29455211	2	29232345	3524873	3689112		NC_000002.12:29232344:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2586G>A (p.Glu862=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001531205	2	29455216	2	29232350	1531205	1604623	rs2148183297	NC_000002.12:29232349:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2584G>C (p.Glu862Gln)	ALK	E862Q	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002447091	2	29455218	2	29232352	2447091	2422214		NC_000002.12:29232351:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2584G>A (p.Glu862Lys)	ALK	E862K	Neuroblastoma, susceptibility to, 3|not provided	VCV001496252	2	29455218	2	29232352	1496252	1359284	rs1461504517	NC_000002.12:29232351:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2583G>T (p.Leu861=)	ALK		Hereditary cancer-predisposing syndrome	VCV003524264	2	29455219	2	29232353	3524264	3682432		NC_000002.12:29232352:C:A	single nucleotide variant	synonymous variant	Likely benign	Aug 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2583G>C (p.Leu861=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001077546	2	29455219	2	29232353	1077546	1069522	rs201079493	NC_000002.12:29232352:C:G	single nucleotide variant	synonymous variant	Likely benign	Oct 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2583G>A (p.Leu861=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000772746	2	29455219	2	29232353	772746	697546	rs201079493	NC_000002.12:29232352:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2582T>G (p.Leu861Arg)	ALK	L861R	Neuroblastoma, susceptibility to, 3	VCV002166609	2	29455220	2	29232354	2166609	1895453		NC_000002.12:29232353:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2579G>T (p.Arg860Ile)	ALK	R860I	not provided|Neuroblastoma, susceptibility to, 3	VCV000895175	2	29455223	2	29232357	895175	884680	rs1194282326	NC_000002.12:29232356:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2579G>A (p.Arg860Lys)	ALK	R860K	Neuroblastoma, susceptibility to, 3	VCV000641179	2	29455223	2	29232357	641179	629860	rs1194282326	NC_000002.12:29232356:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 28, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2577G>A (p.Glu859=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000696321	2	29455225	2	29232359	696321	683498	rs61754865	NC_000002.12:29232358:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2577G>C (p.Glu859Asp)	ALK	E859D	not provided|Neuroblastoma, susceptibility to, 3|not specified|Hereditary cancer-predisposing syndrome	VCV000133464	2	29455225	2	29232359	133464	137203	rs61754865	NC_000002.12:29232358:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2575G>A (p.Glu859Lys)	ALK	E859K	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001059073	2	29455227	2	29232361	1059073	1041394	rs2148183312	NC_000002.12:29232360:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2571C>G (p.His857Gln)	ALK	H857Q	Neuroblastoma, susceptibility to, 3	VCV003689955	2	29455231	2	29232365	3689955	3823870		NC_000002.12:29232364:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2571C>T (p.His857=)	ALK		Hereditary cancer-predisposing syndrome	VCV003523325	2	29455231	2	29232365	3523325	3688883		NC_000002.12:29232364:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2570A>T (p.His857Leu)	ALK	H857L	Neuroblastoma, susceptibility to, 3	VCV000836709	2	29455232	2	29232366	836709	826343	rs1664237639	NC_000002.12:29232365:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2569C>T (p.His857Tyr)	ALK	H857Y	Hereditary cancer-predisposing syndrome|not specified|Neuroblastoma, susceptibility to, 3	VCV000929023	2	29455233	2	29232367	929023	916863	rs754393402	NC_000002.12:29232366:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2567T>C (p.Phe856Ser)	ALK	F856S	Neuroblastoma, susceptibility to, 3	VCV000653234	2	29455235	2	29232369	653234	629861	rs1573139504	NC_000002.12:29232368:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2566T>A (p.Phe856Ile)	ALK	F856I	Hereditary cancer-predisposing syndrome	VCV003525165	2	29455236	2	29232370	3525165	3685521		NC_000002.12:29232369:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2565G>C (p.Thr855=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002452129	2	29455237	2	29232371	2452129	2426769		NC_000002.12:29232370:C:G	single nucleotide variant	synonymous variant	Likely benign	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2565G>T (p.Thr855=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002154423	2	29455237	2	29232371	2154423	1889316		NC_000002.12:29232370:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2565G>A (p.Thr855=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000412933	2	29455237	2	29232371	412933	392935	rs752329968	NC_000002.12:29232370:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2564C>T (p.Thr855Met)	ALK	T855M	Neuroblastoma, susceptibility to, 3	VCV001010773	2	29455238	2	29232372	1010773	988708	rs1295878742	NC_000002.12:29232371:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2560G>C (p.Asp854His)	ALK	D854H	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001448530	2	29455242	2	29232376	1448530	1423229	rs189078025	NC_000002.12:29232375:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2560G>A (p.Asp854Asn)	ALK	D854N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000404350	2	29455242	2	29232376	404350	392938	rs189078025	NC_000002.12:29232375:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 29, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2559A>G (p.Thr853=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001552661	2	29455243	2	29232377	1552661	1639266	rs2148183335	NC_000002.12:29232376:T:C	single nucleotide variant	synonymous variant	Likely benign	Jan 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2558C>T (p.Thr853Ile)	ALK	T853I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002452104	2	29455244	2	29232378	2452104	2426744		NC_000002.12:29232377:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2554A>G (p.Lys852Glu)	ALK	K852E	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404370	2	29455248	2	29232382	404370	392623	rs371441614	NC_000002.12:29232381:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2552C>T (p.Ala851Val)	ALK	A851V	Hereditary cancer-predisposing syndrome	VCV003525025	2	29455250	2	29232384	3525025	3689264		NC_000002.12:29232383:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2552C>A (p.Ala851Asp)	ALK	A851D	Neuroblastoma, susceptibility to, 3	VCV001061948	2	29455250	2	29232384	1061948	1041395	rs571017977	NC_000002.12:29232383:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2551G>T (p.Ala851Ser)	ALK	A851S	Neuroblastoma, susceptibility to, 3	VCV002676336	2	29455251	2	29232385	2676336	2834757		NC_000002.12:29232384:C:A	single nucleotide variant	missense variant	Uncertain significance	May 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2550G>A (p.Gly850=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001652316	2	29455252	2	29232386	1652316	1664229	rs772710286	NC_000002.12:29232385:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2549G>A (p.Gly850Glu)	ALK	G850E	Neuroblastoma, susceptibility to, 3	VCV002994433	2	29455253	2	29232387	2994433	3152101		NC_000002.12:29232386:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2548G>C (p.Gly850Arg)	ALK	G850R	Neuroblastoma, susceptibility to, 3	VCV000566505	2	29455254	2	29232388	566505	561337	rs200563480	NC_000002.12:29232387:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2548G>A (p.Gly850Arg)	ALK	G850R	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470797	2	29455254	2	29232388	470797	450903	rs200563480	NC_000002.12:29232387:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2547C>T (p.Tyr849=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001078872	2	29455255	2	29232389	1078872	1069523	rs747529982	NC_000002.12:29232388:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2546A>C (p.Tyr849Ser)	ALK	Y849S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000956808	2	29455256	2	29232390	956808	942861	rs1043717591	NC_000002.12:29232389:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2546A>G (p.Tyr849Cys)	ALK	Y849C	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538264	2	29455256	2	29232390	538264	518151	rs1043717591	NC_000002.12:29232389:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2545T>C (p.Tyr849His)	ALK	Y849H	Hereditary cancer-predisposing syndrome	VCV003525156	2	29455257	2	29232391	3525156	3685512		NC_000002.12:29232390:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2544C>T (p.Ala848=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003649902	2	29455258	2	29232392	3649902	3787898		NC_000002.12:29232391:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2543C>G (p.Ala848Gly)	ALK	A848G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002916822	2	29455259	2	29232393	2916822	3076884		NC_000002.12:29232392:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2543C>T (p.Ala848Val)	ALK	A848V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001005484	2	29455259	2	29232393	1005484	988709	rs1664239038	NC_000002.12:29232392:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2542G>A (p.Ala848Thr)	ALK	A848T	Neuroblastoma, susceptibility to, 3	VCV003008326	2	29455260	2	29232394	3008326	3165977		NC_000002.12:29232393:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2542G>T (p.Ala848Ser)	ALK	A848S	Hereditary cancer-predisposing syndrome	VCV002452119	2	29455260	2	29232394	2452119	2426759		NC_000002.12:29232393:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2540G>A (p.Arg847Lys)	ALK	R847K	Hereditary cancer-predisposing syndrome	VCV003286067	2	29455262	2	29232396	3286067	3444807		NC_000002.12:29232395:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2536G>C (p.Gly846Arg)	ALK	G846R	Neuroblastoma, susceptibility to, 3	VCV003663886	2	29455266	2	29232400	3663886	3798476		NC_000002.12:29232399:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2536G>A (p.Gly846Ser)	ALK	G846S	Hereditary cancer-predisposing syndrome	VCV001792766	2	29455266	2	29232400	1792766	1851815		NC_000002.12:29232399:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2535_2536inv (p.Gly846Ser)	ALK	G846S	Neuroblastoma, susceptibility to, 3	VCV000954603	2	29455266 - 29455267	2	29232400 - 29232401	954603	942862		NC_000002.12:29232399:CA:TG	Inversion	missense variant	Uncertain significance	Dec 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2535T>A (p.Gly845=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223839	2	29455267	2	29232401	3223839	3380861		NC_000002.12:29232400:A:T	single nucleotide variant	synonymous variant	Likely benign	Oct 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2535T>G (p.Gly845=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001151536	2	29455267	2	29232401	1151536	1133658	rs2256740	NC_000002.12:29232400:A:C	single nucleotide variant	synonymous variant	Likely benign	Mar 7, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2535T>C (p.Gly845=)	ALK		Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3|not specified	VCV000259268	2	29455267	2	29232401	259268	250719	rs2256740	NC_000002.12:29232400:A:G	single nucleotide variant	synonymous variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2532T>C (p.Gly844=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000412942	2	29455270	2	29232404	412942	392629	rs553485553	NC_000002.12:29232403:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2530G>A (p.Gly844Ser)	ALK	G844S	Neuroblastoma, susceptibility to, 3	VCV001523939	2	29455272	2	29232406	1523939	1382502	rs2148183406	NC_000002.12:29232405:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2530G>C (p.Gly844Arg)	ALK	G844R	Neuroblastoma, susceptibility to, 3	VCV001507922	2	29455272	2	29232406	1507922	1442576	rs2148183406	NC_000002.12:29232405:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2527G>A (p.Gly843Arg)	ALK	G843R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000858266	2	29455275	2	29232409	858266	826344	rs748379491	NC_000002.12:29232408:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2526C>A (p.Ala842=)	ALK		Hereditary cancer-predisposing syndrome	VCV001792589	2	29455276	2	29232410	1792589	1851639		NC_000002.12:29232409:G:T	single nucleotide variant	synonymous variant	Likely benign	May 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2526C>T (p.Ala842=)	ALK		not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000239807	2	29455276	2	29232410	239807	238737	rs145271283	NC_000002.12:29232409:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2524G>T (p.Ala842Ser)	ALK	A842S	Hereditary cancer-predisposing syndrome	VCV003223838	2	29455278	2	29232412	3223838	3380860		NC_000002.12:29232411:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2521G>A (p.Ala841Thr)	ALK	A841T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404312	2	29455281	2	29232415	404312	392630	rs766322560	NC_000002.12:29232414:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2520T>C (p.Ile840=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001595614	2	29455282	2	29232416	1595614	1656604	rs2148183433	NC_000002.12:29232415:A:G	single nucleotide variant	synonymous variant	Likely benign	Feb 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2519T>C (p.Ile840Thr)	ALK	I840T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000658921	2	29455283	2	29232417	658921	629862	rs774200047	NC_000002.12:29232416:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2518A>G (p.Ile840Val)	ALK	I840V	Neuroblastoma, susceptibility to, 3	VCV003020523	2	29455284	2	29232418	3020523	3179431		NC_000002.12:29232417:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2516T>C (p.Ile839Thr)	ALK	I839T	Hereditary cancer-predisposing syndrome	VCV003223837	2	29455286	2	29232420	3223837	3380859		NC_000002.12:29232419:A:G	single nucleotide variant	missense variant	Uncertain significance	May 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2515A>G (p.Ile839Val)	ALK	I839V	Neuroblastoma, susceptibility to, 3	VCV000576026	2	29455287	2	29232421	576026	558374	rs1371180882	NC_000002.12:29232420:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2514G>A (p.Leu838=)	ALK		Hereditary cancer-predisposing syndrome	VCV001792441	2	29455288	2	29232422	1792441	1842029		NC_000002.12:29232421:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 24, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2513T>C (p.Leu838Pro)	ALK	L838P	Neuroblastoma, susceptibility to, 3	VCV002676345	2	29455289	2	29232423	2676345	2834766		NC_000002.12:29232422:A:G	single nucleotide variant	missense variant	Uncertain significance	May 12, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2513del (p.Leu838fs)	ALK	L838fs	Neuroblastoma, susceptibility to, 3	VCV000649841	2	29455289	2	29232423	649841	629863	rs1573139642	NC_000002.12:29232422:A:	Deletion	frameshift variant	Uncertain significance	Dec 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2511C>T (p.Pro837=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002869547	2	29455291	2	29232425	2869547	3024428		NC_000002.12:29232424:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2510C>G (p.Pro837Arg)	ALK	P837R	Neuroblastoma, susceptibility to, 3	VCV002693937	2	29455292	2	29232426	2693937	2863902		NC_000002.12:29232425:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2509C>T (p.Pro837Ser)	ALK	P837S	Neuroblastoma, susceptibility to, 3	VCV003673617	2	29455293	2	29232427	3673617	3806242		NC_000002.12:29232426:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2508G>T (p.Val836=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001658108	2	29455294	2	29232428	1658108	1594109	rs2148183455	NC_000002.12:29232427:C:A	single nucleotide variant	synonymous variant	Likely benign	May 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2506G>C (p.Val836Leu)	ALK	V836L	Neuroblastoma, susceptibility to, 3	VCV002154594	2	29455296	2	29232430	2154594	1885561		NC_000002.12:29232429:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2506del (p.Val836fs)	ALK	V836fs	Neuroblastoma, susceptibility to, 3	VCV000943780	2	29455296	2	29232430	943780	931358	rs1664240821	NC_000002.12:29232429:CC:C	Deletion	frameshift variant	Uncertain significance	May 25, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2505G>T (p.Pro835=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001080183	2	29455297	2	29232431	1080183	1069524	rs201700728	NC_000002.12:29232430:C:A	single nucleotide variant	synonymous variant	Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2505G>C (p.Pro835=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000698517	2	29455297	2	29232431	698517	686187	rs201700728	NC_000002.12:29232430:C:G	single nucleotide variant	synonymous variant	Likely benign	Dec 5, 2019	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2505G>A (p.Pro835=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538284	2	29455297	2	29232431	538284	518153	rs201700728	NC_000002.12:29232430:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2504C>T (p.Pro835Leu)	ALK	P835L	ALK-related disorder|Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000538251	2	29455298	2	29232432	538251	518129	rs376091121	NC_000002.12:29232431:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2503C>T (p.Pro835Ser)	ALK	P835S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000653727	2	29455299	2	29232433	653727	629864	rs763771560	NC_000002.12:29232432:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2502G>C (p.Val834=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003650174	2	29455300	2	29232434	3650174	3788170		NC_000002.12:29232433:C:G	single nucleotide variant	synonymous variant	Likely benign	Apr 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2501T>A (p.Val834Glu)	ALK	V834E	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001047180	2	29455301	2	29232435	1047180	1024449	rs750849080	NC_000002.12:29232434:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 22, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2498G>A (p.Gly833Glu)	ALK	G833E	not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000656360	2	29455304	2	29232438	656360	629865	rs1573139708	NC_000002.12:29232437:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2497G>T (p.Gly833Ter)	ALK	G833*	Neuroblastoma, susceptibility to, 3	VCV000571876	2	29455305	2	29232439	571876	558376	rs74360487	NC_000002.12:29232438:C:A	single nucleotide variant	nonsense	Uncertain significance	Nov 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2496T>A (p.Asp832Glu)	ALK	D832E	Neuroblastoma, susceptibility to, 3	VCV002870420	2	29455306	2	29232440	2870420	3031304		NC_000002.12:29232439:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2494G>C (p.Asp832His)	ALK	D832H	Neuroblastoma, susceptibility to, 3	VCV003022558	2	29455308	2	29232442	3022558	3176312		NC_000002.12:29232441:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2494G>A (p.Asp832Asn)	ALK	D832N	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001511236	2	29455308	2	29232442	1511236	1378051	rs1376612666	NC_000002.12:29232441:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2490G>A (p.Met830Ile)	ALK	M830I	Hereditary cancer-predisposing syndrome	VCV003286333	2	29455312	2	29232446	3286333	3455156		NC_000002.12:29232445:C:T	single nucleotide variant	missense variant	Uncertain significance	May 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2489T>C (p.Met830Thr)	ALK	M830T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000569201	2	29455313	2	29232447	569201	558378	rs1417845239	NC_000002.12:29232446:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2488A>G (p.Met830Val)	ALK	M830V	Hereditary cancer-predisposing syndrome	VCV003223836	2	29455314	2	29232448	3223836	3380858		NC_000002.12:29232447:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2488A>T (p.Met830Leu)	ALK	M830L	not provided|Neuroblastoma, susceptibility to, 3	VCV000335701	2	29455314	2	29232448	335701	285972	rs780536554	NC_000002.12:29232447:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2488-1G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000966484	2	29455315	2	29232449	966484	960474	rs1311699420	NC_000002.12:29232448:C:T	single nucleotide variant	splice acceptor variant	Uncertain significance	Oct 16, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2488-2A>G	ALK		not provided	VCV002499934	2	29455316	2	29232450	2499934	2477913		NC_000002.12:29232449:T:C	single nucleotide variant	splice acceptor variant	Uncertain significance	Oct 24, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2488-3C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001423912	2	29455317	2	29232451	1423912	1415096	rs2148183487	NC_000002.12:29232450:G:A	single nucleotide variant	intron variant	Uncertain significance	Oct 17, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2488-5G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001655848	2	29455319	2	29232453	1655848	1529095	rs2148183488	NC_000002.12:29232452:C:T	single nucleotide variant	intron variant	Likely benign	Dec 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2488-6G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001004726	2	29455320	2	29232454	1004726	988710	rs1664242016	NC_000002.12:29232453:C:G	single nucleotide variant	intron variant	Uncertain significance	Feb 8, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2488-7T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002053537	2	29455321	2	29232455	2053537	2104952		NC_000002.12:29232454:A:G	single nucleotide variant	intron variant	Likely benign	Jun 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2488-7del	ALK		Neuroblastoma, susceptibility to, 3	VCV000766413	2	29455321	2	29232455	766413	774698	rs1573139744	NC_000002.12:29232454:A:	Deletion	intron variant	Likely benign	Sep 2, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2488-8C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001100284	2	29455322	2	29232456	1100284	1091251	rs1244099578	NC_000002.12:29232455:G:C	single nucleotide variant	intron variant	Likely benign	Feb 2, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2488-9C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002045296	2	29455323	2	29232457	2045296	2103188		NC_000002.12:29232456:G:A	single nucleotide variant	intron variant	Likely benign	Sep 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2488-11C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003724583	2	29455325	2	29232459	3724583	3854363		NC_000002.12:29232458:G:A	single nucleotide variant	intron variant	Likely benign	Nov 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2488-15G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001666928	2	29455329	2	29232463	1666928	1622353	rs2148183504	NC_000002.12:29232462:C:T	single nucleotide variant	intron variant	Likely benign	Oct 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2488-19G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV003004698	2	29455333	2	29232467	3004698	3164940		NC_000002.12:29232466:C:T	single nucleotide variant	intron variant	Likely benign	Jun 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2488-20T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002795948	2	29455334	2	29232468	2795948	2958367		NC_000002.12:29232467:A:C	single nucleotide variant	intron variant	Likely benign	Nov 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2488-20T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001665833	2	29455334	2	29232468	1665833	1655562	rs2148183508	NC_000002.12:29232467:A:G	single nucleotide variant	intron variant	Likely benign	Aug 2, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2488-165A>G	ALK		not provided	VCV001211348	2	29455479	2	29232613	1211348	1201345	rs76337448	NC_000002.12:29232612:T:C	single nucleotide variant	intron variant	Likely benign	Jul 20, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2487+251A>T	ALK		not provided	VCV001249541	2	29456180	2	29233314	1249541	1241166	rs79309332	NC_000002.12:29233313:T:A	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2487+240dup	ALK		not provided	VCV001218341	2	29456183 - 29456184	2	29233317 - 29233318	1218341	1208323	rs576884153	NC_000002.12:29233317:TTTTTTTT:TTTTTTTTT	Duplication	intron variant	Likely benign	Jul 5, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2487+47A>G	ALK		not provided	VCV001292707	2	29456384	2	29233518	1292707	1282513	rs77684724	NC_000002.12:29233517:T:C	single nucleotide variant	intron variant	Benign	Jun 26, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2487+46C>T	ALK		not provided	VCV001293453	2	29456385	2	29233519	1293453	1283258	rs76630156	NC_000002.12:29233518:G:A	single nucleotide variant	intron variant	Benign	Jul 5, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2487+20A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002722087	2	29456411	2	29233545	2722087	2881297		NC_000002.12:29233544:T:C	single nucleotide variant	intron variant	Likely benign	Jan 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2487+15_2487+16del	ALK		Neuroblastoma, susceptibility to, 3	VCV002773230	2	29456415 - 29456416	2	29233549 - 29233550	2773230	2930508		NC_000002.12:29233548:GC:	Deletion	intron variant	Likely benign	Jun 5, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2487+15G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002085680	2	29456416	2	29233550	2085680	2137039		NC_000002.12:29233549:C:T	single nucleotide variant	intron variant	Likely benign	Jul 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2487+11T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001573530	2	29456420	2	29233554	1573530	1637245	rs2148184400	NC_000002.12:29233553:A:G	single nucleotide variant	intron variant	Likely benign	Jul 24, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2487+10G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001632314	2	29456421	2	29233555	1632314	1630841	rs1158838448	NC_000002.12:29233554:C:T	single nucleotide variant	intron variant	Likely benign	Jul 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2487+8G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002118283	2	29456423	2	29233557	2118283	2176065		NC_000002.12:29233556:C:T	single nucleotide variant	intron variant	Likely benign	Mar 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2487+6G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000957747	2	29456425	2	29233559	957747	959637	rs1664279510	NC_000002.12:29233558:C:T	single nucleotide variant	intron variant	Uncertain significance	Oct 31, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2487+4_2487+5dup	ALK		Neuroblastoma, susceptibility to, 3	VCV000933709	2	29456425 - 29456426	2	29233559 - 29233560	933709	939889	rs1664279648	NC_000002.12:29233559:CA:CACA	Duplication	intron variant	Uncertain significance	Dec 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2487+4_2487+5insA	ALK		ALK-related disorder|Neuroblastoma, susceptibility to, 3|not provided	VCV000538179	2	29456426 - 29456427	2	29233560 - 29233561	538179	518131	rs755502856	NC_000002.12:29233560::T	Insertion	intron variant	Uncertain significance	Nov 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2487+4T>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002077158	2	29456427	2	29233561	2077158	2131217		NC_000002.12:29233560:A:T	single nucleotide variant	intron variant	Uncertain significance	Dec 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2487+4T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001045454	2	29456427	2	29233561	1045454	1024450	rs368430854	NC_000002.12:29233560:A:G	single nucleotide variant	intron variant	Uncertain significance	Sep 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2480T>C (p.Val827Ala)	ALK	V827A	Neuroblastoma, susceptibility to, 3	VCV000470796	2	29456438	2	29233572	470796	451050	rs753584062	NC_000002.12:29233571:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2479G>C (p.Val827Leu)	ALK	V827L	Neuroblastoma, susceptibility to, 3	VCV001394200	2	29456439	2	29233573	1394200	1338223	rs756963896	NC_000002.12:29233572:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2479G>A (p.Val827Ile)	ALK	V827I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470795	2	29456439	2	29233573	470795	450749	rs756963896	NC_000002.12:29233572:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 26, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2478C>T (p.Tyr826=)	ALK		Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000239806	2	29456440	2	29233574	239806	238738	rs142126984	NC_000002.12:29233573:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2475C>G (p.Thr825=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001522747	2	29456443	2	29233577	1522747	1459941	rs2148184433	NC_000002.12:29233576:G:C	single nucleotide variant	synonymous variant	Uncertain significance	Feb 10, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2474C>T (p.Thr825Ile)	ALK	T825I	Neuroblastoma, susceptibility to, 3	VCV000656594	2	29456444	2	29233578	656594	629866	rs1573141513	NC_000002.12:29233577:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2472C>T (p.Ala824=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001082398	2	29456446	2	29233580	1082398	1069525	rs2148184442	NC_000002.12:29233579:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 25, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2456_2470dup (p.Gly823_Ala824insGlyGlyGlyGlyGly)	ALK		Neuroblastoma, susceptibility to, 3	VCV002428714	2	29456447 - 29456448	2	29233581 - 29233582	2428714	2402156		NC_000002.12:29233581:CTCCACCCCCTCCTCCTCC:CTCCACCCCCTCCTCCTCCACCCCCTCCTCCTCC	Duplication	inframe_insertion	Uncertain significance	Jul 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2470G>T (p.Ala824Ser)	ALK	A824S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538191	2	29456448	2	29233582	538191	518162	rs571958914	NC_000002.12:29233581:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2469A>G (p.Gly823=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223835	2	29456449	2	29233583	3223835	3380857		NC_000002.12:29233582:T:C	single nucleotide variant	synonymous variant	Likely benign	Mar 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2463G>T (p.Gly821=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003004795	2	29456455	2	29233589	3004795	3165037		NC_000002.12:29233588:C:A	single nucleotide variant	synonymous variant	Likely benign	May 30, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2463G>A (p.Gly821=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001122372	2	29456455	2	29233589	1122372	1112746	rs371626235	NC_000002.12:29233588:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2454AGG[2] (p.Gly823del)	ALK	G823del	Neuroblastoma, susceptibility to, 3	VCV003637267	2	29456456 - 29456458	2	29233590 - 29233592	3637267	3771421		NC_000002.12:29233589:CCTCCTCCTCC:CCTCCTCC	Microsatellite		Uncertain significance	Sep 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2462G>T (p.Gly821Val)	ALK	G821V	Hereditary cancer-predisposing syndrome	VCV001791654	2	29456456	2	29233590	1791654	1848471		NC_000002.12:29233589:C:A	single nucleotide variant	missense variant	Uncertain significance	May 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2461G>A (p.Gly821Arg)	ALK	G821R	Neuroblastoma, susceptibility to, 3	VCV000857467	2	29456457	2	29233591	857467	826345	rs201590062	NC_000002.12:29233590:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2460A>G (p.Gly820=)	ALK		Hereditary cancer-predisposing syndrome	VCV001791623	2	29456458	2	29233592	1791623	1848441		NC_000002.12:29233591:T:C	single nucleotide variant	synonymous variant	Likely benign	Jul 9, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2459del (p.Gly820fs)	ALK	G820fs	Neuroblastoma, susceptibility to, 3	VCV001504293	2	29456459	2	29233593	1504293	1337168	rs2148184481	NC_000002.12:29233592:CC:C	Deletion	frameshift variant	Uncertain significance	Oct 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2459G>A (p.Gly820Glu)	ALK	G820E	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000645243	2	29456459	2	29233593	645243	629867	rs1573141557	NC_000002.12:29233592:C:T	single nucleotide variant	missense variant	Uncertain significance	May 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2458G>A (p.Gly820Arg)	ALK	G820R	Neuroblastoma, susceptibility to, 3	VCV000835197	2	29456460	2	29233594	835197	826346	rs1664281575	NC_000002.12:29233593:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2456dup (p.Gly820fs)	ALK	G820fs	Neuroblastoma, susceptibility to, 3	VCV001476103	2	29456461 - 29456462	2	29233595 - 29233596	1476103	1423822	rs2148184483	NC_000002.12:29233595:CC:CCC	Duplication	frameshift variant	Uncertain significance	Aug 6, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2457A>G (p.Gly819=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000703442	2	29456461	2	29233595	703442	691142	rs147842434	NC_000002.12:29233594:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2456G>A (p.Gly819Glu)	ALK	G819E	Neuroblastoma, susceptibility to, 3	VCV002791219	2	29456462	2	29233596	2791219	2953650		NC_000002.12:29233595:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2454A>G (p.Gly818=)	ALK		Hereditary cancer-predisposing syndrome	VCV003524796	2	29456464	2	29233598	3524796	3689035		NC_000002.12:29233597:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2453G>A (p.Gly818Glu)	ALK	G818E	not provided	VCV002574973	2	29456465	2	29233599	2574973	2739909		NC_000002.12:29233598:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2452G>A (p.Gly818Arg)	ALK	G818R	not provided|Neuroblastoma, susceptibility to, 3	VCV000582105	2	29456466	2	29233600	582105	558380	rs777803249	NC_000002.12:29233599:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2451C>A (p.Gly817=)	ALK		not provided	VCV003234821	2	29456467	2	29233601	3234821	3393943		NC_000002.12:29233600:G:T	single nucleotide variant	synonymous variant	Likely benign	Apr 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2451C>T (p.Gly817=)	ALK		Neuroblastoma, susceptibility to, 3|not specified|Hereditary cancer-predisposing syndrome	VCV000239805	2	29456467	2	29233601	239805	238739	rs183314518	NC_000002.12:29233600:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2449G>A (p.Gly817Ser)	ALK	G817S	Neuroblastoma, susceptibility to, 3	VCV003707061	2	29456469	2	29233603	3707061	3846547		NC_000002.12:29233602:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2448A>G (p.Gly816=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001576476	2	29456470	2	29233604	1576476	1586807	rs2148184490	NC_000002.12:29233603:T:C	single nucleotide variant	synonymous variant	Likely benign	Mar 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2447G>A (p.Gly816Glu)	ALK	G816E	Neuroblastoma, susceptibility to, 3	VCV002675826	2	29456471	2	29233605	2675826	2835944		NC_000002.12:29233604:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2445A>G (p.Ala815=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001791376	2	29456473	2	29233607	1791376	1848196		NC_000002.12:29233606:T:C	single nucleotide variant	synonymous variant	Likely benign	May 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2445A>C (p.Ala815=)	ALK		Hereditary cancer-predisposing syndrome	VCV000821290	2	29456473	2	29233607	821290	806909	rs778587823	NC_000002.12:29233606:T:G	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2443G>C (p.Ala815Pro)	ALK	A815P	Hereditary cancer-predisposing syndrome	VCV003223833	2	29456475	2	29233609	3223833	3380855		NC_000002.12:29233608:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2443G>T (p.Ala815Ser)	ALK	A815S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470794	2	29456475	2	29233609	470794	451060	rs200486099	NC_000002.12:29233608:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2442G>A (p.Trp814Ter)	ALK	W814*	Neuroblastoma, susceptibility to, 3	VCV001933629	2	29456476	2	29233610	1933629	1992510		NC_000002.12:29233609:C:T	single nucleotide variant	nonsense	Uncertain significance	Mar 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2442G>T (p.Trp814Cys)	ALK	W814C	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001384671	2	29456476	2	29233610	1384671	1348946	rs2148184506	NC_000002.12:29233609:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2440T>G (p.Trp814Gly)	ALK	W814G	Neuroblastoma, susceptibility to, 3	VCV000936201	2	29456478	2	29233612	936201	931359	rs1664282523	NC_000002.12:29233611:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2439G>A (p.Glu813=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470793	2	29456479	2	29233613	470793	451061	rs745610953	NC_000002.12:29233612:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2436T>C (p.His812=)	ALK		Hereditary cancer-predisposing syndrome	VCV003524079	2	29456482	2	29233616	3524079	3682247		NC_000002.12:29233615:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2436T>A (p.His812Gln)	ALK	H812Q	Hereditary cancer-predisposing syndrome	VCV001791236	2	29456482	2	29233616	1791236	1851597		NC_000002.12:29233615:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2435A>G (p.His812Arg)	ALK	H812R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000852582	2	29456483	2	29233617	852582	826347	rs866703896	NC_000002.12:29233616:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2434C>G (p.His812Asp)	ALK	H812D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000852416	2	29456484	2	29233618	852416	826348	rs1404474970	NC_000002.12:29233617:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2431G>A (p.Val811Met)	ALK	V811M	Neuroblastoma, susceptibility to, 3	VCV000836307	2	29456487	2	29233621	836307	826349	rs771935814	NC_000002.12:29233620:C:T	single nucleotide variant	missense variant	Uncertain significance	May 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2430C>G (p.Ser810Arg)	ALK	S810R	Neuroblastoma, susceptibility to, 3	VCV001017010	2	29456488	2	29233622	1017010	1003985	rs150292405	NC_000002.12:29233621:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2430C>T (p.Ser810=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000335702	2	29456488	2	29233622	335702	285982	rs150292405	NC_000002.12:29233621:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2428A>G (p.Ser810Gly)	ALK	S810G	Neuroblastoma, susceptibility to, 3	VCV001365275	2	29456490	2	29233624	1365275	1502318	rs2148184523	NC_000002.12:29233623:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2425A>G (p.Arg809Gly)	ALK	R809G	Hereditary cancer-predisposing syndrome	VCV003285723	2	29456493	2	29233627	3285723	3440954		NC_000002.12:29233626:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2424C>T (p.Asn808=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001148865	2	29456494	2	29233628	1148865	1133659	rs768347719	NC_000002.12:29233627:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2423A>G (p.Asn808Ser)	ALK	N808S	Neuroblastoma, susceptibility to, 3	VCV001391141	2	29456495	2	29233629	1391141	1489858	rs2148184532	NC_000002.12:29233628:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2420dup (p.Asn808fs)	ALK	N808fs	Neuroblastoma, susceptibility to, 3	VCV001010934	2	29456497 - 29456498	2	29233631 - 29233632	1010934	988711	rs1664283510	NC_000002.12:29233631:A:AA	Duplication	frameshift variant	Uncertain significance	Mar 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2420T>C (p.Val807Ala)	ALK	V807A	Neuroblastoma, susceptibility to, 3	VCV002780428	2	29456498	2	29233632	2780428	2944167		NC_000002.12:29233631:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2418T>C (p.Arg806=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001146429	2	29456500	2	29233634	1146429	1133660	rs776266666	NC_000002.12:29233633:A:G	single nucleotide variant	synonymous variant	Likely benign	May 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2417G>T (p.Arg806Leu)	ALK	R806L	Neuroblastoma, susceptibility to, 3	VCV000864716	2	29456501	2	29233635	864716	826350	rs761568836	NC_000002.12:29233634:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2417G>A (p.Arg806His)	ALK	R806H	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470792	2	29456501	2	29233635	470792	451052	rs761568836	NC_000002.12:29233634:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2416C>A (p.Arg806Ser)	ALK	R806S	Neuroblastoma, susceptibility to, 3	VCV001351311	2	29456502	2	29233636	1351311	1407661	rs80227749	NC_000002.12:29233635:G:T	single nucleotide variant	missense variant	Uncertain significance	May 4, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2416C>T (p.Arg806Cys)	ALK	R806C	Neuroblastoma, susceptibility to, 3|not provided|ALK-related disorder|Hereditary cancer-predisposing syndrome	VCV000404347	2	29456502	2	29233636	404347	392740	rs80227749	NC_000002.12:29233635:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 2, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2415C>T (p.Ile805=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003523076	2	29456503	2	29233637	3523076	3688634		NC_000002.12:29233636:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2415C>G (p.Ile805Met)	ALK	I805M	not provided|Neuroblastoma, susceptibility to, 3	VCV002085025	2	29456503	2	29233637	2085025	2140368		NC_000002.12:29233636:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2404GAA[2] (p.Glu804del)	ALK	E804del	Neuroblastoma, susceptibility to, 3	VCV000575390	2	29456506 - 29456508	2	29233640 - 29233642	575390	561338	rs1558630567	NC_000002.12:29233639:TTCTTCTTCT:TTCTTCT	Microsatellite	inframe_deletion	Uncertain significance	Jul 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2410G>A (p.Glu804Lys)	ALK	E804K	Neuroblastoma, susceptibility to, 3	VCV002078238	2	29456508	2	29233642	2078238	2138753		NC_000002.12:29233641:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2406A>G (p.Glu802=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001566942	2	29456512	2	29233646	1566942	1622585	rs2148184567	NC_000002.12:29233645:T:C	single nucleotide variant	synonymous variant	Likely benign	Jun 18, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2403A>G (p.Ile801Met)	ALK	I801M	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003286434	2	29456515	2	29233649	3286434	3455257		NC_000002.12:29233648:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2402T>C (p.Ile801Thr)	ALK	I801T	Neuroblastoma, susceptibility to, 3	VCV003683768	2	29456516	2	29233650	3683768	3808617		NC_000002.12:29233649:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2401A>G (p.Ile801Val)	ALK	I801V	Neuroblastoma, susceptibility to, 3	VCV000942912	2	29456517	2	29233651	942912	931360	rs1664284078	NC_000002.12:29233650:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2400G>C (p.Val800=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000715294	2	29456518	2	29233652	715294	719840	rs1573141693	NC_000002.12:29233651:C:G	single nucleotide variant	synonymous variant	Likely benign	Jun 28, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2399T>A (p.Val800Glu)	ALK	V800E	Neuroblastoma, susceptibility to, 3	VCV002827106	2	29456519	2	29233653	2827106	2983058		NC_000002.12:29233652:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2397T>C (p.Asn799=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001554720	2	29456521	2	29233655	1554720	1652156	rs1483960716	NC_000002.12:29233654:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2396A>G (p.Asn799Ser)	ALK	N799S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001356932	2	29456522	2	29233656	1356932	1348363	rs563120454	NC_000002.12:29233655:T:C	single nucleotide variant	missense variant	Uncertain significance	May 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2395A>G (p.Asn799Asp)	ALK	N799D	Hereditary cancer-predisposing syndrome	VCV003522000	2	29456523	2	29233657	3522000	3684988		NC_000002.12:29233656:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2394C>A (p.Asn798Lys)	ALK	N798K	Neuroblastoma, susceptibility to, 3	VCV002766636	2	29456524	2	29233658	2766636	2929098		NC_000002.12:29233657:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2394C>T (p.Asn798=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001114229	2	29456524	2	29233658	1114229	1091252	rs2148184583	NC_000002.12:29233657:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 2, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2393A>G (p.Asn798Ser)	ALK	N798S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001959957	2	29456525	2	29233659	1959957	2016213		NC_000002.12:29233658:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2393A>C (p.Asn798Thr)	ALK	N798T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001360166	2	29456525	2	29233659	1360166	1363612	rs2148184587	NC_000002.12:29233658:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2392A>T (p.Asn798Tyr)	ALK	N798Y	Neuroblastoma, susceptibility to, 3	VCV002894376	2	29456526	2	29233660	2894376	3056017		NC_000002.12:29233659:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2391G>A (p.Glu797=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000767368	2	29456527	2	29233661	767368	697547	rs372037531	NC_000002.12:29233660:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 10, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2390A>G (p.Glu797Gly)	ALK	E797G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002723277	2	29456528	2	29233662	2723277	2885067		NC_000002.12:29233661:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2389G>A (p.Glu797Lys)	ALK	E797K	Neuroblastoma, susceptibility to, 3	VCV002675898	2	29456529	2	29233663	2675898	2836015		NC_000002.12:29233662:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2387G>A (p.Gly796Glu)	ALK	G796E	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002624786	2	29456531	2	29233665	2624786	2790281		NC_000002.12:29233664:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2386G>A (p.Gly796Arg)	ALK	G796R	Neuroblastoma, susceptibility to, 3	VCV001432224	2	29456532	2	29233666	1432224	1484335	rs942512399	NC_000002.12:29233665:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2385T>G (p.Ile795Met)	ALK	I795M	Hereditary cancer-predisposing syndrome	VCV003524524	2	29456533	2	29233667	3524524	3679189		NC_000002.12:29233666:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2385T>C (p.Ile795=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001154059	2	29456533	2	29233667	1154059	1133661	rs2148184598	NC_000002.12:29233666:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 18, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2384T>A (p.Ile795Asn)	ALK	I795N	Hereditary cancer-predisposing syndrome	VCV001790476	2	29456534	2	29233668	1790476	1841377		NC_000002.12:29233667:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2384T>C (p.Ile795Thr)	ALK	I795T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404318	2	29456534	2	29233668	404318	392940	rs763503560	NC_000002.12:29233667:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2382C>T (p.Cys794=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002032836	2	29456536	2	29233670	2032836	2079197		NC_000002.12:29233669:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2381G>T (p.Cys794Phe)	ALK	C794F	Neuroblastoma, susceptibility to, 3	VCV002037152	2	29456537	2	29233671	2037152	2097644		NC_000002.12:29233670:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2378T>C (p.Val793Ala)	ALK	V793A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001496388	2	29456540	2	29233674	1496388	1359420	rs1664284981	NC_000002.12:29233673:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2377G>C (p.Val793Leu)	ALK	V793L	Hereditary cancer-predisposing syndrome	VCV002586669	2	29456541	2	29233675	2586669	2756852		NC_000002.12:29233674:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2376A>G (p.Lys792=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001102790	2	29456542	2	29233676	1102790	1091253	rs1664285138	NC_000002.12:29233675:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2374A>G (p.Lys792Glu)	ALK	K792E	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000656562	2	29456544	2	29233678	656562	629868	rs950513733	NC_000002.12:29233677:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2373G>A (p.Gln791=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001554585	2	29456545	2	29233679	1554585	1652021	rs1344236918	NC_000002.12:29233678:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 24, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2373G>C (p.Gln791His)	ALK	Q791H	Neuroblastoma, susceptibility to, 3	VCV001464962	2	29456545	2	29233679	1464962	1514673	rs1344236918	NC_000002.12:29233678:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2372A>G (p.Gln791Arg)	ALK	Q791R	Hereditary cancer-predisposing syndrome	VCV002452138	2	29456546	2	29233680	2452138	2426778		NC_000002.12:29233679:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2370C>A (p.Ile790=)	ALK		Hereditary cancer-predisposing syndrome	VCV001790294	2	29456548	2	29233682	1790294	1845039		NC_000002.12:29233681:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 2, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2366T>G (p.Leu789Ter)	ALK	L789*	Neuroblastoma, susceptibility to, 3	VCV001353869	2	29456552	2	29233686	1353869	1495988	rs2148184625	NC_000002.12:29233685:A:C	single nucleotide variant	nonsense	Uncertain significance	May 16, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2361C>T (p.Asn787=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001790168	2	29456557	2	29233691	1790168	1844914		NC_000002.12:29233690:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2361C>A (p.Asn787Lys)	ALK	N787K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000951043	2	29456557	2	29233691	951043	922719	rs777889776	NC_000002.12:29233690:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2360A>G (p.Asn787Ser)	ALK	N787S	Neuroblastoma, susceptibility to, 3	VCV002769350	2	29456558	2	29233692	2769350	2923625		NC_000002.12:29233691:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2359A>G (p.Asn787Asp)	ALK	N787D	Neuroblastoma, susceptibility to, 3	VCV001011920	2	29456559	2	29233693	1011920	988712	rs1664285603	NC_000002.12:29233692:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2358A>G (p.Thr786=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003223832	2	29456560	2	29233694	3223832	3380854		NC_000002.12:29233693:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2357C>G (p.Thr786Arg)	ALK	T786R	Hereditary cancer-predisposing syndrome	VCV003524513	2	29456561	2	29233695	3524513	3679178		NC_000002.12:29233694:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2356A>G (p.Thr786Ala)	ALK	T786A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001375962	2	29456562	2	29233696	1375962	1470348	rs375227499	NC_000002.12:29233695:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2356A>C (p.Thr786Pro)	ALK	T786P	Neuroblastoma, susceptibility to, 3	VCV000858447	2	29456562	2	29233696	858447	826351	rs375227499	NC_000002.12:29233695:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2356-2A>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003724164	2	29456564	2	29233698	3724164	3857376		NC_000002.12:29233697:T:A	single nucleotide variant	splice acceptor variant	Uncertain significance	Oct 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2356-4A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003701119	2	29456566	2	29233700	3701119	3834589		NC_000002.12:29233699:T:C	single nucleotide variant	intron variant	Likely benign	Feb 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2356-7T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002837410	2	29456569	2	29233703	2837410	2995967		NC_000002.12:29233702:A:C	single nucleotide variant	intron variant	Likely benign	Feb 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2356-11dup	ALK		Neuroblastoma, susceptibility to, 3	VCV002199530	2	29456572 - 29456573	2	29233706 - 29233707	2199530	1924376		NC_000002.12:29233706:AAAAA:AAAAAA	Duplication	intron variant	Benign	Jun 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2356-11del	ALK		Neuroblastoma, susceptibility to, 3	VCV001575837	2	29456573	2	29233707	1575837	1551865	rs768069628	NC_000002.12:29233706:AAAAA:AAAA	Deletion	intron variant	Likely benign	Jul 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2356-16del	ALK		Neuroblastoma, susceptibility to, 3	VCV001543983	2	29456578	2	29233712	1543983	1611521	rs752838625	NC_000002.12:29233711:G:	Deletion	intron variant	Likely benign	Feb 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2356-16C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001535973	2	29456578	2	29233712	1535973	1648677	rs551864909	NC_000002.12:29233711:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2356-16C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001496789	2	29456578	2	29233712	1496789	1382191	rs551864909	NC_000002.12:29233711:G:C	single nucleotide variant	intron variant	Likely benign	Aug 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2356-17G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002198428	2	29456579	2	29233713	2198428	1933654		NC_000002.12:29233712:C:T	single nucleotide variant	intron variant	Likely benign	Mar 14, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2356-19G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001554661	2	29456581	2	29233715	1554661	1652097	rs745673569	NC_000002.12:29233714:C:T	single nucleotide variant	intron variant	Likely benign	Dec 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2356-20C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001460788	2	29456582	2	29233716	1460788	1419597	rs577586643	NC_000002.12:29233715:G:A	single nucleotide variant	intron variant	Likely benign	Nov 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2356-304_2356-303insC	ALK		not provided	VCV001238683	2	29456865 - 29456866	2	29233999 - 29234000	1238683	1227811	rs147039589	NC_000002.12:29233999::G	Insertion	intron variant	Benign	Aug 11, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2356-320A>G	ALK		not provided	VCV001244656	2	29456882	2	29234016	1244656	1237185	rs78287501	NC_000002.12:29234015:T:C	single nucleotide variant	intron variant	Benign	Aug 11, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2355+276C>T	ALK		not provided	VCV001245220	2	29462270	2	29239404	1245220	1235173	rs76788680	NC_000002.12:29239403:G:A	single nucleotide variant	intron variant	Benign	Mar 24, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2355+275C>T	ALK		not provided	VCV001257708	2	29462271	2	29239405	1257708	1249757	rs74535085	NC_000002.12:29239404:G:A	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2355+248A>T	ALK		not provided	VCV001270953	2	29462298	2	29239432	1270953	1260805	rs78743580	NC_000002.12:29239431:T:A	single nucleotide variant	intron variant	Benign	Jul 5, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2355+141T>C	ALK		not provided	VCV001250724	2	29462405	2	29239539	1250724	1238533	rs13397113	NC_000002.12:29239538:A:G	single nucleotide variant	intron variant	Benign	Jun 26, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2355+26C>T	ALK		not provided	VCV001292671	2	29462520	2	29239654	1292671	1282477	rs77855517	NC_000002.12:29239653:G:A	single nucleotide variant	intron variant	Benign	Jul 5, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2355+20G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002048737	2	29462526	2	29239660	2048737	2114381		NC_000002.12:29239659:C:A	single nucleotide variant	intron variant	Likely benign	Mar 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2355+19_2355+20delinsAA	ALK		Neuroblastoma, susceptibility to, 3	VCV001579028	2	29462526 - 29462527	2	29239660 - 29239661	1579028	1565019	rs2148188644	NC_000002.12:29239659:CC:TT	Indel	intron variant	Likely benign	Jun 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2355+19G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003727056	2	29462527	2	29239661	3727056	3851677		NC_000002.12:29239660:C:A	single nucleotide variant	intron variant	Likely benign	Dec 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2355+19G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001974919	2	29462527	2	29239661	1974919	2030190		NC_000002.12:29239660:C:T	single nucleotide variant	intron variant	Likely benign	Apr 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2355+18G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002029811	2	29462528	2	29239662	2029811	2089003		NC_000002.12:29239661:C:T	single nucleotide variant	intron variant	Likely benign	Sep 10, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2355+17G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002039868	2	29462529	2	29239663	2039868	2091330		NC_000002.12:29239662:C:T	single nucleotide variant	intron variant	Likely benign	Feb 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2355+15C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003679378	2	29462531	2	29239665	3679378	3814402		NC_000002.12:29239664:G:C	single nucleotide variant	intron variant	Likely benign	Aug 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2355+10C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003664919	2	29462536	2	29239670	3664919	3802041		NC_000002.12:29239669:G:A	single nucleotide variant	intron variant	Likely benign	Sep 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2355+8C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000795554	2	29462538	2	29239672	795554	787209	rs1198288574	NC_000002.12:29239671:G:C	single nucleotide variant	intron variant	Likely benign	Nov 17, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2355+7G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001596691	2	29462539	2	29239673	1596691	1602287	rs1236531902	NC_000002.12:29239672:C:T	single nucleotide variant	intron variant	Likely benign	May 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2355+7G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001118627	2	29462539	2	29239673	1118627	1091254	rs1236531902	NC_000002.12:29239672:C:A	single nucleotide variant	intron variant	Likely benign	Aug 27, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2355+6T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002070931	2	29462540	2	29239674	2070931	2130155		NC_000002.12:29239673:A:C	single nucleotide variant	intron variant	Uncertain significance	Oct 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2355+3A>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002025676	2	29462543	2	29239677	2025676	2081024		NC_000002.12:29239676:T:A	single nucleotide variant	intron variant	Uncertain significance	Aug 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2355+1G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002903895	2	29462545	2	29239679	2903895	3061640		NC_000002.12:29239678:C:A	single nucleotide variant	splice donor variant	Uncertain significance	Apr 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2355T>G (p.Ser785Arg)	ALK	S785R	Neuroblastoma, susceptibility to, 3	VCV002956510	2	29462546	2	29239680	2956510	3115564		NC_000002.12:29239679:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2354G>C (p.Ser785Thr)	ALK	S785T	Neuroblastoma, susceptibility to, 3	VCV002755822	2	29462547	2	29239681	2755822	2916994		NC_000002.12:29239680:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2354G>T (p.Ser785Ile)	ALK	S785I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001483362	2	29462547	2	29239681	1483362	1380481	rs1441640593	NC_000002.12:29239680:C:A	single nucleotide variant	missense variant	Uncertain significance	May 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2354G>A (p.Ser785Asn)	ALK	S785N	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000655880	2	29462547	2	29239681	655880	629869	rs1441640593	NC_000002.12:29239680:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2353A>G (p.Ser785Gly)	ALK	S785G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001034684	2	29462548	2	29239682	1034684	1024451	rs1664471687	NC_000002.12:29239681:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2350C>A (p.Pro784Thr)	ALK	P784T	Neuroblastoma, susceptibility to, 3	VCV000938150	2	29462551	2	29239685	938150	931361	rs1177791435	NC_000002.12:29239684:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2348G>A (p.Cys783Tyr)	ALK	C783Y	Hereditary cancer-predisposing syndrome	VCV003525005	2	29462553	2	29239687	3525005	3689244		NC_000002.12:29239686:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2345C>T (p.Ala782Val)	ALK	A782V	Neuroblastoma, susceptibility to, 3	VCV003703331	2	29462556	2	29239690	3703331	3835498		NC_000002.12:29239689:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2345C>G (p.Ala782Gly)	ALK	A782G	Neuroblastoma, susceptibility to, 3	VCV001388505	2	29462556	2	29239690	1388505	1371246	rs769390697	NC_000002.12:29239689:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2344G>A (p.Ala782Thr)	ALK	A782T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000571234	2	29462557	2	29239691	571234	561339	rs549721018	NC_000002.12:29239690:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2343C>T (p.Asp781=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000239804	2	29462558	2	29239692	239804	238740	rs61754933	NC_000002.12:29239691:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2340G>A (p.Glu780=)	ALK		Hereditary cancer-predisposing syndrome	VCV001789862	2	29462561	2	29239695	1789862	1847993		NC_000002.12:29239694:C:T	single nucleotide variant	synonymous variant	Likely benign	May 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2339A>G (p.Glu780Gly)	ALK	E780G	Neuroblastoma, susceptibility to, 3	VCV002081932	2	29462562	2	29239696	2081932	2135886		NC_000002.12:29239695:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2339A>T (p.Glu780Val)	ALK	E780V	Hereditary cancer-predisposing syndrome	VCV001789809	2	29462562	2	29239696	1789809	1847940		NC_000002.12:29239695:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2338G>A (p.Glu780Lys)	ALK	E780K	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002001398	2	29462563	2	29239697	2001398	2058038		NC_000002.12:29239696:C:T	single nucleotide variant	missense variant	Uncertain significance	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2337A>C (p.Gly779=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470789	2	29462564	2	29239698	470789	451053	rs775839459	NC_000002.12:29239697:T:G	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2335G>A (p.Gly779Arg)	ALK	G779R	Hereditary cancer-predisposing syndrome	VCV003524305	2	29462566	2	29239700	3524305	3678970		NC_000002.12:29239699:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2334G>A (p.Gln778=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001655714	2	29462567	2	29239701	1655714	1616064	rs2148188685	NC_000002.12:29239700:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 25, 2020	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2332C>G (p.Gln778Glu)	ALK	Q778E	Neuroblastoma, susceptibility to, 3	VCV003241651	2	29462569	2	29239703	3241651	3400629		NC_000002.12:29239702:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2332C>A (p.Gln778Lys)	ALK	Q778K	Hereditary cancer-predisposing syndrome	VCV003223831	2	29462569	2	29239703	3223831	3380853		NC_000002.12:29239702:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2331G>A (p.Gln777=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002032768	2	29462570	2	29239704	2032768	2079131		NC_000002.12:29239703:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2331G>T (p.Gln777His)	ALK	Q777H	Neuroblastoma, susceptibility to, 3	VCV001370692	2	29462570	2	29239704	1370692	1430760	rs2148188686	NC_000002.12:29239703:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2330A>C (p.Gln777Pro)	ALK	Q777P	Neuroblastoma, susceptibility to, 3	VCV001484279	2	29462571	2	29239705	1484279	1455209	rs1448527132	NC_000002.12:29239704:T:G	single nucleotide variant	missense variant	Uncertain significance	May 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2328G>A (p.Gly776=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000412905	2	29462573	2	29239707	412905	392950	rs764607514	NC_000002.12:29239706:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2327G>A (p.Gly776Glu)	ALK	G776E	Neuroblastoma, susceptibility to, 3	VCV001022257	2	29462574	2	29239708	1022257	1003986	rs1664472832	NC_000002.12:29239707:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2324T>A (p.Val775Asp)	ALK	V775D	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002452121	2	29462577	2	29239711	2452121	2426761		NC_000002.12:29239710:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2324T>C (p.Val775Ala)	ALK	V775A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002177661	2	29462577	2	29239711	2177661	1919353		NC_000002.12:29239710:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2323G>A (p.Val775Ile)	ALK	V775I	Hereditary cancer-predisposing syndrome	VCV003521251	2	29462578	2	29239712	3521251	3688123		NC_000002.12:29239711:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2323G>C (p.Val775Leu)	ALK	V775L	Hereditary cancer-predisposing syndrome	VCV001789613	2	29462578	2	29239712	1789613	1847744		NC_000002.12:29239711:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2323G>T (p.Val775Phe)	ALK	V775F	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001002096	2	29462578	2	29239712	1002096	988713	rs1664472929	NC_000002.12:29239711:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2322G>T (p.Leu774=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001127795	2	29462579	2	29239713	1127795	1112747	rs777172061	NC_000002.12:29239712:C:A	single nucleotide variant	synonymous variant	Likely benign	Sep 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2322G>C (p.Leu774=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000763151	2	29462579	2	29239713	763151	763176	rs777172061	NC_000002.12:29239712:C:G	single nucleotide variant	synonymous variant	Likely benign	Jul 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2319C>T (p.Ile773=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001789528	2	29462582	2	29239716	1789528	1847659		NC_000002.12:29239715:G:A	single nucleotide variant	synonymous variant	Likely benign	May 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2319C>G (p.Ile773Met)	ALK	I773M	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000957309	2	29462582	2	29239716	957309	942863	rs1227146625	NC_000002.12:29239715:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2317A>G (p.Ile773Val)	ALK	I773V	Hereditary cancer-predisposing syndrome	VCV003523183	2	29462584	2	29239718	3523183	3688741		NC_000002.12:29239717:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2317A>C (p.Ile773Leu)	ALK	I773L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002193684	2	29462584	2	29239718	2193684	1929361		NC_000002.12:29239717:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2316C>T (p.Tyr772=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001131097	2	29462585	2	29239719	1131097	1112748	rs762222300	NC_000002.12:29239718:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2315A>G (p.Tyr772Cys)	ALK	Y772C	Neuroblastoma, susceptibility to, 3	VCV002753485	2	29462586	2	29239720	2753485	2919852		NC_000002.12:29239719:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2313G>T (p.Leu771=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001563644	2	29462588	2	29239722	1563644	1620148	rs538761543	NC_000002.12:29239721:C:A	single nucleotide variant	synonymous variant	Likely benign	Jun 3, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2313G>A (p.Leu771=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001077567	2	29462588	2	29239722	1077567	1069526	rs538761543	NC_000002.12:29239721:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2312T>C (p.Leu771Pro)	ALK	L771P	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001921770	2	29462589	2	29239723	1921770	1979385		NC_000002.12:29239722:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2310G>A (p.Met770Ile)	ALK	M770I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001060075	2	29462591	2	29239725	1060075	1041396	rs1256405098	NC_000002.12:29239724:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2308A>G (p.Met770Val)	ALK	M770V	Hereditary cancer-predisposing syndrome	VCV002566577	2	29462593	2	29239727	2566577	2734420		NC_000002.12:29239726:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2307C>T (p.Asp769=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001167915	2	29462594	2	29239728	1167915	1154133	rs553770508	NC_000002.12:29239727:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2306A>G (p.Asp769Gly)	ALK	D769G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002675923	2	29462595	2	29239729	2675923	2836040		NC_000002.12:29239728:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2306A>T (p.Asp769Val)	ALK	D769V	Neuroblastoma, susceptibility to, 3	VCV001440505	2	29462595	2	29239729	1440505	1461790	rs1205473928	NC_000002.12:29239728:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2305G>A (p.Asp769Asn)	ALK	D769N	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002039126	2	29462596	2	29239730	2039126	2098319		NC_000002.12:29239729:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2304T>C (p.Asp768=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470787	2	29462597	2	29239731	470787	451064	rs758649392	NC_000002.12:29239730:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2303A>T (p.Asp768Val)	ALK	D768V	Neuroblastoma, susceptibility to, 3	VCV002840341	2	29462598	2	29239732	2840341	3000165		NC_000002.12:29239731:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2303A>G (p.Asp768Gly)	ALK	D768G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001475653	2	29462598	2	29239732	1475653	1400684	rs2148188725	NC_000002.12:29239731:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2302G>C (p.Asp768His)	ALK	D768H	Neuroblastoma, susceptibility to, 3	VCV002810185	2	29462599	2	29239733	2810185	2968713		NC_000002.12:29239732:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2302G>A (p.Asp768Asn)	ALK	D768N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000961165	2	29462599	2	29239733	961165	942864	rs766666105	NC_000002.12:29239732:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2301G>A (p.Lys767=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001565348	2	29462600	2	29239734	1565348	1621421	rs2148188733	NC_000002.12:29239733:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2300A>G (p.Lys767Arg)	ALK	K767R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002163552	2	29462601	2	29239735	2163552	1888036		NC_000002.12:29239734:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2298G>A (p.Glu766=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003682155	2	29462603	2	29239737	3682155	3808299		NC_000002.12:29239736:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 11, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2296G>A (p.Glu766Lys)	ALK	E766K	not provided	VCV003252131	2	29462605	2	29239739	3252131	3410927		NC_000002.12:29239738:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2294T>C (p.Leu765Pro)	ALK	L765P	Hereditary cancer-predisposing syndrome	VCV003223830	2	29462607	2	29239741	3223830	3380852		NC_000002.12:29239740:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2292C>T (p.Asn764=)	ALK		Hereditary cancer-predisposing syndrome	VCV001789128	2	29462609	2	29239743	1789128	1850799		NC_000002.12:29239742:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 15, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2291A>G (p.Asn764Ser)	ALK	N764S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001789116	2	29462610	2	29239744	1789116	1850787		NC_000002.12:29239743:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2289C>T (p.Phe763=)	ALK		Hereditary cancer-predisposing syndrome	VCV001789055	2	29462612	2	29239746	1789055	1841268		NC_000002.12:29239745:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2287T>G (p.Phe763Val)	ALK	F763V	Neuroblastoma, susceptibility to, 3	VCV002675754	2	29462614	2	29239748	2675754	2835873		NC_000002.12:29239747:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2286C>G (p.Ile762Met)	ALK	I762M	Neuroblastoma, susceptibility to, 3	VCV001010914	2	29462615	2	29239749	1010914	988714	rs1664474290	NC_000002.12:29239748:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2285T>A (p.Ile762Asn)	ALK	I762N	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470786	2	29462616	2	29239750	470786	450752	rs1169776576	NC_000002.12:29239749:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2284A>G (p.Ile762Val)	ALK	I762V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404331	2	29462617	2	29239751	404331	392563	rs751419856	NC_000002.12:29239750:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 30, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2283C>T (p.Gly761=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000572323	2	29462618	2	29239752	572323	558382	rs1411353677	NC_000002.12:29239751:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2281G>C (p.Gly761Arg)	ALK	G761R	not provided	VCV003343070	2	29462620	2	29239754	3343070	3502302		NC_000002.12:29239753:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2281G>A (p.Gly761Ser)	ALK	G761S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001007469	2	29462620	2	29239754	1007469	988715	rs1664474572	NC_000002.12:29239753:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2280G>T (p.Leu760=)	ALK		Hereditary cancer-predisposing syndrome	VCV001788939	2	29462621	2	29239755	1788939	1841153		NC_000002.12:29239754:C:A	single nucleotide variant	synonymous variant	Likely benign	Apr 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2280G>A (p.Leu760=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001487953	2	29462621	2	29239755	1487953	1481985	rs2148188760	NC_000002.12:29239754:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2280G>C (p.Leu760=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001086303	2	29462621	2	29239755	1086303	1069527	rs2148188760	NC_000002.12:29239754:C:G	single nucleotide variant	synonymous variant	Likely benign	Dec 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2278C>T (p.Leu760=)	ALK		Hereditary cancer-predisposing syndrome	VCV002562261	2	29462623	2	29239757	2562261	2721114		NC_000002.12:29239756:G:A	single nucleotide variant	synonymous variant	Likely benign	May 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2277G>A (p.Val759=)	ALK		Hereditary cancer-predisposing syndrome	VCV001788876	2	29462624	2	29239758	1788876	1841090		NC_000002.12:29239757:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2276T>G (p.Val759Gly)	ALK	V759G	Neuroblastoma, susceptibility to, 3	VCV000999526	2	29462625	2	29239759	999526	988716	rs1664474690	NC_000002.12:29239758:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2275G>A (p.Val759Met)	ALK	V759M	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000538197	2	29462626	2	29239760	538197	518172	rs199691702	NC_000002.12:29239759:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 31, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2274T>C (p.Ser758=)	ALK		Hereditary cancer-predisposing syndrome	VCV001788838	2	29462627	2	29239761	1788838	1841052		NC_000002.12:29239760:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 9, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2262_2273del (p.His755_Ser758del)	ALK		Neuroblastoma, susceptibility to, 3	VCV002157983	2	29462628 - 29462639	2	29239762 - 29239773	2157983	1886360		NC_000002.12:29239761:GACACGCCGTGGGAC:GAC	Deletion	inframe_deletion	Uncertain significance	Nov 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2272T>A (p.Ser758Thr)	ALK	S758T	Neuroblastoma, susceptibility to, 3	VCV002052982	2	29462629	2	29239763	2052982	2108280		NC_000002.12:29239762:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2270T>C (p.Val757Ala)	ALK	V757A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001061860	2	29462631	2	29239765	1061860	1041397	rs781098925	NC_000002.12:29239764:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2269G>C (p.Val757Leu)	ALK	V757L	Neuroblastoma, susceptibility to, 3	VCV003655210	2	29462632	2	29239766	3655210	3789353		NC_000002.12:29239765:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2269G>T (p.Val757Leu)	ALK	V757L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001492617	2	29462632	2	29239766	1492617	1516755	rs371005946	NC_000002.12:29239765:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2269G>A (p.Val757Met)	ALK	V757M	not provided|Neuroblastoma, susceptibility to, 3|Ovarian cancer	VCV000470785	2	29462632	2	29239766	470785	450760	rs371005946	NC_000002.12:29239765:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2268C>T (p.Gly756=)	ALK		not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000412906	2	29462633	2	29239767	412906	392631	rs149853746	NC_000002.12:29239766:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2266G>A (p.Gly756Ser)	ALK	G756S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000862767	2	29462635	2	29239769	862767	826352	rs747611056	NC_000002.12:29239768:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2265C>A (p.His755Gln)	ALK	H755Q	Neuroblastoma, susceptibility to, 3	VCV002037781	2	29462636	2	29239770	2037781	2094402		NC_000002.12:29239769:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2265C>T (p.His755=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538306	2	29462636	2	29239770	538306	518066	rs770603023	NC_000002.12:29239769:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2264A>G (p.His755Arg)	ALK	H755R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001788677	2	29462637	2	29239771	1788677	1840891		NC_000002.12:29239770:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2264A>T (p.His755Leu)	ALK	H755L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538271	2	29462637	2	29239771	538271	518133	rs375480327	NC_000002.12:29239770:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2263C>T (p.His755Tyr)	ALK	H755Y	Hereditary cancer-predisposing syndrome	VCV003524206	2	29462638	2	29239772	3524206	3682374		NC_000002.12:29239771:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2263C>A (p.His755Asn)	ALK	H755N	not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470784	2	29462638	2	29239772	470784	451056	rs925915337	NC_000002.12:29239771:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2262C>T (p.Ser754=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001937312	2	29462639	2	29239773	1937312	2003932		NC_000002.12:29239772:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 2, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2260T>A (p.Ser754Thr)	ALK	S754T	Neuroblastoma, susceptibility to, 3	VCV001056017	2	29462641	2	29239775	1056017	1041398	rs1278118769	NC_000002.12:29239774:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2259G>A (p.Arg753=)	ALK		Hereditary cancer-predisposing syndrome	VCV001788563	2	29462642	2	29239776	1788563	1844623		NC_000002.12:29239775:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2258G>T (p.Arg753Leu)	ALK	R753L	Neuroblastoma, susceptibility to, 3	VCV002080469	2	29462643	2	29239777	2080469	2135702		NC_000002.12:29239776:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2258G>A (p.Arg753Gln)	ALK	R753Q	not provided|Neuroblastoma, susceptibility to, 3|Neoplasm	VCV000404365	2	29462643	2	29239777	404365	392565	rs187200776	NC_000002.12:29239776:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 19, 2024	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	
NM_004304.5(ALK):c.2257C>G (p.Arg753Gly)	ALK	R753G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001434180	2	29462644	2	29239778	1434180	1497878	rs745499366	NC_000002.12:29239777:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2257C>A (p.Arg753=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000751686	2	29462644	2	29239778	751686	763177	rs745499366	NC_000002.12:29239777:G:T	single nucleotide variant	synonymous variant	Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2257C>T (p.Arg753Trp)	ALK	R753W	Neuroblastoma, susceptibility to, 3|ALK-related disorder	VCV000538196	2	29462644	2	29239778	538196	518177	rs745499366	NC_000002.12:29239777:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2255T>G (p.Met752Arg)	ALK	M752R	Hereditary cancer-predisposing syndrome	VCV002566584	2	29462646	2	29239780	2566584	2734427		NC_000002.12:29239779:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2252T>A (p.Met751Lys)	ALK	M751K	Neuroblastoma, susceptibility to, 3	VCV003706415	2	29462649	2	29239783	3706415	3835987		NC_000002.12:29239782:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2251A>G (p.Met751Val)	ALK	M751V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003523693	2	29462650	2	29239784	3523693	3685365		NC_000002.12:29239783:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2251A>T (p.Met751Leu)	ALK	M751L	Neuroblastoma, susceptibility to, 3	VCV002867350	2	29462650	2	29239784	2867350	3027138		NC_000002.12:29239783:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2250C>T (p.Thr750=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001657919	2	29462651	2	29239785	1657919	1541657	rs2148188823	NC_000002.12:29239784:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2249C>T (p.Thr750Ile)	ALK	T750I	Hereditary cancer-predisposing syndrome	VCV002477023	2	29462652	2	29239786	2477023	2457486		NC_000002.12:29239785:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2249C>A (p.Thr750Asn)	ALK	T750N	Neuroblastoma, susceptibility to, 3	VCV002045252	2	29462652	2	29239786	2045252	2103144		NC_000002.12:29239785:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2248A>G (p.Thr750Ala)	ALK	T750A	Neuroblastoma, susceptibility to, 3	VCV002742820	2	29462653	2	29239787	2742820	2900583		NC_000002.12:29239786:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2247C>T (p.Asn749=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001532867	2	29462654	2	29239788	1532867	1605422	rs2148188824	NC_000002.12:29239787:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 6, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2246A>G (p.Asn749Ser)	ALK	N749S	Hereditary cancer-predisposing syndrome	VCV003525331	2	29462655	2	29239789	3525331	3685687		NC_000002.12:29239788:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2245A>G (p.Asn749Asp)	ALK	N749D	Hereditary cancer-predisposing syndrome	VCV003223828	2	29462656	2	29239790	3223828	3380850		NC_000002.12:29239789:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2235_2243dup (p.Lys748_Asn749insGlyGlyLys)	ALK		not provided|Neuroblastoma, susceptibility to, 3	VCV002675983	2	29462657 - 29462658	2	29239791 - 29239792	2675983	2834405		NC_000002.12:29239791:TTCCCGCCTTTCCCGCC:TTCCCGCCTTTCCCGCCTTTCCCGCC	Duplication		Uncertain significance	Dec 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2244G>A (p.Lys748=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001150905	2	29462657	2	29239791	1150905	1133662	rs1192824871	NC_000002.12:29239790:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2243A>G (p.Lys748Arg)	ALK	K748R	Neuroblastoma, susceptibility to, 3	VCV000935649	2	29462658	2	29239792	935649	931362	rs1558633442	NC_000002.12:29239791:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2243A>C (p.Lys748Thr)	ALK	K748T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000579342	2	29462658	2	29239792	579342	561348	rs1558633442	NC_000002.12:29239791:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2242A>C (p.Lys748Gln)	ALK	K748Q	Neuroblastoma, susceptibility to, 3	VCV002841185	2	29462659	2	29239793	2841185	2993338		NC_000002.12:29239792:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2241G>T (p.Gly747=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223827	2	29462660	2	29239794	3223827	3380849		NC_000002.12:29239793:C:A	single nucleotide variant	synonymous variant	Likely benign	Sep 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2241G>A (p.Gly747=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000758377	2	29462660	2	29239794	758377	763178	rs1287951823	NC_000002.12:29239793:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 6, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2240G>A (p.Gly747Glu)	ALK	G747E	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003223826	2	29462661	2	29239795	3223826	3380848		NC_000002.12:29239794:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2239G>A (p.Gly747Arg)	ALK	G747R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000239803	2	29462662	2	29239796	239803	238741	rs762395127	NC_000002.12:29239795:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 20, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2238C>G (p.Gly746=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001788219	2	29462663	2	29239797	1788219	1844282		NC_000002.12:29239796:G:C	single nucleotide variant	synonymous variant	Likely benign	May 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2238C>T (p.Gly746=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538296	2	29462663	2	29239797	538296	518138	rs142109683	NC_000002.12:29239796:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2236G>A (p.Gly746Ser)	ALK	G746S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538270	2	29462665	2	29239799	538270	518223	rs1553397495	NC_000002.12:29239798:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2235A>G (p.Lys745=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001104683	2	29462666	2	29239800	1104683	1091255	rs2148188842	NC_000002.12:29239799:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2231G>C (p.Gly744Ala)	ALK	G744A	Hereditary cancer-predisposing syndrome	VCV002602002	2	29462670	2	29239804	2602002	2774520		NC_000002.12:29239803:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2230G>A (p.Gly744Arg)	ALK	G744R	Neuroblastoma, susceptibility to, 3	VCV000967217	2	29462671	2	29239805	967217	953065	rs1168161055	NC_000002.12:29239804:C:T	single nucleotide variant	missense variant	Uncertain significance	May 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2229C>A (p.Gly743=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002181515	2	29462672	2	29239806	2181515	1916744		NC_000002.12:29239805:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2229C>T (p.Gly743=)	ALK		Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000404313	2	29462672	2	29239806	404313	392572	rs111253753	NC_000002.12:29239805:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2226T>C (p.Ala742=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223825	2	29462675	2	29239809	3223825	3380847		NC_000002.12:29239808:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2222C>A (p.Ala741Asp)	ALK	A741D	Hereditary cancer-predisposing syndrome	VCV001787948	2	29462679	2	29239813	1787948	1847391		NC_000002.12:29239812:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2222C>G (p.Ala741Gly)	ALK	A741G	Neuroblastoma, susceptibility to, 3	VCV000964099	2	29462679	2	29239813	964099	942865	rs1664477105	NC_000002.12:29239812:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2221G>A (p.Ala741Thr)	ALK	A741T	Hereditary cancer-predisposing syndrome	VCV003525285	2	29462680	2	29239814	3525285	3685641		NC_000002.12:29239813:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2218G>C (p.Gly740Arg)	ALK	G740R	Neuroblastoma, susceptibility to, 3	VCV001428352	2	29462683	2	29239817	1428352	1379643	rs766541301	NC_000002.12:29239816:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2218G>A (p.Gly740Arg)	ALK	G740R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000960751	2	29462683	2	29239817	960751	942866	rs766541301	NC_000002.12:29239816:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2217C>A (p.Tyr739Ter)	ALK	Y739*	Neuroblastoma, susceptibility to, 3	VCV000954812	2	29462684	2	29239818	954812	942867	rs141858653	NC_000002.12:29239817:G:T	single nucleotide variant	nonsense	Uncertain significance	Oct 27, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2217C>T (p.Tyr739=)	ALK		not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470783	2	29462684	2	29239818	470783	450767	rs141858653	NC_000002.12:29239817:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2213G>C (p.Gly738Ala)	ALK	G738A	Neuroblastoma, susceptibility to, 3	VCV003643599	2	29462688	2	29239822	3643599	3783296		NC_000002.12:29239821:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2213G>T (p.Gly738Val)	ALK	G738V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002452097	2	29462688	2	29239822	2452097	2426737		NC_000002.12:29239821:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2212G>A (p.Gly738Ser)	ALK	G738S	Neuroblastoma, susceptibility to, 3	VCV000843410	2	29462689	2	29239823	843410	826353	rs1375509946	NC_000002.12:29239822:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2211G>C (p.Ser737=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002867736	2	29462690	2	29239824	2867736	3023921		NC_000002.12:29239823:C:G	single nucleotide variant	synonymous variant	Likely benign	Mar 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2211G>T (p.Ser737=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001148294	2	29462690	2	29239824	1148294	1133663	rs755251302	NC_000002.12:29239823:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 24, 2019	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2211G>A (p.Ser737=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001101734	2	29462690	2	29239824	1101734	1091256	rs755251302	NC_000002.12:29239823:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2210C>T (p.Ser737Leu)	ALK	S737L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000335703	2	29462691	2	29239825	335703	286757	rs368581969	NC_000002.12:29239824:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2207T>C (p.Ile736Thr)	ALK	I736T	Neuroblastoma, susceptibility to, 3	VCV001063979	2	29462694	2	29239828	1063979	1041399	rs2148188895	NC_000002.12:29239827:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2205C>T (p.Ser735=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001141448	2	29462696	2	29239830	1141448	1133664	rs2148188901	NC_000002.12:29239829:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2205-2A>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000842923	2	29462698	2	29239832	842923	851424	rs1664477879	NC_000002.12:29239831:T:A	single nucleotide variant	splice acceptor variant	Uncertain significance	Feb 12, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2205-3C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002030155	2	29462699	2	29239833	2030155	2085502		NC_000002.12:29239832:G:A	single nucleotide variant	intron variant	Uncertain significance	Sep 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2205-5T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002747060	2	29462701	2	29239835	2747060	2907820		NC_000002.12:29239834:A:C	single nucleotide variant	intron variant	Likely benign	Jul 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2205-8C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001130935	2	29462704	2	29239838	1130935	1112749	rs2148188914	NC_000002.12:29239837:G:C	single nucleotide variant	intron variant	Likely benign	Jun 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2205-9C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001124845	2	29462705	2	29239839	1124845	1112750	rs1046349000	NC_000002.12:29239838:G:C	single nucleotide variant	intron variant	Likely benign	Aug 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2205-10C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001556639	2	29462706	2	29239840	1556639	1592783	rs2148188916	NC_000002.12:29239839:G:A	single nucleotide variant	intron variant	Likely benign	Jun 26, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2205-13T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002728823	2	29462709	2	29239843	2728823	2882849		NC_000002.12:29239842:A:G	single nucleotide variant	intron variant	Likely benign	Mar 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2205-15T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003632326	2	29462711	2	29239845	3632326	3766494		NC_000002.12:29239844:A:C	single nucleotide variant	intron variant	Likely benign	May 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2205-17T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001532037	2	29462713	2	29239847	1532037	1582957	rs2148188920	NC_000002.12:29239846:A:G	single nucleotide variant	intron variant	Likely benign	Feb 12, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2205-19G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001622903	2	29462715	2	29239849	1622903	1627529	rs757410904	NC_000002.12:29239848:C:T	single nucleotide variant	intron variant	Likely benign	Jun 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2205-19G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001565184	2	29462715	2	29239849	1565184	1621257	rs757410904	NC_000002.12:29239848:C:A	single nucleotide variant	intron variant	Likely benign	Dec 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2205-20C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002068210	2	29462716	2	29239850	2068210	2125735		NC_000002.12:29239849:G:T	single nucleotide variant	intron variant	Likely benign	Sep 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2205-20C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001597969	2	29462716	2	29239850	1597969	1660575	rs371397667	NC_000002.12:29239849:G:A	single nucleotide variant	intron variant	Likely benign	Oct 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2205-116G>A	ALK		Lung adenocarcinoma	VCV002431139	2	29462812	2	29239946	2431139	2404645		NC_000002.12:29239945:C:T	single nucleotide variant	intron variant	Uncertain significance	Jun 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+212A>G	ALK		not provided	VCV001292699	2	29473759	2	29250893	1292699	1282505	rs7581939	NC_000002.12:29250892:T:C	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+135G>T	ALK		not provided	VCV001213646	2	29473836	2	29250970	1213646	1203639	rs116695535	NC_000002.12:29250969:C:A	single nucleotide variant	intron variant	Likely benign	Jul 15, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+125G>A	ALK		not provided	VCV001200026	2	29473846	2	29250980	1200026	1189890	rs80031559	NC_000002.12:29250979:C:T	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+120C>A	ALK		not provided	VCV001248306	2	29473851	2	29250985	1248306	1239962	rs78124972	NC_000002.12:29250984:G:T	single nucleotide variant	intron variant	Benign	Jul 5, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+45G>A	ALK		not provided	VCV001204694	2	29473926	2	29251060	1204694	1193146	rs13405107	NC_000002.12:29251059:C:T	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+20A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001624092	2	29473951	2	29251085	1624092	1562931	rs1467208566	NC_000002.12:29251084:T:C	single nucleotide variant	intron variant	Likely benign	Oct 19, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+19G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001537931	2	29473952	2	29251086	1537931	1619158	rs935722256	NC_000002.12:29251085:C:G	single nucleotide variant	intron variant	Likely benign	Feb 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+19G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001537415	2	29473952	2	29251086	1537415	1597008	rs935722256	NC_000002.12:29251085:C:T	single nucleotide variant	intron variant	Likely benign	Aug 18, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+18G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002753929	2	29473953	2	29251087	2753929	2916399		NC_000002.12:29251086:C:A	single nucleotide variant	intron variant	Likely benign	Jan 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+16G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003722600	2	29473955	2	29251089	3722600	3857113		NC_000002.12:29251088:C:A	single nucleotide variant	intron variant	Likely benign	Oct 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+16G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002733725	2	29473955	2	29251089	2733725	2898060		NC_000002.12:29251088:C:T	single nucleotide variant	intron variant	Likely benign	Jan 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+15G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002015199	2	29473956	2	29251090	2015199	2067997		NC_000002.12:29251089:C:A	single nucleotide variant	intron variant	Likely benign	Jan 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+15G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001600742	2	29473956	2	29251090	1600742	1546169	rs200910314	NC_000002.12:29251089:C:G	single nucleotide variant	intron variant	Benign	Jan 20, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+15G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001455055	2	29473956	2	29251090	1455055	1441541	rs200910314	NC_000002.12:29251089:C:T	single nucleotide variant	intron variant	Likely benign	Nov 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+14del	ALK		Neuroblastoma, susceptibility to, 3	VCV002038507	2	29473957	2	29251091	2038507	2101575		NC_000002.12:29251090:T:	Deletion	intron variant	Likely benign	Nov 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+14A>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001591900	2	29473957	2	29251091	1591900	1578016	rs778407286	NC_000002.12:29251090:T:A	single nucleotide variant	intron variant	Likely benign	Apr 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+13G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002076691	2	29473958	2	29251092	2076691	2138494		NC_000002.12:29251091:C:T	single nucleotide variant	intron variant	Likely benign	Jan 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+12A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002718503	2	29473959	2	29251093	2718503	2876899		NC_000002.12:29251092:T:C	single nucleotide variant	intron variant	Likely benign	Nov 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+9G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001492629	2	29473962	2	29251096	1492629	1516767	rs2148197166	NC_000002.12:29251095:C:T	single nucleotide variant	intron variant	Likely benign	May 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+8T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001129452	2	29473963	2	29251097	1129452	1112751	rs758076491	NC_000002.12:29251096:A:G	single nucleotide variant	intron variant	Likely benign	Nov 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+8T>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001051901	2	29473963	2	29251097	1051901	1041400	rs758076491	NC_000002.12:29251096:A:T	single nucleotide variant	intron variant	Likely benign	Apr 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+7A>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001982685	2	29473964	2	29251098	1982685	2035445		NC_000002.12:29251097:T:G	single nucleotide variant	intron variant	Likely benign	Jul 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+5G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV000964166	2	29473966	2	29251100	964166	959638	rs367892725	NC_000002.12:29251099:C:G	single nucleotide variant	intron variant	Uncertain significance	Oct 3, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+5G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000578692	2	29473966	2	29251100	578692	558384	rs367892725	NC_000002.12:29251099:C:T	single nucleotide variant	intron variant	Uncertain significance	Aug 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+4C>T	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000574693	2	29473967	2	29251101	574693	558037	rs201806531	NC_000002.12:29251100:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 2, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2204+4C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000571298	2	29473967	2	29251101	571298	558039	rs201806531	NC_000002.12:29251100:G:T	single nucleotide variant	intron variant	Uncertain significance	Aug 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+4C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000404352	2	29473967	2	29251101	404352	392741	rs201806531	NC_000002.12:29251100:G:C	single nucleotide variant	intron variant	Uncertain significance	Jan 6, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2204+3G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002869047	2	29473968	2	29251102	2869047	3027530		NC_000002.12:29251101:C:T	single nucleotide variant	intron variant	Uncertain significance	Nov 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2202C>T (p.Tyr734=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002159076	2	29473973	2	29251107	2159076	1893968		NC_000002.12:29251106:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2200T>G (p.Tyr734Asp)	ALK	Y734D	Neuroblastoma, susceptibility to, 3	VCV003673081	2	29473975	2	29251109	3673081	3803919		NC_000002.12:29251108:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2199C>G (p.Thr733=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001597258	2	29473976	2	29251110	1597258	1664793	rs1475364383	NC_000002.12:29251109:G:C	single nucleotide variant	synonymous variant	Likely benign	Mar 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2199C>T (p.Thr733=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000702845	2	29473976	2	29251110	702845	691143	rs1475364383	NC_000002.12:29251109:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2197A>T (p.Thr733Ser)	ALK	T733S	Hereditary cancer-predisposing syndrome	VCV003223823	2	29473978	2	29251112	3223823	3380845		NC_000002.12:29251111:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2196C>T (p.Asp732=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002032050	2	29473979	2	29251113	2032050	2086110		NC_000002.12:29251112:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2194G>T (p.Asp732Tyr)	ALK	D732Y	Hereditary cancer-predisposing syndrome	VCV003285221	2	29473981	2	29251115	3285221	3444399		NC_000002.12:29251114:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2194G>A (p.Asp732Asn)	ALK	D732N	Familial isolated pituitary adenoma|Neuroblastoma, susceptibility to, 3	VCV000576618	2	29473981	2	29251115	576618	561356	rs768366852	NC_000002.12:29251114:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2193C>A (p.Thr731=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001605770	2	29473982	2	29251116	1605770	1646822	rs56017149	NC_000002.12:29251115:G:T	single nucleotide variant	synonymous variant	Likely benign	Dec 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2193C>G (p.Thr731=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001115061	2	29473982	2	29251116	1115061	1091257	rs56017149	NC_000002.12:29251115:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2193C>T (p.Thr731=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000412919	2	29473982	2	29251116	412919	392745	rs56017149	NC_000002.12:29251115:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2192C>G (p.Thr731Ser)	ALK	T731S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001787438	2	29473983	2	29251117	1787438	1850419		NC_000002.12:29251116:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2192C>A (p.Thr731Asn)	ALK	T731N	Neuroblastoma, susceptibility to, 3	VCV001001467	2	29473983	2	29251117	1001467	988717	rs1664804232	NC_000002.12:29251116:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2191A>G (p.Thr731Ala)	ALK	T731A	Neuroblastoma, susceptibility to, 3	VCV000942962	2	29473984	2	29251118	942962	931363	rs1664804307	NC_000002.12:29251117:T:C	single nucleotide variant	missense variant	Uncertain significance	May 31, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2190C>T (p.Ala730=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001132745	2	29473985	2	29251119	1132745	1112752	rs2148197228	NC_000002.12:29251118:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2188G>A (p.Ala730Thr)	ALK	A730T	Neuroblastoma, susceptibility to, 3	VCV001523380	2	29473987	2	29251121	1523380	1350549	rs1664804373	NC_000002.12:29251120:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2185C>G (p.Pro729Ala)	ALK	P729A	Neuroblastoma, susceptibility to, 3	VCV001425736	2	29473990	2	29251124	1425736	1428110	rs2148197245	NC_000002.12:29251123:G:C	single nucleotide variant	missense variant	Uncertain significance	May 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2183_2184insCTGGTG (p.Val728_Pro729insTrpTrp)	ALK		Neuroblastoma, susceptibility to, 3	VCV002893747	2	29473991 - 29473992	2	29251125 - 29251126	2893747	3049132		NC_000002.12:29251125::CACCAG	Insertion	inframe_insertion	Uncertain significance	Nov 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2184G>A (p.Val728=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002851104	2	29473991	2	29251125	2851104	3009606		NC_000002.12:29251124:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 31, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2184G>T (p.Val728=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002105163	2	29473991	2	29251125	2105163	2159169		NC_000002.12:29251124:C:A	single nucleotide variant	synonymous variant	Likely benign	Mar 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2178G>A (p.Trp726Ter)	ALK	W726*	Neuroblastoma, susceptibility to, 3	VCV002107722	2	29473997	2	29251131	2107722	2166886		NC_000002.12:29251130:C:T	single nucleotide variant	nonsense	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2177G>A (p.Trp726Ter)	ALK	W726*	Neuroblastoma, susceptibility to, 3	VCV000651797	2	29473998	2	29251132	651797	629870	rs1573160453	NC_000002.12:29251131:C:T	single nucleotide variant	nonsense	Uncertain significance	Nov 4, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2175C>A (p.Ile725=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001787171	2	29474000	2	29251134	1787171	1840692		NC_000002.12:29251133:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2175C>T (p.Ile725=)	ALK		Hereditary cancer-predisposing syndrome|not specified|Neuroblastoma, susceptibility to, 3	VCV000335704	2	29474000	2	29251134	335704	288993	rs57881134	NC_000002.12:29251133:G:A	single nucleotide variant	synonymous variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2172G>A (p.Gln724=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223822	2	29474003	2	29251137	3223822	3380844		NC_000002.12:29251136:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2172G>T (p.Gln724His)	ALK	Q724H	Neuroblastoma, susceptibility to, 3	VCV001499496	2	29474003	2	29251137	1499496	1389199	rs771511785	NC_000002.12:29251136:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2169C>T (p.Ile723=)	ALK		Hereditary cancer-predisposing syndrome	VCV001787031	2	29474006	2	29251140	1787031	1840552		NC_000002.12:29251139:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 20, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2168T>A (p.Ile723Asn)	ALK	I723N	Hereditary cancer-predisposing syndrome	VCV001787017	2	29474007	2	29251141	1787017	1840538		NC_000002.12:29251140:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2168T>C (p.Ile723Thr)	ALK	I723T	Neuroblastoma, susceptibility to, 3	VCV001034785	2	29474007	2	29251141	1034785	1024452	rs1664804969	NC_000002.12:29251140:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2165G>C (p.Gly722Ala)	ALK	G722A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001519417	2	29474010	2	29251144	1519417	1433911	rs140527448	NC_000002.12:29251143:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2164G>C (p.Gly722Arg)	ALK	G722R	Neuroblastoma, susceptibility to, 3	VCV000641119	2	29474011	2	29251145	641119	629871	rs1573160483	NC_000002.12:29251144:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2159T>C (p.Leu720Pro)	ALK	L720P	Hereditary cancer-predisposing syndrome	VCV003223821	2	29474016	2	29251150	3223821	3380843		NC_000002.12:29251149:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2159del (p.Leu720fs)	ALK	L720fs	Neuroblastoma, susceptibility to, 3	VCV001520529	2	29474016	2	29251150	1520529	1355888	rs2148197328	NC_000002.12:29251149:A:	Deletion	frameshift variant	Uncertain significance	Sep 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2159T>A (p.Leu720Gln)	ALK	L720Q	Neuroblastoma, susceptibility to, 3	VCV001494251	2	29474016	2	29251150	1494251	1349994	rs1336406369	NC_000002.12:29251149:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2158C>G (p.Leu720Val)	ALK	L720V	Hereditary cancer-predisposing syndrome	VCV003223820	2	29474017	2	29251151	3223820	3380842		NC_000002.12:29251150:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2158C>A (p.Leu720Met)	ALK	L720M	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001786841	2	29474017	2	29251151	1786841	1844210		NC_000002.12:29251150:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2158C>T (p.Leu720=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001102898	2	29474017	2	29251151	1102898	1091258	rs774579604	NC_000002.12:29251150:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2157C>T (p.Pro719=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002994782	2	29474018	2	29251152	2994782	3148628		NC_000002.12:29251151:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2156C>T (p.Pro719Leu)	ALK	P719L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001786820	2	29474019	2	29251153	1786820	1844189		NC_000002.12:29251152:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2155C>A (p.Pro719Thr)	ALK	P719T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001435601	2	29474020	2	29251154	1435601	1500597	rs759652463	NC_000002.12:29251153:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2155C>T (p.Pro719Ser)	ALK	P719S	Neuroblastoma, susceptibility to, 3|not provided	VCV001022091	2	29474020	2	29251154	1022091	1003987	rs759652463	NC_000002.12:29251153:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2154C>T (p.Gly718=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001639300	2	29474021	2	29251155	1639300	1646888	rs1573160513	NC_000002.12:29251154:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2154C>A (p.Gly718=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000757490	2	29474021	2	29251155	757490	763179	rs1573160513	NC_000002.12:29251154:G:T	single nucleotide variant	synonymous variant	Likely benign	Sep 24, 2020	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2153G>T (p.Gly718Val)	ALK	G718V	Hereditary cancer-predisposing syndrome	VCV001692776	2	29474022	2	29251156	1692776	1685216	rs1573160519	NC_000002.12:29251155:C:A	single nucleotide variant	missense variant	Uncertain significance	May 25, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2153G>A (p.Gly718Asp)	ALK	G718D	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001429640	2	29474022	2	29251156	1429640	1477373	rs1573160519	NC_000002.12:29251155:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2153del (p.Gly718fs)	ALK	G718fs	Neuroblastoma, susceptibility to, 3	VCV001051429	2	29474022	2	29251156	1051429	1041401	rs2148197344	NC_000002.12:29251155:CCC:CC	Deletion	frameshift variant	Uncertain significance	Jul 15, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2152G>C (p.Gly718Arg)	ALK	G718R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000961962	2	29474023	2	29251157	961962	942868	rs1664805998	NC_000002.12:29251156:C:G	single nucleotide variant	missense variant	Uncertain significance	May 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2151G>A (p.Glu717=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001954390	2	29474024	2	29251158	1954390	2018405		NC_000002.12:29251157:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2151G>C (p.Glu717Asp)	ALK	E717D	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000576240	2	29474024	2	29251158	576240	558041	rs772363561	NC_000002.12:29251157:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2149G>C (p.Glu717Gln)	ALK	E717Q	Neuroblastoma, susceptibility to, 3	VCV001954003	2	29474026	2	29251160	1954003	2008120		NC_000002.12:29251159:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2149G>A (p.Glu717Lys)	ALK	E717K	not specified|Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000239802	2	29474026	2	29251160	239802	238742	rs147858673	NC_000002.12:29251159:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2148C>A (p.Ser716Arg)	ALK	S716R	Hereditary cancer-predisposing syndrome	VCV001786670	2	29474027	2	29251161	1786670	1844039		NC_000002.12:29251160:G:T	single nucleotide variant	missense variant	Uncertain significance	May 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2148C>T (p.Ser716=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not specified	VCV000239801	2	29474027	2	29251161	239801	238743	rs55733526	NC_000002.12:29251160:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2147G>A (p.Ser716Asn)	ALK	S716N	Hereditary cancer-predisposing syndrome	VCV003285979	2	29474028	2	29251162	3285979	3444719		NC_000002.12:29251161:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2147G>T (p.Ser716Ile)	ALK	S716I	Neuroblastoma, susceptibility to, 3	VCV001450646	2	29474028	2	29251162	1450646	1351167	rs2148197375	NC_000002.12:29251161:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2146A>G (p.Ser716Gly)	ALK	S716G	Hereditary cancer-predisposing syndrome	VCV003223818	2	29474029	2	29251163	3223818	3380840		NC_000002.12:29251162:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2145G>A (p.Gly715=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002792752	2	29474030	2	29251164	2792752	2953884		NC_000002.12:29251163:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2144G>A (p.Gly715Glu)	ALK	G715E	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001000895	2	29474031	2	29251165	1000895	988718	rs763862465	NC_000002.12:29251164:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2143G>A (p.Gly715Arg)	ALK	G715R	Neuroblastoma, susceptibility to, 3	VCV001944984	2	29474032	2	29251166	1944984	1998683		NC_000002.12:29251165:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2142G>A (p.Val714=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001654045	2	29474033	2	29251167	1654045	1526863	rs2148197393	NC_000002.12:29251166:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2140G>T (p.Val714Leu)	ALK	V714L	Hereditary cancer-predisposing syndrome	VCV003524493	2	29474035	2	29251169	3524493	3679158		NC_000002.12:29251168:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2140G>A (p.Val714Met)	ALK	V714M	Neuroblastoma, susceptibility to, 3	VCV002730339	2	29474035	2	29251169	2730339	2886940		NC_000002.12:29251168:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2138A>C (p.Glu713Ala)	ALK	E713A	not provided	VCV003343015	2	29474037	2	29251171	3343015	3502247		NC_000002.12:29251170:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2137G>C (p.Glu713Gln)	ALK	E713Q	Neuroblastoma, susceptibility to, 3	VCV002813042	2	29474038	2	29251172	2813042	2972844		NC_000002.12:29251171:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2136G>A (p.Val712=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003016084	2	29474039	2	29251173	3016084	3171208		NC_000002.12:29251172:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2136G>T (p.Val712=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001112657	2	29474039	2	29251173	1112657	1091259	rs375095655	NC_000002.12:29251172:C:A	single nucleotide variant	synonymous variant	Likely benign	Jan 20, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2134G>T (p.Val712Leu)	ALK	V712L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001375865	2	29474041	2	29251175	1375865	1470251	rs78723472	NC_000002.12:29251174:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2134G>A (p.Val712Met)	ALK	V712M	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001045813	2	29474041	2	29251175	1045813	1024453	rs78723472	NC_000002.12:29251174:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2133C>G (p.Ser711Arg)	ALK	S711R	Neuroblastoma, susceptibility to, 3	VCV003679390	2	29474042	2	29251176	3679390	3814414		NC_000002.12:29251175:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2133C>T (p.Ser711=)	ALK		not provided|not specified|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000239800	2	29474042	2	29251176	239800	238744	rs77102810	NC_000002.12:29251175:G:A	single nucleotide variant	synonymous variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2132G>A (p.Ser711Asn)	ALK	S711N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001981297	2	29474043	2	29251177	1981297	2035365		NC_000002.12:29251176:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2131A>C (p.Ser711Arg)	ALK	S711R	Neuroblastoma, susceptibility to, 3	VCV001354330	2	29474044	2	29251178	1354330	1341448	rs1166188112	NC_000002.12:29251177:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2131A>G (p.Ser711Gly)	ALK	S711G	Neuroblastoma, susceptibility to, 3	VCV000943151	2	29474044	2	29251178	943151	931364	rs1166188112	NC_000002.12:29251177:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2130G>C (p.Leu710=)	ALK		Hereditary cancer-predisposing syndrome	VCV001786399	2	29474045	2	29251179	1786399	1847149		NC_000002.12:29251178:C:G	single nucleotide variant	synonymous variant	Likely benign	Mar 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2130G>A (p.Leu710=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470781	2	29474045	2	29251179	470781	450905	rs370001834	NC_000002.12:29251178:C:T	single nucleotide variant	synonymous variant	Likely benign	May 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2129T>G (p.Leu710Arg)	ALK	L710R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001000590	2	29474046	2	29251180	1000590	988719	rs1664807217	NC_000002.12:29251179:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2128C>A (p.Leu710Met)	ALK	L710M	Neuroblastoma, susceptibility to, 3	VCV002716151	2	29474047	2	29251181	2716151	2869387		NC_000002.12:29251180:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2127C>T (p.Asn709=)	ALK		Hereditary cancer-predisposing syndrome	VCV001786335	2	29474048	2	29251182	1786335	1847085		NC_000002.12:29251181:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 5, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2127C>A (p.Asn709Lys)	ALK	N709K	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000133463	2	29474048	2	29251182	133463	137202	rs376175333	NC_000002.12:29251181:G:T	single nucleotide variant	missense variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2126A>G (p.Asn709Ser)	ALK	N709S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000664882	2	29474049	2	29251183	664882	629872	rs1573160589	NC_000002.12:29251182:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2124C>T (p.Ser708=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001961726	2	29474051	2	29251185	1961726	2016695		NC_000002.12:29251184:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2122T>G (p.Ser708Ala)	ALK	S708A	Hereditary cancer-predisposing syndrome|not provided	VCV002447096	2	29474053	2	29251187	2447096	2422219		NC_000002.12:29251186:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2117A>G (p.Gln706Arg)	ALK	Q706R	Neuroblastoma, susceptibility to, 3	VCV000967373	2	29474058	2	29251192	967373	953066	rs1664807502	NC_000002.12:29251191:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2116C>T (p.Gln706Ter)	ALK	Q706*	Neuroblastoma, susceptibility to, 3	VCV002696796	2	29474059	2	29251193	2696796	2858215		NC_000002.12:29251192:G:A	single nucleotide variant	nonsense	Uncertain significance	Nov 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2115C>T (p.Tyr705=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003223817	2	29474060	2	29251194	3223817	3380839		NC_000002.12:29251193:G:A	single nucleotide variant	synonymous variant	Likely benign	May 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2113T>C (p.Tyr705His)	ALK	Y705H	Hereditary cancer-predisposing syndrome	VCV002452091	2	29474062	2	29251196	2452091	2426731		NC_000002.12:29251195:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2112C>G (p.Ala704=)	ALK		Hereditary cancer-predisposing syndrome	VCV001786126	2	29474063	2	29251197	1786126	1846878		NC_000002.12:29251196:G:C	single nucleotide variant	synonymous variant	Likely benign	Sep 17, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2111C>T (p.Ala704Val)	ALK	A704V	Hereditary cancer-predisposing syndrome	VCV001786121	2	29474064	2	29251198	1786121	1846874		NC_000002.12:29251197:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2110G>T (p.Ala704Ser)	ALK	A704S	Neuroblastoma, susceptibility to, 3	VCV002145216	2	29474065	2	29251199	2145216	1870161		NC_000002.12:29251198:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2110G>A (p.Ala704Thr)	ALK	A704T	ALK-related disorder|Neuroblastoma, susceptibility to, 3|not provided	VCV000575004	2	29474065	2	29251199	575004	558386	rs34829159	NC_000002.12:29251198:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2109C>T (p.Asn703=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma Susceptibility|Neuroblastoma, susceptibility to, 3	VCV000335705	2	29474066	2	29251200	335705	286758	rs560163657	NC_000002.12:29251199:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2106C>T (p.Asn702=)	ALK		Hereditary cancer-predisposing syndrome	VCV003286034	2	29474069	2	29251203	3286034	3444774		NC_000002.12:29251202:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2105A>G (p.Asn702Ser)	ALK	N702S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002315358	2	29474070	2	29251204	2315358	2309884		NC_000002.12:29251203:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2099dup (p.Cys701fs)	ALK	C701fs	Neuroblastoma, susceptibility to, 3	VCV002814040	2	29474075 - 29474076	2	29251209 - 29251210	2814040	2966154		NC_000002.12:29251209:T:TT	Duplication	frameshift variant	Uncertain significance	Nov 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2100G>A (p.Gln700=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000412936	2	29474075	2	29251209	412936	392748	rs757872815	NC_000002.12:29251208:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2099A>G (p.Gln700Arg)	ALK	Q700R	Neuroblastoma, susceptibility to, 3	VCV000944929	2	29474076	2	29251210	944929	922720	rs1664808216	NC_000002.12:29251209:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2096C>T (p.Ala699Val)	ALK	A699V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001721035	2	29474079	2	29251213	1721035	1775017		NC_000002.12:29251212:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2095G>A (p.Ala699Thr)	ALK	A699T	Neuroblastoma, susceptibility to, 3	VCV003683860	2	29474080	2	29251214	3683860	3808709		NC_000002.12:29251213:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2094G>A (p.Gln698=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000412932	2	29474081	2	29251215	412932	392633	rs1060503881	NC_000002.12:29251214:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2093A>G (p.Gln698Arg)	ALK	Q698R	Neuroblastoma, susceptibility to, 3	VCV001357100	2	29474082	2	29251216	1357100	1345077	rs2148197557	NC_000002.12:29251215:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2091C>T (p.Thr697=)	ALK		Hereditary cancer-predisposing syndrome	VCV001785738	2	29474084	2	29251218	1785738	1849996		NC_000002.12:29251217:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 16, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2091C>A (p.Thr697=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001589575	2	29474084	2	29251218	1589575	1607597	rs1252650401	NC_000002.12:29251217:G:T	single nucleotide variant	synonymous variant	Likely benign	May 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2090C>A (p.Thr697Asn)	ALK	T697N	Neuroblastoma, susceptibility to, 3	VCV001385540	2	29474085	2	29251219	1385540	1368284	rs1339495215	NC_000002.12:29251218:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2089A>T (p.Thr697Ser)	ALK	T697S	Neuroblastoma, susceptibility to, 3	VCV002115778	2	29474086	2	29251220	2115778	2182717		NC_000002.12:29251219:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2089A>G (p.Thr697Ala)	ALK	T697A	Hereditary cancer-predisposing syndrome	VCV001785681	2	29474086	2	29251220	1785681	1849939		NC_000002.12:29251219:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2087C>T (p.Pro696Leu)	ALK	P696L	Hereditary cancer-predisposing syndrome	VCV003223816	2	29474088	2	29251222	3223816	3380838		NC_000002.12:29251221:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2086C>A (p.Pro696Thr)	ALK	P696T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000954045	2	29474089	2	29251223	954045	942869	rs1664808733	NC_000002.12:29251222:G:T	single nucleotide variant	missense variant	Uncertain significance	May 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2085C>G (p.Gly695=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002477418	2	29474090	2	29251224	2477418	2453767		NC_000002.12:29251223:G:C	single nucleotide variant	synonymous variant	Likely benign	Aug 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2085C>T (p.Gly695=)	ALK		Hereditary cancer-predisposing syndrome	VCV001785628	2	29474090	2	29251224	1785628	1849886		NC_000002.12:29251223:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 21, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2083G>T (p.Gly695Cys)	ALK	G695C	Neuroblastoma, susceptibility to, 3	VCV002676167	2	29474092	2	29251226	2676167	2834588		NC_000002.12:29251225:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2082T>C (p.His694=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001115095	2	29474093	2	29251227	1115095	1091260	rs746356545	NC_000002.12:29251226:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2080C>T (p.His694Tyr)	ALK	H694Y	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001047061	2	29474095	2	29251229	1047061	1024454	rs772087086	NC_000002.12:29251228:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2079C>G (p.Pro693=)	ALK		Hereditary cancer-predisposing syndrome	VCV003286184	2	29474096	2	29251230	3286184	3455007		NC_000002.12:29251229:G:C	single nucleotide variant	synonymous variant	Likely benign	May 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2079C>T (p.Pro693=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000747956	2	29474096	2	29251230	747956	747583	rs1573160689	NC_000002.12:29251229:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2078C>T (p.Pro693Leu)	ALK	P693L	Neuroblastoma, susceptibility to, 3	VCV001463691	2	29474097	2	29251231	1463691	1508254	rs2148197596	NC_000002.12:29251230:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2076_2077insT (p.Pro693fs)	ALK	P693fs	Neuroblastoma, susceptibility to, 3	VCV002118667	2	29474098 - 29474099	2	29251232 - 29251233	2118667	2172676		NC_000002.12:29251232::A	Insertion	frameshift variant	Uncertain significance	Mar 28, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2077C>A (p.Pro693Thr)	ALK	P693T	Neuroblastoma, susceptibility to, 3	VCV001041822	2	29474098	2	29251232	1041822	1024455	rs1026390293	NC_000002.12:29251231:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2076G>T (p.Gly692=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001552268	2	29474099	2	29251233	1552268	1586347	rs1573160699	NC_000002.12:29251232:C:A	single nucleotide variant	synonymous variant	Likely benign	Jan 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2076G>C (p.Gly692=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000820662	2	29474099	2	29251233	820662	806910	rs1573160699	NC_000002.12:29251232:C:G	single nucleotide variant	synonymous variant	Likely benign	Sep 30, 2021	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2075G>A (p.Gly692Glu)	ALK	G692E	Neuroblastoma, susceptibility to, 3	VCV002756052	2	29474100	2	29251234	2756052	2914197		NC_000002.12:29251233:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2042-65_2074delinsTCTGA	ALK		Neuroblastoma, susceptibility to, 3	VCV002044600	2	29474101 - 29474198	2	29251235 - 29251332	2044600	2096025			Indel	splice acceptor variant	Uncertain significance	Dec 17, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2074G>A (p.Gly692Arg)	ALK	G692R	Neuroblastoma, susceptibility to, 3	VCV000470779	2	29474101	2	29251235	470779	451059	rs373846404	NC_000002.12:29251234:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2073C>A (p.Ser691Arg)	ALK	S691R	Neuroblastoma, susceptibility to, 3	VCV001434553	2	29474102	2	29251236	1434553	1494369	rs370435082	NC_000002.12:29251235:G:T	single nucleotide variant	missense variant	Uncertain significance	May 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2073C>G (p.Ser691Arg)	ALK	S691R	not provided|Neuroblastoma, susceptibility to, 3|not specified	VCV000643330	2	29474102	2	29251236	643330	629873	rs370435082	NC_000002.12:29251235:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2073C>T (p.Ser691=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470778	2	29474102	2	29251236	470778	450907	rs370435082	NC_000002.12:29251235:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Nov 7, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2072G>A (p.Ser691Asn)	ALK	S691N	Hereditary cancer-predisposing syndrome	VCV002586681	2	29474103	2	29251237	2586681	2756864		NC_000002.12:29251236:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2070C>G (p.Ala690=)	ALK		Hereditary cancer-predisposing syndrome	VCV001785386	2	29474105	2	29251239	1785386	1840183		NC_000002.12:29251238:G:C	single nucleotide variant	synonymous variant	Likely benign	Feb 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2068G>A (p.Ala690Thr)	ALK	A690T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001381263	2	29474107	2	29251241	1381263	1496226	rs375105843	NC_000002.12:29251240:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2068G>T (p.Ala690Ser)	ALK	A690S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001058505	2	29474107	2	29251241	1058505	1041402	rs375105843	NC_000002.12:29251240:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2067G>A (p.Gly689=)	ALK		Hereditary cancer-predisposing syndrome	VCV003285767	2	29474108	2	29251242	3285767	3444507		NC_000002.12:29251241:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2067G>C (p.Gly689=)	ALK		Hereditary cancer-predisposing syndrome	VCV000820642	2	29474108	2	29251242	820642	806911	rs1573160737	NC_000002.12:29251241:C:G	single nucleotide variant	synonymous variant	Likely benign	Oct 22, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2065G>A (p.Gly689Arg)	ALK	G689R	Neuroblastoma, susceptibility to, 3	VCV001460589	2	29474110	2	29251244	1460589	1504638	rs1664809619	NC_000002.12:29251243:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2065G>C (p.Gly689Arg)	ALK	G689R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000899326	2	29474110	2	29251244	899326	884681	rs1664809619	NC_000002.12:29251243:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2061_2062del (p.Cys688fs)	ALK	C688fs	Neuroblastoma, susceptibility to, 3	VCV003654997	2	29474113 - 29474114	2	29251247 - 29251248	3654997	3789140		NC_000002.12:29251246:AT:	Deletion	frameshift variant	Uncertain significance	May 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2061A>T (p.Thr687=)	ALK		Hereditary cancer-predisposing syndrome	VCV001785231	2	29474114	2	29251248	1785231	1840028		NC_000002.12:29251247:T:A	single nucleotide variant	synonymous variant	Likely benign	Dec 10, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2061A>C (p.Thr687=)	ALK		Hereditary cancer-predisposing syndrome	VCV001785228	2	29474114	2	29251248	1785228	1840025		NC_000002.12:29251247:T:G	single nucleotide variant	synonymous variant	Likely benign	Nov 9, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2061A>G (p.Thr687=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001368244	2	29474114	2	29251248	1368244	1424780	rs1216551906	NC_000002.12:29251247:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2055CAC[1] (p.Thr687del)	ALK	T687del	Neuroblastoma, susceptibility to, 3	VCV001392969	2	29474115 - 29474117	2	29251249 - 29251251	1392969	1402697	rs2148197659	NC_000002.12:29251248:GTGGTG:GTG	Microsatellite	inframe_deletion	Uncertain significance	Nov 13, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2059A>G (p.Thr687Ala)	ALK	T687A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000643900	2	29474116	2	29251250	643900	629874	rs1465724413	NC_000002.12:29251249:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2055C>T (p.Phe685=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002906541	2	29474120	2	29251254	2906541	3069438		NC_000002.12:29251253:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2053T>G (p.Phe685Val)	ALK	F685V	Hereditary cancer-predisposing syndrome	VCV003524418	2	29474122	2	29251256	3524418	3679083		NC_000002.12:29251255:A:C	single nucleotide variant	missense variant	Likely benign	Aug 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2052G>A (p.Leu684=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001785094	2	29474123	2	29251257	1785094	1843739		NC_000002.12:29251256:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2052G>C (p.Leu684=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001528009	2	29474123	2	29251257	1528009	1603156	rs1664809971	NC_000002.12:29251256:C:G	single nucleotide variant	synonymous variant	Likely benign	Apr 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2050C>A (p.Leu684Met)	ALK	L684M	Neuroblastoma, susceptibility to, 3	VCV001354524	2	29474125	2	29251259	1354524	1434110	rs1664810025	NC_000002.12:29251258:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2050C>G (p.Leu684Val)	ALK	L684V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001054861	2	29474125	2	29251259	1054861	1041403	rs1664810025	NC_000002.12:29251258:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2046T>C (p.His682=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002914964	2	29474129	2	29251263	2914964	3079702		NC_000002.12:29251262:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2045A>C (p.His682Pro)	ALK	H682P	Hereditary cancer-predisposing syndrome	VCV003286544	2	29474130	2	29251264	3286544	3455367		NC_000002.12:29251263:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2044C>T (p.His682Tyr)	ALK	H682Y	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002586708	2	29474131	2	29251265	2586708	2756891		NC_000002.12:29251264:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2044C>A (p.His682Asn)	ALK	H682N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002129087	2	29474131	2	29251265	2129087	2175336		NC_000002.12:29251264:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2042T>C (p.Val681Ala)	ALK	V681A	Hereditary cancer-predisposing syndrome	VCV003285597	2	29474133	2	29251267	3285597	3440829		NC_000002.12:29251266:A:G	single nucleotide variant	missense variant	Uncertain significance	May 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2042-9G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001673466	2	29474142	2	29251276	1673466	1595653	rs1553399134	NC_000002.12:29251275:C:G	single nucleotide variant	intron variant	Likely benign	Oct 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2042-9G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000538280	2	29474142	2	29251276	538280	518069	rs1553399134	NC_000002.12:29251275:C:T	single nucleotide variant	intron variant	Likely benign	Nov 13, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.2042-10T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001100758	2	29474143	2	29251277	1100758	1091261	rs2148197746	NC_000002.12:29251276:A:G	single nucleotide variant	intron variant	Likely benign	Apr 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2042-12C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003667174	2	29474145	2	29251279	3667174	3799186		NC_000002.12:29251278:G:A	single nucleotide variant	intron variant	Likely benign	Oct 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2042-13T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002809553	2	29474146	2	29251280	2809553	2971922		NC_000002.12:29251279:A:G	single nucleotide variant	intron variant	Likely benign	Nov 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2042-15C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002802732	2	29474148	2	29251282	2802732	2970254		NC_000002.12:29251281:G:A	single nucleotide variant	intron variant	Likely benign	Sep 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2042-18T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001589981	2	29474151	2	29251285	1589981	1576527	rs2148197773	NC_000002.12:29251284:A:G	single nucleotide variant	intron variant	Likely benign	Mar 14, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2042-19C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003713907	2	29474152	2	29251286	3713907	3844752		NC_000002.12:29251285:G:C	single nucleotide variant	intron variant	Likely benign	Jul 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2042-20C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001587252	2	29474153	2	29251287	1587252	1541768	rs773170319	NC_000002.12:29251286:G:T	single nucleotide variant	intron variant	Likely benign	Oct 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2042-35C>T	ALK		not provided	VCV001209117	2	29474168	2	29251302	1209117	1196907	rs13413612	NC_000002.12:29251301:G:A	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2041+110T>A	ALK		not provided	VCV001191006	2	29497855	2	29274989	1191006	1179519	rs115762671	NC_000002.12:29274988:A:T	single nucleotide variant	intron variant	Likely benign	Apr 3, 2019	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2041+19_2041+30del	ALK		Neuroblastoma, susceptibility to, 3	VCV001461423	2	29497935 - 29497946	2	29275069 - 29275080	1461423	1498254	rs2148214920	NC_000002.12:29275068:TGTGCTCACATTTGTG:TGTG	Deletion	intron variant	Likely benign	Jan 14, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2041+19A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002104003	2	29497946	2	29275080	2104003	2165760		NC_000002.12:29275079:T:C	single nucleotide variant	intron variant	Likely benign	Mar 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2041+17C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002126571	2	29497948	2	29275082	2126571	2181871		NC_000002.12:29275081:G:C	single nucleotide variant	intron variant	Likely benign	Apr 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2041+15C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001630891	2	29497950	2	29275084	1630891	1619043	rs183024732	NC_000002.12:29275083:G:A	single nucleotide variant	intron variant	Benign	Jan 27, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.2041+14T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001622502	2	29497951	2	29275085	1622502	1561349	rs2148214935	NC_000002.12:29275084:A:C	single nucleotide variant	intron variant	Likely benign	Jun 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2041+13C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001639411	2	29497952	2	29275086	1639411	1646999	rs1293978616	NC_000002.12:29275085:G:A	single nucleotide variant	intron variant	Likely benign	Sep 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2041+13C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001352059	2	29497952	2	29275086	1352059	1482595	rs1293978616	NC_000002.12:29275085:G:C	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2041+12G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001613526	2	29497953	2	29275087	1613526	1578263	rs2148214937	NC_000002.12:29275086:C:T	single nucleotide variant	intron variant	Likely benign	May 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2041+10C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002912434	2	29497955	2	29275089	2912434	3070547		NC_000002.12:29275088:G:A	single nucleotide variant	intron variant	Likely benign	Aug 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2041+9del	ALK		Neuroblastoma, susceptibility to, 3	VCV001150606	2	29497956	2	29275090	1150606	1133665	rs2148214942	NC_000002.12:29275089:AA:A	Deletion	intron variant	Likely benign	May 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2041+8T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV000796926	2	29497957	2	29275091	796926	787133	rs1573183399	NC_000002.12:29275090:A:G	single nucleotide variant	intron variant	Likely benign	Dec 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.2041+6G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002767091	2	29497959	2	29275093	2767091	2926535		NC_000002.12:29275092:C:T	single nucleotide variant	intron variant	Uncertain significance	Oct 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2041+6G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002163064	2	29497959	2	29275093	2163064	1891481		NC_000002.12:29275092:C:A	single nucleotide variant	intron variant	Uncertain significance	Oct 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2041+5G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003722594	2	29497960	2	29275094	3722594	3857107		NC_000002.12:29275093:C:A	single nucleotide variant	intron variant	Uncertain significance	Oct 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2041+5G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000404387	2	29497960	2	29275094	404387	392576	rs1060500232	NC_000002.12:29275093:C:T	single nucleotide variant	intron variant	Uncertain significance	Nov 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2041+4A>G	ALK		Neuroblastoma, susceptibility to, 3|not provided	VCV001349480	2	29497961	2	29275095	1349480	1394243	rs1172214438	NC_000002.12:29275094:T:C	single nucleotide variant	intron variant	Uncertain significance	Sep 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2041+2T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001442044	2	29497963	2	29275097	1442044	1474910	rs2148214956	NC_000002.12:29275096:A:G	single nucleotide variant	splice donor variant	Uncertain significance	Oct 16, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.2041G>C (p.Val681Leu)	ALK	V681L	Neuroblastoma, susceptibility to, 3	VCV001521704	2	29497965	2	29275099	1521704	1347598	rs1665497617	NC_000002.12:29275098:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.2041G>A (p.Val681Ile)	ALK	V681I	Neuroblastoma, susceptibility to, 3	VCV000864003	2	29497965	2	29275099	864003	826354	rs1665497617	NC_000002.12:29275098:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2040A>G (p.Thr680=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000655057	2	29497966	2	29275100	655057	629875	rs748335936	NC_000002.12:29275099:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 11, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2039C>A (p.Thr680Lys)	ALK	T680K	Hereditary cancer-predisposing syndrome	VCV003525411	2	29497967	2	29275101	3525411	3685767		NC_000002.12:29275100:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2039C>T (p.Thr680Ile)	ALK	T680I	Neuroblastoma, susceptibility to, 3|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000133462	2	29497967	2	29275101	133462	137201	rs35228363	NC_000002.12:29275100:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2036C>A (p.Pro679His)	ALK	P679H	Neuroblastoma, susceptibility to, 3	VCV002095685	2	29497970	2	29275104	2095685	2149602		NC_000002.12:29275103:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2036C>G (p.Pro679Arg)	ALK	P679R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000579853	2	29497970	2	29275104	579853	558388	rs1558648699	NC_000002.12:29275103:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2036C>T (p.Pro679Leu)	ALK	P679L	Neuroblastoma, susceptibility to, 3	VCV000568025	2	29497970	2	29275104	568025	560591	rs1558648699	NC_000002.12:29275103:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2035C>A (p.Pro679Thr)	ALK	P679T	Hereditary cancer-predisposing syndrome	VCV001784809	2	29497971	2	29275105	1784809	1843454		NC_000002.12:29275104:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2032G>A (p.Asp678Asn)	ALK	D678N	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001501343	2	29497974	2	29275108	1501343	1402091	rs892131322	NC_000002.12:29275107:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2032G>T (p.Asp678Tyr)	ALK	D678Y	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001002763	2	29497974	2	29275108	1002763	988720	rs892131322	NC_000002.12:29275107:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2032G>C (p.Asp678His)	ALK	D678H	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001002333	2	29497974	2	29275108	1002333	988721	rs892131322	NC_000002.12:29275107:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2028C>A (p.Ile676=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002860576	2	29497978	2	29275112	2860576	3025504		NC_000002.12:29275111:G:T	single nucleotide variant	synonymous variant	Likely benign	Apr 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2028C>T (p.Ile676=)	ALK		Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV001120988	2	29497978	2	29275112	1120988	1112753	rs772973901	NC_000002.12:29275111:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Aug 27, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2026A>T (p.Ile676Phe)	ALK	I676F	Neuroblastoma, susceptibility to, 3	VCV002817153	2	29497980	2	29275114	2817153	2980811		NC_000002.12:29275113:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.2025del (p.Ile676fs)	ALK	I676fs	Neuroblastoma, susceptibility to, 3	VCV000572488	2	29497981	2	29275115	572488	560593	rs35670445	NC_000002.12:29275114:GGGGG:GGGG	Deletion	frameshift variant	Uncertain significance	Jul 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2023C>T (p.Pro675Ser)	ALK	P675S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000566042	2	29497983	2	29275117	566042	561359	rs1469128263	NC_000002.12:29275116:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2022C>G (p.Thr674=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002854548	2	29497984	2	29275118	2854548	3007085		NC_000002.12:29275117:G:C	single nucleotide variant	synonymous variant	Likely benign	Apr 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2022C>A (p.Thr674=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001784579	2	29497984	2	29275118	1784579	1846639		NC_000002.12:29275117:G:T	single nucleotide variant	synonymous variant	Likely benign	Sep 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2022C>T (p.Thr674=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000761276	2	29497984	2	29275118	761276	763180	rs1573183477	NC_000002.12:29275117:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 29, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2021C>A (p.Thr674Asn)	ALK	T674N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000576150	2	29497985	2	29275119	576150	558043	rs1178181097	NC_000002.12:29275118:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2018A>C (p.Gln673Pro)	ALK	Q673P	Neuroblastoma, susceptibility to, 3	VCV002712002	2	29497988	2	29275122	2712002	2871729		NC_000002.12:29275121:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2018A>G (p.Gln673Arg)	ALK	Q673R	Neuroblastoma, susceptibility to, 3	VCV000839167	2	29497988	2	29275122	839167	826355	rs762808842	NC_000002.12:29275121:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.2016A>T (p.Arg672Ser)	ALK	R672S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404376	2	29497990	2	29275124	404376	392579	rs1060500225	NC_000002.12:29275123:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.2015G>C (p.Arg672Thr)	ALK	R672T	Hereditary cancer-predisposing syndrome	VCV003223815	2	29497991	2	29275125	3223815	3380837		NC_000002.12:29275124:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2014A>G (p.Arg672Gly)	ALK	R672G	Neuroblastoma, susceptibility to, 3	VCV003724704	2	29497992	2	29275126	3724704	3854484		NC_000002.12:29275125:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2013A>G (p.Pro671=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001136963	2	29497993	2	29275127	1136963	1112754	rs2148214996	NC_000002.12:29275126:T:C	single nucleotide variant	synonymous variant	Likely benign	Aug 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2012C>T (p.Pro671Leu)	ALK	P671L	not provided|Neuroblastoma, susceptibility to, 3	VCV000404366	2	29497994	2	29275128	404366	392953	rs767998637	NC_000002.12:29275127:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2011C>A (p.Pro671Thr)	ALK	P671T	Neuroblastoma, susceptibility to, 3	VCV000939446	2	29497995	2	29275129	939446	931365	rs145780832	NC_000002.12:29275128:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2011C>T (p.Pro671Ser)	ALK	P671S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000239799	2	29497995	2	29275129	239799	238745	rs145780832	NC_000002.12:29275128:G:A	single nucleotide variant	missense variant	Benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2009C>T (p.Ser670Leu)	ALK	S670L	Neuroblastoma, susceptibility to, 3	VCV003007154	2	29497997	2	29275131	3007154	3162274		NC_000002.12:29275130:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2006A>T (p.Asn669Ile)	ALK	N669I	Hereditary cancer-predisposing syndrome	VCV003524817	2	29498000	2	29275134	3524817	3689056		NC_000002.12:29275133:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2006A>G (p.Asn669Ser)	ALK	N669S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001485419	2	29498000	2	29275134	1485419	1471766	rs149640902	NC_000002.12:29275133:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.2005A>T (p.Asn669Tyr)	ALK	N669Y	Neuroblastoma, susceptibility to, 3	VCV003714133	2	29498001	2	29275135	3714133	3844978		NC_000002.12:29275134:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2004A>G (p.Glu668=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223814	2	29498002	2	29275136	3223814	3380836		NC_000002.12:29275135:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2002G>A (p.Glu668Lys)	ALK	E668K	Neuroblastoma, susceptibility to, 3	VCV001027161	2	29498004	2	29275138	1027161	1003988	rs1208550472	NC_000002.12:29275137:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2001G>C (p.Gly667=)	ALK		Hereditary cancer-predisposing syndrome	VCV003524929	2	29498005	2	29275139	3524929	3689168		NC_000002.12:29275138:C:G	single nucleotide variant	synonymous variant	Likely benign	Oct 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2000G>C (p.Gly667Ala)	ALK	G667A	Neuroblastoma, susceptibility to, 3	VCV002006374	2	29498006	2	29275140	2006374	2069469		NC_000002.12:29275139:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.2000G>A (p.Gly667Glu)	ALK	G667E	Neuroblastoma, susceptibility to, 3	VCV000957762	2	29498006	2	29275140	957762	942870	rs1665499933	NC_000002.12:29275139:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1999G>A (p.Gly667Arg)	ALK	G667R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404326	2	29498007	2	29275141	404326	392636	rs539763601	NC_000002.12:29275140:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 29, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1998C>A (p.Pro666=)	ALK		Hereditary cancer-predisposing syndrome	VCV001784086	2	29498008	2	29275142	1784086	1849645		NC_000002.12:29275141:G:T	single nucleotide variant	synonymous variant	Likely benign	Sep 3, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1998C>T (p.Pro666=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000412911	2	29498008	2	29275142	412911	392955	rs549825750	NC_000002.12:29275141:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1997C>T (p.Pro666Leu)	ALK	P666L	Hereditary cancer-predisposing syndrome	VCV003223813	2	29498009	2	29275143	3223813	80473	rs138534542	NC_000002.12:29275142:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1996C>G (p.Pro666Ala)	ALK	P666A	Neuroblastoma, susceptibility to, 3	VCV002845529	2	29498010	2	29275144	2845529	3011728		NC_000002.12:29275143:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1996C>T (p.Pro666Ser)	ALK	P666S	Neuroblastoma, susceptibility to, 3	VCV001038075	2	29498010	2	29275144	1038075	1024456	rs752439739	NC_000002.12:29275143:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1993A>C (p.Lys665Gln)	ALK	K665Q	Hereditary cancer-predisposing syndrome	VCV001692775	2	29498013	2	29275147	1692775	1685215	rs2148215042	NC_000002.12:29275146:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1992G>A (p.Leu664=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001783993	2	29498014	2	29275148	1783993	1849552		NC_000002.12:29275147:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1990C>A (p.Leu664Met)	ALK	L664M	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002170016	2	29498016	2	29275150	2170016	1900038		NC_000002.12:29275149:G:T	single nucleotide variant	missense variant	Uncertain significance	May 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1989G>C (p.Glu663Asp)	ALK	E663D	Neuroblastoma, susceptibility to, 3	VCV003627287	2	29498017	2	29275151	3627287	3752467		NC_000002.12:29275150:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1989G>A (p.Glu663=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001895744	2	29498017	2	29275151	1895744	1952541		NC_000002.12:29275150:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1989G>T (p.Glu663Asp)	ALK	E663D	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000965114	2	29498017	2	29275151	965114	953067	rs760401344	NC_000002.12:29275150:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1988A>C (p.Glu663Ala)	ALK	E663A	Neuroblastoma, susceptibility to, 3	VCV003722166	2	29498018	2	29275152	3722166	3860270		NC_000002.12:29275151:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1987G>A (p.Glu663Lys)	ALK	E663K	Hereditary cancer-predisposing syndrome	VCV001783890	2	29498019	2	29275153	1783890	1849449		NC_000002.12:29275152:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1986G>A (p.Lys662=)	ALK		Hereditary cancer-predisposing syndrome	VCV001783876	2	29498020	2	29275154	1783876	1839972		NC_000002.12:29275153:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1983C>T (p.Asn661=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003223812	2	29498023	2	29275157	3223812	3380835		NC_000002.12:29275156:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1983C>A (p.Asn661Lys)	ALK	N661K	Neuroblastoma, susceptibility to, 3	VCV000404386	2	29498023	2	29275157	404386	392638	rs758860363	NC_000002.12:29275156:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1981A>G (p.Asn661Asp)	ALK	N661D	Hereditary cancer-predisposing syndrome	VCV002312008	2	29498025	2	29275159	2312008	2298761		NC_000002.12:29275158:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1980A>G (p.Pro660=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002089792	2	29498026	2	29275160	2089792	2155462		NC_000002.12:29275159:T:C	single nucleotide variant	synonymous variant	Likely benign	Jan 26, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1980A>C (p.Pro660=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001149264	2	29498026	2	29275160	1149264	1133666	rs1665501060	NC_000002.12:29275159:T:G	single nucleotide variant	synonymous variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1979C>A (p.Pro660Gln)	ALK	P660Q	Neuroblastoma, susceptibility to, 3	VCV003586400	2	29498027	2	29275161	3586400	3717107		NC_000002.12:29275160:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1978C>G (p.Pro660Ala)	ALK	P660A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001064279	2	29498028	2	29275162	1064279	1041404	rs1321508395	NC_000002.12:29275161:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1977C>A (p.Asn659Lys)	ALK	N659K	Neuroblastoma, susceptibility to, 3	VCV001383216	2	29498029	2	29275163	1383216	1509812	rs780562062	NC_000002.12:29275162:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1977C>G (p.Asn659Lys)	ALK	N659K	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538263	2	29498029	2	29275163	538263	518082	rs780562062	NC_000002.12:29275162:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1976A>G (p.Asn659Ser)	ALK	N659S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000862188	2	29498030	2	29275164	862188	826356	rs980989671	NC_000002.12:29275163:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1970A>G (p.Glu657Gly)	ALK	E657G	Neuroblastoma, susceptibility to, 3	VCV002676317	2	29498036	2	29275170	2676317	2834738		NC_000002.12:29275169:T:C	single nucleotide variant	missense variant	Uncertain significance	May 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1969G>C (p.Glu657Gln)	ALK	E657Q	Neuroblastoma, susceptibility to, 3	VCV002883649	2	29498037	2	29275171	2883649	3046404		NC_000002.12:29275170:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1967T>C (p.Phe656Ser)	ALK	F656S	Hereditary cancer-predisposing syndrome	VCV002585676	2	29498039	2	29275173	2585676	2753236		NC_000002.12:29275172:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1965G>T (p.Leu655=)	ALK		Hereditary cancer-predisposing syndrome	VCV003285656	2	29498041	2	29275175	3285656	85464	rs142967087	NC_000002.12:29275174:C:A	single nucleotide variant	synonymous variant	Likely benign	Mar 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1965G>A (p.Leu655=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002045662	2	29498041	2	29275175	2045662	2099670		NC_000002.12:29275174:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1963C>G (p.Leu655Val)	ALK	L655V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001783482	2	29498043	2	29275177	1783482	1839578		NC_000002.12:29275176:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1963C>T (p.Leu655=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001618919	2	29498043	2	29275177	1618919	1548694	rs572963793	NC_000002.12:29275176:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1962C>G (p.Asn654Lys)	ALK	N654K	Neuroblastoma, susceptibility to, 3	VCV003650066	2	29498044	2	29275178	3650066	3788062		NC_000002.12:29275177:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1962C>T (p.Asn654=)	ALK		Hereditary cancer-predisposing syndrome	VCV001783463	2	29498044	2	29275178	1783463	1839559		NC_000002.12:29275177:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 3, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1962C>A (p.Asn654Lys)	ALK	N654K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470777	2	29498044	2	29275178	470777	450770	rs755124993	NC_000002.12:29275177:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1957A>G (p.Arg653Gly)	ALK	R653G	Hereditary cancer-predisposing syndrome	VCV001783325	2	29498049	2	29275183	1783325	1843270		NC_000002.12:29275182:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1954T>G (p.Ser652Ala)	ALK	S652A	Hereditary cancer-predisposing syndrome	VCV002586713	2	29498052	2	29275186	2586713	2756896		NC_000002.12:29275185:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1954T>C (p.Ser652Pro)	ALK	S652P	Neuroblastoma, susceptibility to, 3	VCV001437146	2	29498052	2	29275186	1437146	1435716	rs2148215120	NC_000002.12:29275185:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1952A>G (p.Lys651Arg)	ALK	K651R	Hereditary cancer-predisposing syndrome	VCV003525103	2	29498054	2	29275188	3525103	3689342		NC_000002.12:29275187:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1952A>C (p.Lys651Thr)	ALK	K651T	Hereditary cancer-predisposing syndrome	VCV001783253	2	29498054	2	29275188	1783253	1843198		NC_000002.12:29275187:T:G	single nucleotide variant	missense variant	Likely benign	Apr 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1950C>G (p.Pro650=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001783220	2	29498056	2	29275190	1783220	1843165		NC_000002.12:29275189:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1949C>T (p.Pro650Leu)	ALK	P650L	Neuroblastoma, susceptibility to, 3	VCV002782997	2	29498057	2	29275191	2782997	2938098		NC_000002.12:29275190:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1948C>A (p.Pro650Thr)	ALK	P650T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000640930	2	29498058	2	29275192	640930	629876	rs1178904580	NC_000002.12:29275191:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1947A>C (p.Ala649=)	ALK		Hereditary cancer-predisposing syndrome	VCV001783145	2	29498059	2	29275193	1783145	1843090		NC_000002.12:29275192:T:G	single nucleotide variant	synonymous variant	Likely benign	Apr 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1946C>T (p.Ala649Val)	ALK	A649V	Hereditary cancer-predisposing syndrome	VCV003223810	2	29498060	2	29275194	3223810	3380833		NC_000002.12:29275193:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1944A>G (p.Thr648=)	ALK		Hereditary cancer-predisposing syndrome	VCV002452108	2	29498062	2	29275196	2452108	2426748		NC_000002.12:29275195:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1943C>A (p.Thr648Lys)	ALK	T648K	Neuroblastoma, susceptibility to, 3	VCV002759297	2	29498063	2	29275197	2759297	2917879		NC_000002.12:29275196:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1943C>T (p.Thr648Ile)	ALK	T648I	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000133461	2	29498063	2	29275197	133461	137200	rs116202066	NC_000002.12:29275196:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1942A>G (p.Thr648Ala)	ALK	T648A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002745070	2	29498064	2	29275198	2745070	2897233		NC_000002.12:29275197:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1941T>C (p.Asn647=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001620635	2	29498065	2	29275199	1620635	1549107	rs777545745	NC_000002.12:29275198:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1937A>G (p.Gln646Arg)	ALK	Q646R	Neuroblastoma, susceptibility to, 3	VCV000946641	2	29498069	2	29275203	946641	922721	rs1311437200	NC_000002.12:29275202:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1935G>A (p.Leu645=)	ALK		Hereditary cancer-predisposing syndrome|not provided	VCV001782952	2	29498071	2	29275205	1782952	1846315		NC_000002.12:29275204:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1933C>A (p.Leu645Met)	ALK	L645M	Hereditary cancer-predisposing syndrome	VCV002562262	2	29498073	2	29275207	2562262	2721115		NC_000002.12:29275206:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1933C>T (p.Leu645=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001578775	2	29498073	2	29275207	1578775	1652457	rs770797778	NC_000002.12:29275206:G:A	single nucleotide variant	synonymous variant	Likely benign	May 31, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1932C>T (p.Ile644=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001658662	2	29498074	2	29275208	1658662	1564038	rs2148215167	NC_000002.12:29275207:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1931T>C (p.Ile644Thr)	ALK	I644T	Neuroblastoma, susceptibility to, 3	VCV001718950	2	29498075	2	29275209	1718950	1776454		NC_000002.12:29275208:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1931T>G (p.Ile644Ser)	ALK	I644S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000935056	2	29498075	2	29275209	935056	931366	rs774398992	NC_000002.12:29275208:A:C	single nucleotide variant	missense variant	Uncertain significance	May 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1930A>G (p.Ile644Val)	ALK	I644V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003285422	2	29498076	2	29275210	3285422	3440654		NC_000002.12:29275209:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1929G>A (p.Lys643=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223808	2	29498077	2	29275211	3223808	3380831		NC_000002.12:29275210:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1929G>T (p.Lys643Asn)	ALK	K643N	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV002566569	2	29498077	2	29275211	2566569	2734412		NC_000002.12:29275210:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1928A>C (p.Lys643Thr)	ALK	K643T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002151606	2	29498078	2	29275212	2151606	1881773		NC_000002.12:29275211:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1926C>T (p.Asp642=)	ALK		Hereditary cancer-predisposing syndrome	VCV001782771	2	29498080	2	29275214	1782771	1846135		NC_000002.12:29275213:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 13, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1926C>A (p.Asp642Glu)	ALK	D642E	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001052984	2	29498080	2	29275214	1052984	1041405	rs2148215171	NC_000002.12:29275213:G:T	single nucleotide variant	missense variant	Uncertain significance	May 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1924G>A (p.Asp642Asn)	ALK	D642N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000646665	2	29498082	2	29275216	646665	629877	rs1573183654	NC_000002.12:29275215:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1923G>A (p.Glu641=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223807	2	29498083	2	29275217	3223807	3380830		NC_000002.12:29275216:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 2, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1923G>T (p.Glu641Asp)	ALK	E641D	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001044190	2	29498083	2	29275217	1044190	1024457	rs1665503142	NC_000002.12:29275216:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1921G>A (p.Glu641Lys)	ALK	E641K	Hereditary cancer-predisposing syndrome	VCV003286304	2	29498085	2	29275219	3286304	3455127		NC_000002.12:29275218:C:T	single nucleotide variant	missense variant	Uncertain significance	May 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1918G>T (p.Gly640Ter)	ALK	G640*	Neuroblastoma, susceptibility to, 3	VCV002882912	2	29498088	2	29275222	2882912	3053220		NC_000002.12:29275221:C:A	single nucleotide variant	nonsense	Uncertain significance	Mar 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1918G>A (p.Gly640Arg)	ALK	G640R	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000404360	2	29498088	2	29275222	404360	392751	rs144453491	NC_000002.12:29275221:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1917C>T (p.Ser639=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000239798	2	29498089	2	29275223	239798	238746	rs56249474	NC_000002.12:29275222:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1915A>G (p.Ser639Gly)	ALK	S639G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000643335	2	29498091	2	29275225	643335	629878	rs1573183673	NC_000002.12:29275224:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1914T>A (p.Ile638=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001151276	2	29498092	2	29275226	1151276	1133667	rs2148215193	NC_000002.12:29275225:A:T	single nucleotide variant	synonymous variant	Likely benign	Mar 20, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1913-2A>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002751208	2	29498095	2	29275229	2751208	2913246		NC_000002.12:29275228:T:G	single nucleotide variant	splice acceptor variant	Uncertain significance	Aug 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1913-4_1913-3delinsAA	ALK		Neuroblastoma, susceptibility to, 3	VCV002761259	2	29498096 - 29498097	2	29275230 - 29275231	2761259	2925025		NC_000002.12:29275229:GC:TT	Indel	intron variant	Uncertain significance	Sep 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1913-3C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000851197	2	29498096	2	29275230	851197	851426	rs1209588035	NC_000002.12:29275229:G:A	single nucleotide variant	intron variant	Uncertain significance	Mar 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1913-7A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000696155	2	29498100	2	29275234	696155	685131	rs1379154467	NC_000002.12:29275233:T:C	single nucleotide variant	intron variant	Likely benign	Sep 26, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1913-10T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001132234	2	29498103	2	29275237	1132234	1112755	rs2148215204	NC_000002.12:29275236:A:G	single nucleotide variant	intron variant	Likely benign	May 2, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1913-15T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002048283	2	29498108	2	29275242	2048283	2103586		NC_000002.12:29275241:A:G	single nucleotide variant	intron variant	Likely benign	Mar 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1913-16G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001557014	2	29498109	2	29275243	1557014	1561673	rs760419450	NC_000002.12:29275242:C:T	single nucleotide variant	intron variant	Likely benign	Jul 6, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1913-17G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001453522	2	29498110	2	29275244	1453522	1428803	rs763798074	NC_000002.12:29275243:C:A	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.1913-20T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002841187	2	29498113	2	29275247	2841187	2993340		NC_000002.12:29275246:A:C	single nucleotide variant	intron variant	Likely benign	Feb 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1912+83_1912+86del	ALK		not provided	VCV001177680	2	29498182 - 29498185	2	29275316 - 29275319	1177680	1167243	rs113955793	NC_000002.12:29275315:CAGTCAG:CAG	Deletion	intron variant	Likely benign	Sep 12, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1912+58T>C	ALK		not provided	VCV001265584	2	29498210	2	29275344	1265584	1255051	rs4589708	NC_000002.12:29275343:A:G	single nucleotide variant	intron variant	Benign	Jun 24, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1912+19del	ALK		Neuroblastoma, susceptibility to, 3	VCV002124000	2	29498249	2	29275383	2124000	2174128		NC_000002.12:29275382:GGGG:GGG	Deletion	intron variant	Benign	Apr 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1912+18C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001909146	2	29498250	2	29275384	1909146	1965919		NC_000002.12:29275383:G:C	single nucleotide variant	intron variant	Likely benign	Dec 25, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1912+17C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002150912	2	29498251	2	29275385	2150912	1888408		NC_000002.12:29275384:G:A	single nucleotide variant	intron variant	Likely benign	Apr 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1912+15A>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002698804	2	29498253	2	29275387	2698804	2855095		NC_000002.12:29275386:T:A	single nucleotide variant	intron variant	Likely benign	Jul 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1912+15A>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001570456	2	29498253	2	29275387	1570456	1536951	rs2148215373	NC_000002.12:29275386:T:G	single nucleotide variant	intron variant	Likely benign	Oct 13, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1912+12C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002702780	2	29498256	2	29275390	2702780	2866331		NC_000002.12:29275389:G:A	single nucleotide variant	intron variant	Likely benign	Dec 13, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1912+10C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001152799	2	29498258	2	29275392	1152799	1133668	rs2148215381	NC_000002.12:29275391:G:A	single nucleotide variant	intron variant	Likely benign	May 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1912+1del	ALK		Neuroblastoma, susceptibility to, 3	VCV002026739	2	29498267	2	29275401	2026739	2084659		NC_000002.12:29275400:C:	Deletion	splice donor variant	Uncertain significance	Aug 24, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1912+1G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001401978	2	29498267	2	29275401	1401978	1453788	rs1430369916	NC_000002.12:29275400:C:T	single nucleotide variant	splice donor variant	Uncertain significance	Jun 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1911C>T (p.Thr637=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538266	2	29498269	2	29275403	538266	518190	rs1553402750	NC_000002.12:29275402:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Apr 4, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1910C>G (p.Thr637Ser)	ALK	T637S	Neuroblastoma, susceptibility to, 3	VCV002196162	2	29498270	2	29275404	2196162	1923636		NC_000002.12:29275403:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1908C>G (p.Leu636=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000899327	2	29498272	2	29275406	899327	884682	rs1268649558	NC_000002.12:29275405:G:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 14, 2023	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1907T>C (p.Leu636Pro)	ALK	L636P	Neuroblastoma, susceptibility to, 3	VCV003011277	2	29498273	2	29275407	3011277	3180663		NC_000002.12:29275406:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1906C>T (p.Leu636Phe)	ALK	L636F	Hereditary cancer-predisposing syndrome	VCV001782394	2	29498274	2	29275408	1782394	1842778		NC_000002.12:29275407:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1904A>G (p.Tyr635Cys)	ALK	Y635C	Neuroblastoma, susceptibility to, 3	VCV002915280	2	29498276	2	29275410	2915280	3076650		NC_000002.12:29275409:T:C	single nucleotide variant	missense variant	Uncertain significance	May 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1902C>T (p.Cys634=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002141035	2	29498278	2	29275412	2141035	1875533		NC_000002.12:29275411:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1902C>G (p.Cys634Trp)	ALK	C634W	Neuroblastoma, susceptibility to, 3	VCV001397210	2	29498278	2	29275412	1397210	1437777	rs1215374113	NC_000002.12:29275411:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1899C>T (p.Asp633=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002729761	2	29498281	2	29275415	2729761	2889803		NC_000002.12:29275414:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1893C>T (p.Ser631=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002706026	2	29498287	2	29275421	2706026	2877351		NC_000002.12:29275420:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1892G>C (p.Ser631Thr)	ALK	S631T	Hereditary cancer-predisposing syndrome	VCV003524574	2	29498288	2	29275422	3524574	3679239		NC_000002.12:29275421:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1892G>A (p.Ser631Asn)	ALK	S631N	Neuroblastoma, susceptibility to, 3	VCV001057709	2	29498288	2	29275422	1057709	1041406	rs1665515584	NC_000002.12:29275421:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1890C>A (p.Ile630=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001567721	2	29498290	2	29275424	1567721	1657229	rs1278070199	NC_000002.12:29275423:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1890C>T (p.Ile630=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000899328	2	29498290	2	29275424	899328	884683	rs1278070199	NC_000002.12:29275423:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Nov 26, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1889T>A (p.Ile630Asn)	ALK	I630N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001719637	2	29498291	2	29275425	1719637	1772293		NC_000002.12:29275424:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1888A>T (p.Ile630Phe)	ALK	I630F	Hereditary cancer-predisposing syndrome	VCV002561058	2	29498292	2	29275426	2561058	2717217		NC_000002.12:29275425:T:A	single nucleotide variant	missense variant	Uncertain significance	May 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1887C>T (p.Ser629=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001093680	2	29498293	2	29275427	1093680	1069528	rs2148215413	NC_000002.12:29275426:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1885T>C (p.Ser629Pro)	ALK	S629P	Neuroblastoma, susceptibility to, 3	VCV001719636	2	29498295	2	29275429	1719636	1772292		NC_000002.12:29275428:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1884C>T (p.Ile628=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000746811	2	29498296	2	29275430	746811	747584	rs1208681809	NC_000002.12:29275429:G:A	single nucleotide variant	synonymous variant	Likely benign	May 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1882A>G (p.Ile628Val)	ALK	I628V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001013961	2	29498298	2	29275432	1013961	1003989	rs775145742	NC_000002.12:29275431:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1880A>C (p.Asn627Thr)	ALK	N627T	Hereditary cancer-predisposing syndrome	VCV003223806	2	29498300	2	29275434	3223806	3380829		NC_000002.12:29275433:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1880A>G (p.Asn627Ser)	ALK	N627S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001408784	2	29498300	2	29275434	1408784	1500450	rs1025380501	NC_000002.12:29275433:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1879A>G (p.Asn627Asp)	ALK	N627D	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001781837	2	29498301	2	29275435	1781837	1835233		NC_000002.12:29275434:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1879A>C (p.Asn627His)	ALK	N627H	Hereditary cancer-predisposing syndrome	VCV001781833	2	29498301	2	29275435	1781833	1835229		NC_000002.12:29275434:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1875T>G (p.Phe625Leu)	ALK	F625L	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000538226	2	29498305	2	29275439	538226	518202	rs1553402765	NC_000002.12:29275438:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1874T>C (p.Phe625Ser)	ALK	F625S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001379306	2	29498306	2	29275440	1379306	1486535	rs760213029	NC_000002.12:29275439:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1872T>C (p.Ala624=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000758515	2	29498308	2	29275442	758515	763181	rs1573183882	NC_000002.12:29275441:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 20, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1871C>G (p.Ala624Gly)	ALK	A624G	Hereditary cancer-predisposing syndrome	VCV003524785	2	29498309	2	29275443	3524785	3689024		NC_000002.12:29275442:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1871C>T (p.Ala624Val)	ALK	A624V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000581121	2	29498309	2	29275443	581121	560595	rs906659904	NC_000002.12:29275442:G:A	single nucleotide variant	missense variant	Uncertain significance	May 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1870G>C (p.Ala624Pro)	ALK	A624P	Neuroblastoma, susceptibility to, 3	VCV000945298	2	29498310	2	29275444	945298	922722	rs1665516398	NC_000002.12:29275443:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1869G>A (p.Val623=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002186157	2	29498311	2	29275445	2186157	1921369		NC_000002.12:29275444:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1868T>C (p.Val623Ala)	ALK	V623A	Neuroblastoma, susceptibility to, 3	VCV002186482	2	29498312	2	29275446	2186482	1917827		NC_000002.12:29275445:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1867G>T (p.Val623Leu)	ALK	V623L	not provided	VCV002446073	2	29498313	2	29275447	2446073	2419495		NC_000002.12:29275446:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1867G>A (p.Val623Met)	ALK	V623M	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000949388	2	29498313	2	29275447	949388	922723	rs768256091	NC_000002.12:29275446:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1866C>T (p.Ile622=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000743351	2	29498314	2	29275448	743351	747585	rs139123232	NC_000002.12:29275447:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1865T>C (p.Ile622Thr)	ALK	I622T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001491306	2	29498315	2	29275449	1491306	1508541	rs1665516730	NC_000002.12:29275448:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 30, 2023	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1864A>G (p.Ile622Val)	ALK	I622V	Neuroblastoma, susceptibility to, 3	VCV002087462	2	29498316	2	29275450	2087462	2137523		NC_000002.12:29275449:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1864A>T (p.Ile622Phe)	ALK	I622F	Neuroblastoma, susceptibility to, 3	VCV002042984	2	29498316	2	29275450	2042984	2095708		NC_000002.12:29275449:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1863C>T (p.Ala621=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001781541	2	29498317	2	29275451	1781541	1838887		NC_000002.12:29275450:G:A	single nucleotide variant	synonymous variant	Likely benign	May 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1862C>A (p.Ala621Asp)	ALK	A621D	Hereditary cancer-predisposing syndrome	VCV002624793	2	29498318	2	29275452	2624793	2790288		NC_000002.12:29275451:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1859G>C (p.Arg620Thr)	ALK	R620T	Neuroblastoma, susceptibility to, 3	VCV000860412	2	29498321	2	29275455	860412	826357	rs1665516911	NC_000002.12:29275454:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1857C>A (p.Ser619=)	ALK		Hereditary cancer-predisposing syndrome	VCV002566578	2	29498323	2	29275457	2566578	2734421		NC_000002.12:29275456:G:T	single nucleotide variant	synonymous variant	Likely benign	Apr 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1857C>T (p.Ser619=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001546925	2	29498323	2	29275457	1546925	1645901	rs1476212862	NC_000002.12:29275456:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 10, 2020	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1855T>C (p.Ser619Pro)	ALK	S619P	Hereditary cancer-predisposing syndrome	VCV003223805	2	29498325	2	29275459	3223805	3380828		NC_000002.12:29275458:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1854A>C (p.Gly618=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538275	2	29498326	2	29275460	538275	518204	rs145060046	NC_000002.12:29275459:T:G	single nucleotide variant	synonymous variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1853G>C (p.Gly618Ala)	ALK	G618A	Neuroblastoma, susceptibility to, 3	VCV002766819	2	29498327	2	29275461	2766819	2926264		NC_000002.12:29275460:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1853G>A (p.Gly618Glu)	ALK	G618E	Neuroblastoma, susceptibility to, 3	VCV001364566	2	29498327	2	29275461	1364566	1409047	rs766821017	NC_000002.12:29275460:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1852G>A (p.Gly618Arg)	ALK	G618R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000653409	2	29498328	2	29275462	653409	629879	rs1573183907	NC_000002.12:29275461:C:T	single nucleotide variant	missense variant	Uncertain significance	May 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1851A>G (p.Gln617=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001083438	2	29498329	2	29275463	1083438	1069529	rs201268211	NC_000002.12:29275462:T:C	single nucleotide variant	synonymous variant	Likely benign	Jul 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1849C>T (p.Gln617Ter)	ALK	Q617*	Neuroblastoma, susceptibility to, 3	VCV003721070	2	29498331	2	29275465	3721070	3853441		NC_000002.12:29275464:G:A	single nucleotide variant	nonsense	Uncertain significance	Feb 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1849C>A (p.Gln617Lys)	ALK	Q617K	Neuroblastoma, susceptibility to, 3	VCV001051846	2	29498331	2	29275465	1051846	1041407	rs2148215449	NC_000002.12:29275464:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1846G>A (p.Gly616Arg)	ALK	G616R	Hereditary cancer-predisposing syndrome	VCV003223804	2	29498334	2	29275468	3223804	3380827		NC_000002.12:29275467:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1845G>A (p.Trp615Ter)	ALK	W615*	Neuroblastoma, susceptibility to, 3	VCV001369880	2	29498335	2	29275469	1369880	1437586	rs2148215455	NC_000002.12:29275468:C:T	single nucleotide variant	nonsense	Uncertain significance	Jul 26, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1844G>T (p.Trp615Leu)	ALK	W615L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001041539	2	29498336	2	29275470	1041539	1024458	rs1665517386	NC_000002.12:29275469:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1843T>A (p.Trp615Arg)	ALK	W615R	Neuroblastoma, susceptibility to, 3|not provided	VCV001370741	2	29498337	2	29275471	1370741	1430809	rs774517608	NC_000002.12:29275470:A:T	single nucleotide variant	missense variant	Uncertain significance	May 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1843T>G (p.Trp615Gly)	ALK	W615G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001017698	2	29498337	2	29275471	1017698	1003990	rs774517608	NC_000002.12:29275470:A:C	single nucleotide variant	missense variant	Uncertain significance	May 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1842G>A (p.Trp614Ter)	ALK	W614*	Neuroblastoma, susceptibility to, 3	VCV002911471	2	29498338	2	29275472	2911471	3078823		NC_000002.12:29275471:C:T	single nucleotide variant	nonsense	Uncertain significance	Feb 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1842G>C (p.Trp614Cys)	ALK	W614C	Hereditary cancer-predisposing syndrome|not provided	VCV002412871	2	29498338	2	29275472	2412871	2401598		NC_000002.12:29275471:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1841G>C (p.Trp614Ser)	ALK	W614S	Neuroblastoma, susceptibility to, 3	VCV002770054	2	29498339	2	29275473	2770054	2929923		NC_000002.12:29275472:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1841G>T (p.Trp614Leu)	ALK	W614L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000567781	2	29498339	2	29275473	567781	561360	rs760038434	NC_000002.12:29275472:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1840T>G (p.Trp614Gly)	ALK	W614G	Neuroblastoma, susceptibility to, 3	VCV002780097	2	29498340	2	29275474	2780097	2947293		NC_000002.12:29275473:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1839A>G (p.Ala613=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001082462	2	29498341	2	29275475	1082462	1069530	rs143141901	NC_000002.12:29275474:T:C	single nucleotide variant	synonymous variant	Likely benign	Apr 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1837G>T (p.Ala613Ser)	ALK	A613S	Neuroblastoma, susceptibility to, 3	VCV003645138	2	29498343	2	29275477	3645138	3783553		NC_000002.12:29275476:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1837G>C (p.Ala613Pro)	ALK	A613P	Neuroblastoma, susceptibility to, 3	VCV002818358	2	29498343	2	29275477	2818358	2984573		NC_000002.12:29275476:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1837G>A (p.Ala613Thr)	ALK	A613T	Neuroblastoma, susceptibility to, 3|Ovarian cancer	VCV000654949	2	29498343	2	29275477	654949	629880	rs61744521	NC_000002.12:29275476:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 9, 2023	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1836C>G (p.Val612=)	ALK		Hereditary cancer-predisposing syndrome	VCV003524615	2	29498344	2	29275478	3524615	3679280		NC_000002.12:29275477:G:C	single nucleotide variant	synonymous variant	Likely benign	Sep 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1836C>T (p.Val612=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001114778	2	29498344	2	29275478	1114778	1091262	rs752799164	NC_000002.12:29275477:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1835T>C (p.Val612Ala)	ALK	V612A	Neuroblastoma, susceptibility to, 3	VCV002849604	2	29498345	2	29275479	2849604	3009393		NC_000002.12:29275478:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1834G>A (p.Val612Ile)	ALK	V612I	not provided|Neuroblastoma, susceptibility to, 3	VCV000538243	2	29498346	2	29275480	538243	518084	rs1431784023	NC_000002.12:29275479:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1833G>C (p.Met611Ile)	ALK	M611I	Neuroblastoma, susceptibility to, 3	VCV003607003	2	29498347	2	29275481	3607003	3737124		NC_000002.12:29275480:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1833G>A (p.Met611Ile)	ALK	M611I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001439779	2	29498347	2	29275481	1439779	1346306	rs1302907379	NC_000002.12:29275480:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 8, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1833G>T (p.Met611Ile)	ALK	M611I	Neuroblastoma, susceptibility to, 3	VCV000566304	2	29498347	2	29275481	566304	558390	rs1302907379	NC_000002.12:29275480:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1831A>T (p.Met611Leu)	ALK	M611L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001719431	2	29498349	2	29275483	1719431	1774735		NC_000002.12:29275482:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1830G>C (p.Gln610His)	ALK	Q610H	Neuroblastoma, susceptibility to, 3	VCV001943319	2	29498350	2	29275484	1943319	1998306		NC_000002.12:29275483:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1829A>G (p.Gln610Arg)	ALK	Q610R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001780898	2	29498351	2	29275485	1780898	1839167		NC_000002.12:29275484:T:C	single nucleotide variant	missense variant	Uncertain significance	May 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1828C>T (p.Gln610Ter)	ALK	Q610*	Neuroblastoma, susceptibility to, 3	VCV002015346	2	29498352	2	29275486	2015346	2068144		NC_000002.12:29275485:G:A	single nucleotide variant	nonsense	Uncertain significance	Jul 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1827G>A (p.Leu609=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000705998	2	29498353	2	29275487	705998	691144	rs140284088	NC_000002.12:29275486:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1825C>G (p.Leu609Val)	ALK	L609V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001003120	2	29498355	2	29275489	1003120	988722	rs1665518534	NC_000002.12:29275488:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1824G>C (p.Trp608Cys)	ALK	W608C	Neuroblastoma, susceptibility to, 3	VCV003726456	2	29498356	2	29275490	3726456	3854946		NC_000002.12:29275489:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1821C>T (p.Phe607=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002006674	2	29498359	2	29275493	2006674	2065909		NC_000002.12:29275492:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1820T>A (p.Phe607Tyr)	ALK	F607Y	not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470776	2	29498360	2	29275494	470776	451071	rs1304239235	NC_000002.12:29275493:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1818G>A (p.Arg606=)	ALK		Hereditary cancer-predisposing syndrome	VCV002452115	2	29498362	2	29275496	2452115	2426755		NC_000002.12:29275495:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1818G>T (p.Arg606Ser)	ALK	R606S	Neuroblastoma, susceptibility to, 3	VCV001713900	2	29498362	2	29275496	1713900	1773171		NC_000002.12:29275495:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1818-1G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001384183	2	29498363	2	29275497	1384183	1447779	rs1665518836	NC_000002.12:29275496:C:T	single nucleotide variant	splice acceptor variant	Uncertain significance	Jul 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1818-4A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002008174	2	29498366	2	29275500	2008174	2069986		NC_000002.12:29275499:T:C	single nucleotide variant	intron variant	Likely benign	Jun 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1818-6G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002189710	2	29498368	2	29275502	2189710	1922330		NC_000002.12:29275501:C:T	single nucleotide variant	intron variant	Likely benign	Jul 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1818-10A>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001465631	2	29498372	2	29275506	1465631	1353863	rs2148215505	NC_000002.12:29275505:T:A	single nucleotide variant	intron variant	Likely benign	Aug 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1818-11G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003646631	2	29498373	2	29275507	3646631	3787184		NC_000002.12:29275506:C:A	single nucleotide variant	intron variant	Likely benign	Feb 3, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.1818-13T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002784929	2	29498375	2	29275509	2784929	2938731		NC_000002.12:29275508:A:G	single nucleotide variant	intron variant	Likely benign	Apr 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1818-14C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002995739	2	29498376	2	29275510	2995739	3166377		NC_000002.12:29275509:G:A	single nucleotide variant	intron variant	Likely benign	Jan 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1818-14C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002874160	2	29498376	2	29275510	2874160	3040980		NC_000002.12:29275509:G:C	single nucleotide variant	intron variant	Likely benign	May 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1818-17C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001627874	2	29498379	2	29275513	1627874	1531092	rs2148215511	NC_000002.12:29275512:G:T	single nucleotide variant	intron variant	Likely benign	Nov 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1818-193G>A	ALK		not provided	VCV001203091	2	29498555	2	29275689	1203091	1193147	rs73920766	NC_000002.12:29275688:C:T	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1818-206G>A	ALK		not provided	VCV001196195	2	29498568	2	29275702	1196195	1186434	rs114523409	NC_000002.12:29275701:C:T	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1817+279G>T	ALK		not provided	VCV001255001	2	29519475	2	29296609	1255001	1244933	rs13406263	NC_000002.12:29296608:C:A	single nucleotide variant	intron variant	Benign	Feb 11, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+148AC[12]	ALK		not provided	VCV001278710	2	29519588 - 29519589	2	29296722 - 29296723	1278710	1267290	rs3054024	NC_000002.12:29296722:GTGTGTGTGTGTGTGTGTG:GTGTGTGTGTGTGTGTGTGTGTGTG	Microsatellite	intron variant	Benign	Aug 10, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+148AC[11]	ALK		not provided	VCV001221014	2	29519588 - 29519589	2	29296722 - 29296723	1221014	1211411	rs3054024	NC_000002.12:29296722:GTGTGTGTGTGTGTGTGTG:GTGTGTGTGTGTGTGTGTGTGTG	Microsatellite	intron variant	Benign	Aug 11, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+148AC[10]	ALK		not provided	VCV001201973	2	29519588 - 29519589	2	29296722 - 29296723	1201973	1189891	rs3054024	NC_000002.12:29296722:GTGTGTGTGTGTGTGTGTG:GTGTGTGTGTGTGTGTGTGTG	Microsatellite	intron variant	Likely benign	Aug 19, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+132G>A	ALK		not provided	VCV001274259	2	29519622	2	29296756	1274259	1262435	rs2272409	NC_000002.12:29296755:C:T	single nucleotide variant	intron variant	Benign	Jun 24, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1817+123G>A	ALK		not provided	VCV000676903	2	29519631	2	29296765	676903	659062	rs78817793	NC_000002.12:29296764:C:T	single nucleotide variant	intron variant	Benign	Jun 16, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1817+39A>G	ALK		not provided	VCV001202179	2	29519715	2	29296849	1202179	1189892	rs78066015	NC_000002.12:29296848:T:C	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+20C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001574940	2	29519734	2	29296868	1574940	1585263	rs2148230952	NC_000002.12:29296867:G:A	single nucleotide variant	intron variant	Likely benign	Oct 24, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+19C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001672204	2	29519735	2	29296869	1672204	1647513	rs1666197923	NC_000002.12:29296868:G:A	single nucleotide variant	intron variant	Likely benign	May 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+18C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001548003	2	29519736	2	29296870	1548003	1537821	rs2148230954	NC_000002.12:29296869:G:C	single nucleotide variant	intron variant	Likely benign	Apr 20, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+14A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001985276	2	29519740	2	29296874	1985276	2043128		NC_000002.12:29296873:T:C	single nucleotide variant	intron variant	Likely benign	Dec 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+14A>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001906555	2	29519740	2	29296874	1906555	1962039		NC_000002.12:29296873:T:G	single nucleotide variant	intron variant	Likely benign	Feb 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+13C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001568629	2	29519741	2	29296875	1568629	1634230	rs764293538	NC_000002.12:29296874:G:T	single nucleotide variant	intron variant	Likely benign	Dec 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+11T>C	ALK		Hereditary cancer-predisposing syndrome|not specified|Neuroblastoma, susceptibility to, 3	VCV000508894	2	29519743	2	29296877	508894	500110	rs185559774	NC_000002.12:29296876:A:G	single nucleotide variant	intron variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1817+10A>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002049202	2	29519744	2	29296878	2049202	2110971		NC_000002.12:29296877:T:G	single nucleotide variant	intron variant	Likely benign	Dec 20, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+10A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000697465	2	29519744	2	29296878	697465	689713	rs539018263	NC_000002.12:29296877:T:C	single nucleotide variant	intron variant	Likely benign	Oct 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+9T>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000470775	2	29519745	2	29296879	470775	450912	rs1553405983	NC_000002.12:29296878:A:T	single nucleotide variant	intron variant	Likely benign	Nov 22, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+8C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000701106	2	29519746	2	29296880	701106	689714	rs371738899	NC_000002.12:29296879:G:A	single nucleotide variant	intron variant	Likely benign	Oct 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+8C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000662133	2	29519746	2	29296880	662133	651021	rs371738899	NC_000002.12:29296879:G:C	single nucleotide variant	intron variant	Likely benign	Jan 19, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+7T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001612610	2	29519747	2	29296881	1612610	1601693	rs2148230978	NC_000002.12:29296880:A:G	single nucleotide variant	intron variant	Likely benign	Nov 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+6C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000656667	2	29519748	2	29296882	656667	650931	rs1558658288	NC_000002.12:29296881:G:T	single nucleotide variant	intron variant	Uncertain significance	Oct 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+5G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002006876	2	29519749	2	29296883	2006876	2066111		NC_000002.12:29296882:C:G	single nucleotide variant	intron variant	Uncertain significance	Jun 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+3A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001051918	2	29519751	2	29296885	1051918	1041408	rs2148230980	NC_000002.12:29296884:T:C	single nucleotide variant	intron variant	Uncertain significance	Dec 27, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1817+1G>A	ALK		Hereditary cancer-predisposing syndrome	VCV001692774	2	29519753	2	29296887	1692774	1685214	rs2148230982	NC_000002.12:29296886:C:T	single nucleotide variant	splice donor variant	Uncertain significance	Oct 6, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1816A>G (p.Arg606Gly)	ALK	R606G	Neuroblastoma, susceptibility to, 3	VCV001393858	2	29519755	2	29296889	1393858	1422397	rs1666198944	NC_000002.12:29296888:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1814A>T (p.Asp605Val)	ALK	D605V	Neuroblastoma, susceptibility to, 3	VCV003723465	2	29519757	2	29296891	3723465	3850676		NC_000002.12:29296890:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1814A>C (p.Asp605Ala)	ALK	D605A	Hereditary cancer-predisposing syndrome	VCV003223803	2	29519757	2	29296891	3223803	3380826		NC_000002.12:29296890:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1812T>C (p.Ser604=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001780619	2	29519759	2	29296893	1780619	1831914		NC_000002.12:29296892:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1811C>G (p.Ser604Cys)	ALK	S604C	Hereditary cancer-predisposing syndrome	VCV003223802	2	29519760	2	29296894	3223802	3380825		NC_000002.12:29296893:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1809G>A (p.Val603=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002452114	2	29519762	2	29296896	2452114	2426754		NC_000002.12:29296895:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1809G>T (p.Val603=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000750166	2	29519762	2	29296896	750166	747586	rs141025125	NC_000002.12:29296895:C:A	single nucleotide variant	synonymous variant	Likely benign	Feb 28, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1806T>C (p.Asp602=)	ALK		Hereditary cancer-predisposing syndrome	VCV001780491	2	29519765	2	29296899	1780491	1831787		NC_000002.12:29296898:A:G	single nucleotide variant	synonymous variant	Likely benign	May 21, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1806T>G (p.Asp602Glu)	ALK	D602E	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001018849	2	29519765	2	29296899	1018849	1003991	rs753871185	NC_000002.12:29296898:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1804G>C (p.Asp602His)	ALK	D602H	Neuroblastoma, susceptibility to, 3	VCV003615841	2	29519767	2	29296901	3615841	3745519		NC_000002.12:29296900:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1804G>T (p.Asp602Tyr)	ALK	D602Y	Hereditary cancer-predisposing syndrome	VCV001780460	2	29519767	2	29296901	1780460	1831756		NC_000002.12:29296900:C:A	single nucleotide variant	missense variant	Uncertain significance	May 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1804G>A (p.Asp602Asn)	ALK	D602N	Neuroblastoma, susceptibility to, 3	VCV000639969	2	29519767	2	29296901	639969	629881	rs1165866210	NC_000002.12:29296900:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1803del (p.Asp602fs)	ALK	D602fs	not provided|Neuroblastoma, susceptibility to, 3	VCV001411899	2	29519768	2	29296902	1411899	1349039	rs926903893	NC_000002.12:29296901:G:	Deletion	frameshift variant	Uncertain significance	Apr 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1803C>T (p.Leu601=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000706226	2	29519768	2	29296902	706226	691145	rs769055778	NC_000002.12:29296901:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1800C>T (p.Leu600=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001088942	2	29519771	2	29296905	1088942	1069531	rs779990542	NC_000002.12:29296904:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1798C>T (p.Leu600Phe)	ALK	L600F	Neuroblastoma, susceptibility to, 3	VCV001062994	2	29519773	2	29296907	1062994	1041409	rs2148231015	NC_000002.12:29296906:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1797T>C (p.Pro599=)	ALK		Hereditary cancer-predisposing syndrome	VCV001780289	2	29519774	2	29296908	1780289	1834990		NC_000002.12:29296907:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1795C>G (p.Pro599Ala)	ALK	P599A	Hereditary cancer-predisposing syndrome	VCV002452117	2	29519776	2	29296910	2452117	2426757		NC_000002.12:29296909:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1795C>T (p.Pro599Ser)	ALK	P599S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001370144	2	29519776	2	29296910	1370144	1352483	rs2148231018	NC_000002.12:29296909:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1794G>C (p.Leu598Phe)	ALK	L598F	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002964021	2	29519777	2	29296911	2964021	3127435		NC_000002.12:29296910:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1794G>T (p.Leu598Phe)	ALK	L598F	ALK-related disorder|Neuroblastoma, susceptibility to, 3	VCV000662395	2	29519777	2	29296911	662395	629882	rs942266375	NC_000002.12:29296910:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1794G>A (p.Leu598=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470773	2	29519777	2	29296911	470773	451065	rs942266375	NC_000002.12:29296910:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1790T>C (p.Val597Ala)	ALK	V597A	Neuroblastoma, susceptibility to, 3	VCV000538208	2	29519781	2	29296915	538208	518224	rs747000305	NC_000002.12:29296914:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1789G>A (p.Val597Met)	ALK	V597M	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV003019881	2	29519782	2	29296916	3019881	3182749		NC_000002.12:29296915:C:T	single nucleotide variant	missense variant	Uncertain significance	May 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1789G>C (p.Val597Leu)	ALK	V597L	Neuroblastoma, susceptibility to, 3	VCV002676038	2	29519782	2	29296916	2676038	2834459		NC_000002.12:29296915:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1789G>T (p.Val597Leu)	ALK	V597L	Neuroblastoma, susceptibility to, 3	VCV001932917	2	29519782	2	29296916	1932917	1985335		NC_000002.12:29296915:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1788G>A (p.Met596Ile)	ALK	M596I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000840952	2	29519783	2	29296917	840952	826358	rs1273699854	NC_000002.12:29296916:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1787T>C (p.Met596Thr)	ALK	M596T	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000538254	2	29519784	2	29296918	538254	518233	rs754810505	NC_000002.12:29296917:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 7, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1786A>G (p.Met596Val)	ALK	M596V	Neuroblastoma, susceptibility to, 3	VCV002073394	2	29519785	2	29296919	2073394	2123482		NC_000002.12:29296918:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1785G>A (p.Trp595Ter)	ALK	W595*	Neuroblastoma, susceptibility to, 3	VCV001429395	2	29519786	2	29296920	1429395	1454511	rs2148231045	NC_000002.12:29296919:C:T	single nucleotide variant	nonsense	Uncertain significance	Jun 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1782G>A (p.Gln594=)	ALK		Hereditary cancer-predisposing syndrome	VCV001780029	2	29519789	2	29296923	1780029	1834730		NC_000002.12:29296922:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1782G>C (p.Gln594His)	ALK	Q594H	Neuroblastoma, susceptibility to, 3	VCV000660597	2	29519789	2	29296923	660597	629883	rs1573203576	NC_000002.12:29296922:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1781A>G (p.Gln594Arg)	ALK	Q594R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001780001	2	29519790	2	29296924	1780001	1834702		NC_000002.12:29296923:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1779G>C (p.Trp593Cys)	ALK	W593C	Neuroblastoma, susceptibility to, 3	VCV001362152	2	29519792	2	29296926	1362152	1376777	rs2148231055	NC_000002.12:29296925:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1773C>T (p.Ser591=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223801	2	29519798	2	29296932	3223801	3380824		NC_000002.12:29296931:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1772G>T (p.Ser591Ile)	ALK	S591I	Neuroblastoma, susceptibility to, 3	VCV003659567	2	29519799	2	29296933	3659567	3790507		NC_000002.12:29296932:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1768T>G (p.Leu590Val)	ALK	L590V	Hereditary cancer-predisposing syndrome	VCV002624795	2	29519803	2	29296937	2624795	2790290		NC_000002.12:29296936:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1768T>C (p.Leu590=)	ALK		Hereditary cancer-predisposing syndrome	VCV001779726	2	29519803	2	29296937	1779726	1838378		NC_000002.12:29296936:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 16, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1767C>T (p.Gly589=)	ALK		Hereditary cancer-predisposing syndrome	VCV001779705	2	29519804	2	29296938	1779705	1838358		NC_000002.12:29296937:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1766G>C (p.Gly589Ala)	ALK	G589A	not provided	VCV001312625	2	29519805	2	29296939	1312625	1302886	rs769505453	NC_000002.12:29296938:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1766G>T (p.Gly589Val)	ALK	G589V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001008766	2	29519805	2	29296939	1008766	988723	rs769505453	NC_000002.12:29296938:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1766G>A (p.Gly589Asp)	ALK	G589D	Neuroblastoma, susceptibility to, 3	VCV000569275	2	29519805	2	29296939	569275	558392	rs769505453	NC_000002.12:29296938:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1761T>C (p.Tyr587=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001597770	2	29519810	2	29296944	1597770	1570909	rs2148231070	NC_000002.12:29296943:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1760A>T (p.Tyr587Phe)	ALK	Y587F	Neuroblastoma, susceptibility to, 3	VCV002700330	2	29519811	2	29296945	2700330	2855329		NC_000002.12:29296944:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1760A>G (p.Tyr587Cys)	ALK	Y587C	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000959611	2	29519811	2	29296945	959611	942871	rs1338200771	NC_000002.12:29296944:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1758C>T (p.Ala586=)	ALK		Hereditary cancer-predisposing syndrome	VCV001779511	2	29519813	2	29296947	1779511	1839078		NC_000002.12:29296946:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1757C>A (p.Ala586Asp)	ALK	A586D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000654286	2	29519814	2	29296948	654286	629884	rs1046338903	NC_000002.12:29296947:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2024	criteria provided, multiple submitters, no conflicts				Uncertain significance	Jul 31, 2024	criteria provided, single submitter	
NM_004304.5(ALK):c.1757C>T (p.Ala586Val)	ALK	A586V	Neuroblastoma, susceptibility to, 3	VCV000570733	2	29519814	2	29296948	570733	558045	rs1046338903	NC_000002.12:29296947:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1756G>A (p.Ala586Thr)	ALK	A586T	not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470772	2	29519815	2	29296949	470772	450775	rs75158395	NC_000002.12:29296948:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 19, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1755C>A (p.Ala585=)	ALK		Hereditary cancer-predisposing syndrome	VCV001779459	2	29519816	2	29296950	1779459	1828673		NC_000002.12:29296949:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 16, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1755C>T (p.Ala585=)	ALK		not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000239797	2	29519816	2	29296950	239797	238747	rs373605278	NC_000002.12:29296949:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1754C>A (p.Ala585Asp)	ALK	A585D	Hereditary cancer-predisposing syndrome	VCV003223800	2	29519817	2	29296951	3223800	3380823		NC_000002.12:29296950:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1753G>A (p.Ala585Thr)	ALK	A585T	Neuroblastoma, susceptibility to, 3|not provided	VCV000423499	2	29519818	2	29296952	423499	405716	rs772496459	NC_000002.12:29296951:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1752C>A (p.Val584=)	ALK		Hereditary cancer-predisposing syndrome	VCV003286166	2	29519819	2	29296953	3286166	3444906		NC_000002.12:29296952:G:T	single nucleotide variant	synonymous variant	Likely benign	May 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1752C>T (p.Val584=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not specified	VCV000412935	2	29519819	2	29296953	412935	392753	rs367912697	NC_000002.12:29296952:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1751T>C (p.Val584Ala)	ALK	V584A	Hereditary cancer-predisposing syndrome	VCV002447097	2	29519820	2	29296954	2447097	2422220		NC_000002.12:29296953:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1750G>A (p.Val584Ile)	ALK	V584I	not provided	VCV003363875	2	29519821	2	29296955	3363875	3523084		NC_000002.12:29296954:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1749T>C (p.His583=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002150092	2	29519822	2	29296956	2150092	1881558		NC_000002.12:29296955:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1749T>A (p.His583Gln)	ALK	H583Q	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000573537	2	29519822	2	29296956	573537	560597	rs761184891	NC_000002.12:29296955:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1748A>G (p.His583Arg)	ALK	H583R	Hereditary cancer-predisposing syndrome	VCV003524848	2	29519823	2	29296957	3524848	3689087		NC_000002.12:29296956:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1747C>A (p.His583Asn)	ALK	H583N	Neuroblastoma, susceptibility to, 3	VCV003005345	2	29519824	2	29296958	3005345	3161759		NC_000002.12:29296957:G:T	single nucleotide variant	missense variant	Uncertain significance	May 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1747C>T (p.His583Tyr)	ALK	H583Y	Neuroblastoma, susceptibility to, 3	VCV001027326	2	29519824	2	29296958	1027326	1003992	rs1666202984	NC_000002.12:29296957:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1743C>G (p.Val581=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003286395	2	29519828	2	29296962	3286395	3455218		NC_000002.12:29296961:G:C	single nucleotide variant	synonymous variant	Likely benign	Aug 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1742T>C (p.Val581Ala)	ALK	V581A	Neuroblastoma, susceptibility to, 3	VCV003241697	2	29519829	2	29296963	3241697	3400675		NC_000002.12:29296962:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1742T>G (p.Val581Gly)	ALK	V581G	Hereditary cancer-predisposing syndrome	VCV001779227	2	29519829	2	29296963	1779227	1828442		NC_000002.12:29296962:A:C	single nucleotide variant	missense variant	Uncertain significance	May 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1741G>A (p.Val581Ile)	ALK	V581I	Neuroblastoma, susceptibility to, 3	VCV003666263	2	29519830	2	29296964	3666263	3792069		NC_000002.12:29296963:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1741G>T (p.Val581Phe)	ALK	V581F	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000836289	2	29519830	2	29296964	836289	826359	rs1666203352	NC_000002.12:29296963:C:A	single nucleotide variant	missense variant	Uncertain significance	May 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1740G>A (p.Met580Ile)	ALK	M580I	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000837119	2	29519831	2	29296965	837119	826360	rs1460645072	NC_000002.12:29296964:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1739T>A (p.Met580Lys)	ALK	M580K	Hereditary cancer-predisposing syndrome	VCV002586688	2	29519832	2	29296966	2586688	2756871		NC_000002.12:29296965:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1738A>G (p.Met580Val)	ALK	M580V	Neuroblastoma, susceptibility to, 3	VCV003718886	2	29519833	2	29296967	3718886	3859588		NC_000002.12:29296966:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1738A>T (p.Met580Leu)	ALK	M580L	Neuroblastoma, susceptibility to, 3	VCV003626983	2	29519833	2	29296967	3626983	3755623		NC_000002.12:29296966:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1737G>T (p.Arg579Ser)	ALK	R579S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001779112	2	29519834	2	29296968	1779112	1831696		NC_000002.12:29296967:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1737G>A (p.Arg579=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001528931	2	29519834	2	29296968	1528931	1634700	rs373833989	NC_000002.12:29296967:C:T	single nucleotide variant	synonymous variant	Likely benign	May 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1736G>A (p.Arg579Lys)	ALK	R579K	Neuroblastoma, susceptibility to, 3	VCV002890801	2	29519835	2	29296969	2890801	3044903		NC_000002.12:29296968:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1736G>C (p.Arg579Thr)	ALK	R579T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002452111	2	29519835	2	29296969	2452111	2426751		NC_000002.12:29296968:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1734C>T (p.Gly578=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000998993	2	29519837	2	29296971	998993	988724	rs1666203885	NC_000002.12:29296970:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Mar 12, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1733G>A (p.Gly578Asp)	ALK	G578D	Hereditary cancer-predisposing syndrome	VCV003286405	2	29519838	2	29296972	3286405	3455228		NC_000002.12:29296971:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1733G>T (p.Gly578Val)	ALK	G578V	Neuroblastoma, susceptibility to, 3	VCV000958356	2	29519838	2	29296972	958356	942872	rs1666203993	NC_000002.12:29296971:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1729C>G (p.Gln577Glu)	ALK	Q577E	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000652210	2	29519842	2	29296976	652210	629885	rs1430381834	NC_000002.12:29296975:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1729C>A (p.Gln577Lys)	ALK	Q577K	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538256	2	29519842	2	29296976	538256	518086	rs1430381834	NC_000002.12:29296975:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1728G>A (p.Glu576=)	ALK		Hereditary cancer-predisposing syndrome	VCV002566604	2	29519843	2	29296977	2566604	2734447		NC_000002.12:29296976:C:T	single nucleotide variant	synonymous variant	Likely benign	May 31, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1728G>T (p.Glu576Asp)	ALK	E576D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001042894	2	29519843	2	29296977	1042894	1024459	rs765326883	NC_000002.12:29296976:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1726G>C (p.Glu576Gln)	ALK	E576Q	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001913746	2	29519845	2	29296979	1913746	1970077		NC_000002.12:29296978:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1726G>T (p.Glu576Ter)	ALK	E576*	Neuroblastoma, susceptibility to, 3	VCV000965323	2	29519845	2	29296979	965323	953068	rs750740789	NC_000002.12:29296978:C:A	single nucleotide variant	nonsense	Uncertain significance	Nov 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1725G>C (p.Lys575Asn)	ALK	K575N	not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470771	2	29519846	2	29296980	470771	451072	rs1010580453	NC_000002.12:29296979:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1722G>A (p.Gly574=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001158253	2	29519849	2	29296983	1158253	1133669	rs1666204709	NC_000002.12:29296982:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1720G>C (p.Gly574Arg)	ALK	G574R	Neuroblastoma, susceptibility to, 3	VCV000899329	2	29519851	2	29296985	899329	884684	rs762358335	NC_000002.12:29296984:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 13, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1720G>A (p.Gly574Arg)	ALK	G574R	not provided|Diffuse midline glioma, H3 K27-altered|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470770	2	29519851	2	29296985	470770	451081	rs762358335	NC_000002.12:29296984:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1719C>A (p.Thr573=)	ALK		Hereditary cancer-predisposing syndrome|not provided	VCV000795070	2	29519852	2	29296986	795070	781305	rs74830770	NC_000002.12:29296985:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1719C>T (p.Thr573=)	ALK		not provided|not specified|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000239791	2	29519852	2	29296986	239791	238748	rs74830770	NC_000002.12:29296985:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1718C>G (p.Thr573Ser)	ALK	T573S	Hereditary cancer-predisposing syndrome	VCV002566561	2	29519853	2	29296987	2566561	2734404		NC_000002.12:29296986:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 31, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1718C>A (p.Thr573Asn)	ALK	T573N	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001015782	2	29519853	2	29296987	1015782	1003993	rs1666205088	NC_000002.12:29296986:G:T	single nucleotide variant	missense variant	Uncertain significance	May 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1718C>T (p.Thr573Ile)	ALK	T573I	Neuroblastoma, susceptibility to, 3	VCV000835244	2	29519853	2	29296987	835244	826361	rs1666205088	NC_000002.12:29296986:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1715A>G (p.Lys572Arg)	ALK	K572R	Neuroblastoma, susceptibility to, 3	VCV002703165	2	29519856	2	29296990	2703165	2862861		NC_000002.12:29296989:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1714A>T (p.Lys572Ter)	ALK	K572*	Neuroblastoma, susceptibility to, 3	VCV001466801	2	29519857	2	29296991	1466801	1346428	rs2148231179	NC_000002.12:29296990:T:A	single nucleotide variant	nonsense	Uncertain significance	Aug 5, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1713C>T (p.Asn571=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001131445	2	29519858	2	29296992	1131445	1112756	rs902275025	NC_000002.12:29296991:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1713C>G (p.Asn571Lys)	ALK	N571K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470769	2	29519858	2	29296992	470769	451083	rs902275025	NC_000002.12:29296991:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1710G>T (p.Glu570Asp)	ALK	E570D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001053777	2	29519861	2	29296995	1053777	1041410	rs751328130	NC_000002.12:29296994:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1710G>A (p.Glu570=)	ALK		not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538302	2	29519861	2	29296995	538302	518234	rs751328130	NC_000002.12:29296994:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1709A>C (p.Glu570Ala)	ALK	E570A	Neuroblastoma, susceptibility to, 3	VCV001359097	2	29519862	2	29296996	1359097	1357374	rs1666205563	NC_000002.12:29296995:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1708G>A (p.Glu570Lys)	ALK	E570K	Neuroblastoma, susceptibility to, 3	VCV003654875	2	29519863	2	29296997	3654875	3778970		NC_000002.12:29296996:C:T	single nucleotide variant	missense variant	Uncertain significance	May 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1708G>C (p.Glu570Gln)	ALK	E570Q	Hereditary cancer-predisposing syndrome	VCV001778497	2	29519863	2	29296997	1778497	1834469		NC_000002.12:29296996:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1706T>C (p.Val569Ala)	ALK	V569A	Neuroblastoma, susceptibility to, 3	VCV002676191	2	29519865	2	29296999	2676191	2834612		NC_000002.12:29296998:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1705G>A (p.Val569Met)	ALK	V569M	Neuroblastoma, susceptibility to, 3	VCV000470768	2	29519866	2	29297000	470768	451068	rs754971913	NC_000002.12:29296999:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1704A>G (p.Leu568=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002709707	2	29519867	2	29297001	2709707	2874605		NC_000002.12:29297000:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1704A>C (p.Leu568=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001121854	2	29519867	2	29297001	1121854	1112757	rs2148231200	NC_000002.12:29297000:T:G	single nucleotide variant	synonymous variant	Likely benign	Dec 23, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1703T>C (p.Leu568Pro)	ALK	L568P	Neuroblastoma, susceptibility to, 3	VCV001038149	2	29519868	2	29297002	1038149	1024460	rs1666205873	NC_000002.12:29297001:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1702C>T (p.Leu568=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002817476	2	29519869	2	29297003	2817476	2977287		NC_000002.12:29297002:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1702C>A (p.Leu568Ile)	ALK	L568I	Neuroblastoma, susceptibility to, 3	VCV001043924	2	29519869	2	29297003	1043924	1024461	rs1666205957	NC_000002.12:29297002:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 31, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1701G>C (p.Val567=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000760179	2	29519870	2	29297004	760179	763182	rs1573203701	NC_000002.12:29297003:C:G	single nucleotide variant	synonymous variant	Likely benign	Jun 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1700T>G (p.Val567Gly)	ALK	V567G	Neuroblastoma, susceptibility to, 3	VCV000944737	2	29519871	2	29297005	944737	922724	rs1666206131	NC_000002.12:29297004:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1699G>A (p.Val567Met)	ALK	V567M	Neuroblastoma, susceptibility to, 3	VCV000470767	2	29519872	2	29297006	470767	451069	rs1553406025	NC_000002.12:29297005:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1698G>T (p.Leu566Phe)	ALK	L566F	Hereditary cancer-predisposing syndrome	VCV002566554	2	29519873	2	29297007	2566554	2734397		NC_000002.12:29297006:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1698G>A (p.Leu566=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000665166	2	29519873	2	29297007	665166	629886	rs1558658399	NC_000002.12:29297006:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1695C>T (p.Ser565=)	ALK		Hereditary cancer-predisposing syndrome	VCV001778219	2	29519876	2	29297010	1778219	1838151		NC_000002.12:29297009:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 16, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1693T>A (p.Ser565Thr)	ALK	S565T	Neuroblastoma, susceptibility to, 3	VCV002086677	2	29519878	2	29297012	2086677	2140718		NC_000002.12:29297011:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1690G>T (p.Val564Leu)	ALK	V564L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001778134	2	29519881	2	29297015	1778134	1838066		NC_000002.12:29297014:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1690G>A (p.Val564Met)	ALK	V564M	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001052846	2	29519881	2	29297015	1052846	1041411	rs780939762	NC_000002.12:29297014:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1690G>C (p.Val564Leu)	ALK	V564L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001006113	2	29519881	2	29297015	1006113	988725	rs780939762	NC_000002.12:29297014:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1689C>A (p.Asn563Lys)	ALK	N563K	Neuroblastoma, susceptibility to, 3	VCV001896699	2	29519882	2	29297016	1896699	1956085		NC_000002.12:29297015:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1689C>G (p.Asn563Lys)	ALK	N563K	Neuroblastoma, susceptibility to, 3	VCV001403088	2	29519882	2	29297016	1403088	1392700	rs565743321	NC_000002.12:29297015:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1689C>T (p.Asn563=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000412925	2	29519882	2	29297016	412925	392583	rs565743321	NC_000002.12:29297015:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1685G>T (p.Gly562Val)	ALK	G562V	Neuroblastoma, susceptibility to, 3	VCV002705186	2	29519886	2	29297020	2705186	2860195		NC_000002.12:29297019:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1684_1685del (p.Gly562fs)	ALK	G562fs	Neuroblastoma, susceptibility to, 3	VCV001482321	2	29519886 - 29519887	2	29297020 - 29297021	1482321	1445557	rs1666207064	NC_000002.12:29297019:CCCC:CC	Deletion	frameshift variant	Uncertain significance	Jul 21, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1682G>C (p.Arg561Thr)	ALK	R561T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000954227	2	29519889	2	29297023	954227	942873	rs1666207256	NC_000002.12:29297022:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1682G>A (p.Arg561Lys)	ALK	R561K	Neuroblastoma, susceptibility to, 3	VCV000951251	2	29519889	2	29297023	951251	922725	rs1666207256	NC_000002.12:29297022:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1681A>G (p.Arg561Gly)	ALK	R561G	Neuroblastoma, susceptibility to, 3	VCV002700120	2	29519890	2	29297024	2700120	2858972		NC_000002.12:29297023:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1679_1680insTTTTTTTTTTTTTTTTTTTTNNNNNNNNNNCCTGACCTCATGATCCACCCGCCTCGGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACCGCGCCCGGCCATTCGTGGAGTCTT (p.Leu560delinsPhePhePhePhePhePhePheXaaXaaXaaXaaLeuThrSerTer)	ALK		Neuroblastoma, susceptibility to, 3	VCV003723936	2	29519891 - 29519892	2	29297025 - 29297026	3723936	3860752			Insertion	nonsense	Uncertain significance	Oct 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1680G>A (p.Leu560=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001077381	2	29519891	2	29297025	1077381	1069532	rs1253378000	NC_000002.12:29297024:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1679T>G (p.Leu560Trp)	ALK	L560W	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV002447094	2	29519892	2	29297026	2447094	2422217		NC_000002.12:29297025:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1678T>C (p.Leu560=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003662306	2	29519893	2	29297027	3662306	3794740		NC_000002.12:29297026:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1677C>T (p.Val559=)	ALK		Hereditary cancer-predisposing syndrome	VCV003525142	2	29519894	2	29297028	3525142	3689381		NC_000002.12:29297027:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1676T>A (p.Val559Asp)	ALK	V559D	Neuroblastoma, susceptibility to, 3	VCV002882227	2	29519895	2	29297029	2882227	3042830		NC_000002.12:29297028:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1676T>C (p.Val559Ala)	ALK	V559A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001417603	2	29519895	2	29297029	1417603	1374090	rs2148231259	NC_000002.12:29297028:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1675G>A (p.Val559Ile)	ALK	V559I	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000855607	2	29519896	2	29297030	855607	826362	rs1666207586	NC_000002.12:29297029:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1671T>A (p.Arg557=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000934102	2	29519900	2	29297034	934102	931367	rs1666207701	NC_000002.12:29297033:A:T	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1670G>T (p.Arg557Leu)	ALK	R557L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000965945	2	29519901	2	29297035	965945	953069	rs200468507	NC_000002.12:29297034:C:A	single nucleotide variant	missense variant	Uncertain significance	May 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1670G>A (p.Arg557His)	ALK	R557H	not provided|Neuroblastoma, susceptibility to, 3	VCV000470766	2	29519901	2	29297035	470766	451098	rs200468507	NC_000002.12:29297034:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1669C>T (p.Arg557Cys)	ALK	R557C	Neuroblastoma, susceptibility to, 3	VCV001024948	2	29519902	2	29297036	1024948	1003994	rs200364883	NC_000002.12:29297035:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1669C>G (p.Arg557Gly)	ALK	R557G	Neuroblastoma, susceptibility to, 3	VCV000568005	2	29519902	2	29297036	568005	558047	rs200364883	NC_000002.12:29297035:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1668T>C (p.Ile556=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001633475	2	29519903	2	29297037	1633475	1598400	rs780401491	NC_000002.12:29297036:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 17, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1666A>C (p.Ile556Leu)	ALK	I556L	Neuroblastoma, susceptibility to, 3	VCV002888079	2	29519905	2	29297039	2888079	3054491		NC_000002.12:29297038:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1665C>T (p.Leu555=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470765	2	29519906	2	29297040	470765	450782	rs1553406040	NC_000002.12:29297039:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1663C>T (p.Leu555Phe)	ALK	L555F	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001024513	2	29519908	2	29297042	1024513	1003995	rs769229444	NC_000002.12:29297041:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1662G>A (p.Trp554Ter)	ALK	W554*	Neuroblastoma, susceptibility to, 3	VCV000662447	2	29519909	2	29297043	662447	629887	rs1573203754	NC_000002.12:29297042:C:T	single nucleotide variant	nonsense	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1656G>A (p.Met552Ile)	ALK	M552I	Neuroblastoma, susceptibility to, 3	VCV001009938	2	29519915	2	29297049	1009938	988726	rs1205245551	NC_000002.12:29297048:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1652G>T (p.Arg551Leu)	ALK	R551L	Hereditary cancer-predisposing syndrome	VCV002586707	2	29519919	2	29297053	2586707	2756890		NC_000002.12:29297052:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1652G>A (p.Arg551Gln)	ALK	R551Q	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404361	2	29519919	2	29297053	404361	392641	rs374136388	NC_000002.12:29297052:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1651C>T (p.Arg551Ter)	ALK	R551*	Neuroblastoma, susceptibility to, 3|not provided	VCV000859296	2	29519920	2	29297054	859296	826363	rs1172956542	NC_000002.12:29297053:G:A	single nucleotide variant	nonsense	Uncertain significance	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1650C>T (p.Leu550=)	ALK		Hereditary cancer-predisposing syndrome	VCV001777249	2	29519921	2	29297055	1777249	1831141		NC_000002.12:29297054:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1650C>A (p.Leu550=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538298	2	29519921	2	29297055	538298	518207	rs762374963	NC_000002.12:29297054:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1650C>G (p.Leu550=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470764	2	29519921	2	29297055	470764	450783	rs762374963	NC_000002.12:29297054:G:C	single nucleotide variant	synonymous variant	Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1649T>C (p.Leu550Pro)	ALK	L550P	Hereditary cancer-predisposing syndrome	VCV003223798	2	29519922	2	29297056	3223798	3380821		NC_000002.12:29297055:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1648C>T (p.Leu550Phe)	ALK	L550F	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Ovarian cancer	VCV000412915	2	29519923	2	29297057	412915	392643	rs769821764	NC_000002.12:29297056:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1648-1G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000937332	2	29519924	2	29297058	937332	939890	rs1666209215	NC_000002.12:29297057:C:T	single nucleotide variant	splice acceptor variant	Uncertain significance	Jun 24, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1648-2A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003646684	2	29519925	2	29297059	3646684	3787237		NC_000002.12:29297058:T:C	single nucleotide variant	splice acceptor variant	Uncertain significance	Mar 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1648-5C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002763478	2	29519928	2	29297062	2763478	2925517		NC_000002.12:29297061:G:A	single nucleotide variant	intron variant	Likely benign	Sep 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1648-6T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000957011	2	29519929	2	29297063	957011	959639	rs1349124891	NC_000002.12:29297062:A:C	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1648-7C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001077641	2	29519930	2	29297064	1077641	1069533	rs773367358	NC_000002.12:29297063:G:A	single nucleotide variant	intron variant	Likely benign	Mar 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1648-9C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000847698	2	29519932	2	29297066	847698	850857	rs763269771	NC_000002.12:29297065:G:T	single nucleotide variant	intron variant	Likely benign	Aug 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1648-10G>A	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000239796	2	29519933	2	29297067	239796	238749	rs375646347	NC_000002.12:29297066:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1648-11C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001671335	2	29519934	2	29297068	1671335	1530225	rs751420024	NC_000002.12:29297067:G:A	single nucleotide variant	intron variant	Likely benign	Nov 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1648-15T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001592189	2	29519938	2	29297072	1592189	1643651	rs2148231311	NC_000002.12:29297071:A:C	single nucleotide variant	intron variant	Likely benign	Oct 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1648-16C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001622790	2	29519939	2	29297073	1622790	1627416	rs759295991	NC_000002.12:29297072:G:C	single nucleotide variant	intron variant	Likely benign	Sep 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1648-18C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003708664	2	29519941	2	29297075	3708664	3846853		NC_000002.12:29297074:G:A	single nucleotide variant	intron variant	Likely benign	Apr 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1648-162C>T	ALK		not provided	VCV001180168	2	29520085	2	29297219	1180168	1168916	rs4666194	NC_000002.12:29297218:G:A	single nucleotide variant	intron variant	Benign	Jun 24, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1647+336C>T	ALK		not provided	VCV001231432	2	29540834	2	29317968	1231432	1221393	rs10197663	NC_000002.12:29317967:G:A	single nucleotide variant	intron variant	Benign	Feb 11, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1647+178A>G	ALK		not provided	VCV000676902	2	29540992	2	29318126	676902	659153	rs10189673	NC_000002.12:29318125:T:C	single nucleotide variant	intron variant	Benign	Jun 16, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1647+95T>A	ALK		not provided	VCV001183248	2	29541075	2	29318209	1183248	1170957	rs73920775	NC_000002.12:29318208:A:T	single nucleotide variant	intron variant	Likely benign	Jul 20, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1647+66G>A	ALK		not provided	VCV000676804	2	29541104	2	29318238	676804	659063	rs2276549	NC_000002.12:29318237:C:T	single nucleotide variant	intron variant	Benign	Jun 15, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1647+20T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002955414	2	29541150	2	29318284	2955414	3125317		NC_000002.12:29318283:A:G	single nucleotide variant	intron variant	Likely benign	Jul 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1647+20T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002836887	2	29541150	2	29318284	2836887	2999266		NC_000002.12:29318283:A:C	single nucleotide variant	intron variant	Likely benign	Feb 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1647+17C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002722659	2	29541153	2	29318287	2722659	2891759		NC_000002.12:29318286:G:C	single nucleotide variant	intron variant	Likely benign	Sep 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1647+13G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001671370	2	29541157	2	29318291	1671370	1530260	rs2148247887	NC_000002.12:29318290:C:A	single nucleotide variant	intron variant	Likely benign	Jun 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1647+12T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002778137	2	29541158	2	29318292	2778137	2946631		NC_000002.12:29318291:A:G	single nucleotide variant	intron variant	Likely benign	Sep 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1647+12T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002722704	2	29541158	2	29318292	2722704	2887932		NC_000002.12:29318291:A:C	single nucleotide variant	intron variant	Likely benign	Dec 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1647+11T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002919508	2	29541159	2	29318293	2919508	3072390		NC_000002.12:29318292:A:G	single nucleotide variant	intron variant	Likely benign	Jun 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1647+11T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002866543	2	29541159	2	29318293	2866543	3020151		NC_000002.12:29318292:A:C	single nucleotide variant	intron variant	Likely benign	May 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1647+10C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002741420	2	29541160	2	29318294	2741420	2896172		NC_000002.12:29318293:G:A	single nucleotide variant	intron variant	Likely benign	Aug 7, 2023	criteria provided, single submitter							
NC_000002.11:g.(?_29541160)_(29606735_?)dup	ALK|LOC122756683		Neuroblastoma, susceptibility to, 3	VCV000651257	2	29541160 - 29606735	2	29318294 - 29383869	651257	650827			Duplication		Uncertain significance	Jul 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1647+8T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002887356	2	29541162	2	29318296	2887356	3044061		NC_000002.12:29318295:A:C	single nucleotide variant	intron variant	Likely benign	Sep 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1647+4A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001497321	2	29541166	2	29318300	1497321	1475942	rs2148247925	NC_000002.12:29318299:T:C	single nucleotide variant	intron variant	Uncertain significance	Jun 8, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1647+2C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002836365	2	29541168	2	29318302	2836365	2992352		NC_000002.12:29318301:G:T	single nucleotide variant	splice donor variant	Uncertain significance	Aug 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1645G>A (p.Glu549Lys)	ALK	E549K	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000851756	2	29541172	2	29318306	851756	826364	rs1388997240	NC_000002.12:29318305:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1641A>G (p.Pro547=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001623918	2	29541176	2	29318310	1623918	1594685	rs1488980653	NC_000002.12:29318309:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 15, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1641A>T (p.Pro547=)	ALK		Hereditary cancer-predisposing syndrome	VCV000819731	2	29541176	2	29318310	819731	806912	rs1488980653	NC_000002.12:29318309:T:A	single nucleotide variant	synonymous variant	Likely benign	Aug 2, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1640C>T (p.Pro547Leu)	ALK	P547L	Neuroblastoma, susceptibility to, 3	VCV002169409	2	29541177	2	29318311	2169409	1903356		NC_000002.12:29318310:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1639C>A (p.Pro547Thr)	ALK	P547T	Neuroblastoma, susceptibility to, 3	VCV001488035	2	29541178	2	29318312	1488035	1504744	rs2148247961	NC_000002.12:29318311:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1639C>T (p.Pro547Ser)	ALK	P547S	Neuroblastoma, susceptibility to, 3	VCV001464513	2	29541178	2	29318312	1464513	1446058	rs2148247961	NC_000002.12:29318311:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1639C>G (p.Pro547Ala)	ALK	P547A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001449527	2	29541178	2	29318312	1449527	1416583	rs2148247961	NC_000002.12:29318311:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1638T>A (p.Ser546=)	ALK		Hereditary cancer-predisposing syndrome	VCV002586663	2	29541179	2	29318313	2586663	2756846		NC_000002.12:29318312:A:T	single nucleotide variant	synonymous variant	Likely benign	Jun 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1638T>G (p.Ser546=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001573200	2	29541179	2	29318313	1573200	1573566	rs2148247965	NC_000002.12:29318312:A:C	single nucleotide variant	synonymous variant	Likely benign	Mar 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1637C>G (p.Ser546Cys)	ALK	S546C	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001011551	2	29541180	2	29318314	1011551	988727	rs1666893427	NC_000002.12:29318313:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1635C>T (p.Ser545=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223797	2	29541182	2	29318316	3223797	3380820		NC_000002.12:29318315:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1635C>G (p.Ser545Arg)	ALK	S545R	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000854968	2	29541182	2	29318316	854968	826365	rs1666893501	NC_000002.12:29318315:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1634G>A (p.Ser545Asn)	ALK	S545N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001001211	2	29541183	2	29318317	1001211	988728	rs147033307	NC_000002.12:29318316:C:T	single nucleotide variant	missense variant	Uncertain significance	May 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1630A>C (p.Lys544Gln)	ALK	K544Q	Hereditary cancer-predisposing syndrome	VCV003522518	2	29541187	2	29318321	3522518	3678502		NC_000002.12:29318320:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1629C>T (p.Ile543=)	ALK		Hereditary cancer-predisposing syndrome	VCV001776754	2	29541188	2	29318322	1776754	1834028		NC_000002.12:29318321:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 17, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1628T>C (p.Ile543Thr)	ALK	I543T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001776744	2	29541189	2	29318323	1776744	1834018		NC_000002.12:29318322:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1628T>A (p.Ile543Asn)	ALK	I543N	Neuroblastoma, susceptibility to, 3	VCV001060665	2	29541189	2	29318323	1060665	1041412	rs1666893671	NC_000002.12:29318322:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1627A>G (p.Ile543Val)	ALK	I543V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001776720	2	29541190	2	29318324	1776720	1833994		NC_000002.12:29318323:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1626del (p.Ile543fs)	ALK	I543fs	Neuroblastoma, susceptibility to, 3	VCV002818012	2	29541191	2	29318325	2818012	2987653		NC_000002.12:29318324:C:	Deletion	frameshift variant	Uncertain significance	Oct 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1626G>A (p.Pro542=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000703721	2	29541191	2	29318325	703721	691146	rs143916398	NC_000002.12:29318324:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1626G>C (p.Pro542=)	ALK		Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3|not specified	VCV000335706	2	29541191	2	29318325	335706	286759	rs143916398	NC_000002.12:29318324:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1625C>G (p.Pro542Arg)	ALK	P542R	Neuroblastoma, susceptibility to, 3	VCV002151222	2	29541192	2	29318326	2151222	1884789		NC_000002.12:29318325:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1625C>T (p.Pro542Leu)	ALK	P542L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470763	2	29541192	2	29318326	470763	451074	rs372456536	NC_000002.12:29318325:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1624C>T (p.Pro542Ser)	ALK	P542S	Hereditary cancer-predisposing syndrome	VCV002452120	2	29541193	2	29318327	2452120	2426760		NC_000002.12:29318326:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1623A>G (p.Ala541=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001152188	2	29541194	2	29318328	1152188	1133670	rs948499342	NC_000002.12:29318327:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1622C>T (p.Ala541Val)	ALK	A541V	Neuroblastoma, susceptibility to, 3	VCV001421026	2	29541195	2	29318329	1421026	1399753	rs1553409296	NC_000002.12:29318328:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1622C>A (p.Ala541Glu)	ALK	A541E	Neuroblastoma, susceptibility to, 3	VCV000470762	2	29541195	2	29318329	470762	451076	rs1553409296	NC_000002.12:29318328:G:T	single nucleotide variant	missense variant	Uncertain significance	May 18, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.1621G>A (p.Ala541Thr)	ALK	A541T	Hereditary cancer-predisposing syndrome	VCV003285167	2	29541196	2	29318330	3285167	3444345		NC_000002.12:29318329:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1621G>C (p.Ala541Pro)	ALK	A541P	Hereditary cancer-predisposing syndrome	VCV003223796	2	29541196	2	29318330	3223796	3380819		NC_000002.12:29318329:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1617T>A (p.Phe539Leu)	ALK	F539L	Neuroblastoma, susceptibility to, 3	VCV003648425	2	29541200	2	29318334	3648425	3787703		NC_000002.12:29318333:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1614G>T (p.Thr538=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001106679	2	29541203	2	29318337	1106679	1091263	rs374205057	NC_000002.12:29318336:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1614G>A (p.Thr538=)	ALK		Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000702121	2	29541203	2	29318337	702121	686188	rs374205057	NC_000002.12:29318336:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1613C>A (p.Thr538Lys)	ALK	T538K	Neuroblastoma, susceptibility to, 3	VCV002054361	2	29541204	2	29318338	2054361	2112243		NC_000002.12:29318337:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1613C>T (p.Thr538Met)	ALK	T538M	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470761	2	29541204	2	29318338	470761	451078	rs775302364	NC_000002.12:29318337:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1610C>T (p.Ala537Val)	ALK	A537V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002814462	2	29541207	2	29318341	2814462	2976415		NC_000002.12:29318340:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1609G>T (p.Ala537Ser)	ALK	A537S	Neuroblastoma, susceptibility to, 3	VCV002703396	2	29541208	2	29318342	2703396	2859687		NC_000002.12:29318341:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1609G>A (p.Ala537Thr)	ALK	A537T	Neuroblastoma, susceptibility to, 3	VCV002005566	2	29541208	2	29318342	2005566	2052330		NC_000002.12:29318341:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1605C>G (p.Thr535=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002844318	2	29541212	2	29318346	2844318	3007959		NC_000002.12:29318345:G:C	single nucleotide variant	synonymous variant	Likely benign	Mar 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1604C>A (p.Thr535Asn)	ALK	T535N	Neuroblastoma, susceptibility to, 3	VCV003671665	2	29541213	2	29318347	3671665	3803803		NC_000002.12:29318346:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1604C>G (p.Thr535Ser)	ALK	T535S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003285785	2	29541213	2	29318347	3285785	3444525		NC_000002.12:29318346:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1604C>T (p.Thr535Ile)	ALK	T535I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001776240	2	29541213	2	29318347	1776240	1837470		NC_000002.12:29318346:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1601T>C (p.Val534Ala)	ALK	V534A	Neuroblastoma, susceptibility to, 3	VCV000664839	2	29541216	2	29318350	664839	629888	rs1573223031	NC_000002.12:29318349:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1599A>G (p.Thr533=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000795244	2	29541218	2	29318352	795244	781306	rs1334495224	NC_000002.12:29318351:T:C	single nucleotide variant	synonymous variant	Likely benign	Nov 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1598C>T (p.Thr533Ile)	ALK	T533I	Neuroblastoma, susceptibility to, 3	VCV002420629	2	29541219	2	29318353	2420629	1942001		NC_000002.12:29318352:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1597A>G (p.Thr533Ala)	ALK	T533A	Neuroblastoma, susceptibility to, 3	VCV003642207	2	29541220	2	29318354	3642207	3769064		NC_000002.12:29318353:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1595C>A (p.Ala532Asp)	ALK	A532D	Hereditary cancer-predisposing syndrome	VCV003524686	2	29541222	2	29318356	3524686	3679350		NC_000002.12:29318355:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1594G>A (p.Ala532Thr)	ALK	A532T	Hereditary cancer-predisposing syndrome	VCV003525441	2	29541223	2	29318357	3525441	3685797		NC_000002.12:29318356:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1593T>G (p.Ser531Arg)	ALK	S531R	Neuroblastoma, susceptibility to, 3	VCV000969796	2	29541224	2	29318358	969796	953070	rs763979460	NC_000002.12:29318357:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1593T>C (p.Ser531=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000697530	2	29541224	2	29318358	697530	686189	rs763979460	NC_000002.12:29318357:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1591A>G (p.Ser531Gly)	ALK	S531G	Neuroblastoma, susceptibility to, 3	VCV000861839	2	29541226	2	29318360	861839	826366	rs1666895080	NC_000002.12:29318359:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1589A>C (p.Glu530Ala)	ALK	E530A	Hereditary cancer-predisposing syndrome	VCV002624790	2	29541228	2	29318362	2624790	2790285		NC_000002.12:29318361:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1589A>G (p.Glu530Gly)	ALK	E530G	Neuroblastoma, susceptibility to, 3	VCV001007209	2	29541228	2	29318362	1007209	988729	rs1666895159	NC_000002.12:29318361:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1588G>C (p.Glu530Gln)	ALK	E530Q	Neuroblastoma, susceptibility to, 3	VCV000573439	2	29541229	2	29318363	573439	558394	rs1558667792	NC_000002.12:29318362:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1585T>G (p.Ser529Ala)	ALK	S529A	Neuroblastoma, susceptibility to, 3	VCV001024922	2	29541232	2	29318366	1024922	1003996	rs1666895485	NC_000002.12:29318365:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1584T>C (p.Ala528=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000697157	2	29541233	2	29318367	697157	683499	rs368877224	NC_000002.12:29318366:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1583C>T (p.Ala528Val)	ALK	A528V	Neuroblastoma, susceptibility to, 3	VCV003723354	2	29541234	2	29318368	3723354	3850565		NC_000002.12:29318367:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1582G>A (p.Ala528Thr)	ALK	A528T	Neuroblastoma, susceptibility to, 3|Familial isolated pituitary adenoma|Hereditary cancer-predisposing syndrome	VCV000580080	2	29541235	2	29318369	580080	558396	rs758494304	NC_000002.12:29318368:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1581C>G (p.Pro527=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000772976	2	29541236	2	29318370	772976	697548	rs141720931	NC_000002.12:29318369:G:C	single nucleotide variant	synonymous variant	Likely benign	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1581C>T (p.Pro527=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000412927	2	29541236	2	29318370	412927	392585	rs141720931	NC_000002.12:29318369:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1580C>G (p.Pro527Arg)	ALK	P527R	Neuroblastoma, susceptibility to, 3	VCV000651636	2	29541237	2	29318371	651636	629889	rs781414872	NC_000002.12:29318370:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1579C>T (p.Pro527Ser)	ALK	P527S	Neuroblastoma, susceptibility to, 3	VCV002766981	2	29541238	2	29318372	2766981	2926425		NC_000002.12:29318371:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1579C>A (p.Pro527Thr)	ALK	P527T	Neuroblastoma, susceptibility to, 3	VCV002180758	2	29541238	2	29318372	2180758	1909574		NC_000002.12:29318371:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1579C>G (p.Pro527Ala)	ALK	P527A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002156651	2	29541238	2	29318372	2156651	1886322		NC_000002.12:29318371:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1578C>A (p.Val526=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001562944	2	29541239	2	29318373	1562944	1643355	rs1553409325	NC_000002.12:29318372:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1578C>T (p.Val526=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470760	2	29541239	2	29318373	470760	451079	rs1553409325	NC_000002.12:29318372:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1577T>A (p.Val526Asp)	ALK	V526D	Hereditary cancer-predisposing syndrome	VCV001775617	2	29541240	2	29318374	1775617	1830814		NC_000002.12:29318373:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1576G>A (p.Val526Ile)	ALK	V526I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001420296	2	29541241	2	29318375	1420296	1503075	rs749779880	NC_000002.12:29318374:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1575T>C (p.Asp525=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003681074	2	29541242	2	29318376	3681074	3814816		NC_000002.12:29318375:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1574A>G (p.Asp525Gly)	ALK	D525G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV001522686	2	29541243	2	29318377	1522686	1459881	rs1666896402	NC_000002.12:29318376:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1572T>C (p.Thr524=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000763495	2	29541245	2	29318379	763495	763183	rs1573223096	NC_000002.12:29318378:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 29, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1571C>T (p.Thr524Ile)	ALK	T524I	Neuroblastoma, susceptibility to, 3	VCV003630205	2	29541246	2	29318380	3630205	3769546		NC_000002.12:29318379:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1571C>G (p.Thr524Ser)	ALK	T524S	Neuroblastoma, susceptibility to, 3	VCV001010396	2	29541246	2	29318380	1010396	988730	rs771205105	NC_000002.12:29318379:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1569C>G (p.Thr523=)	ALK		Hereditary cancer-predisposing syndrome	VCV002586679	2	29541248	2	29318382	2586679	2756862		NC_000002.12:29318381:G:C	single nucleotide variant	synonymous variant	Likely benign	Jul 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1569C>T (p.Thr523=)	ALK		Hereditary cancer-predisposing syndrome	VCV001775440	2	29541248	2	29318382	1775440	1830637		NC_000002.12:29318381:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 16, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1569C>A (p.Thr523=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001149789	2	29541248	2	29318382	1149789	1133671	rs1396066431	NC_000002.12:29318381:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1568C>A (p.Thr523Asn)	ALK	T523N	Neuroblastoma, susceptibility to, 3	VCV002705795	2	29541249	2	29318383	2705795	2856932		NC_000002.12:29318382:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1568C>T (p.Thr523Ile)	ALK	T523I	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538204	2	29541249	2	29318383	538204	518089	rs1553409330	NC_000002.12:29318382:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1566T>C (p.Ser522=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470759	2	29541251	2	29318385	470759	451080	rs774478966	NC_000002.12:29318384:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1565G>A (p.Ser522Asn)	ALK	S522N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000961664	2	29541252	2	29318386	961664	942874	rs1553409333	NC_000002.12:29318385:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1565G>T (p.Ser522Ile)	ALK	S522I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470758	2	29541252	2	29318386	470758	451091	rs1553409333	NC_000002.12:29318385:C:A	single nucleotide variant	missense variant	Uncertain significance	May 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1564A>G (p.Ser522Gly)	ALK	S522G	Neuroblastoma, susceptibility to, 3	VCV000965250	2	29541253	2	29318387	965250	953071	rs1573223126	NC_000002.12:29318386:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1564A>T (p.Ser522Cys)	ALK	S522C	Neuroblastoma, susceptibility to, 3	VCV000639685	2	29541253	2	29318387	639685	629890	rs1573223126	NC_000002.12:29318386:T:A	single nucleotide variant	missense variant	Uncertain significance	May 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1563C>T (p.Leu521=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000412922	2	29541254	2	29318388	412922	392959	rs79904886	NC_000002.12:29318387:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1562T>C (p.Leu521Pro)	ALK	L521P	Neuroblastoma, susceptibility to, 3	VCV002107121	2	29541255	2	29318389	2107121	2170175		NC_000002.12:29318388:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1561C>T (p.Leu521Phe)	ALK	L521F	Neuroblastoma, susceptibility to, 3	VCV000942309	2	29541256	2	29318390	942309	931368	rs772274018	NC_000002.12:29318389:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1559T>C (p.Leu520Ser)	ALK	L520S	Neuroblastoma, susceptibility to, 3	VCV003726108	2	29541258	2	29318392	3726108	3858016		NC_000002.12:29318391:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1559T>G (p.Leu520Trp)	ALK	L520W	Hereditary cancer-predisposing syndrome	VCV001775218	2	29541258	2	29318392	1775218	1833803		NC_000002.12:29318391:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1557A>G (p.Leu519=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001775169	2	29541260	2	29318394	1775169	1833754		NC_000002.12:29318393:T:C	single nucleotide variant	synonymous variant	Likely benign	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1555C>T (p.Leu519=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000412921	2	29541262	2	29318396	412921	392646	rs1060503878	NC_000002.12:29318395:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1554T>C (p.Ala518=)	ALK		not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000701662	2	29541263	2	29318397	701662	686190	rs376644900	NC_000002.12:29318396:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1552G>A (p.Ala518Thr)	ALK	A518T	Neuroblastoma, susceptibility to, 3	VCV003638420	2	29541265	2	29318399	3638420	3774715		NC_000002.12:29318398:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1552G>T (p.Ala518Ser)	ALK	A518S	Neuroblastoma, susceptibility to, 3	VCV002190557	2	29541265	2	29318399	2190557	1915373		NC_000002.12:29318398:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1552G>C (p.Ala518Pro)	ALK	A518P	Neuroblastoma, susceptibility to, 3	VCV000999264	2	29541265	2	29318399	999264	988731	rs1666897900	NC_000002.12:29318398:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1551T>C (p.His517=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001090997	2	29541266	2	29318400	1090997	1069534	rs763856615	NC_000002.12:29318399:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1550A>G (p.His517Arg)	ALK	H517R	Familial isolated pituitary adenoma|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000335707	2	29541267	2	29318401	335707	286765	rs367674546	NC_000002.12:29318400:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 12, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1548C>T (p.Asp516=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000797863	2	29541269	2	29318403	797863	781307	rs1573223163	NC_000002.12:29318402:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 7, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1547A>G (p.Asp516Gly)	ALK	D516G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470757	2	29541270	2	29318404	470757	451099	rs761724656	NC_000002.12:29318403:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1547-1G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002971530	2	29541271	2	29318405	2971530	3129323		NC_000002.12:29318404:C:T	single nucleotide variant	splice acceptor variant	Uncertain significance	Feb 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1547-4C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003730129	2	29541274	2	29318408	3730129	3862199		NC_000002.12:29318407:G:C	single nucleotide variant	intron variant	Likely benign	Aug 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1547-5C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003706112	2	29541275	2	29318409	3706112	3839565		NC_000002.12:29318408:G:C	single nucleotide variant	intron variant	Likely benign	May 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1547-5C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000700254	2	29541275	2	29318409	700254	689715	rs764739691	NC_000002.12:29318408:G:A	single nucleotide variant	intron variant	Benign	Nov 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1547-6T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000848338	2	29541276	2	29318410	848338	850859	rs1249683834	NC_000002.12:29318409:A:C	single nucleotide variant	intron variant	Likely benign	Oct 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1547-7C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002785712	2	29541277	2	29318411	2785712	2945559		NC_000002.12:29318410:G:A	single nucleotide variant	intron variant	Likely benign	Dec 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1547-9C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001938997	2	29541279	2	29318413	1938997	2004324		NC_000002.12:29318412:G:A	single nucleotide variant	intron variant	Likely benign	Aug 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1547-12C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001580275	2	29541282	2	29318416	1580275	1653098	rs2148248345	NC_000002.12:29318415:G:C	single nucleotide variant	intron variant	Likely benign	May 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1547-13T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002989081	2	29541283	2	29318417	2989081	3154556		NC_000002.12:29318416:A:G	single nucleotide variant	intron variant	Likely benign	Sep 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1547-16T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002167346	2	29541286	2	29318420	2167346	1906466		NC_000002.12:29318419:A:G	single nucleotide variant	intron variant	Likely benign	Jul 28, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1547-17C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002120986	2	29541287	2	29318421	2120986	2184038		NC_000002.12:29318420:G:A	single nucleotide variant	intron variant	Likely benign	Apr 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1547-29G>A	ALK		not provided	VCV001203378	2	29541299	2	29318433	1203378	1193148	rs144545604	NC_000002.12:29318432:C:T	single nucleotide variant	intron variant	Likely benign	Jun 21, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1547-166del	ALK		not provided	VCV001245833	2	29541436	2	29318570	1245833	1234502	rs71403658	NC_000002.12:29318569:TTTTTTTTTTTTTTT:TTTTTTTTTTTTTT	Deletion	intron variant	Benign	Aug 9, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1547-167_1547-166del	ALK		not provided	VCV001178888	2	29541436 - 29541437	2	29318570 - 29318571	1178888	1167955	rs71403658	NC_000002.12:29318569:TTTTTTTTTTTTTTT:TTTTTTTTTTTTT	Deletion	intron variant	Likely benign	Aug 10, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1546+103G>A	ALK		not provided	VCV000676838	2	29543514	2	29320648	676838	659175	rs12151564	NC_000002.12:29320647:C:T	single nucleotide variant	intron variant	Benign	Jun 20, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1546+17G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001619447	2	29543600	2	29320734	1619447	1614995	rs373690440	NC_000002.12:29320733:C:T	single nucleotide variant	intron variant	Likely benign	Oct 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1546+16T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001603246	2	29543601	2	29320735	1603246	1524320	rs2148250809	NC_000002.12:29320734:A:G	single nucleotide variant	intron variant	Likely benign	Nov 19, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1546+11T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002715724	2	29543606	2	29320740	2715724	2872849		NC_000002.12:29320739:A:G	single nucleotide variant	intron variant	Likely benign	Feb 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1546+9_1546+10del	ALK		Neuroblastoma, susceptibility to, 3	VCV001955615	2	29543607 - 29543608	2	29320741 - 29320742	1955615	2008440		NC_000002.12:29320740:GC:	Deletion	intron variant	Likely benign	Jun 30, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1546+9G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002764910	2	29543608	2	29320742	2764910	2928676		NC_000002.12:29320741:C:G	single nucleotide variant	intron variant	Likely benign	Jun 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1546+9G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001572628	2	29543608	2	29320742	1572628	1658247	rs2148250819	NC_000002.12:29320741:C:A	single nucleotide variant	intron variant	Likely benign	Oct 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1546+8T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001634547	2	29543609	2	29320743	1634547	1546500	rs2148250821	NC_000002.12:29320742:A:G	single nucleotide variant	intron variant	Likely benign	May 12, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1546+7C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001996566	2	29543610	2	29320744	1996566	2053641		NC_000002.12:29320743:G:T	single nucleotide variant	intron variant	Likely benign	May 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1546+7C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001578470	2	29543610	2	29320744	1578470	1587938	rs1275181342	NC_000002.12:29320743:G:C	single nucleotide variant	intron variant	Likely benign	Aug 16, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1546+7C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000538311	2	29543610	2	29320744	538311	518096	rs1275181342	NC_000002.12:29320743:G:A	single nucleotide variant	intron variant	Likely benign	Oct 16, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.1546+6A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002801368	2	29543611	2	29320745	2801368	2959894		NC_000002.12:29320744:T:C	single nucleotide variant	intron variant	Uncertain significance	Jun 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1546+4C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000538299	2	29543613	2	29320747	538299	518236	rs1553409762	NC_000002.12:29320746:G:A	single nucleotide variant	intron variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1546+1G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002731728	2	29543616	2	29320750	2731728	2890483		NC_000002.12:29320749:C:G	single nucleotide variant	splice donor variant	Uncertain significance	Mar 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1546+1G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001363088	2	29543616	2	29320750	1363088	1396408	rs2148250829	NC_000002.12:29320749:C:T	single nucleotide variant	splice donor variant	Uncertain significance	Jun 22, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1546G>A (p.Asp516Asn)	ALK	D516N	Neuroblastoma, susceptibility to, 3	VCV002203044	2	29543617	2	29320751	2203044	1925274		NC_000002.12:29320750:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1545A>C (p.Gln515His)	ALK	Q515H	Neuroblastoma, susceptibility to, 3	VCV002095722	2	29543618	2	29320752	2095722	2149639		NC_000002.12:29320751:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1545A>G (p.Gln515=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001428892	2	29543618	2	29320752	1428892	1457856	rs2148250832	NC_000002.12:29320751:T:C	single nucleotide variant	synonymous variant	Uncertain significance	May 18, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1544A>G (p.Gln515Arg)	ALK	Q515R	Neuroblastoma, susceptibility to, 3	VCV001717242	2	29543619	2	29320753	1717242	1776067		NC_000002.12:29320752:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1543C>G (p.Gln515Glu)	ALK	Q515E	Neuroblastoma, susceptibility to, 3	VCV000855138	2	29543620	2	29320754	855138	826367	rs1485228012	NC_000002.12:29320753:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1542C>T (p.His514=)	ALK		Hereditary cancer-predisposing syndrome	VCV002566600	2	29543621	2	29320755	2566600	2734443		NC_000002.12:29320754:G:A	single nucleotide variant	synonymous variant	Likely benign	May 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1542C>A (p.His514Gln)	ALK	H514Q	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001513637	2	29543621	2	29320755	1513637	1468826	rs2148250838	NC_000002.12:29320754:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1539C>T (p.Asp513=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223794	2	29543624	2	29320758	3223794	3380817		NC_000002.12:29320757:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1537G>C (p.Asp513His)	ALK	D513H	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001774744	2	29543626	2	29320760	1774744	1837280		NC_000002.12:29320759:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1536G>A (p.Gln512=)	ALK		Hereditary cancer-predisposing syndrome	VCV002566588	2	29543627	2	29320761	2566588	2734431		NC_000002.12:29320760:C:T	single nucleotide variant	synonymous variant	Likely benign	May 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1535A>G (p.Gln512Arg)	ALK	Q512R	Neuroblastoma, susceptibility to, 3	VCV003658368	2	29543628	2	29320762	3658368	3796789		NC_000002.12:29320761:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1530G>T (p.Arg510=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002029281	2	29543633	2	29320767	2029281	2082073		NC_000002.12:29320766:C:A	single nucleotide variant	synonymous variant	Likely benign	Sep 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1530G>A (p.Arg510=)	ALK		Hereditary cancer-predisposing syndrome	VCV001774621	2	29543633	2	29320767	1774621	1837159		NC_000002.12:29320766:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 9, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1529G>A (p.Arg510Gln)	ALK	R510Q	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000569256	2	29543634	2	29320768	569256	558049	rs776351932	NC_000002.12:29320767:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1528C>G (p.Arg510Gly)	ALK	R510G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001353593	2	29543635	2	29320769	1353593	1499591	rs201449759	NC_000002.12:29320768:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1528C>T (p.Arg510Trp)	ALK	R510W	not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470755	2	29543635	2	29320769	470755	450784	rs201449759	NC_000002.12:29320768:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1525G>C (p.Ala509Pro)	ALK	A509P	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001039517	2	29543638	2	29320772	1039517	1024462	rs772615782	NC_000002.12:29320771:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1524T>G (p.Asp508Glu)	ALK	D508E	Hereditary cancer-predisposing syndrome	VCV001774509	2	29543639	2	29320773	1774509	1837048		NC_000002.12:29320772:A:C	single nucleotide variant	missense variant	Uncertain significance	May 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1524T>C (p.Asp508=)	ALK		Hereditary cancer-predisposing syndrome	VCV001774506	2	29543639	2	29320773	1774506	1837045		NC_000002.12:29320772:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 31, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1523A>T (p.Asp508Val)	ALK	D508V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001417233	2	29543640	2	29320774	1417233	1377600	rs995433670	NC_000002.12:29320773:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1522G>T (p.Asp508Tyr)	ALK	D508Y	Neuroblastoma, susceptibility to, 3	VCV002726973	2	29543641	2	29320775	2726973	2886163		NC_000002.12:29320774:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1519A>C (p.Lys507Gln)	ALK	K507Q	Neuroblastoma, susceptibility to, 3	VCV002133501	2	29543644	2	29320778	2133501	2190190		NC_000002.12:29320777:T:G	single nucleotide variant	missense variant	Uncertain significance	May 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1517T>C (p.Leu506Pro)	ALK	L506P	Neuroblastoma, susceptibility to, 3|Familial isolated pituitary adenoma	VCV000538198	2	29543646	2	29320780	538198	518210	rs762569153	NC_000002.12:29320779:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1516C>T (p.Leu506=)	ALK		Hereditary cancer-predisposing syndrome	VCV002452113	2	29543647	2	29320781	2452113	2426753		NC_000002.12:29320780:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1516C>G (p.Leu506Val)	ALK	L506V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000839587	2	29543647	2	29320781	839587	826368	rs765773161	NC_000002.12:29320780:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1515C>A (p.Thr505=)	ALK		Hereditary cancer-predisposing syndrome	VCV003524584	2	29543648	2	29320782	3524584	3679249		NC_000002.12:29320781:G:T	single nucleotide variant	synonymous variant	Likely benign	Sep 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1514C>T (p.Thr505Ile)	ALK	T505I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538214	2	29543649	2	29320783	538214	518139	rs751321667	NC_000002.12:29320782:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1513A>T (p.Thr505Ser)	ALK	T505S	Neuroblastoma, susceptibility to, 3	VCV003653963	2	29543650	2	29320784	3653963	3785966		NC_000002.12:29320783:T:A	single nucleotide variant	missense variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1512G>A (p.Arg504=)	ALK		Hereditary cancer-predisposing syndrome	VCV001692773	2	29543651	2	29320785	1692773	1685213	rs1558669722	NC_000002.12:29320784:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1511G>A (p.Arg504Lys)	ALK	R504K	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000858007	2	29543652	2	29320786	858007	826369	rs1667011797	NC_000002.12:29320785:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1508T>C (p.Val503Ala)	ALK	V503A	Hereditary cancer-predisposing syndrome	VCV003223793	2	29543655	2	29320789	3223793	3380816		NC_000002.12:29320788:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1507G>A (p.Val503Ile)	ALK	V503I	not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470754	2	29543656	2	29320790	470754	451101	rs1229156257	NC_000002.12:29320789:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1505A>G (p.Gln502Arg)	ALK	Q502R	Neuroblastoma, susceptibility to, 3	VCV003722738	2	29543658	2	29320792	3722738	3857250		NC_000002.12:29320791:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1504C>A (p.Gln502Lys)	ALK	Q502K	Neuroblastoma, susceptibility to, 3	VCV002799606	2	29543659	2	29320793	2799606	2959430		NC_000002.12:29320792:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1504C>T (p.Gln502Ter)	ALK	Q502*	Neuroblastoma, susceptibility to, 3	VCV001368872	2	29543659	2	29320793	1368872	1417762	rs2148250921	NC_000002.12:29320792:G:A	single nucleotide variant	nonsense	Uncertain significance	Nov 2, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1502G>T (p.Trp501Leu)	ALK	W501L	Neuroblastoma, susceptibility to, 3	VCV000945259	2	29543661	2	29320795	945259	922726	rs1667012482	NC_000002.12:29320794:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1500A>C (p.Gln500His)	ALK	Q500H	Neuroblastoma, susceptibility to, 3	VCV000943183	2	29543663	2	29320797	943183	931369	rs2293564	NC_000002.12:29320796:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1500A>G (p.Gln500=)	ALK		Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3|not specified	VCV000259266	2	29543663	2	29320797	259266	250720	rs2293564	NC_000002.12:29320796:T:C	single nucleotide variant	synonymous variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1497T>A (p.Pro499=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001634381	2	29543666	2	29320800	1634381	1632468	rs2148250933	NC_000002.12:29320799:A:T	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1496C>A (p.Pro499His)	ALK	P499H	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001064267	2	29543667	2	29320801	1064267	1041413	rs1558669753	NC_000002.12:29320800:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1496C>T (p.Pro499Leu)	ALK	P499L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000570555	2	29543667	2	29320801	570555	558051	rs1558669753	NC_000002.12:29320800:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1495C>T (p.Pro499Ser)	ALK	P499S	Neuroblastoma, susceptibility to, 3	VCV003656169	2	29543668	2	29320802	3656169	3783036		NC_000002.12:29320801:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1495C>A (p.Pro499Thr)	ALK	P499T	Hereditary cancer-predisposing syndrome	VCV003524644	2	29543668	2	29320802	3524644	3679308		NC_000002.12:29320801:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1494T>C (p.Thr498=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002987813	2	29543669	2	29320803	2987813	3150658		NC_000002.12:29320802:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1493C>A (p.Thr498Asn)	ALK	T498N	Hereditary cancer-predisposing syndrome	VCV002452135	2	29543670	2	29320804	2452135	2426775		NC_000002.12:29320803:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1492A>C (p.Thr498Pro)	ALK	T498P	Hereditary cancer-predisposing syndrome	VCV003524378	2	29543671	2	29320805	3524378	3679043		NC_000002.12:29320804:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1492A>T (p.Thr498Ser)	ALK	T498S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000836442	2	29543671	2	29320805	836442	826370	rs1667013379	NC_000002.12:29320804:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1491C>T (p.His497=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003727725	2	29543672	2	29320806	3727725	3858348		NC_000002.12:29320805:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1489C>T (p.His497Tyr)	ALK	H497Y	not provided|Neuroblastoma, susceptibility to, 3	VCV001319123	2	29543674	2	29320808	1319123	1309376	rs2148250941	NC_000002.12:29320807:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2021	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1488C>A (p.Pro496=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001132484	2	29543675	2	29320809	1132484	1112759	rs1189878579	NC_000002.12:29320808:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1488C>G (p.Pro496=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001129814	2	29543675	2	29320809	1129814	1112758	rs1189878579	NC_000002.12:29320808:G:C	single nucleotide variant	synonymous variant	Likely benign	Apr 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1487C>T (p.Pro496Leu)	ALK	P496L	Neuroblastoma, susceptibility to, 3	VCV001035977	2	29543676	2	29320810	1035977	1024463	rs1231969163	NC_000002.12:29320809:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1482G>T (p.Leu494=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002102864	2	29543681	2	29320815	2102864	2161924		NC_000002.12:29320814:C:A	single nucleotide variant	synonymous variant	Likely benign	Feb 24, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1482G>A (p.Leu494=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001556681	2	29543681	2	29320815	1556681	1592825	rs1573227401	NC_000002.12:29320814:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1482G>C (p.Leu494=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000757936	2	29543681	2	29320815	757936	763184	rs1573227401	NC_000002.12:29320814:C:G	single nucleotide variant	synonymous variant	Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1479A>G (p.Thr493=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001646294	2	29543684	2	29320818	1646294	1533864	rs757874850	NC_000002.12:29320817:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 3, 2021	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1476C>A (p.Gly492=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001531577	2	29543687	2	29320821	1531577	1666073	rs1667014321	NC_000002.12:29320820:G:T	single nucleotide variant	synonymous variant	Likely benign	Apr 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1476C>T (p.Gly492=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001360073	2	29543687	2	29320821	1360073	1473946	rs1667014321	NC_000002.12:29320820:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Jun 9, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1474G>A (p.Gly492Ser)	ALK	G492S	Neuroblastoma, susceptibility to, 3	VCV001440362	2	29543689	2	29320823	1440362	1461648	rs1667014493	NC_000002.12:29320822:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1474G>T (p.Gly492Cys)	ALK	G492C	Neuroblastoma, susceptibility to, 3	VCV001377999	2	29543689	2	29320823	1377999	1469804	rs1667014493	NC_000002.12:29320822:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1474G>C (p.Gly492Arg)	ALK	G492R	Neuroblastoma, susceptibility to, 3	VCV000972566	2	29543689	2	29320823	972566	953072	rs1667014493	NC_000002.12:29320822:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1473A>T (p.Gln491His)	ALK	Q491H	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV001471963	2	29543690	2	29320824	1471963	1385111	rs1573227409	NC_000002.12:29320823:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1472A>C (p.Gln491Pro)	ALK	Q491P	Hereditary cancer-predisposing syndrome	VCV001773379	2	29543691	2	29320825	1773379	1833273		NC_000002.12:29320824:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1469C>A (p.Thr490Asn)	ALK	T490N	Hereditary cancer-predisposing syndrome	VCV002452109	2	29543694	2	29320828	2452109	2426749		NC_000002.12:29320827:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1467G>C (p.Trp489Cys)	ALK	W489C	Neuroblastoma, susceptibility to, 3	VCV003712747	2	29543696	2	29320830	3712747	3844457		NC_000002.12:29320829:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1464C>T (p.Gly488=)	ALK		Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3|not specified	VCV000259265	2	29543699	2	29320833	259265	250721	rs56165377	NC_000002.12:29320832:G:A	single nucleotide variant	synonymous variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1463G>A (p.Gly488Asp)	ALK	G488D	Neuroblastoma, susceptibility to, 3	VCV002172963	2	29543700	2	29320834	2172963	1904325		NC_000002.12:29320833:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1461T>C (p.Cys487=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002699659	2	29543702	2	29320836	2699659	2861932		NC_000002.12:29320835:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1460G>A (p.Cys487Tyr)	ALK	C487Y	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000965181	2	29543703	2	29320837	965181	953073	rs1667015469	NC_000002.12:29320836:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1459T>G (p.Cys487Gly)	ALK	C487G	Neuroblastoma, susceptibility to, 3	VCV002779556	2	29543704	2	29320838	2779556	2937253		NC_000002.12:29320837:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1459T>A (p.Cys487Ser)	ALK	C487S	Neuroblastoma, susceptibility to, 3	VCV001515606	2	29543704	2	29320838	1515606	1505470	rs2148251026	NC_000002.12:29320837:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1458C>T (p.Phe486=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001673902	2	29543705	2	29320839	1673902	1649202	rs1667015627	NC_000002.12:29320838:G:A	single nucleotide variant	synonymous variant	Likely benign	May 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1456T>C (p.Phe486Leu)	ALK	F486L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001718683	2	29543707	2	29320841	1718683	1776187		NC_000002.12:29320840:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1455C>T (p.Gly485=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001773037	2	29543708	2	29320842	1773037	1836880		NC_000002.12:29320841:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1454G>C (p.Gly485Ala)	ALK	G485A	Hereditary cancer-predisposing syndrome	VCV003524464	2	29543709	2	29320843	3524464	3679129		NC_000002.12:29320842:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1452T>C (p.Asp484=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001107636	2	29543711	2	29320845	1107636	1091264	rs750873368	NC_000002.12:29320844:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1447G>C (p.Glu483Gln)	ALK	E483Q	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000651397	2	29543716	2	29320850	651397	629891	rs1453170969	NC_000002.12:29320849:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 13, 2022	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1446T>G (p.Phe482Leu)	ALK	F482L	Neuroblastoma, susceptibility to, 3	VCV001046422	2	29543717	2	29320851	1046422	1024464	rs1174777663	NC_000002.12:29320850:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1443C>G (p.Asn481Lys)	ALK	N481K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002161862	2	29543720	2	29320854	2161862	1884250		NC_000002.12:29320853:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1443C>A (p.Asn481Lys)	ALK	N481K	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001348465	2	29543720	2	29320854	1348465	1459695	rs200448968	NC_000002.12:29320853:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1442A>G (p.Asn481Ser)	ALK	N481S	Hereditary cancer-predisposing syndrome	VCV002566559	2	29543721	2	29320855	2566559	2734402		NC_000002.12:29320854:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1441A>T (p.Asn481Tyr)	ALK	N481Y	Hereditary cancer-predisposing syndrome	VCV002452118	2	29543722	2	29320856	2452118	2426758		NC_000002.12:29320855:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1440C>A (p.Cys480Ter)	ALK	C480*	Neuroblastoma, susceptibility to, 3	VCV000956589	2	29543723	2	29320857	956589	942875	rs1667016608	NC_000002.12:29320856:G:T	single nucleotide variant	nonsense	Uncertain significance	Jan 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1437C>T (p.Tyr479=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001132988	2	29543726	2	29320860	1132988	1112760	rs2148251070	NC_000002.12:29320859:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 23, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1436A>T (p.Tyr479Phe)	ALK	Y479F	Neuroblastoma, susceptibility to, 3	VCV002819512	2	29543727	2	29320861	2819512	2987867		NC_000002.12:29320860:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1435T>C (p.Tyr479His)	ALK	Y479H	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470752	2	29543728	2	29320862	470752	450921	rs1400418889	NC_000002.12:29320861:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1432T>A (p.Phe478Ile)	ALK	F478I	Neuroblastoma, susceptibility to, 3|not provided	VCV001041831	2	29543731	2	29320865	1041831	1024465	rs1667016994	NC_000002.12:29320864:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1431T>C (p.Gly477=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002724452	2	29543732	2	29320866	2724452	2888383		NC_000002.12:29320865:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1429G>T (p.Gly477Cys)	ALK	G477C	Neuroblastoma, susceptibility to, 3	VCV001714052	2	29543734	2	29320868	1714052	1773323		NC_000002.12:29320867:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1428G>A (p.Val476=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001346283	2	29543735	2	29320869	1346283	1378572	rs1667017111	NC_000002.12:29320868:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1427T>A (p.Val476Glu)	ALK	V476E	Hereditary cancer-predisposing syndrome	VCV003286126	2	29543736	2	29320870	3286126	3444866		NC_000002.12:29320869:A:T	single nucleotide variant	missense variant	Uncertain significance	May 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1427T>C (p.Val476Ala)	ALK	V476A	Neuroblastoma, susceptibility to, 3|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000133485	2	29543736	2	29320870	133485	137224	rs35093491	NC_000002.12:29320869:A:G	single nucleotide variant	missense variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1426G>C (p.Val476Leu)	ALK	V476L	Hereditary cancer-predisposing syndrome	VCV002559753	2	29543737	2	29320871	2559753	2727840		NC_000002.12:29320870:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1426G>A (p.Val476Met)	ALK	V476M	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001063712	2	29543737	2	29320871	1063712	1041414	rs984951289	NC_000002.12:29320870:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1422G>T (p.Leu474=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001137109	2	29543741	2	29320875	1137109	1112761	rs2148251105	NC_000002.12:29320874:C:A	single nucleotide variant	synonymous variant	Likely benign	Jun 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1420C>T (p.Leu474=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003627662	2	29543743	2	29320877	3627662	3761648		NC_000002.12:29320876:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1419A>T (p.Lys473Asn)	ALK	K473N	Hereditary cancer-predisposing syndrome	VCV002586692	2	29543744	2	29320878	2586692	2756875		NC_000002.12:29320877:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1419A>G (p.Lys473=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001078907	2	29543744	2	29320878	1078907	1069535	rs1268853000	NC_000002.12:29320877:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1418A>C (p.Lys473Thr)	ALK	K473T	Hereditary cancer-predisposing syndrome	VCV002566593	2	29543745	2	29320879	2566593	2734436		NC_000002.12:29320878:T:G	single nucleotide variant	missense variant	Uncertain significance	May 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1418A>T (p.Lys473Ile)	ALK	K473I	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000574857	2	29543745	2	29320879	574857	561363	rs768799403	NC_000002.12:29320878:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1416G>A (p.Arg472=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001134978	2	29543747	2	29320881	1134978	1112762	rs1325368309	NC_000002.12:29320880:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1415G>A (p.Arg472Gln)	ALK	R472Q	Hereditary cancer-predisposing syndrome	VCV003524444	2	29543748	2	29320882	3524444	3679109		NC_000002.12:29320881:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1415-3T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV000404391	2	29543751	2	29320885	404391	392648	rs747885672	NC_000002.12:29320884:A:G	single nucleotide variant	intron variant	Uncertain significance	Dec 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1415-4A>G	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001108500	2	29543752	2	29320886	1108500	1091265	rs769450437	NC_000002.12:29320885:T:C	single nucleotide variant	intron variant	Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1415-5C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000698011	2	29543753	2	29320887	698011	689716	rs957699962	NC_000002.12:29320886:G:A	single nucleotide variant	intron variant	Likely benign	Jan 1, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.1415-6C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003639368	2	29543754	2	29320888	3639368	3768365		NC_000002.12:29320887:G:C	single nucleotide variant	intron variant	Likely benign	Feb 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1415-11TC[2]	ALK		Neuroblastoma, susceptibility to, 3	VCV001159914	2	29543754 - 29543755	2	29320888 - 29320889	1159914	1133672	rs2148251132	NC_000002.12:29320887:GAGAGAG:GAGAG	Microsatellite	intron variant	Likely benign	Dec 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1415-6C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000779498	2	29543754	2	29320888	779498	778981	rs375507924	NC_000002.12:29320887:G:A	single nucleotide variant	intron variant	Likely benign	Feb 3, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.1415-8C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002142570	2	29543756	2	29320890	2142570	1875770		NC_000002.12:29320889:G:A	single nucleotide variant	intron variant	Likely benign	Sep 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1415-9T>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001900622	2	29543757	2	29320891	1900622	1953959		NC_000002.12:29320890:A:T	single nucleotide variant	intron variant	Likely benign	Sep 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1415-10C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001144810	2	29543758	2	29320892	1144810	1133673	rs1330820854	NC_000002.12:29320891:G:C	single nucleotide variant	intron variant	Likely benign	Nov 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1415-12_1415-11insA	ALK		Neuroblastoma, susceptibility to, 3	VCV001914028	2	29543759 - 29543760	2	29320893 - 29320894	1914028	1970359		NC_000002.12:29320893::T	Insertion	intron variant	Likely benign	Sep 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1415-12C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002917900	2	29543760	2	29320894	2917900	3072099		NC_000002.12:29320893:G:T	single nucleotide variant	intron variant	Likely benign	Apr 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1415-14_1415-13del	ALK		Neuroblastoma, susceptibility to, 3	VCV001914029	2	29543761 - 29543762	2	29320895 - 29320896	1914029	1970360		NC_000002.12:29320894:CA:	Deletion	intron variant	Likely benign	Sep 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1415-19CT[2]	ALK		Neuroblastoma, susceptibility to, 3	VCV002062709	2	29543762 - 29543763	2	29320896 - 29320897	2062709	2127985		NC_000002.12:29320895:AGAGAG:AGAG	Microsatellite	intron variant	Likely benign	Aug 22, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1415-17C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001968520	2	29543765	2	29320899	1968520	2028528		NC_000002.12:29320898:G:C	single nucleotide variant	intron variant	Likely benign	Jun 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1415-17C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001582336	2	29543765	2	29320899	1582336	1662399	rs773943842	NC_000002.12:29320898:G:A	single nucleotide variant	intron variant	Likely benign	Jan 22, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.1415-26A>G	ALK		not provided	VCV001219238	2	29543774	2	29320908	1219238	1209216	rs115117646	NC_000002.12:29320907:T:C	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1414+62C>T	ALK		not provided	VCV001204104	2	29551154	2	29328288	1204104	1193149	rs111236214	NC_000002.12:29328287:G:A	single nucleotide variant	intron variant	Likely benign	Sep 24, 2020	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1414+55C>T	ALK		not provided	VCV001238293	2	29551161	2	29328295	1238293	1228708	rs62130643	NC_000002.12:29328294:G:A	single nucleotide variant	intron variant	Benign	Jun 21, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1414+20C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002038374	2	29551196	2	29328330	2038374	2101443		NC_000002.12:29328329:G:A	single nucleotide variant	intron variant	Likely benign	Feb 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1414+19C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002092991	2	29551197	2	29328331	2092991	2145734		NC_000002.12:29328330:G:A	single nucleotide variant	intron variant	Likely benign	Sep 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1414+18C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001590088	2	29551198	2	29328332	1590088	1576633	rs2148258156	NC_000002.12:29328331:G:C	single nucleotide variant	intron variant	Likely benign	Dec 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1414+14G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001990705	2	29551202	2	29328336	1990705	2044644		NC_000002.12:29328335:C:A	single nucleotide variant	intron variant	Likely benign	Mar 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1414+12G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001544838	2	29551204	2	29328338	1544838	1644244	rs1473086953	NC_000002.12:29328337:C:T	single nucleotide variant	intron variant	Likely benign	May 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1414+8G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001087375	2	29551208	2	29328342	1087375	1069536	rs2148258170	NC_000002.12:29328341:C:T	single nucleotide variant	intron variant	Likely benign	Jan 26, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1414+4A>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003649741	2	29551212	2	29328346	3649741	3777703		NC_000002.12:29328345:T:A	single nucleotide variant	intron variant	Uncertain significance	Apr 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1414+3G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002727188	2	29551213	2	29328347	2727188	2882506		NC_000002.12:29328346:C:T	single nucleotide variant	intron variant	Uncertain significance	Sep 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1414+2T>G	ALK		not provided	VCV002573984	2	29551214	2	29328348	2573984	2738926		NC_000002.12:29328347:A:C	single nucleotide variant	splice donor variant	Uncertain significance	Jan 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1414+1G>A	ALK		not provided|Neuroblastoma, susceptibility to, 3	VCV000470749	2	29551215	2	29328349	470749	451094	rs777414641	NC_000002.12:29328348:C:T	single nucleotide variant	splice donor variant	Uncertain significance	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1414C>G (p.Arg472Gly)	ALK	R472G	Neuroblastoma, susceptibility to, 3	VCV000970544	2	29551216	2	29328350	970544	953074	rs749263944	NC_000002.12:29328349:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1414C>T (p.Arg472Trp)	ALK	R472W	Neuroblastoma, susceptibility to, 3	VCV000470751	2	29551216	2	29328350	470751	451104	rs749263944	NC_000002.12:29328349:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1413C>T (p.Cys471=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000566722	2	29551217	2	29328351	566722	561365	rs770707805	NC_000002.12:29328350:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 8, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1410G>T (p.Met470Ile)	ALK	M470I	Hereditary cancer-predisposing syndrome	VCV002566575	2	29551220	2	29328354	2566575	2734418		NC_000002.12:29328353:C:A	single nucleotide variant	missense variant	Likely benign	Apr 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1409T>C (p.Met470Thr)	ALK	M470T	Hereditary cancer-predisposing syndrome	VCV003223792	2	29551221	2	29328355	3223792	3380815		NC_000002.12:29328354:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1408A>T (p.Met470Leu)	ALK	M470L	Neuroblastoma, susceptibility to, 3	VCV003637557	2	29551222	2	29328356	3637557	3767841		NC_000002.12:29328355:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1408A>G (p.Met470Val)	ALK	M470V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001771948	2	29551222	2	29328356	1771948	1829760		NC_000002.12:29328355:T:C	single nucleotide variant	missense variant	Uncertain significance	May 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1407G>A (p.Gln469=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001102574	2	29551223	2	29328357	1102574	1091266	rs538554121	NC_000002.12:29328356:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1404C>A (p.Ser468Arg)	ALK	S468R	Neuroblastoma, susceptibility to, 3	VCV001518406	2	29551226	2	29328360	1518406	1508799	rs1667337590	NC_000002.12:29328359:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1403G>A (p.Ser468Asn)	ALK	S468N	Neuroblastoma, susceptibility to, 3	VCV000943946	2	29551227	2	29328361	943946	922727	rs1573239187	NC_000002.12:29328360:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1402A>G (p.Ser468Gly)	ALK	S468G	Neuroblastoma, susceptibility to, 3	VCV002701997	2	29551228	2	29328362	2701997	2859580		NC_000002.12:29328361:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1401G>C (p.Glu467Asp)	ALK	E467D	Hereditary cancer-predisposing syndrome	VCV003285954	2	29551229	2	29328363	3285954	3444694		NC_000002.12:29328362:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1399G>A (p.Glu467Lys)	ALK	E467K	Hereditary cancer-predisposing syndrome	VCV001771707	2	29551231	2	29328365	1771707	1832903		NC_000002.12:29328364:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1399G>T (p.Glu467Ter)	ALK	E467*	Neuroblastoma, susceptibility to, 3	VCV001508478	2	29551231	2	29328365	1508478	1439689	rs2148258207	NC_000002.12:29328364:C:A	single nucleotide variant	nonsense	Uncertain significance	Dec 15, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1397A>G (p.Asp466Gly)	ALK	D466G	Neuroblastoma, susceptibility to, 3	VCV003729038	2	29551233	2	29328367	3729038	3861973		NC_000002.12:29328366:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.1397A>T (p.Asp466Val)	ALK	D466V	Neuroblastoma, susceptibility to, 3	VCV003241705	2	29551233	2	29328367	3241705	3400683		NC_000002.12:29328366:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1392AGA[1] (p.Glu465del)	ALK	E465del	Neuroblastoma, susceptibility to, 3	VCV000649329	2	29551233 - 29551235	2	29328367 - 29328369	649329	629892	rs1573239194	NC_000002.12:29328366:TCTTCT:TCT	Microsatellite	inframe_deletion	Uncertain significance	Oct 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1396G>A (p.Asp466Asn)	ALK	D466N	Neuroblastoma, susceptibility to, 3	VCV000845443	2	29551234	2	29328368	845443	826371	rs1667337818	NC_000002.12:29328367:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1395A>G (p.Glu465=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001114645	2	29551235	2	29328369	1114645	1091267	rs2148258217	NC_000002.12:29328368:T:C	single nucleotide variant	synonymous variant	Likely benign	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1393G>A (p.Glu465Lys)	ALK	E465K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470746	2	29551237	2	29328371	470746	451106	rs1553411110	NC_000002.12:29328370:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1392A>G (p.Gly464=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001664437	2	29551238	2	29328372	1664437	1654606	rs745322358	NC_000002.12:29328371:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 22, 2020	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1391G>T (p.Gly464Val)	ALK	G464V	Neuroblastoma, susceptibility to, 3	VCV000656787	2	29551239	2	29328373	656787	629893	rs771689864	NC_000002.12:29328372:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1390G>A (p.Gly464Arg)	ALK	G464R	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000404393	2	29551240	2	29328374	404393	392756	rs55706535	NC_000002.12:29328373:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1389G>A (p.Gln463=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003655825	2	29551241	2	29328375	3655825	3782692		NC_000002.12:29328374:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1389G>C (p.Gln463His)	ALK	Q463H	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001038559	2	29551241	2	29328375	1038559	1024466	rs1667338201	NC_000002.12:29328374:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1388A>C (p.Gln463Pro)	ALK	Q463P	Neuroblastoma, susceptibility to, 3	VCV002759806	2	29551242	2	29328376	2759806	2924859		NC_000002.12:29328375:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1388A>G (p.Gln463Arg)	ALK	Q463R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001771449	2	29551242	2	29328376	1771449	1832645		NC_000002.12:29328375:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1387del (p.Gln463fs)	ALK	Q463fs	Neuroblastoma, susceptibility to, 3	VCV001055379	2	29551243	2	29328377	1055379	1041415	rs2148258233	NC_000002.12:29328376:GGG:GG	Deletion	frameshift variant	Uncertain significance	Mar 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1386C>G (p.Ala462=)	ALK		Hereditary cancer-predisposing syndrome	VCV002566565	2	29551244	2	29328378	2566565	2734408		NC_000002.12:29328377:G:C	single nucleotide variant	synonymous variant	Likely benign	Apr 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1386C>T (p.Ala462=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001133494	2	29551244	2	29328378	1133494	1112763	rs2148258238	NC_000002.12:29328377:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1385C>T (p.Ala462Val)	ALK	A462V	Neuroblastoma, susceptibility to, 3	VCV003728350	2	29551245	2	29328379	3728350	3855550		NC_000002.12:29328378:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1385C>A (p.Ala462Asp)	ALK	A462D	Neuroblastoma, susceptibility to, 3	VCV003653462	2	29551245	2	29328379	3653462	3788895		NC_000002.12:29328378:G:T	single nucleotide variant	missense variant	Uncertain significance	May 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1384G>T (p.Ala462Ser)	ALK	A462S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001771363	2	29551246	2	29328380	1771363	1832559		NC_000002.12:29328379:C:A	single nucleotide variant	missense variant	Uncertain significance	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1383T>G (p.Cys461Trp)	ALK	C461W	Hereditary cancer-predisposing syndrome	VCV002566582	2	29551247	2	29328381	2566582	2734425		NC_000002.12:29328380:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1382G>A (p.Cys461Tyr)	ALK	C461Y	Neuroblastoma, susceptibility to, 3	VCV002752864	2	29551248	2	29328382	2752864	2913605		NC_000002.12:29328381:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1381del (p.Cys461fs)	ALK	C461fs	Neuroblastoma, susceptibility to, 3	VCV001994650	2	29551249	2	29328383	1994650	2053016		NC_000002.12:29328382:A:	Deletion	frameshift variant	Uncertain significance	May 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1380C>A (p.Asp460Glu)	ALK	D460E	Neuroblastoma, susceptibility to, 3	VCV001994651	2	29551250	2	29328384	1994651	2053017		NC_000002.12:29328383:G:T	single nucleotide variant	missense variant	Uncertain significance	May 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1379A>G (p.Asp460Gly)	ALK	D460G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000645095	2	29551251	2	29328385	645095	629894	rs149198543	NC_000002.12:29328384:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1378G>A (p.Asp460Asn)	ALK	D460N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001771224	2	29551252	2	29328386	1771224	1836362		NC_000002.12:29328385:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1377G>C (p.Gln459His)	ALK	Q459H	Neuroblastoma, susceptibility to, 3	VCV003241646	2	29551253	2	29328387	3241646	3400624		NC_000002.12:29328386:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1376A>G (p.Gln459Arg)	ALK	Q459R	ALK-related disorder|Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000239795	2	29551254	2	29328388	239795	238750	rs773380015	NC_000002.12:29328387:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1375C>G (p.Gln459Glu)	ALK	Q459E	Ovarian cancer|Neuroblastoma, susceptibility to, 3	VCV001002636	2	29551255	2	29328389	1002636	988732	rs1466204048	NC_000002.12:29328388:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 24, 2023	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1374C>T (p.His458=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000800142	2	29551256	2	29328390	800142	781308	rs763543532	NC_000002.12:29328389:G:A	single nucleotide variant	synonymous variant	Likely benign	May 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1372C>T (p.His458Tyr)	ALK	H458Y	Neuroblastoma, susceptibility to, 3	VCV002443128	2	29551258	2	29328392	2443128	2416848		NC_000002.12:29328391:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1372C>G (p.His458Asp)	ALK	H458D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001771070	2	29551258	2	29328392	1771070	1836208		NC_000002.12:29328391:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1371C>G (p.Phe457Leu)	ALK	F457L	Neuroblastoma, susceptibility to, 3	VCV001364995	2	29551259	2	29328393	1364995	1502041	rs2148258267	NC_000002.12:29328392:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1371C>T (p.Phe457=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001139554	2	29551259	2	29328393	1139554	1112764	rs2148258267	NC_000002.12:29328392:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 12, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1368C>T (p.Asp456=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001556487	2	29551262	2	29328396	1556487	1529870	rs2148258275	NC_000002.12:29328395:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 16, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1366G>A (p.Asp456Asn)	ALK	D456N	Neuroblastoma, susceptibility to, 3	VCV001482327	2	29551264	2	29328398	1482327	1445563	rs2148258283	NC_000002.12:29328397:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1361C>G (p.Ala454Gly)	ALK	A454G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000949454	2	29551269	2	29328403	949454	922728	rs766818130	NC_000002.12:29328402:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1361C>T (p.Ala454Val)	ALK	A454V	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000538225	2	29551269	2	29328403	538225	518147	rs766818130	NC_000002.12:29328402:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1360G>A (p.Ala454Thr)	ALK	A454T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001401930	2	29551270	2	29328404	1401930	1453740	rs755089158	NC_000002.12:29328403:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1357C>T (p.Gln453Ter)	ALK	Q453*	Neuroblastoma, susceptibility to, 3	VCV002693976	2	29551273	2	29328407	2693976	2863941		NC_000002.12:29328406:G:A	single nucleotide variant	nonsense	Uncertain significance	Nov 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1357C>G (p.Gln453Glu)	ALK	Q453E	Neuroblastoma, susceptibility to, 3	VCV002091128	2	29551273	2	29328407	2091128	2145167		NC_000002.12:29328406:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1356G>A (p.Gly452=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001080509	2	29551274	2	29328408	1080509	1069537	rs767578442	NC_000002.12:29328407:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1355G>A (p.Gly452Glu)	ALK	G452E	Neuroblastoma, susceptibility to, 3	VCV001376305	2	29551275	2	29328409	1376305	1466838	rs2148258315	NC_000002.12:29328408:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.1354G>A (p.Gly452Arg)	ALK	G452R	Hereditary cancer-predisposing syndrome	VCV003523211	2	29551276	2	29328410	3523211	3688769		NC_000002.12:29328409:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1354G>C (p.Gly452Arg)	ALK	G452R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001692772	2	29551276	2	29328410	1692772	1685212	rs1277320933	NC_000002.12:29328409:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1351C>G (p.Leu451Val)	ALK	L451V	Neuroblastoma, susceptibility to, 3	VCV001037762	2	29551279	2	29328413	1037762	1024467	rs199970780	NC_000002.12:29328412:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1350G>A (p.Gln450=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001770593	2	29551280	2	29328414	1770593	1826295		NC_000002.12:29328413:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1347C>T (p.Leu449=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001583422	2	29551283	2	29328417	1583422	1601118	rs2148258326	NC_000002.12:29328416:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 11, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1346T>G (p.Leu449Arg)	ALK	L449R	Neuroblastoma, susceptibility to, 3	VCV001021806	2	29551284	2	29328418	1021806	1003997	rs1667339511	NC_000002.12:29328417:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1345C>T (p.Leu449Phe)	ALK	L449F	Hereditary cancer-predisposing syndrome	VCV002566581	2	29551285	2	29328419	2566581	2734424		NC_000002.12:29328418:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1344C>A (p.Val448=)	ALK		Hereditary cancer-predisposing syndrome	VCV001770420	2	29551286	2	29328420	1770420	1829525		NC_000002.12:29328419:G:T	single nucleotide variant	synonymous variant	Likely benign	Jan 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1344C>G (p.Val448=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001127554	2	29551286	2	29328420	1127554	1112765	rs896199996	NC_000002.12:29328419:G:C	single nucleotide variant	synonymous variant	Likely benign	Mar 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1343T>A (p.Val448Asp)	ALK	V448D	Neuroblastoma, susceptibility to, 3	VCV000565782	2	29551287	2	29328421	565782	558053	rs1425828384	NC_000002.12:29328420:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1340C>A (p.Thr447Lys)	ALK	T447K	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002566585	2	29551290	2	29328424	2566585	2734428		NC_000002.12:29328423:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1338G>A (p.Gly446=)	ALK		Hereditary cancer-predisposing syndrome	VCV001770289	2	29551292	2	29328426	1770289	1829394		NC_000002.12:29328425:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 16, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.1338G>T (p.Gly446=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001360652	2	29551292	2	29328426	1360652	1360218	rs2148258343	NC_000002.12:29328425:C:A	single nucleotide variant	synonymous variant	Likely benign	Dec 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1337G>A (p.Gly446Glu)	ALK	G446E	Hereditary cancer-predisposing syndrome	VCV003524482	2	29551293	2	29328427	3524482	3679147		NC_000002.12:29328426:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1337G>C (p.Gly446Ala)	ALK	G446A	Hereditary cancer-predisposing syndrome	VCV002566605	2	29551293	2	29328427	2566605	2734448		NC_000002.12:29328426:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1336G>A (p.Gly446Arg)	ALK	G446R	Neuroblastoma, susceptibility to, 3	VCV002802982	2	29551294	2	29328428	2802982	2970504		NC_000002.12:29328427:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1335T>C (p.Asn445=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001125992	2	29551295	2	29328429	1125992	1112766	rs2148258353	NC_000002.12:29328428:A:G	single nucleotide variant	synonymous variant	Likely benign	Feb 14, 2020	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1333A>C (p.Asn445His)	ALK	N445H	Hereditary cancer-predisposing syndrome	VCV003223791	2	29551297	2	29328431	3223791	3380814		NC_000002.12:29328430:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1332G>C (p.Trp444Cys)	ALK	W444C	Hereditary cancer-predisposing syndrome	VCV003524150	2	29551298	2	29328432	3524150	3682318		NC_000002.12:29328431:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1332G>T (p.Trp444Cys)	ALK	W444C	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002767027	2	29551298	2	29328432	2767027	2926471		NC_000002.12:29328431:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1329T>C (p.Cys443=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000759031	2	29551301	2	29328435	759031	763185	rs1573239309	NC_000002.12:29328434:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 26, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1326T>C (p.Thr442=)	ALK		Hereditary cancer-predisposing syndrome	VCV002601759	2	29551304	2	29328438	2601759	2778057		NC_000002.12:29328437:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1325C>T (p.Thr442Ile)	ALK	T442I	Neuroblastoma, susceptibility to, 3	VCV003685187	2	29551305	2	29328439	3685187	3809174		NC_000002.12:29328438:G:A	single nucleotide variant	missense variant	Uncertain significance	May 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1323_1325del (p.Thr442del)	ALK	T442del	Neuroblastoma, susceptibility to, 3	VCV002847496	2	29551305 - 29551307	2	29328439 - 29328441	2847496	3012416		NC_000002.12:29328438:GTG:	Deletion	inframe_deletion	Uncertain significance	Mar 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1324A>G (p.Thr442Ala)	ALK	T442A	Neuroblastoma, susceptibility to, 3	VCV000941111	2	29551306	2	29328440	941111	931370	rs1667340141	NC_000002.12:29328439:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1323C>T (p.Phe441=)	ALK		Hereditary cancer-predisposing syndrome	VCV001769948	2	29551307	2	29328441	1769948	1832433		NC_000002.12:29328440:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 3, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1322T>C (p.Phe441Ser)	ALK	F441S	Neuroblastoma, susceptibility to, 3	VCV003697828	2	29551308	2	29328442	3697828	3829423		NC_000002.12:29328441:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1322T>G (p.Phe441Cys)	ALK	F441C	Hereditary cancer-predisposing syndrome	VCV001769936	2	29551308	2	29328442	1769936	1832421		NC_000002.12:29328441:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1320C>T (p.Ser440=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003608306	2	29551310	2	29328444	3608306	3740584		NC_000002.12:29328443:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1319C>T (p.Ser440Phe)	ALK	S440F	Neuroblastoma, susceptibility to, 3	VCV000960779	2	29551311	2	29328445	960779	942876	rs1667340308	NC_000002.12:29328444:G:A	single nucleotide variant	missense variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1318T>A (p.Ser440Thr)	ALK	S440T	Hereditary cancer-predisposing syndrome	VCV003523645	2	29551312	2	29328446	3523645	3685317		NC_000002.12:29328445:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1318T>C (p.Ser440Pro)	ALK	S440P	Neuroblastoma, susceptibility to, 3	VCV001714338	2	29551312	2	29328446	1714338	1770955		NC_000002.12:29328445:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1317C>T (p.Ser439=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000700277	2	29551313	2	29328447	700277	686191	rs748996936	NC_000002.12:29328446:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1313A>T (p.Gln438Leu)	ALK	Q438L	Neuroblastoma, susceptibility to, 3	VCV001381773	2	29551317	2	29328451	1381773	1341732	rs2148258388	NC_000002.12:29328450:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1312C>T (p.Gln438Ter)	ALK	Q438*	Neuroblastoma, susceptibility to, 3	VCV003717025	2	29551318	2	29328452	3717025	3859020		NC_000002.12:29328451:G:A	single nucleotide variant	nonsense	Uncertain significance	Sep 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1312C>A (p.Gln438Lys)	ALK	Q438K	Neuroblastoma, susceptibility to, 3	VCV003007237	2	29551318	2	29328452	3007237	3158534		NC_000002.12:29328451:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1310_1311delinsAA (p.Leu437Gln)	ALK	L437Q	Neuroblastoma, susceptibility to, 3	VCV001400236	2	29551319 - 29551320	2	29328453 - 29328454	1400236	1440463	rs2148258390	NC_000002.12:29328452:CA:TT	Indel	missense variant	Uncertain significance	Jun 15, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1311G>A (p.Leu437=)	ALK		Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV001114212	2	29551319	2	29328453	1114212	1091268	rs757241673	NC_000002.12:29328452:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 19, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1309C>T (p.Leu437=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001545878	2	29551321	2	29328455	1545878	1612550	rs2148258398	NC_000002.12:29328454:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1308C>T (p.Ala436=)	ALK		Hereditary cancer-predisposing syndrome	VCV002452123	2	29551322	2	29328456	2452123	2426763		NC_000002.12:29328455:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 30, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1307C>G (p.Ala436Gly)	ALK	A436G	Neuroblastoma, susceptibility to, 3	VCV002822731	2	29551323	2	29328457	2822731	2978690		NC_000002.12:29328456:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1307C>T (p.Ala436Val)	ALK	A436V	Neuroblastoma, susceptibility to, 3	VCV000948969	2	29551323	2	29328457	948969	922729	rs1430324218	NC_000002.12:29328456:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1306G>A (p.Ala436Thr)	ALK	A436T	Neuroblastoma, susceptibility to, 3	VCV000895234	2	29551324	2	29328458	895234	884685	rs745772939	NC_000002.12:29328457:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1306G>C (p.Ala436Pro)	ALK	A436P	not provided|Neuroblastoma, susceptibility to, 3	VCV000404341	2	29551324	2	29328458	404341	392588	rs745772939	NC_000002.12:29328457:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1305G>A (p.Met435Ile)	ALK	M435I	Neuroblastoma, susceptibility to, 3	VCV002766515	2	29551325	2	29328459	2766515	2928978		NC_000002.12:29328458:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1301A>G (p.Lys434Arg)	ALK	K434R	Neuroblastoma, susceptibility to, 3	VCV000570882	2	29551329	2	29328463	570882	558398	rs1558675795	NC_000002.12:29328462:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1300A>G (p.Lys434Glu)	ALK	K434E	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000971921	2	29551330	2	29328464	971921	953075	rs1667341023	NC_000002.12:29328463:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1296C>T (p.Gly432=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001540157	2	29551334	2	29328468	1540157	1544775	rs2148258416	NC_000002.12:29328467:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1295G>A (p.Gly432Asp)	ALK	G432D	Neuroblastoma, susceptibility to, 3	VCV001987673	2	29551335	2	29328469	1987673	2040320		NC_000002.12:29328468:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1295G>T (p.Gly432Val)	ALK	G432V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001769196	2	29551335	2	29328469	1769196	1835633		NC_000002.12:29328468:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1292C>T (p.Pro431Leu)	ALK	P431L	Hereditary cancer-predisposing syndrome	VCV003223790	2	29551338	2	29328472	3223790	3380813		NC_000002.12:29328471:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1291C>T (p.Pro431Ser)	ALK	P431S	Neuroblastoma, susceptibility to, 3	VCV000961638	2	29551339	2	29328473	961638	942877	rs1667341414	NC_000002.12:29328472:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1290C>T (p.Ser430=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003524130	2	29551340	2	29328474	3524130	3682298		NC_000002.12:29328473:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1289C>A (p.Ser430Tyr)	ALK	S430Y	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001045740	2	29551341	2	29328475	1045740	1024468	rs1667341491	NC_000002.12:29328474:G:T	single nucleotide variant	missense variant	Uncertain significance	May 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1288T>C (p.Ser430Pro)	ALK	S430P	Neuroblastoma, susceptibility to, 3	VCV003608895	2	29551342	2	29328476	3608895	3737721		NC_000002.12:29328475:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1288T>A (p.Ser430Thr)	ALK	S430T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001381220	2	29551342	2	29328476	1381220	1500061	rs2148258441	NC_000002.12:29328475:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1286C>G (p.Thr429Arg)	ALK	T429R	Hereditary cancer-predisposing syndrome	VCV003523740	2	29551344	2	29328478	3523740	3685412		NC_000002.12:29328477:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1286C>T (p.Thr429Ile)	ALK	T429I	Neuroblastoma, susceptibility to, 3	VCV000839644	2	29551344	2	29328478	839644	826372	rs775129242	NC_000002.12:29328477:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1284A>T (p.Gly428=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002957311	2	29551346	2	29328480	2957311	3122409		NC_000002.12:29328479:T:A	single nucleotide variant	synonymous variant	Likely benign	Oct 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1283G>A (p.Gly428Glu)	ALK	G428E	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001970141	2	29551347	2	29328481	1970141	2028854		NC_000002.12:29328480:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1283G>T (p.Gly428Val)	ALK	G428V	Neuroblastoma, susceptibility to, 3	VCV001968558	2	29551347	2	29328481	1968558	2028566		NC_000002.12:29328480:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1283-1G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002108443	2	29551348	2	29328482	2108443	2159857		NC_000002.12:29328481:C:T	single nucleotide variant	splice acceptor variant	Uncertain significance	Oct 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1283-5T>C	ALK		not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|Familial isolated pituitary adenoma	VCV000470745	2	29551352	2	29328486	470745	450922	rs377214413	NC_000002.12:29328485:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1283-7T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV003710499	2	29551354	2	29328488	3710499	3847388		NC_000002.12:29328487:A:G	single nucleotide variant	intron variant	Likely benign	Nov 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1283-8C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003707599	2	29551355	2	29328489	3707599	3843205		NC_000002.12:29328488:G:A	single nucleotide variant	intron variant	Likely benign	Oct 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1283-9G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV003726339	2	29551356	2	29328490	3726339	3854830		NC_000002.12:29328489:C:T	single nucleotide variant	intron variant	Likely benign	Nov 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1283-14TG[2]	ALK		Neuroblastoma, susceptibility to, 3	VCV000707089	2	29551356 - 29551357	2	29328490 - 29328491	707089	695144	rs1573239381	NC_000002.12:29328489:CACACA:CACA	Microsatellite	intron variant	Likely benign	Jan 7, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.1283-10T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV003721492	2	29551357	2	29328491	3721492	3853857		NC_000002.12:29328490:A:G	single nucleotide variant	intron variant	Likely benign	Sep 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1283-12T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001636479	2	29551359	2	29328493	1636479	1558386	rs2148258457	NC_000002.12:29328492:A:G	single nucleotide variant	intron variant	Likely benign	Jul 15, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1283-13G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV003693963	2	29551360	2	29328494	3693963	3832065		NC_000002.12:29328493:C:G	single nucleotide variant	intron variant	Likely benign	May 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1283-15C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002722105	2	29551362	2	29328496	2722105	2881315		NC_000002.12:29328495:G:C	single nucleotide variant	intron variant	Likely benign	Aug 5, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1283-15C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002155295	2	29551362	2	29328496	2155295	1882863		NC_000002.12:29328495:G:T	single nucleotide variant	intron variant	Likely benign	Dec 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1283-21GT[2]	ALK		Neuroblastoma, susceptibility to, 3	VCV002811902	2	29551363 - 29551364	2	29328497 - 29328498	2811902	2969140		NC_000002.12:29328496:ACACACA:ACACA	Microsatellite	intron variant	Likely benign	Nov 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1283-17G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002829571	2	29551364	2	29328498	2829571	2980400		NC_000002.12:29328497:C:G	single nucleotide variant	intron variant	Likely benign	Aug 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1283-19G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV003730132	2	29551366	2	29328500	3730132	3862202		NC_000002.12:29328499:C:T	single nucleotide variant	intron variant	Likely benign	Jul 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1283-19G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV003706859	2	29551366	2	29328500	3706859	3846345		NC_000002.12:29328499:C:G	single nucleotide variant	intron variant	Likely benign	Jun 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1283-20T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002721352	2	29551367	2	29328501	2721352	2887877		NC_000002.12:29328500:A:G	single nucleotide variant	intron variant	Likely benign	May 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1283-47T>A	ALK		not provided	VCV001233000	2	29551394	2	29328528	1233000	1223413	rs11901987	NC_000002.12:29328527:A:T	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1283-49C>T	ALK		not provided	VCV001292843	2	29551396	2	29328530	1292843	1282649	rs11885503	NC_000002.12:29328529:G:A	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1283-146C>G	ALK		not provided	VCV001239302	2	29551493	2	29328627	1239302	1229632	rs4549035	NC_000002.12:29328626:G:C	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1282+296T>G	ALK		not provided	VCV001242090	2	29606302	2	29383436	1242090	1232865	rs6755127	NC_000002.12:29383435:A:C	single nucleotide variant	intron variant	Benign	Feb 11, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1282+250T>C	ALK		not provided	VCV001193653	2	29606348	2	29383482	1193653	1183179	rs115557048	NC_000002.12:29383481:A:G	single nucleotide variant	intron variant	Likely benign	Jul 20, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1282+164G>A	ALK		not provided	VCV001297416	2	29606434	2	29383568	1297416	1287205	rs13428230	NC_000002.12:29383567:C:T	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1282+121G>A	ALK		not provided	VCV001243423	2	29606477	2	29383611	1243423	1232912	rs114485452	NC_000002.12:29383610:C:T	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1282+19C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002790462	2	29606579	2	29383713	2790462	2960226		NC_000002.12:29383712:G:A	single nucleotide variant	intron variant	Likely benign	Jan 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1282+19C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001558121	2	29606579	2	29383713	1558121	1541140	rs758341143	NC_000002.12:29383712:G:C	single nucleotide variant	intron variant	Likely benign	Jan 26, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.1282+14G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002038608	2	29606584	2	29383718	2038608	2101676		NC_000002.12:29383717:C:G	single nucleotide variant	intron variant	Likely benign	Dec 9, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1282+12T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002898935	2	29606586	2	29383720	2898935	3060570		NC_000002.12:29383719:A:G	single nucleotide variant	intron variant	Likely benign	Nov 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1282+11C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003677258	2	29606587	2	29383721	3677258	3817459		NC_000002.12:29383720:G:A	single nucleotide variant	intron variant	Likely benign	May 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1282+6T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002700955	2	29606592	2	29383726	2700955	2865795		NC_000002.12:29383725:A:G	single nucleotide variant	intron variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1282+5C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001025554	2	29606593	2	29383727	1025554	1003998	rs1668960950	NC_000002.12:29383726:G:C	single nucleotide variant	intron variant	Uncertain significance	Jul 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1282+3A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002141689	2	29606595	2	29383729	2141689	1869224		NC_000002.12:29383728:T:C	single nucleotide variant	intron variant	Uncertain significance	Jan 2, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.1282+1G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002098176	2	29606597	2	29383731	2098176	2147032		NC_000002.12:29383730:C:T	single nucleotide variant	splice donor variant	Uncertain significance	Feb 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1282G>A (p.Gly428Arg)	ALK	G428R	Neuroblastoma, susceptibility to, 3	VCV000660816	2	29606598	2	29383732	660816	629895	rs1573303300	NC_000002.12:29383731:C:T	single nucleotide variant	missense variant	Uncertain significance	May 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1281A>C (p.Glu427Asp)	ALK	E427D	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002159784	2	29606599	2	29383733	2159784	1886860		NC_000002.12:29383732:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1279G>A (p.Glu427Lys)	ALK	E427K	not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470744	2	29606601	2	29383735	470744	451095	rs371652715	NC_000002.12:29383734:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 10, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1278T>G (p.Ser426Arg)	ALK	S426R	Neuroblastoma, susceptibility to, 3	VCV002415188	2	29606602	2	29383736	2415188	1943629		NC_000002.12:29383735:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1277G>A (p.Ser426Asn)	ALK	S426N	not provided	VCV003371606	2	29606603	2	29383737	3371606	3530796		NC_000002.12:29383736:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1277G>C (p.Ser426Thr)	ALK	S426T	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000412912	2	29606603	2	29383737	412912	392960	rs111796753	NC_000002.12:29383736:C:G	single nucleotide variant	missense variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1276A>G (p.Ser426Gly)	ALK	S426G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001447493	2	29606604	2	29383738	1447493	1503547	rs1558300778	NC_000002.12:29383737:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1274G>A (p.Cys425Tyr)	ALK	C425Y	Neuroblastoma, susceptibility to, 3	VCV001018963	2	29606606	2	29383740	1018963	1003999	rs1318224093	NC_000002.12:29383739:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1273T>C (p.Cys425Arg)	ALK	C425R	Neuroblastoma, susceptibility to, 3	VCV002091996	2	29606607	2	29383741	2091996	2152494		NC_000002.12:29383740:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1273T>G (p.Cys425Gly)	ALK	C425G	Neuroblastoma, susceptibility to, 3	VCV001492803	2	29606607	2	29383741	1492803	1515639	rs2148301432	NC_000002.12:29383740:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1272C>A (p.Asn424Lys)	ALK	N424K	Neuroblastoma, susceptibility to, 3	VCV003665832	2	29606608	2	29383742	3665832	3795705		NC_000002.12:29383741:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1272C>T (p.Asn424=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001653546	2	29606608	2	29383742	1653546	1548119	rs747832091	NC_000002.12:29383741:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1270A>G (p.Asn424Asp)	ALK	N424D	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000575461	2	29606610	2	29383744	575461	558400	rs771340984	NC_000002.12:29383743:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1269G>T (p.Lys423Asn)	ALK	K423N	Neuroblastoma, susceptibility to, 3	VCV002764126	2	29606611	2	29383745	2764126	2922295		NC_000002.12:29383744:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1269G>C (p.Lys423Asn)	ALK	K423N	Neuroblastoma, susceptibility to, 3	VCV001511964	2	29606611	2	29383745	1511964	1455599	rs1370402590	NC_000002.12:29383744:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1266G>A (p.Leu422=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002895084	2	29606614	2	29383748	2895084	3052624		NC_000002.12:29383747:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1263C>G (p.Ala421=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002750097	2	29606617	2	29383751	2750097	2919055		NC_000002.12:29383750:G:C	single nucleotide variant	synonymous variant	Likely benign	May 30, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1262C>T (p.Ala421Val)	ALK	A421V	Neuroblastoma, susceptibility to, 3	VCV001372880	2	29606618	2	29383752	1372880	1440258	rs1267142388	NC_000002.12:29383751:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.1262C>A (p.Ala421Asp)	ALK	A421D	Neuroblastoma, susceptibility to, 3	VCV001008978	2	29606618	2	29383752	1008978	988733	rs1267142388	NC_000002.12:29383751:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1261G>T (p.Ala421Ser)	ALK	A421S	Neuroblastoma, susceptibility to, 3	VCV002748924	2	29606619	2	29383753	2748924	2915284		NC_000002.12:29383752:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1261G>A (p.Ala421Thr)	ALK	A421T	Neuroblastoma, susceptibility to, 3	VCV001511817	2	29606619	2	29383753	1511817	1455452	rs2148301460	NC_000002.12:29383752:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1260T>C (p.Phe420=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001119652	2	29606620	2	29383754	1119652	1091269	rs774639115	NC_000002.12:29383753:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1258T>C (p.Phe420Leu)	ALK	F420L	Neuroblastoma, susceptibility to, 3	VCV002848451	2	29606622	2	29383756	2848451	3015348		NC_000002.12:29383755:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1257C>T (p.Phe419=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000755100	2	29606623	2	29383757	755100	763186	rs760042577	NC_000002.12:29383756:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1254C>T (p.Asp418=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001541622	2	29606626	2	29383760	1541622	1631505	rs1668962410	NC_000002.12:29383759:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 17, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1254C>A (p.Asp418Glu)	ALK	D418E	Neuroblastoma, susceptibility to, 3	VCV001010130	2	29606626	2	29383760	1010130	988734	rs1668962410	NC_000002.12:29383759:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1253A>T (p.Asp418Val)	ALK	D418V	Neuroblastoma, susceptibility to, 3	VCV003241707	2	29606627	2	29383761	3241707	3400685		NC_000002.12:29383760:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1253A>G (p.Asp418Gly)	ALK	D418G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001442301	2	29606627	2	29383761	1442301	1475166	rs2148301472	NC_000002.12:29383760:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1252G>C (p.Asp418His)	ALK	D418H	Neuroblastoma, susceptibility to, 3	VCV002415060	2	29606628	2	29383762	2415060	1943495		NC_000002.12:29383761:C:G	single nucleotide variant	missense variant	Uncertain significance	May 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1251G>A (p.Val417=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002122136	2	29606629	2	29383763	2122136	2173561		NC_000002.12:29383762:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1250T>C (p.Val417Ala)	ALK	V417A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001489268	2	29606630	2	29383764	1489268	1498760	rs2148301479	NC_000002.12:29383763:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1249del (p.Val417fs)	ALK	V417fs	Neuroblastoma, susceptibility to, 3	VCV001002687	2	29606631	2	29383765	1002687	988735	rs1668962676	NC_000002.12:29383764:C:	Deletion	frameshift variant	Uncertain significance	Jan 18, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1249G>C (p.Val417Leu)	ALK	V417L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538232	2	29606631	2	29383765	538232	518149	rs886055931	NC_000002.12:29383764:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1249G>A (p.Val417Met)	ALK	V417M	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000335708	2	29606631	2	29383765	335708	288996	rs886055931	NC_000002.12:29383764:C:T	single nucleotide variant	missense variant	Uncertain significance	May 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1248A>G (p.Ala416=)	ALK		Hereditary cancer-predisposing syndrome	VCV003525125	2	29606632	2	29383766	3525125	3689364		NC_000002.12:29383765:T:C	single nucleotide variant	synonymous variant	Likely benign	Nov 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1248A>C (p.Ala416=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003021342	2	29606632	2	29383766	3021342	3172547		NC_000002.12:29383765:T:G	single nucleotide variant	synonymous variant	Likely benign	Oct 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1247C>A (p.Ala416Glu)	ALK	A416E	Hereditary cancer-predisposing syndrome	VCV001759766	2	29606633	2	29383767	1759766	1813367		NC_000002.12:29383766:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1247C>T (p.Ala416Val)	ALK	A416V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000652225	2	29606633	2	29383767	652225	629896	rs772529363	NC_000002.12:29383766:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1246G>T (p.Ala416Ser)	ALK	A416S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538253	2	29606634	2	29383768	538253	518212	rs775917326	NC_000002.12:29383767:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1246G>A (p.Ala416Thr)	ALK	A416T	Neuroblastoma, susceptibility to, 3	VCV000404338	2	29606634	2	29383768	404338	392593	rs775917326	NC_000002.12:29383767:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1244C>G (p.Ser415Cys)	ALK	S415C	Hereditary cancer-predisposing syndrome	VCV003286135	2	29606636	2	29383770	3286135	3444875		NC_000002.12:29383769:G:C	single nucleotide variant	missense variant	Uncertain significance	May 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1243T>C (p.Ser415Pro)	ALK	S415P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001421659	2	29606637	2	29383771	1421659	1423075	rs1668963051	NC_000002.12:29383770:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1242G>A (p.Leu414=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002869540	2	29606638	2	29383772	2869540	3024421		NC_000002.12:29383771:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1242G>C (p.Leu414Phe)	ALK	L414F	Neuroblastoma, susceptibility to, 3	VCV002057544	2	29606638	2	29383772	2057544	2116701		NC_000002.12:29383771:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1239C>T (p.Ser413=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001081922	2	29606641	2	29383775	1081922	1069538	rs2148301523	NC_000002.12:29383774:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1237A>G (p.Ser413Gly)	ALK	S413G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000845692	2	29606643	2	29383777	845692	826373	rs1477421090	NC_000002.12:29383776:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1236C>G (p.Arg412=)	ALK		Hereditary cancer-predisposing syndrome	VCV003286502	2	29606644	2	29383778	3286502	3455325		NC_000002.12:29383777:G:C	single nucleotide variant	synonymous variant	Likely benign	Jun 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1236C>T (p.Arg412=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001613077	2	29606644	2	29383778	1613077	1663228	rs2148301533	NC_000002.12:29383777:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 9, 2021	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1235G>T (p.Arg412Leu)	ALK	R412L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000858049	2	29606645	2	29383779	858049	826374	rs1388736375	NC_000002.12:29383778:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1235G>A (p.Arg412His)	ALK	R412H	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000538229	2	29606645	2	29383779	538229	518159	rs1388736375	NC_000002.12:29383778:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1234C>T (p.Arg412Cys)	ALK	R412C	not specified|Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000239794	2	29606646	2	29383780	239794	238751	rs147102592	NC_000002.12:29383779:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1230A>G (p.Gly410=)	ALK		Hereditary cancer-predisposing syndrome	VCV001755358	2	29606650	2	29383784	1755358	1818648		NC_000002.12:29383783:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 7, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1229G>C (p.Gly410Ala)	ALK	G410A	Hereditary cancer-predisposing syndrome	VCV002566612	2	29606651	2	29383785	2566612	2734455		NC_000002.12:29383784:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1229G>A (p.Gly410Glu)	ALK	G410E	Neuroblastoma, susceptibility to, 3|not provided	VCV001022941	2	29606651	2	29383785	1022941	1004000	rs760717114	NC_000002.12:29383784:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1228G>A (p.Gly410Arg)	ALK	G410R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000954757	2	29606652	2	29383786	954757	942878	rs764207516	NC_000002.12:29383785:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1227T>C (p.Ser409=)	ALK		Hereditary cancer-predisposing syndrome	VCV001754671	2	29606653	2	29383787	1754671	1812127		NC_000002.12:29383786:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 4, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1226G>A (p.Ser409Asn)	ALK	S409N	Neuroblastoma, susceptibility to, 3	VCV001506889	2	29606654	2	29383788	1506889	1426949	rs2148301582	NC_000002.12:29383787:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1225A>C (p.Ser409Arg)	ALK	S409R	Hereditary cancer-predisposing syndrome	VCV003223789	2	29606655	2	29383789	3223789	3380812		NC_000002.12:29383788:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1225A>G (p.Ser409Gly)	ALK	S409G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000665340	2	29606655	2	29383789	665340	629897	rs374842018	NC_000002.12:29383788:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1224C>T (p.Ser408=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002762259	2	29606656	2	29383790	2762259	2930755		NC_000002.12:29383789:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1223C>G (p.Ser408Cys)	ALK	S408C	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV001504384	2	29606657	2	29383791	1504384	1337259	rs1348960950	NC_000002.12:29383790:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1221C>T (p.Ile407=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002196337	2	29606659	2	29383793	2196337	1923810		NC_000002.12:29383792:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1220T>C (p.Ile407Thr)	ALK	I407T	Neuroblastoma, susceptibility to, 3	VCV003241696	2	29606660	2	29383794	3241696	3400674		NC_000002.12:29383793:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1201_1218dup (p.Tyr406_Ile407insArgValAlaLeuGluTyr)	ALK		Neuroblastoma, susceptibility to, 3	VCV003586403	2	29606661 - 29606662	2	29383795 - 29383796	3586403	3717110		NC_000002.12:29383795:GTATTCCAGGGCCACTCG:GTATTCCAGGGCCACTCGGTATTCCAGGGCCACTCG	Duplication		Uncertain significance	Feb 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1219A>G (p.Ile407Val)	ALK	I407V	Hereditary cancer-predisposing syndrome	VCV001752376	2	29606661	2	29383795	1752376	1804231		NC_000002.12:29383794:T:C	single nucleotide variant	missense variant	Likely benign	Mar 31, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1219A>T (p.Ile407Phe)	ALK	I407F	Neuroblastoma, susceptibility to, 3	VCV001719142	2	29606661	2	29383795	1719142	1774446		NC_000002.12:29383794:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1219A>C (p.Ile407Leu)	ALK	I407L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000654315	2	29606661	2	29383795	654315	629898	rs765139446	NC_000002.12:29383794:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 27, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1218C>T (p.Tyr406=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000701315	2	29606662	2	29383796	701315	686192	rs750201156	NC_000002.12:29383795:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.1215A>T (p.Glu405Asp)	ALK	E405D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000133484	2	29606665	2	29383799	133484	137223	rs370235133	NC_000002.12:29383798:T:A	single nucleotide variant	missense variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1214A>T (p.Glu405Val)	ALK	E405V	Neuroblastoma, susceptibility to, 3	VCV000538180	2	29606666	2	29383800	538180	518238	rs1553309548	NC_000002.12:29383799:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1210C>G (p.Leu404Val)	ALK	L404V	Neuroblastoma, susceptibility to, 3	VCV002828785	2	29606670	2	29383804	2828785	2987304		NC_000002.12:29383803:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1210C>T (p.Leu404=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001093368	2	29606670	2	29383804	1093368	1069539	rs1668964417	NC_000002.12:29383803:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1209C>T (p.Ala403=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001119642	2	29606671	2	29383805	1119642	1091270	rs1219558254	NC_000002.12:29383804:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1208C>T (p.Ala403Val)	ALK	A403V	Hereditary cancer-predisposing syndrome	VCV003286688	2	29606672	2	29383806	3286688	3451559		NC_000002.12:29383805:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1208C>A (p.Ala403Asp)	ALK	A403D	Neuroblastoma, susceptibility to, 3	VCV000404323	2	29606672	2	29383806	404323	392961	rs1060500211	NC_000002.12:29383805:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 23, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1207G>A (p.Ala403Thr)	ALK	A403T	Neuroblastoma, susceptibility to, 3	VCV001461333	2	29606673	2	29383807	1461333	1498164	rs1267269954	NC_000002.12:29383806:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1206G>A (p.Val402=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001123884	2	29606674	2	29383808	1123884	1112767	rs1489452308	NC_000002.12:29383807:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1203A>C (p.Arg401=)	ALK		Hereditary cancer-predisposing syndrome	VCV002586693	2	29606677	2	29383811	2586693	2756876		NC_000002.12:29383810:T:G	single nucleotide variant	synonymous variant	Likely benign	Jul 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1202G>A (p.Arg401Gln)	ALK	R401Q	Neuroblastoma, susceptibility to, 3	VCV000663434	2	29606678	2	29383812	663434	629899	rs188859061	NC_000002.12:29383811:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1201C>A (p.Arg401=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003724173	2	29606679	2	29383813	3724173	3857383		NC_000002.12:29383812:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1201C>T (p.Arg401Ter)	ALK	R401*	Neuroblastoma, susceptibility to, 3	VCV001470261	2	29606679	2	29383813	1470261	1372223	rs865931787	NC_000002.12:29383812:G:A	single nucleotide variant	nonsense	Uncertain significance	May 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1194C>T (p.Asn398=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001745657	2	29606686	2	29383820	1745657	1802709		NC_000002.12:29383819:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1193A>G (p.Asn398Ser)	ALK	N398S	Neuroblastoma, susceptibility to, 3|Familial isolated pituitary adenoma	VCV000470743	2	29606687	2	29383821	470743	450791	rs754512910	NC_000002.12:29383820:T:C	single nucleotide variant	missense variant	Uncertain significance	May 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1190A>G (p.Asp397Gly)	ALK	D397G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001424887	2	29606690	2	29383824	1424887	1353394	rs368122868	NC_000002.12:29383823:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1190A>T (p.Asp397Val)	ALK	D397V	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000404390	2	29606690	2	29383824	404390	392757	rs368122868	NC_000002.12:29383823:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 15, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1189G>C (p.Asp397His)	ALK	D397H	Neuroblastoma, susceptibility to, 3	VCV001369576	2	29606691	2	29383825	1369576	1414588	rs747810439	NC_000002.12:29383824:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1189G>A (p.Asp397Asn)	ALK	D397N	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000470741	2	29606691	2	29383825	470741	450792	rs747810439	NC_000002.12:29383824:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 7, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1188A>G (p.Pro396=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001133395	2	29606692	2	29383826	1133395	1112768	rs1412095749	NC_000002.12:29383825:T:C	single nucleotide variant	synonymous variant	Likely benign	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1186C>A (p.Pro396Thr)	ALK	P396T	Neuroblastoma, susceptibility to, 3	VCV003704639	2	29606694	2	29383828	3704639	3839387		NC_000002.12:29383827:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1186C>G (p.Pro396Ala)	ALK	P396A	Hereditary cancer-predisposing syndrome	VCV003223787	2	29606694	2	29383828	3223787	3380810		NC_000002.12:29383827:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1185T>C (p.Arg395=)	ALK		Hereditary cancer-predisposing syndrome	VCV001743342	2	29606695	2	29383829	1743342	1805488		NC_000002.12:29383828:A:G	single nucleotide variant	synonymous variant	Likely benign	Feb 13, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1184G>A (p.Arg395His)	ALK	R395H	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000470740	2	29606696	2	29383830	470740	450796	rs769910087	NC_000002.12:29383829:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 19, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1183C>A (p.Arg395Ser)	ALK	R395S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001051537	2	29606697	2	29383831	1051537	1041416	rs779282861	NC_000002.12:29383830:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1183C>T (p.Arg395Cys)	ALK	R395C	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000470739	2	29606697	2	29383831	470739	450924	rs779282861	NC_000002.12:29383830:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1182G>A (p.Gly394=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001135706	2	29606698	2	29383832	1135706	1112769	rs1470291492	NC_000002.12:29383831:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1180G>A (p.Gly394Arg)	ALK	G394R	not provided|Neuroblastoma, susceptibility to, 3	VCV000843389	2	29606700	2	29383834	843389	826375	rs775514690	NC_000002.12:29383833:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1179C>G (p.Ile393Met)	ALK	I393M	Hereditary cancer-predisposing syndrome	VCV003286106	2	29606701	2	29383835	3286106	3444846		NC_000002.12:29383834:G:C	single nucleotide variant	missense variant	Uncertain significance	May 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1179C>A (p.Ile393=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001121951	2	29606701	2	29383835	1121951	1112770	rs371642412	NC_000002.12:29383834:G:T	single nucleotide variant	synonymous variant	Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1179del (p.Ile393fs)	ALK	I393fs	Neuroblastoma, susceptibility to, 3	VCV000950751	2	29606701	2	29383835	950751	922730	rs1668965828	NC_000002.12:29383834:G:	Deletion	frameshift variant	Uncertain significance	Apr 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1179C>T (p.Ile393=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000412930	2	29606701	2	29383835	412930	392595	rs371642412	NC_000002.12:29383834:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1175G>C (p.Arg392Thr)	ALK	R392T	Neuroblastoma, susceptibility to, 3	VCV001437106	2	29606705	2	29383839	1437106	1435676	rs2148301750	NC_000002.12:29383838:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1175G>A (p.Arg392Lys)	ALK	R392K	Neuroblastoma, susceptibility to, 3	VCV001373815	2	29606705	2	29383839	1373815	1378954	rs2148301750	NC_000002.12:29383838:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.1174A>T (p.Arg392Ter)	ALK	R392*	Neuroblastoma, susceptibility to, 3	VCV002005077	2	29606706	2	29383840	2005077	2055705		NC_000002.12:29383839:T:A	single nucleotide variant	nonsense	Uncertain significance	Jun 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1170G>C (p.Gln390His)	ALK	Q390H	Neuroblastoma, susceptibility to, 3	VCV003614211	2	29606710	2	29383844	3614211	3748906		NC_000002.12:29383843:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1168C>G (p.Gln390Glu)	ALK	Q390E	Hereditary cancer-predisposing syndrome	VCV003223786	2	29606712	2	29383846	3223786	3380809		NC_000002.12:29383845:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1167C>T (p.Leu389=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000701525	2	29606713	2	29383847	701525	686193	rs1573303556	NC_000002.12:29383846:G:A	single nucleotide variant	synonymous variant	Likely benign	May 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1165C>T (p.Leu389Phe)	ALK	L389F	Neuroblastoma, susceptibility to, 3	VCV001957542	2	29606715	2	29383849	1957542	2009070		NC_000002.12:29383848:G:A	single nucleotide variant	missense variant	Uncertain significance	May 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1161_1162dup (p.Val388fs)	ALK	V388fs	Neuroblastoma, susceptibility to, 3	VCV003647332	2	29606717 - 29606718	2	29383851 - 29383852	3647332	3780625		NC_000002.12:29383851:CT:CTCT	Duplication	frameshift variant	Uncertain significance	Mar 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1163T>A (p.Val388Glu)	ALK	V388E	Neuroblastoma, susceptibility to, 3	VCV001020743	2	29606717	2	29383851	1020743	1004001	rs1668966196	NC_000002.12:29383850:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1160C>G (p.Thr387Arg)	ALK	T387R	Neuroblastoma, susceptibility to, 3	VCV001507849	2	29606720	2	29383854	1507849	1352308	rs2148301787	NC_000002.12:29383853:G:C	single nucleotide variant	missense variant	Uncertain significance	May 21, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1159A>G (p.Thr387Ala)	ALK	T387A	Hereditary cancer-predisposing syndrome	VCV003524212	2	29606721	2	29383855	3524212	3682380		NC_000002.12:29383854:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1157G>A (p.Trp386Ter)	ALK	W386*	Neuroblastoma, susceptibility to, 3	VCV002762921	2	29606723	2	29383857	2762921	2927982		NC_000002.12:29383856:C:T	single nucleotide variant	nonsense	Uncertain significance	Sep 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1155T>A (p.Gly385=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002764396	2	29606725	2	29383859	2764396	2931599		NC_000002.12:29383858:A:T	single nucleotide variant	synonymous variant	Uncertain significance	Sep 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1155T>C (p.Gly385=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001022772	2	29606725	2	29383859	1022772	1004002	rs369505500	NC_000002.12:29383858:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Feb 21, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1155-1G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000661104	2	29606726	2	29383860	661104	650987	rs1573303570	NC_000002.12:29383859:C:T	single nucleotide variant	splice acceptor variant	Uncertain significance	Jan 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1155-4_1155-3delinsAA	ALK		Neuroblastoma, susceptibility to, 3	VCV003650074	2	29606728 - 29606729	2	29383862 - 29383863	3650074	3788070		NC_000002.12:29383861:GG:TT	Indel	intron variant	Uncertain significance	Apr 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1155-3C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003611132	2	29606728	2	29383862	3611132	3744698		NC_000002.12:29383861:G:A	single nucleotide variant	intron variant	Uncertain significance	Apr 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1155-4C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002724444	2	29606729	2	29383863	2724444	2888375		NC_000002.12:29383862:G:A	single nucleotide variant	intron variant	Likely benign	Jun 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1155-5A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002109821	2	29606730	2	29383864	2109821	2163696		NC_000002.12:29383863:T:C	single nucleotide variant	intron variant	Uncertain significance	Apr 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1155-6A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002110670	2	29606731	2	29383865	2110670	2171134		NC_000002.12:29383864:T:C	single nucleotide variant	intron variant	Likely benign	Mar 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1155-9T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001009720	2	29606734	2	29383868	1009720	988736	rs1668967647	NC_000002.12:29383867:A:G	single nucleotide variant	intron variant	Likely benign	Sep 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1155-10A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000569871	2	29606735	2	29383869	569871	560599	rs373017069	NC_000002.12:29383868:T:C	single nucleotide variant	intron variant	Uncertain significance	Oct 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1155-11A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001584180	2	29606736	2	29383870	1584180	1581438	rs1338300871	NC_000002.12:29383869:T:C	single nucleotide variant	intron variant	Likely benign	Aug 24, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1155-12C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001637432	2	29606737	2	29383871	1637432	1525460	rs956099492	NC_000002.12:29383870:G:A	single nucleotide variant	intron variant	Likely benign	Jul 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1155-14T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003675905	2	29606739	2	29383873	3675905	3813521		NC_000002.12:29383872:A:C	single nucleotide variant	intron variant	Likely benign	Feb 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1155-16T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV003692210	2	29606741	2	29383875	3692210	3831597		NC_000002.12:29383874:A:G	single nucleotide variant	intron variant	Likely benign	Mar 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1155-19dup	ALK		Neuroblastoma, susceptibility to, 3	VCV001546503	2	29606743 - 29606744	2	29383877 - 29383878	1546503	1526352	rs1668968004	NC_000002.12:29383877:A:AA	Duplication	intron variant	Likely benign	Jun 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1155-19T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001530725	2	29606744	2	29383878	1530725	1635197	rs2148301842	NC_000002.12:29383877:A:G	single nucleotide variant	intron variant	Likely benign	Mar 27, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1155-20_1155-19del	ALK		Neuroblastoma, susceptibility to, 3|not specified	VCV000516581	2	29606744 - 29606745	2	29383878 - 29383879	516581	500114	rs140451928	NC_000002.12:29383877:AGAG:AG	Microsatellite	intron variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1155-99C>T	ALK		not provided	VCV001236390	2	29606824	2	29383958	1236390	1228099	rs4499385	NC_000002.12:29383957:G:A	single nucleotide variant	intron variant	Benign	Jul 5, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1155-8502A>C	ALK		not provided	VCV001181100	2	29615227	2	29392361	1181100	1170958	rs55731984	NC_000002.12:29392360:T:G	single nucleotide variant	intron variant	Benign	Jun 14, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1155-8508A>G	ALK		Neuroblastoma, susceptibility to, 3|not provided	VCV001259303	2	29615233	2	29392367	1259303	1250066	rs4322799	NC_000002.12:29392366:T:C	single nucleotide variant	intron variant	Benign	Sep 20, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1155-8694G>T	ALK		not provided	VCV001244821	2	29615419	2	29392553	1244821	1236058	rs4525647	NC_000002.12:29392552:C:A	single nucleotide variant	intron variant	Benign	Jun 15, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1155-8708C>A	ALK		not provided	VCV001259767	2	29615433	2	29392567	1259767	1249252	rs13415294	NC_000002.12:29392566:G:T	single nucleotide variant	intron variant	Benign	Jun 14, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1155-8718A>C	ALK		not provided	VCV001291874	2	29615443	2	29392577	1291874	1281688	rs4322800	NC_000002.12:29392576:T:G	single nucleotide variant	intron variant	Benign	Jun 14, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1154+60A>G	ALK		not provided	VCV001227030	2	29754721	2	29531855	1227030	1217002	rs11689790	NC_000002.12:29531854:T:C	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1154+20C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV003000177	2	29754761	2	29531895	3000177	3160472		NC_000002.12:29531894:G:T	single nucleotide variant	intron variant	Likely benign	Jul 30, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1154+20C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001558361	2	29754761	2	29531895	1558361	1594950	rs2148158375	NC_000002.12:29531894:G:A	single nucleotide variant	intron variant	Likely benign	Jul 21, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1154+18T>A	ALK		Neuroblastoma, susceptibility to, 3	VCV003725080	2	29754763	2	29531897	3725080	3850983		NC_000002.12:29531896:A:T	single nucleotide variant	intron variant	Likely benign	Nov 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1154+17G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002895141	2	29754764	2	29531898	2895141	3049230		NC_000002.12:29531897:C:T	single nucleotide variant	intron variant	Likely benign	Sep 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1154+16T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001611702	2	29754765	2	29531899	1611702	1552218	rs1001922228	NC_000002.12:29531898:A:G	single nucleotide variant	intron variant	Likely benign	Aug 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1154+16T>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001536785	2	29754765	2	29531899	1536785	1533069	rs1001922228	NC_000002.12:29531898:A:T	single nucleotide variant	intron variant	Likely benign	Aug 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1154+15del	ALK		Neuroblastoma, susceptibility to, 3	VCV002968127	2	29754766	2	29531900	2968127	3128516		NC_000002.12:29531899:T:	Deletion	intron variant	Likely benign	Jan 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1154+15A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002867542	2	29754766	2	29531900	2867542	3027329		NC_000002.12:29531899:T:C	single nucleotide variant	intron variant	Likely benign	Jul 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1154+15A>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002139620	2	29754766	2	29531900	2139620	1871907		NC_000002.12:29531899:T:A	single nucleotide variant	intron variant	Likely benign	Jul 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1154+11C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001633761	2	29754770	2	29531904	1633761	1661162	rs1673128789	NC_000002.12:29531903:G:A	single nucleotide variant	intron variant	Likely benign	Jun 27, 2022	criteria provided, single submitter							
NC_000002.11:g.(?_29754771)_(29754992_?)dup	ALK		Neuroblastoma, susceptibility to, 3	VCV000652974	2	29754771 - 29754992	2	29531905 - 29532126	652974	650828			Duplication		Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1154+7A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000758320	2	29754774	2	29531908	758320	774702	rs773631201	NC_000002.12:29531907:T:C	single nucleotide variant	intron variant	Likely benign	Sep 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1154+5G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002000852	2	29754776	2	29531910	2000852	2061356		NC_000002.12:29531909:C:A	single nucleotide variant	intron variant	Uncertain significance	May 30, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1154+5G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001449906	2	29754776	2	29531910	1449906	1413088	rs2148158406	NC_000002.12:29531909:C:T	single nucleotide variant	intron variant	Uncertain significance	Dec 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1154+4A>T	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538281	2	29754777	2	29531911	538281	518247	rs763253846	NC_000002.12:29531910:T:A	single nucleotide variant	intron variant	Benign/Likely benign	Mar 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1154+1G>A	ALK		not provided|Neuroblastoma, susceptibility to, 3	VCV000648078	2	29754780	2	29531914	648078	651031	rs766100418	NC_000002.12:29531913:C:T	single nucleotide variant	splice donor variant	Uncertain significance	Mar 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1154G>A (p.Gly385Asp)	ALK	G385D	Neuroblastoma, susceptibility to, 3|not provided	VCV000665337	2	29754781	2	29531915	665337	629900	rs774127733	NC_000002.12:29531914:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1154G>C (p.Gly385Ala)	ALK	G385A	not provided|Neuroblastoma, susceptibility to, 3	VCV000404317	2	29754781	2	29531915	404317	392970	rs774127733	NC_000002.12:29531914:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1152T>C (p.His384=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470737	2	29754783	2	29531917	470737	451100	rs1553328114	NC_000002.12:29531916:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1150C>T (p.His384Tyr)	ALK	H384Y	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001006168	2	29754785	2	29531919	1006168	988737	rs1243305009	NC_000002.12:29531918:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1149G>C (p.Lys383Asn)	ALK	K383N	Hereditary cancer-predisposing syndrome	VCV003223783	2	29754786	2	29531920	3223783	3380806		NC_000002.12:29531919:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1149G>A (p.Lys383=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001554812	2	29754786	2	29531920	1554812	1564556	rs767442144	NC_000002.12:29531919:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 21, 2021	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1148A>C (p.Lys383Thr)	ALK	K383T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002918434	2	29754787	2	29531921	2918434	3080554		NC_000002.12:29531920:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1148A>T (p.Lys383Met)	ALK	K383M	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000538201	2	29754787	2	29531921	538201	518098	rs140928266	NC_000002.12:29531920:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 18, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1146G>C (p.Gly382=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001095308	2	29754789	2	29531923	1095308	1069540	rs755660917	NC_000002.12:29531922:C:G	single nucleotide variant	synonymous variant	Likely benign	May 31, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1145G>C (p.Gly382Ala)	ALK	G382A	Hereditary cancer-predisposing syndrome	VCV003223782	2	29754790	2	29531924	3223782	3380805		NC_000002.12:29531923:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1144G>A (p.Gly382Arg)	ALK	G382R	Hereditary cancer-predisposing syndrome	VCV003524757	2	29754791	2	29531925	3524757	3688996		NC_000002.12:29531924:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1144G>C (p.Gly382Arg)	ALK	G382R	Neuroblastoma, susceptibility to, 3	VCV003241726	2	29754791	2	29531925	3241726	3400704		NC_000002.12:29531924:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1141C>G (p.Pro381Ala)	ALK	P381A	Neuroblastoma, susceptibility to, 3	VCV001024906	2	29754794	2	29531928	1024906	1004003	rs1451908328	NC_000002.12:29531927:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1139C>G (p.Thr380Ser)	ALK	T380S	Neuroblastoma, susceptibility to, 3	VCV001350680	2	29754796	2	29531930	1350680	1492268	rs2148158461	NC_000002.12:29531929:G:C	single nucleotide variant	missense variant	Uncertain significance	May 2, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1137C>T (p.Pro379=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002983182	2	29754798	2	29531932	2983182	3142258		NC_000002.12:29531931:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1137C>A (p.Pro379=)	ALK		Hereditary cancer-predisposing syndrome	VCV001729990	2	29754798	2	29531932	1729990	1792197		NC_000002.12:29531931:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 21, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1136C>G (p.Pro379Arg)	ALK	P379R	Neuroblastoma, susceptibility to, 3	VCV001485315	2	29754799	2	29531933	1485315	1394041	rs2148158462	NC_000002.12:29531932:G:C	single nucleotide variant	missense variant	Uncertain significance	May 13, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1135C>T (p.Pro379Ser)	ALK	P379S	Neuroblastoma, susceptibility to, 3	VCV001957565	2	29754800	2	29531934	1957565	2009093		NC_000002.12:29531933:G:A	single nucleotide variant	missense variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1134G>A (p.Met378Ile)	ALK	M378I	not provided|Neuroblastoma, susceptibility to, 3	VCV001393239	2	29754801	2	29531935	1393239	1402966	rs989538225	NC_000002.12:29531934:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1133T>G (p.Met378Arg)	ALK	M378R	Neuroblastoma, susceptibility to, 3	VCV002904726	2	29754802	2	29531936	2904726	3068922		NC_000002.12:29531935:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1133T>A (p.Met378Lys)	ALK	M378K	Neuroblastoma, susceptibility to, 3	VCV001440195	2	29754802	2	29531936	1440195	1368645	rs1178669386	NC_000002.12:29531935:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 28, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1133T>C (p.Met378Thr)	ALK	M378T	Neuroblastoma, susceptibility to, 3	VCV000470736	2	29754802	2	29531936	470736	450811	rs1178669386	NC_000002.12:29531935:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1128C>G (p.Leu376=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001161598	2	29754807	2	29531941	1161598	1133674	rs200396075	NC_000002.12:29531940:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 10, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1128C>T (p.Leu376=)	ALK		not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000412926	2	29754807	2	29531941	412926	392972	rs200396075	NC_000002.12:29531940:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1127T>C (p.Leu376Pro)	ALK	L376P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000855412	2	29754808	2	29531942	855412	826376	rs966612700	NC_000002.12:29531941:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1126C>T (p.Leu376Phe)	ALK	L376F	Neuroblastoma, susceptibility to, 3	VCV001378066	2	29754809	2	29531943	1378066	1469871	rs2148158493	NC_000002.12:29531942:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1125C>T (p.Ile375=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001660552	2	29754810	2	29531944	1660552	1641654	rs1297081293	NC_000002.12:29531943:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1125C>A (p.Ile375=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000760977	2	29754810	2	29531944	760977	763187	rs1297081293	NC_000002.12:29531943:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 11, 2020	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1124T>A (p.Ile375Asn)	ALK	I375N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001431184	2	29754811	2	29531945	1431184	1467860	rs929806482	NC_000002.12:29531944:A:T	single nucleotide variant	missense variant	Uncertain significance	May 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1124T>C (p.Ile375Thr)	ALK	I375T	Neuroblastoma, susceptibility to, 3	VCV000580984	2	29754811	2	29531945	580984	558402	rs929806482	NC_000002.12:29531944:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1123A>G (p.Ile375Val)	ALK	I375V	Hereditary cancer-predisposing syndrome	VCV003525044	2	29754812	2	29531946	3525044	3689283		NC_000002.12:29531945:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1122G>A (p.Glu374=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002033692	2	29754813	2	29531947	2033692	2096752		NC_000002.12:29531946:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1120G>C (p.Glu374Gln)	ALK	E374Q	not provided	VCV003343060	2	29754815	2	29531949	3343060	3502292		NC_000002.12:29531948:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1119A>C (p.Arg373Ser)	ALK	R373S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002728589	2	29754816	2	29531950	2728589	2886486		NC_000002.12:29531949:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1118G>T (p.Arg373Ile)	ALK	R373I	Neuroblastoma, susceptibility to, 3|not provided	VCV001001113	2	29754817	2	29531951	1001113	988738	rs1318677209	NC_000002.12:29531950:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1117A>G (p.Arg373Gly)	ALK	R373G	Neuroblastoma, susceptibility to, 3	VCV002988660	2	29754818	2	29531952	2988660	3143857		NC_000002.12:29531951:T:C	single nucleotide variant	missense variant	Uncertain significance	May 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1116A>C (p.Ala372=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000412931	2	29754819	2	29531953	412931	392599	rs1060503880	NC_000002.12:29531952:T:G	single nucleotide variant	synonymous variant	Likely benign	Sep 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1115C>G (p.Ala372Gly)	ALK	A372G	Neuroblastoma, susceptibility to, 3	VCV002917230	2	29754820	2	29531954	2917230	3074472		NC_000002.12:29531953:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1114G>C (p.Ala372Pro)	ALK	A372P	Neuroblastoma, susceptibility to, 3	VCV000941329	2	29754821	2	29531955	941329	931371	rs753549939	NC_000002.12:29531954:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1114G>A (p.Ala372Thr)	ALK	A372T	Neuroblastoma, susceptibility to, 3	VCV000841997	2	29754821	2	29531955	841997	826377	rs753549939	NC_000002.12:29531954:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1113T>C (p.Ala371=)	ALK		Hereditary cancer-predisposing syndrome	VCV001795796	2	29754822	2	29531956	1795796	1853155		NC_000002.12:29531955:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 16, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1112C>A (p.Ala371Asp)	ALK	A371D	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002870565	2	29754823	2	29531957	2870565	3031449		NC_000002.12:29531956:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1112C>G (p.Ala371Gly)	ALK	A371G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000841421	2	29754823	2	29531957	841421	826378	rs1673130758	NC_000002.12:29531956:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1111G>A (p.Ala371Thr)	ALK	A371T	Neuroblastoma, susceptibility to, 3|not specified|Hereditary cancer-predisposing syndrome|Ovarian cancer	VCV000133483	2	29754824	2	29531958	133483	137222	rs149968229	NC_000002.12:29531957:C:T	single nucleotide variant	missense variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1110G>A (p.Glu370=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000412929	2	29754825	2	29531959	412929	392760	rs138784554	NC_000002.12:29531958:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1108G>A (p.Glu370Lys)	ALK	E370K	Neuroblastoma, susceptibility to, 3|not provided	VCV000470735	2	29754827	2	29531961	470735	451112	rs373120394	NC_000002.12:29531960:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1107C>A (p.Asn369Lys)	ALK	N369K	Neuroblastoma, susceptibility to, 3	VCV000859405	2	29754828	2	29531962	859405	826379	rs114429299	NC_000002.12:29531961:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1107C>T (p.Asn369=)	ALK		Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000412920	2	29754828	2	29531962	412920	392974	rs114429299	NC_000002.12:29531961:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1106A>G (p.Asn369Ser)	ALK	N369S	Hereditary cancer-predisposing syndrome	VCV001793705	2	29754829	2	29531963	1793705	1845830		NC_000002.12:29531962:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1103A>T (p.His368Leu)	ALK	H368L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000999310	2	29754832	2	29531966	999310	988739	rs1673131453	NC_000002.12:29531965:T:A	single nucleotide variant	missense variant	Uncertain significance	May 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1102C>T (p.His368Tyr)	ALK	H368Y	Hereditary cancer-predisposing syndrome	VCV002566587	2	29754833	2	29531967	2566587	2734430		NC_000002.12:29531966:G:A	single nucleotide variant	missense variant	Uncertain significance	May 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1100C>G (p.Pro367Arg)	ALK	P367R	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000133482	2	29754835	2	29531969	133482	137221	rs144030155	NC_000002.12:29531968:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1099C>T (p.Pro367Ser)	ALK	P367S	Neuroblastoma, susceptibility to, 3	VCV001356878	2	29754836	2	29531970	1356878	1348309	rs1312459820	NC_000002.12:29531969:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1098G>A (p.Leu366=)	ALK		Hereditary cancer-predisposing syndrome	VCV001791308	2	29754837	2	29531971	1791308	1848128		NC_000002.12:29531970:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 5, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1096C>T (p.Leu366=)	ALK		Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV001082159	2	29754839	2	29531973	1082159	1069541	rs1450281991	NC_000002.12:29531972:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 23, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1095G>C (p.Leu365=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001613742	2	29754840	2	29531974	1613742	1536497	rs1313071479	NC_000002.12:29531973:C:G	single nucleotide variant	synonymous variant	Likely benign	Apr 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1095G>T (p.Leu365=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001586048	2	29754840	2	29531974	1586048	1593693	rs1313071479	NC_000002.12:29531973:C:A	single nucleotide variant	synonymous variant	Likely benign	Oct 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1095G>A (p.Leu365=)	ALK		not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000822156	2	29754840	2	29531974	822156	806913	rs1313071479	NC_000002.12:29531973:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1092G>A (p.Gln364=)	ALK		Hereditary cancer-predisposing syndrome	VCV002452133	2	29754843	2	29531977	2452133	2426773		NC_000002.12:29531976:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1090C>T (p.Gln364Ter)	ALK	Q364*	Neuroblastoma, susceptibility to, 3	VCV003711937	2	29754845	2	29531979	3711937	3837617		NC_000002.12:29531978:G:A	single nucleotide variant	nonsense	Uncertain significance	Dec 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1089C>G (p.Ala363=)	ALK		Hereditary cancer-predisposing syndrome	VCV001788429	2	29754846	2	29531980	1788429	1844490		NC_000002.12:29531979:G:C	single nucleotide variant	synonymous variant	Likely benign	Feb 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1088C>T (p.Ala363Val)	ALK	A363V	Neuroblastoma, susceptibility to, 3	VCV003641438	2	29754847	2	29531981	3641438	3775595		NC_000002.12:29531980:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1088C>G (p.Ala363Gly)	ALK	A363G	Neuroblastoma, susceptibility to, 3	VCV002918870	2	29754847	2	29531981	2918870	3077619		NC_000002.12:29531980:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1088C>A (p.Ala363Asp)	ALK	A363D	Hereditary cancer-predisposing syndrome	VCV001788168	2	29754847	2	29531981	1788168	1847610		NC_000002.12:29531980:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1086T>C (p.Ile362=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001996472	2	29754849	2	29531983	1996472	2053547		NC_000002.12:29531982:A:G	single nucleotide variant	synonymous variant	Likely benign	May 31, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1086T>A (p.Ile362=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001101459	2	29754849	2	29531983	1101459	1091271	rs1039091045	NC_000002.12:29531982:A:T	single nucleotide variant	synonymous variant	Likely benign	Feb 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1085T>C (p.Ile362Thr)	ALK	I362T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001005559	2	29754850	2	29531984	1005559	988740	rs1265733958	NC_000002.12:29531983:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1084A>G (p.Ile362Val)	ALK	I362V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001054700	2	29754851	2	29531985	1054700	1041417	rs1465809492	NC_000002.12:29531984:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 10, 2022	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1083C>A (p.Tyr361Ter)	ALK	Y361*	Neuroblastoma, susceptibility to, 3	VCV002087479	2	29754852	2	29531986	2087479	2133771		NC_000002.12:29531985:G:T	single nucleotide variant	nonsense	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1083C>T (p.Tyr361=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470734	2	29754852	2	29531986	470734	451113	rs146261919	NC_000002.12:29531985:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1081T>C (p.Tyr361His)	ALK	Y361H	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001062330	2	29754854	2	29531988	1062330	1041418	rs2148158586	NC_000002.12:29531987:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1080G>T (p.Arg360Ser)	ALK	R360S	Neuroblastoma, susceptibility to, 3	VCV002699391	2	29754855	2	29531989	2699391	2865514		NC_000002.12:29531988:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1079G>C (p.Arg360Thr)	ALK	R360T	Hereditary cancer-predisposing syndrome	VCV001785810	2	29754856	2	29531990	1785810	1850068		NC_000002.12:29531989:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1079G>A (p.Arg360Lys)	ALK	R360K	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001008443	2	29754856	2	29531990	1008443	988741	rs1673132479	NC_000002.12:29531989:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1078A>T (p.Arg360Trp)	ALK	R360W	Neuroblastoma, susceptibility to, 3	VCV002676367	2	29754857	2	29531991	2676367	2834787		NC_000002.12:29531990:T:A	single nucleotide variant	missense variant	Uncertain significance	May 12, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1078A>C (p.Arg360=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001085101	2	29754857	2	29531991	1085101	1069542	rs2148158589	NC_000002.12:29531990:T:G	single nucleotide variant	synonymous variant	Likely benign	Dec 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1077A>G (p.Gly359=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002150093	2	29754858	2	29531992	2150093	1881559		NC_000002.12:29531991:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1076G>A (p.Gly359Glu)	ALK	G359E	Neuroblastoma, susceptibility to, 3	VCV001482361	2	29754859	2	29531993	1482361	1441728	rs2148158595	NC_000002.12:29531992:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.1075G>A (p.Gly359Arg)	ALK	G359R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001784732	2	29754860	2	29531994	1784732	1846790		NC_000002.12:29531993:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1075G>C (p.Gly359Arg)	ALK	G359R	Neuroblastoma, susceptibility to, 3	VCV000843440	2	29754860	2	29531994	843440	826380	rs1673132541	NC_000002.12:29531993:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1074T>C (p.Ser358=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470732	2	29754861	2	29531995	470732	451107	rs920664584	NC_000002.12:29531994:A:G	single nucleotide variant	synonymous variant	Likely benign	Feb 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1071C>T (p.Pro357=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001585364	2	29754864	2	29531998	1585364	1627299	rs770056506	NC_000002.12:29531997:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1069C>A (p.Pro357Thr)	ALK	P357T	Neuroblastoma, susceptibility to, 3|not provided	VCV001958688	2	29754866	2	29532000	1958688	2012366		NC_000002.12:29531999:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1068G>A (p.Gln356=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001101386	2	29754867	2	29532001	1101386	1091272	rs2148158617	NC_000002.12:29532000:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1067A>G (p.Gln356Arg)	ALK	Q356R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000239792	2	29754868	2	29532002	239792	238752	rs773367495	NC_000002.12:29532001:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1065G>A (p.Leu355=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001586657	2	29754870	2	29532004	1586657	1562814	rs1673132858	NC_000002.12:29532003:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 29, 2021	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1063C>T (p.Leu355=)	ALK		Hereditary cancer-predisposing syndrome	VCV002586675	2	29754872	2	29532006	2586675	2756858		NC_000002.12:29532005:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 30, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1062C>A (p.His354Gln)	ALK	H354Q	Neuroblastoma, susceptibility to, 3	VCV002816646	2	29754873	2	29532007	2816646	2984148		NC_000002.12:29532006:G:T	single nucleotide variant	missense variant	Uncertain significance	May 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1062C>T (p.His354=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470731	2	29754873	2	29532007	470731	450926	rs749474186	NC_000002.12:29532006:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1061A>G (p.His354Arg)	ALK	H354R	Neuroblastoma, susceptibility to, 3	VCV003639366	2	29754874	2	29532008	3639366	3768363		NC_000002.12:29532007:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1060C>A (p.His354Asn)	ALK	H354N	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003223781	2	29754875	2	29532009	3223781	3380804		NC_000002.12:29532008:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1060C>T (p.His354Tyr)	ALK	H354Y	Neuroblastoma, susceptibility to, 3	VCV002718787	2	29754875	2	29532009	2718787	2877183		NC_000002.12:29532008:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1060C>G (p.His354Asp)	ALK	H354D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001350379	2	29754875	2	29532009	1350379	1469339	rs1490289892	NC_000002.12:29532008:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1059G>A (p.Arg353=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000412928	2	29754876	2	29532010	412928	392987	rs771143499	NC_000002.12:29532009:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1057A>G (p.Arg353Gly)	ALK	R353G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001778879	2	29754878	2	29532012	1778879	1831463		NC_000002.12:29532011:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1056C>G (p.His352Gln)	ALK	H352Q	Neuroblastoma, susceptibility to, 3	VCV002811454	2	29754879	2	29532013	2811454	2972535		NC_000002.12:29532012:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1053G>A (p.Val351=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001114035	2	29754882	2	29532016	1114035	1091273	rs2148158654	NC_000002.12:29532015:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1052T>C (p.Val351Ala)	ALK	V351A	Neuroblastoma, susceptibility to, 3	VCV001471047	2	29754883	2	29532017	1471047	1395274	rs1673133219	NC_000002.12:29532016:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.1050G>T (p.Ser350=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001118030	2	29754885	2	29532019	1118030	1091274	rs749145522	NC_000002.12:29532018:C:A	single nucleotide variant	synonymous variant	Likely benign	May 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1050G>A (p.Ser350=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000577505	2	29754885	2	29532019	577505	560601	rs749145522	NC_000002.12:29532018:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1049C>T (p.Ser350Leu)	ALK	S350L	Neuroblastoma, susceptibility to, 3	VCV000653709	2	29754886	2	29532020	653709	629901	rs759426382	NC_000002.12:29532019:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1048T>G (p.Ser350Ala)	ALK	S350A	Hereditary cancer-predisposing syndrome	VCV003223780	2	29754887	2	29532021	3223780	3380803		NC_000002.12:29532020:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1047C>G (p.Val349=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001133512	2	29754888	2	29532022	1133512	1112771	rs1673133465	NC_000002.12:29532021:G:C	single nucleotide variant	synonymous variant	Likely benign	Nov 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1045G>A (p.Val349Ile)	ALK	V349I	not provided|Neuroblastoma, susceptibility to, 3	VCV000641781	2	29754890	2	29532024	641781	629902	rs370848188	NC_000002.12:29532023:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1044C>G (p.Ala348=)	ALK		Hereditary cancer-predisposing syndrome	VCV001774938	2	29754891	2	29532025	1774938	1833523		NC_000002.12:29532024:G:C	single nucleotide variant	synonymous variant	Likely benign	Aug 3, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1044C>T (p.Ala348=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538283	2	29754891	2	29532025	538283	518248	rs200293454	NC_000002.12:29532024:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 15, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1043C>T (p.Ala348Val)	ALK	A348V	Neuroblastoma, susceptibility to, 3	VCV001910712	2	29754892	2	29532026	1910712	1966185		NC_000002.12:29532025:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1043C>A (p.Ala348Asp)	ALK	A348D	Neuroblastoma, susceptibility to, 3|not provided	VCV000656656	2	29754892	2	29532026	656656	629903	rs760596486	NC_000002.12:29532025:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1042G>A (p.Ala348Thr)	ALK	A348T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000567481	2	29754893	2	29532027	567481	561366	rs763611527	NC_000002.12:29532026:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1041G>A (p.Leu347=)	ALK		Hereditary cancer-predisposing syndrome	VCV001774298	2	29754894	2	29532028	1774298	1827404		NC_000002.12:29532027:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 24, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.1039C>A (p.Leu347Met)	ALK	L347M	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001933571	2	29754896	2	29532030	1933571	1992452		NC_000002.12:29532029:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1039C>T (p.Leu347=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000760598	2	29754896	2	29532030	760598	763188	rs747355737	NC_000002.12:29532029:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1037C>T (p.Thr346Ile)	ALK	T346I	Neuroblastoma, susceptibility to, 3	VCV001471752	2	29754898	2	29532032	1471752	1388779	rs981203904	NC_000002.12:29532031:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1036A>C (p.Thr346Pro)	ALK	T346P	Neuroblastoma, susceptibility to, 3	VCV001015171	2	29754899	2	29532033	1015171	1004004	rs1673134390	NC_000002.12:29532032:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1035C>T (p.Cys345=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001082622	2	29754900	2	29532034	1082622	1069543	rs2148158692	NC_000002.12:29532033:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 27, 2020	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1034G>T (p.Cys345Phe)	ALK	C345F	Neuroblastoma, susceptibility to, 3	VCV002749956	2	29754901	2	29532035	2749956	2918914		NC_000002.12:29532034:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1034G>A (p.Cys345Tyr)	ALK	C345Y	Neuroblastoma, susceptibility to, 3	VCV000566296	2	29754901	2	29532035	566296	561368	rs1558370551	NC_000002.12:29532034:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1032C>G (p.His344Gln)	ALK	H344Q	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002086197	2	29754903	2	29532037	2086197	2144113		NC_000002.12:29532036:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1032C>T (p.His344=)	ALK		not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001115994	2	29754903	2	29532037	1115994	1091275	rs2148158695	NC_000002.12:29532036:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 14, 2023	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.1031A>C (p.His344Pro)	ALK	H344P	Hereditary cancer-predisposing syndrome	VCV003223779	2	29754904	2	29532038	3223779	3380802		NC_000002.12:29532037:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1031A>G (p.His344Arg)	ALK	H344R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002128274	2	29754904	2	29532038	2128274	2182277		NC_000002.12:29532037:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1030C>A (p.His344Asn)	ALK	H344N	Neuroblastoma, susceptibility to, 3	VCV002140791	2	29754905	2	29532039	2140791	1875289		NC_000002.12:29532038:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1029G>A (p.Glu343=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001770503	2	29754906	2	29532040	1770503	1826205		NC_000002.12:29532039:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1029G>T (p.Glu343Asp)	ALK	E343D	Neuroblastoma, susceptibility to, 3	VCV000948373	2	29754906	2	29532040	948373	922731	rs750010561	NC_000002.12:29532039:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1027G>A (p.Glu343Lys)	ALK	E343K	Neuroblastoma, susceptibility to, 3	VCV001002031	2	29754908	2	29532042	1002031	988742	rs1673134817	NC_000002.12:29532041:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.1026T>C (p.Ser342=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538308	2	29754909	2	29532043	538308	518250	rs958346511	NC_000002.12:29532042:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1025G>A (p.Ser342Asn)	ALK	S342N	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001383403	2	29754910	2	29532044	1383403	1354544	rs2148158708	NC_000002.12:29532043:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1024A>C (p.Ser342Arg)	ALK	S342R	Neuroblastoma, susceptibility to, 3	VCV000664494	2	29754911	2	29532045	664494	629904	rs973756393	NC_000002.12:29532044:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1024A>G (p.Ser342Gly)	ALK	S342G	Neuroblastoma, susceptibility to, 3	VCV000538213	2	29754911	2	29532045	538213	518116	rs973756393	NC_000002.12:29532044:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.1022G>A (p.Ser341Asn)	ALK	S341N	Neuroblastoma, susceptibility to, 3	VCV000567783	2	29754913	2	29532047	567783	558404	rs1279941719	NC_000002.12:29532046:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.1021A>G (p.Ser341Gly)	ALK	S341G	Neuroblastoma, susceptibility to, 3	VCV001056340	2	29754914	2	29532048	1056340	1041419	rs755433685	NC_000002.12:29532047:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1017G>C (p.Arg339Ser)	ALK	R339S	Neuroblastoma, susceptibility to, 3	VCV003727420	2	29754918	2	29532052	3727420	3861645		NC_000002.12:29532051:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1017G>A (p.Arg339=)	ALK		Hereditary cancer-predisposing syndrome	VCV002586684	2	29754918	2	29532052	2586684	2756867		NC_000002.12:29532051:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 12, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1012A>T (p.Met338Leu)	ALK	M338L	Hereditary cancer-predisposing syndrome	VCV003525304	2	29754923	2	29532057	3525304	3685660		NC_000002.12:29532056:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1012A>G (p.Met338Val)	ALK	M338V	Hereditary cancer-predisposing syndrome	VCV003285919	2	29754923	2	29532057	3285919	3444659		NC_000002.12:29532056:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1009T>C (p.Trp337Arg)	ALK	W337R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001034976	2	29754926	2	29532060	1034976	1024469	rs886726765	NC_000002.12:29532059:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1008G>T (p.Pro336=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002724276	2	29754927	2	29532061	2724276	2892078		NC_000002.12:29532060:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.1008G>A (p.Pro336=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000701094	2	29754927	2	29532061	701094	686194	rs757878984	NC_000002.12:29532060:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1007C>T (p.Pro336Leu)	ALK	P336L	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000839027	2	29754928	2	29532062	839027	826381	rs1450440625	NC_000002.12:29532061:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1001T>G (p.Leu334Arg)	ALK	L334R	Hereditary cancer-predisposing syndrome	VCV003524637	2	29754934	2	29532068	3524637	3679302		NC_000002.12:29532067:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.1001T>A (p.Leu334Gln)	ALK	L334Q	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001470149	2	29754934	2	29532068	1470149	1375992	rs2148158767	NC_000002.12:29532067:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.1000C>T (p.Leu334=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001082845	2	29754935	2	29532069	1082845	1069544	rs2148158771	NC_000002.12:29532068:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.994A>G (p.Thr332Ala)	ALK	T332A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000939348	2	29754941	2	29532075	939348	931372	rs1673135833	NC_000002.12:29532074:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.993C>T (p.His331=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002091572	2	29754942	2	29532076	2091572	2155955		NC_000002.12:29532075:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.991C>T (p.His331Tyr)	ALK	H331Y	Neuroblastoma, susceptibility to, 3	VCV003619997	2	29754944	2	29532078	3619997	3753837		NC_000002.12:29532077:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.990G>T (p.Lys330Asn)	ALK	K330N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002561065	2	29754945	2	29532079	2561065	2717224		NC_000002.12:29532078:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.990G>A (p.Lys330=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001544634	2	29754945	2	29532079	1544634	1524911	rs1247687646	NC_000002.12:29532078:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.989A>G (p.Lys330Arg)	ALK	K330R	Neuroblastoma, susceptibility to, 3	VCV001052901	2	29754946	2	29532080	1052901	1041420	rs781677582	NC_000002.12:29532079:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.985T>G (p.Ser329Ala)	ALK	S329A	Neuroblastoma, susceptibility to, 3	VCV001463154	2	29754950	2	29532084	1463154	1511591	rs1673136181	NC_000002.12:29532083:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.984C>T (p.Asp328=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001768382	2	29754951	2	29532085	1768382	1828792		NC_000002.12:29532084:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.983A>G (p.Asp328Gly)	ALK	D328G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000839521	2	29754952	2	29532086	839521	826382	rs556138942	NC_000002.12:29532085:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.980C>G (p.Ala327Gly)	ALK	A327G	Hereditary cancer-predisposing syndrome	VCV001768278	2	29754955	2	29532089	1768278	1825711		NC_000002.12:29532088:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.980C>A (p.Ala327Asp)	ALK	A327D	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000582548	2	29754955	2	29532089	582548	558406	rs1414553731	NC_000002.12:29532088:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.979G>T (p.Ala327Ser)	ALK	A327S	Neuroblastoma, susceptibility to, 3	VCV003722337	2	29754956	2	29532090	3722337	3860441		NC_000002.12:29532089:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.978A>G (p.Ser326=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001581033	2	29754957	2	29532091	1581033	1566160	rs756622399	NC_000002.12:29532090:T:C	single nucleotide variant	synonymous variant	Likely benign	May 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.974C>T (p.Thr325Ile)	ALK	T325I	Hereditary cancer-predisposing syndrome	VCV003223935	2	29754961	2	29532095	3223935	3380957		NC_000002.12:29532094:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.972C>A (p.Asn324Lys)	ALK	N324K	Hereditary cancer-predisposing syndrome	VCV003285936	2	29754963	2	29532097	3285936	3444676		NC_000002.12:29532096:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.971A>G (p.Asn324Ser)	ALK	N324S	Neuroblastoma, susceptibility to, 3	VCV000580126	2	29754964	2	29532098	580126	560603	rs1558370621	NC_000002.12:29532097:T:C	single nucleotide variant	missense variant	Uncertain significance	May 30, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.970A>G (p.Asn324Asp)	ALK	N324D	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001767932	2	29754965	2	29532099	1767932	1825365		NC_000002.12:29532098:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.966_968del (p.Leu323del)	ALK	L323del	Neuroblastoma, susceptibility to, 3	VCV000950601	2	29754967 - 29754969	2	29532101 - 29532103	950601	922732	rs1673136781	NC_000002.12:29532100:AGAAG:AG	Deletion	inframe_deletion	Uncertain significance	Aug 17, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.967C>T (p.Leu323Phe)	ALK	L323F	Neuroblastoma, susceptibility to, 3	VCV001720326	2	29754968	2	29532102	1720326	1779365		NC_000002.12:29532101:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.966T>G (p.Leu322=)	ALK		Hereditary cancer-predisposing syndrome	VCV003286201	2	29754969	2	29532103	3286201	3455024		NC_000002.12:29532102:A:C	single nucleotide variant	synonymous variant	Likely benign	May 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.953-14_964dup	ALK		Neuroblastoma, susceptibility to, 3	VCV003662732	2	29754970 - 29754971	2	29532104 - 29532105	3662732	3791102		NC_000002.12:29532104:GGAGAAAGGAGCCTGGAAAGAGACAGGGA:GGAGAAAGGAGCCTGGAAAGAGACAGGGAGAAAGGAGCCTGGAAAGAGACAGGGA	Duplication	splice acceptor variant	Uncertain significance	Aug 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.964C>T (p.Leu322Phe)	ALK	L322F	Neuroblastoma, susceptibility to, 3	VCV003661421	2	29754971	2	29532105	3661421	3801100		NC_000002.12:29532104:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.963C>T (p.Leu321=)	ALK		Hereditary cancer-predisposing syndrome	VCV001767633	2	29754972	2	29532106	1767633	1818284		NC_000002.12:29532105:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 25, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.961C>T (p.Leu321Phe)	ALK	L321F	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002118937	2	29754974	2	29532108	2118937	2172946		NC_000002.12:29532107:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.960T>C (p.Phe320=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001161639	2	29754975	2	29532109	1161639	1133675	rs749339430	NC_000002.12:29532108:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.958T>C (p.Phe320Leu)	ALK	F320L	Hereditary cancer-predisposing syndrome	VCV003223934	2	29754977	2	29532111	3223934	3380956		NC_000002.12:29532110:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.957C>G (p.Ser319=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001159555	2	29754978	2	29532112	1159555	1133676	rs1673137075	NC_000002.12:29532111:G:C	single nucleotide variant	synonymous variant	Likely benign	Mar 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.957C>T (p.Ser319=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001128200	2	29754978	2	29532112	1128200	1112772	rs1673137075	NC_000002.12:29532111:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 15, 2021	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.954C>G (p.Gly318=)	ALK		Hereditary cancer-predisposing syndrome|not provided	VCV002561060	2	29754981	2	29532115	2561060	2717219		NC_000002.12:29532114:G:C	single nucleotide variant	synonymous variant	Likely benign	Apr 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.954C>A (p.Gly318=)	ALK		Hereditary cancer-predisposing syndrome	VCV000823324	2	29754981	2	29532115	823324	806914	rs1045878688	NC_000002.12:29532114:G:T	single nucleotide variant	synonymous variant	Likely benign	Jul 27, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.953G>T (p.Gly318Val)	ALK	G318V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002919595	2	29754982	2	29532116	2919595	3072477		NC_000002.12:29532115:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.953G>C (p.Gly318Ala)	ALK	G318A	Neuroblastoma, susceptibility to, 3	VCV002147979	2	29754982	2	29532116	2147979	1877291		NC_000002.12:29532115:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.953G>A (p.Gly318Asp)	ALK	G318D	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538212	2	29754982	2	29532116	538212	518252	rs770893847	NC_000002.12:29532115:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.953-2A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002720597	2	29754984	2	29532118	2720597	2891000		NC_000002.12:29532117:T:C	single nucleotide variant	splice acceptor variant	Uncertain significance	Jun 5, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.953-4C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001579050	2	29754986	2	29532120	1579050	1565041	rs1305945636	NC_000002.12:29532119:G:A	single nucleotide variant	intron variant	Likely benign	Apr 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.953-5T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001114137	2	29754987	2	29532121	1114137	1091276	rs746073787	NC_000002.12:29532120:A:G	single nucleotide variant	intron variant	Likely benign	Nov 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.953-7T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002179377	2	29754989	2	29532123	2179377	1919774		NC_000002.12:29532122:A:G	single nucleotide variant	intron variant	Likely benign	Feb 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.953-8C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000470908	2	29754990	2	29532124	470908	450928	rs1239282210	NC_000002.12:29532123:G:A	single nucleotide variant	intron variant	Likely benign	Jan 16, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.953-15C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002123477	2	29754997	2	29532131	2123477	2177376		NC_000002.12:29532130:G:A	single nucleotide variant	intron variant	Likely benign	Nov 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.953-17T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002966112	2	29754999	2	29532133	2966112	3121270		NC_000002.12:29532132:A:G	single nucleotide variant	intron variant	Likely benign	Dec 24, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.953-20T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001534022	2	29755002	2	29532136	1534022	1584512	rs2148158866	NC_000002.12:29532135:A:G	single nucleotide variant	intron variant	Likely benign	Feb 3, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.953-21G>A	ALK		not provided	VCV000676927	2	29755003	2	29532137	676927	659065	rs62131079	NC_000002.12:29532136:C:T	single nucleotide variant	intron variant	Likely benign	Jun 17, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.953-112T>A	ALK		not provided	VCV001186127	2	29755094	2	29532228	1186127	1176165	rs11899073	NC_000002.12:29532227:A:T	single nucleotide variant	intron variant	Likely benign	Jul 20, 2018	criteria provided, single submitter							
GRCh38/hg38 2p23.2-23.1(chr2:29578407-29941203)x1	ALK		See cases	VCV000147695	2	29801273 - 30164069	2	29578407 - 29941203	147695	157446			copy number loss		Benign	Oct 1, 2010	no assertion criteria provided							
NM_004304.5(ALK):c.952+192C>A	ALK		not provided	VCV000676861	2	29917524	2	29694658	676861	659156	rs13419205	NC_000002.12:29694657:G:T	single nucleotide variant	intron variant	Benign	Jun 20, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.952+19G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV003641352	2	29917697	2	29694831	3641352	3775510		NC_000002.12:29694830:C:G	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.952+19G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV003604405	2	29917697	2	29694831	3604405	3743156		NC_000002.12:29694830:C:T	single nucleotide variant	intron variant	Likely benign	Jun 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.952+18G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001651148	2	29917698	2	29694832	1651148	1578523	rs1678504078	NC_000002.12:29694831:C:T	single nucleotide variant	intron variant	Likely benign	Apr 21, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.952+17T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001662123	2	29917699	2	29694833	1662123	1577005	rs2148289521	NC_000002.12:29694832:A:C	single nucleotide variant	intron variant	Likely benign	Jul 8, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.952+16C>T	ALK		Neuroblastoma, susceptibility to, 3|not provided|not specified	VCV000516902	2	29917700	2	29694834	516902	500154	rs112736234	NC_000002.12:29694833:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.952+15G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003725343	2	29917701	2	29694835	3725343	3851246		NC_000002.12:29694834:C:A	single nucleotide variant	intron variant	Likely benign	Nov 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.952+15G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001528200	2	29917701	2	29694835	1528200	1603347	rs781259749	NC_000002.12:29694834:C:T	single nucleotide variant	intron variant	Likely benign	Jul 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.952+12G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002746281	2	29917704	2	29694838	2746281	2911791		NC_000002.12:29694837:C:T	single nucleotide variant	intron variant	Likely benign	Jul 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.952+12G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001640779	2	29917704	2	29694838	1640779	1550450	rs754270761	NC_000002.12:29694837:C:A	single nucleotide variant	intron variant	Likely benign	Jul 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.952+4A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001908244	2	29917712	2	29694846	1908244	1962428		NC_000002.12:29694845:T:C	single nucleotide variant	intron variant	Uncertain significance	Oct 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.952+3A>T	ALK		Neuroblastoma, susceptibility to, 3	VCV003725941	2	29917713	2	29694847	3725941	3857849		NC_000002.12:29694846:T:A	single nucleotide variant	intron variant	Uncertain significance	Nov 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.952+3A>G	ALK		not provided|Neuroblastoma, susceptibility to, 3	VCV000538211	2	29917713	2	29694847	538211	518214	rs1200110360	NC_000002.12:29694846:T:C	single nucleotide variant	intron variant	Uncertain significance	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.952+1G>A	ALK		not provided|Neuroblastoma, susceptibility to, 3	VCV000997488	2	29917715	2	29694849	997488	985186	rs1678504706	NC_000002.12:29694848:C:T	single nucleotide variant	splice donor variant	Uncertain significance	Apr 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.952G>A (p.Gly318Ser)	ALK	G318S	not provided|Neuroblastoma, susceptibility to, 3	VCV000239851	2	29917716	2	29694850	239851	238753	rs878854661	NC_000002.12:29694849:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.946C>G (p.Pro316Ala)	ALK	P316A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002586698	2	29917722	2	29694856	2586698	2756881		NC_000002.12:29694855:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.946C>T (p.Pro316Ser)	ALK	P316S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001517391	2	29917722	2	29694856	1517391	1515550	rs1254406721	NC_000002.12:29694855:G:A	single nucleotide variant	missense variant	Uncertain significance	May 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.946C>A (p.Pro316Thr)	ALK	P316T	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000646572	2	29917722	2	29694856	646572	629905	rs1254406721	NC_000002.12:29694855:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.945G>T (p.Met315Ile)	ALK	M315I	Neuroblastoma, susceptibility to, 3	VCV001056904	2	29917723	2	29694857	1056904	1041421	rs2148289584	NC_000002.12:29694856:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.944T>C (p.Met315Thr)	ALK	M315T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001039025	2	29917724	2	29694858	1039025	1024470	rs1678504929	NC_000002.12:29694857:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.943A>T (p.Met315Leu)	ALK	M315L	Neuroblastoma, susceptibility to, 3	VCV002108065	2	29917725	2	29694859	2108065	2163238		NC_000002.12:29694858:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.940_942del (p.Glu314del)	ALK	E314del	Neuroblastoma, susceptibility to, 3	VCV003629043	2	29917726 - 29917728	2	29694860 - 29694862	3629043	3752917		NC_000002.12:29694859:CTCCT:CT	Deletion	inframe_deletion	Uncertain significance	May 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.941A>G (p.Glu314Gly)	ALK	E314G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538228	2	29917727	2	29694861	538228	518119	rs778845512	NC_000002.12:29694860:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 29, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.940G>A (p.Glu314Lys)	ALK	E314K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470907	2	29917728	2	29694862	470907	451115	rs538448899	NC_000002.12:29694861:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.939G>A (p.Lys313=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000794585	2	29917729	2	29694863	794585	781309	rs1573561713	NC_000002.12:29694862:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.937A>C (p.Lys313Gln)	ALK	K313Q	Neuroblastoma, susceptibility to, 3	VCV002802739	2	29917731	2	29694865	2802739	2970261		NC_000002.12:29694864:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.936T>C (p.Ser312=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223933	2	29917732	2	29694866	3223933	3380955		NC_000002.12:29694865:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.934_936del (p.Ser312del)	ALK	S312del	Neuroblastoma, susceptibility to, 3	VCV000940583	2	29917732 - 29917734	2	29694866 - 29694868	940583	931373	rs1678505254	NC_000002.12:29694865:AGAA:A	Deletion	inframe_deletion	Uncertain significance	Oct 11, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.935C>G (p.Ser312Cys)	ALK	S312C	Hereditary cancer-predisposing syndrome	VCV002586715	2	29917733	2	29694867	2586715	2756898		NC_000002.12:29694866:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.935C>T (p.Ser312Phe)	ALK	S312F	Hereditary cancer-predisposing syndrome	VCV002586700	2	29917733	2	29694867	2586700	2756883		NC_000002.12:29694866:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.932G>C (p.Arg311Pro)	ALK	R311P	Neuroblastoma, susceptibility to, 3	VCV000645075	2	29917736	2	29694870	645075	629906	rs150966028	NC_000002.12:29694869:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.932G>A (p.Arg311His)	ALK	R311H	Neuroblastoma, susceptibility to, 3|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000133480	2	29917736	2	29694870	133480	137219	rs150966028	NC_000002.12:29694869:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.931C>A (p.Arg311Ser)	ALK	R311S	Neuroblastoma, susceptibility to, 3	VCV000644699	2	29917737	2	29694871	644699	629907	rs149837139	NC_000002.12:29694870:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.931C>T (p.Arg311Cys)	ALK	R311C	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538222	2	29917737	2	29694871	538222	518261	rs149837139	NC_000002.12:29694870:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.930G>A (p.Glu310=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538294	2	29917738	2	29694872	538294	518263	rs367712624	NC_000002.12:29694871:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.930G>T (p.Glu310Asp)	ALK	E310D	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000335709	2	29917738	2	29694872	335709	288997	rs367712624	NC_000002.12:29694871:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.928G>C (p.Glu310Gln)	ALK	E310Q	Neuroblastoma, susceptibility to, 3	VCV001352557	2	29917740	2	29694874	1352557	1505767	rs2148289633	NC_000002.12:29694873:C:G	single nucleotide variant	missense variant	Uncertain significance	May 10, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.926C>A (p.Ala309Glu)	ALK	A309E	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001993392	2	29917742	2	29694876	1993392	2049179		NC_000002.12:29694875:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 23, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.925dup (p.Ala309fs)	ALK	A309fs	Neuroblastoma, susceptibility to, 3	VCV000658779	2	29917742 - 29917743	2	29694876 - 29694877	658779	629908	rs1573561737	NC_000002.12:29694876:CCCC:CCCCC	Duplication	frameshift variant	Uncertain significance	Jan 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.926C>T (p.Ala309Val)	ALK	A309V	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404372	2	29917742	2	29694876	404372	392769	rs748017801	NC_000002.12:29694875:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.925del (p.Ala309fs)	ALK	A309fs	Neuroblastoma, susceptibility to, 3	VCV001010541	2	29917743	2	29694877	1010541	988743	rs1573561737	NC_000002.12:29694876:CCCC:CCC	Deletion	frameshift variant	Uncertain significance	May 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.925G>A (p.Ala309Thr)	ALK	A309T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404349	2	29917743	2	29694877	404349	392772	rs145681577	NC_000002.12:29694876:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.924G>A (p.Gly308=)	ALK		Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000239850	2	29917744	2	29694878	239850	238754	rs878854660	NC_000002.12:29694877:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.920_922dup (p.Pro307_Gly308insAla)	ALK		not provided|Neuroblastoma, susceptibility to, 3	VCV000404375	2	29917745 - 29917746	2	29694879 - 29694880	404375	392996	rs746818719	NC_000002.12:29694879:CAG:CAGCAG	Duplication	inframe_insertion	Uncertain significance	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.922G>A (p.Gly308Arg)	ALK	G308R	Neuroblastoma, susceptibility to, 3	VCV000470906	2	29917746	2	29694880	470906	450813	rs1553348499	NC_000002.12:29694879:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.921T>G (p.Pro307=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001149995	2	29917747	2	29694881	1149995	1133677	rs1391544676	NC_000002.12:29694880:A:C	single nucleotide variant	synonymous variant	Likely benign	Aug 15, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.921T>C (p.Pro307=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001078983	2	29917747	2	29694881	1078983	1069545	rs1391544676	NC_000002.12:29694880:A:G	single nucleotide variant	synonymous variant	Likely benign	May 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.920C>T (p.Pro307Leu)	ALK	P307L	Neuroblastoma, susceptibility to, 3	VCV002150614	2	29917748	2	29694882	2150614	1888111		NC_000002.12:29694881:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.919C>T (p.Pro307Ser)	ALK	P307S	Neuroblastoma, susceptibility to, 3|ALK-related disorder|not provided	VCV000538176	2	29917749	2	29694883	538176	518271	rs199790669	NC_000002.12:29694882:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.918G>A (p.Gly306=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003650863	2	29917750	2	29694884	3650863	3781593		NC_000002.12:29694883:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.917G>A (p.Gly306Glu)	ALK	G306E	Neuroblastoma, susceptibility to, 3	VCV001466341	2	29917751	2	29694885	1466341	1347700	rs2148289672	NC_000002.12:29694884:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.916G>A (p.Gly306Arg)	ALK	G306R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000998990	2	29917752	2	29694886	998990	988744	rs879113112	NC_000002.12:29694885:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.915T>C (p.Asp305=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001615403	2	29917753	2	29694887	1615403	1547345	rs2148289680	NC_000002.12:29694886:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 5, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.914A>T (p.Asp305Val)	ALK	D305V	Hereditary cancer-predisposing syndrome	VCV001765958	2	29917754	2	29694888	1765958	1817908		NC_000002.12:29694887:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.914A>G (p.Asp305Gly)	ALK	D305G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000838753	2	29917754	2	29694888	838753	826383	rs774123293	NC_000002.12:29694887:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.911T>C (p.Leu304Pro)	ALK	L304P	Hereditary cancer-predisposing syndrome	VCV001765882	2	29917757	2	29694891	1765882	1817832		NC_000002.12:29694890:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.910C>A (p.Leu304Met)	ALK	L304M	Hereditary cancer-predisposing syndrome	VCV003524736	2	29917758	2	29694892	3524736	3688975		NC_000002.12:29694891:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.910C>T (p.Leu304=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001997830	2	29917758	2	29694892	1997830	2057050		NC_000002.12:29694891:G:A	single nucleotide variant	synonymous variant	Likely benign	May 22, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.906C>G (p.Asp302Glu)	ALK	D302E	Hereditary cancer-predisposing syndrome	VCV003524776	2	29917762	2	29694896	3524776	3689015		NC_000002.12:29694895:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.906C>A (p.Asp302Glu)	ALK	D302E	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002566555	2	29917762	2	29694896	2566555	2734398		NC_000002.12:29694895:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.905A>G (p.Asp302Gly)	ALK	D302G	Hereditary cancer-predisposing syndrome	VCV001765616	2	29917763	2	29694897	1765616	1821256		NC_000002.12:29694896:T:C	single nucleotide variant	missense variant	Uncertain significance	May 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.904G>C (p.Asp302His)	ALK	D302H	Neuroblastoma, susceptibility to, 3	VCV000852636	2	29917764	2	29694898	852636	826384	rs1275855734	NC_000002.12:29694897:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.902T>C (p.Met301Thr)	ALK	M301T	Hereditary cancer-predisposing syndrome	VCV003223932	2	29917766	2	29694900	3223932	3380954		NC_000002.12:29694899:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.902T>A (p.Met301Lys)	ALK	M301K	Neuroblastoma, susceptibility to, 3	VCV000840995	2	29917766	2	29694900	840995	826385	rs372244228	NC_000002.12:29694899:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.901A>G (p.Met301Val)	ALK	M301V	Neuroblastoma, susceptibility to, 3	VCV000972626	2	29917767	2	29694901	972626	953076	rs754427541	NC_000002.12:29694900:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.900G>T (p.Gln300His)	ALK	Q300H	Neuroblastoma, susceptibility to, 3	VCV001428091	2	29917768	2	29694902	1428091	1464246	rs1233069820	NC_000002.12:29694901:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.899A>G (p.Gln300Arg)	ALK	Q300R	Hereditary cancer-predisposing syndrome	VCV001765373	2	29917769	2	29694903	1765373	1821014		NC_000002.12:29694902:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.898C>A (p.Gln300Lys)	ALK	Q300K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001478016	2	29917770	2	29694904	1478016	1351524	rs1254596043	NC_000002.12:29694903:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.897C>T (p.Ser299=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001161743	2	29917771	2	29694905	1161743	1133678	rs1389708232	NC_000002.12:29694904:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 26, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.896C>A (p.Ser299Tyr)	ALK	S299Y	Neuroblastoma, susceptibility to, 3	VCV002700590	2	29917772	2	29694906	2700590	2855589		NC_000002.12:29694905:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.894C>T (p.Ala298=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001160396	2	29917774	2	29694908	1160396	1133679	rs2148289738	NC_000002.12:29694907:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.893C>A (p.Ala298Asp)	ALK	A298D	Hereditary cancer-predisposing syndrome	VCV001765179	2	29917775	2	29694909	1765179	1824673		NC_000002.12:29694908:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.893C>G (p.Ala298Gly)	ALK	A298G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538202	2	29917775	2	29694909	538202	518130	rs750435024	NC_000002.12:29694908:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.893C>T (p.Ala298Val)	ALK	A298V	Neuroblastoma, susceptibility to, 3	VCV000470905	2	29917775	2	29694909	470905	451122	rs750435024	NC_000002.12:29694908:G:A	single nucleotide variant	missense variant	Uncertain significance	May 27, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.892G>T (p.Ala298Ser)	ALK	A298S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001016842	2	29917776	2	29694910	1016842	1004005	rs577240830	NC_000002.12:29694909:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.892G>A (p.Ala298Thr)	ALK	A298T	Neuroblastoma, susceptibility to, 3|not provided	VCV000404355	2	29917776	2	29694910	404355	392655	rs577240830	NC_000002.12:29694909:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.891G>A (p.Glu297=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001922899	2	29917777	2	29694911	1922899	1979645		NC_000002.12:29694910:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.889G>C (p.Glu297Gln)	ALK	E297Q	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002562269	2	29917779	2	29694913	2562269	2721122		NC_000002.12:29694912:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.889G>A (p.Glu297Lys)	ALK	E297K	Neuroblastoma, susceptibility to, 3	VCV001404485	2	29917779	2	29694913	1404485	1480181	rs2148289760	NC_000002.12:29694912:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.888G>A (p.Glu296=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000858086	2	29917780	2	29694914	858086	826386	rs1678508164	NC_000002.12:29694913:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.887A>T (p.Glu296Val)	ALK	E296V	Neuroblastoma, susceptibility to, 3	VCV001024943	2	29917781	2	29694915	1024943	1004006	rs1678508228	NC_000002.12:29694914:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.886G>C (p.Glu296Gln)	ALK	E296Q	Neuroblastoma, susceptibility to, 3	VCV000656385	2	29917782	2	29694916	656385	629909	rs56077855	NC_000002.12:29694915:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.886G>A (p.Glu296Lys)	ALK	E296K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538274	2	29917782	2	29694916	538274	518160	rs56077855	NC_000002.12:29694915:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.885C>A (p.Ser295=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001764902	2	29917783	2	29694917	1764902	1824396		NC_000002.12:29694916:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.885C>T (p.Ser295=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000412938	2	29917783	2	29694917	412938	392657	rs1060503882	NC_000002.12:29694916:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.884C>T (p.Ser295Phe)	ALK	S295F	Neuroblastoma, susceptibility to, 3	VCV000579201	2	29917784	2	29694918	579201	558408	rs754823963	NC_000002.12:29694917:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.882C>T (p.Pro294=)	ALK		Hereditary cancer-predisposing syndrome	VCV001764798	2	29917786	2	29694920	1764798	1814619		NC_000002.12:29694919:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.881C>T (p.Pro294Leu)	ALK	P294L	Neuroblastoma, susceptibility to, 3	VCV001053663	2	29917787	2	29694921	1053663	1041422	rs1678508737	NC_000002.12:29694920:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.879C>G (p.Ile293Met)	ALK	I293M	Hereditary cancer-predisposing syndrome	VCV002566594	2	29917789	2	29694923	2566594	2734437		NC_000002.12:29694922:G:C	single nucleotide variant	missense variant	Uncertain significance	May 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.879C>T (p.Ile293=)	ALK		Hereditary cancer-predisposing syndrome	VCV001764682	2	29917789	2	29694923	1764682	1814503		NC_000002.12:29694922:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.877A>C (p.Ile293Leu)	ALK	I293L	Hereditary cancer-predisposing syndrome	VCV003524109	2	29917791	2	29694925	3524109	3682277		NC_000002.12:29694924:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.877A>T (p.Ile293Phe)	ALK	I293F	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002586705	2	29917791	2	29694925	2586705	2756888		NC_000002.12:29694924:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.877A>G (p.Ile293Val)	ALK	I293V	Neuroblastoma, susceptibility to, 3	VCV001482563	2	29917791	2	29694925	1482563	1441928	rs2148289798	NC_000002.12:29694924:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.876C>T (p.Arg292=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002168911	2	29917792	2	29694926	2168911	1906736		NC_000002.12:29694925:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.875G>T (p.Arg292Leu)	ALK	R292L	Neuroblastoma, susceptibility to, 3	VCV001412952	2	29917793	2	29694927	1412952	1356549	rs149145987	NC_000002.12:29694926:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.875G>A (p.Arg292His)	ALK	R292H	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000404322	2	29917793	2	29694927	404322	392773	rs149145987	NC_000002.12:29694926:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 9, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.874C>G (p.Arg292Gly)	ALK	R292G	Neuroblastoma, susceptibility to, 3	VCV001445281	2	29917794	2	29694928	1445281	1397607	rs201750304	NC_000002.12:29694927:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.874C>T (p.Arg292Cys)	ALK	R292C	not provided|Neuroblastoma, susceptibility to, 3	VCV000576969	2	29917794	2	29694928	576969	560605	rs201750304	NC_000002.12:29694927:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.873C>T (p.Arg291=)	ALK		Hereditary cancer-predisposing syndrome	VCV002452127	2	29917795	2	29694929	2452127	2426767		NC_000002.12:29694928:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.872G>A (p.Arg291His)	ALK	R291H	Ovarian cancer|not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404374	2	29917796	2	29694930	404374	392778	rs572340007	NC_000002.12:29694929:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.871C>A (p.Arg291Ser)	ALK	R291S	Neuroblastoma, susceptibility to, 3	VCV000659947	2	29917797	2	29694931	659947	629910	rs748854412	NC_000002.12:29694930:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.871C>T (p.Arg291Cys)	ALK	R291C	Neuroblastoma, susceptibility to, 3|not provided	VCV000470903	2	29917797	2	29694931	470903	451110	rs748854412	NC_000002.12:29694930:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.870G>A (p.Trp290Ter)	ALK	W290*	Neuroblastoma, susceptibility to, 3	VCV000567185	2	29917798	2	29694932	567185	561371	rs1558446122	NC_000002.12:29694931:C:T	single nucleotide variant	nonsense	Uncertain significance	Nov 25, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.867C>T (p.Ser289=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002906757	2	29917801	2	29694935	2906757	3069654		NC_000002.12:29694934:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.866C>T (p.Ser289Phe)	ALK	S289F	Neuroblastoma, susceptibility to, 3	VCV002149092	2	29917802	2	29694936	2149092	1877540		NC_000002.12:29694935:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.865T>C (p.Ser289Pro)	ALK	S289P	Neuroblastoma, susceptibility to, 3	VCV001042330	2	29917803	2	29694937	1042330	1024471	rs1678509684	NC_000002.12:29694936:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.864G>C (p.Trp288Cys)	ALK	W288C	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002954865	2	29917804	2	29694938	2954865	3115219		NC_000002.12:29694937:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.864G>T (p.Trp288Cys)	ALK	W288C	Neuroblastoma, susceptibility to, 3	VCV000953433	2	29917804	2	29694938	953433	942879	rs1678509747	NC_000002.12:29694937:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.863G>A (p.Trp288Ter)	ALK	W288*	Neuroblastoma, susceptibility to, 3	VCV001053895	2	29917805	2	29694939	1053895	1041423	rs1678509815	NC_000002.12:29694938:C:T	single nucleotide variant	nonsense	Uncertain significance	Jun 11, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.863G>T (p.Trp288Leu)	ALK	W288L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000968678	2	29917805	2	29694939	968678	953077	rs1678509815	NC_000002.12:29694938:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.862T>G (p.Trp288Gly)	ALK	W288G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002418236	2	29917806	2	29694940	2418236	1948250		NC_000002.12:29694939:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.861C>T (p.Ser287=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001608547	2	29917807	2	29694941	1608547	1659965	rs1321970113	NC_000002.12:29694940:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 28, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.861C>G (p.Ser287Arg)	ALK	S287R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001404311	2	29917807	2	29694941	1404311	1480008	rs1321970113	NC_000002.12:29694940:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.858G>A (p.Gln286=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002566591	2	29917810	2	29694944	2566591	2734434		NC_000002.12:29694943:C:T	single nucleotide variant	synonymous variant	Likely benign	May 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.858G>C (p.Gln286His)	ALK	Q286H	not provided	VCV002503132	2	29917810	2	29694944	2503132	2668313		NC_000002.12:29694943:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.851G>A (p.Arg284Lys)	ALK	R284K	Neuroblastoma, susceptibility to, 3	VCV000567496	2	29917817	2	29694951	567496	558055	rs1558446131	NC_000002.12:29694950:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.850A>G (p.Arg284Gly)	ALK	R284G	Neuroblastoma, susceptibility to, 3	VCV001487419	2	29917818	2	29694952	1487419	1485312	rs1199266892	NC_000002.12:29694951:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.850A>T (p.Arg284Trp)	ALK	R284W	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000841412	2	29917818	2	29694952	841412	826387	rs1199266892	NC_000002.12:29694951:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.848T>G (p.Leu283Arg)	ALK	L283R	Hereditary cancer-predisposing syndrome	VCV003223931	2	29917820	2	29694954	3223931	3380953		NC_000002.12:29694953:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.847C>T (p.Leu283Phe)	ALK	L283F	Hereditary cancer-predisposing syndrome	VCV003223930	2	29917821	2	29694955	3223930	3380952		NC_000002.12:29694954:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.846C>T (p.Asp282=)	ALK		not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000392109	2	29917822	2	29694956	392109	366357	rs56116528	NC_000002.12:29694955:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.844G>C (p.Asp282His)	ALK	D282H	Hereditary cancer-predisposing syndrome	VCV002562272	2	29917824	2	29694958	2562272	2721125		NC_000002.12:29694957:C:G	single nucleotide variant	missense variant	Uncertain significance	May 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.844G>T (p.Asp282Tyr)	ALK	D282Y	Neuroblastoma, susceptibility to, 3	VCV002004682	2	29917824	2	29694958	2004682	2058748		NC_000002.12:29694957:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.844G>A (p.Asp282Asn)	ALK	D282N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001006044	2	29917824	2	29694958	1006044	988745	rs1678510612	NC_000002.12:29694957:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.843T>A (p.His281Gln)	ALK	H281Q	Neuroblastoma, susceptibility to, 3	VCV000538210	2	29917825	2	29694959	538210	518272	rs759250272	NC_000002.12:29694958:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.842A>G (p.His281Arg)	ALK	H281R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000843056	2	29917826	2	29694960	843056	826388	rs1678510762	NC_000002.12:29694959:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.841C>A (p.His281Asn)	ALK	H281N	Hereditary cancer-predisposing syndrome	VCV003523152	2	29917827	2	29694961	3523152	3688710		NC_000002.12:29694960:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.841C>T (p.His281Tyr)	ALK	H281Y	Neuroblastoma, susceptibility to, 3	VCV002057217	2	29917827	2	29694961	2057217	2106039		NC_000002.12:29694960:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.839T>G (p.Leu280Arg)	ALK	L280R	Hereditary cancer-predisposing syndrome	VCV002452131	2	29917829	2	29694963	2452131	2426771		NC_000002.12:29694962:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.839T>C (p.Leu280Pro)	ALK	L280P	Neuroblastoma, susceptibility to, 3	VCV001357738	2	29917829	2	29694963	1357738	1367635	rs764532876	NC_000002.12:29694962:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.838C>G (p.Leu280Val)	ALK	L280V	Neuroblastoma, susceptibility to, 3	VCV002703882	2	29917830	2	29694964	2703882	2856308		NC_000002.12:29694963:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.838C>T (p.Leu280=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001570945	2	29917830	2	29694964	1570945	1646173	rs1287899598	NC_000002.12:29694963:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.836C>G (p.Pro279Arg)	ALK	P279R	Neuroblastoma, susceptibility to, 3	VCV003677375	2	29917832	2	29694966	3677375	3817576		NC_000002.12:29694965:G:C	single nucleotide variant	missense variant	Uncertain significance	May 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.833C>G (p.Pro278Arg)	ALK	P278R	Neuroblastoma, susceptibility to, 3	VCV001468257	2	29917835	2	29694969	1468257	1362502	rs199703254	NC_000002.12:29694968:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.833C>T (p.Pro278Leu)	ALK	P278L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000581011	2	29917835	2	29694969	581011	561392	rs199703254	NC_000002.12:29694968:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 8, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.832C>T (p.Pro278Ser)	ALK	P278S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001692788	2	29917836	2	29694970	1692788	1685228	rs762417760	NC_000002.12:29694969:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.832C>A (p.Pro278Thr)	ALK	P278T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001408528	2	29917836	2	29694970	1408528	1500194	rs762417760	NC_000002.12:29694969:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 6, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.831C>G (p.Ser277=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000710534	2	29917837	2	29694971	710534	719841	rs765615879	NC_000002.12:29694970:G:C	single nucleotide variant	synonymous variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.830C>G (p.Ser277Cys)	ALK	S277C	Neuroblastoma, susceptibility to, 3	VCV001379234	2	29917838	2	29694972	1379234	1486463	rs1486167712	NC_000002.12:29694971:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.830C>T (p.Ser277Phe)	ALK	S277F	Neuroblastoma, susceptibility to, 3	VCV000567231	2	29917838	2	29694972	567231	561401	rs1486167712	NC_000002.12:29694971:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.830C>A (p.Ser277Tyr)	ALK	S277Y	Neuroblastoma, susceptibility to, 3	VCV000538217	2	29917838	2	29694972	538217	518216	rs1486167712	NC_000002.12:29694971:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.828T>C (p.Tyr276=)	ALK		Hereditary cancer-predisposing syndrome	VCV001762769	2	29917840	2	29694974	1762769	1817167		NC_000002.12:29694973:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 29, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.826T>C (p.Tyr276His)	ALK	Y276H	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538268	2	29917842	2	29694976	538268	518132	rs1553348530	NC_000002.12:29694975:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.825G>A (p.Glu275=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001922996	2	29917843	2	29694977	1922996	1979742		NC_000002.12:29694976:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.825G>T (p.Glu275Asp)	ALK	E275D	Neuroblastoma, susceptibility to, 3	VCV001035164	2	29917843	2	29694977	1035164	1024472	rs924625340	NC_000002.12:29694976:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.824A>G (p.Glu275Gly)	ALK	E275G	Neuroblastoma, susceptibility to, 3	VCV003689726	2	29917844	2	29694978	3689726	3823641		NC_000002.12:29694977:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.823G>C (p.Glu275Gln)	ALK	E275Q	Neuroblastoma, susceptibility to, 3	VCV002161533	2	29917845	2	29694979	2161533	1887312		NC_000002.12:29694978:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.822G>A (p.Leu274=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538182	2	29917846	2	29694980	538182	518135	rs1265006535	NC_000002.12:29694979:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.821T>C (p.Leu274Pro)	ALK	L274P	Neuroblastoma, susceptibility to, 3	VCV003586404	2	29917847	2	29694981	3586404	3717111		NC_000002.12:29694980:A:G	single nucleotide variant	missense variant	Uncertain significance	May 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.820C>A (p.Leu274Met)	ALK	L274M	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001470046	2	29917848	2	29694982	1470046	1375889	rs2148289980	NC_000002.12:29694981:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.819G>A (p.Glu273=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV003223929	2	29917849	2	29694983	3223929	3380951		NC_000002.12:29694982:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.819G>T (p.Glu273Asp)	ALK	E273D	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000646901	2	29917849	2	29694983	646901	629911	rs758537157	NC_000002.12:29694982:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 26, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.817G>T (p.Glu273Ter)	ALK	E273*	Neuroblastoma, susceptibility to, 3	VCV002055716	2	29917851	2	29694985	2055716	2116168		NC_000002.12:29694984:C:A	single nucleotide variant	nonsense	Uncertain significance	Jul 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.817G>A (p.Glu273Lys)	ALK	E273K	Neuroblastoma, susceptibility to, 3	VCV001062252	2	29917851	2	29694985	1062252	1041424	rs2148289990	NC_000002.12:29694984:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.816T>C (p.Cys272=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001109220	2	29917852	2	29694986	1109220	1091277	rs1678511938	NC_000002.12:29694985:A:G	single nucleotide variant	synonymous variant	Likely benign	Jun 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.815G>A (p.Cys272Tyr)	ALK	C272Y	Hereditary cancer-predisposing syndrome	VCV001762220	2	29917853	2	29694987	1762220	1820356		NC_000002.12:29694986:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.814T>C (p.Cys272Arg)	ALK	C272R	Neuroblastoma, susceptibility to, 3	VCV002180826	2	29917854	2	29694988	2180826	1919927		NC_000002.12:29694987:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.813del (p.Cys272fs)	ALK	C272fs	Neuroblastoma, susceptibility to, 3	VCV002061703	2	29917855	2	29694989	2061703	2120851		NC_000002.12:29694988:GGGG:GGG	Deletion	frameshift variant	Uncertain significance	Dec 27, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.812C>G (p.Pro271Arg)	ALK	P271R	Neuroblastoma, susceptibility to, 3	VCV000470902	2	29917856	2	29694990	470902	450929	rs1553348534	NC_000002.12:29694989:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.811C>A (p.Pro271Thr)	ALK	P271T	Hereditary cancer-predisposing syndrome	VCV003285695	2	29917857	2	29694991	3285695	3440926		NC_000002.12:29694990:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.810C>T (p.Phe270=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001128694	2	29917858	2	29694992	1128694	1112773	rs575893409	NC_000002.12:29694991:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.808T>C (p.Phe270Leu)	ALK	F270L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000133481	2	29917860	2	29694994	133481	137220	rs143229596	NC_000002.12:29694993:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.807C>T (p.Asp269=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001900731	2	29917861	2	29694995	1900731	1963561		NC_000002.12:29694994:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.806A>G (p.Asp269Gly)	ALK	D269G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003523409	2	29917862	2	29694996	3523409	3685082		NC_000002.12:29694995:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.806A>T (p.Asp269Val)	ALK	D269V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002130842	2	29917862	2	29694996	2130842	2186137		NC_000002.12:29694995:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.798C>T (p.Cys266=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003645422	2	29917870	2	29695004	3645422	3783837		NC_000002.12:29695003:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.797G>A (p.Cys266Tyr)	ALK	C266Y	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001761461	2	29917871	2	29695005	1761461	1813768		NC_000002.12:29695004:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.796T>A (p.Cys266Ser)	ALK	C266S	Neuroblastoma, susceptibility to, 3	VCV003658944	2	29917872	2	29695006	3658944	3793941		NC_000002.12:29695005:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.795G>A (p.Glu265=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002714609	2	29917873	2	29695007	2714609	2879457		NC_000002.12:29695006:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.794A>T (p.Glu265Val)	ALK	E265V	Hereditary cancer-predisposing syndrome	VCV003524596	2	29917874	2	29695008	3524596	3679261		NC_000002.12:29695007:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.794A>G (p.Glu265Gly)	ALK	E265G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000575253	2	29917874	2	29695008	575253	558057	rs140497106	NC_000002.12:29695007:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.793G>C (p.Glu265Gln)	ALK	E265Q	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002586683	2	29917875	2	29695009	2586683	2756866		NC_000002.12:29695008:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.792G>A (p.Leu264=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003701373	2	29917876	2	29695010	3701373	3826621		NC_000002.12:29695009:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.790C>G (p.Leu264Val)	ALK	L264V	Hereditary cancer-predisposing syndrome	VCV002561059	2	29917878	2	29695012	2561059	2717218		NC_000002.12:29695011:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.790C>T (p.Leu264=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001672031	2	29917878	2	29695012	1672031	1647340	rs2148290067	NC_000002.12:29695011:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.789T>A (p.Gly263=)	ALK		Hereditary cancer-predisposing syndrome	VCV003524554	2	29917879	2	29695013	3524554	3679219		NC_000002.12:29695012:A:T	single nucleotide variant	synonymous variant	Likely benign	Sep 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.788G>C (p.Gly263Ala)	ALK	G263A	Neuroblastoma, susceptibility to, 3	VCV002856669	2	29917880	2	29695014	2856669	3017568		NC_000002.12:29695013:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 3, 2023	criteria provided, single submitter							
NC_000002.12:g.29695015del	ALK		Neuroblastoma, susceptibility to, 3	VCV002174295	2	29917880	2	29695014	2174295	1908243		NC_000002.12:29695013:CC:C	Deletion	genic upstream transcript variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.788G>A (p.Gly263Asp)	ALK	G263D	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV001761044	2	29917880	2	29695014	1761044	1816659		NC_000002.12:29695013:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.788-1G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002092658	2	29917881	2	29695015	2092658	2145401		NC_000002.12:29695014:C:T	single nucleotide variant	splice acceptor variant	Uncertain significance	Feb 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.788-2A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000864325	2	29917882	2	29695016	864325	851428	rs1678513810	NC_000002.12:29695015:T:C	single nucleotide variant	splice acceptor variant	Uncertain significance	Mar 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.788-3C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002988051	2	29917883	2	29695017	2988051	3147074		NC_000002.12:29695016:G:A	single nucleotide variant	intron variant	Uncertain significance	May 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.788-7_788-5del	ALK		Neuroblastoma, susceptibility to, 3	VCV003617060	2	29917885 - 29917887	2	29695019 - 29695021	3617060	3750027		NC_000002.12:29695018:AATAATA:AATA	Microsatellite	intron variant	Likely benign	Jul 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.788-5T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV000863979	2	29917885	2	29695019	863979	851176	rs749234736	NC_000002.12:29695018:A:G	single nucleotide variant	intron variant	Likely benign	Jun 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.788-6T>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002803054	2	29917886	2	29695020	2803054	2970576		NC_000002.12:29695019:A:T	single nucleotide variant	intron variant	Likely benign	Jul 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.788-6T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002147380	2	29917886	2	29695020	2147380	1880570		NC_000002.12:29695019:A:G	single nucleotide variant	intron variant	Likely benign	Apr 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.788-7A>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001088335	2	29917887	2	29695021	1088335	1069546	rs770622974	NC_000002.12:29695020:T:A	single nucleotide variant	intron variant	Likely benign	Oct 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.788-7A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000699002	2	29917887	2	29695021	699002	689717	rs770622974	NC_000002.12:29695020:T:C	single nucleotide variant	intron variant	Likely benign	Dec 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.788-9T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002146259	2	29917889	2	29695023	2146259	1876864		NC_000002.12:29695022:A:G	single nucleotide variant	intron variant	Likely benign	Nov 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.788-10A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001156575	2	29917890	2	29695024	1156575	1133680	rs1678514162	NC_000002.12:29695023:T:C	single nucleotide variant	intron variant	Likely benign	Dec 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.788-12C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001565412	2	29917892	2	29695026	1565412	1621485	rs1573561983	NC_000002.12:29695025:G:A	single nucleotide variant	intron variant	Likely benign	Jul 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.788-14G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002919373	2	29917894	2	29695028	2919373	3075297		NC_000002.12:29695027:C:T	single nucleotide variant	intron variant	Uncertain significance	Aug 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.788-17C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001667642	2	29917897	2	29695031	1667642	1656926	rs1230413927	NC_000002.12:29695030:G:A	single nucleotide variant	intron variant	Likely benign	Feb 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.788-18C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002073435	2	29917898	2	29695032	2073435	2123523		NC_000002.12:29695031:G:A	single nucleotide variant	intron variant	Likely benign	May 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.788-18C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001976027	2	29917898	2	29695032	1976027	2023675		NC_000002.12:29695031:G:C	single nucleotide variant	intron variant	Likely benign	Jan 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.788-19C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002790422	2	29917899	2	29695033	2790422	2960186		NC_000002.12:29695032:G:T	single nucleotide variant	intron variant	Likely benign	Nov 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.788-19C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002015565	2	29917899	2	29695033	2015565	2068363		NC_000002.12:29695032:G:A	single nucleotide variant	intron variant	Likely benign	Jul 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.788-19C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001550757	2	29917899	2	29695033	1550757	1574446	rs745521483	NC_000002.12:29695032:G:C	single nucleotide variant	intron variant	Likely benign	Nov 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.788-20A>C	ALK		Neuroblastoma, susceptibility to, 3	VCV003661330	2	29917900	2	29695034	3661330	3790989		NC_000002.12:29695033:T:G	single nucleotide variant	intron variant	Likely benign	Aug 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.788-60G>C	ALK		not provided	VCV001251902	2	29917940	2	29695074	1251902	1240996	rs2256376	NC_000002.12:29695073:C:G	single nucleotide variant	intron variant	Benign	Jun 24, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.788-105A>G	ALK		not provided	VCV001208811	2	29917985	2	29695119	1208811	1196908	rs144342287	NC_000002.12:29695118:T:C	single nucleotide variant	intron variant	Likely benign	Apr 5, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.788-193A>G	ALK		not provided	VCV001250192	2	29918073	2	29695207	1250192	1240567	rs75549758	NC_000002.12:29695206:T:C	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.787+112T>C	ALK		not provided	VCV001182694	2	29940332	2	29717466	1182694	1170959	rs116369425	NC_000002.12:29717465:A:G	single nucleotide variant	intron variant	Likely benign	Jul 14, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.787+17T>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002165210	2	29940427	2	29717561	2165210	1895350		NC_000002.12:29717560:A:T	single nucleotide variant	intron variant	Likely benign	Feb 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.787+17T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001589258	2	29940427	2	29717561	1589258	1554165	rs1378706967	NC_000002.12:29717560:A:G	single nucleotide variant	intron variant	Likely benign	Aug 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.787+16A>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001621174	2	29940428	2	29717562	1621174	1615421	rs2148307184	NC_000002.12:29717561:T:A	single nucleotide variant	intron variant	Likely benign	Apr 23, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.787+14T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001529406	2	29940430	2	29717564	1529406	1604121	rs1394439148	NC_000002.12:29717563:A:C	single nucleotide variant	intron variant	Likely benign	Dec 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.787+8T>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001665276	2	29940436	2	29717570	1665276	1621144	rs2148307194	NC_000002.12:29717569:A:T	single nucleotide variant	intron variant	Likely benign	Jun 6, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.787+7A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001359370	2	29940437	2	29717571	1359370	1370550	rs1679298159	NC_000002.12:29717570:T:C	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.787+6T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV000642506	2	29940438	2	29717572	642506	651038	rs1558457269	NC_000002.12:29717571:A:G	single nucleotide variant	intron variant	Uncertain significance	Jan 20, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.787+4A>G	ALK		not provided|Neuroblastoma, susceptibility to, 3	VCV003368654	2	29940440	2	29717574	3368654	3527849		NC_000002.12:29717573:T:C	single nucleotide variant	intron variant	Uncertain significance	Jun 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.787+4A>C	ALK		Neuroblastoma, susceptibility to, 3	VCV000958140	2	29940440	2	29717574	958140	959640	rs377100808	NC_000002.12:29717573:T:G	single nucleotide variant	intron variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.787G>A (p.Gly263Ser)	ALK	G263S	Neuroblastoma, susceptibility to, 3	VCV002737206	2	29940444	2	29717578	2737206	2901883		NC_000002.12:29717577:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.786T>C (p.Tyr262=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV003223928	2	29940445	2	29717579	3223928	3380950		NC_000002.12:29717578:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Aug 15, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.784T>C (p.Tyr262His)	ALK	Y262H	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001061904	2	29940447	2	29717581	1061904	1041425	rs2148307204	NC_000002.12:29717580:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.783A>T (p.Arg261=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000703997	2	29940448	2	29717582	703997	691147	rs777698508	NC_000002.12:29717581:T:A	single nucleotide variant	synonymous variant	Likely benign	Dec 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.782G>T (p.Arg261Leu)	ALK	R261L	Neuroblastoma, susceptibility to, 3|not provided	VCV000860142	2	29940449	2	29717583	860142	826389	rs375097381	NC_000002.12:29717582:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.782G>A (p.Arg261Gln)	ALK	R261Q	Neuroblastoma, susceptibility to, 3|not provided|ALK-related disorder|Hereditary cancer-predisposing syndrome	VCV000404364	2	29940449	2	29717583	404364	392781	rs375097381	NC_000002.12:29717582:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.781C>G (p.Arg261Gly)	ALK	R261G	Neuroblastoma, susceptibility to, 3	VCV003241790	2	29940450	2	29717584	3241790	3400768		NC_000002.12:29717583:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.781C>T (p.Arg261Ter)	ALK	R261*	ALK-related disorder|Neuroblastoma, susceptibility to, 3	VCV000470900	2	29940450	2	29717584	470900	451117	rs972790555	NC_000002.12:29717583:G:A	single nucleotide variant	nonsense	Uncertain significance	Oct 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.780C>A (p.Ser260Arg)	ALK	S260R	Neuroblastoma, susceptibility to, 3	VCV002055009	2	29940451	2	29717585	2055009	2109010		NC_000002.12:29717584:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.780C>T (p.Ser260=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001589647	2	29940451	2	29717585	1589647	1607669	rs1233157268	NC_000002.12:29717584:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 26, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.779G>A (p.Ser260Asn)	ALK	S260N	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000952639	2	29940452	2	29717586	952639	922733	rs1679298966	NC_000002.12:29717585:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.776G>T (p.Arg259Leu)	ALK	R259L	Hereditary cancer-predisposing syndrome	VCV003524295	2	29940455	2	29717589	3524295	3678960		NC_000002.12:29717588:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.776G>C (p.Arg259Pro)	ALK	R259P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001024392	2	29940455	2	29717589	1024392	1004007	rs138686378	NC_000002.12:29717588:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 20, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.776G>A (p.Arg259His)	ALK	R259H	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000133469	2	29940455	2	29717589	133469	137208	rs138686378	NC_000002.12:29717588:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.775C>A (p.Arg259Ser)	ALK	R259S	Neuroblastoma, susceptibility to, 3	VCV000948994	2	29940456	2	29717590	948994	922734	rs771593278	NC_000002.12:29717589:G:T	single nucleotide variant	missense variant	Uncertain significance	May 5, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.775C>G (p.Arg259Gly)	ALK	R259G	Neuroblastoma, susceptibility to, 3	VCV000574357	2	29940456	2	29717590	574357	558410	rs771593278	NC_000002.12:29717589:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.775C>T (p.Arg259Cys)	ALK	R259C	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404385	2	29940456	2	29717590	404385	392603	rs771593278	NC_000002.12:29717589:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 12, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.773A>G (p.His258Arg)	ALK	H258R	Neuroblastoma, susceptibility to, 3	VCV000971243	2	29940458	2	29717592	971243	953078	rs770063749	NC_000002.12:29717591:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.772C>G (p.His258Asp)	ALK	H258D	Hereditary cancer-predisposing syndrome	VCV001760345	2	29940459	2	29717593	1760345	1819773		NC_000002.12:29717592:G:C	single nucleotide variant	missense variant	Uncertain significance	May 10, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.772C>T (p.His258Tyr)	ALK	H258Y	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001003730	2	29940459	2	29717593	1003730	988746	rs1679299436	NC_000002.12:29717592:G:A	single nucleotide variant	missense variant	Uncertain significance	May 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.771T>C (p.Ser257=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001153165	2	29940460	2	29717594	1153165	1133681	rs773497455	NC_000002.12:29717593:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.770C>G (p.Ser257Cys)	ALK	S257C	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001760252	2	29940461	2	29717595	1760252	1823488		NC_000002.12:29717594:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.770C>T (p.Ser257Phe)	ALK	S257F	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000933764	2	29940461	2	29717595	933764	931374	rs1679299604	NC_000002.12:29717594:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.769T>A (p.Ser257Thr)	ALK	S257T	Hereditary cancer-predisposing syndrome	VCV002561053	2	29940462	2	29717596	2561053	2717212		NC_000002.12:29717595:A:T	single nucleotide variant	missense variant	Uncertain significance	May 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.768G>A (p.Leu256=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000746979	2	29940463	2	29717597	746979	747587	rs201536994	NC_000002.12:29717596:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jul 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.766C>T (p.Leu256=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000700714	2	29940465	2	29717599	700714	686195	rs1573580077	NC_000002.12:29717598:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.761C>G (p.Pro254Arg)	ALK	P254R	Neuroblastoma, susceptibility to, 3	VCV000470899	2	29940470	2	29717604	470899	451124	rs1553351744	NC_000002.12:29717603:G:C	single nucleotide variant	missense variant	Uncertain significance	May 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.760C>T (p.Pro254Ser)	ALK	P254S	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000579025	2	29940471	2	29717605	579025	558059	rs774815140	NC_000002.12:29717604:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 7, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.759C>T (p.Phe253=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001759695	2	29940472	2	29717606	1759695	1813296		NC_000002.12:29717605:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.758T>G (p.Phe253Cys)	ALK	F253C	Neuroblastoma, susceptibility to, 3	VCV003710987	2	29940473	2	29717607	3710987	3843996		NC_000002.12:29717606:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.758T>A (p.Phe253Tyr)	ALK	F253Y	Neuroblastoma, susceptibility to, 3	VCV002168037	2	29940473	2	29717607	2168037	1899354		NC_000002.12:29717606:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.758T>C (p.Phe253Ser)	ALK	F253S	Neuroblastoma, susceptibility to, 3	VCV001389449	2	29940473	2	29717607	1389449	1376929	rs759574066	NC_000002.12:29717606:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.756C>T (p.Ser252=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001545084	2	29940475	2	29717609	1545084	1644490	rs1679300243	NC_000002.12:29717608:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 26, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.755C>T (p.Ser252Phe)	ALK	S252F	Neuroblastoma, susceptibility to, 3	VCV000849745	2	29940476	2	29717610	849745	826390	rs868525145	NC_000002.12:29717609:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.753C>T (p.Asp251=)	ALK		Hereditary cancer-predisposing syndrome	VCV003524947	2	29940478	2	29717612	3524947	3689186		NC_000002.12:29717611:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.752A>G (p.Asp251Gly)	ALK	D251G	Neuroblastoma, susceptibility to, 3	VCV002831526	2	29940479	2	29717613	2831526	3001126		NC_000002.12:29717612:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.751G>A (p.Asp251Asn)	ALK	D251N	Hereditary cancer-predisposing syndrome	VCV003524073	2	29940480	2	29717614	3524073	3682241		NC_000002.12:29717613:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.748A>G (p.Lys250Glu)	ALK	K250E	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001043366	2	29940483	2	29717617	1043366	1024473	rs767630195	NC_000002.12:29717616:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.747G>A (p.Met249Ile)	ALK	M249I	Hereditary cancer-predisposing syndrome	VCV002477497	2	29940484	2	29717618	2477497	2453846		NC_000002.12:29717617:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.746T>C (p.Met249Thr)	ALK	M249T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002099364	2	29940485	2	29717619	2099364	2150685		NC_000002.12:29717618:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.745A>G (p.Met249Val)	ALK	M249V	Neuroblastoma, susceptibility to, 3	VCV000944971	2	29940486	2	29717620	944971	922735	rs1679300524	NC_000002.12:29717619:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.744A>G (p.Ile248Met)	ALK	I248M	Neuroblastoma, susceptibility to, 3	VCV000638883	2	29940487	2	29717621	638883	629912	rs1573580109	NC_000002.12:29717620:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.742A>G (p.Ile248Val)	ALK	I248V	Neuroblastoma, susceptibility to, 3	VCV002676097	2	29940489	2	29717623	2676097	2834518		NC_000002.12:29717622:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.741G>A (p.Trp247Ter)	ALK	W247*	Neuroblastoma, susceptibility to, 3	VCV002033363	2	29940490	2	29717624	2033363	2100295		NC_000002.12:29717623:C:T	single nucleotide variant	nonsense	Uncertain significance	Sep 29, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.741G>C (p.Trp247Cys)	ALK	W247C	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001352352	2	29940490	2	29717624	1352352	1482888	rs2148307275	NC_000002.12:29717623:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.740G>A (p.Trp247Ter)	ALK	W247*	Neuroblastoma, susceptibility to, 3	VCV000577188	2	29940491	2	29717625	577188	561405	rs1558457342	NC_000002.12:29717624:C:T	single nucleotide variant	nonsense	Uncertain significance	Feb 7, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.739T>C (p.Trp247Arg)	ALK	W247R	Neuroblastoma, susceptibility to, 3	VCV002760825	2	29940492	2	29717626	2760825	2918119		NC_000002.12:29717625:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.738C>T (p.Thr246=)	ALK		Hereditary cancer-predisposing syndrome	VCV003286592	2	29940493	2	29717627	3286592	3455415		NC_000002.12:29717626:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.737C>G (p.Thr246Ser)	ALK	T246S	Neuroblastoma, susceptibility to, 3	VCV003692508	2	29940494	2	29717628	3692508	3831895		NC_000002.12:29717627:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.737C>T (p.Thr246Ile)	ALK	T246I	Hereditary cancer-predisposing syndrome	VCV003523856	2	29940494	2	29717628	3523856	3682024		NC_000002.12:29717627:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.735C>T (p.Leu245=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000741321	2	29940496	2	29717630	741321	747588	rs752920768	NC_000002.12:29717629:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.732T>A (p.Asn244Lys)	ALK	N244K	Neuroblastoma, susceptibility to, 3	VCV003611436	2	29940499	2	29717633	3611436	3745002		NC_000002.12:29717632:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.732T>C (p.Asn244=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001084358	2	29940499	2	29717633	1084358	1069547	rs760894224	NC_000002.12:29717632:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 4, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.731A>C (p.Asn244Thr)	ALK	N244T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470898	2	29940500	2	29717634	470898	450814	rs763986679	NC_000002.12:29717633:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.730A>T (p.Asn244Tyr)	ALK	N244Y	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404332	2	29940501	2	29717635	404332	393006	rs753646573	NC_000002.12:29717634:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.728G>C (p.Trp243Ser)	ALK	W243S	Hereditary cancer-predisposing syndrome	VCV003286220	2	29940503	2	29717637	3286220	3455043		NC_000002.12:29717636:C:G	single nucleotide variant	missense variant	Uncertain significance	May 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.726A>G (p.Thr242=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001622225	2	29940505	2	29717639	1622225	1593428	rs1679301048	NC_000002.12:29717638:T:C	single nucleotide variant	synonymous variant	Likely benign	May 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.725C>T (p.Thr242Ile)	ALK	T242I	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001002998	2	29940506	2	29717640	1002998	988747	rs1679301106	NC_000002.12:29717639:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.724A>G (p.Thr242Ala)	ALK	T242A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001468726	2	29940507	2	29717641	1468726	1359085	rs2148307303	NC_000002.12:29717640:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 3, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.723T>C (p.Phe241=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002771977	2	29940508	2	29717642	2771977	2924087		NC_000002.12:29717641:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.723T>G (p.Phe241Leu)	ALK	F241L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002566563	2	29940508	2	29717642	2566563	2734406		NC_000002.12:29717641:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.723T>A (p.Phe241Leu)	ALK	F241L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001019712	2	29940508	2	29717642	1019712	1004008	rs146281095	NC_000002.12:29717641:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.722T>C (p.Phe241Ser)	ALK	F241S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV003007562	2	29940509	2	29717643	3007562	3158859		NC_000002.12:29717642:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.720T>C (p.Tyr240=)	ALK		Hereditary cancer-predisposing syndrome	VCV003524020	2	29940511	2	29717645	3524020	3682188		NC_000002.12:29717644:A:G	single nucleotide variant	synonymous variant	Likely benign	Jun 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.719A>T (p.Tyr240Phe)	ALK	Y240F	Neuroblastoma, susceptibility to, 3	VCV002125869	2	29940512	2	29717646	2125869	2185038		NC_000002.12:29717645:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.719A>G (p.Tyr240Cys)	ALK	Y240C	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000573005	2	29940512	2	29717646	573005	558412	rs550608288	NC_000002.12:29717645:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 20, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.717T>C (p.Asp239=)	ALK		Hereditary cancer-predisposing syndrome	VCV003285896	2	29940514	2	29717648	3285896	3444636		NC_000002.12:29717647:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.715G>T (p.Asp239Tyr)	ALK	D239Y	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001757435	2	29940516	2	29717650	1757435	1815633		NC_000002.12:29717649:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.714T>C (p.Pro238=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003676495	2	29940517	2	29717651	3676495	3810390		NC_000002.12:29717650:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.714T>G (p.Pro238=)	ALK		Hereditary cancer-predisposing syndrome	VCV001757394	2	29940517	2	29717651	1757394	1815593		NC_000002.12:29717650:A:C	single nucleotide variant	synonymous variant	Likely benign	May 3, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.712_714del (p.Pro238del)	ALK	P238del	Neuroblastoma, susceptibility to, 3	VCV000470897	2	29940517 - 29940519	2	29717651 - 29717653	470897	451118	rs1311300230	NC_000002.12:29717650:AGGAG:AG	Deletion	inframe_deletion	Uncertain significance	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.712C>T (p.Pro238Ser)	ALK	P238S	Neuroblastoma, susceptibility to, 3	VCV002895537	2	29940519	2	29717653	2895537	3049626		NC_000002.12:29717652:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.711T>G (p.Ser237=)	ALK		Hereditary cancer-predisposing syndrome	VCV003524246	2	29940520	2	29717654	3524246	3682414		NC_000002.12:29717653:A:C	single nucleotide variant	synonymous variant	Likely benign	Aug 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.711T>C (p.Ser237=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002839328	2	29940520	2	29717654	2839328	2996599		NC_000002.12:29717653:A:G	single nucleotide variant	synonymous variant	Likely benign	Feb 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.709_711del (p.Ser237del)	ALK	S237del	Neuroblastoma, susceptibility to, 3	VCV000663149	2	29940520 - 29940522	2	29717654 - 29717656	663149	629913	rs1573580166	NC_000002.12:29717653:AGAAG:AG	Deletion	inframe_deletion	Uncertain significance	Apr 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.709T>C (p.Ser237Pro)	ALK	S237P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000862027	2	29940522	2	29717656	862027	826391	rs757916299	NC_000002.12:29717655:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 18, 2023	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.707C>G (p.Pro236Arg)	ALK	P236R	Ovarian cancer	VCV002445255	2	29940524	2	29717658	2445255	2418982		NC_000002.12:29717657:G:C	single nucleotide variant	missense variant	Benign	Jan 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.705T>C (p.Ser235=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002897783	2	29940526	2	29717660	2897783	3067164		NC_000002.12:29717659:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.705T>G (p.Ser235=)	ALK		Hereditary cancer-predisposing syndrome	VCV001756953	2	29940526	2	29717660	1756953	1818958		NC_000002.12:29717659:A:C	single nucleotide variant	synonymous variant	Likely benign	Mar 23, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.704_705insCCCTTC (p.235SP[3])	ALK		Neuroblastoma, susceptibility to, 3	VCV001376745	2	29940526 - 29940527	2	29717660 - 29717661	1376745	1479609	rs2148307359	NC_000002.12:29717660:GAAGG:GAAGGGGAAGG	Insertion	inframe_insertion	Uncertain significance	Oct 21, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.704C>A (p.Ser235Tyr)	ALK	S235Y	Hereditary cancer-predisposing syndrome	VCV003223926	2	29940527	2	29717661	3223926	3380948		NC_000002.12:29717660:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.701_702delinsGA (p.Pro234Arg)	ALK	P234R	Neuroblastoma, susceptibility to, 3	VCV001016830	2	29940529 - 29940530	2	29717663 - 29717664	1016830	1004009	rs1679302255	NC_000002.12:29717662:AG:TC	Indel	missense variant	Uncertain significance	Feb 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.702T>A (p.Pro234=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided|not specified	VCV000259274	2	29940529	2	29717663	259274	250722	rs2246745	NC_000002.12:29717662:A:T	single nucleotide variant	synonymous variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.702T>G (p.Pro234=)	ALK		Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000239849	2	29940529	2	29717663	239849	238755	rs2246745	NC_000002.12:29717662:A:C	single nucleotide variant	synonymous variant	Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.701C>G (p.Pro234Arg)	ALK	P234R	Neuroblastoma, susceptibility to, 3	VCV003019225	2	29940530	2	29717664	3019225	3175589		NC_000002.12:29717663:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.701C>T (p.Pro234Leu)	ALK	P234L	Neuroblastoma, susceptibility to, 3	VCV000957683	2	29940530	2	29717664	957683	942880	rs948241251	NC_000002.12:29717663:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.700C>T (p.Pro234Ser)	ALK	P234S	Hereditary cancer-predisposing syndrome	VCV003223925	2	29940531	2	29717665	3223925	3380947		NC_000002.12:29717664:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.700C>A (p.Pro234Thr)	ALK	P234T	Neuroblastoma, susceptibility to, 3	VCV000404314	2	29940531	2	29717665	404314	392782	rs1060500209	NC_000002.12:29717664:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2016	criteria provided, single submitter							
NM_004304.5(ALK):c.699G>A (p.Met233Ile)	ALK	M233I	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000470896	2	29940532	2	29717666	470896	450820	rs778129557	NC_000002.12:29717665:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.697A>T (p.Met233Leu)	ALK	M233L	Neuroblastoma, susceptibility to, 3	VCV002720322	2	29940534	2	29717668	2720322	2880833		NC_000002.12:29717667:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.697A>G (p.Met233Val)	ALK	M233V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000851355	2	29940534	2	29717668	851355	826392	rs771254732	NC_000002.12:29717667:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.696C>A (p.Asn232Lys)	ALK	N232K	Neuroblastoma, susceptibility to, 3	VCV002997696	2	29940535	2	29717669	2997696	3167040		NC_000002.12:29717668:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.695A>G (p.Asn232Ser)	ALK	N232S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001756310	2	29940536	2	29717670	1756310	1812488		NC_000002.12:29717669:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.695A>C (p.Asn232Thr)	ALK	N232T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001052134	2	29940536	2	29717670	1052134	1041426	rs774904862	NC_000002.12:29717669:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.692C>T (p.Thr231Ile)	ALK	T231I	Hereditary cancer-predisposing syndrome	VCV003223924	2	29940539	2	29717673	3223924	3380946		NC_000002.12:29717672:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.692C>G (p.Thr231Arg)	ALK	T231R	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000538218	2	29940539	2	29717673	538218	518276	rs142120301	NC_000002.12:29717672:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 12, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.691A>G (p.Thr231Ala)	ALK	T231A	Neuroblastoma, susceptibility to, 3	VCV000969344	2	29940540	2	29717674	969344	953079	rs1060500230	NC_000002.12:29717673:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.691A>C (p.Thr231Pro)	ALK	T231P	Neuroblastoma, susceptibility to, 3	VCV000404383	2	29940540	2	29717674	404383	392659	rs1060500230	NC_000002.12:29717673:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 7, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.690A>G (p.Pro230=)	ALK		Hereditary cancer-predisposing syndrome	VCV003524994	2	29940541	2	29717675	3524994	3689233		NC_000002.12:29717674:T:C	single nucleotide variant	synonymous variant	Likely benign	Oct 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.689C>A (p.Pro230Gln)	ALK	P230Q	Neuroblastoma, susceptibility to, 3	VCV002840276	2	29940542	2	29717676	2840276	3003497		NC_000002.12:29717675:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.689C>T (p.Pro230Leu)	ALK	P230L	Neuroblastoma, susceptibility to, 3	VCV001510286	2	29940542	2	29717676	1510286	1442341	rs1679303194	NC_000002.12:29717675:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.688C>T (p.Pro230Ser)	ALK	P230S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV001755987	2	29940543	2	29717677	1755987	1815482		NC_000002.12:29717676:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.687A>G (p.Ser229=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002416112	2	29940544	2	29717678	2416112	1937468		NC_000002.12:29717677:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.686C>T (p.Ser229Leu)	ALK	S229L	Neuroblastoma, susceptibility to, 3	VCV000839698	2	29940545	2	29717679	839698	826393	rs1447260360	NC_000002.12:29717678:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.685T>C (p.Ser229Pro)	ALK	S229P	Hereditary cancer-predisposing syndrome	VCV003524119	2	29940546	2	29717680	3524119	3682287		NC_000002.12:29717679:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.684A>G (p.Glu228=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000703715	2	29940547	2	29717681	703715	691148	rs926663315	NC_000002.12:29717680:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.683A>G (p.Glu228Gly)	ALK	E228G	Neuroblastoma, susceptibility to, 3	VCV001358176	2	29940548	2	29717682	1358176	1460475	rs2148307404	NC_000002.12:29717681:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.682G>C (p.Glu228Gln)	ALK	E228Q	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001360032	2	29940549	2	29717683	1360032	1473905	rs2148307408	NC_000002.12:29717682:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.679T>C (p.Leu227=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000470895	2	29940552	2	29717686	470895	450931	rs201659891	NC_000002.12:29717685:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.678C>T (p.Ser226=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001156393	2	29940553	2	29717687	1156393	1133682	rs2148307413	NC_000002.12:29717686:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 8, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.677C>T (p.Ser226Phe)	ALK	S226F	Neuroblastoma, susceptibility to, 3	VCV000965852	2	29940554	2	29717688	965852	953080	rs1679303562	NC_000002.12:29717687:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 26, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.675C>T (p.Ser225=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001755283	2	29940556	2	29717690	1755283	1818573		NC_000002.12:29717689:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.674G>A (p.Ser225Asn)	ALK	S225N	Hereditary cancer-predisposing syndrome	VCV001755235	2	29940557	2	29717691	1755235	1818525		NC_000002.12:29717690:C:T	single nucleotide variant	missense variant	Uncertain significance	May 2, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.673A>G (p.Ser225Gly)	ALK	S225G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000663615	2	29940558	2	29717692	663615	629914	rs1456830388	NC_000002.12:29717691:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.672T>C (p.His224=)	ALK		Hereditary cancer-predisposing syndrome	VCV001755134	2	29940559	2	29717693	1755134	1822223		NC_000002.12:29717692:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 9, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.671A>G (p.His224Arg)	ALK	H224R	Hereditary cancer-predisposing syndrome	VCV002452099	2	29940560	2	29717694	2452099	2426739		NC_000002.12:29717693:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.670C>A (p.His224Asn)	ALK	H224N	Neuroblastoma, susceptibility to, 3	VCV001517606	2	29940561	2	29717695	1517606	1420508	rs1407129567	NC_000002.12:29717694:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.670C>T (p.His224Tyr)	ALK	H224Y	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001016731	2	29940561	2	29717695	1016731	1004010	rs1407129567	NC_000002.12:29717694:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.669T>C (p.Gly223=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001135178	2	29940562	2	29717696	1135178	1112774	rs1052858121	NC_000002.12:29717695:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.668G>A (p.Gly223Asp)	ALK	G223D	Neuroblastoma, susceptibility to, 3	VCV001349455	2	29940563	2	29717697	1349455	1394218	rs775574527	NC_000002.12:29717696:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.668-3C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001039654	2	29940566	2	29717700	1039654	1024474	rs1679303988	NC_000002.12:29717699:G:A	single nucleotide variant	intron variant	Uncertain significance	May 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.668-5T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV002847257	2	29940568	2	29717702	2847257	3012178		NC_000002.12:29717701:A:G	single nucleotide variant	intron variant	Likely benign	Mar 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.668-5T>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001557774	2	29940568	2	29717702	1557774	1628216	rs901852575	NC_000002.12:29717701:A:T	single nucleotide variant	intron variant	Likely benign	Nov 19, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.668-6G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001528116	2	29940569	2	29717703	1528116	1603263	rs2148307433	NC_000002.12:29717702:C:T	single nucleotide variant	intron variant	Likely benign	Jul 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.668-12T>G	ALK		Neuroblastoma, susceptibility to, 3	VCV003656808	2	29940575	2	29717709	3656808	3789664		NC_000002.12:29717708:A:C	single nucleotide variant	intron variant	Likely benign	Jun 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.668-13T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001618143	2	29940576	2	29717710	1618143	1527465	rs1158740527	NC_000002.12:29717709:A:G	single nucleotide variant	intron variant	Likely benign	Nov 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.668-14A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002135434	2	29940577	2	29717711	2135434	2188689		NC_000002.12:29717710:T:C	single nucleotide variant	intron variant	Likely benign	May 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.668-17T>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001596644	2	29940580	2	29717714	1596644	1633727	rs760840075	NC_000002.12:29717713:A:T	single nucleotide variant	intron variant	Likely benign	May 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.668-18C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002140792	2	29940581	2	29717715	2140792	1875290		NC_000002.12:29717714:G:T	single nucleotide variant	intron variant	Likely benign	Jun 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.668-18C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001541633	2	29940581	2	29717715	1541633	1631516	rs2148307448	NC_000002.12:29717714:G:C	single nucleotide variant	intron variant	Likely benign	May 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.668-20T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001543829	2	29940583	2	29717717	1543829	1557984	rs1679304541	NC_000002.12:29717716:A:G	single nucleotide variant	intron variant	Likely benign	Oct 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.668-257G>A	ALK		not provided	VCV001269633	2	29940820	2	29717954	1269633	1259491	rs2270353	NC_000002.12:29717953:C:T	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, multiple submitters, no conflicts							
GRCh38/hg38 2p23.1(chr2:29907153-30845898)x3	ALK|CAPN13|LBH|LCLAT1|LINC01936|LOC122756685|LOC122756686|LOC126806182|LOC129388838|LOC129933417|LOC129933418|LOC129933419|LOC129933420|LOC129933421|LOC129933422|LOC129933423|LOC129933424|LOC129933425|LOC129933426|LOC129933427|LOC129933428|LOC129933429|LOC129933430|LOC129933431|LOC129933432|LOC129933433|LOC129933434|LOC129933435|LOC129933436|LOC129933437|LOC129933438|SNORA10B|YPEL5		See cases	VCV000147374	2	30130019 - 31068764	2	29907153 - 30845898	147374	157125			copy number gain		Uncertain significance	Dec 22, 2010	no assertion criteria provided							
NM_004304.5(ALK):c.667+236T>A	ALK		not provided	VCV001192101	2	30142623	2	29919757	1192101	1179520	rs151284880	NC_000002.12:29919756:A:T	single nucleotide variant	intron variant	Likely benign	Jul 14, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.667+119C>T	ALK		not provided	VCV001186561	2	30142740	2	29919874	1186561	1176166	rs114330016	NC_000002.12:29919873:G:A	single nucleotide variant	intron variant	Likely benign	Jul 6, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.667+99C>T	ALK		not provided	VCV001181874	2	30142760	2	29919894	1181874	1170960	rs140542591	NC_000002.12:29919893:G:A	single nucleotide variant	intron variant	Likely benign	Jul 6, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.667+17T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV001574278	2	30142842	2	29919976	1574278	1659463	rs1343781387	NC_000002.12:29919975:A:G	single nucleotide variant	intron variant	Likely benign	Dec 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.667+16C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001367909	2	30142843	2	29919977	1367909	1424447	rs768827717	NC_000002.12:29919976:G:C	single nucleotide variant	intron variant	Uncertain significance	Aug 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.667+14G>C	ALK		Neuroblastoma, susceptibility to, 3	VCV003641735	2	30142845	2	29919979	3641735	3772457		NC_000002.12:29919978:C:G	single nucleotide variant	intron variant	Likely benign	Apr 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.667+14G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002168833	2	30142845	2	29919979	2168833	1906658		NC_000002.12:29919978:C:T	single nucleotide variant	intron variant	Likely benign	Oct 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.667+14G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001573776	2	30142845	2	29919979	1573776	1538980	rs781586901	NC_000002.12:29919978:C:A	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.667+13C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001630708	2	30142846	2	29919980	1630708	1618860	rs762116831	NC_000002.12:29919979:G:A	single nucleotide variant	intron variant	Likely benign	Aug 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.667+13C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001565582	2	30142846	2	29919980	1565582	1590172	rs762116831	NC_000002.12:29919979:G:C	single nucleotide variant	intron variant	Likely benign	Jan 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.667+12C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV002102463	2	30142847	2	29919981	2102463	2165508		NC_000002.12:29919980:G:A	single nucleotide variant	intron variant	Likely benign	Feb 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.667+11C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV002915453	2	30142848	2	29919982	2915453	3076823		NC_000002.12:29919981:G:C	single nucleotide variant	intron variant	Likely benign	Oct 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.667+11C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001562160	2	30142848	2	29919982	1562160	1577224	rs765124982	NC_000002.12:29919981:G:T	single nucleotide variant	intron variant	Likely benign	Jan 8, 2025	criteria provided, single submitter							
NC_000002.11:g.(?_30142849)_(30143535_?)dup	ALK		Neuroblastoma, susceptibility to, 3	VCV000645357	2	30142849 - 30143535	2	29919983 - 29920669	645357	650757			Duplication		Uncertain significance	Apr 15, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.667+9C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV001655506	2	30142850	2	29919984	1655506	1615856	rs773016330	NC_000002.12:29919983:G:A	single nucleotide variant	intron variant	Likely benign	Nov 24, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.667+8G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV001639426	2	30142851	2	29919985	1639426	1647014	rs2148442762	NC_000002.12:29919984:C:T	single nucleotide variant	intron variant	Likely benign	Jul 15, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.667+6C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV001061781	2	30142853	2	29919987	1061781	1041427	rs1292761264	NC_000002.12:29919986:G:C	single nucleotide variant	intron variant	Uncertain significance	Aug 13, 2022	criteria provided, single submitter							
NC_000002.11:g.(?_30142853)_(30143531_?)dup	ALK		Neuroblastoma, susceptibility to, 3	VCV000470730	2	30142853 - 30143531	2	29919987 - 29920665	470730	448539			Duplication		Uncertain significance	Mar 30, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.667+4A>G	ALK		not provided|Neuroblastoma, susceptibility to, 3	VCV002704634	2	30142855	2	29919989	2704634	2863046		NC_000002.12:29919988:T:C	single nucleotide variant	intron variant	Uncertain significance	Dec 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.663_667+1dup	ALK		ALK-related disorder	VCV003345842	2	30142857 - 30142858	2	29919991 - 29919992	3345842	3505511		NC_000002.12:29919991:CCAGTCCC:CCAGTCCCAGTCCC	Duplication	splice donor variant	Uncertain significance	Jul 24, 2024	no assertion criteria provided							
NM_004304.5(ALK):c.667+1G>T	ALK		not provided	VCV003390442	2	30142858	2	29919992	3390442	3549572		NC_000002.12:29919991:C:A	single nucleotide variant	splice donor variant	Uncertain significance	Jun 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.667+1G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV002011831	2	30142858	2	29919992	2011831	2067208		NC_000002.12:29919991:C:T	single nucleotide variant	splice donor variant	Uncertain significance	Jun 28, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.665C>G (p.Thr222Ser)	ALK	T222S	Neuroblastoma, susceptibility to, 3	VCV003647111	2	30142861	2	29919995	3647111	3784244		NC_000002.12:29919994:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.665C>T (p.Thr222Ile)	ALK	T222I	Neuroblastoma, susceptibility to, 3	VCV001372981	2	30142861	2	29919995	1372981	1440359	rs2148442788	NC_000002.12:29919994:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.663G>C (p.Gly221=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470894	2	30142863	2	29919997	470894	450823	rs762819109	NC_000002.12:29919996:C:G	single nucleotide variant	synonymous variant	Likely benign	Sep 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.662G>C (p.Gly221Ala)	ALK	G221A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002782979	2	30142864	2	29919998	2782979	2938080		NC_000002.12:29919997:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.662G>A (p.Gly221Glu)	ALK	G221E	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000963224	2	30142864	2	29919998	963224	942881	rs1667944325	NC_000002.12:29919997:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.661G>A (p.Gly221Arg)	ALK	G221R	Neuroblastoma, susceptibility to, 3	VCV000948451	2	30142865	2	29919999	948451	922736	rs199584443	NC_000002.12:29919998:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.661G>C (p.Gly221Arg)	ALK	G221R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000470893	2	30142865	2	29919999	470893	451128	rs199584443	NC_000002.12:29919998:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.660C>T (p.Phe220=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000897126	2	30142866	2	29920000	897126	884686	rs1667944556	NC_000002.12:29919999:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 6, 2023	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.658T>C (p.Phe220Leu)	ALK	F220L	Neuroblastoma, susceptibility to, 3	VCV001445744	2	30142868	2	29920002	1445744	1490614	rs1484797934	NC_000002.12:29920001:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.656T>C (p.Ile219Thr)	ALK	I219T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001405220	2	30142870	2	29920004	1405220	1484017	rs2148442808	NC_000002.12:29920003:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.655A>C (p.Ile219Leu)	ALK	I219L	Neuroblastoma, susceptibility to, 3	VCV001372930	2	30142871	2	29920005	1372930	1440308	rs886055932	NC_000002.12:29920004:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.655A>G (p.Ile219Val)	ALK	I219V	Neuroblastoma, susceptibility to, 3|not provided	VCV000335710	2	30142871	2	29920005	335710	288998	rs886055932	NC_000002.12:29920004:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.654G>C (p.Gln218His)	ALK	Q218H	Neuroblastoma, susceptibility to, 3	VCV002862579	2	30142872	2	29920006	2862579	3022628		NC_000002.12:29920005:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.653A>G (p.Gln218Arg)	ALK	Q218R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001064259	2	30142873	2	29920007	1064259	1041428	rs751419585	NC_000002.12:29920006:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.651C>T (p.Phe217=)	ALK		Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV001573654	2	30142875	2	29920009	1573654	1637369	rs2148442816	NC_000002.12:29920008:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.649T>C (p.Phe217Leu)	ALK	F217L	Neuroblastoma, susceptibility to, 3	VCV002887732	2	30142877	2	29920011	2887732	3044437		NC_000002.12:29920010:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.648C>A (p.Leu216=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003723595	2	30142878	2	29920012	3723595	3850806		NC_000002.12:29920011:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.647T>A (p.Leu216His)	ALK	L216H	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003284933	2	30142879	2	29920013	3284933	3444112		NC_000002.12:29920012:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.647T>G (p.Leu216Arg)	ALK	L216R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001753759	2	30142879	2	29920013	1753759	1808140		NC_000002.12:29920012:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.646C>G (p.Leu216Val)	ALK	L216V	Neuroblastoma, susceptibility to, 3	VCV000648894	2	30142880	2	29920014	648894	629915	rs1035402110	NC_000002.12:29920013:G:C	single nucleotide variant	missense variant	Uncertain significance	May 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.645del (p.Leu216fs)	ALK	L216fs	Neuroblastoma, susceptibility to, 3	VCV002801837	2	30142881	2	29920015	2801837	2952600		NC_000002.12:29920014:AA:A	Deletion	frameshift variant	Uncertain significance	Jan 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.645T>C (p.Leu215=)	ALK		Neuroblastoma, susceptibility to, 3|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000239848	2	30142881	2	29920015	239848	238756	rs115392387	NC_000002.12:29920014:A:G	single nucleotide variant	synonymous variant	Benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.643C>A (p.Leu215Ile)	ALK	L215I	Neuroblastoma, susceptibility to, 3	VCV001714184	2	30142883	2	29920017	1714184	1770801		NC_000002.12:29920016:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.642C>A (p.Arg214=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223921	2	30142884	2	29920018	3223921	3380943		NC_000002.12:29920017:G:T	single nucleotide variant	synonymous variant	Likely benign	Feb 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.641G>A (p.Arg214His)	ALK	R214H	Neuroblastoma, susceptibility to, 3	VCV000538178	2	30142885	2	29920019	538178	518143	rs766999851	NC_000002.12:29920018:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.640C>T (p.Arg214Cys)	ALK	R214C	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000538189	2	30142886	2	29920020	538189	518145	rs370297427	NC_000002.12:29920019:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.637C>A (p.Pro213Thr)	ALK	P213T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002676083	2	30142889	2	29920023	2676083	2834504		NC_000002.12:29920022:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.637C>T (p.Pro213Ser)	ALK	P213S	Neuroblastoma, susceptibility to, 3	VCV002127886	2	30142889	2	29920023	2127886	2185763		NC_000002.12:29920022:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.636G>A (p.Gln212=)	ALK		Hereditary cancer-predisposing syndrome	VCV003285813	2	30142890	2	29920024	3285813	3444553		NC_000002.12:29920023:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.636G>T (p.Gln212His)	ALK	Q212H	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002722689	2	30142890	2	29920024	2722689	2887917		NC_000002.12:29920023:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.634C>T (p.Gln212Ter)	ALK	Q212*	Neuroblastoma, susceptibility to, 3	VCV003730304	2	30142892	2	29920026	3730304	3862370		NC_000002.12:29920025:G:A	single nucleotide variant	nonsense	Uncertain significance	Nov 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.632C>T (p.Ser211Phe)	ALK	S211F	Neuroblastoma, susceptibility to, 3	VCV003642706	2	30142894	2	29920028	3642706	3765477		NC_000002.12:29920027:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.630C>T (p.Ala210=)	ALK		Hereditary cancer-predisposing syndrome	VCV003523336	2	30142896	2	29920030	3523336	3688894		NC_000002.12:29920029:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.630C>G (p.Ala210=)	ALK		Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV001097267	2	30142896	2	29920030	1097267	1069548	rs1337002578	NC_000002.12:29920029:G:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jul 17, 2023	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.629C>T (p.Ala210Val)	ALK	A210V	Hereditary cancer-predisposing syndrome	VCV001752689	2	30142897	2	29920031	1752689	1801123		NC_000002.12:29920030:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.628_629delinsCT (p.Ala210Leu)	ALK	A210L	Neuroblastoma, susceptibility to, 3	VCV001524522	2	30142897 - 30142898	2	29920031 - 29920032	1524522	1462996	rs2148442846	NC_000002.12:29920030:GC:AG	Indel	missense variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.628G>C (p.Ala210Pro)	ALK	A210P	Hereditary cancer-predisposing syndrome	VCV001752657	2	30142898	2	29920032	1752657	1801091		NC_000002.12:29920031:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 6, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.628G>A (p.Ala210Thr)	ALK	A210T	Neuroblastoma, susceptibility to, 3	VCV000538209	2	30142898	2	29920032	538209	518150	rs755697363	NC_000002.12:29920031:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.627C>A (p.Arg209=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001154292	2	30142899	2	29920033	1154292	1133683	rs1165267868	NC_000002.12:29920032:G:T	single nucleotide variant	synonymous variant	Likely benign	Jan 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.627C>G (p.Arg209=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000826291	2	30142899	2	29920033	826291	806915	rs1165267868	NC_000002.12:29920032:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 29, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.627C>T (p.Arg209=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000779295	2	30142899	2	29920033	779295	708228	rs1165267868	NC_000002.12:29920032:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.626G>A (p.Arg209His)	ALK	R209H	Hereditary cancer-predisposing syndrome	VCV003223920	2	30142900	2	29920034	3223920	3380942		NC_000002.12:29920033:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.625C>A (p.Arg209Ser)	ALK	R209S	Hereditary cancer-predisposing syndrome	VCV003223919	2	30142901	2	29920035	3223919	3380941		NC_000002.12:29920034:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.625C>T (p.Arg209Cys)	ALK	R209C	Neuroblastoma, susceptibility to, 3	VCV002676138	2	30142901	2	29920035	2676138	2834559		NC_000002.12:29920034:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.625C>G (p.Arg209Gly)	ALK	R209G	Neuroblastoma, susceptibility to, 3	VCV001412744	2	30142901	2	29920035	1412744	1356342	rs1365924896	NC_000002.12:29920034:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.623T>C (p.Ile208Thr)	ALK	I208T	Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype|Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000836167	2	30142903	2	29920037	836167	826394	rs372226787	NC_000002.12:29920036:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.622A>G (p.Ile208Val)	ALK	I208V	Hereditary cancer-predisposing syndrome	VCV001752321	2	30142904	2	29920038	1752321	1804176		NC_000002.12:29920037:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.620C>T (p.Ala207Val)	ALK	A207V	Neuroblastoma, susceptibility to, 3	VCV001413737	2	30142906	2	29920040	1413737	1361640	rs2148442860	NC_000002.12:29920039:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.618G>A (p.Ala206=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000239847	2	30142908	2	29920042	239847	238757	rs779178799	NC_000002.12:29920041:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.617C>T (p.Ala206Val)	ALK	A206V	Neuroblastoma, susceptibility to, 3|not provided	VCV001437301	2	30142909	2	29920043	1437301	1513917	rs1337143722	NC_000002.12:29920042:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.616G>A (p.Ala206Thr)	ALK	A206T	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538257	2	30142910	2	29920044	538257	518152	rs141093002	NC_000002.12:29920043:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 18, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.615C>A (p.Ser205=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000898289	2	30142911	2	29920045	898289	884687	rs567498111	NC_000002.12:29920044:G:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.615C>T (p.Ser205=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000739943	2	30142911	2	29920045	739943	747589	rs567498111	NC_000002.12:29920044:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.615C>G (p.Ser205=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000412941	2	30142911	2	29920045	412941	392606	rs567498111	NC_000002.12:29920044:G:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.614C>T (p.Ser205Phe)	ALK	S205F	Neuroblastoma, susceptibility to, 3	VCV001507846	2	30142912	2	29920046	1507846	1352305	rs2148442872	NC_000002.12:29920045:G:A	single nucleotide variant	missense variant	Uncertain significance	May 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.612G>C (p.Leu204=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002724272	2	30142914	2	29920048	2724272	2892074		NC_000002.12:29920047:C:G	single nucleotide variant	synonymous variant	Likely benign	Dec 14, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.612G>T (p.Leu204=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002025207	2	30142914	2	29920048	2025207	2084410		NC_000002.12:29920047:C:A	single nucleotide variant	synonymous variant	Likely benign	Aug 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.612G>A (p.Leu204=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001147497	2	30142914	2	29920048	1147497	1133684	rs1184727611	NC_000002.12:29920047:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.611T>C (p.Leu204Pro)	ALK	L204P	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000656164	2	30142915	2	29920049	656164	629916	rs1426655261	NC_000002.12:29920048:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.609G>C (p.Arg203Ser)	ALK	R203S	Neuroblastoma, susceptibility to, 3	VCV002986235	2	30142917	2	29920051	2986235	3146551		NC_000002.12:29920050:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.609G>A (p.Arg203=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001126245	2	30142917	2	29920051	1126245	1112775	rs1667946918	NC_000002.12:29920050:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 19, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.608G>A (p.Arg203Lys)	ALK	R203K	Neuroblastoma, susceptibility to, 3	VCV001973765	2	30142918	2	29920052	1973765	2026463		NC_000002.12:29920051:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.607A>G (p.Arg203Gly)	ALK	R203G	Neuroblastoma, susceptibility to, 3	VCV003646061	2	30142919	2	29920053	3646061	3776580		NC_000002.12:29920052:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.605G>A (p.Gly202Glu)	ALK	G202E	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000404373	2	30142921	2	29920055	404373	392662	rs1060500224	NC_000002.12:29920054:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.602_603del (p.Glu201fs)	ALK	E201fs	Neuroblastoma, susceptibility to, 3	VCV002024376	2	30142923 - 30142924	2	29920057 - 29920058	2024376	2077153		NC_000002.12:29920056:CTCTCT:CTCT	Microsatellite	frameshift variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.603G>A (p.Glu201=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001079120	2	30142923	2	29920057	1079120	1069549	rs2148442896	NC_000002.12:29920056:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 11, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.602A>T (p.Glu201Val)	ALK	E201V	Hereditary cancer-predisposing syndrome	VCV001751165	2	30142924	2	29920058	1751165	1800894		NC_000002.12:29920057:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.600A>G (p.Arg200=)	ALK		Hereditary cancer-predisposing syndrome	VCV001751054	2	30142926	2	29920060	1751054	1800783		NC_000002.12:29920059:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 1, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.599G>T (p.Arg200Ile)	ALK	R200I	Hereditary cancer-predisposing syndrome	VCV003525135	2	30142927	2	29920061	3525135	3689374		NC_000002.12:29920060:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.599G>C (p.Arg200Thr)	ALK	R200T	Neuroblastoma, susceptibility to, 3	VCV001373201	2	30142927	2	29920061	1373201	1463201	rs978946990	NC_000002.12:29920060:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.597C>T (p.Gly199=)	ALK		not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000335711	2	30142929	2	29920063	335711	285985	rs200868013	NC_000002.12:29920062:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.596G>C (p.Gly199Ala)	ALK	G199A	Neuroblastoma, susceptibility to, 3	VCV002984282	2	30142930	2	29920064	2984282	3149715		NC_000002.12:29920063:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.596G>T (p.Gly199Val)	ALK	G199V	Hereditary cancer-predisposing syndrome	VCV001750781	2	30142930	2	29920064	1750781	1803931		NC_000002.12:29920063:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.596G>A (p.Gly199Asp)	ALK	G199D	Neuroblastoma, susceptibility to, 3	VCV001494783	2	30142930	2	29920064	1494783	1344925	rs1292996434	NC_000002.12:29920063:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.595G>A (p.Gly199Ser)	ALK	G199S	Neuroblastoma, susceptibility to, 3	VCV000951142	2	30142931	2	29920065	951142	922737	rs747517546	NC_000002.12:29920064:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.595G>T (p.Gly199Cys)	ALK	G199C	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000937917	2	30142931	2	29920065	937917	931375	rs747517546	NC_000002.12:29920064:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.594G>A (p.Val198=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002091676	2	30142932	2	29920066	2091676	2156059		NC_000002.12:29920065:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.593T>C (p.Val198Ala)	ALK	V198A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001750618	2	30142933	2	29920067	1750618	1803768		NC_000002.12:29920066:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.592G>C (p.Val198Leu)	ALK	V198L	not provided	VCV002690885	2	30142934	2	29920068	2690885	2851915		NC_000002.12:29920067:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.592G>T (p.Val198Leu)	ALK	V198L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001750565	2	30142934	2	29920068	1750565	1803715		NC_000002.12:29920067:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.592G>A (p.Val198Met)	ALK	V198M	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000133460	2	30142934	2	29920068	133460	137199	rs77677701	NC_000002.12:29920067:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.591A>T (p.Glu197Asp)	ALK	E197D	Neuroblastoma, susceptibility to, 3	VCV002861581	2	30142935	2	29920069	2861581	3019056		NC_000002.12:29920068:T:A	single nucleotide variant	missense variant	Uncertain significance	May 2, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.590A>G (p.Glu197Gly)	ALK	E197G	Neuroblastoma, susceptibility to, 3	VCV002056205	2	30142936	2	29920070	2056205	2112788		NC_000002.12:29920069:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.588G>C (p.Ser196=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000724813	2	30142938	2	29920072	724813	733444	rs781350285	NC_000002.12:29920071:C:G	single nucleotide variant	synonymous variant	Likely benign	Dec 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.588G>A (p.Ser196=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470892	2	30142938	2	29920072	470892	450827	rs781350285	NC_000002.12:29920071:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.587C>A (p.Ser196Ter)	ALK	S196*	Neuroblastoma, susceptibility to, 3	VCV003724168	2	30142939	2	29920073	3724168	3857380		NC_000002.12:29920072:G:T	single nucleotide variant	nonsense	Uncertain significance	Oct 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.587C>T (p.Ser196Leu)	ALK	S196L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV001061573	2	30142939	2	29920073	1061573	1041429	rs1235761698	NC_000002.12:29920072:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.585G>T (p.Ala195=)	ALK		Hereditary cancer-predisposing syndrome	VCV001750135	2	30142941	2	29920075	1750135	1807113		NC_000002.12:29920074:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 20, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.585G>C (p.Ala195=)	ALK		Hereditary cancer-predisposing syndrome	VCV001750132	2	30142941	2	29920075	1750132	1807110		NC_000002.12:29920074:C:G	single nucleotide variant	synonymous variant	Likely benign	Oct 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.585G>A (p.Ala195=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001135965	2	30142941	2	29920075	1135965	1112776	rs2148442931	NC_000002.12:29920074:C:T	single nucleotide variant	synonymous variant	Likely benign	May 27, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.584C>A (p.Ala195Glu)	ALK	A195E	Hereditary cancer-predisposing syndrome	VCV001750061	2	30142942	2	29920076	1750061	1807039		NC_000002.12:29920075:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.583G>A (p.Ala195Thr)	ALK	A195T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001059470	2	30142943	2	29920077	1059470	1041430	rs138296547	NC_000002.12:29920076:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.579G>A (p.Lys193=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001102916	2	30142947	2	29920081	1102916	1091278	rs2148442947	NC_000002.12:29920080:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 18, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.578A>T (p.Lys193Met)	ALK	K193M	Neuroblastoma, susceptibility to, 3	VCV002125565	2	30142948	2	29920082	2125565	2174396		NC_000002.12:29920081:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.576G>C (p.Glu192Asp)	ALK	E192D	Neuroblastoma, susceptibility to, 3	VCV002705255	2	30142950	2	29920084	2705255	2860263		NC_000002.12:29920083:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.576G>A (p.Glu192=)	ALK		Hereditary cancer-predisposing syndrome	VCV001749539	2	30142950	2	29920084	1749539	1800567		NC_000002.12:29920083:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 13, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.575A>G (p.Glu192Gly)	ALK	E192G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001749463	2	30142951	2	29920085	1749463	1800491		NC_000002.12:29920084:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.574G>C (p.Glu192Gln)	ALK	E192Q	Neuroblastoma, susceptibility to, 3	VCV002793401	2	30142952	2	29920086	2793401	2950648		NC_000002.12:29920085:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.574G>T (p.Glu192Ter)	ALK	E192*	Neuroblastoma, susceptibility to, 3	VCV002014264	2	30142952	2	29920086	2014264	2064477		NC_000002.12:29920085:C:A	single nucleotide variant	nonsense	Uncertain significance	Mar 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.574G>A (p.Glu192Lys)	ALK	E192K	not provided|Neuroblastoma, susceptibility to, 3	VCV000470891	2	30142952	2	29920086	470891	450934	rs770006984	NC_000002.12:29920085:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.573C>T (p.Pro191=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001664006	2	30142953	2	29920087	1664006	1588828	rs145440822	NC_000002.12:29920086:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.573C>G (p.Pro191=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000412916	2	30142953	2	29920087	412916	392609	rs145440822	NC_000002.12:29920086:G:C	single nucleotide variant	synonymous variant	Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.571C>T (p.Pro191Ser)	ALK	P191S	Neuroblastoma, susceptibility to, 3	VCV003241658	2	30142955	2	29920089	3241658	3400636		NC_000002.12:29920088:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.570G>A (p.Met190Ile)	ALK	M190I	Neuroblastoma, susceptibility to, 3	VCV003640672	2	30142956	2	29920090	3640672	3772257		NC_000002.12:29920089:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.569T>C (p.Met190Thr)	ALK	M190T	Neuroblastoma, susceptibility to, 3	VCV000665606	2	30142957	2	29920091	665606	629917	rs1572502891	NC_000002.12:29920090:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.568A>G (p.Met190Val)	ALK	M190V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000964569	2	30142958	2	29920092	964569	942882	rs901176586	NC_000002.12:29920091:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.567G>T (p.Leu189=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001931544	2	30142959	2	29920093	1931544	1981808		NC_000002.12:29920092:C:A	single nucleotide variant	synonymous variant	Likely benign	May 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.567G>A (p.Leu189=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001152071	2	30142959	2	29920093	1152071	1133685	rs2148442976	NC_000002.12:29920092:C:T	single nucleotide variant	synonymous variant	Likely benign	May 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.566T>C (p.Leu189Pro)	ALK	L189P	Neuroblastoma, susceptibility to, 3	VCV003241607	2	30142960	2	29920094	3241607	3400585		NC_000002.12:29920093:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.566T>G (p.Leu189Arg)	ALK	L189R	Hereditary cancer-predisposing syndrome	VCV003223917	2	30142960	2	29920094	3223917	3380939		NC_000002.12:29920093:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.565C>T (p.Leu189=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003702947	2	30142961	2	29920095	3702947	3835118		NC_000002.12:29920094:G:A	single nucleotide variant	synonymous variant	Likely benign	May 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.564C>T (p.Arg188=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001668879	2	30142962	2	29920096	1668879	1602765	rs2148442985	NC_000002.12:29920095:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 19, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.563G>C (p.Arg188Pro)	ALK	R188P	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV003241667	2	30142963	2	29920097	3241667	3400645		NC_000002.12:29920096:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.563G>T (p.Arg188Leu)	ALK	R188L	Neuroblastoma, susceptibility to, 3	VCV002912442	2	30142963	2	29920097	2912442	3070555		NC_000002.12:29920096:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.563G>A (p.Arg188His)	ALK	R188H	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001521723	2	30142963	2	29920097	1521723	1347617	rs770625956	NC_000002.12:29920096:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.562C>T (p.Arg188Cys)	ALK	R188C	Neuroblastoma, susceptibility to, 3	VCV001476595	2	30142964	2	29920098	1476595	1339368	rs1306212162	NC_000002.12:29920097:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.561C>T (p.Ile187=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001547989	2	30142965	2	29920099	1547989	1537807	rs1410159912	NC_000002.12:29920098:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.561C>A (p.Ile187=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001093382	2	30142965	2	29920099	1093382	1069550	rs1410159912	NC_000002.12:29920098:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2019	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.560T>A (p.Ile187Asn)	ALK	I187N	Neuroblastoma, susceptibility to, 3	VCV001371067	2	30142966	2	29920100	1371067	1427273	rs2148442990	NC_000002.12:29920099:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.558G>C (p.Arg186Ser)	ALK	R186S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000569728	2	30142968	2	29920102	569728	560607	rs1558549504	NC_000002.12:29920101:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.557G>A (p.Arg186Lys)	ALK	R186K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000968355	2	30142969	2	29920103	968355	953081	rs774403380	NC_000002.12:29920102:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.556A>G (p.Arg186Gly)	ALK	R186G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002167365	2	30142970	2	29920104	2167365	1906485		NC_000002.12:29920103:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.555G>A (p.Leu185=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003725890	2	30142971	2	29920105	3725890	3857799		NC_000002.12:29920104:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.553C>T (p.Leu185=)	ALK		Hereditary cancer-predisposing syndrome	VCV001748190	2	30142973	2	29920107	1748190	1810378		NC_000002.12:29920106:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 11, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.552A>G (p.Arg184=)	ALK		Hereditary cancer-predisposing syndrome	VCV001748113	2	30142974	2	29920108	1748113	1810302		NC_000002.12:29920107:T:C	single nucleotide variant	synonymous variant	Likely benign	Mar 14, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.551G>T (p.Arg184Leu)	ALK	R184L	Neuroblastoma, susceptibility to, 3	VCV000577702	2	30142975	2	29920109	577702	558414	rs1558549514	NC_000002.12:29920108:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.550C>T (p.Arg184Ter)	ALK	R184*	Neuroblastoma, susceptibility to, 3	VCV001926698	2	30142976	2	29920110	1926698	1990763		NC_000002.12:29920109:G:A	single nucleotide variant	nonsense	Uncertain significance	Mar 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.548G>T (p.Gly183Val)	ALK	G183V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000999469	2	30142978	2	29920112	999469	988748	rs1060500223	NC_000002.12:29920111:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.548G>A (p.Gly183Glu)	ALK	G183E	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404371	2	30142978	2	29920112	404371	392783	rs1060500223	NC_000002.12:29920111:C:T	single nucleotide variant	missense variant	Uncertain significance	May 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.547G>A (p.Gly183Arg)	ALK	G183R	Hereditary cancer-predisposing syndrome	VCV001747792	2	30142979	2	29920113	1747792	1800090		NC_000002.12:29920112:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.545A>G (p.Glu182Gly)	ALK	E182G	Neuroblastoma, susceptibility to, 3	VCV002818207	2	30142981	2	29920115	2818207	2984422		NC_000002.12:29920114:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.544G>A (p.Glu182Lys)	ALK	E182K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001747599	2	30142982	2	29920116	1747599	1799897		NC_000002.12:29920115:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.544G>T (p.Glu182Ter)	ALK	E182*	Neuroblastoma, susceptibility to, 3	VCV001387549	2	30142982	2	29920116	1387549	1474274	rs1229550831	NC_000002.12:29920115:C:A	single nucleotide variant	nonsense	Uncertain significance	Nov 10, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.543C>G (p.Gly181=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002477221	2	30142983	2	29920117	2477221	2453570		NC_000002.12:29920116:G:C	single nucleotide variant	synonymous variant	Likely benign	Dec 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.543C>T (p.Gly181=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470890	2	30142983	2	29920117	470890	450935	rs984559507	NC_000002.12:29920116:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.542G>A (p.Gly181Asp)	ALK	G181D	Neuroblastoma, susceptibility to, 3	VCV002764956	2	30142984	2	29920118	2764956	2928722		NC_000002.12:29920117:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.540A>G (p.Gln180=)	ALK		Hereditary cancer-predisposing syndrome	VCV001747342	2	30142986	2	29920120	1747342	1803093		NC_000002.12:29920119:T:C	single nucleotide variant	synonymous variant	Likely benign	May 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.540A>C (p.Gln180His)	ALK	Q180H	Neuroblastoma, susceptibility to, 3	VCV000660784	2	30142986	2	29920120	660784	629918	rs1572502948	NC_000002.12:29920119:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.537C>G (p.Arg179=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002866311	2	30142989	2	29920123	2866311	3023784		NC_000002.12:29920122:G:C	single nucleotide variant	synonymous variant	Likely benign	Mar 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.537C>T (p.Arg179=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002586664	2	30142989	2	29920123	2586664	2756847		NC_000002.12:29920122:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.536G>A (p.Arg179His)	ALK	R179H	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001436502	2	30142990	2	29920124	1436502	1340893	rs1316424431	NC_000002.12:29920123:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 2, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.536G>T (p.Arg179Leu)	ALK	R179L	Neuroblastoma, susceptibility to, 3	VCV001038235	2	30142990	2	29920124	1038235	1024475	rs1316424431	NC_000002.12:29920123:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 18, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.535C>A (p.Arg179Ser)	ALK	R179S	Hereditary cancer-predisposing syndrome	VCV001747054	2	30142991	2	29920125	1747054	1802805		NC_000002.12:29920124:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.535C>T (p.Arg179Cys)	ALK	R179C	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000858126	2	30142991	2	29920125	858126	826395	rs62129830	NC_000002.12:29920124:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.534T>G (p.Ile178Met)	ALK	I178M	Neuroblastoma, susceptibility to, 3	VCV002750295	2	30142992	2	29920126	2750295	2919253		NC_000002.12:29920125:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.534T>C (p.Ile178=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001106223	2	30142992	2	29920126	1106223	1091279	rs2148443040	NC_000002.12:29920125:A:G	single nucleotide variant	synonymous variant	Likely benign	May 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.532A>G (p.Ile178Val)	ALK	I178V	Neuroblastoma, susceptibility to, 3	VCV001017832	2	30142994	2	29920128	1017832	1004011	rs1667950122	NC_000002.12:29920127:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.531G>T (p.Trp177Cys)	ALK	W177C	Neuroblastoma, susceptibility to, 3	VCV001521383	2	30142995	2	29920129	1521383	1347278	rs2148443045	NC_000002.12:29920128:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.530G>A (p.Trp177Ter)	ALK	W177*	Neuroblastoma, susceptibility to, 3	VCV002981251	2	30142996	2	29920130	2981251	3138548		NC_000002.12:29920129:C:T	single nucleotide variant	nonsense	Uncertain significance	Nov 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.527G>C (p.Trp176Ser)	ALK	W176S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001746554	2	30142999	2	29920133	1746554	1806101		NC_000002.12:29920132:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.526T>C (p.Trp176Arg)	ALK	W176R	Neuroblastoma, susceptibility to, 3	VCV000948804	2	30143000	2	29920134	948804	922738	rs1365096158	NC_000002.12:29920133:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.523A>G (p.Ser175Gly)	ALK	S175G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470889	2	30143003	2	29920137	470889	450830	rs767019998	NC_000002.12:29920136:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.522C>T (p.Phe174=)	ALK		Hereditary cancer-predisposing syndrome	VCV001746205	2	30143004	2	29920138	1746205	1809694		NC_000002.12:29920137:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 11, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.522C>A (p.Phe174Leu)	ALK	F174L	Neuroblastoma, susceptibility to, 3|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000133458	2	30143004	2	29920138	133458	137197	rs587778020	NC_000002.12:29920137:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.520T>C (p.Phe174Leu)	ALK	F174L	Neuroblastoma, susceptibility to, 3	VCV001501877	2	30143006	2	29920140	1501877	1411095	rs1667950450	NC_000002.12:29920139:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.518T>C (p.Leu173Pro)	ALK	L173P	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002989714	2	30143008	2	29920142	2989714	3147443		NC_000002.12:29920141:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.517C>T (p.Leu173=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002913033	2	30143009	2	29920143	2913033	3079074		NC_000002.12:29920142:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.517C>G (p.Leu173Val)	ALK	L173V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001415520	2	30143009	2	29920143	1415520	1375027	rs760343255	NC_000002.12:29920142:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.516G>T (p.Glu172Asp)	ALK	E172D	Neuroblastoma, susceptibility to, 3	VCV000951831	2	30143010	2	29920144	951831	922739	rs1667950612	NC_000002.12:29920143:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.514G>A (p.Glu172Lys)	ALK	E172K	Neuroblastoma, susceptibility to, 3	VCV001025394	2	30143012	2	29920146	1025394	1004012	rs1667950677	NC_000002.12:29920145:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.513C>T (p.Ser171=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404325	2	30143013	2	29920147	404325	392663	rs534035801	NC_000002.12:29920146:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.512G>C (p.Ser171Thr)	ALK	S171T	Neuroblastoma, susceptibility to, 3	VCV002829673	2	30143014	2	29920148	2829673	2990335		NC_000002.12:29920147:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.512G>T (p.Ser171Ile)	ALK	S171I	Hereditary cancer-predisposing syndrome	VCV001745540	2	30143014	2	29920148	1745540	1802592		NC_000002.12:29920147:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.512G>A (p.Ser171Asn)	ALK	S171N	Neuroblastoma, susceptibility to, 3	VCV001046640	2	30143014	2	29920148	1046640	1024476	rs753403262	NC_000002.12:29920147:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.510C>T (p.Leu170=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000335712	2	30143016	2	29920150	335712	285989	rs886055933	NC_000002.12:29920149:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Oct 23, 2023	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.508C>T (p.Leu170Phe)	ALK	L170F	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001745258	2	30143018	2	29920152	1745258	1802311		NC_000002.12:29920151:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.507T>G (p.Asn169Lys)	ALK	N169K	Hereditary cancer-predisposing syndrome	VCV002566601	2	30143019	2	29920153	2566601	2734444		NC_000002.12:29920152:A:C	single nucleotide variant	missense variant	Uncertain significance	May 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.507T>C (p.Asn169=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000335713	2	30143019	2	29920153	335713	285994	rs780271684	NC_000002.12:29920152:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 28, 2021	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.506A>G (p.Asn169Ser)	ALK	N169S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538235	2	30143020	2	29920154	538235	518155	rs752129360	NC_000002.12:29920153:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 25, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.505A>G (p.Asn169Asp)	ALK	N169D	Neuroblastoma, susceptibility to, 3	VCV000572290	2	30143021	2	29920155	572290	560609	rs932619554	NC_000002.12:29920154:T:C	single nucleotide variant	missense variant	Uncertain significance	May 16, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.504C>G (p.Phe168Leu)	ALK	F168L	Hereditary cancer-predisposing syndrome	VCV003523383	2	30143022	2	29920156	3523383	3688941		NC_000002.12:29920155:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.504C>T (p.Phe168=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470888	2	30143022	2	29920156	470888	451140	rs1049819210	NC_000002.12:29920155:G:A	single nucleotide variant	synonymous variant	Likely benign	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.503T>C (p.Phe168Ser)	ALK	F168S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000404315	2	30143023	2	29920157	404315	392785	rs755498584	NC_000002.12:29920156:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.502T>C (p.Phe168Leu)	ALK	F168L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000662369	2	30143024	2	29920158	662369	629919	rs1374532256	NC_000002.12:29920157:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.501G>A (p.Gln167=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001744820	2	30143025	2	29920159	1744820	1805666		NC_000002.12:29920158:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.501G>T (p.Gln167His)	ALK	Q167H	Neuroblastoma, susceptibility to, 3	VCV000569680	2	30143025	2	29920159	569680	561410	rs781440137	NC_000002.12:29920158:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.498C>G (p.Leu166=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001744567	2	30143028	2	29920162	1744567	1809348		NC_000002.12:29920161:G:C	single nucleotide variant	synonymous variant	Likely benign	Apr 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.498C>A (p.Leu166=)	ALK		Hereditary cancer-predisposing syndrome	VCV001744564	2	30143028	2	29920162	1744564	1809345		NC_000002.12:29920161:G:T	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.498C>T (p.Leu166=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538305	2	30143028	2	29920162	538305	518164	rs373986433	NC_000002.12:29920161:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.497T>C (p.Leu166Pro)	ALK	L166P	Hereditary cancer-predisposing syndrome	VCV003524242	2	30143029	2	29920163	3524242	3682410		NC_000002.12:29920162:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.495G>T (p.Leu165=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002857283	2	30143031	2	29920165	2857283	3024776		NC_000002.12:29920164:C:A	single nucleotide variant	synonymous variant	Likely benign	Apr 18, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.492G>T (p.Gly164=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001744195	2	30143034	2	29920168	1744195	1799091		NC_000002.12:29920167:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.492G>A (p.Gly164=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001531404	2	30143034	2	29920168	1531404	1604822	rs2148443148	NC_000002.12:29920167:C:T	single nucleotide variant	synonymous variant	Likely benign	May 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.491G>A (p.Gly164Glu)	ALK	G164E	Neuroblastoma, susceptibility to, 3	VCV002729703	2	30143035	2	29920169	2729703	2889745		NC_000002.12:29920168:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.490G>A (p.Gly164Arg)	ALK	G164R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404346	2	30143036	2	29920170	404346	392611	rs1060500219	NC_000002.12:29920169:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.487G>A (p.Val163Met)	ALK	V163M	Neuroblastoma, susceptibility to, 3	VCV001006725	2	30143039	2	29920173	1006725	988749	rs55697431	NC_000002.12:29920172:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.487G>T (p.Val163Leu)	ALK	V163L	Neuroblastoma, susceptibility to, 3|not specified|Hereditary cancer-predisposing syndrome	VCV000133459	2	30143039	2	29920173	133459	137198	rs55697431	NC_000002.12:29920172:C:A	single nucleotide variant	missense variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.486T>A (p.Ala162=)	ALK		Hereditary cancer-predisposing syndrome	VCV002477408	2	30143040	2	29920174	2477408	2453757		NC_000002.12:29920173:A:T	single nucleotide variant	synonymous variant	Likely benign	Nov 26, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.485C>T (p.Ala162Val)	ALK	A162V	Neuroblastoma, susceptibility to, 3	VCV000651059	2	30143041	2	29920175	651059	629920	rs1572503074	NC_000002.12:29920174:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.484G>A (p.Ala162Thr)	ALK	A162T	Neuroblastoma, susceptibility to, 3	VCV002742446	2	30143042	2	29920176	2742446	2903215		NC_000002.12:29920175:C:T	single nucleotide variant	missense variant	Uncertain significance	May 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.483G>C (p.Ala161=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000697324	2	30143043	2	29920177	697324	683500	rs897652080	NC_000002.12:29920176:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.482C>T (p.Ala161Val)	ALK	A161V	not provided|Neuroblastoma, susceptibility to, 3|Neoplasm	VCV002728241	2	30143044	2	29920178	2728241	2889579		NC_000002.12:29920177:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2023	criteria provided, multiple submitters, no conflicts				Uncertain significance	Jul 31, 2024	criteria provided, single submitter	
NM_004304.5(ALK):c.482C>A (p.Ala161Glu)	ALK	A161E	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001495156	2	30143044	2	29920178	1495156	1368942	rs2148443167	NC_000002.12:29920177:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.481G>C (p.Ala161Pro)	ALK	A161P	Hereditary cancer-predisposing syndrome	VCV003525244	2	30143045	2	29920179	3525244	3685600		NC_000002.12:29920178:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.481G>T (p.Ala161Ser)	ALK	A161S	Neuroblastoma, susceptibility to, 3	VCV002120333	2	30143045	2	29920179	2120333	2173053		NC_000002.12:29920178:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.481G>A (p.Ala161Thr)	ALK	A161T	Neuroblastoma, susceptibility to, 3	VCV002049574	2	30143045	2	29920179	2049574	2107461		NC_000002.12:29920178:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.478G>T (p.Glu160Ter)	ALK	E160*	Neuroblastoma, susceptibility to, 3	VCV002705389	2	30143048	2	29920182	2705389	2860397		NC_000002.12:29920181:C:A	single nucleotide variant	nonsense	Uncertain significance	Jan 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.478G>A (p.Glu160Lys)	ALK	E160K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000961120	2	30143048	2	29920182	961120	942883	rs1667952034	NC_000002.12:29920181:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.477G>C (p.Gly159=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001108553	2	30143049	2	29920183	1108553	1091280	rs770771709	NC_000002.12:29920182:C:G	single nucleotide variant	synonymous variant	Likely benign	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.477G>A (p.Gly159=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000706127	2	30143049	2	29920183	706127	691149	rs770771709	NC_000002.12:29920182:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.474dup (p.Gly159fs)	ALK	G159fs	Neuroblastoma, susceptibility to, 3	VCV001007159	2	30143051 - 30143052	2	29920185 - 29920186	1007159	988750	rs1244823020	NC_000002.12:29920185:GGGGGG:GGGGGGG	Duplication	frameshift variant	Uncertain significance	Dec 10, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.475G>A (p.Gly159Arg)	ALK	G159R	not provided|Neuroblastoma, susceptibility to, 3	VCV000951508	2	30143051	2	29920185	951508	922740	rs367875912	NC_000002.12:29920184:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.474C>A (p.Pro158=)	ALK		Hereditary cancer-predisposing syndrome	VCV002452132	2	30143052	2	29920186	2452132	2426772		NC_000002.12:29920185:G:T	single nucleotide variant	synonymous variant	Likely benign	Feb 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.474C>G (p.Pro158=)	ALK		Hereditary cancer-predisposing syndrome	VCV001742823	2	30143052	2	29920186	1742823	1808906		NC_000002.12:29920185:G:C	single nucleotide variant	synonymous variant	Likely benign	May 20, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.474C>T (p.Pro158=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000741701	2	30143052	2	29920186	741701	747590	rs1298233277	NC_000002.12:29920185:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.474del (p.Glu160fs)	ALK	E160fs	Neuroblastoma, susceptibility to, 3	VCV000470885	2	30143052	2	29920186	470885	450945	rs1244823020	NC_000002.12:29920185:GGGGGG:GGGGG	Deletion	frameshift variant	Uncertain significance	Mar 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.473C>G (p.Pro158Arg)	ALK	P158R	Hereditary cancer-predisposing syndrome	VCV003524746	2	30143053	2	29920187	3524746	3688985		NC_000002.12:29920186:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.472C>T (p.Pro158Ser)	ALK	P158S	Neuroblastoma, susceptibility to, 3	VCV000664576	2	30143054	2	29920188	664576	629921	rs536284304	NC_000002.12:29920187:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.472C>A (p.Pro158Thr)	ALK	P158T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000239843	2	30143054	2	29920188	239843	238758	rs536284304	NC_000002.12:29920187:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 2, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.470C>T (p.Pro157Leu)	ALK	P157L	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000570092	2	30143056	2	29920190	570092	560611	rs775385954	NC_000002.12:29920189:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 30, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.469C>G (p.Pro157Ala)	ALK	P157A	Hereditary cancer-predisposing syndrome	VCV003524427	2	30143057	2	29920191	3524427	3679092		NC_000002.12:29920190:G:C	single nucleotide variant	missense variant	Likely benign	Aug 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.469C>A (p.Pro157Thr)	ALK	P157T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001440259	2	30143057	2	29920191	1440259	1368709	rs74774946	NC_000002.12:29920190:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.469C>T (p.Pro157Ser)	ALK	P157S	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000239842	2	30143057	2	29920191	239842	238759	rs74774946	NC_000002.12:29920190:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.468G>T (p.Gly156=)	ALK		Hereditary cancer-predisposing syndrome	VCV001742472	2	30143058	2	29920192	1742472	1798673		NC_000002.12:29920191:C:A	single nucleotide variant	synonymous variant	Likely benign	Jun 20, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.468G>C (p.Gly156=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001139085	2	30143058	2	29920192	1139085	1112777	rs776407160	NC_000002.12:29920191:C:G	single nucleotide variant	synonymous variant	Likely benign	May 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.466G>T (p.Gly156Trp)	ALK	G156W	Neuroblastoma, susceptibility to, 3	VCV003619359	2	30143060	2	29920194	3619359	3756382		NC_000002.12:29920193:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.466G>A (p.Gly156Arg)	ALK	G156R	Neuroblastoma, susceptibility to, 3	VCV000470883	2	30143060	2	29920194	470883	450946	rs761318889	NC_000002.12:29920193:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.465C>G (p.Val155=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002822582	2	30143061	2	29920195	2822582	2978541		NC_000002.12:29920194:G:C	single nucleotide variant	synonymous variant	Likely benign	Dec 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.465C>T (p.Val155=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001742232	2	30143061	2	29920195	1742232	1798433		NC_000002.12:29920194:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.464T>G (p.Val155Gly)	ALK	V155G	Neuroblastoma, susceptibility to, 3	VCV001503527	2	30143062	2	29920196	1503527	1401244	rs1206463887	NC_000002.12:29920195:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.464T>A (p.Val155Asp)	ALK	V155D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001008011	2	30143062	2	29920196	1008011	988751	rs1206463887	NC_000002.12:29920195:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.463G>A (p.Val155Ile)	ALK	V155I	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001016540	2	30143063	2	29920197	1016540	1004013	rs751920643	NC_000002.12:29920196:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.463G>C (p.Val155Leu)	ALK	V155L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000857536	2	30143063	2	29920197	857536	826396	rs751920643	NC_000002.12:29920196:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.462C>T (p.Cys154=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001742013	2	30143064	2	29920198	1742013	1801656		NC_000002.12:29920197:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.457G>T (p.Gly153Cys)	ALK	G153C	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003241818	2	30143069	2	29920203	3241818	3400796		NC_000002.12:29920202:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.457G>A (p.Gly153Ser)	ALK	G153S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000853333	2	30143069	2	29920203	853333	826397	rs1485515006	NC_000002.12:29920202:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.456G>C (p.Glu152Asp)	ALK	E152D	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538247	2	30143070	2	29920204	538247	518167	rs1553380299	NC_000002.12:29920203:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.455A>T (p.Glu152Val)	ALK	E152V	Neuroblastoma, susceptibility to, 3	VCV003644449	2	30143071	2	29920205	3644449	3765934		NC_000002.12:29920204:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.455A>G (p.Glu152Gly)	ALK	E152G	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538215	2	30143071	2	29920205	538215	518156	rs1553380301	NC_000002.12:29920204:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.454G>C (p.Glu152Gln)	ALK	E152Q	Neuroblastoma, susceptibility to, 3	VCV000404388	2	30143072	2	29920206	404388	392788	rs1060500233	NC_000002.12:29920205:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.452T>C (p.Leu151Ser)	ALK	L151S	Hereditary cancer-predisposing syndrome	VCV002452102	2	30143074	2	29920208	2452102	2426742		NC_000002.12:29920207:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.451T>C (p.Leu151=)	ALK		Hereditary cancer-predisposing syndrome	VCV001741207	2	30143075	2	29920209	1741207	1808584		NC_000002.12:29920208:A:G	single nucleotide variant	synonymous variant	Likely benign	May 18, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.450C>G (p.Ile150Met)	ALK	I150M	Hereditary cancer-predisposing syndrome	VCV003524502	2	30143076	2	29920210	3524502	3679167		NC_000002.12:29920209:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.450C>T (p.Ile150=)	ALK		Hereditary cancer-predisposing syndrome	VCV002561055	2	30143076	2	29920210	2561055	2717214		NC_000002.12:29920209:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.448A>C (p.Ile150Leu)	ALK	I150L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001692787	2	30143078	2	29920212	1692787	1685227	rs1203267790	NC_000002.12:29920211:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.447G>C (p.Ala149=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002091721	2	30143079	2	29920213	2091721	2156104		NC_000002.12:29920212:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.447G>T (p.Ala149=)	ALK		Hereditary cancer-predisposing syndrome	VCV001740902	2	30143079	2	29920213	1740902	1798402		NC_000002.12:29920212:C:A	single nucleotide variant	synonymous variant	Likely benign	Jan 2, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.447G>A (p.Ala149=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001740897	2	30143079	2	29920213	1740897	1798397		NC_000002.12:29920212:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.446C>A (p.Ala149Glu)	ALK	A149E	Neuroblastoma, susceptibility to, 3	VCV002128756	2	30143080	2	29920214	2128756	2178779		NC_000002.12:29920213:G:T	single nucleotide variant	missense variant	Uncertain significance	May 30, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.440AGG[3] (p.Glu148dup)	ALK		Neuroblastoma, susceptibility to, 3	VCV000949197	2	30143080 - 30143081	2	29920214 - 29920215	949197	922741	rs1667953492	NC_000002.12:29920214:CCTCCTC:CCTCCTCCTC	Microsatellite	inframe_insertion	Uncertain significance	Jun 26, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.446C>T (p.Ala149Val)	ALK	A149V	Neuroblastoma, susceptibility to, 3	VCV000568081	2	30143080	2	29920214	568081	561414	rs374276783	NC_000002.12:29920213:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 7, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.445G>A (p.Ala149Thr)	ALK	A149T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001740765	2	30143081	2	29920215	1740765	1798265		NC_000002.12:29920214:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.443A>T (p.Glu148Val)	ALK	E148V	Neuroblastoma, susceptibility to, 3	VCV001404095	2	30143083	2	29920217	1404095	1479794	rs1331266292	NC_000002.12:29920216:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.443A>C (p.Glu148Ala)	ALK	E148A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000640562	2	30143083	2	29920217	640562	629922	rs1331266292	NC_000002.12:29920216:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.442G>A (p.Glu148Lys)	ALK	E148K	Hereditary cancer-predisposing syndrome	VCV001740545	2	30143084	2	29920218	1740545	1798047		NC_000002.12:29920217:C:T	single nucleotide variant	missense variant	Uncertain significance	May 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.441G>A (p.Glu147=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002111822	2	30143085	2	29920219	2111822	2160643		NC_000002.12:29920218:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 14, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.439G>A (p.Glu147Lys)	ALK	E147K	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001010866	2	30143087	2	29920221	1010866	988752	rs756273623	NC_000002.12:29920220:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.438C>T (p.Gly146=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001977995	2	30143088	2	29920222	1977995	2044968		NC_000002.12:29920221:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Dec 23, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.438C>A (p.Gly146=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001740195	2	30143088	2	29920222	1740195	1791228		NC_000002.12:29920221:G:T	single nucleotide variant	synonymous variant	Likely benign	Dec 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.437G>A (p.Gly146Asp)	ALK	G146D	Neuroblastoma, susceptibility to, 3	VCV003702498	2	30143089	2	29920223	3702498	3838549		NC_000002.12:29920222:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.436G>A (p.Gly146Ser)	ALK	G146S	Neuroblastoma, susceptibility to, 3	VCV001401376	2	30143090	2	29920224	1401376	1379363	rs2148443264	NC_000002.12:29920223:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 31, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.435G>T (p.Leu145=)	ALK		Hereditary cancer-predisposing syndrome	VCV001740004	2	30143091	2	29920225	1740004	1794450		NC_000002.12:29920224:C:A	single nucleotide variant	synonymous variant	Likely benign	Sep 25, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.434T>C (p.Leu145Pro)	ALK	L145P	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV001442170	2	30143092	2	29920226	1442170	1475035	rs1305698643	NC_000002.12:29920225:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.433C>G (p.Leu145Val)	ALK	L145V	Neuroblastoma, susceptibility to, 3	VCV002872782	2	30143093	2	29920227	2872782	3037861		NC_000002.12:29920226:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.433C>T (p.Leu145=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001150717	2	30143093	2	29920227	1150717	1133686	rs1022616693	NC_000002.12:29920226:G:A	single nucleotide variant	synonymous variant	Likely benign	May 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.432G>A (p.Glu144=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001153154	2	30143094	2	29920228	1153154	1133687	rs968483486	NC_000002.12:29920227:C:T	single nucleotide variant	synonymous variant	Likely benign	May 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.425_430dup (p.Val142_Leu143dup)	ALK		Neuroblastoma, susceptibility to, 3	VCV001059626	2	30143095 - 30143096	2	29920229 - 29920230	1059626	1041431	rs2148443279	NC_000002.12:29920229:CCAGCACCA:CCAGCACCAGCACCA	Duplication	inframe_insertion	Uncertain significance	Mar 5, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.430G>A (p.Glu144Lys)	ALK	E144K	Neuroblastoma, susceptibility to, 3	VCV003667495	2	30143096	2	29920230	3667495	3796071		NC_000002.12:29920229:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.428T>C (p.Leu143Pro)	ALK	L143P	Hereditary cancer-predisposing syndrome	VCV002447092	2	30143098	2	29920232	2447092	2422215		NC_000002.12:29920231:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.427dup (p.Leu143fs)	ALK	L143fs	Neuroblastoma, susceptibility to, 3	VCV002002155	2	30143098 - 30143099	2	29920232 - 29920233	2002155	2051501		NC_000002.12:29920232:G:GG	Duplication	frameshift variant	Uncertain significance	Jun 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.428T>A (p.Leu143Gln)	ALK	L143Q	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV001017861	2	30143098	2	29920232	1017861	1004014	rs777656583	NC_000002.12:29920231:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.428T>G (p.Leu143Arg)	ALK	L143R	not provided|Neuroblastoma, susceptibility to, 3	VCV000580609	2	30143098	2	29920232	580609	561416	rs777656583	NC_000002.12:29920231:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.427C>A (p.Leu143Met)	ALK	L143M	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001739323	2	30143099	2	29920233	1739323	1797693		NC_000002.12:29920232:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.427C>T (p.Leu143=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001104257	2	30143099	2	29920233	1104257	1091281	rs1176553598	NC_000002.12:29920232:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.426G>A (p.Val142=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002793271	2	30143100	2	29920234	2793271	2950518		NC_000002.12:29920233:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.426G>T (p.Val142=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000757852	2	30143100	2	29920234	757852	763189	rs903662070	NC_000002.12:29920233:C:A	single nucleotide variant	synonymous variant	Likely benign	Apr 11, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.424G>C (p.Val142Leu)	ALK	V142L	Hereditary cancer-predisposing syndrome	VCV001739076	2	30143102	2	29920236	1739076	1788073		NC_000002.12:29920235:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.424G>A (p.Val142Met)	ALK	V142M	Neuroblastoma, susceptibility to, 3	VCV001717769	2	30143102	2	29920236	1717769	1771745		NC_000002.12:29920235:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.419A>G (p.Gln140Arg)	ALK	Q140R	Neuroblastoma, susceptibility to, 3	VCV001057503	2	30143107	2	29920241	1057503	1041432	rs2148443304	NC_000002.12:29920240:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.404_418del (p.Leu135_Lys139del)	ALK		Neuroblastoma, susceptibility to, 3	VCV003623649	2	30143108 - 30143122	2	29920242 - 29920256	3623649	3751449		NC_000002.12:29920241:GCTTGGCACGCCGGAGCTTG:GCTTG	Deletion	inframe_deletion	Uncertain significance	Jun 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.417G>A (p.Lys139=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001589830	2	30143109	2	29920243	1589830	1576376	rs978498374	NC_000002.12:29920242:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.415A>C (p.Lys139Gln)	ALK	K139Q	Neuroblastoma, susceptibility to, 3	VCV003653750	2	30143111	2	29920245	3653750	3785754		NC_000002.12:29920244:T:G	single nucleotide variant	missense variant	Uncertain significance	May 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.415A>G (p.Lys139Glu)	ALK	K139E	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001416958	2	30143111	2	29920245	1416958	1487698	rs749530596	NC_000002.12:29920244:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 18, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.414C>G (p.Ala138=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001121408	2	30143112	2	29920246	1121408	1112778	rs1483565631	NC_000002.12:29920245:G:C	single nucleotide variant	synonymous variant	Likely benign	Jul 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.413C>G (p.Ala138Gly)	ALK	A138G	Neuroblastoma, susceptibility to, 3	VCV002881604	2	30143113	2	29920247	2881604	3036960		NC_000002.12:29920246:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.412G>C (p.Ala138Pro)	ALK	A138P	Neuroblastoma, susceptibility to, 3	VCV003617169	2	30143114	2	29920248	3617169	3758941		NC_000002.12:29920247:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.412G>A (p.Ala138Thr)	ALK	A138T	Neuroblastoma, susceptibility to, 3	VCV001462432	2	30143114	2	29920248	1462432	1432835	rs2148443328	NC_000002.12:29920247:C:T	single nucleotide variant	missense variant	Uncertain significance	May 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.411T>G (p.Arg137=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003709551	2	30143115	2	29920249	3709551	3840411		NC_000002.12:29920248:A:C	single nucleotide variant	synonymous variant	Likely benign	Jun 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.410G>A (p.Arg137His)	ALK	R137H	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001466311	2	30143116	2	29920250	1466311	1347670	rs2148443334	NC_000002.12:29920249:C:T	single nucleotide variant	missense variant	Uncertain significance	May 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.409C>A (p.Arg137Ser)	ALK	R137S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000952441	2	30143117	2	29920251	952441	922742	rs757382067	NC_000002.12:29920250:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.409C>T (p.Arg137Cys)	ALK	R137C	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538265	2	30143117	2	29920251	538265	518280	rs757382067	NC_000002.12:29920250:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.409C>G (p.Arg137Gly)	ALK	R137G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538185	2	30143117	2	29920251	538185	518161	rs757382067	NC_000002.12:29920250:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 14, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.395_408del (p.Val132fs)	ALK	V132fs	Neuroblastoma, susceptibility to, 3	VCV002816078	2	30143118 - 30143131	2	29920252 - 29920265	2816078	2976748		NC_000002.12:29920251:CCGGAGCTTGCGCAC:C	Deletion	frameshift variant	Uncertain significance	Nov 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.408del (p.Arg137fs)	ALK	R137fs	Neuroblastoma, susceptibility to, 3	VCV001445263	2	30143118	2	29920252	1445263	1397589	rs2148443342	NC_000002.12:29920251:CC:C	Deletion	frameshift variant	Uncertain significance	Nov 5, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.408G>C (p.Arg136=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001158760	2	30143118	2	29920252	1158760	1133688	rs1667954474	NC_000002.12:29920251:C:G	single nucleotide variant	synonymous variant	Likely benign	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.407G>A (p.Arg136Gln)	ALK	R136Q	Neuroblastoma, susceptibility to, 3	VCV000470864	2	30143119	2	29920253	470864	450950	rs745712273	NC_000002.12:29920252:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.406C>T (p.Arg136Trp)	ALK	R136W	Neuroblastoma, susceptibility to, 3	VCV001394913	2	30143120	2	29920254	1394913	1415802	rs1386626390	NC_000002.12:29920253:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.406C>A (p.Arg136=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001095896	2	30143120	2	29920254	1095896	1069551	rs1386626390	NC_000002.12:29920253:G:T	single nucleotide variant	synonymous variant	Likely benign	Jul 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.405C>G (p.Leu135=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470862	2	30143121	2	29920255	470862	451125	rs771825127	NC_000002.12:29920254:G:C	single nucleotide variant	synonymous variant	Likely benign	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.402G>C (p.Lys134Asn)	ALK	K134N	Ovarian cancer	VCV002445401	2	30143124	2	29920258	2445401	2419127		NC_000002.12:29920257:C:G	single nucleotide variant	missense variant	Likely pathogenic	Jan 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.402G>A (p.Lys134=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001737190	2	30143124	2	29920258	1737190	1790389		NC_000002.12:29920257:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.401A>G (p.Lys134Arg)	ALK	K134R	Hereditary cancer-predisposing syndrome	VCV001737086	2	30143125	2	29920259	1737086	1790285		NC_000002.12:29920258:T:C	single nucleotide variant	missense variant	Uncertain significance	May 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.400A>G (p.Lys134Glu)	ALK	K134E	Neuroblastoma, susceptibility to, 3	VCV003678647	2	30143126	2	29920260	3678647	3807383		NC_000002.12:29920259:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.400A>C (p.Lys134Gln)	ALK	K134Q	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001736990	2	30143126	2	29920260	1736990	1794032		NC_000002.12:29920259:T:G	single nucleotide variant	missense variant	Uncertain significance	May 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.398_399delinsAA (p.Arg133Gln)	ALK	R133Q	Neuroblastoma, susceptibility to, 3	VCV002016384	2	30143127 - 30143128	2	29920261 - 29920262	2016384	2075590		NC_000002.12:29920260:GC:TT	Indel	missense variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.398G>T (p.Arg133Leu)	ALK	R133L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001064256	2	30143128	2	29920262	1064256	1041433	rs768229646	NC_000002.12:29920261:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.398G>A (p.Arg133His)	ALK	R133H	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000853376	2	30143128	2	29920262	853376	826398	rs768229646	NC_000002.12:29920261:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 12, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.397C>A (p.Arg133Ser)	ALK	R133S	Neuroblastoma, susceptibility to, 3	VCV002153191	2	30143129	2	29920263	2153191	1885452		NC_000002.12:29920262:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.397C>T (p.Arg133Cys)	ALK	R133C	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538219	2	30143129	2	29920263	538219	518221	rs775940832	NC_000002.12:29920262:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 20, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.396G>A (p.Val132=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001555143	2	30143130	2	29920264	1555143	1564887	rs761545303	NC_000002.12:29920263:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 12, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.396G>C (p.Val132=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538293	2	30143130	2	29920264	538293	518225	rs761545303	NC_000002.12:29920263:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.394G>A (p.Val132Met)	ALK	V132M	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000656593	2	30143132	2	29920266	656593	629924	rs1262491330	NC_000002.12:29920265:C:T	single nucleotide variant	missense variant	Uncertain significance	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.394G>T (p.Val132Leu)	ALK	V132L	Neuroblastoma, susceptibility to, 3	VCV000648415	2	30143132	2	29920266	648415	629923	rs1262491330	NC_000002.12:29920265:C:A	single nucleotide variant	missense variant	Uncertain significance	May 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.393C>A (p.Ser131=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001610006	2	30143133	2	29920267	1610006	1550962	rs765026986	NC_000002.12:29920266:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.393C>G (p.Ser131=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000841721	2	30143133	2	29920267	841721	826399	rs765026986	NC_000002.12:29920266:G:C	single nucleotide variant	synonymous variant	Likely benign	Jun 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.393C>T (p.Ser131=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470857	2	30143133	2	29920267	470857	451126	rs765026986	NC_000002.12:29920266:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.392C>G (p.Ser131Cys)	ALK	S131C	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000861341	2	30143134	2	29920268	861341	826400	rs1667955289	NC_000002.12:29920267:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.389G>A (p.Gly130Asp)	ALK	G130D	Hereditary cancer-predisposing syndrome	VCV002586673	2	30143137	2	29920271	2586673	2756856		NC_000002.12:29920270:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.389G>T (p.Gly130Val)	ALK	G130V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538220	2	30143137	2	29920271	538220	518168	rs1553380330	NC_000002.12:29920270:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.388G>A (p.Gly130Ser)	ALK	G130S	Neuroblastoma, susceptibility to, 3	VCV003658524	2	30143138	2	29920272	3658524	3796945		NC_000002.12:29920271:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.387C>T (p.Gly129=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001092714	2	30143139	2	29920273	1092714	1069552	rs772964441	NC_000002.12:29920272:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.386G>A (p.Gly129Asp)	ALK	G129D	Neuroblastoma, susceptibility to, 3	VCV001056625	2	30143140	2	29920274	1056625	1041434	rs760041708	NC_000002.12:29920273:C:T	single nucleotide variant	missense variant	Uncertain significance	May 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.386G>C (p.Gly129Ala)	ALK	G129A	Neuroblastoma, susceptibility to, 3	VCV000660577	2	30143140	2	29920274	660577	629925	rs760041708	NC_000002.12:29920273:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.386G>T (p.Gly129Val)	ALK	G129V	Hereditary cancer-predisposing syndrome|ALK-related disorder|Neuroblastoma, susceptibility to, 3	VCV000335714	2	30143140	2	29920274	335714	289004	rs760041708	NC_000002.12:29920273:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.385G>A (p.Gly129Ser)	ALK	G129S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000470853	2	30143141	2	29920275	470853	451146	rs1553380334	NC_000002.12:29920274:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.384G>A (p.Lys128=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000335715	2	30143142	2	29920276	335715	289005	rs753267950	NC_000002.12:29920275:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.383A>C (p.Lys128Thr)	ALK	K128T	Neuroblastoma, susceptibility to, 3	VCV002112064	2	30143143	2	29920277	2112064	2160885		NC_000002.12:29920276:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.383A>G (p.Lys128Arg)	ALK	K128R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470852	2	30143143	2	29920277	470852	450953	rs756510939	NC_000002.12:29920276:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.381G>C (p.Leu127=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003719799	2	30143145	2	29920279	3719799	3849618		NC_000002.12:29920278:C:G	single nucleotide variant	synonymous variant	Likely benign	Sep 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.379C>G (p.Leu127Val)	ALK	L127V	Neuroblastoma, susceptibility to, 3	VCV003241843	2	30143147	2	29920281	3241843	3400821		NC_000002.12:29920280:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.378G>A (p.Val126=)	ALK		Hereditary cancer-predisposing syndrome	VCV003285713	2	30143148	2	29920282	3285713	3440944		NC_000002.12:29920281:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.378G>T (p.Val126=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002415570	2	30143148	2	29920282	2415570	1940672		NC_000002.12:29920281:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.377T>C (p.Val126Ala)	ALK	V126A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538286	2	30143149	2	29920283	538286	518166	rs764265048	NC_000002.12:29920282:A:G	single nucleotide variant	missense variant	Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.376G>C (p.Val126Leu)	ALK	V126L	Neuroblastoma, susceptibility to, 3	VCV001439933	2	30143150	2	29920284	1439933	1368383	rs753812162	NC_000002.12:29920283:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.376G>A (p.Val126Met)	ALK	V126M	Neuroblastoma, susceptibility to, 3	VCV000838381	2	30143150	2	29920284	838381	826401	rs753812162	NC_000002.12:29920283:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.375G>A (p.Arg125=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002120806	2	30143151	2	29920285	2120806	2183858		NC_000002.12:29920284:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 2, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.375G>C (p.Arg125Ser)	ALK	R125S	Neuroblastoma, susceptibility to, 3	VCV000948483	2	30143151	2	29920285	948483	922743	rs1667956255	NC_000002.12:29920284:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.373A>G (p.Arg125Gly)	ALK	R125G	Hereditary cancer-predisposing syndrome	VCV003223873	2	30143153	2	29920287	3223873	3380895		NC_000002.12:29920286:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.371C>T (p.Ser124Phe)	ALK	S124F	Neuroblastoma, susceptibility to, 3	VCV002880558	2	30143155	2	29920289	2880558	3034051		NC_000002.12:29920288:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.371C>G (p.Ser124Cys)	ALK	S124C	Neuroblastoma, susceptibility to, 3	VCV001395741	2	30143155	2	29920289	1395741	1425140	rs2148443409	NC_000002.12:29920288:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.370T>C (p.Ser124Pro)	ALK	S124P	Neuroblastoma, susceptibility to, 3	VCV000859322	2	30143156	2	29920290	859322	826402	rs1364916594	NC_000002.12:29920289:A:G	single nucleotide variant	missense variant	Uncertain significance	May 2, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.369G>C (p.Leu123=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002913022	2	30143157	2	29920291	2913022	3079063		NC_000002.12:29920290:C:G	single nucleotide variant	synonymous variant	Likely benign	Jan 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.368T>C (p.Leu123Pro)	ALK	L123P	Neuroblastoma, susceptibility to, 3	VCV002785582	2	30143158	2	29920292	2785582	2945429		NC_000002.12:29920291:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.365C>G (p.Thr122Arg)	ALK	T122R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000939228	2	30143161	2	29920295	939228	931376	rs1367800764	NC_000002.12:29920294:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.365C>T (p.Thr122Met)	ALK	T122M	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538194	2	30143161	2	29920295	538194	518169	rs1367800764	NC_000002.12:29920294:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.364A>G (p.Thr122Ala)	ALK	T122A	Neuroblastoma, susceptibility to, 3	VCV000575925	2	30143162	2	29920296	575925	561421	rs1558549790	NC_000002.12:29920295:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.363G>A (p.Arg121=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002751311	2	30143163	2	29920297	2751311	2908607		NC_000002.12:29920296:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.362G>C (p.Arg121Pro)	ALK	R121P	Neuroblastoma, susceptibility to, 3	VCV003646312	2	30143164	2	29920298	3646312	3776831		NC_000002.12:29920297:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.362G>A (p.Arg121Gln)	ALK	R121Q	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000834951	2	30143164	2	29920298	834951	826403	rs779147984	NC_000002.12:29920297:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.362G>T (p.Arg121Leu)	ALK	R121L	Neuroblastoma, susceptibility to, 3	VCV000404368	2	30143164	2	29920298	404368	392797	rs779147984	NC_000002.12:29920297:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.361C>G (p.Arg121Gly)	ALK	R121G	Neuroblastoma, susceptibility to, 3	VCV002778034	2	30143165	2	29920299	2778034	2937029		NC_000002.12:29920298:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.361C>T (p.Arg121Trp)	ALK	R121W	Neuroblastoma, susceptibility to, 3	VCV000938797	2	30143165	2	29920299	938797	931377	rs746089013	NC_000002.12:29920298:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.361C>A (p.Arg121=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000730558	2	30143165	2	29920299	730558	733445	rs746089013	NC_000002.12:29920298:G:T	single nucleotide variant	synonymous variant	Likely benign	Dec 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.360C>T (p.Ala120=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001594699	2	30143166	2	29920300	1594699	1621823	rs2148443423	NC_000002.12:29920299:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.360C>G (p.Ala120=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001151491	2	30143166	2	29920300	1151491	1133689	rs2148443423	NC_000002.12:29920299:G:C	single nucleotide variant	synonymous variant	Likely benign	Dec 6, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.359C>A (p.Ala120Asp)	ALK	A120D	Neuroblastoma, susceptibility to, 3	VCV002894440	2	30143167	2	29920301	2894440	3056081		NC_000002.12:29920300:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.359C>T (p.Ala120Val)	ALK	A120V	Neuroblastoma, susceptibility to, 3	VCV002044637	2	30143167	2	29920301	2044637	2096062		NC_000002.12:29920300:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.358G>A (p.Ala120Thr)	ALK	A120T	Neuroblastoma, susceptibility to, 3	VCV002707916	2	30143168	2	29920302	2707916	2877948		NC_000002.12:29920301:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.357G>A (p.Glu119=)	ALK		Hereditary cancer-predisposing syndrome	VCV001692785	2	30143169	2	29920303	1692785	1685225	rs758250431	NC_000002.12:29920302:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 6, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.357G>C (p.Glu119Asp)	ALK	E119D	Neuroblastoma, susceptibility to, 3	VCV001431170	2	30143169	2	29920303	1431170	1467846	rs758250431	NC_000002.12:29920302:C:G	single nucleotide variant	missense variant	Uncertain significance	May 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.347_357del (p.Ala116fs)	ALK	A116fs	Neuroblastoma, susceptibility to, 3	VCV000640498	2	30143169 - 30143179	2	29920303 - 29920313	640498	629926	rs1572503347	NC_000002.12:29920302:CTCTGCCGGGGCT:CT	Deletion	frameshift variant	Uncertain significance	Jul 25, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.357G>T (p.Glu119Asp)	ALK	E119D	Hereditary cancer-predisposing syndrome|Ovarian cancer|Neuroblastoma, susceptibility to, 3|not provided	VCV000538246	2	30143169	2	29920303	538246	518171	rs758250431	NC_000002.12:29920302:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.356A>T (p.Glu119Val)	ALK	E119V	Hereditary cancer-predisposing syndrome	VCV002477308	2	30143170	2	29920304	2477308	2453657		NC_000002.12:29920303:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.355G>A (p.Glu119Lys)	ALK	E119K	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000661774	2	30143171	2	29920305	661774	629927	rs1572503350	NC_000002.12:29920304:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.354A>C (p.Ala118=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001148254	2	30143172	2	29920306	1148254	1133690	rs779794415	NC_000002.12:29920305:T:G	single nucleotide variant	synonymous variant	Likely benign	Sep 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.354A>G (p.Ala118=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001102362	2	30143172	2	29920306	1102362	1091282	rs779794415	NC_000002.12:29920305:T:C	single nucleotide variant	synonymous variant	Likely benign	Jun 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.354A>T (p.Ala118=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000699874	2	30143172	2	29920306	699874	686196	rs779794415	NC_000002.12:29920305:T:A	single nucleotide variant	synonymous variant	Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.352G>A (p.Ala118Thr)	ALK	A118T	Hereditary cancer-predisposing syndrome	VCV003524957	2	30143174	2	29920308	3524957	3689196		NC_000002.12:29920307:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.352G>C (p.Ala118Pro)	ALK	A118P	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000945000	2	30143174	2	29920308	945000	922744	rs1383948379	NC_000002.12:29920307:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.352G>T (p.Ala118Ser)	ALK	A118S	Neuroblastoma, susceptibility to, 3	VCV000582734	2	30143174	2	29920308	582734	558061	rs1383948379	NC_000002.12:29920307:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.351G>C (p.Pro117=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001086124	2	30143175	2	29920309	1086124	1069553	rs1049747209	NC_000002.12:29920308:C:G	single nucleotide variant	synonymous variant	Likely benign	Dec 17, 2021	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.351G>T (p.Pro117=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000718240	2	30143175	2	29920309	718240	719842	rs1049747209	NC_000002.12:29920308:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.351G>A (p.Pro117=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470833	2	30143175	2	29920309	470833	450831	rs1049747209	NC_000002.12:29920308:C:T	single nucleotide variant	synonymous variant	Likely benign	May 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.350C>A (p.Pro117Gln)	ALK	P117Q	Neuroblastoma, susceptibility to, 3	VCV003683976	2	30143176	2	29920310	3683976	3808824		NC_000002.12:29920309:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.350C>T (p.Pro117Leu)	ALK	P117L	not provided|Neuroblastoma, susceptibility to, 3	VCV000572689	2	30143176	2	29920310	572689	558416	rs201290745	NC_000002.12:29920309:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.350C>G (p.Pro117Arg)	ALK	P117R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000470832	2	30143176	2	29920310	470832	450973	rs201290745	NC_000002.12:29920309:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.349C>G (p.Pro117Ala)	ALK	P117A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001732018	2	30143177	2	29920311	1732018	1789050		NC_000002.12:29920310:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.349C>T (p.Pro117Ser)	ALK	P117S	Neuroblastoma, susceptibility to, 3	VCV000641850	2	30143177	2	29920311	641850	629928	rs1289331589	NC_000002.12:29920310:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.348C>A (p.Ala116=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001731909	2	30143178	2	29920312	1731909	1792812		NC_000002.12:29920311:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.348C>T (p.Ala116=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001080287	2	30143178	2	29920312	1080287	1069554	rs575314773	NC_000002.12:29920311:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.347C>G (p.Ala116Gly)	ALK	A116G	Hereditary cancer-predisposing syndrome	VCV002587536	2	30143179	2	29920313	2587536	2763874		NC_000002.12:29920312:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.347C>T (p.Ala116Val)	ALK	A116V	Neuroblastoma, susceptibility to, 3	VCV001378603	2	30143179	2	29920313	1378603	1493033	rs1572503383	NC_000002.12:29920312:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.347C>A (p.Ala116Asp)	ALK	A116D	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000944870	2	30143179	2	29920313	944870	922745	rs1572503383	NC_000002.12:29920312:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.344C>G (p.Pro115Arg)	ALK	P115R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001016481	2	30143182	2	29920316	1016481	1004015	rs1222939884	NC_000002.12:29920315:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.344C>T (p.Pro115Leu)	ALK	P115L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000659392	2	30143182	2	29920316	659392	629929	rs1222939884	NC_000002.12:29920315:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.343C>T (p.Pro115Ser)	ALK	P115S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000582424	2	30143183	2	29920317	582424	558418	rs1023682229	NC_000002.12:29920316:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.342A>G (p.Ser114=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000765506	2	30143184	2	29920318	765506	763190	rs1572503392	NC_000002.12:29920317:T:C	single nucleotide variant	synonymous variant	Likely benign	Jul 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.340del (p.Ser114fs)	ALK	S114fs	Neuroblastoma, susceptibility to, 3	VCV000858561	2	30143186	2	29920320	858561	826404	rs1667958140	NC_000002.12:29920319:AA:A	Deletion	frameshift variant	Uncertain significance	Oct 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.339T>G (p.Gly113=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002858171	2	30143187	2	29920321	2858171	3018217		NC_000002.12:29920320:A:C	single nucleotide variant	synonymous variant	Likely benign	Apr 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.338G>A (p.Gly113Asp)	ALK	G113D	Neuroblastoma, susceptibility to, 3	VCV001719260	2	30143188	2	29920322	1719260	1774564		NC_000002.12:29920321:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.338G>T (p.Gly113Val)	ALK	G113V	Neuroblastoma, susceptibility to, 3	VCV001026281	2	30143188	2	29920322	1026281	1004016	rs1479433859	NC_000002.12:29920321:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.337G>T (p.Gly113Cys)	ALK	G113C	Hereditary cancer-predisposing syndrome	VCV002561056	2	30143189	2	29920323	2561056	2717215		NC_000002.12:29920322:C:A	single nucleotide variant	missense variant	Uncertain significance	May 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.337G>C (p.Gly113Arg)	ALK	G113R	Neuroblastoma, susceptibility to, 3	VCV001983724	2	30143189	2	29920323	1983724	2042879		NC_000002.12:29920322:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.337G>A (p.Gly113Ser)	ALK	G113S	Neuroblastoma, susceptibility to, 3	VCV001393067	2	30143189	2	29920323	1393067	1402794	rs748952373	NC_000002.12:29920322:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.336C>A (p.Ala112=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001060434	2	30143190	2	29920324	1060434	1041435	rs776604754	NC_000002.12:29920323:G:T	single nucleotide variant	synonymous variant	Likely benign	Jul 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.336C>T (p.Ala112=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538309	2	30143190	2	29920324	538309	518283	rs776604754	NC_000002.12:29920323:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.336C>G (p.Ala112=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000239822	2	30143190	2	29920324	239822	238760	rs776604754	NC_000002.12:29920323:G:C	single nucleotide variant	synonymous variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.335C>A (p.Ala112Asp)	ALK	A112D	Neuroblastoma, susceptibility to, 3	VCV003648777	2	30143191	2	29920325	3648777	3784634		NC_000002.12:29920324:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.335C>G (p.Ala112Gly)	ALK	A112G	Hereditary cancer-predisposing syndrome	VCV002561062	2	30143191	2	29920325	2561062	2717221		NC_000002.12:29920324:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.334G>A (p.Ala112Thr)	ALK	A112T	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000855320	2	30143192	2	29920326	855320	826405	rs1060500227	NC_000002.12:29920325:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.334G>C (p.Ala112Pro)	ALK	A112P	Neuroblastoma, susceptibility to, 3	VCV000404378	2	30143192	2	29920326	404378	392802	rs1060500227	NC_000002.12:29920325:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.333C>G (p.Thr111=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001730387	2	30143193	2	29920327	1730387	1788721		NC_000002.12:29920326:G:C	single nucleotide variant	synonymous variant	Likely benign	Feb 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.333C>T (p.Thr111=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001086081	2	30143193	2	29920327	1086081	1069555	rs747647954	NC_000002.12:29920326:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.332C>G (p.Thr111Ser)	ALK	T111S	Neuroblastoma, susceptibility to, 3	VCV002752858	2	30143194	2	29920328	2752858	2913599		NC_000002.12:29920327:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.332C>T (p.Thr111Ile)	ALK	T111I	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001058721	2	30143194	2	29920328	1058721	1041436	rs1667958706	NC_000002.12:29920327:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.331A>G (p.Thr111Ala)	ALK	T111A	Hereditary cancer-predisposing syndrome	VCV002452101	2	30143195	2	29920329	2452101	2426741		NC_000002.12:29920328:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.330G>T (p.Trp110Cys)	ALK	W110C	Neuroblastoma, susceptibility to, 3	VCV003241748	2	30143196	2	29920330	3241748	3400726		NC_000002.12:29920329:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.330G>C (p.Trp110Cys)	ALK	W110C	Hereditary cancer-predisposing syndrome	VCV001730071	2	30143196	2	29920330	1730071	1792277		NC_000002.12:29920329:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.328T>G (p.Trp110Gly)	ALK	W110G	Hereditary cancer-predisposing syndrome	VCV003523866	2	30143198	2	29920332	3523866	3682034		NC_000002.12:29920331:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.328T>C (p.Trp110Arg)	ALK	W110R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001061980	2	30143198	2	29920332	1061980	1041437	rs1572503431	NC_000002.12:29920331:A:G	single nucleotide variant	missense variant	Uncertain significance	May 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.328T>A (p.Trp110Arg)	ALK	W110R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001047773	2	30143198	2	29920332	1047773	1024477	rs1572503431	NC_000002.12:29920331:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.327C>A (p.Ser109=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003525389	2	30143199	2	29920333	3525389	3685745		NC_000002.12:29920332:G:T	single nucleotide variant	synonymous variant	Likely benign	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.327C>T (p.Ser109=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470823	2	30143199	2	29920333	470823	451127	rs769422234	NC_000002.12:29920332:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 29, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.326C>T (p.Ser109Phe)	ALK	S109F	Neuroblastoma, susceptibility to, 3	VCV002742824	2	30143200	2	29920334	2742824	2900587		NC_000002.12:29920333:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.325T>C (p.Ser109Pro)	ALK	S109P	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000663241	2	30143201	2	29920335	663241	629930	rs1572503443	NC_000002.12:29920334:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.324C>T (p.Val108=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001102026	2	30143202	2	29920336	1102026	1091283	rs773054326	NC_000002.12:29920335:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.302_323del (p.Leu101fs)	ALK	L101fs	Neuroblastoma, susceptibility to, 3	VCV002842585	2	30143203 - 30143224	2	29920337 - 29920358	2842585	2997291		NC_000002.12:29920336:ACCCCCGGCGCCGGCCCCAGCAACC:ACC	Deletion	frameshift variant	Uncertain significance	Mar 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.322G>C (p.Val108Leu)	ALK	V108L	Hereditary cancer-predisposing syndrome	VCV003286192	2	30143204	2	29920338	3286192	3455015		NC_000002.12:29920337:C:G	single nucleotide variant	missense variant	Uncertain significance	May 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.322G>T (p.Val108Phe)	ALK	V108F	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001422733	2	30143204	2	29920338	1422733	1412627	rs1338077965	NC_000002.12:29920337:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.322G>A (p.Val108Ile)	ALK	V108I	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001019332	2	30143204	2	29920338	1019332	1004017	rs1338077965	NC_000002.12:29920337:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.321G>T (p.Gly107=)	ALK		Hereditary cancer-predisposing syndrome	VCV002561054	2	30143205	2	29920339	2561054	2717213		NC_000002.12:29920338:C:A	single nucleotide variant	synonymous variant	Likely benign	Mar 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.321G>C (p.Gly107=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001663132	2	30143205	2	29920339	1663132	1555938	rs1353027067	NC_000002.12:29920338:C:G	single nucleotide variant	synonymous variant	Likely benign	Jan 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.321G>A (p.Gly107=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001152574	2	30143205	2	29920339	1152574	1133691	rs1353027067	NC_000002.12:29920338:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.320G>C (p.Gly107Ala)	ALK	G107A	Hereditary cancer-predisposing syndrome	VCV001728918	2	30143206	2	29920340	1728918	1785208		NC_000002.12:29920339:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.320G>A (p.Gly107Glu)	ALK	G107E	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001450921	2	30143206	2	29920340	1450921	1351442	rs762635291	NC_000002.12:29920339:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.320G>T (p.Gly107Val)	ALK	G107V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470821	2	30143206	2	29920340	470821	451135	rs762635291	NC_000002.12:29920339:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.318G>T (p.Pro106=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001545376	2	30143208	2	29920342	1545376	1559097	rs1298853396	NC_000002.12:29920341:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.318G>C (p.Pro106=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001542634	2	30143208	2	29920342	1542634	1610170	rs1298853396	NC_000002.12:29920341:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.317dup (p.Val108fs)	ALK	V108fs	Neuroblastoma, susceptibility to, 3	VCV001487075	2	30143208 - 30143209	2	29920342 - 29920343	1487075	1406932	rs2148443529	NC_000002.12:29920342:GG:GGG	Duplication	frameshift variant	Uncertain significance	Jan 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.318G>A (p.Pro106=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538289	2	30143208	2	29920342	538289	518230	rs1298853396	NC_000002.12:29920341:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.317C>T (p.Pro106Leu)	ALK	P106L	Neuroblastoma, susceptibility to, 3	VCV000949887	2	30143209	2	29920343	949887	922746	rs1037485859	NC_000002.12:29920342:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.317C>G (p.Pro106Arg)	ALK	P106R	Neuroblastoma, susceptibility to, 3	VCV000570895	2	30143209	2	29920343	570895	561423	rs1037485859	NC_000002.12:29920342:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.315G>T (p.Ala105=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002110663	2	30143211	2	29920345	2110663	2171127		NC_000002.12:29920344:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.315G>C (p.Ala105=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001150321	2	30143211	2	29920345	1150321	1133692	rs897667874	NC_000002.12:29920344:C:G	single nucleotide variant	synonymous variant	Likely benign	Sep 15, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.315G>A (p.Ala105=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470818	2	30143211	2	29920345	470818	451148	rs897667874	NC_000002.12:29920344:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.314C>G (p.Ala105Gly)	ALK	A105G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002892266	2	30143212	2	29920346	2892266	3048524		NC_000002.12:29920345:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.314C>T (p.Ala105Val)	ALK	A105V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002068417	2	30143212	2	29920346	2068417	2125940		NC_000002.12:29920345:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.314C>A (p.Ala105Glu)	ALK	A105E	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001477260	2	30143212	2	29920346	1477260	1413445	rs772569032	NC_000002.12:29920345:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.313G>A (p.Ala105Thr)	ALK	A105T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538238	2	30143213	2	29920347	538238	518284	rs1553380367	NC_000002.12:29920346:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.312G>A (p.Pro104=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000758827	2	30143214	2	29920348	758827	763191	rs1312913111	NC_000002.12:29920347:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.311C>G (p.Pro104Arg)	ALK	P104R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002915162	2	30143215	2	29920349	2915162	3076532		NC_000002.12:29920348:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.310C>G (p.Pro104Ala)	ALK	P104A	Neuroblastoma, susceptibility to, 3	VCV000657838	2	30143216	2	29920350	657838	629931	rs576431612	NC_000002.12:29920349:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 28, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.310C>A (p.Pro104Thr)	ALK	P104T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000335716	2	30143216	2	29920350	335716	285999	rs576431612	NC_000002.12:29920349:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.310C>T (p.Pro104Ser)	ALK	P104S	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000239819	2	30143216	2	29920350	239819	238761	rs576431612	NC_000002.12:29920349:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.309G>A (p.Gly103=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002803848	2	30143217	2	29920351	2803848	2963672		NC_000002.12:29920350:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.308G>A (p.Gly103Glu)	ALK	G103E	Neuroblastoma, susceptibility to, 3	VCV000955712	2	30143218	2	29920352	955712	942884	rs1667960211	NC_000002.12:29920351:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.307G>A (p.Gly103Arg)	ALK	G103R	Neuroblastoma, susceptibility to, 3	VCV001059620	2	30143219	2	29920353	1059620	1041438	rs1321334043	NC_000002.12:29920352:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.305T>A (p.Leu102Gln)	ALK	L102Q	Neuroblastoma, susceptibility to, 3	VCV002785470	2	30143221	2	29920355	2785470	2945317		NC_000002.12:29920354:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.303G>A (p.Leu101=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003726218	2	30143223	2	29920357	3726218	3858126		NC_000002.12:29920356:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.302T>C (p.Leu101Ser)	ALK	L101S	Hereditary cancer-predisposing syndrome	VCV003285665	2	30143224	2	29920358	3285665	3440896		NC_000002.12:29920357:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.301T>G (p.Leu101Val)	ALK	L101V	Neuroblastoma, susceptibility to, 3	VCV003645891	2	30143225	2	29920359	3645891	3780466		NC_000002.12:29920358:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.299G>A (p.Arg100Lys)	ALK	R100K	Neuroblastoma, susceptibility to, 3	VCV003241670	2	30143227	2	29920361	3241670	3400648		NC_000002.12:29920360:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 6, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.298A>C (p.Arg100=)	ALK		Hereditary cancer-predisposing syndrome	VCV001798485	2	30143228	2	29920362	1798485	1856624		NC_000002.12:29920361:T:G	single nucleotide variant	synonymous variant	Likely benign	Jun 28, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.298A>G (p.Arg100Gly)	ALK	R100G	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000470813	2	30143228	2	29920362	470813	451157	rs764559656	NC_000002.12:29920361:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.270_297dup (p.Arg100fs)	ALK	R100fs	Neuroblastoma, susceptibility to, 3	VCV000470801	2	30143228 - 30143229	2	29920362 - 29920363	470801	450974	rs1553380382	NC_000002.12:29920362:GAGCAGCGGGGCGCAGTCCAGAGCTAGCGAGC:GAGCAGCGGGGCGCAGTCCAGAGCTAGCGAGCAGCGGGGCGCAGTCCAGAGCTAGCGAGC	Duplication	frameshift variant	Uncertain significance	Jun 21, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.297C>A (p.Leu99=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000730547	2	30143229	2	29920363	730547	733447	rs545367563	NC_000002.12:29920362:G:T	single nucleotide variant	synonymous variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.297C>T (p.Leu99=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000722889	2	30143229	2	29920363	722889	733446	rs545367563	NC_000002.12:29920362:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.295C>A (p.Leu99Ile)	ALK	L99I	Hereditary cancer-predisposing syndrome	VCV003285874	2	30143231	2	29920365	3285874	3444614		NC_000002.12:29920364:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.295C>T (p.Leu99Phe)	ALK	L99F	Neuroblastoma, susceptibility to, 3	VCV001391381	2	30143231	2	29920365	1391381	1390061	rs1165577510	NC_000002.12:29920364:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.294G>C (p.Leu98=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001969444	2	30143232	2	29920366	1969444	2022251		NC_000002.12:29920365:C:G	single nucleotide variant	synonymous variant	Likely benign	May 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.294G>T (p.Leu98=)	ALK		Hereditary cancer-predisposing syndrome	VCV001798045	2	30143232	2	29920366	1798045	1853664		NC_000002.12:29920365:C:A	single nucleotide variant	synonymous variant	Likely benign	Oct 3, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.292C>T (p.Leu98=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000793261	2	30143234	2	29920368	793261	781310	rs1572503528	NC_000002.12:29920367:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 25, 2020	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.291G>A (p.Pro97=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001797691	2	30143235	2	29920369	1797691	1854609		NC_000002.12:29920368:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.291G>T (p.Pro97=)	ALK		Hereditary cancer-predisposing syndrome	VCV001692778	2	30143235	2	29920369	1692778	1685218	rs2148443574	NC_000002.12:29920368:C:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Aug 10, 2021	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.290C>T (p.Pro97Leu)	ALK	P97L	Neuroblastoma, susceptibility to, 3	VCV002730981	2	30143236	2	29920370	2730981	2893602		NC_000002.12:29920369:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.290C>G (p.Pro97Arg)	ALK	P97R	Neuroblastoma, susceptibility to, 3	VCV000538190	2	30143236	2	29920370	538190	518173	rs765290844	NC_000002.12:29920369:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.289C>A (p.Pro97Thr)	ALK	P97T	Neuroblastoma, susceptibility to, 3	VCV003723850	2	30143237	2	29920371	3723850	3860666		NC_000002.12:29920370:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.289C>T (p.Pro97Ser)	ALK	P97S	Neuroblastoma, susceptibility to, 3	VCV001517074	2	30143237	2	29920371	1517074	1515234	rs1331610896	NC_000002.12:29920370:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.288C>T (p.Ala96=)	ALK		Hereditary cancer-predisposing syndrome	VCV001797271	2	30143238	2	29920372	1797271	1855845		NC_000002.12:29920371:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 11, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.288C>A (p.Ala96=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470811	2	30143238	2	29920372	470811	451136	rs1372884724	NC_000002.12:29920371:G:T	single nucleotide variant	synonymous variant	Likely benign	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.286G>A (p.Ala96Thr)	ALK	A96T	not provided|Neuroblastoma, susceptibility to, 3	VCV000470810	2	30143240	2	29920374	470810	451139	rs1057065255	NC_000002.12:29920373:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.285C>T (p.Cys95=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001605557	2	30143241	2	29920375	1605557	1646609	rs2148443583	NC_000002.12:29920374:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.284G>A (p.Cys95Tyr)	ALK	C95Y	Hereditary cancer-predisposing syndrome	VCV003523506	2	30143242	2	29920376	3523506	3685179		NC_000002.12:29920375:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.282C>T (p.Asp94=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002843423	2	30143244	2	29920378	2843423	3004078		NC_000002.12:29920377:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.282C>G (p.Asp94Glu)	ALK	D94E	Neuroblastoma, susceptibility to, 3	VCV000565719	2	30143244	2	29920378	565719	558420	rs1558549961	NC_000002.12:29920377:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.280G>T (p.Asp94Tyr)	ALK	D94Y	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000538262	2	30143246	2	29920380	538262	518180	rs1060500234	NC_000002.12:29920379:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.280G>C (p.Asp94His)	ALK	D94H	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404389	2	30143246	2	29920380	404389	392625	rs1060500234	NC_000002.12:29920379:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.279G>A (p.Leu93=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000779505	2	30143247	2	29920381	779505	708229	rs1186319001	NC_000002.12:29920380:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.277C>T (p.Leu93=)	ALK		Hereditary cancer-predisposing syndrome	VCV003521909	2	30143249	2	29920383	3521909	3684897		NC_000002.12:29920382:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.276T>C (p.Ala92=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002844316	2	30143250	2	29920384	2844316	3007957		NC_000002.12:29920383:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.276T>A (p.Ala92=)	ALK		Hereditary cancer-predisposing syndrome	VCV002562258	2	30143250	2	29920384	2562258	2721111		NC_000002.12:29920383:A:T	single nucleotide variant	synonymous variant	Likely benign	Apr 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.275C>G (p.Ala92Gly)	ALK	A92G	Neuroblastoma, susceptibility to, 3	VCV001473393	2	30143251	2	29920385	1473393	1391273	rs1667961757	NC_000002.12:29920384:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.275C>T (p.Ala92Val)	ALK	A92V	Neuroblastoma, susceptibility to, 3	VCV001042219	2	30143251	2	29920385	1042219	1024478	rs1667961757	NC_000002.12:29920384:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.274G>T (p.Ala92Ser)	ALK	A92S	Neuroblastoma, susceptibility to, 3	VCV003626206	2	30143252	2	29920386	3626206	3761499		NC_000002.12:29920385:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.273A>G (p.Leu91=)	ALK		Hereditary cancer-predisposing syndrome	VCV001795397	2	30143253	2	29920387	1795397	1854057		NC_000002.12:29920386:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 21, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.272T>A (p.Leu91Gln)	ALK	L91Q	Neuroblastoma, susceptibility to, 3	VCV001717030	2	30143254	2	29920388	1717030	1775855		NC_000002.12:29920387:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.270G>A (p.Ser90=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002785658	2	30143256	2	29920390	2785658	2945505		NC_000002.12:29920389:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.270G>C (p.Ser90=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001929169	2	30143256	2	29920390	1929169	1988057		NC_000002.12:29920389:C:G	single nucleotide variant	synonymous variant	Likely benign	Aug 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.270G>T (p.Ser90=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001795066	2	30143256	2	29920390	1795066	1849275		NC_000002.12:29920389:C:A	single nucleotide variant	synonymous variant	Likely benign	Oct 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.269C>T (p.Ser90Leu)	ALK	S90L	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV002148195	2	30143257	2	29920391	2148195	1870983		NC_000002.12:29920390:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 28, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.267C>G (p.Gly89=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002899707	2	30143259	2	29920393	2899707	3067794		NC_000002.12:29920392:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.267C>A (p.Gly89=)	ALK		not specified|Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000239812	2	30143259	2	29920393	239812	238762	rs192127241	NC_000002.12:29920392:G:T	single nucleotide variant	synonymous variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.266G>T (p.Gly89Val)	ALK	G89V	not specified|Neuroblastoma, susceptibility to, 3	VCV002061972	2	30143260	2	29920394	2061972	2121120		NC_000002.12:29920393:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.266G>C (p.Gly89Ala)	ALK	G89A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000570899	2	30143260	2	29920394	570899	558422	rs1558549988	NC_000002.12:29920393:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.265G>A (p.Gly89Ser)	ALK	G89S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001375580	2	30143261	2	29920395	1375580	1392352	rs1468357046	NC_000002.12:29920394:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.257_263dup (p.Ser90fs)	ALK	S90fs	Neuroblastoma, susceptibility to, 3	VCV002741869	2	30143262 - 30143263	2	29920396 - 29920397	2741869	2906515		NC_000002.12:29920396:CGGGCCTCGGGCCT:CGGGCCTCGGGCCTCGGGCCT	Microsatellite	frameshift variant	Uncertain significance	May 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.264C>T (p.Arg88=)	ALK		Hereditary cancer-predisposing syndrome	VCV002452103	2	30143262	2	29920396	2452103	2426743		NC_000002.12:29920395:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 11, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.264C>A (p.Arg88=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001794297	2	30143262	2	29920396	1794297	1852968		NC_000002.12:29920395:G:T	single nucleotide variant	synonymous variant	Likely benign	Jan 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.263G>A (p.Arg88His)	ALK	R88H	Hereditary cancer-predisposing syndrome	VCV003223842	2	30143263	2	29920397	3223842	3380864		NC_000002.12:29920396:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.262C>T (p.Arg88Cys)	ALK	R88C	Neuroblastoma, susceptibility to, 3	VCV002994218	2	30143264	2	29920398	2994218	3155815		NC_000002.12:29920397:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.262C>A (p.Arg88Ser)	ALK	R88S	Neuroblastoma, susceptibility to, 3	VCV000837422	2	30143264	2	29920398	837422	826406	rs754768477	NC_000002.12:29920397:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.261C>T (p.Ala87=)	ALK		Hereditary cancer-predisposing syndrome	VCV000821578	2	30143265	2	29920399	821578	806916	rs1572503631	NC_000002.12:29920398:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 23, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.260C>T (p.Ala87Val)	ALK	A87V	Neuroblastoma, susceptibility to, 3	VCV002197987	2	30143266	2	29920400	2197987	1924148		NC_000002.12:29920399:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.260C>A (p.Ala87Asp)	ALK	A87D	Hereditary cancer-predisposing syndrome	VCV001793770	2	30143266	2	29920400	1793770	1845895		NC_000002.12:29920399:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.259G>A (p.Ala87Thr)	ALK	A87T	Hereditary cancer-predisposing syndrome	VCV002566557	2	30143267	2	29920401	2566557	2734400		NC_000002.12:29920400:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.258G>C (p.Glu86Asp)	ALK	E86D	Neuroblastoma, susceptibility to, 3	VCV000239808	2	30143268	2	29920402	239808	238763	rs878854654	NC_000002.12:29920401:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.256G>T (p.Glu86Ter)	ALK	E86*	Neuroblastoma, susceptibility to, 3	VCV002839866	2	30143270	2	29920404	2839866	3003088		NC_000002.12:29920403:C:A	single nucleotide variant	nonsense	Uncertain significance	Apr 3, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.256G>A (p.Glu86Lys)	ALK	E86K	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001056563	2	30143270	2	29920404	1056563	1041439	rs1448609696	NC_000002.12:29920403:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.255C>T (p.Pro85=)	ALK		not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538312	2	30143271	2	29920405	538312	518182	rs372277804	NC_000002.12:29920404:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.254C>T (p.Pro85Leu)	ALK	P85L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001043248	2	30143272	2	29920406	1043248	1024479	rs748100651	NC_000002.12:29920405:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 30, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.253C>T (p.Pro85Ser)	ALK	P85S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002994913	2	30143273	2	29920407	2994913	3148758		NC_000002.12:29920406:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.252G>C (p.Arg84Ser)	ALK	R84S	Neuroblastoma, susceptibility to, 3	VCV003727944	2	30143274	2	29920408	3727944	3858567		NC_000002.12:29920407:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.252G>T (p.Arg84Ser)	ALK	R84S	Neuroblastoma, susceptibility to, 3	VCV001462138	2	30143274	2	29920408	1462138	1507465	rs2148443625	NC_000002.12:29920407:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.250A>C (p.Arg84=)	ALK		Hereditary cancer-predisposing syndrome	VCV003525224	2	30143276	2	29920410	3525224	3685580		NC_000002.12:29920409:T:G	single nucleotide variant	synonymous variant	Likely benign	Nov 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.249C>A (p.Gly83=)	ALK		Hereditary cancer-predisposing syndrome	VCV003524285	2	30143277	2	29920411	3524285	3678950		NC_000002.12:29920410:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 9, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.249C>T (p.Gly83=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000642831	2	30143277	2	29920411	642831	629932	rs1466800086	NC_000002.12:29920410:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.248G>T (p.Gly83Val)	ALK	G83V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000574147	2	30143278	2	29920412	574147	558424	rs769440812	NC_000002.12:29920411:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.247G>A (p.Gly83Ser)	ALK	G83S	Neuroblastoma, susceptibility to, 3	VCV001489475	2	30143279	2	29920413	1489475	1495081	rs2148443637	NC_000002.12:29920412:C:T	single nucleotide variant	missense variant	Uncertain significance	May 20, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.246T>G (p.Ala82=)	ALK		Hereditary cancer-predisposing syndrome	VCV001791772	2	30143280	2	29920414	1791772	1845205		NC_000002.12:29920413:A:C	single nucleotide variant	synonymous variant	Likely benign	Jul 26, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.246T>A (p.Ala82=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001095399	2	30143280	2	29920414	1095399	1069556	rs1295922670	NC_000002.12:29920413:A:T	single nucleotide variant	synonymous variant	Likely benign	Sep 13, 2020	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.245C>G (p.Ala82Gly)	ALK	A82G	Hereditary cancer-predisposing syndrome	VCV003223834	2	30143281	2	29920415	3223834	3380856		NC_000002.12:29920414:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 28, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.244G>C (p.Ala82Pro)	ALK	A82P	Hereditary cancer-predisposing syndrome	VCV002586706	2	30143282	2	29920416	2586706	2756889		NC_000002.12:29920415:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.244G>A (p.Ala82Thr)	ALK	A82T	Neuroblastoma, susceptibility to, 3	VCV000538205	2	30143282	2	29920416	538205	518286	rs1322397265	NC_000002.12:29920415:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.242A>G (p.Lys81Arg)	ALK	K81R	Neuroblastoma, susceptibility to, 3	VCV002758436	2	30143284	2	29920418	2758436	2910535		NC_000002.12:29920417:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.238C>T (p.Leu80=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001665804	2	30143288	2	29920422	1665804	1655533	rs2148443647	NC_000002.12:29920421:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.237G>T (p.Glu79Asp)	ALK	E79D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001009325	2	30143289	2	29920423	1009325	988753	rs1022670397	NC_000002.12:29920422:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.235G>A (p.Glu79Lys)	ALK	E79K	Neuroblastoma, susceptibility to, 3	VCV003728051	2	30143291	2	29920425	3728051	3855251		NC_000002.12:29920424:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.234G>A (p.Ser78=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470791	2	30143292	2	29920426	470791	450833	rs1338599727	NC_000002.12:29920425:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.233C>T (p.Ser78Leu)	ALK	S78L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001789837	2	30143293	2	29920427	1789837	1847968		NC_000002.12:29920426:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.233C>G (p.Ser78Trp)	ALK	S78W	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470790	2	30143293	2	29920427	470790	451144	rs748978993	NC_000002.12:29920426:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 19, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.231C>T (p.Ser77=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470788	2	30143295	2	29920429	470788	450975	rs1462178129	NC_000002.12:29920428:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.230C>T (p.Ser77Phe)	ALK	S77F	Hereditary cancer-predisposing syndrome	VCV002624792	2	30143296	2	29920430	2624792	2790287		NC_000002.12:29920429:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.228C>G (p.Ser76=)	ALK		Hereditary cancer-predisposing syndrome	VCV002566576	2	30143298	2	29920432	2566576	2734419		NC_000002.12:29920431:G:C	single nucleotide variant	synonymous variant	Likely benign	Apr 16, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.228C>T (p.Ser76=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002002626	2	30143298	2	29920432	2002626	2061850		NC_000002.12:29920431:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 7, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.227C>T (p.Ser76Phe)	ALK	S76F	Hereditary cancer-predisposing syndrome	VCV003223829	2	30143299	2	29920433	3223829	3380851		NC_000002.12:29920432:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.227C>G (p.Ser76Cys)	ALK	S76C	Neuroblastoma, susceptibility to, 3	VCV001471262	2	30143299	2	29920433	1471262	1488333	rs2148443665	NC_000002.12:29920432:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.224C>A (p.Pro75Gln)	ALK	P75Q	Neuroblastoma, susceptibility to, 3	VCV000895297	2	30143302	2	29920436	895297	884688	rs1667963680	NC_000002.12:29920435:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.224C>T (p.Pro75Leu)	ALK	P75L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000847043	2	30143302	2	29920436	847043	826407	rs1667963680	NC_000002.12:29920435:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.222A>G (p.Pro74=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001089388	2	30143304	2	29920438	1089388	1069557	rs770659336	NC_000002.12:29920437:T:C	single nucleotide variant	synonymous variant	Likely benign	Jun 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.221C>G (p.Pro74Arg)	ALK	P74R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001398531	2	30143305	2	29920439	1398531	1427598	rs1187464179	NC_000002.12:29920438:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.221C>T (p.Pro74Leu)	ALK	P74L	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000566374	2	30143305	2	29920439	566374	558426	rs1187464179	NC_000002.12:29920438:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.220C>A (p.Pro74Thr)	ALK	P74T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001787737	2	30143306	2	29920440	1787737	1850717		NC_000002.12:29920439:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.219G>A (p.Leu73=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003658533	2	30143307	2	29920441	3658533	3796954		NC_000002.12:29920440:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.216G>A (p.Leu72=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002854945	2	30143310	2	29920444	2854945	3017125		NC_000002.12:29920443:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.216G>T (p.Leu72=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001538649	2	30143310	2	29920444	1538649	1544135	rs2148443679	NC_000002.12:29920443:C:A	single nucleotide variant	synonymous variant	Likely benign	Jan 20, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.215T>G (p.Leu72Arg)	ALK	L72R	Hereditary cancer-predisposing syndrome	VCV001786891	2	30143311	2	29920445	1786891	1844260		NC_000002.12:29920444:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.214C>T (p.Leu72=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223819	2	30143312	2	29920446	3223819	3380841		NC_000002.12:29920445:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.213A>C (p.Leu71=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001125836	2	30143313	2	29920447	1125836	1112779	rs774033636	NC_000002.12:29920446:T:G	single nucleotide variant	synonymous variant	Likely benign	Sep 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.213A>G (p.Leu71=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470782	2	30143313	2	29920447	470782	451160	rs774033636	NC_000002.12:29920446:T:C	single nucleotide variant	synonymous variant	Likely benign	May 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.210C>G (p.Asp70Glu)	ALK	D70E	Hereditary cancer-predisposing syndrome	VCV003524189	2	30143316	2	29920450	3524189	3682357		NC_000002.12:29920449:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.210C>T (p.Asp70=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000767510	2	30143316	2	29920450	767510	697549	rs1572503722	NC_000002.12:29920449:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.209A>C (p.Asp70Ala)	ALK	D70A	Neuroblastoma, susceptibility to, 3	VCV002108275	2	30143317	2	29920451	2108275	2159689		NC_000002.12:29920450:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.209A>G (p.Asp70Gly)	ALK	D70G	Hereditary cancer-predisposing syndrome	VCV001785852	2	30143317	2	29920451	1785852	1850110		NC_000002.12:29920450:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.208G>A (p.Asp70Asn)	ALK	D70N	Neuroblastoma, susceptibility to, 3	VCV001043891	2	30143318	2	29920452	1043891	1024480	rs1365620880	NC_000002.12:29920451:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.207G>A (p.Arg69=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000470780	2	30143319	2	29920453	470780	450837	rs1553380407	NC_000002.12:29920452:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.206G>T (p.Arg69Leu)	ALK	R69L	Neuroblastoma, susceptibility to, 3	VCV002012390	2	30143320	2	29920454	2012390	2063896		NC_000002.12:29920453:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.206G>A (p.Arg69Gln)	ALK	R69Q	not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000404392	2	30143320	2	29920454	404392	392668	rs769061878	NC_000002.12:29920453:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.205C>A (p.Arg69=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003713646	2	30143321	2	29920455	3713646	3838029		NC_000002.12:29920454:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.205C>T (p.Arg69Trp)	ALK	R69W	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000953366	2	30143321	2	29920455	953366	942885	rs1052259770	NC_000002.12:29920454:G:A	single nucleotide variant	missense variant	Uncertain significance	May 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.204C>T (p.Ala68=)	ALK		Neuroblastoma, susceptibility to, 3	VCV003670571	2	30143322	2	29920456	3670571	3799979		NC_000002.12:29920455:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.203C>T (p.Ala68Val)	ALK	A68V	Hereditary cancer-predisposing syndrome	VCV001784874	2	30143323	2	29920457	1784874	1843519		NC_000002.12:29920456:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.202G>A (p.Ala68Thr)	ALK	A68T	Hereditary cancer-predisposing syndrome	VCV003525256	2	30143324	2	29920458	3525256	3685612		NC_000002.12:29920457:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.202G>C (p.Ala68Pro)	ALK	A68P	Neuroblastoma, susceptibility to, 3	VCV000662362	2	30143324	2	29920458	662362	629933	rs1414978905	NC_000002.12:29920457:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.202G>T (p.Ala68Ser)	ALK	A68S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not provided	VCV000538187	2	30143324	2	29920458	538187	518292	rs1414978905	NC_000002.12:29920457:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.201C>G (p.Tyr67Ter)	ALK	Y67*	Neuroblastoma, susceptibility to, 3	VCV003705282	2	30143325	2	29920459	3705282	3846061		NC_000002.12:29920458:G:C	single nucleotide variant	nonsense	Uncertain significance	Dec 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.201C>A (p.Tyr67Ter)	ALK	Y67*	Neuroblastoma, susceptibility to, 3	VCV003605120	2	30143325	2	29920459	3605120	3736535		NC_000002.12:29920458:G:T	single nucleotide variant	nonsense	Uncertain significance	Jun 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.201C>T (p.Tyr67=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001533557	2	30143325	2	29920459	1533557	1530697	rs1434101448	NC_000002.12:29920458:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 5, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.198C>G (p.Val66=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001783930	2	30143328	2	29920462	1783930	1849489		NC_000002.12:29920461:G:C	single nucleotide variant	synonymous variant	Likely benign	Dec 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.198C>T (p.Val66=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001555134	2	30143328	2	29920462	1555134	1564878	rs2148443705	NC_000002.12:29920461:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.196G>T (p.Val66Phe)	ALK	V66F	Hereditary cancer-predisposing syndrome	VCV001783595	2	30143330	2	29920464	1783595	1839691		NC_000002.12:29920463:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.194G>A (p.Arg65His)	ALK	R65H	Neuroblastoma, susceptibility to, 3	VCV003695079	2	30143332	2	29920466	3695079	3825117		NC_000002.12:29920465:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.194G>T (p.Arg65Leu)	ALK	R65L	Neuroblastoma, susceptibility to, 3	VCV002868342	2	30143332	2	29920466	2868342	3020655		NC_000002.12:29920465:C:A	single nucleotide variant	missense variant	Uncertain significance	May 17, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.193C>A (p.Arg65Ser)	ALK	R65S	Neuroblastoma, susceptibility to, 3	VCV003241682	2	30143333	2	29920467	3241682	3400660		NC_000002.12:29920466:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.193C>G (p.Arg65Gly)	ALK	R65G	Hereditary cancer-predisposing syndrome	VCV002452126	2	30143333	2	29920467	2452126	2426766		NC_000002.12:29920466:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.193del (p.Arg65fs)	ALK	R65fs	Neuroblastoma, susceptibility to, 3	VCV001348170	2	30143333	2	29920467	1348170	1459401	rs2148443715	NC_000002.12:29920466:GG:G	Deletion	frameshift variant	Uncertain significance	Mar 7, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.193C>T (p.Arg65Cys)	ALK	R65C	Neuroblastoma, susceptibility to, 3	VCV001063961	2	30143333	2	29920467	1063961	1041440	rs1343353214	NC_000002.12:29920466:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.192C>G (p.Phe64Leu)	ALK	F64L	Neuroblastoma, susceptibility to, 3	VCV001516924	2	30143334	2	29920468	1516924	1495697	rs376663390	NC_000002.12:29920467:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.192C>T (p.Phe64=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001126873	2	30143334	2	29920468	1126873	1112780	rs376663390	NC_000002.12:29920467:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.189C>G (p.Leu63=)	ALK		Hereditary cancer-predisposing syndrome	VCV001782238	2	30143337	2	29920471	1782238	1842622		NC_000002.12:29920470:G:C	single nucleotide variant	synonymous variant	Likely benign	Aug 26, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.189C>T (p.Leu63=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001144315	2	30143337	2	29920471	1144315	1133693	rs1298548615	NC_000002.12:29920470:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.189C>A (p.Leu63=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001131554	2	30143337	2	29920471	1131554	1112781	rs1298548615	NC_000002.12:29920470:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.188T>C (p.Leu63Pro)	ALK	L63P	Hereditary cancer-predisposing syndrome	VCV003285420	2	30143338	2	29920472	3285420	3440652		NC_000002.12:29920471:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.187C>T (p.Leu63Phe)	ALK	L63F	Neuroblastoma, susceptibility to, 3	VCV002078506	2	30143339	2	29920473	2078506	2135036		NC_000002.12:29920472:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.186G>T (p.Ser62=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001781667	2	30143340	2	29920474	1781667	1839013		NC_000002.12:29920473:C:A	single nucleotide variant	synonymous variant	Likely benign	Jun 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.186G>A (p.Ser62=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001781661	2	30143340	2	29920474	1781661	1839007		NC_000002.12:29920473:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.185C>G (p.Ser62Trp)	ALK	S62W	Neuroblastoma, susceptibility to, 3	VCV002762360	2	30143341	2	29920475	2762360	2930856		NC_000002.12:29920474:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.185C>T (p.Ser62Leu)	ALK	S62L	Neuroblastoma, susceptibility to, 3	VCV000641791	2	30143341	2	29920475	641791	629934	rs1572503765	NC_000002.12:29920474:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.184T>C (p.Ser62Pro)	ALK	S62P	Neuroblastoma, susceptibility to, 3	VCV003659479	2	30143342	2	29920476	3659479	3790419		NC_000002.12:29920475:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.183C>G (p.Pro61=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002754120	2	30143343	2	29920477	2754120	2916588		NC_000002.12:29920476:G:C	single nucleotide variant	synonymous variant	Likely benign	Dec 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.183C>T (p.Pro61=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001781124	2	30143343	2	29920477	1781124	1839392		NC_000002.12:29920476:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.182C>T (p.Pro61Leu)	ALK	P61L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV002973641	2	30143344	2	29920478	2973641	3140060		NC_000002.12:29920477:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.180G>T (p.Val60=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002034029	2	30143346	2	29920480	2034029	2093235		NC_000002.12:29920479:C:A	single nucleotide variant	synonymous variant	Likely benign	Oct 4, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.180G>A (p.Val60=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000470774	2	30143346	2	29920480	470774	451145	rs1239004394	NC_000002.12:29920479:C:T	single nucleotide variant	synonymous variant	Likely benign	May 7, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.178G>A (p.Val60Met)	ALK	V60M	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000939004	2	30143348	2	29920482	939004	931378	rs1031804606	NC_000002.12:29920481:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.176T>C (p.Val59Ala)	ALK	V59A	Neuroblastoma, susceptibility to, 3	VCV002749210	2	30143350	2	29920484	2749210	2912551		NC_000002.12:29920483:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 2, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.175G>A (p.Val59Met)	ALK	V59M	Neuroblastoma, susceptibility to, 3	VCV002908603	2	30143351	2	29920485	2908603	3066111		NC_000002.12:29920484:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.175G>T (p.Val59Leu)	ALK	V59L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000538245	2	30143351	2	29920485	538245	518174	rs1553380428	NC_000002.12:29920484:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.174C>T (p.Phe58=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538301	2	30143352	2	29920486	538301	518296	rs762994068	NC_000002.12:29920485:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.172T>C (p.Phe58Leu)	ALK	F58L	Neuroblastoma, susceptibility to, 3|not provided	VCV001023439	2	30143354	2	29920488	1023439	1004018	rs1667965302	NC_000002.12:29920487:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.171C>T (p.Asp57=)	ALK		Hereditary cancer-predisposing syndrome|not specified|Neuroblastoma, susceptibility to, 3	VCV000259267	2	30143355	2	29920489	259267	250723	rs138165457	NC_000002.12:29920488:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.167T>C (p.Val56Ala)	ALK	V56A	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001393989	2	30143359	2	29920493	1393989	1422527	rs2148443759	NC_000002.12:29920492:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.165A>G (p.Ala55=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002072540	2	30143361	2	29920495	2072540	2130469		NC_000002.12:29920494:T:C	single nucleotide variant	synonymous variant	Likely benign	Apr 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.164C>T (p.Ala55Val)	ALK	A55V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001520805	2	30143362	2	29920496	1520805	1356164	rs1217013970	NC_000002.12:29920495:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.164C>A (p.Ala55Glu)	ALK	A55E	Familial isolated pituitary adenoma	VCV000620599	2	30143362	2	29920496	620599	611988	rs1217013970	NC_000002.12:29920495:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.163G>T (p.Ala55Ser)	ALK	A55S	Neuroblastoma, susceptibility to, 3	VCV000857288	2	30143363	2	29920497	857288	826408	rs1268569052	NC_000002.12:29920496:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.162G>A (p.Leu54=)	ALK		Hereditary cancer-predisposing syndrome	VCV003525097	2	30143364	2	29920498	3525097	3689336		NC_000002.12:29920497:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 1, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.160C>G (p.Leu54Val)	ALK	L54V	Neuroblastoma, susceptibility to, 3	VCV003241591	2	30143366	2	29920500	3241591	3400569		NC_000002.12:29920499:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.160C>T (p.Leu54=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001126579	2	30143366	2	29920500	1126579	1112782	rs1023566110	NC_000002.12:29920499:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 11, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.158G>A (p.Ser53Asn)	ALK	S53N	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001045346	2	30143368	2	29920502	1045346	1024481	rs754798392	NC_000002.12:29920501:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.157A>G (p.Ser53Gly)	ALK	S53G	Neuroblastoma, susceptibility to, 3	VCV002877448	2	30143369	2	29920503	2877448	3041657		NC_000002.12:29920502:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.156G>C (p.Lys52Asn)	ALK	K52N	Hereditary cancer-predisposing syndrome	VCV003223795	2	30143370	2	29920504	3223795	3380818		NC_000002.12:29920503:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.156G>T (p.Lys52Asn)	ALK	K52N	Hereditary cancer-predisposing syndrome	VCV002310295	2	30143370	2	29920504	2310295	2298344		NC_000002.12:29920503:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.154A>G (p.Lys52Glu)	ALK	K52E	Hereditary cancer-predisposing syndrome	VCV001775007	2	30143372	2	29920506	1775007	1833592		NC_000002.12:29920505:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.153G>A (p.Arg51=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470756	2	30143373	2	29920507	470756	451162	rs200204526	NC_000002.12:29920506:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.151A>C (p.Arg51=)	ALK		Hereditary cancer-predisposing syndrome	VCV001774383	2	30143375	2	29920509	1774383	1836922		NC_000002.12:29920508:T:G	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.151A>G (p.Arg51Gly)	ALK	R51G	not provided	VCV001319122	2	30143375	2	29920509	1319122	1309375	rs904831964	NC_000002.12:29920508:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.149A>T (p.Gln50Leu)	ALK	Q50L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001508232	2	30143377	2	29920511	1508232	1442883	rs1060500222	NC_000002.12:29920510:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.149A>G (p.Gln50Arg)	ALK	Q50R	not provided|Neuroblastoma, susceptibility to, 3	VCV000404356	2	30143377	2	29920511	404356	392626	rs1060500222	NC_000002.12:29920510:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.147G>C (p.Leu49=)	ALK		Hereditary cancer-predisposing syndrome	VCV002586682	2	30143379	2	29920513	2586682	2756865		NC_000002.12:29920512:C:G	single nucleotide variant	synonymous variant	Likely benign	Jul 9, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.146T>G (p.Leu49Arg)	ALK	L49R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001045027	2	30143380	2	29920514	1045027	1024482	rs1667966165	NC_000002.12:29920513:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.145C>T (p.Leu49=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470753	2	30143381	2	29920515	470753	451147	rs369007050	NC_000002.12:29920514:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.144C>T (p.Arg48=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001772895	2	30143382	2	29920516	1772895	1836738		NC_000002.12:29920515:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.144C>G (p.Arg48=)	ALK		Hereditary cancer-predisposing syndrome	VCV001772887	2	30143382	2	29920516	1772887	1836730		NC_000002.12:29920515:G:C	single nucleotide variant	synonymous variant	Likely benign	Jun 15, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.143G>T (p.Arg48Leu)	ALK	R48L	Neuroblastoma, susceptibility to, 3	VCV002875892	2	30143383	2	29920517	2875892	3041407		NC_000002.12:29920516:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.143G>C (p.Arg48Pro)	ALK	R48P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001772683	2	30143383	2	29920517	1772683	1836527		NC_000002.12:29920516:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.142C>A (p.Arg48Ser)	ALK	R48S	Neuroblastoma, susceptibility to, 3	VCV000404354	2	30143384	2	29920518	404354	392673	rs1060500221	NC_000002.12:29920517:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.141G>T (p.Ser47=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002035609	2	30143385	2	29920519	2035609	2097393		NC_000002.12:29920518:C:A	single nucleotide variant	synonymous variant	Likely benign	Sep 19, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.141G>C (p.Ser47=)	ALK		Hereditary cancer-predisposing syndrome	VCV001772232	2	30143385	2	29920519	1772232	1826644		NC_000002.12:29920518:C:G	single nucleotide variant	synonymous variant	Likely benign	Jun 13, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.141G>A (p.Ser47=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470750	2	30143385	2	29920519	470750	450979	rs572351075	NC_000002.12:29920518:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.140C>T (p.Ser47Leu)	ALK	S47L	not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470748	2	30143386	2	29920520	470748	450842	rs541315214	NC_000002.12:29920519:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.139T>G (p.Ser47Ala)	ALK	S47A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000895298	2	30143387	2	29920521	895298	884689	rs1402352282	NC_000002.12:29920520:A:C	single nucleotide variant	missense variant	Uncertain significance	May 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.138C>T (p.Tyr46=)	ALK		Hereditary cancer-predisposing syndrome	VCV001771509	2	30143388	2	29920522	1771509	1832705		NC_000002.12:29920521:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 12, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.135C>T (p.Ser45=)	ALK		Hereditary cancer-predisposing syndrome	VCV001770796	2	30143391	2	29920525	1770796	1826496		NC_000002.12:29920524:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 24, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.135C>A (p.Ser45Arg)	ALK	S45R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000850265	2	30143391	2	29920525	850265	826409	rs1667966785	NC_000002.12:29920524:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.134G>C (p.Ser45Thr)	ALK	S45T	Neuroblastoma, susceptibility to, 3	VCV001354824	2	30143392	2	29920526	1354824	1434409	rs2148443832	NC_000002.12:29920525:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 3, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.132C>T (p.Leu44=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001619779	2	30143394	2	29920528	1619779	1527794	rs778487357	NC_000002.12:29920527:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 30, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.132C>G (p.Leu44=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001103672	2	30143394	2	29920528	1103672	1091284	rs778487357	NC_000002.12:29920527:G:C	single nucleotide variant	synonymous variant	Likely benign	Dec 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.131T>C (p.Leu44Pro)	ALK	L44P	Neuroblastoma, susceptibility to, 3	VCV001016230	2	30143395	2	29920529	1016230	1004019	rs1304641292	NC_000002.12:29920528:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.131T>G (p.Leu44Arg)	ALK	L44R	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000639239	2	30143395	2	29920529	639239	629935	rs1304641292	NC_000002.12:29920528:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.130C>T (p.Leu44Phe)	ALK	L44F	Neuroblastoma, susceptibility to, 3	VCV003661915	2	30143396	2	29920530	3661915	3797780		NC_000002.12:29920529:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.129A>T (p.Pro43=)	ALK		Hereditary cancer-predisposing syndrome	VCV001769300	2	30143397	2	29920531	1769300	1835737		NC_000002.12:29920530:T:A	single nucleotide variant	synonymous variant	Likely benign	Apr 21, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.129A>G (p.Pro43=)	ALK		Hereditary cancer-predisposing syndrome	VCV001769298	2	30143397	2	29920531	1769298	1835735		NC_000002.12:29920530:T:C	single nucleotide variant	synonymous variant	Likely benign	Jan 16, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.128C>T (p.Pro43Leu)	ALK	P43L	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000818814	2	30143398	2	29920532	818814	806917	rs78378278	NC_000002.12:29920531:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.128C>G (p.Pro43Arg)	ALK	P43R	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000566142	2	30143398	2	29920532	566142	558063	rs78378278	NC_000002.12:29920531:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.127C>A (p.Pro43Thr)	ALK	P43T	Hereditary cancer-predisposing syndrome	VCV002452130	2	30143399	2	29920533	2452130	2426770		NC_000002.12:29920532:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.126G>A (p.Glu42=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001765078	2	30143400	2	29920534	1765078	1824572		NC_000002.12:29920533:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.105_124dup (p.Glu42fs)	ALK	E42fs	Neuroblastoma, susceptibility to, 3	VCV003617859	2	30143401 - 30143402	2	29920535 - 29920536	3617859	3756174		NC_000002.12:29920535:CCCGGGGCTGCAGCGGCGGCCCCG:CCCGGGGCTGCAGCGGCGGCCCCGGGGCTGCAGCGGCGGCCCCG	Duplication	frameshift variant	Uncertain significance	Jul 30, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.105_124del (p.Pro36fs)	ALK	P36fs	Neuroblastoma, susceptibility to, 3	VCV002034976	2	30143402 - 30143421	2	29920536 - 29920555	2034976	2100634		NC_000002.12:29920535:CCCGGGGCTGCAGCGGCGGCCCCG:CCCG	Deletion	frameshift variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.124G>C (p.Glu42Gln)	ALK	E42Q	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000538255	2	30143402	2	29920536	538255	518232	rs1553380444	NC_000002.12:29920535:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.122G>A (p.Arg41Gln)	ALK	R41Q	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000641819	2	30143404	2	29920538	641819	629936	rs1572503919	NC_000002.12:29920537:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.121C>A (p.Arg41=)	ALK		Hereditary cancer-predisposing syndrome|not provided	VCV003223788	2	30143405	2	29920539	3223788	3380811		NC_000002.12:29920538:G:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Feb 20, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.121C>T (p.Arg41Trp)	ALK	R41W	Neuroblastoma, susceptibility to, 3	VCV000239793	2	30143405	2	29920539	239793	238764	rs878854653	NC_000002.12:29920538:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.120C>G (p.Pro40=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002825316	2	30143406	2	29920540	2825316	2986401		NC_000002.12:29920539:G:C	single nucleotide variant	synonymous variant	Likely benign	Dec 31, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.120C>T (p.Pro40=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001669886	2	30143406	2	29920540	1669886	1582564	rs768904675	NC_000002.12:29920539:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 25, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.119C>T (p.Pro40Leu)	ALK	P40L	not provided|Neuroblastoma, susceptibility to, 3	VCV000664464	2	30143407	2	29920541	664464	629937	rs200212200	NC_000002.12:29920540:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.119C>A (p.Pro40His)	ALK	P40H	not provided|Neuroblastoma, susceptibility to, 3	VCV000569493	2	30143407	2	29920541	569493	560613	rs200212200	NC_000002.12:29920540:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.118C>G (p.Pro40Ala)	ALK	P40A	Neuroblastoma, susceptibility to, 3	VCV000656046	2	30143408	2	29920542	656046	629938	rs371679329	NC_000002.12:29920541:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.118C>T (p.Pro40Ser)	ALK	P40S	not provided|Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470742	2	30143408	2	29920542	470742	451152	rs371679329	NC_000002.12:29920541:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.117G>T (p.Gln39His)	ALK	Q39H	Neuroblastoma, susceptibility to, 3	VCV001720360	2	30143409	2	29920543	1720360	1776542		NC_000002.12:29920542:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.117G>A (p.Gln39=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000470738	2	30143409	2	29920543	470738	451169	rs1225169683	NC_000002.12:29920542:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.116A>G (p.Gln39Arg)	ALK	Q39R	Neuroblastoma, susceptibility to, 3	VCV003649859	2	30143410	2	29920544	3649859	3787855		NC_000002.12:29920543:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.116A>C (p.Gln39Pro)	ALK	Q39P	Neuroblastoma, susceptibility to, 3	VCV002096912	2	30143410	2	29920544	2096912	2157401		NC_000002.12:29920543:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.114G>A (p.Leu38=)	ALK		Hereditary cancer-predisposing syndrome	VCV003223784	2	30143412	2	29920546	3223784	3380807		NC_000002.12:29920545:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.112C>T (p.Leu38=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002734188	2	30143414	2	29920548	2734188	2898519		NC_000002.12:29920547:G:A	single nucleotide variant	synonymous variant	Likely benign	May 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.111G>C (p.Pro37=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002121232	2	30143415	2	29920549	2121232	2180414		NC_000002.12:29920548:C:G	single nucleotide variant	synonymous variant	Likely benign	Jul 30, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.111G>A (p.Pro37=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000698928	2	30143415	2	29920549	698928	686197	rs1292866467	NC_000002.12:29920548:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.110C>T (p.Pro37Leu)	ALK	P37L	Neuroblastoma, susceptibility to, 3	VCV001011652	2	30143416	2	29920550	1011652	988754	rs1437432300	NC_000002.12:29920549:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.108G>C (p.Pro36=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003286364	2	30143418	2	29920552	3286364	3455187		NC_000002.12:29920551:C:G	single nucleotide variant	synonymous variant	Likely benign	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.108G>A (p.Pro36=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000412923	2	30143418	2	29920552	412923	392674	rs1060503879	NC_000002.12:29920551:C:T	single nucleotide variant	synonymous variant	Likely benign	May 31, 2021	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.107C>A (p.Pro36Gln)	ALK	P36Q	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV001061494	2	30143419	2	29920553	1061494	1041442	rs773691688	NC_000002.12:29920552:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.107C>G (p.Pro36Arg)	ALK	P36R	Neuroblastoma, susceptibility to, 3	VCV001055921	2	30143419	2	29920553	1055921	1041441	rs773691688	NC_000002.12:29920552:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.107C>T (p.Pro36Leu)	ALK	P36L	Neuroblastoma, susceptibility to, 3|ALK-related disorder|Hereditary cancer-predisposing syndrome	VCV000470733	2	30143419	2	29920553	470733	451171	rs773691688	NC_000002.12:29920552:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 15, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.106C>T (p.Pro36Ser)	ALK	P36S	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000133457	2	30143420	2	29920554	133457	137196	rs201490095	NC_000002.12:29920553:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.105G>A (p.Gly35=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002477350	2	30143421	2	29920555	2477350	2453699		NC_000002.12:29920554:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.104G>T (p.Gly35Val)	ALK	G35V	Neuroblastoma, susceptibility to, 3	VCV002918599	2	30143422	2	29920556	2918599	3077352		NC_000002.12:29920555:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.104G>A (p.Gly35Glu)	ALK	G35E	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001062556	2	30143422	2	29920556	1062556	1041443	rs766479433	NC_000002.12:29920555:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 31, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.103G>A (p.Gly35Arg)	ALK	G35R	Neuroblastoma, susceptibility to, 3	VCV001369997	2	30143423	2	29920557	1369997	1437703	rs2148443908	NC_000002.12:29920556:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.102G>A (p.Ala34=)	ALK		Neuroblastoma, susceptibility to, 3|not specified|Hereditary cancer-predisposing syndrome	VCV000515799	2	30143424	2	29920558	515799	499664	rs561278614	NC_000002.12:29920557:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.101C>T (p.Ala34Val)	ALK	A34V	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000658836	2	30143425	2	29920559	658836	629939	rs1572503974	NC_000002.12:29920558:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.99T>C (p.Ala33=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002046820	2	30143427	2	29920561	2046820	2093096		NC_000002.12:29920560:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 5, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.98C>G (p.Ala33Gly)	ALK	A33G	Neuroblastoma, susceptibility to, 3	VCV000960961	2	30143428	2	29920562	960961	942886	rs1037134870	NC_000002.12:29920561:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.97G>C (p.Ala33Pro)	ALK	A33P	Hereditary cancer-predisposing syndrome	VCV003285944	2	30143429	2	29920563	3285944	3444684		NC_000002.12:29920562:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.97G>T (p.Ala33Ser)	ALK	A33S	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV002144155	2	30143429	2	29920563	2144155	1876060		NC_000002.12:29920562:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.96A>G (p.Pro32=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002418581	2	30143430	2	29920564	2418581	1944475		NC_000002.12:29920563:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 22, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.95C>G (p.Pro32Arg)	ALK	P32R	Neuroblastoma, susceptibility to, 3	VCV003708618	2	30143431	2	29920565	3708618	3846807		NC_000002.12:29920564:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 14, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.95C>T (p.Pro32Leu)	ALK	P32L	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000579738	2	30143431	2	29920565	579738	561426	rs759748510	NC_000002.12:29920564:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 12, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.94C>A (p.Pro32Thr)	ALK	P32T	Hereditary cancer-predisposing syndrome	VCV003285647	2	30143432	2	29920566	3285647	3440879		NC_000002.12:29920565:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.94C>G (p.Pro32Ala)	ALK	P32A	Neuroblastoma, susceptibility to, 3|not provided	VCV000662031	2	30143432	2	29920566	662031	629940	rs573276657	NC_000002.12:29920565:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.93C>T (p.Ser31=)	ALK		Hereditary cancer-predisposing syndrome	VCV001766825	2	30143433	2	29920567	1766825	1825068		NC_000002.12:29920566:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 20, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.93C>G (p.Ser31=)	ALK		Hereditary cancer-predisposing syndrome	VCV001766817	2	30143433	2	29920567	1766817	1825060		NC_000002.12:29920566:G:C	single nucleotide variant	synonymous variant	Likely benign	Jun 13, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.92C>G (p.Ser31Cys)	ALK	S31C	Hereditary cancer-predisposing syndrome	VCV001766480	2	30143434	2	29920568	1766480	1815057		NC_000002.12:29920567:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.91T>G (p.Ser31Ala)	ALK	S31A	Neuroblastoma, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome	VCV000404340	2	30143435	2	29920569	404340	392644	rs1026192345	NC_000002.12:29920568:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.90C>T (p.Gly30=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001765797	2	30143436	2	29920570	1765797	1817747		NC_000002.12:29920569:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.89G>A (p.Gly30Asp)	ALK	G30D	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000566737	2	30143437	2	29920571	566737	561430	rs1558550220	NC_000002.12:29920570:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.87G>A (p.Ala29=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001106359	2	30143439	2	29920573	1106359	1091285	rs1408956474	NC_000002.12:29920572:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.87G>C (p.Ala29=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470904	2	30143439	2	29920573	470904	450983	rs1408956474	NC_000002.12:29920572:C:G	single nucleotide variant	synonymous variant	Likely benign	Sep 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.86C>T (p.Ala29Val)	ALK	A29V	Neuroblastoma, susceptibility to, 3	VCV000955684	2	30143440	2	29920574	955684	942887	rs1667969126	NC_000002.12:29920573:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.85G>T (p.Ala29Ser)	ALK	A29S	Neuroblastoma, susceptibility to, 3	VCV001514481	2	30143441	2	29920575	1514481	1485524	rs1326321652	NC_000002.12:29920574:C:A	single nucleotide variant	missense variant	Uncertain significance	May 23, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.85G>A (p.Ala29Thr)	ALK	A29T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000949522	2	30143441	2	29920575	949522	922747	rs1326321652	NC_000002.12:29920574:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 19, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.84C>T (p.Arg28=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538234	2	30143442	2	29920576	538234	518235	rs1355709394	NC_000002.12:29920575:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.83G>A (p.Arg28His)	ALK	R28H	Neuroblastoma, susceptibility to, 3	VCV001026691	2	30143443	2	29920577	1026691	1004020	rs1667969323	NC_000002.12:29920576:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.82C>G (p.Arg28Gly)	ALK	R28G	Neuroblastoma, susceptibility to, 3	VCV000957941	2	30143444	2	29920578	957941	942888	rs1060500231	NC_000002.12:29920577:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.82C>T (p.Arg28Cys)	ALK	R28C	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000404384	2	30143444	2	29920578	404384	392652	rs1060500231	NC_000002.12:29920577:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.81G>A (p.Gln27=)	ALK		Hereditary cancer-predisposing syndrome	VCV001762420	2	30143445	2	29920579	1762420	1816819		NC_000002.12:29920578:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 2, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.80A>C (p.Gln27Pro)	ALK	Q27P	Hereditary cancer-predisposing syndrome	VCV002586714	2	30143446	2	29920580	2586714	2756897		NC_000002.12:29920579:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.80A>G (p.Gln27Arg)	ALK	Q27R	Neuroblastoma, susceptibility to, 3	VCV000834471	2	30143446	2	29920580	834471	826410	rs752501243	NC_000002.12:29920579:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.79C>G (p.Gln27Glu)	ALK	Q27E	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000654877	2	30143447	2	29920581	654877	629941	rs1469224885	NC_000002.12:29920580:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.77G>A (p.Gly26Asp)	ALK	G26D	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001367317	2	30143449	2	29920583	1367317	1405037	rs755942639	NC_000002.12:29920582:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.76G>C (p.Gly26Arg)	ALK	G26R	Hereditary cancer-predisposing syndrome	VCV002586689	2	30143450	2	29920584	2586689	2756872		NC_000002.12:29920583:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.76G>A (p.Gly26Ser)	ALK	G26S	Hereditary cancer-predisposing syndrome|not provided|Neuroblastoma, susceptibility to, 3	VCV000404337	2	30143450	2	29920584	404337	392682	rs1060500214	NC_000002.12:29920583:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 1, 2025	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.75C>T (p.Thr25=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001144314	2	30143451	2	29920585	1144314	1133694	rs764176323	NC_000002.12:29920584:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.75C>A (p.Thr25=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001093674	2	30143451	2	29920585	1093674	1069558	rs764176323	NC_000002.12:29920584:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.74C>A (p.Thr25Asn)	ALK	T25N	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001023840	2	30143452	2	29920586	1023840	1004021	rs753812499	NC_000002.12:29920585:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.74C>T (p.Thr25Ile)	ALK	T25I	Neuroblastoma, susceptibility to, 3	VCV000949215	2	30143452	2	29920586	949215	922748	rs753812499	NC_000002.12:29920585:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.73A>G (p.Thr25Ala)	ALK	T25A	Neuroblastoma, susceptibility to, 3	VCV003677317	2	30143453	2	29920587	3677317	3817518		NC_000002.12:29920586:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.72G>A (p.Gly24=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000335717	2	30143454	2	29920588	335717	286766	rs756782371	NC_000002.12:29920587:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.71G>C (p.Gly24Ala)	ALK	G24A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003223927	2	30143455	2	29920589	3223927	3380949		NC_000002.12:29920588:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.71G>A (p.Gly24Glu)	ALK	G24E	Neuroblastoma, susceptibility to, 3	VCV001722130	2	30143455	2	29920589	1722130	1776992		NC_000002.12:29920588:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.67A>G (p.Met23Val)	ALK	M23V	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003223923	2	30143459	2	29920593	3223923	3380945		NC_000002.12:29920592:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.66G>A (p.Gly22=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002796461	2	30143460	2	29920594	2796461	2954999		NC_000002.12:29920593:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 8, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.66G>C (p.Gly22=)	ALK		not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000701749	2	30143460	2	29920594	701749	686198	rs778418435	NC_000002.12:29920593:C:G	single nucleotide variant	synonymous variant	Likely benign	Sep 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.64G>C (p.Gly22Arg)	ALK	G22R	Hereditary cancer-predisposing syndrome	VCV003286267	2	30143462	2	29920596	3286267	3455090		NC_000002.12:29920595:C:G	single nucleotide variant	missense variant	Uncertain significance	May 20, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.64G>A (p.Gly22Arg)	ALK	G22R	Hereditary cancer-predisposing syndrome	VCV003223922	2	30143462	2	29920596	3223922	3380944		NC_000002.12:29920595:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.63C>T (p.Ser21=)	ALK		Hereditary cancer-predisposing syndrome	VCV002561063	2	30143463	2	29920597	2561063	2717222		NC_000002.12:29920596:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 10, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.62C>T (p.Ser21Phe)	ALK	S21F	Hereditary cancer-predisposing syndrome|ALK-related disorder|Neuroblastoma, susceptibility to, 3	VCV002148222	2	30143464	2	29920598	2148222	1871010		NC_000002.12:29920597:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.61T>C (p.Ser21Pro)	ALK	S21P	Neuroblastoma, susceptibility to, 3	VCV000860798	2	30143465	2	29920599	860798	826411	rs1275224090	NC_000002.12:29920598:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2019	criteria provided, single submitter							
NM_004304.5(ALK):c.60C>T (p.Gly20=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001751597	2	30143466	2	29920600	1751597	1811218		NC_000002.12:29920599:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.59G>A (p.Gly20Asp)	ALK	G20D	Neuroblastoma, susceptibility to, 3	VCV000665721	2	30143467	2	29920601	665721	629942	rs1572504071	NC_000002.12:29920600:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.58G>A (p.Gly20Ser)	ALK	G20S	Neuroblastoma, susceptibility to, 3|not provided	VCV002730213	2	30143468	2	29920602	2730213	2886814		NC_000002.12:29920601:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.56T>A (p.Val19Glu)	ALK	V19E	Hereditary cancer-predisposing syndrome	VCV003525195	2	30143470	2	29920604	3525195	3685551		NC_000002.12:29920603:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.56T>G (p.Val19Gly)	ALK	V19G	Hereditary cancer-predisposing syndrome	VCV003223918	2	30143470	2	29920604	3223918	3380940		NC_000002.12:29920603:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.55G>A (p.Val19Met)	ALK	V19M	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001499233	2	30143471	2	29920605	1499233	1488978	rs1057384991	NC_000002.12:29920604:C:T	single nucleotide variant	missense variant	Uncertain significance	May 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.55G>C (p.Val19Leu)	ALK	V19L	Neuroblastoma, susceptibility to, 3	VCV001483276	2	30143471	2	29920605	1483276	1380395	rs1057384991	NC_000002.12:29920604:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.53C>A (p.Ala18Asp)	ALK	A18D	Neuroblastoma, susceptibility to, 3	VCV003630155	2	30143473	2	29920607	3630155	3769497		NC_000002.12:29920606:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.53C>T (p.Ala18Val)	ALK	A18V	not provided	VCV003371863	2	30143473	2	29920607	3371863	3531053		NC_000002.12:29920606:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 2, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.52G>C (p.Ala18Pro)	ALK	A18P	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000942592	2	30143474	2	29920608	942592	931379	rs1203105916	NC_000002.12:29920607:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.49G>T (p.Ala17Ser)	ALK	A17S	Neuroblastoma, susceptibility to, 3	VCV003654757	2	30143477	2	29920611	3654757	3778852		NC_000002.12:29920610:C:A	single nucleotide variant	missense variant	Uncertain significance	May 28, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.44_49delinsACACGA (p.Ser15_Ala17delinsTyrThrThr)	ALK		not provided	VCV002577561	2	30143477 - 30143482	2	29920611 - 29920616	2577561	2742454		NC_000002.12:29920610:CCGTGG:TCGTGT	Indel	missense variant	Uncertain significance	Aug 29, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.49G>A (p.Ala17Thr)	ALK	A17T	Neuroblastoma, susceptibility to, 3	VCV000576343	2	30143477	2	29920611	576343	561443	rs369196372	NC_000002.12:29920610:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.48G>C (p.Thr16=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001588581	2	30143478	2	29920612	1588581	1640908	rs758016860	NC_000002.12:29920611:C:G	single nucleotide variant	synonymous variant	Likely benign	Apr 21, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.48G>A (p.Thr16=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001349765	2	30143478	2	29920612	1349765	1394528	rs758016860	NC_000002.12:29920611:C:T	single nucleotide variant	synonymous variant	Likely benign	May 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.47C>T (p.Thr16Met)	ALK	T16M	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV003018211	2	30143479	2	29920613	3018211	3182388		NC_000002.12:29920612:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 9, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.47C>G (p.Thr16Arg)	ALK	T16R	Neuroblastoma, susceptibility to, 3	VCV002812755	2	30143479	2	29920613	2812755	2975987		NC_000002.12:29920612:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 8, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.46A>G (p.Thr16Ala)	ALK	T16A	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000953108	2	30143480	2	29920614	953108	942889	rs1572504096	NC_000002.12:29920613:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 24, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.46A>C (p.Thr16Pro)	ALK	T16P	Neuroblastoma, susceptibility to, 3	VCV000640555	2	30143480	2	29920614	640555	629943	rs1572504096	NC_000002.12:29920613:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.44C>T (p.Ser15Phe)	ALK	S15F	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000835668	2	30143482	2	29920616	835668	826412	rs770134645	NC_000002.12:29920615:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.44C>A (p.Ser15Tyr)	ALK	S15Y	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000576342	2	30143482	2	29920616	576342	561454	rs770134645	NC_000002.12:29920615:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.43T>C (p.Ser15Pro)	ALK	S15P	Hereditary cancer-predisposing syndrome	VCV002566562	2	30143483	2	29920617	2566562	2734405		NC_000002.12:29920616:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.43T>A (p.Ser15Thr)	ALK	S15T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001740323	2	30143483	2	29920617	1740323	1791356		NC_000002.12:29920616:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.40C>G (p.Leu14Val)	ALK	L14V	Hereditary cancer-predisposing syndrome	VCV003285864	2	30143486	2	29920620	3285864	3444604		NC_000002.12:29920619:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 11, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.40C>T (p.Leu14Phe)	ALK	L14F	Neuroblastoma, susceptibility to, 3	VCV001966621	2	30143486	2	29920620	1966621	2031787		NC_000002.12:29920619:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.37C>T (p.Leu13=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001109231	2	30143489	2	29920623	1109231	1091286	rs749730757	NC_000002.12:29920622:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 16, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.35T>C (p.Leu12Pro)	ALK	L12P	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000843592	2	30143491	2	29920625	843592	826413	rs1165737526	NC_000002.12:29920624:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 31, 2023	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.34C>T (p.Leu12=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001084325	2	30143492	2	29920626	1084325	1069559	rs2148444097	NC_000002.12:29920625:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 27, 2020	criteria provided, single submitter							
NM_004304.5(ALK):c.33G>C (p.Pro11=)	ALK		Hereditary cancer-predisposing syndrome	VCV001731047	2	30143493	2	29920627	1731047	1795421		NC_000002.12:29920626:C:G	single nucleotide variant	synonymous variant	Likely benign	Jun 2, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.33G>T (p.Pro11=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001448036	2	30143493	2	29920627	1448036	1400048	rs774442098	NC_000002.12:29920626:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 16, 2021	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.33G>A (p.Pro11=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001092181	2	30143493	2	29920627	1092181	1069560	rs774442098	NC_000002.12:29920626:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.32C>T (p.Pro11Leu)	ALK	P11L	not provided|Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV000335718	2	30143494	2	29920628	335718	289006	rs767822322	NC_000002.12:29920627:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 15, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.31C>T (p.Pro11Ser)	ALK	P11S	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001976571	2	30143495	2	29920629	1976571	2034423		NC_000002.12:29920628:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.30G>A (p.Leu10=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001727620	2	30143496	2	29920630	1727620	1785100		NC_000002.12:29920629:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.28C>T (p.Leu10=)	ALK		Hereditary cancer-predisposing syndrome	VCV001797421	2	30143498	2	29920632	1797421	1854339		NC_000002.12:29920631:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.27_28delinsGT (p.Leu9_Leu10=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000470800	2	30143498 - 30143499	2	29920632 - 29920633	470800	451153	rs1553380482	NC_000002.12:29920631:GG:AC	Indel	synonymous variant	Likely benign	Dec 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.27C>A (p.Leu9=)	ALK		Hereditary cancer-predisposing syndrome	VCV003284879	2	30143499	2	29920633	3284879	3444058		NC_000002.12:29920632:G:T	single nucleotide variant	synonymous variant	Likely benign	Mar 19, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.26_27delinsCG (p.Leu9Pro)	ALK	L9P	Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000574480	2	30143499 - 30143500	2	29920633 - 29920634	574480	560615	rs1558550306	NC_000002.12:29920632:GA:CG	Indel	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.27C>G (p.Leu9=)	ALK		Hereditary cancer-predisposing syndrome|not provided|not specified|Neuroblastoma, susceptibility to, 3	VCV000259269	2	30143499	2	29920633	259269	250724	rs4358080	NC_000002.12:29920632:G:C	single nucleotide variant	synonymous variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.26T>A (p.Leu9His)	ALK	L9H	Hereditary cancer-predisposing syndrome	VCV003286465	2	30143500	2	29920634	3286465	3455288		NC_000002.12:29920633:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.26T>G (p.Leu9Arg)	ALK	L9R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001044358	2	30143500	2	29920634	1044358	1024483	rs764671855	NC_000002.12:29920633:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.25C>T (p.Leu9Phe)	ALK	L9F	Hereditary cancer-predisposing syndrome	VCV003524323	2	30143501	2	29920635	3524323	3678988		NC_000002.12:29920634:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.25C>A (p.Leu9Ile)	ALK	L9I	Neuroblastoma, susceptibility to, 3	VCV001520783	2	30143501	2	29920635	1520783	1356142	rs1335279051	NC_000002.12:29920634:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.24G>C (p.Trp8Cys)	ALK	W8C	Hereditary cancer-predisposing syndrome	VCV003522529	2	30143502	2	29920636	3522529	3678513		NC_000002.12:29920635:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.24G>T (p.Trp8Cys)	ALK	W8C	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000538174	2	30143502	2	29920636	538174	518298	rs749905243	NC_000002.12:29920635:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.22T>C (p.Trp8Arg)	ALK	W8R	Neuroblastoma, susceptibility to, 3	VCV000576674	2	30143504	2	29920638	576674	558065	rs1222954765	NC_000002.12:29920637:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.21G>C (p.Leu7=)	ALK		Neuroblastoma, susceptibility to, 3	VCV000763694	2	30143505	2	29920639	763694	763192	rs1000240288	NC_000002.12:29920638:C:G	single nucleotide variant	synonymous variant	Likely benign	Feb 2, 2025	criteria provided, single submitter							
NM_004304.5(ALK):c.20T>G (p.Leu7Arg)	ALK	L7R	Hereditary cancer-predisposing syndrome	VCV002447093	2	30143506	2	29920640	2447093	2422216		NC_000002.12:29920639:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.20T>C (p.Leu7Pro)	ALK	L7P	Neuroblastoma, susceptibility to, 3	VCV001500346	2	30143506	2	29920640	1500346	1408708	rs1351584977	NC_000002.12:29920639:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.19del (p.Leu7fs)	ALK	L7fs	Neuroblastoma, susceptibility to, 3	VCV002050349	2	30143507	2	29920641	2050349	2104352		NC_000002.12:29920640:GG:G	Deletion	frameshift variant	Uncertain significance	Dec 8, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.18C>A (p.Leu6=)	ALK		Neuroblastoma, susceptibility to, 3	VCV002049676	2	30143508	2	29920642	2049676	2107563		NC_000002.12:29920641:G:T	single nucleotide variant	synonymous variant	Likely benign	Dec 20, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.18C>T (p.Leu6=)	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV001782272	2	30143508	2	29920642	1782272	1842656		NC_000002.12:29920641:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.16C>T (p.Leu6Phe)	ALK	L6F	Hereditary cancer-predisposing syndrome	VCV001778326	2	30143510	2	29920644	1778326	1834299		NC_000002.12:29920643:G:A	single nucleotide variant	missense variant	Uncertain significance	May 13, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.15G>A (p.Gly5=)	ALK		Neuroblastoma, susceptibility to, 3|Hereditary cancer-predisposing syndrome	VCV001159788	2	30143511	2	29920645	1159788	1133695	rs1667973227	NC_000002.12:29920644:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.13G>A (p.Gly5Arg)	ALK	G5R	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470747	2	30143513	2	29920647	470747	451154	rs1272214012	NC_000002.12:29920646:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 9, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.12C>A (p.Ile4=)	ALK		Hereditary cancer-predisposing syndrome	VCV001769339	2	30143514	2	29920648	1769339	1835776		NC_000002.12:29920647:G:T	single nucleotide variant	synonymous variant	Likely benign	May 23, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.12C>T (p.Ile4=)	ALK		Hereditary cancer-predisposing syndrome	VCV001692771	2	30143514	2	29920648	1692771	1685211	rs779744459	NC_000002.12:29920647:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 26, 2021	criteria provided, single submitter							
NM_004304.5(ALK):c.11T>C (p.Ile4Thr)	ALK	I4T	Hereditary cancer-predisposing syndrome	VCV003525148	2	30143515	2	29920649	3525148	3685504		NC_000002.12:29920648:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.10A>G (p.Ile4Val)	ALK	I4V	Neuroblastoma, susceptibility to, 3	VCV003616144	2	30143516	2	29920650	3616144	3745822		NC_000002.12:29920649:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.9C>T (p.Ala3=)	ALK		Neuroblastoma, susceptibility to, 3	VCV001590230	2	30143517	2	29920651	1590230	1642124	rs2148444182	NC_000002.12:29920650:G:A	single nucleotide variant	synonymous variant	Likely benign	May 13, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.8C>T (p.Ala3Val)	ALK	A3V	Neuroblastoma, susceptibility to, 3	VCV002187036	2	30143518	2	29920652	2187036	1914445		NC_000002.12:29920651:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.7G>A (p.Ala3Thr)	ALK	A3T	Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3	VCV000470901	2	30143519	2	29920653	470901	450845	rs1446332510	NC_000002.12:29920652:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 14, 2024	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.5G>C (p.Gly2Ala)	ALK	G2A	Neuroblastoma, susceptibility to, 3	VCV002676042	2	30143521	2	29920655	2676042	2834463		NC_000002.12:29920654:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.4G>A (p.Gly2Arg)	ALK	G2R	Neuroblastoma, susceptibility to, 3	VCV000962598	2	30143522	2	29920656	962598	942890	rs1667974338	NC_000002.12:29920655:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2T>C (p.Met1Thr)	ALK	M1T	Neuroblastoma, susceptibility to, 3	VCV002724837	2	30143524	2	29920658	2724837	2888765		NC_000002.12:29920657:A:G	single nucleotide variant	missense variant|initiator_codon_variant	Uncertain significance	Nov 2, 2022	criteria provided, single submitter							
NM_004304.5(ALK):c.1A>T (p.Met1Leu)	ALK	M1L	Neuroblastoma, susceptibility to, 3	VCV001389098	2	30143525	2	29920659	1389098	1476678	rs1202047396	NC_000002.12:29920658:T:A	single nucleotide variant	missense variant|initiator_codon_variant	Uncertain significance	Oct 14, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.-2G>T	ALK		Hereditary cancer-predisposing syndrome	VCV000822532	2	30143527	2	29920661	822532	806918	rs1202718057	NC_000002.12:29920660:C:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Nov 2, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.-3G>A	ALK		not provided	VCV003371608	2	30143528	2	29920662	3371608	3530798		NC_000002.12:29920661:C:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	Mar 29, 2024	criteria provided, single submitter							
NM_004304.5(ALK):c.-3G>C	ALK		Hereditary cancer-predisposing syndrome	VCV000485078	2	30143528	2	29920662	485078	472787	rs1031317995	NC_000002.12:29920661:C:G	single nucleotide variant	5 prime UTR variant	Uncertain significance	Apr 6, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.-5G>A	ALK		Hereditary cancer-predisposing syndrome|Neuroblastoma, susceptibility to, 3|not provided	VCV000335719	2	30143530	2	29920664	335719	289007	rs56270786	NC_000002.12:29920663:C:T	single nucleotide variant	5 prime UTR variant	Benign/Likely benign	Oct 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.-6G>A	ALK		not specified	VCV000510874	2	30143531	2	29920665	510874	500156	rs778056023	NC_000002.12:29920664:C:T	single nucleotide variant	5 prime UTR variant	Likely benign	Jul 17, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.-32G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000896718	2	30143557	2	29920691	896718	884690	rs771429852	NC_000002.12:29920690:C:T	single nucleotide variant	5 prime UTR variant	Likely benign	Jan 12, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-61C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000896719	2	30143586	2	29920720	896719	884691	rs1052528841	NC_000002.12:29920719:G:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-128A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000896720	2	30143653	2	29920787	896720	884692	rs1246468331	NC_000002.12:29920786:T:C	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-151G>A	ALK		not provided	VCV001198321	2	30143676	2	29920810	1198321	1186435	rs73922108	NC_000002.12:29920809:C:T	single nucleotide variant	5 prime UTR variant	Likely benign	Aug 27, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-156G>T	ALK		Neuroblastoma, susceptibility to, 3|not provided	VCV000335720	2	30143681	2	29920815	335720	289385	rs141444957	NC_000002.12:29920814:C:A	single nucleotide variant	5 prime UTR variant	Likely benign	Jul 20, 2018	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.-161T>C	ALK		Neuroblastoma, susceptibility to, 3	VCV000335721	2	30143686	2	29920820	335721	289402	rs886055934	NC_000002.12:29920819:A:G	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-273G>C	ALK		Neuroblastoma, susceptibility to, 3|not provided	VCV000335722	2	30143798	2	29920932	335722	289420	rs72857538	NC_000002.12:29920931:C:G	single nucleotide variant	5 prime UTR variant	Likely benign	Apr 24, 2019	criteria provided, multiple submitters, no conflicts							
NM_004304.5(ALK):c.-276G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000335723	2	30143801	2	29920935	335723	289015	rs886055935	NC_000002.12:29920934:C:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-292G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000335724	2	30143817	2	29920951	335724	289021	rs578166431	NC_000002.12:29920950:C:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-312G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000335725	2	30143837	2	29920971	335725	289022	rs886055936	NC_000002.12:29920970:C:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-313C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000335726	2	30143838	2	29920972	335726	289028	rs72857540	NC_000002.12:29920971:G:C	single nucleotide variant	5 prime UTR variant	Likely benign	Apr 27, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.-376G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000897190	2	30143901	2	29921035	897190	884693	rs1254508871	NC_000002.12:29921034:C:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-403G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000335727	2	30143928	2	29921062	335727	286002	rs572286447	NC_000002.12:29921061:C:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-415T>C	ALK		Neuroblastoma, susceptibility to, 3|not provided	VCV000335728	2	30143940	2	29921074	335728	286018	rs755231246	NC_000002.12:29921073:A:G	single nucleotide variant	5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 1, 2022	criteria provided, conflicting classifications							
NM_004304.5(ALK):c.-490C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000898358	2	30144015	2	29921149	898358	884694	rs957194330	NC_000002.12:29921148:G:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-539G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000898359	2	30144064	2	29921198	898359	884695	rs200662898	NC_000002.12:29921197:C:T	single nucleotide variant	5 prime UTR variant	Benign	Jun 13, 2017	criteria provided, single submitter							
NM_004304.5(ALK):c.-566G>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000335729	2	30144091	2	29921225	335729	286019	rs886055937	NC_000002.12:29921224:C:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-611G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000898360	2	30144136	2	29921270	898360	884696	rs1667997371	NC_000002.12:29921269:C:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-619G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000898361	2	30144144	2	29921278	898361	884697	rs138384829	NC_000002.12:29921277:C:T	single nucleotide variant	5 prime UTR variant	Likely benign	Jan 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-624C>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000335730	2	30144149	2	29921283	335730	289422	rs886055938	NC_000002.12:29921282:G:C	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-677G>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000898362	2	30144202	2	29921336	898362	884698	rs368770999	NC_000002.12:29921335:C:T	single nucleotide variant	5 prime UTR variant	Likely benign	Jan 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-699A>G	ALK		Neuroblastoma, susceptibility to, 3	VCV000898363	2	30144224	2	29921358	898363	884699	rs943046273	NC_000002.12:29921357:T:C	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 15, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-751C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000335731	2	30144276	2	29921410	335731	289079	rs547587734	NC_000002.12:29921409:G:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-826C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000335732	2	30144351	2	29921485	335732	289425	rs886055939	NC_000002.12:29921484:G:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-830C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000895378	2	30144355	2	29921489	895378	884700	rs1227238002	NC_000002.12:29921488:G:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Mar 16, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-896C>T	ALK		Neuroblastoma, susceptibility to, 3	VCV000895379	2	30144421	2	29921555	895379	884701	rs1020153617	NC_000002.12:29921554:G:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_004304.5(ALK):c.-922C>A	ALK		Neuroblastoma, susceptibility to, 3	VCV000895380	2	30144447	2	29921581	895380	884702	rs372410498	NC_000002.12:29921580:G:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
GRCh37/hg19 2p24.1-22.2(chr2:20938401-37327210)x3	ABHD1|ADCY3|ADGRF3|AGBL5|ALK|APOB|ASXL2|ATAD2B|ATRAID|BABAM2|BIRC6|CAD|CAPN13|CAPN14|CCDC121|CENPA|CENPO|CGREF1|CIB4|CIMIP2C|CLIP4|CRIM1|DNAJC27|DNAJC5G|DNMT3A|DPY30|DPYSL5|DRC1|DTNB|EFR3B|EHD3|EIF2B4|EMILIN1|FAM228A|FAM228B|FAM98A|FEZ2|FKBP1B|FNDC4|FOSL2|GALNT14|GAREM2|GCKR|GPATCH11|GPN1|GTF3C2|HADHA|HADHB|HEATR5B|IFT172|ITSN2|KCNK3|KHK|KIF3C|KLHL29|KRTCAP3|LBH|LCLAT1|LDAH|LTBP1|MAPRE3|MEMO1|MFSD2B|MPV17|MRPL33|NCOA1|NLRC4|NRBP1|OST4|OTOF|PCARE|PFN4|PLB1|POMC|PPM1G|PPP1CB|PREB|PRR30|PTRHD1|RAB10|RASGRP3|RBKS|SELENOI|SF3B6|SLC30A3|SLC30A6|SLC35F6|SLC4A1AP|SLC5A6|SNX17|SPAST|SPATA31H1|SPDYA|SRD5A2|STRN|SUPT7L|TCF23|TDRD15|TMEM214|TOGARAM2|TP53I3|TRIM54|TRMT61B|TTC27|UBXN2A|UCN|VIT|WDCP|WDR43|XDH|YIPF4|YPEL5|ZNF512|ZNF513		not provided	VCV003391842	2	20938401 - 37327210			3391842	3550922			copy number gain		Pathogenic	Feb 19, 2024	criteria provided, single submitter							
Single allele	ALK		Rhabdomyosarcoma	VCV003390885	2	29446394 - 30142859			3390885	2668236			Deletion								Likely oncogenic	Nov 13, 2024	no assertion criteria provided	
NC_000002.11:g.(?_29287735)_(29430158_?)del	ALK|CLIP4|PCARE		not provided	VCV003247472	2	29287735 - 29430158			3247472	3403988			Deletion		Pathogenic	Nov 18, 2022	criteria provided, single submitter							
NC_000002.11:g.(?_29436891)_(29440263_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV003247362	2	29436891 - 29440263			3247362	3405819			Deletion		Uncertain significance	Jul 14, 2023	criteria provided, single submitter							
NC_000002.11:g.(?_30143165)_(30144434_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV003247361	2	30143165 - 30144434			3247361	3405818			Deletion		Uncertain significance	Mar 23, 2020	criteria provided, single submitter							
NC_000002.11:g.(?_29519734)_(29606745_?)dup	ALK		Neuroblastoma, susceptibility to, 3	VCV003247360	2	29519734 - 29606745			3247360	3405817			Duplication		Uncertain significance	Aug 16, 2023	criteria provided, single submitter							
NC_000002.11:g.(?_29119585)_(29420552_?)dup	ALK|CLIP4|PCARE|TOGARAM2|WDR43		Neuroblastoma, susceptibility to, 3	VCV003247359	2	29119585 - 29420552			3247359	3405816			Duplication		Uncertain significance	Sep 22, 2023	criteria provided, single submitter							
NC_000002.11:g.(?_29754771)_(30143525_?)dup	ALK		Neuroblastoma, susceptibility to, 3	VCV003247357	2	29754771 - 30143525			3247357	3405814			Duplication		Uncertain significance	Aug 20, 2023	criteria provided, single submitter							
NC_000002.11:g.(?_29541150)_(29541290_?)dup	ALK		Neuroblastoma, susceptibility to, 3	VCV003247356	2	29541150 - 29541290			3247356	3405813			Duplication		Uncertain significance	Nov 24, 2023	criteria provided, single submitter							
NC_000002.11:g.(?_29754761)_(29755002_?)dup	ALK		Neuroblastoma, susceptibility to, 3	VCV003247355	2	29754761 - 29755002			3247355	3405812			Duplication		Uncertain significance	Dec 21, 2023	criteria provided, single submitter							
NC_000002.11:g.(?_29917706)_(29940573_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV003247354	2	29917706 - 29940573			3247354	3405811			Deletion		Uncertain significance	Oct 27, 2023	criteria provided, single submitter							
NC_000002.11:g.(?_29551206)_(29551357_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV003247353	2	29551206 - 29551357			3247353	3405810			Deletion		Uncertain significance	Jun 14, 2023	criteria provided, single submitter							
NC_000002.11:g.(?_29450430)_(29450548_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV003247352	2	29450430 - 29450548			3247352	3405809			Deletion		Uncertain significance	Sep 26, 2023	criteria provided, single submitter							
NC_000002.11:g.(?_29462536)_(29462706_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV003247351	2	29462536 - 29462706			3247351	3405808			Deletion		Uncertain significance	Mar 22, 2023	criteria provided, single submitter							
NC_000002.11:g.(?_29473961)_(29474143_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV003247350	2	29473961 - 29474143			3247350	3405807			Deletion		Uncertain significance	Aug 27, 2023	criteria provided, single submitter							
GRCh37/hg19 2p25.3-22.3(chr2:12771-35541353)x3	ABHD1|ACP1|ADAM17|ADCY3|ADGRF3|ADI1|AGBL5|ALK|ALKAL2|ALLC|APOB|ASAP2|ASXL2|ATAD2B|ATP6V1C2|ATRAID|BABAM2|BIRC6|C2orf48|C2orf50|CAD|CAPN13|CAPN14|CCDC121|CENPA|CENPO|CGREF1|CIB4|CIMIP2C|CLIP4|CMPK2|COLEC11|CPSF3|CYRIA|CYS1|DCDC2C|DDX1|DNAJC27|DNAJC5G|DNMT3A|DPY30|DPYSL5|DRC1|DTNB|E2F6|EFR3B|EHD3|EIF2B4|EIPR1|EMILIN1|FAM110C|FAM228A|FAM228B|FAM98A|FKBP1B|FNDC4|FOSL2|GALNT14|GAREM2|GCKR|GDF7|GEN1|GPN1|GREB1|GRHL1|GTF3C2|HADHA|HADHB|HPCAL1|HS1BP3|IAH1|ID2|IFT172|ITGB1BP1|ITSN2|KCNF1|KCNK3|KCNS3|KHK|KIDINS220|KIF3C|KLF11|KLHL29|KRTCAP3|LAPTM4A|LBH|LCLAT1|LDAH|LINC00570|LPIN1|LRATD1|LTBP1|MAPRE3|MATN3|MBOAT2|MEMO1|MFSD2B|MPV17|MRPL33|MSGN1|MYCN|MYCNOS|MYT1L|NBAS|NCOA1|NLRC4|NOL10|NRBP1|NT5C1B|NT5C1B-RDH14|NTSR2|ODC1|OSR1|OST4|OTOF|PCARE|PDIA6|PFN4|PLB1|POMC|PPM1G|PPP1CB|PREB|PRR30|PTRHD1|PUM2|PXDN|RAB10|RAD51AP2|RASGRP3|RBKS|RDH14|RHOB|RNASEH1|RNF144A|ROCK2|RPS7|RRM2|RSAD2|SDC1|SELENOI|SF3B6|SH3YL1|SLC30A3|SLC30A6|SLC35F6|SLC4A1AP|SLC5A6|SLC66A3|SMC6|SNTG2|SNX17|SOX11|SPAST|SPATA31H1|SPDYA|SRD5A2|SUPT7L|TAF1B|TCF23|TDRD15|TMEM18|TMEM214|TOGARAM2|TP53I3|TPO|TRAPPC12|TRIB2|TRIM54|TRMT61B|TTC27|TTC32|UBXN2A|UCN|VSNL1|WDCP|WDR35|WDR43|XDH|YIPF4|YPEL5|YWHAQ|ZNF512|ZNF513		See cases	VCV003148883	2	12771 - 35541353			3148883	3308131			copy number gain		Pathogenic		criteria provided, single submitter							
GRCh37/hg19 2p23.2-23.1(chr2:28244046-30256324)x3	ALK|BABAM2|CLIP4|FOSL2|PCARE|PLB1|PPP1CB|SPDYA|TOGARAM2|TRMT61B|WDR43		not specified	VCV003062642	2	28244046 - 30256324			3062642	3222864			copy number gain		Uncertain significance		criteria provided, single submitter							
NC_000002.11:g.(?_24443763)_(30143525_?)dup	ADGRF3|AGBL5|CGREF1|CCDC121|CENPA|CENPO|CIMIP2C|CLIP4|CIB4|ABHD1|ADCY3|ALK|ASXL2|ATRAID|BABAM2|CAD|DNAJC27|DNAJC5G|DNMT3A|DPYSL5|DRC1|DTNB|EFR3B|EIF2B4|EMILIN1|FNDC4|FOSL2|GAREM2|GCKR|GPN1|GTF3C2|HADHA|HADHB|IFT172|ITSN2|KCNK3|KHK|KIF3C|KRTCAP3|MAPRE3|MPV17|MRPL33|NCOA1|NRBP1|OST4|OTOF|PCARE|PLB1|POMC|PPM1G|PPP1CB|PREB|PRR30|PTRHD1|RAB10|RBKS|SELENOI|SLC30A3|SLC35F6|SLC4A1AP|SLC5A6|SNX17|SPATA31H1|SPDYA|SUPT7L|TCF23|TMEM214|TOGARAM2|TRIM54|TRMT61B|UCN|WDR43|ZNF512|ZNF513		not provided	VCV002425074	2	24443763 - 30143525			2425074	1946136			Duplication		Uncertain significance	Sep 23, 2022	criteria provided, single submitter							
NC_000002.11:g.(?_29416090)_(30143525_?)dup	ALK		Neuroblastoma, susceptibility to, 3	VCV002425061	2	29416090 - 30143525			2425061	1946123			Duplication		Uncertain significance	Sep 21, 2022	criteria provided, single submitter							
NC_000002.11:g.(?_29551196)_(29940583_?)dup	ALK		Neuroblastoma, susceptibility to, 3	VCV002425060	2	29551196 - 29940583			2425060	1946122			Duplication		Uncertain significance	Apr 1, 2022	criteria provided, single submitter							
NC_000002.11:g.(?_29416090)_(29551357_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV002425059	2	29416090 - 29551357			2425059	1946121			Deletion		Uncertain significance	Apr 24, 2022	criteria provided, single submitter							
NC_000002.11:g.(?_29419616)_(29420562_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV002425058	2	29419616 - 29420562			2425058	1946120			Deletion		Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NC_000002.11:g.(?_29606588)_(29940573_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV002425057	2	29606588 - 29940573			2425057	1946119			Deletion		Uncertain significance	Jan 11, 2022	criteria provided, single submitter							
NC_000002.11:g.(?_29455160)_(29456572_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV002425056	2	29455160 - 29456572			2425056	1946118			Deletion		Uncertain significance	Jun 14, 2023	criteria provided, single submitter							
NC_000002.11:g.(?_29754771)_(29754992_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV002425055	2	29754771 - 29754992			2425055	1946117			Deletion		Uncertain significance	Jan 17, 2023	criteria provided, single submitter							
NC_000002.11:g.(?_29419626)_(29419736_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV002425054	2	29419626 - 29419736			2425054	1946116			Deletion		Uncertain significance	Apr 1, 2022	criteria provided, single submitter							
GRCh37/hg19 2p23.1(chr2:30063188-30290288)x3	ALK		not provided	VCV001808898	2	30063188 - 30290288			1808898	1865902			copy number gain		Uncertain significance	Jun 28, 2021	criteria provided, single submitter							
GRCh37/hg19 2p25.3-22.3(chr2:706460-35523639)x3	ABHD1|ADAM17|ADCY3|ADGRF3|ADI1|AGBL5|ALK|ALLC|APOB|ASAP2|ASXL2|ATAD2B|ATP6V1C2|ATRAID|BABAM2|BIRC6|C2orf16|C2orf48|C2orf50|CAD|CAPN13|CAPN14|CCDC121|CENPA|CENPO|CGREF1|CIB4|CLIP4|CMPK2|COLEC11|CPSF3|CYRIA|CYS1|DCDC2C|DDX1|DNAJC27|DNAJC5G|DNMT3A|DPY30|DPYSL5|DRC1|DTNB|E2F6|EFR3B|EHD3|EIF2B4|EIPR1|EMILIN1|FAM166C|FAM228A|FAM228B|FAM98A|FKBP1B|FNDC4|FOSL2|GALNT14|GAREM2|GCKR|GDF7|GEN1|GPN1|GREB1|GRHL1|GTF3C2|HADHA|HADHB|HPCAL1|HS1BP3|IAH1|ID2|IFT172|ITGB1BP1|ITSN2|KCNF1|KCNK3|KCNS3|KHK|KIDINS220|KIF3C|KLF11|KLHL29|KRTCAP3|LAPTM4A|LBH|LCLAT1|LDAH|LINC00570|LPIN1|LRATD1|LTBP1|MAPRE3|MATN3|MBOAT2|MEMO1|MFSD2B|MPV17|MRPL33|MSGN1|MYCN|MYCNOS|MYT1L|NBAS|NCOA1|NLRC4|NOL10|NRBP1|NT5C1B|NT5C1B-RDH14|NTSR2|ODC1|OSR1|OST4|OTOF|PCARE|PDIA6|PFN4|PLB1|POMC|PPM1G|PPP1CB|PREB|PRR30|PTRHD1|PUM2|PXDN|RAB10|RAD51AP2|RASGRP3|RBKS|RDH14|RHOB|RNASEH1|RNF144A|ROCK2|RPS7|RRM2|RSAD2|SDC1|SELENOI|SF3B6|SLC30A3|SLC30A6|SLC35F6|SLC4A1AP|SLC5A6|SLC66A3|SMC6|SNTG2|SNX17|SOX11|SPAST|SPDYA|SRD5A2|SUPT7L|TAF1B|TCF23|TDRD15|TMEM214|TOGARAM2|TP53I3|TPO|TRAPPC12|TRIB2|TRIM54|TRMT61B|TTC27|TTC32|UBXN2A|UCN|VSNL1|WDCP|WDR35|WDR43|XDH|YIPF4|YPEL5|YWHAQ|ZNF512|ZNF513		not provided	VCV001808629	2	706460 - 35523639			1808629	1865633			copy number gain		Pathogenic	Apr 15, 2022	criteria provided, single submitter							
GRCh37/hg19 2p25.1-q13(chr2:11504318-111365996)x1	ACTG2|ACTR1B|ACTR2|ACYP2|ADCY3|ADD2|ADGRF3|ADRA2B|AFF3|AFTPH|AGBL5|ALK|ALMS1|ANKRD23|ANKRD36|ANKRD36B|ANKRD36C|ANKRD39|ANKRD53|ANTXR1|ANXA4|APLF|APOB|ARHGAP25|ARHGEF33|ARID5A|ASB3|ASPRV1|ASTL|ASXL2|ATAD2B|ATL2|ATOH8|ATP6V1B1|ATP6V1E2|ATRAID|AUP1|B3GNT2|BABAM2|BCL11A|BCYRN1|BIRC6|BMP10|BOLA3|C1D|C2orf15|C2orf42|C2orf49|C2orf68|C2orf73|C2orf74|C2orf78|C2orf81|CAD|CALM2|CAMKMT|CAPG|CAPN13|CAPN14|CCDC121|CCDC138|CCDC142|CCDC85A|CCDC88A|CCT4|CCT7|CD207|CD8A|CD8B|CDC42EP3|CDKL4|CEBPZ|CENPA|CENPO|CEP68|CFAP36|CGREF1|CHAC2|CHMP3|CHST10|CIAO1|CIB4|CIMIP2C|CLEC4F|CLHC1|CLIP4|CNGA3|CNNM3|CNNM4|CNOT11|CNRIP1|COA5|COMMD1|COX5B|COX7A2L|CRACDL|CREG2|CRIM1|CRIPT|CTNNA2|CYP1B1|CYP26B1|CYRIA|DCTN1|DDX1|DGUOK|DHX57|DNAAF10|DNAH6|DNAJC27|DNAJC5G|DNMT3A|DOK1|DPY30|DPYSL5|DQX1|DRC1|DTNB|DUSP11|DUSP2|DYNC2LI1|DYSF|E2F6|ECRG4|EDAR|EFEMP1|EFR3B|EGR4|EHBP1|EHD3|EIF2AK2|EIF2AK3|EIF2B4|EIF5B|ELMOD3|EMILIN1|EML4|EML6|EMX1|EPAS1|EPCAM|ERLEC1|ETAA1|EVA1A|EXOC6B|FABP1|FAHD2A|FAHD2B|FAM136A|FAM161A|FAM178B|FAM228A|FAM228B|FAM98A|FANCL|FBXO11|FBXO41|FBXO48|FER1L5|FEZ2|FHL2|FIGLA|FKBP1B|FNDC4|FOSL2|FOXI3|FOXN2|FSHR|GALM|GALNT14|GAREM2|GCC2|GCFC2|GCKR|GDF7|GEMIN6|GEN1|GFPT1|GGCX|GKN1|GKN2|GMCL1|GNLY|GPAT2|GPATCH11|GPN1|GPR45|GPR75|GPR75-ASB3|GREB1|GTF2A1L|GTF3C2|HAAO|HADHA|HADHB|HEATR5B|HK2|HNRNPLL|HS1BP3|HTRA2|IFT172|IGKC|IL18R1|IL18RAP|IL1R1|IL1R2|IL1RL1|IL1RL2|IMMT|INO80B|INPP4A|ITPRIPL1|ITSN2|KANSL3|KCMF1|KCNG3|KCNIP3|KCNK12|KCNK3|KCNS3|KDM3A|KHK|KIF3C|KLHL29|KRCC1|KRTCAP3|LAPTM4A|LBH|LBX2|LCLAT1|LDAH|LGALSL|LHCGR|LIMS1|LIMS3|LIMS4|LINC00570|LINC01873|LINC02898|LIPT1|LMAN2L|LONRF2|LOXL3|LPIN1|LRATD1|LRPPRC|LRRTM1|LRRTM4|LTBP1|LYG1|LYG2|M1AP|MAL|MALL|MAP4K3|MAP4K4|MAPRE3|MAT2A|MATN3|MCEE|MCFD2|MDH1|MEIS1|MEMO1|MFSD2B|MFSD9|MGAT4A|MIR216A|MIR217|MITD1|MOB1A|MOGS|MORN2|MPHOSPH10|MPV17|MRPL19|MRPL30|MRPL33|MRPL35|MRPL53|MRPS5|MRPS9|MSGN1|MSH2|MSH2-OT1|MSH6|MTA3|MTHFD2|MTIF2|MXD1|MYCN|MYCNOS|NAGK|NAT8|NAT8B|NBAS|NCAPH|NCK2|NCOA1|NDUFAF7|NFU1|NLRC4|NMS|NOTO|NPAS2|NPHP1|NRBP1|NRXN1|NT5C1B|NT5C1B-RDH14|NTSR2|OSR1|OST4|OTOF|OTX1|OXER1|PAIP2B|PAPOLG|PCARE|PCBP1|PCGF1|PCYOX1|PDCL3|PELI1|PEX13|PFN4|PIGF|PKDCC|PLB1|PLEK|PLEKHH2|PLGLB1|PNO1|PNPT1|POLE4|POLR1A|POMC|POU3F3|PPM1B|PPM1G|PPP1CB|PPP1R21|PPP3R1|PPP4R3B|PRADC1|PREB|PREPL|PRKCE|PRKD3|PROKR1|PROM2|PRR30|PSME4|PTCD3|PTRHD1|PUM2|PUS10|QPCT|RAB10|RAB11FIP5|RAB1A|RAD51AP2|RANBP2|RASGRP3|RBKS|RDH14|REEP1|REG1A|REG1B|REG3A|REG3G|REL|RETSAT|REV1|RFX8|RGPD1|RGPD2|RGPD3|RGPD4|RGPD5|RGPD6|RHOB|RHOQ|RMDN2|RMND5A|RNF103|RNF103-CHMP3|RNF149|RNF181|RPIA|RPL31|RPS27A|RTKN|RTN4|SANBR|SDC1|SELENOI|SEMA4C|SEMA4F|SEPTIN10|SERTAD2|SF3B6|SFTPB|SFXN5|SH2D6|SIX2|SIX3|SLC1A4|SLC30A3|SLC30A6|SLC35F6|SLC3A1|SLC4A1AP|SLC4A5|SLC5A6|SLC5A7|SLC8A1|SLC9A2|SLC9A4|SMC6|SMYD1|SMYD5|SNRNP200|SNRNP27|SNRPG|SNX17|SOCS5|SOS1|SOS1-IT1|SOWAHC|SPAST|SPATA31H1|SPDYA|SPMIP9|SPR|SPRED2|SPTBN1|SRBD1|SRD5A2|SRSF7|ST3GAL5|ST6GAL2|STAMBP|STARD7|STON1|STON1-GTF2A1L|STPG4|STRN|SUCLG1|SULT1C2|SULT1C3|SULT1C4|SULT6B1|SUPT7L|TACR1|TBC1D8|TCF23|TCF7L1|TDRD15|TEKT4|TET3|TEX261|TGFA|TGFBRAP1|TGOLN2|THADA|THNSL2|THUMPD2|TIA1|TLX2|TMEM127|TMEM131|TMEM150A|TMEM17|TMEM178A|TMEM182|TMEM214|TMEM247|TMSB10|TOGARAM2|TP53I3|TPRKB|TRABD2A|TRIB2|TRIM43|TRIM43B|TRIM54|TRMT61B|TSGA10|TSPYL6|TTC27|TTC31|TTC32|TTC7A|TXNDC9|UBXN2A|UCN|UGP2|UNC50|USP34|USP39|UXS1|VAMP5|VAMP8|VAX2|VIT|VPS54|VRK2|VSNL1|VWA3B|WBP1|WDCP|WDPCP|WDR35|WDR43|WDR54|XDH|XPO1|YIPF4|YPEL5|ZAP70|ZFP36L2|ZNF2|ZNF512|ZNF513|ZNF514|ZNF638|AAK1|ABCG5|ABCG8|ABHD1		See cases	VCV001708190	2	11504318 - 111365996			1708190	1706487			copy number loss		Pathogenic		no assertion criteria provided							
GRCh37/hg19 2p25.3-q37.3(chr2:1-243199373)	ACMSD|ALLC|ARHGAP15|ARHGAP25|BOK|CASP8|CERKL|CERS6|CFAP210|COA5|CYBRD1|CYP1B1|DNAH6|DNAH7|EIF2AK3|FAM124B|FAM136A|FAM161A|FAM168B|FOXD4L1|FOXI3|FOXN2|FRZB|GPC1|HOXD11|HOXD12|HOXD13|IL36A|IL36B|KCNG3|LINC02898|LINC03124|MARCHF4|MARCHF7|MOGAT1|NAB1|NABP1|NOP58|NOSTRIN|NOTO|PDCD1|PDCL3|POLR1A|POLR1B|PSMD14|PSME4|REG3A|RPE|SFTPB|SFXN5|SGO2|SGPP2|SOCS5|STK36|STK39|STON1|THAP4|TRAPPC12|TRIB2|UGT1A10|UGT1A3|WDR43|WDR54|WDR75|WIPF1|XDH|XIRP2|XPO1|XRCC5|YIPF4|YPEL5|YWHAQ|UGT1A5|UGT1A6|WNT10A|WNT6|WDSUB1|UGT1A4|UGT1A9|UNC50|UNC80|TSN|TSPYL6|TTC21B|TTC27|TTC31|TTC32|TTC7A|TRIM54|TRIP12|UGT1A7|UGT1A8|UPP2|USP34|USP37|USP39|THNSL2|THSD7B|THUMPD2|TIA1|TIGD1|TLK1|TLX2|TM4SF20|TMBIM1|TMEFF2|TMEM177|TMEM178A|TMEM18|TMEM182|USP40|STRADB|STRN|SUCLG1|SULT1C2|SULT1C3|SULT1C4|SULT6B1|SUMO1|SUPT7L|TACR1|TRIM43|TRIM43B|STON1-GTF2A1L|STPG4|TRMT61B|TRPM8|TSGA10|SP110|SP140|SP140L|SPAG16|SPEG|SPHKAP|SPMIP9|SPR|SLC11A1|SLC16A14|SLC19A3|SLC23A3|SLC39A10|SLC3A1|SLC40A1|SLC1A4|SLC20A1|SH2D6|SH3BP4|SH3YL1|SIX2|SIX3|SP3|SP5|SP9|SPOPL|SPP2|RPIA|RPL31|RPL37A|RPRM|RPS27A|RSAD2|RTKN|RTN4|RTP5|RGPD1|RESP18|RETREG2|SANBR|RPS7|RRM2|RUFY4|SAG|REG3G|RGPD2|RGPD3|RGPD4|RGPD5|RGPD6|R3HDM1|RAB10|RAB11FIP5|RAB17|RAB1A|RAB3GAP1|PTMA|PTPN18|PTPN4|PTPRN|PTRHD1|REL|RETSAT|REV1|RFTN2|RFX8|PTCD3|PTH2R|POTEI|POTEJ|PPP1R1C|PPP1R21|PPP1R7|PPP3R1|POMC|POTEF|PUM2|PUS10|PXDN|PDE11A|PDK1|PECR|PELI1|PER2|PEX13|PFN4|PGAP1|PHOSPHO2|PID1|PIGF|PIKFYVE|PDE1A|PDE6D|PDIA6|QPCT|POLR2D|NPAS2|NPHP1|NT5DC4|NTSR2|NUP35|NXPH2|NYAP2|OBSL1|ODC1|OLA1|NCKAP5|NCL|NCOA1|NPPC|NT5C1B-RDH14|POTEE|NAGK|NAT8|NAT8B|NBAS|NBEAL1|MRPL53|MPHOSPH10|MPP4|MPV17|NCAPH|NDUFA10|NDUFAF7|NCK2|NCKAP1|MOGS|MORN2|MREG|METTL21A|METTL5|METTL8|MFF|MEIS1|MEMO1|MERTK|METAP1D|MROH2A|MRPL19|MRPL30|MRPL33|MRPL35|MRPL44|LONRF2|LRP1B|LRP2|LRPPRC|LRRTM4|LNPK|LOXL3|LPIN1|LRATD1|LRRFIP1|LRRTM1|LTBP1|LY75|MARCO|MARS2|MAT2A|MATN3|KCNH7|KCNK12|KCNK3|KCNS3|KCTD18|KDM3A|KHK|KIDINS220|KLHL30|KLHL41|KCNIP3|KCNJ13|KCNJ3|MDH1B|LIPT1|LMAN2L|IL36G|IL36RN|IL37|ILKAP|IMMT|IMP4|ING5|INHA|INHBB|HYCC2|IAH1|ICA1L|ID2|IDH1|IFIH1|HOXD3|ICOS|INO80B|INO80D|INPP1|INPP4A|GTF3C2|GTF3C3|GPR55|GPR75|GPR75-ASB3|GULP1|GRHL1|GTDC1|GTF2A1L|GRB14|GREB1|HOXD4|HOXD8|GDF7|HTR2B|HTRA2|GPD2|GPN1|FSIP2|FTCDNL1|FZD5|FZD7|G6PC2|GAD1|GAL3ST2|GALM|GALNT13|GALNT14|GALNT3|FSHR|FASTKD2|FAM98A|FANCL|FAP|FAM171B|FAM178B|FAM228A|FAM228B|FARP2|FARSB|FASTKD1|ELMOD3|EMILIN1|EML4|EPB41L5|EIF2B4|EIF4E2|EIF5B|EIPR1|EML6|EMX1|EN1|EPAS1|EPC2|DUSP11|DUSP19|DNAJB2|DNAJC10|DNAJC27|DNAJB3|DNAJC5G|DNER|DPY30|DPYSL5|DQX1|DRC1|DTNB|DTYMK|CYP20A1|CYP26B1|D2HGDH|DARS1|DAW1|CYRIA|CYS1|CYTIP|DAPL1|CYP27A1|CYP27C1|COLEC11|COMMD1|COPS7B|COPS8|COQ10B|COX5B|COPS9|COX7A2L|CPO|CPS1|CPSF3|CRACDL|COBLL1|CHRND|CHRNG|CHST10|CIMIP2C|CIMIP5|CIAO1|CIB4|CHMP3|CHN1|CFAP36|CFAP65|CHPF|CHRNA1|CCDC138|CCDC140|CCDC85A|CCDC88A|CCDC93|CCL20|CCNT2|CCDC141|CCDC142|CCDC148|CCDC150|CCDC74A|CCDC74B|CATIP|CAVIN2|CCDC115|CCDC121|C2orf66|C2orf68|C2orf69|C2orf72|C2orf74|BUB1|BZW1|C1D|BOLA3|BOLL|C1QL2|C2CD6|C2orf15|C2orf42|C2orf48|C2orf49|ASNSD1|ASPRV1|ATIC|ASTL|ARHGEF33|ARPC2|ASAP2|ASB1|ASB18|ASB3|ASIC4|ALPG|ALPI|ALMS1|ALPP|ALS2|AMER3|AMMECR1L|ANAPC1|ANKAR|ACTR1B|ACOXL|ACTR2|ACTR3|ACP1|ACVR1|ACSL3|ACTG2|ACVR1C|AAK1|AAMP|ABCA12|ABCB11|ABCB6|ABCG5|ABCG8|ABHD1|ABI2|ACADL|ACKR3|ACVR2A|ACYP2|ADAM17|ADAM23|ADCY3|ADD2|ADGRF3|ADI1|ADRA2B|AFF3|AFTPH|AGAP1|AGBL5|AGFG1|AGPS|AGXT|ALK|ALKAL2|ANKMY1|ANKRD23|ANKRD36|ANKRD36B|ANKRD36C|ANKRD39|ANKRD44|ANKRD53|ANKZF1|ANO7|ANTXR1|ANXA4|AOX1|AP1S3|APLF|APOB|AQP12A|AQP12B|ARHGEF4|ARID5A|ARL4C|ARL5A|ARL6IP6|ARMC9|ASXL2|ATAD2B|ATF2|ATG16L1|ATG4B|ATG9A|ATL2|ATOH8|ATP5MC3|ATP6V1B1|ATP6V1C2|ATP6V1E2|ATRAID|AUP1|B3GALT1|B3GNT2|B3GNT7|BABAM2|BARD1|BAZ2B|BBS5|BCL11A|BCL2L11|BCS1L|BCYRN1|BIN1|BIRC6|BMP10|BMPR2|C2orf76|C2orf78|C2orf80|C2orf81|C2orf83|C2orf88|CAB39|CACNB4|CAD|CALCRL|CALM2|CAMKMT|CAPG|CAPN10|CAPN13|CAPN14|CARF|CASP10|CCNYL1|CCT4|CCT7|CD207|CD28|CD302|CD8A|CD8B|CDC42EP3|CDCA7|CDK15|CDK5R2|CDKL4|CDRT15P3|CEBPZ|CENPA|CENPO|CEP68|CFC1|CFC1B|CFLAR|CGREF1|CHAC2|CHCHD5|CIMIP6|CIR1|CKAP2L|CLASP1|CLEC4F|CLHC1|CLIP4|CLK1|CMKLR2|CMPK2|CNGA3|CNNM3|CNNM4|CNOT11|CNOT9|CNPPD1|CNRIP1|CNTNAP5|COL3A1|COL4A3|COL4A4|COL5A2|COL6A3|CREB1|CREG2|CRIM1|CRIPT|CRYBA2|CRYGA|CRYGB|CRYGC|CRYGD|CSRNP3|CTDSP1|CTLA4|CTNNA2|CUL3|CWC22|CXCR1|CXCR2|CXCR4|DBI|DCAF17|DCDC2C|DCTN1|DDX1|DDX18|DES|DGKD|DGUOK|DHRS9|DHX57|DIRC1|DIRC3|DIS3L2|DLX1|DLX2|DNAAF10|DNMT3A|DNPEP|DOCK10|DOK1|DPP10|DPP4|DUSP2|DUSP28|DYNC1I2|DYNC2LI1|DYSF|DYTN|E2F6|ECEL1|ECRG4|EDAR|EEF1B2|EFEMP1|EFHD1|EFR3B|EGR4|EHBP1|EHD3|EIF2AK2|EPCAM|EPHA4|ERBB4|ERCC3|ERFE|ERICH2|ERLEC1|ERMN|ESPNL|ETAA1|EVA1A|EVX2|EXOC6B|FABP1|FAHD2A|FAHD2B|FAM110C|FAM117B|FBLN7|FBXO11|FBXO36|FBXO41|FBXO48|FER1L5|FEV|FEZ2|FHL2|FIGLA|FIGN|FKBP1B|FKBP7|FLACC1|FMNL2|FN1|FNDC4|FOSL2|GALNT5|GAREM2|GBX2|GCA|GCC2|GCKR|GCFC2|GCG|GEMIN6|GEN1|GFPT1|GGCX|GIGYF2|GKN1|GKN2|GLB1L|GLI2|GLS|GMCL1|GMPPA|GNLY|GORASP2|GPAT2|GPATCH11|GPBAR1|GPR148|GPR155|GPR17|GPR35|GPR39|GPR45|GYPC|HAAO|HADHA|HADHB|HAT1|HDAC4|HDLBP|HEATR5B|HECW2|HES6|HIBCH|HJURP|HK2|HNMT|HNRNPA3|HNRNPLL|HOXD1|HOXD10|HOXD9|HPCAL1|HS1BP3|HS6ST1|HSPD1|HSPE1|IFT172|IFT70A|IFT70B|IGFBP2|IGFBP5|IGKC|IHH|IKZF2|IL18R1|IL18RAP|IL1A|IL1B|IL1F10|IL1R1|IL1R2|IL1RL1|IL1RL2|IL1RN|INSIG2|IQCA1|IRS1|ITGA4|ITGA6|ITGAV|ITGB1BP1|ITGB6|ITM2C|ITPRID2|ITPRIPL1|ITSN2|IWS1|KANSL1L|KANSL3|KCMF1|KCNE4|KCNF1|KIF1A|KIF3C|KLF11|KLF7|KLHL23|KLHL29|KRCC1|KRTCAP3|KYNU|LANCL1|LAPTM4A|LBH|LBX2|LCLAT1|LCT|LDAH|LGALSL|LHCGR|LIMS1|LIMS2|LIMS3|LIMS4|LINC00570|LINC01873|LY75-CD302|LYG1|LYG2|LYPD1|LYPD6|LYPD6B|M1AP|MAB21L4|MAIP1|MAL|MALL|MAP2|MAP3K19|MAP3K2|MAP3K20|MAP4K3|MAP4K4|MAPRE3|MBD5|MBOAT2|MCEE|MCFD2|MCM6|MDH1|MFSD2B|MFSD6|MFSD9|MGAT4A|MGAT5|MIR10B|MIR1258|MIR128-1|MIR149|MIR216A|MIR217|MIR26B|MIR375|MITD1|MLPH|MMADHC|MOB1A|MOB4|MRPS5|MRPS9|MSGN1|MSH2|MSH2-OT1|MSH6|MSTN|MTA3|MTERF4|MTHFD2|MTIF2|MTX2|MXD1|MYCN|MYCNOS|MYL1|MYO1B|MYO3B|MYO7B|MYT1L|MZT2A|MZT2B|NDUFB3|NDUFS1|NEB|NEMP2|NEU2|NEU4|NEUROD1|NFE2L2|NFU1|NGEF|NHEJ1|NIF3L1|NIFK|NLRC4|NMI|NMS|NMUR1|NOL10|NR4A2|NRBP1|NRP2|NRXN1|NT5C1B|OR6B2|OR6B3|ORC2|ORC4|ORMDL1|OSBPL6|OSGEPL1|OSR1|OST4|OTOF|OTOS|OTX1|OXER1|PAIP2B|PAPOLG|PARD3B|PASK|PAX3|PAX8|PCARE|PCBP1|PCGEM1|PCGF1|PCYOX1|PJVK|PKDCC|PKP4|PLA2R1|PLB1|PLCD4|PLCL1|PLEK|PLEKHA3|PLEKHB2|PLEKHH2|PLEKHM3|PLGLB1|PMS1|PNKD|PNO1|PNPT1|POLE4|POU3F3|PPIG|PPIL3|PPM1B|PPM1G|PPP1CB|PPP4R3B|PRADC1|PREB|PREPL|PRKAG3|PRKCE|PRKD3|PRKRA|PRLH|PROC|PROKR1|PROM2|PRPF40A|PRR21|PRR30|PRSS56|PSD4|PSMD1|RAB6C|RABL2A|RAD51AP2|RALB|RAMP1|RANBP2|RAPGEF4|RAPH1|RASGRP3|RBKS|RBM43|RBM44|RBM45|RBMS1|RDH14|REEP1|REG1A|REG1B|RGPD8|RHBDD1|RHOB|RHOQ|RIF1|RMDN2|RMND5A|RNASEH1|RND3|RNF103|RNF103-CHMP3|RNF144A|RNF149|RNF181|RNF25|RNPEPL1|RNU4ATAC|ROCK2|SAP130|SATB2|SCG2|SCLY|SCN1A|SCN2A|SCN3A|SCN7A|SCN9A|SCRN3|SCTR|SDC1|SELENOI|SEMA4C|SEMA4F|SEPTIN10|SEPTIN2|SERPINE2|SERTAD2|SESTD1|SF3B1|SF3B6|SFT2D3|SLC25A12|SLC30A3|SLC30A6|SLC35F5|SLC35F6|SLC38A11|SLC4A10|SLC4A1AP|SLC4A3|SLC4A5|SLC5A6|SLC5A7|SLC66A3|SLC8A1|SLC9A2|SLC9A4|SMARCAL1|SMC6|SMPD4|SMYD1|SMYD5|SNED1|SNORC|SNORD20|SNORD82|SNRNP200|SNRNP27|SNRPG|SNTG2|SNX17|SOS1|SOS1-IT1|SOWAHC|SOX11|SP100|SPAST|SPATA3|SPATA31H1|SPATS2L|SPC25|SPDYA|SPRED2|SPTBN1|SRBD1|SRD5A2|SRSF7|SSB|ST3GAL5|ST6GAL2|STAM2|STAMBP|STARD7|STAT1|STAT4|STEAP3|STK11IP|STK16|STK17B|STK25|TAF1B|TANC1|TANK|TBC1D8|TBR1|TCF23|TCF7L1|TDRD15|TEKT4|TET3|TEX261|TEX44|TFCP2L1|TFPI|TGFA|TGFBRAP1|TGOLN2|THADA|TMEM127|TMEM131|TMEM150A|TMEM163|TMEM169|TMEM17|TMEM185B|TMEM198|TMEM214|TMEM237|TMEM247|TMEM37|TMEM87B|TMSB10|TNFAIP6|TNP1|TNS1|TOGARAM2|TP53I3|TPO|TPRKB|TRABD2A|TRAF3IP1|TRAK2|TTL|TTLL4|TTN|TUBA3D|TUBA3E|TUBA4A|TWIST2|TXNDC9|TYW5|UBE2E3|UBE2F|UBR3|UBXN2A|UBXN4|UCN|UGGT1|UGP2|UGT1A1|UXS1|VAMP5|VAMP8|VAX2|VIL1|VIT|VPS54|VRK2|VSNL1|VWA3B|VWC2L|WBP1|WDCP|WDFY1|WDPCP|WDR12|WDR33|WDR35|ZAP70|ZC3H15|ZC3H6|ZC3H8|ZDBF2|ZNF512|ZEB2|ZFAND2B|ZFP36L2|ZNF142|ZNF2|ZNF385B|ZNF513|ZNF514|ZNF638|ZNF804A|ZNF806|ZNG1B|ZRANB3|ZSWIM2		Mosaic trisomy 2	VCV001703543	2	1 - 243199373			1703543	1695934			copy number gain		Pathogenic		no assertion criteria provided							
GRCh37/hg19 2p23.2-21(chr2:29899368-42441440)	ALK|ARHGEF33|ATL2|BIRC6|CAPN13|CAPN14|CDC42EP3|CDKL4|CEBPZ|CRIM1|CYP1B1|DHX57|DPY30|EHD3|EIF2AK2|EML4|FAM98A|FEZ2|GALM|GALNT14|GEMIN6|GPATCH11|HEATR5B|HNRNPLL|LBH|LCLAT1|LINC02898|LTBP1|MAP4K3|MEMO1|MORN2|NDUFAF7|NLRC4|PKDCC|PRKD3|QPCT|RASGRP3|RMDN2|SLC30A6|SLC8A1|SOS1|SOS1-IT1|SPAST|SRD5A2|SRSF7|STRN|SULT6B1|THUMPD2|TMEM178A|TTC27|VIT|XDH|YIPF4|YPEL5		not specified	VCV001527803	2	29899368 - 42441440			1527803	1519292			copy number loss		Pathogenic	Mar 1, 2022	criteria provided, single submitter							
NC_000002.11:g.(?_29430027)_(29754992_?)dup	ALK		Neuroblastoma, susceptibility to, 3	VCV001450333	2	29430027 - 29754992			1450333	1436213			Duplication		Uncertain significance	Sep 4, 2021	criteria provided, single submitter							
NC_000002.11:g.(?_29416090)_(29430148_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV001443818	2	29416090 - 29430148			1443818	1487817			Deletion		Uncertain significance	Nov 7, 2023	criteria provided, single submitter							
NC_000002.11:g.(?_29416090)_(29416798_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV001440175	2	29416090 - 29416798			1440175	1368625			Deletion		Uncertain significance	Sep 3, 2023	criteria provided, single submitter							
NC_000002.11:g.(?_29519744)_(29519933_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV001421928	2	29519744 - 29519933			1421928	1337542			Deletion		Uncertain significance	Sep 10, 2021	criteria provided, single submitter							
NC_000002.11:g.(?_29416090)_(29606735_?)dup	ALK		Neuroblastoma, susceptibility to, 3	VCV001411127	2	29416090 - 29606735			1411127	1343517			Duplication		Uncertain significance	Nov 3, 2023	criteria provided, single submitter							
NC_000002.11:g.(?_29416090)_(29474143_?)dup	ALK		Neuroblastoma, susceptibility to, 3	VCV001411124	2	29416090 - 29474143			1411124	1343514			Duplication		Uncertain significance	Dec 31, 2022	criteria provided, single submitter							
NC_000002.11:g.(?_29443562)_(29448441_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV001411121	2	29443562 - 29448441			1411121	1343511			Deletion		Uncertain significance	Jun 18, 2021	criteria provided, single submitter							
NC_000002.11:g.(?_29497955)_(29606735_?)dup	ALK		Neuroblastoma, susceptibility to, 3	VCV001374784	2	29497955 - 29606735			1374784	1466071			Duplication		Uncertain significance	May 4, 2022	criteria provided, single submitter							
NC_000002.11:g.(?_29541160)_(29551357_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV001374778	2	29541160 - 29551357			1374778	1466065			Deletion		Uncertain significance	Mar 17, 2023	criteria provided, single submitter							
GRCh37/hg19 2p23.3-21(chr2:24601818-43466284)x3	OTOF|OXER1|THADA|THUMPD2|TMEM178A|TMEM214|TRMT61B|TTC27|UCN|VIT|WDR43|XDH|YIPF4|YPEL5|ZFP36L2|ZNF512|ZNF513|TOGARAM2|TRIM54|PCARE|PKDCC|GTF3C2|HAAO|HADHA|HADHB|PRR30|PTRHD1|PPP1CB|PREB|QPCT|RBKS|RMDN2|RAB10|RASGRP3|PLB1|POMC|PPM1G|PRKD3|GPN1|HEATR5B|HNRNPLL|IFT172|KCNG3|KCNK3|KHK|KIF3C|KRTCAP3|LBH|LCLAT1|LINC02898|LTBP1|MAP4K3|MAPRE3|MEMO1|MORN2|MPV17|MRPL33|MTA3|NCOA1|NDUFAF7|NLRC4|NRBP1|OST4|SELENOI|SLC30A3|SLC30A6|SLC35F6|SLC4A1AP|SLC5A6|SLC8A1|SNX17|SOS1|SOS1-IT1|SPAST|SPDYA|SRD5A2|SRSF7|STRN|SULT6B1|SUPT7L|TCF23|ABHD1|ADCY3|ADGRF3|AGBL5|ALK|ARHGEF33|ASXL2|ATL2|ATRAID|BABAM2|BIRC6|C2orf16|CAD|CAPN13|CAPN14|CCDC121|CDC42EP3|CDKL4|CEBPZ|CENPA|CENPO|CGREF1|CIB4|CLIP4|COX7A2L|CRIM1|CYP1B1|DHX57|DNAJC27|DNAJC5G|DNMT3A|DPY30|DPYSL5|DRC1|DTNB|EFR3B|EHD3|EIF2AK2|EIF2B4|EMILIN1|EML4|FAM166C|FAM98A|FEZ2|FNDC4|FOSL2|GALM|GALNT14|GAREM2|GCKR|GEMIN6|GPATCH11		See cases	VCV001220534	2	24601818 - 43466284			1220534	1210510			copy number gain		Pathogenic	Feb 23, 2021	no assertion criteria provided							
GRCh37/hg19 2p23.3-21(chr2:24881528-43460021)x3	COX7A2L|GEMIN6|GPATCH11|MAP4K3|PRKD3|PRR30|SRD5A2|SRSF7|UCN|VIT|WDR43|XDH|YIPF4|YPEL5|ZFP36L2|ZNF512|ZNF513|PTRHD1|SLC5A6|SLC8A1|QPCT|RAB10|RASGRP3|RBKS|RMDN2|SELENOI|SLC30A3|SLC30A6|SLC35F6|SLC4A1AP|STRN|SULT6B1|SUPT7L|TCF23|THADA|THUMPD2|MAPRE3|MRPL33|MTA3|MORN2|MPV17|HNRNPLL|IFT172|KCNG3|KCNK3|KHK|NCOA1|NDUFAF7|NLRC4|NRBP1|OST4|OTOF|OXER1|PCARE|CRIM1|CYP1B1|EHD3|EIF2AK2|EMILIN1|EML4|FAM98A|DTNB|DPYSL5|DRC1|EIF2B4|FEZ2|EFR3B|MEMO1|GPN1|GTF3C2|HAAO|HADHA|CAPN13|CAPN14|AGBL5|CAD|CCDC121|CDC42EP3|CDKL4|CEBPZ|BABAM2|BIRC6|HADHB|HEATR5B|ABHD1|ADCY3|ADGRF3|ALK|ARHGEF33|ASXL2|ATL2|ATRAID|CENPA|CENPO|CGREF1|CIB4|CIMIP2C|CLIP4|DHX57|DNAJC27|DNAJC5G|DNMT3A|DPY30|FNDC4|FOSL2|GALM|GALNT14|GAREM2|GCKR|KIF3C|KRTCAP3|LBH|LCLAT1|LINC02898|LTBP1|PKDCC|PLB1|POMC|PPM1G|PPP1CB|PREB|SNX17|SOS1|SOS1-IT1|SPAST|SPATA31H1|SPDYA|TMEM178A|TMEM214|TOGARAM2|TRIM54|TRMT61B|TTC27		not provided	VCV001176757	2	24881528 - 43460021			1176757	1165225			copy number gain		Likely pathogenic	Apr 1, 2021	criteria provided, single submitter							
NC_000002.11:g.(?_29119585)_(29450548_?)dup	ALK|CLIP4|PCARE|TOGARAM2|WDR43		Neuroblastoma, susceptibility to, 3	VCV001054327	2	29119585 - 29450548			1054327	1039036			Duplication		Uncertain significance	May 27, 2020	criteria provided, single submitter							
NC_000002.11:g.(?_29119585)_(30143525_?)dup	TOGARAM2|ALK|CLIP4|PCARE|WDR43		Neuroblastoma, susceptibility to, 3	VCV001054326	2	29119585 - 30143525			1054326	1039037			Duplication		Uncertain significance	Sep 20, 2020	criteria provided, single submitter							
NC_000002.11:g.(?_30142849)_(30143525_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV001054325	2	30142849 - 30143525			1054325	1039038			Deletion		Uncertain significance	Oct 4, 2022	criteria provided, single submitter							
NC_000002.11:g.(?_29917706)_(29940573_?)dup	ALK		Neuroblastoma, susceptibility to, 3	VCV001007540	2	29917706 - 29940573			1007540	986210			Duplication		Uncertain significance	Apr 20, 2020	criteria provided, single submitter							
GRCh37/hg19 2p23.2(chr2:29363817-29675766)x1	ALK|CLIP4		not provided	VCV000979976	2	29363817 - 29675766			979976	968054			copy number loss		Uncertain significance	May 15, 2020	no assertion criteria provided							
NC_000002.12:g.(?_29717568)_(29717707_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV000833397	2	29940434 - 29940573			833397	819154			Deletion		Uncertain significance	Mar 3, 2022	criteria provided, single submitter							
NC_000002.12:g.(?_29919983)_(29920659_?)dup	ALK		Neuroblastoma, susceptibility to, 3	VCV000833375	2	30142849 - 30143525			833375	819155			Duplication		Uncertain significance	Jun 9, 2022	criteria provided, single submitter							
NC_000002.12:g.(?_29222334)_(29275506_?)del	ALK		Neuroblastoma, susceptibility to, 3	VCV000832739	2	29445200 - 29498372			832739	819153			Deletion		Uncertain significance	Nov 27, 2019	criteria provided, single submitter							
NC_000002.12:g.(?_29193224)_(29193932_?)dup	ALK		Neuroblastoma, susceptibility to, 3	VCV000831438	2	29416090 - 29416798			831438	819152			Duplication		Uncertain significance	Nov 15, 2022	criteria provided, single submitter							
NC_000002.12:g.(?_29193218)_(29239836_?)dup	ALK		Neuroblastoma, susceptibility to, 3	VCV000831071	2	29416084 - 29462702			831071	819151			Duplication		Uncertain significance	Sep 29, 2021	criteria provided, single submitter							
GRCh37/hg19 2p23.2(chr2:29428149-29486280)x1	ALK		not provided	VCV000814227	2	29428149 - 29486280			814227	802440			copy number loss		Uncertain significance	Apr 3, 2019	no assertion criteria provided							
GRCh37/hg19 2p23.2(chr2:28387514-29616031)x3	CLIP4|FOSL2|PCARE|SPDYA|TRMT61B|ALK|PLB1|TOGARAM2|WDR43|BABAM2|PPP1CB		not provided	VCV000814226	2	28387514 - 29616031			814226	802439			copy number gain		Uncertain significance	Jun 15, 2018	no assertion criteria provided							
GRCh37/hg19 2p23.2-22.2(chr2:29940473-36813297)x1	ALK|BIRC6|CAPN13|CAPN14|CRIM1|DPY30|EHD3|FAM98A|FEZ2|GALNT14|LBH|LCLAT1|LTBP1|MEMO1|NLRC4|RASGRP3|SLC30A6|SPAST|SRD5A2|TTC27|XDH|YIPF4|YPEL5		not provided	VCV000687302	2	29940473 - 36813297			687302	674894			copy number loss		Pathogenic	Aug 16, 2017	no assertion criteria provided							
GRCh37/hg19 2p23.2-22.3(chr2:29240004-32380876)x1	SPAST|ALK|MEMO1|EHD3|LBH|CAPN13|DPY30|YPEL5|GALNT14|CLIP4|SRD5A2|LCLAT1|TOGARAM2|CAPN14|PCARE|XDH		not provided	VCV000562660	2	29240004 - 32380876			562660	553844			copy number loss		Pathogenic	Aug 28, 2017	no assertion criteria provided							
GRCh37/hg19 2p23.2(chr2:29156446-29716164)x4	PCARE|ALK|CLIP4|WDR43|TOGARAM2		not provided	VCV000562596	2	29156446 - 29716164			562596	553780			copy number gain		Likely benign	May 18, 2018	no assertion criteria provided							
inv(2)(p21p23.2)	RASGRP3|HNRNPLL|SOS1-IT1|BIRC6|THUMPD2|GEMIN6|LCLAT1|ATL2|HEATR5B|CRIM1|CDC42EP3|LBH|LTBP1|MEMO1|SPAST|STRN|TMEM178A|ALK|CAPN14|VIT|GALNT14|GPATCH11|FEZ2|QPCT|PRKD3|TTC27|SLC30A6|LINC02898|MORN2|XDH|SOS1|CDKL4|YIPF4|SRSF7|MAP4K3|GALM|EML4|SULT6B1|EIF2AK2|FAM98A|EHD3|RMDN2|CEBPZ|PKDCC|NLRC4|YPEL5|SLC8A1|ARHGEF33|DPY30|CAPN13|NDUFAF7|SRD5A2|DHX57|CYP1B1		Endometrial carcinoma	VCV000547174	2	29447680 - 42554394			547174	537660			Inversion		Likely pathogenic	May 7, 2018	no assertion criteria provided							
t(2;2)(p23;p21)(hg19 chr2:g.42552694::ochr2:g.29446394)	ALK|ARHGEF33|ATL2|BIRC6|CAPN13|CAPN14|CDC42EP3|CDKL4|CEBPZ|CRIM1|CYP1B1|DHX57|DPY30|EHD3|EIF2AK2|EML4|FAM98A|FEZ2|GALM|GALNT14|GEMIN6|GPATCH11|HEATR5B|HNRNPLL|LBH|LCLAT1|LINC02898|LTBP1|MAP4K3|MEMO1|MORN2|NDUFAF7|NLRC4|PKDCC|PRKD3|QPCT|RASGRP3|RMDN2|SLC30A6|SLC8A1|SOS1|SOS1-IT1|SPAST|SRD5A2|SRSF7|STRN|SULT6B1|THUMPD2|TMEM178A|TTC27|VIT|XDH|YIPF4|YPEL5		Small cell lung carcinoma	VCV000487484	2	29446394 - 42552694			487484	480540			Inversion		Pathogenic		no assertion criteria provided							
GRCh37/hg19 2p25.3-q37.3(chr2:12771-242783384)	CCDC85A|CCDC88A|CDC42EP3|CDCA7|CDK15|CFAP210|CFAP36|CFAP65|CIMIP5|CIMIP6|CNOT9|CNPPD1|COPS8|COPS9|CRYBA2|DAPL1|DARS1|DNAJC10|DRC1|DTNB|DTYMK|DYSF|DYTN|E2F6|ECEL1|EIF2B4|EIF4E2|EPAS1|EPB41L5|FAM124B|FAM136A|FAP|FARP2|FBXO48|FER1L5|FEZ2|FHL2|FIGLA|FIGN|FKBP1B|FKBP7|FLACC1|FMNL2|FN1|FNDC4|FSIP2|FTCDNL1|FZD5|FZD7|G6PC2|FARSB|FASTKD1|FASTKD2|FAM178B|FAM98A|FBLN7|FBXO11|FBXO36|FANCL|FBXO41|EPC2|FEV|EPCAM|EML4|EML6|EMX1|EN1|EPHA4|ESPNL|ETAA1|EVA1A|FAM117B|FAM161A|FAM168B|EFHD1|EFR3B|EGR4|EHBP1|EHD3|EIF2AK2|EIF2AK3|FAM228A|FAM228B|EIF5B|ELMOD3|EMILIN1|FAM171B|DUSP11|DUSP19|DYNC1I2|DYNC2LI1|DPYSL5|DQX1|DUSP2|DUSP28|EIPR1|ECRG4|EDAR|EEF1B2|EFEMP1|DBI|DCAF17|DCDC2C|DCTN1|DDX1|DDX18|DES|DGKD|DGUOK|DHRS9|DNAJC27|DNAJC5G|DNER|DNMT3A|DOCK10|DOK1|DNPEP|CRYGA|CRYGB|CYP27C1|D2HGDH|CREB1|CREG2|CRIM1|CRIPT|CYP1B1|CYP20A1|CYP26B1|CYP27A1|CYRIA|CYS1|CYTIP|DPP10|DPP4|DPY30|CNRIP1|COL5A2|COL6A3|COL4A4|COLEC11|COMMD1|COPS7B|DAW1|COQ10B|CPO|CPS1|COX5B|COX7A2L|CIR1|CKAP2L|CNNM3|CHN1|CHPF|CHRNA1|CHRND|CHRNG|CHST10|CIAO1|CIB4|CIMIP2C|CNOT11|CPSF3|CRACDL|CMPK2|CNGA3|CDK5R2|CDKL4|CENPA|CENPO|CERKL|CERS6|GLI2|GLS|GMCL1|CDRT15P3|CD302|CEBPZ|CEP68|CNNM4|CHMP3|CCDC93|CCL20|CCDC142|CCDC148|CCDC150|CCDC74A|CCDC74B|CD8A|CD8B|CCNT2|CCNYL1|CCT4|CCT7|CD207|CD28|CFC1|CFC1B|CFLAR|CGREF1|CHAC2|CHCHD5|CLASP1|CLEC4F|CLHC1|CLIP4|CLK1|CMKLR2|CNTNAP5|COA5|COBLL1|COL3A1|COL4A3|CRYGC|CRYGD|CSRNP3|CTDSP1|CTLA4|CTNNA2|CUL3|CWC22|CXCR1|CXCR2|CXCR4|CYBRD1|DHX57|DIRC1|DIRC3|DIS3L2|DLX1|DLX2|DNAAF10|DNAH6|DNAH7|DNAJB2|DNAJB3|ERBB4|ERCC3|ERFE|ERICH2|ERLEC1|ERMN|EVX2|EXOC6B|FABP1|FAHD2A|FAHD2B|FAM110C|FOSL2|FOXD4L1|FOXI3|FOXN2|FRZB|FSHR|GAD1|GAL3ST2|GALM|GALNT13|GALNT14|GALNT3|GALNT5|GAREM2|GBX2|GCA|GCC2|GCFC2|GCG|GCKR|GDF7|GEMIN6|GEN1|GFPT1|GGCX|GIGYF2|GKN1|GKN2|GLB1L|GMPPA|GNLY|GORASP2|GPAT2|GPATCH11|GPBAR1|GPC1|GPD2|GPN1|GPR148|GPR155|GPR17|GPR35|GPR39|GPR45|GPR55|GPR75|GPR75-ASB3|GRB14|GREB1|GRHL1|GTDC1|GTF2A1L|GTF3C2|GTF3C3|GULP1|GYPC|HAAO|HADHA|HADHB|HAT1|HDAC4|HDLBP|HEATR5B|HECW2|HES6|HIBCH|HJURP|HK2|HNMT|HNRNPA3|HNRNPLL|HOXD1|HOXD10|HOXD11|HOXD12|HOXD13|HOXD3|HOXD4|HOXD8|HOXD9|HPCAL1|HS1BP3|HS6ST1|HSPD1|HSPE1|HTR2B|HTRA2|HYCC2|IAH1|ICA1L|ICOS|ID2|IDH1|IFIH1|IFT172|IFT70A|IFT70B|IGFBP2|IGFBP5|IGKC|IHH|IKZF2|IL18R1|IL18RAP|IL1A|IL1B|IL1F10|IL1R1|IL1R2|IL1RL1|IL1RL2|IL1RN|IL36A|IL36B|IL36G|IL36RN|IL37|ILKAP|IMMT|IMP4|ING5|INHA|INHBB|INO80B|INO80D|INPP1|INPP4A|INSIG2|IQCA1|IRS1|ITGA4|ITGA6|ITGAV|ITGB1BP1|ITGB6|ITM2C|ITPRID2|ITPRIPL1|ITSN2|IWS1|KANSL1L|KANSL3|KCMF1|KCNE4|KCNF1|KCNG3|KCNH7|KCNIP3|KCNJ13|KCNJ3|KCNK12|KCNK3|KCNS3|KCTD18|KDM3A|KHK|KIDINS220|KIF1A|KIF3C|KLF11|KLF7|KLHL23|KLHL29|KLHL30|KLHL41|KRCC1|KRTCAP3|KYNU|LANCL1|LAPTM4A|LBH|LBX2|LCLAT1|LCT|LDAH|LGALSL|LHCGR|LIMS1|LIMS2|LIMS3|LIMS4|LINC00570|LINC01873|LINC02898|LINC03124|LIPT1|LMAN2L|LNPK|LONRF2|LOXL3|LPIN1|LRATD1|LRP1B|LRP2|LRPPRC|LRRFIP1|LRRTM1|LRRTM4|LTBP1|LY75|LY75-CD302|LYG1|LYG2|LYPD1|LYPD6|LYPD6B|M1AP|MAB21L4|MAIP1|MAL|MALL|MAP2|MAP3K19|MAP3K2|MAP3K20|MAP4K3|MAP4K4|MAPRE3|MARCHF4|MARCHF7|MARCO|MARS2|MAT2A|MATN3|MBD5|MBOAT2|MCEE|MCFD2|MCM6|MDH1|MDH1B|MEIS1|MEMO1|MERTK|METAP1D|METTL21A|METTL5|METTL8|MFF|MFSD2B|MFSD6|MFSD9|MGAT4A|MGAT5|MIR10B|MIR1258|MIR128-1|MIR149|MIR216A|MIR217|MIR26B|MIR375|MITD1|MLPH|MMADHC|MOB1A|MOB4|MOGAT1|MOGS|MORN2|MPHOSPH10|MPP4|MPV17|MREG|MROH2A|MRPL19|MRPL30|MRPL33|MRPL35|MRPL44|MRPL53|MRPS5|MRPS9|MSGN1|MSH2|MSH2-OT1|MSH6|MSTN|MTA3|MTERF4|MTHFD2|MTIF2|MTX2|MXD1|MYCN|MYCNOS|MYL1|MYO1B|MYO3B|MYO7B|MYT1L|MZT2A|MZT2B|NAB1|NABP1|NAGK|NAT8|NAT8B|NBAS|NBEAL1|NCAPH|NCK2|NCKAP1|NCKAP5|NCL|NCOA1|NDUFA10|NDUFAF7|NDUFB3|NDUFS1|NEB|NEMP2|NEU2|NEU4|NEUROD1|NFE2L2|NFU1|NGEF|NHEJ1|NIF3L1|NIFK|NLRC4|NMI|NMS|NMUR1|NOL10|NOP58|NOSTRIN|NOTO|NPAS2|NPHP1|NPPC|NR4A2|NRBP1|NRP2|NRXN1|NT5C1B|NT5C1B-RDH14|NT5DC4|NTSR2|NUP35|NXPH2|NYAP2|OBSL1|ODC1|OLA1|OR6B2|OR6B3|ORC2|ORC4|ORMDL1|OSBPL6|OSGEPL1|OSR1|OST4|OTOF|OTOS|OTX1|OXER1|PAIP2B|PAPOLG|PARD3B|PASK|PAX3|PAX8|PCARE|PCBP1|PCGEM1|PCGF1|PCYOX1|PDCL3|PDE11A|PDE1A|PDE6D|PDIA6|PDK1|PECR|PELI1|PER2|PEX13|PFN4|PGAP1|PHOSPHO2|PID1|PIGF|PIKFYVE|PJVK|PKDCC|PKP4|PLA2R1|PLB1|PLCD4|PLCL1|PLEK|PLEKHA3|PLEKHB2|PLEKHH2|PLEKHM3|PLGLB1|PMS1|PNKD|PNO1|PNPT1|POLE4|POLR1A|POLR1B|POLR2D|POMC|POTEE|POTEF|POTEI|POTEJ|POU3F3|PPIG|PPIL3|PPM1B|PPM1G|PPP1CB|PPP1R1C|PPP1R21|PPP1R7|PPP3R1|PPP4R3B|PRADC1|PREB|PREPL|PRKAG3|PRKCE|PRKD3|PRKRA|PRLH|PROC|PROKR1|PROM2|PRPF40A|PRR21|PRR30|PRSS56|PSD4|PSMD1|PSMD14|PSME4|PTCD3|PTH2R|PTMA|PTPN18|PTPN4|PTPRN|PTRHD1|PUM2|PUS10|PXDN|QPCT|R3HDM1|RAB10|RAB11FIP5|RAB17|RAB1A|RAB3GAP1|RAB6C|RABL2A|RAD51AP2|RALB|RAMP1|RANBP2|RAPGEF4|RAPH1|RASGRP3|RBKS|RBM43|RBM44|RBM45|RBMS1|RDH14|REEP1|REG1A|REG1B|REG3A|REG3G|REL|RESP18|RETREG2|RETSAT|REV1|RFTN2|RFX8|RGPD1|RGPD2|RGPD3|RGPD4|RGPD5|RGPD6|RGPD8|RHBDD1|RHOB|RHOQ|RIF1|RMDN2|RMND5A|RNASEH1|RND3|RNF103|RNF103-CHMP3|RNF144A|RNF149|RNF181|RNF25|RNPEPL1|RNU4ATAC|ROCK2|RPE|RPIA|RPL31|RPL37A|RPRM|RPS27A|RPS7|RRM2|RSAD2|RTKN|RTN4|RUFY4|SAG|SANBR|SAP130|SATB2|SCG2|SCLY|SCN1A|SCN2A|SCN3A|SCN7A|SCN9A|SCRN3|SCTR|SDC1|SELENOI|SEMA4C|SEMA4F|SEPTIN10|SEPTIN2|SERPINE2|SERTAD2|SESTD1|SF3B1|SF3B6|SFT2D3|SFTPB|SFXN5|SGO2|SGPP2|SH2D6|SH3BP4|SH3YL1|SIX2|SIX3|SLC11A1|SLC16A14|SLC19A3|SLC1A4|SLC20A1|SLC23A3|SLC25A12|SLC30A3|SLC30A6|SLC35F5|SLC35F6|SLC38A11|SLC39A10|SLC3A1|SLC40A1|SLC4A10|SLC4A1AP|SLC4A3|SLC4A5|SLC5A6|SLC5A7|SLC66A3|SLC8A1|SLC9A2|SLC9A4|SMARCAL1|SMC6|SMPD4|SMYD1|SMYD5|SNED1|SNORC|SNORD20|SNORD82|SNRNP200|SNRNP27|SNRPG|SNTG2|SNX17|SOCS5|SOS1|SOS1-IT1|SOWAHC|SOX11|SP100|SP110|SP140|SP140L|SP3|SP5|SP9|SPAG16|SPAST|SPATA3|SPATA31H1|SPATS2L|SPC25|SPDYA|SPEG|SPHKAP|SPMIP9|SPOPL|SPP2|SPR|SPRED2|SPTBN1|SRBD1|SRD5A2|SRSF7|SSB|ST3GAL5|ST6GAL2|STAM2|STAMBP|STARD7|STAT1|STAT4|STEAP3|STK11IP|STK16|STK17B|STK25|STK36|STK39|STON1|STON1-GTF2A1L|STPG4|STRADB|STRN|SUCLG1|SULT1C2|SULT1C3|SULT1C4|SULT6B1|SUMO1|SUPT7L|TACR1|TAF1B|TANC1|TANK|TBC1D8|TBR1|TCF23|TCF7L1|TDRD15|TEKT4|TET3|TEX261|TEX44|TFCP2L1|TFPI|TGFA|TGFBRAP1|TGOLN2|THADA|THAP4|THNSL2|THSD7B|THUMPD2|TIA1|TIGD1|TLK1|TLX2|TM4SF20|TMBIM1|TMEFF2|TMEM127|TMEM131|TMEM150A|TMEM163|TMEM169|TMEM17|TMEM177|TMEM178A|TMEM18|TMEM182|TMEM185B|TMEM198|TMEM214|TMEM237|TMEM247|TMEM37|TMEM87B|TMSB10|TNFAIP6|TNP1|TNS1|TOGARAM2|TP53I3|TPO|TPRKB|TRABD2A|TRAF3IP1|TRAK2|TRAPPC12|TRIB2|TRIM43|TRIM43B|TRIM54|TRIP12|TRMT61B|TRPM8|TSGA10|TSN|TSPYL6|TTC21B|TTC27|TTC31|TTC32|TTC7A|TTL|TTLL4|TTN|TUBA3D|TUBA3E|TUBA4A|TWIST2|TXNDC9|TYW5|UBE2E3|UBE2F|UBR3|UBXN2A|UBXN4|UCN|UGGT1|UGP2|UGT1A1|UGT1A10|UGT1A3|UGT1A4|UGT1A5|UGT1A6|UGT1A7|UGT1A8|UGT1A9|UNC50|UNC80|UPP2|USP34|USP37|USP39|USP40|UXS1|VAMP5|VAMP8|VAX2|VIL1|VIT|VPS54|VRK2|VSNL1|VWA3B|VWC2L|WBP1|WDCP|WDFY1|WDPCP|WDR12|WDR33|WDR35|WDR43|WDR54|WDR75|WDSUB1|WIPF1|WNT10A|WNT6|XDH|XIRP2|XPO1|XRCC5|YIPF4|YPEL5|YWHAQ|ZAP70|ZC3H15|ZC3H6|ZC3H8|ZDBF2|ZNF512|ZEB2|ZFAND2B|ZFP36L2|ZNF142|ZNF2|ZNF385B|ZNF513|ZNF514|ZNF638|ZNF804A|ZNF806|ZNG1B|ZRANB3|ZSWIM2|AAK1|AAMP|ABCA12|ABCB11|ABCB6|ABCG5|ABCG8|ABHD1|ABI2|ACADL|ACKR3|ACMSD|ACOXL|ACP1|ACSL3|ACTG2|ACTR1B|ACTR2|ACTR3|ACVR1|ACVR1C|ACVR2A|ACYP2|ADAM17|ADAM23|ADCY3|ADD2|ADGRF3|ADI1|ADRA2B|AFF3|AFTPH|AGAP1|AGBL5|AGFG1|AGPS|AGXT|ALK|ALKAL2|ALLC|ALMS1|ALPG|ALPI|ALPP|ALS2|AMER3|AMMECR1L|ANAPC1|ANKAR|ANKMY1|ANKRD23|ANKRD36|ANKRD36B|ANKRD36C|ANKRD39|ANKRD44|ANKRD53|ANKZF1|ANO7|ANTXR1|ANXA4|AOX1|AP1S3|APLF|APOB|AQP12A|AQP12B|ARHGAP15|ARHGAP25|ARHGEF33|ARHGEF4|ARID5A|ARL4C|ARL5A|ARL6IP6|ARMC9|ARPC2|ASAP2|ASB1|ASB18|ASB3|ASIC4|ASNSD1|ASPRV1|ASTL|ASXL2|ATAD2B|ATF2|ATG16L1|ATG4B|ATG9A|ATIC|ATL2|ATOH8|ATP5MC3|ATP6V1B1|ATP6V1C2|ATP6V1E2|ATRAID|AUP1|B3GALT1|B3GNT2|B3GNT7|BABAM2|BARD1|BAZ2B|BBS5|BCL11A|BCL2L11|BCS1L|BCYRN1|BIN1|BIRC6|BMP10|BMPR2|BOK|BOLA3|BOLL|BUB1|BZW1|C1D|C1QL2|C2CD6|C2orf15|C2orf42|C2orf48|C2orf49|C2orf66|C2orf68|C2orf69|C2orf72|C2orf74|C2orf76|C2orf78|C2orf80|C2orf81|C2orf83|C2orf88|CAB39|CACNB4|CAD|CALCRL|CALM2|CAMKMT|CAPG|CAPN10|CAPN13|CAPN14|CARF|CASP10|CASP8|CATIP|CAVIN2|CCDC115|CCDC121|CCDC138|CCDC140|CCDC141		See cases	VCV000442998	2	12771 - 242783384			442998	436660			copy number gain		Pathogenic	Jul 14, 2015	no assertion criteria provided							
GRCh37/hg19 2p25.3-q37.3(chr2:12771-242783384)x3	AAK1|AAMP|ABCA12|ABCB11|ABCB6|ABCG5|ABCG8|ABHD1|ABI2|ACADL|ACKR3|ACMSD|ACOXL|ACP1|ACSL3|ACTG2|ACTR1B|ACTR2|ACTR3|ACVR1|ACVR1C|ACVR2A|ACYP2|ADAM17|ADAM23|ADCY3|ADD2|ADGRF3|ADI1|ADRA2B|AFF3|AFTPH|AGAP1|AGBL5|AGFG1|AGPS|AGXT|ALK|ALKAL2|ALLC|ALMS1|ALPG|ALPI|ALPP|ALS2|AMER3|AMMECR1L|ANAPC1|ANKAR|ANKMY1|ANKRD23|ANKRD36|ANKRD36B|ANKRD36C|ANKRD39|ANKRD44|ANKRD53|ANKZF1|ANO7|ANTXR1|ANXA4|AOX1|AP1S3|APLF|APOB|AQP12A|AQP12B|ARHGAP15|ARHGAP25|ARHGEF33|ARHGEF4|ARID5A|ARL4C|ARL5A|ARL6IP6|ARMC9|ARPC2|ASAP2|ASB1|ASB18|ASB3|ASIC4|ASNSD1|ASPRV1|ASTL|ASXL2|ATAD2B|ATF2|ATG16L1|ATG4B|ATG9A|ATIC|ATL2|ATOH8|ATP5MC3|ATP6V1B1|ATP6V1C2|ATP6V1E2|ATRAID|AUP1|B3GALT1|B3GNT2|B3GNT7|BABAM2|BARD1|BAZ2B|BBS5|BCL11A|BCL2L11|BCS1L|BCYRN1|BIN1|BIRC6|BMP10|BMPR2|BOK|BOLA3|BOLL|BUB1|BZW1|C1D|C1QL2|C2CD6|C2orf15|C2orf42|C2orf48|C2orf49|C2orf66|C2orf68|C2orf69|C2orf72|C2orf74|C2orf76|C2orf78|C2orf80|C2orf81|C2orf83|C2orf88|CAB39|CACNB4|CAD|CALCRL|CALM2|CAMKMT|CAPG|CAPN10|CAPN13|CAPN14|CARF|CASP10|CASP8|CATIP|CAVIN2|CCDC115|CCDC121|CCDC138|CCDC140|CCDC141|CCDC142|CCDC148|CCDC150|CCDC74A|CCDC74B|CCDC85A|CCDC88A|CCDC93|CCL20|CCNT2|CCNYL1|CCT4|CCT7|CD207|CD28|CD302|CD8A|CD8B|CDC42EP3|CDCA7|CDK15|CDK5R2|CDKL4|CDRT15P3|CEBPZ|CENPA|CENPO|CEP68|CERKL|CERS6|CFAP210|CFAP36|CFAP65|CFC1|CFC1B|CFLAR|CGREF1|CHAC2|CHCHD5|CHMP3|CHN1|CHPF|CHRNA1|CHRND|CHRNG|CHST10|CIAO1|CIB4|CIMIP2C|CIMIP5|CIMIP6|CIR1|CKAP2L|CLASP1|CLEC4F|CLHC1|CLIP4|CLK1|CMKLR2|CMPK2|CNGA3|CNNM3|CNNM4|CNOT11|CNOT9|CNPPD1|CNRIP1|CNTNAP5|COA5|COBLL1|COL3A1|COL4A3|COL4A4|COL5A2|COL6A3|COLEC11|COMMD1|COPS7B|COPS8|COPS9|COQ10B|COX5B|COX7A2L|CPO|CPS1|CPSF3|CRACDL|CREB1|CREG2|CRIM1|CRIPT|CRYBA2|CRYGA|CRYGB|CRYGC|CRYGD|CSRNP3|CTDSP1|CTLA4|CTNNA2|CUL3|CWC22|CXCR1|CXCR2|CXCR4|CYBRD1|CYP1B1|CYP20A1|CYP26B1|CYP27A1|CYP27C1|CYRIA|CYS1|CYTIP|D2HGDH|DAPL1|DARS1|DAW1|DBI|DCAF17|DCDC2C|DCTN1|DDX1|DDX18|DES|DGKD|DGUOK|DHRS9|DHX57|DIRC1|DIRC3|DIS3L2|DLX1|DLX2|DNAAF10|DNAH6|DNAH7|DNAJB2|DNAJB3|DNAJC10|DNAJC27|DNAJC5G|DNER|DNMT3A|DNPEP|DOCK10|DOK1|DPP10|DPP4|DPY30|DPYSL5|DQX1|DRC1|DTNB|DTYMK|DUSP11|DUSP19|DUSP2|DUSP28|DYNC1I2|DYNC2LI1|DYSF|DYTN|E2F6|ECEL1|ECRG4|EDAR|EEF1B2|EFEMP1|EFHD1|EFR3B|EGR4|EHBP1|EHD3|EIF2AK2|EIF2AK3|EIF2B4|EIF4E2|EIF5B|EIPR1|ELMOD3|EMILIN1|EML4|EML6|EMX1|EN1|EPAS1|EPB41L5|EPC2|EPCAM|EPHA4|ERBB4|ERCC3|ERFE|ERICH2|ERLEC1|ERMN|ESPNL|ETAA1|EVA1A|EVX2|EXOC6B|FABP1|FAHD2A|FAHD2B|FAM110C|FAM117B|FAM124B|FAM136A|FAM161A|FAM168B|FAM171B|FAM178B|FAM228A|FAM228B|FAM98A|FANCL|FAP|FARP2|FARSB|FASTKD1|FASTKD2|FBLN7|FBXO11|FBXO36|FBXO41|FBXO48|FER1L5|FEV|FEZ2|FHL2|FIGLA|FIGN|FKBP1B|FKBP7|FLACC1|FMNL2|FN1|FNDC4|FOSL2|FOXD4L1|FOXI3|FOXN2|FRZB|FSHR|FSIP2|FTCDNL1|FZD5|FZD7|G6PC2|GAD1|GAL3ST2|GALM|GALNT13|GALNT14|GALNT3|GALNT5|GAREM2|GBX2|GCA|GCC2|GCFC2|GCG|GCKR|GDF7|GEMIN6|GEN1|GFPT1|GGCX|GIGYF2|GKN1|GKN2|GLB1L|GLI2|GLS|GMCL1|GMPPA|GNLY|GORASP2|GPAT2|GPATCH11|GPBAR1|GPC1|GPD2|GPN1|GPR148|GPR155|GPR17|GPR35|GPR39|GPR45|GPR55|GPR75|GPR75-ASB3|GRB14|GREB1|GRHL1|GTDC1|GTF2A1L|GTF3C2|GTF3C3|GULP1|GYPC|HAAO|HADHA|HADHB|HAT1|HDAC4|HDLBP|HEATR5B|HECW2|HES6|HIBCH|HJURP|HK2|HNMT|HNRNPA3|HNRNPLL|HOXD1|HOXD10|HOXD11|HOXD12|HOXD13|HOXD3|HOXD4|HOXD8|HOXD9|HPCAL1|HS1BP3|HS6ST1|HSPD1|HSPE1|HTR2B|HTRA2|HYCC2|IAH1|ICA1L|ICOS|ID2|IDH1|IFIH1|IFT172|IFT70A|IFT70B|IGFBP2|IGFBP5|IGKC|IHH|IKZF2|IL18R1|IL18RAP|IL1A|IL1B|IL1F10|IL1R1|IL1R2|IL1RL1|IL1RL2|IL1RN|IL36A|IL36B|IL36G|IL36RN|IL37|ILKAP|IMMT|IMP4|ING5|INHA|INHBB|INO80B|INO80D|INPP1|INPP4A|INSIG2|IQCA1|IRS1|ITGA4|ITGA6|ITGAV|ITGB1BP1|ITGB6|ITM2C|ITPRID2|ITPRIPL1|ITSN2|IWS1|KANSL1L|KANSL3|KCMF1|KCNE4|KCNF1|KCNG3|KCNH7|KCNIP3|KCNJ13|KCNJ3|KCNK12|KCNK3|KCNS3|KCTD18|KDM3A|KHK|KIDINS220|KIF1A|KIF3C|KLF11|KLF7|KLHL23|KLHL29|KLHL30|KLHL41|KRCC1|KRTCAP3|KYNU|LANCL1|LAPTM4A|LBH|LBX2|LCLAT1|LCT|LDAH|LGALSL|LHCGR|LIMS1|LIMS2|LIMS3|LIMS4|LINC00570|LINC01873|LINC02898|LINC03124|LIPT1|LMAN2L|LNPK|LONRF2|LOXL3|LPIN1|LRATD1|LRP1B|LRP2|LRPPRC|LRRFIP1|LRRTM1|LRRTM4|LTBP1|LY75|LY75-CD302|LYG1|LYG2|LYPD1|LYPD6|LYPD6B|M1AP|MAB21L4|MAIP1|MAL|MALL|MAP2|MAP3K19|MAP3K2|MAP3K20|MAP4K3|MAP4K4|MAPRE3|MARCHF4|MARCHF7|MARCO|MARS2|MAT2A|MATN3|MBD5|MBOAT2|MCEE|MCFD2|MCM6|MDH1|MDH1B|MEIS1|MEMO1|MERTK|METAP1D|METTL21A|METTL5|METTL8|MFF|MFSD2B|MFSD6|MFSD9|MGAT4A|MGAT5|MIR10B|MIR1258|MIR128-1|MIR149|MIR216A|MIR217|MIR26B|MIR375|MITD1|MLPH|MMADHC|MOB1A|MOB4|MOGAT1|MOGS|MORN2|MPHOSPH10|MPP4|MPV17|MREG|MROH2A|MRPL19|MRPL30|MRPL33|MRPL35|MRPL44|MRPL53|MRPS5|MRPS9|MSGN1|MSH2|MSH2-OT1|MSH6|MSTN|MTA3|MTERF4|MTHFD2|MTIF2|MTX2|MXD1|MYCN|MYCNOS|MYL1|MYO1B|MYO3B|MYO7B|MYT1L|MZT2A|MZT2B|NAB1|NABP1|NAGK|NAT8|NAT8B|NBAS|NBEAL1|NCAPH|NCK2|NCKAP1|NCKAP5|NCL|NCOA1|NDUFA10|NDUFAF7|NDUFB3|NDUFS1|NEB|NEMP2|NEU2|NEU4|NEUROD1|NFE2L2|NFU1|NGEF|NHEJ1|NIF3L1|NIFK|NLRC4|NMI|NMS|NMUR1|NOL10|NOP58|NOSTRIN|NOTO|NPAS2|NPHP1|NPPC|NR4A2|NRBP1|NRP2|NRXN1|NT5C1B|NT5C1B-RDH14|NT5DC4|NTSR2|NUP35|NXPH2|NYAP2|OBSL1|ODC1|OLA1|OR6B2|OR6B3|ORC2|ORC4|ORMDL1|OSBPL6|OSGEPL1|OSR1|OST4|OTOF|OTOS|OTX1|OXER1|PAIP2B|PAPOLG|PARD3B|PASK|PAX3|PAX8|PCARE|PCBP1|PCGEM1|PCGF1|PCYOX1|PDCL3|PDE11A|PDE1A|PDE6D|PDIA6|PDK1|PECR|PELI1|PER2|PEX13|PFN4|PGAP1|PHOSPHO2|PID1|PIGF|PIKFYVE|PJVK|PKDCC|PKP4|PLA2R1|PLB1|PLCD4|PLCL1|PLEK|PLEKHA3|PLEKHB2|PLEKHH2|PLEKHM3|PLGLB1|PMS1|PNKD|PNO1|PNPT1|POLE4|POLR1A|POLR1B|POLR2D|POMC|POTEE|POTEF|POTEI|POTEJ|POU3F3|PPIG|PPIL3|PPM1B|PPM1G|PPP1CB|PPP1R1C|PPP1R21|PPP1R7|PPP3R1|PPP4R3B|PRADC1|PREB|PREPL|PRKAG3|PRKCE|PRKD3|PRKRA|PRLH|PROC|PROKR1|PROM2|PRPF40A|PRR21|PRR30|PRSS56|PSD4|PSMD1|PSMD14|PSME4|PTCD3|PTH2R|PTMA|PTPN18|PTPN4|PTPRN|PTRHD1|PUM2|PUS10|PXDN|QPCT|R3HDM1|RAB10|RAB11FIP5|RAB17|RAB1A|RAB3GAP1|RAB6C|RABL2A|RAD51AP2|RALB|RAMP1|RANBP2|RAPGEF4|RAPH1|RASGRP3|RBKS|RBM43|RBM44|RBM45|RBMS1|RDH14|REEP1|REG1A|REG1B|REG3A|REG3G|REL|RESP18|RETREG2|RETSAT|REV1|RFTN2|RFX8|RGPD1|RGPD2|RGPD3|RGPD4|RGPD5|RGPD6|RGPD8|RHBDD1|RHOB|RHOQ|RIF1|RMDN2|RMND5A|RNASEH1|RND3|RNF103|RNF103-CHMP3|RNF144A|RNF149|RNF181|RNF25|RNPEPL1|RNU4ATAC|ROCK2|RPE|RPIA|RPL31|RPL37A|RPRM|RPS27A|RPS7|RRM2|RSAD2|RTKN|RTN4|RUFY4|SAG|SANBR|SAP130|SATB2|SCG2|SCLY|SCN1A|SCN2A|SCN3A|SCN7A|SCN9A|SCRN3|SCTR|SDC1|SELENOI|SEMA4C|SEMA4F|SEPTIN10|SEPTIN2|SERPINE2|SERTAD2|SESTD1|SF3B1|SF3B6|SFT2D3|SFTPB|SFXN5|SGO2|SGPP2|SH2D6|SH3BP4|SH3YL1|SIX2|SIX3|SLC11A1|SLC16A14|SLC19A3|SLC1A4|SLC20A1|SLC23A3|SLC25A12|SLC30A3|SLC30A6|SLC35F5|SLC35F6|SLC38A11|SLC39A10|SLC3A1|SLC40A1|SLC4A10|SLC4A1AP|SLC4A3|SLC4A5|SLC5A6|SLC5A7|SLC66A3|SLC8A1|SLC9A2|SLC9A4|SMARCAL1|SMC6|SMPD4|SMYD1|SMYD5|SNED1|SNORC|SNORD20|SNORD82|SNRNP200|SNRNP27|SNRPG|SNTG2|SNX17|SOCS5|SOS1|SOS1-IT1|SOWAHC|SOX11|SP100|SP110|SP140|SP140L|SP3|SP5|SP9|SPAG16|SPAST|SPATA3|SPATA31H1|SPATS2L|SPC25|SPDYA|SPEG|SPHKAP|SPMIP9|SPOPL|SPP2|SPR|SPRED2|SPTBN1|SRBD1|SRD5A2|SRSF7|SSB|ST3GAL5|ST6GAL2|STAM2|STAMBP|STARD7|STAT1|STAT4|STEAP3|STK11IP|STK16|STK17B|STK25|STK36|STK39|STON1|STON1-GTF2A1L|STPG4|STRADB|STRN|SUCLG1|SULT1C2|SULT1C3|SULT1C4|SULT6B1|SUMO1|SUPT7L|TACR1|TAF1B|TANC1|TANK|TBC1D8|TBR1|TCF23|TCF7L1|TDRD15|TEKT4|TET3|TEX261|TEX44|TFCP2L1|TFPI|TGFA|TGFBRAP1|TGOLN2|THADA|THAP4|THNSL2|THSD7B|THUMPD2|TIA1|TIGD1|TLK1|TLX2|TM4SF20|TMBIM1|TMEFF2|TMEM127|TMEM131|TMEM150A|TMEM163|TMEM169|TMEM17|TMEM177|TMEM178A|TMEM18|TMEM182|TMEM185B|TMEM198|TMEM214|TMEM237|TMEM247|TMEM37|TMEM87B|TMSB10|TNFAIP6|TNP1|TNS1|TOGARAM2|TP53I3|TPO|TPRKB|TRABD2A|TRAF3IP1|TRAK2|TRAPPC12|TRIB2|TRIM43|TRIM43B|TRIM54|TRIP12|TRMT61B|TRPM8|TSGA10|TSN|TSPYL6|TTC21B|TTC27|TTC31|TTC32|TTC7A|TTL|TTLL4|TTN|TUBA3D|TUBA3E|TUBA4A|TWIST2|TXNDC9|TYW5|UBE2E3|UBE2F|UBR3|UBXN2A|UBXN4|UCN|UGGT1|UGP2|UGT1A1|UGT1A10|UGT1A3|UGT1A4|UGT1A5|UGT1A6|UGT1A7|UGT1A8|UGT1A9|UNC50|UNC80|UPP2|USP34|USP37|USP39|USP40|UXS1|VAMP5|VAMP8|VAX2|VIL1|VIT|VPS54|VRK2|VSNL1|VWA3B|VWC2L|WBP1|WDCP|WDFY1|WDPCP|WDR12|WDR33|WDR35|WDR43|WDR54|WDR75|WDSUB1|WIPF1|WNT10A|WNT6|XDH|XIRP2|XPO1|XRCC5|YIPF4|YPEL5|YWHAQ|ZAP70|ZC3H15|ZC3H6|ZC3H8|ZDBF2|ZNF512|ZEB2|ZFAND2B|ZFP36L2|ZNF142|ZNF2|ZNF385B|ZNF513|ZNF514|ZNF638|ZNF804A|ZNF806|ZNG1B|ZRANB3|ZSWIM2		See cases	VCV000442997	2	12771 - 242783384			442997	436659			copy number gain		Pathogenic	Dec 2, 2014	no assertion criteria provided							
GRCh37/hg19 2p23.2(chr2:29317927-29706226)x1	ALK|CLIP4		See cases	VCV000442879	2	29317927 - 29706226			442879	436541			copy number loss		Uncertain significance	Jul 15, 2015	no assertion criteria provided							
GRCh37/hg19 2p23.2-23.1(chr2:28306106-30052309)x3	ALK|BABAM2|CLIP4|FOSL2|PCARE|PLB1|PPP1CB|SPDYA|TOGARAM2|TRMT61B|WDR43		See cases	VCV000442481	2	28306106 - 30052309			442481	436143			copy number gain		Uncertain significance	Oct 21, 2014	no assertion criteria provided							
GRCh37/hg19 2p23.3-16.1(chr2:27861707-60790985)x3	ABCG5|ABCG8|ACYP2|ALK|ARHGEF33|ASB3|ATL2|ATP6V1E2|BABAM2|BCL11A|BCYRN1|BIRC6|C2orf73|CALM2|CAMKMT|CAPN13|CAPN14|CCDC85A|CCDC88A|CDC42EP3|CDKL4|CEBPZ|CFAP36|CHAC2|CLHC1|CLIP4|COX7A2L|CRIM1|CRIPT|CYP1B1|DHX57|DPY30|DYNC2LI1|EFEMP1|EHD3|EIF2AK2|EML4|EML6|EPAS1|EPCAM|ERLEC1|FAM98A|FANCL|FBXO11|FEZ2|FOSL2|FOXN2|FSHR|GALM|GALNT14|GEMIN6|GPATCH11|GPN1|GPR75|GPR75-ASB3|GTF2A1L|HAAO|HEATR5B|HNRNPLL|KCNG3|KCNK12|LBH|LCLAT1|LHCGR|LINC02898|LRPPRC|LTBP1|MAP4K3|MCFD2|MEMO1|MIR216A|MIR217|MORN2|MRPL33|MSH2|MSH2-OT1|MSH6|MTA3|MTIF2|NDUFAF7|NLRC4|NRXN1|OXER1|PCARE|PIGF|PKDCC|PLB1|PLEKHH2|PNPT1|PPM1B|PPP1CB|PPP1R21|PPP4R3B|PREPL|PRKCE|PRKD3|PSME4|QPCT|RASGRP3|RBKS|RHOQ|RMDN2|RPS27A|RTN4|SIX2|SIX3|SLC30A6|SLC3A1|SLC4A1AP|SLC8A1|SOCS5|SOS1|SOS1-IT1|SPAST|SPDYA|SPTBN1|SRBD1|SRD5A2|SRSF7|STON1|STON1-GTF2A1L|STPG4|STRN|SULT6B1|SUPT7L|THADA|THUMPD2|TMEM178A|TMEM247|TOGARAM2|TRMT61B|TSPYL6|TTC27|TTC7A|VIT|VRK2|WDR43|XDH|YIPF4|YPEL5|ZFP36L2		See cases	VCV000402127	2	27861707 - 60790985			402127	389099			copy number gain		Pathogenic	Dec 2, 2016	criteria provided, single submitter							
GRCh37/hg19 2p23.2-21(chr2:28069882-43543420)x3	ALK|ARHGEF33|ATL2|BABAM2|BIRC6|CAPN13|CAPN14|CDC42EP3|CDKL4|CEBPZ|CLIP4|COX7A2L|CRIM1|CYP1B1|DHX57|DPY30|EHD3|EIF2AK2|EML4|FAM98A|FEZ2|FOSL2|GALM|GALNT14|GEMIN6|GPATCH11|HAAO|HEATR5B|HNRNPLL|KCNG3|LBH|LCLAT1|LINC02898|LTBP1|MAP4K3|MEMO1|MORN2|MTA3|NDUFAF7|NLRC4|OXER1|PCARE|PKDCC|PLB1|PPP1CB|PRKD3|QPCT|RASGRP3|RBKS|RMDN2|SLC30A6|SLC8A1|SOS1|SOS1-IT1|SPAST|SPDYA|SRD5A2|SRSF7|STRN|SULT6B1|THADA|THUMPD2|TMEM178A|TOGARAM2|TRMT61B|TTC27|VIT|WDR43|XDH|YIPF4|YPEL5|ZFP36L2		See cases	VCV000394466	2	28069882 - 43543420			394466	381359			copy number gain		Pathogenic		no assertion criteria provided							
NM_004304.5(ALK):c.829T>C (p.Ser277Pro)	ALK	S277P	not provided	VCV003361645					3361645	3520855			single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2023	criteria provided, single submitter							
NM_004304.5(ALK):c.2050_2075del (p.Leu684fs)	ALK	L684fs	not provided	VCV003359933					3359933	3519144			Deletion	frameshift variant	Uncertain significance	Jun 21, 2023	criteria provided, single submitter							
inv(2)(p23.1p23.2)	ALK		Glioblastoma	VCV001177131					1177131	1166552			Inversion		Uncertain significance		no assertion criteria provided							
PRRC2B-ALK fusion	ALK|PRRC2B		epithelioid tumor of the omentum	VCV001012364					1012364	1000083			Translocation		other	Oct 20, 2019	criteria provided, single submitter							
t(2;3)(p12;p14.3)	ALK|SLMAP		Lung carcinoma	VCV000627530					627530	615885			Translocation		Pathogenic	Apr 17, 2019	no assertion criteria provided							
